data_2hfd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hfd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 40.0 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 15.3 Cg_endo -58.25 -63.58 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.068 1.845 . . . . 0.0 112.311 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.475 ' HE1' ' HG ' ' A' ' 42' ' ' SER . 86.9 t80 -64.53 -35.81 82.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 110.186 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.03 -51.49 67.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.613 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -64.64 -46.91 80.5 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.552 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 52' ' ' SER . 70.3 mt -55.38 -46.14 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.496 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 12.8 t90 -62.25 -50.64 70.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -58.51 -32.94 69.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.892 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 4.6 mmp_? -61.29 -57.34 12.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 111.166 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.576 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.8 ptt? -70.79 -29.34 65.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.8 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.817 HD23 ' HG3' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -57.42 -46.4 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.085 0.469 . . . . 0.0 109.897 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.72 -10.12 57.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.863 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HD2' ' HA ' ' A' ' 14' ' ' MET . 50.7 mtt180 -84.89 -5.19 59.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 0.0 110.995 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.19 21.65 8.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.144 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.41 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 52.8 m0 -97.14 115.26 27.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.32 140.82 85.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.154 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.817 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 Cg_exo -76.72 141.76 22.18 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.052 2.501 . . . . 0.0 111.48 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 73' ' ' ALA . 14.2 p -123.28 142.11 41.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.897 0.379 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -102.45 165.1 11.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HA ' HG12 ' A' ' 83' ' ' ILE . 3.4 tm-20 -57.21 -55.76 30.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -70.68 -13.39 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.031 0.443 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 26' ' ' ARG . 21.2 mmt180 -96.19 -8.13 33.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.674 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.564 HD21 HG23 ' A' ' 39' ' ' VAL . 3.0 tm? -66.77 -41.34 87.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.32 -37.83 80.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.854 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -60.92 -55.97 26.62 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.039 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -43.32 68.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.181 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.29 -44.74 84.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.914 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -83.3 -26.99 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.705 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -81.66 -29.75 33.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.53 141.58 28.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.0 111.452 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 8.2 Cg_exo -72.47 -38.38 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.577 2.184 . . . . 0.0 111.045 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -160.15 169.18 23.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.637 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.46 -179.63 31.29 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.092 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 HG13 ' HB ' ' A' ' 97' ' ' VAL . 16.9 m -137.07 145.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HD21 ' A' ' 27' ' ' LEU . 45.2 t -119.0 125.24 74.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.402 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.555 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.8 mp -98.8 116.44 31.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD11 HD12 ' A' ' 96' ' ' LEU . 9.7 mp -98.24 116.06 29.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.475 ' HG ' ' HE1' ' A' ' 7' ' ' PHE . 32.3 t . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.982 0.42 . . . . 0.0 110.942 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 54' ' ' ASN . 46.8 t . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.657 0.265 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' ASN . 17.8 t70 72.42 -22.26 0.22 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.206 1.002 . . . . 0.0 112.599 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 9.6 t30 83.05 99.54 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 123.572 0.749 . . . . 0.0 110.604 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.76 17.67 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 123.983 3.122 . . . . 0.0 114.599 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.23 -41.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -64.26 -24.79 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.247 -176.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.561 HD12 HD22 ' A' ' 116' ' ' LEU . 47.9 mm -67.74 -38.14 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.462 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.05 -49.32 58.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.222 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.66 -28.61 69.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.509 HD21 ' HG ' ' A' ' 116' ' ' LEU . 66.8 tp -60.87 -56.95 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 110.922 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.5 mp -62.23 -29.92 70.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.248 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -75.05 -7.71 54.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -78.04 -6.87 55.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.086 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.81 78.85 9.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.437 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.06 -12.09 21.38 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.592 2.195 . . . . 0.0 113.081 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.44 -25.28 63.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.524 0.678 . . . . 0.0 110.315 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -103.56 120.72 41.43 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.539 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 p -80.66 103.29 10.41 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.418 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.53 ' HB3' HD23 ' A' ' 62' ' ' LEU . 96.8 m95 -83.9 100.39 10.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.094 -173.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.09 107.19 15.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.566 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -87.65 114.07 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.691 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -110.75 124.61 52.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.555 HG23 ' HB2' ' A' ' 40' ' ' LEU . 8.5 pt -110.34 139.76 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.015 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.42 154.85 21.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.169 0.509 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' HB3' ' CG ' ' A' ' 79' ' ' GLN . 7.1 t70 -65.94 162.99 18.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.198 174.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.22 -53.04 62.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.15 -24.57 62.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.251 0.548 . . . . 0.0 110.228 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.473 ' CG ' ' HB3' ' A' ' 76' ' ' ASP . 89.3 mm-40 -76.08 -37.76 57.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.596 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.6 m -59.23 -42.72 91.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -62.45 -42.78 99.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.577 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.13 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.503 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 24' ' ' GLU . 80.2 mt -67.99 -43.77 85.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.351 . . . . 0.0 110.118 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.87 -46.11 94.04 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.636 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.4 -47.32 72.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.014 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.35 -31.17 71.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.732 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -87.77 -34.16 18.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.005 0.431 . . . . 0.0 110.675 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.31 45.09 1.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.145 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 90' ' ' PHE . 3.5 p -100.83 167.82 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' H ' HG23 ' A' ' 89' ' ' VAL . 18.6 m-85 -79.84 -67.61 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.683 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -179.61 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.658 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 90.9 m-85 -51.06 117.22 8.44 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.882 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 5.4 Cg_exo -79.44 132.46 10.09 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.377 2.718 . . . . 0.0 111.889 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.24 -175.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.726 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 m -92.86 109.96 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.806 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.497 HD12 HD11 ' A' ' 41' ' ' LEU . 6.2 mp -96.06 125.86 40.89 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.926 HG13 ' HB2' ' A' ' 104' ' ' ARG . 2.5 p -104.01 132.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.183 0.516 . . . . 0.0 111.288 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -127.68 135.28 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.111 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 m -145.4 144.7 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.97 35.59 54.12 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.119 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.66 12.7 62.23 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.052 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -122.36 166.87 14.02 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 111.288 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -93.79 120.22 33.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.592 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.926 ' HB2' HG13 ' A' ' 97' ' ' VAL . 25.6 mmt180 -79.15 -55.16 5.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.483 0.658 . . . . 0.0 109.78 176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 123' ' ' LEU . . . 162.38 -166.75 36.66 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.939 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.47 134.37 65.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.089 0.471 . . . . 0.0 110.479 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.27 100.3 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.99 -7.9 52.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.174 0.511 . . . . 0.0 110.517 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.49 144.56 23.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.724 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.0 mm -136.53 -56.82 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.649 0.262 . . . . 0.0 111.566 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.762 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 36.9 t60 -88.02 -61.35 0.24 Allowed Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -168.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 23.5 Cg_exo -62.62 123.85 13.1 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.439 1.426 . . . . 0.0 111.864 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.432 ' O ' HG13 ' A' ' 117' ' ' ILE . 11.4 t-105 -76.49 -48.39 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.069 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.32 75.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 110.788 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 39.6 tt0 -75.64 -40.31 56.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.244 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.561 HD22 HD12 ' A' ' 58' ' ' ILE . 50.1 tp -57.57 -44.4 85.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 61' ' ' LEU . 68.8 mt -58.86 -45.37 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 40.5 t30 -61.68 -42.09 98.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.576 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 92.5 mt -60.32 -48.88 79.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.338 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.426 ' O ' HG23 ' A' ' 124' ' ' VAL . 13.3 tpt -65.93 -36.48 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 109.865 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 60.9 ttt180 -56.36 -45.08 80.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.958 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.88 -30.59 70.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.483 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.532 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 83.2 mt -77.63 -36.66 51.42 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.883 -0.186 . . . . 0.0 111.374 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 120' ' ' MET . 34.5 m -82.02 -39.76 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.262 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 120.934 0.397 . . . . 0.0 110.156 173.42 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.47 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 51.3 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 34.0 Cg_endo -66.74 -36.57 23.93 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 121.83 1.686 . . . . 0.0 111.829 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CE2' ' HB2' ' A' ' 77' ' ' LEU . 85.9 t80 -75.3 -38.12 60.49 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.388 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -50.22 -51.48 43.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.709 0.766 . . . . 0.0 109.377 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.27 -45.95 92.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.747 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -54.69 -52.05 63.62 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 111.459 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.443 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.2 t90 -65.78 -37.88 87.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.218 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.725 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -60.05 -33.56 72.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 28.4 mmt85 -59.38 -55.28 36.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.324 0.583 . . . . 0.0 110.336 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.6 mtm -67.39 -31.63 71.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.325 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -69.38 -34.94 75.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -22.0 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 17' ' ' ARG . 19.3 mmm180 -82.09 -8.88 59.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.594 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.9 10.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.851 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 20.9 m -93.45 122.84 61.96 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 3.7 Cg_exo -81.66 117.74 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.435 2.757 . . . . 0.0 111.179 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.11 151.39 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -81.2 159.77 24.5 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HG3' ' HB2' ' A' ' 79' ' ' GLN . 1.5 mp0 -49.63 -57.01 8.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.543 0.737 . . . . 0.0 112.978 -170.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -63.23 -32.4 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.97 0.414 . . . . 0.0 111.521 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -88.53 -11.81 44.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.405 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.43 -42.26 83.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.52 -38.91 59.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.628 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 32' ' ' THR . 11.2 t70 -57.83 -55.6 32.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.565 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -59.82 -46.55 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.776 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.47 -41.5 94.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.86 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 29' ' ' ASP . 11.9 t -73.16 -25.92 60.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.381 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -89.86 -8.63 51.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.784 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 146.33 32.73 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.409 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.71 -39.17 12.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.404 2.069 . . . . 0.0 112.295 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.6 t70 -166.58 177.34 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.13 30.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.441 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 97' ' ' VAL . 15.8 m -136.51 146.24 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.41 125.11 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.214 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.4 mp -94.47 128.34 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 93' ' ' PRO . 56.0 tp -87.41 136.46 32.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.189 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.432 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 66.3 m . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.09 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.38 -69.21 0.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.883 0.739 . . . . 0.0 110.426 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -148.68 85.21 6.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.559 ' HG3' ' HB3' ' A' ' 13' ' ' ARG . 89.5 Cg_endo -79.44 44.36 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.079 2.52 . . . . 0.0 113.677 -169.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.37 -40.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.747 0.308 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -28.69 70.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.628 -173.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.46 -43.66 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.33 89.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.964 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.28 -28.18 59.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.009 0.433 . . . . 0.0 110.552 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 117' ' ' ILE . 56.8 tp -63.55 -47.26 82.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.738 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.32 -28.29 69.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 23.1 mmt180 -73.3 -7.71 52.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.172 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -64.07 -35.45 80.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.348 0.594 . . . . 0.0 109.626 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -129.14 81.94 69.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.537 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.75 8.49 3.66 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.886 2.391 . . . . 0.0 113.007 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.64 -25.19 62.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 0.0 110.221 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.47 127.02 53.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.967 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.4 p -71.66 108.75 5.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.928 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -80.71 105.58 12.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.264 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 102.43 5.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.82 106.59 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.282 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.46 126.57 53.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 20.3 pt -112.23 140.78 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.869 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.39 145.46 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.602 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.63 ' HB3' ' HG2' ' A' ' 79' ' ' GLN . 21.0 t70 -63.41 160.06 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.657 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 65.8 tp -55.49 -52.95 61.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.205 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.16 -30.87 58.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.905 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.63 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 7.3 pt20 -77.75 -22.92 49.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.068 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 74.0 m -63.03 -29.24 70.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 110.063 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -56.13 -44.78 79.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.257 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.02 -37.13 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.396 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.06 -47.71 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.82 97.68 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.505 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.97 -38.73 79.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -71.19 -31.56 67.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.668 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -91.2 -29.56 17.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.027 0.442 . . . . 0.0 110.899 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.87 29.51 4.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.048 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.39 122.78 64.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -136.38 18.82 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 110.715 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -99.55 -165.41 1.22 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.697 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -53.15 143.19 34.32 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 123.622 0.576 . . . . 0.0 112.319 -175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HA ' HD21 ' A' ' 41' ' ' LEU . 37.9 Cg_endo -65.87 140.4 60.82 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.358 2.705 . . . . 0.0 112.56 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.7 -178.23 7.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.699 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 28.1 m -99.0 120.09 38.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.465 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.55 118.42 31.66 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.447 ' HA ' HG13 ' A' ' 38' ' ' VAL . 7.0 p -100.91 124.47 54.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.244 0.545 . . . . 0.0 110.991 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 46.1 m-85 -123.5 119.34 29.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.421 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 63.6 p -95.61 123.61 39.24 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.15 16.12 47.1 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.974 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.57 63.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.941 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 98' ' ' PHE . 15.5 m-80 -102.28 141.1 35.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.277 0.561 . . . . 0.0 111.293 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -70.74 118.88 14.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.187 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -98.01 -48.17 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.535 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.04 -166.24 36.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.064 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.62 134.59 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 110.597 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 94.7 mt -97.46 119.97 36.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -138.08 129.33 27.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.729 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.54 127.63 1.93 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.67 -44.57 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.144 0.472 . . . . 0.0 112.233 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -97.42 -51.04 0.22 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.78 120.85 8.2 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 120.692 1.283 . . . . 0.0 111.864 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 t-105 -96.68 -37.74 10.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.813 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.203 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -81.5 -27.58 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.613 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 6.0 mt -56.72 -44.77 81.95 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.458 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.461 ' HA ' HD13 ' A' ' 61' ' ' LEU . 63.1 mt -65.3 -42.32 93.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -57.11 -57.45 12.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.628 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.38 -41.27 75.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.576 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 124' ' ' VAL . 14.9 tpt -60.49 -50.42 73.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.445 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -66.89 -35.68 80.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.227 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.17 -29.52 73.14 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.604 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.39 -45.76 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 120' ' ' MET . 21.4 m -78.51 -28.09 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.557 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.649 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 20.9 m . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 119.757 -0.163 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 3.9 Cg_exo -76.72 -67.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.126 1.884 . . . . 0.0 112.5 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -59.73 -35.06 73.78 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 110.648 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.41 -49.9 75.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.588 . . . . 0.0 110.725 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.538 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . . . -65.46 -34.23 77.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.533 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.89 -43.67 87.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.184 0.516 . . . . 0.0 110.074 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -38.1 85.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.807 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.5 -33.56 75.13 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 110.331 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -63.21 -53.62 50.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 109.907 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.432 ' HE3' HG21 ' A' ' 74' ' ' ILE . 74.3 mtp -58.73 -40.11 82.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.697 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.0 -35.38 72.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.347 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.82 68.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.625 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -82.76 2.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.27 -0.68 64.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.97 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -67.93 135.04 51.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 109.752 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.4 m -110.47 130.74 22.57 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.314 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 2.7 Cg_exo -76.8 153.72 33.67 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.267 2.645 . . . . 0.0 112.132 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG13 HD23 ' A' ' 27' ' ' LEU . 13.0 p -148.0 152.48 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.214 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -81.74 158.53 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.253 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -43.61 -61.72 1.31 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.004 0.922 . . . . 0.0 112.854 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.1 m -67.53 -29.25 68.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.69 -171.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 26' ' ' ARG . 5.0 ttp-105 -85.86 -17.34 35.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.859 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 22' ' ' VAL . 3.2 tm? -65.18 -39.65 93.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' HH12 ' A' ' 86' ' ' ARG . 18.7 t70 -62.74 -44.27 96.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.886 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.43 -52.84 63.92 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.212 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -50.67 -49.85 56.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.637 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.0 tp -61.44 -34.85 76.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -89.4 -26.3 21.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 0.0 111.851 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -92.59 -35.25 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . . . -96.28 133.02 25.54 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.315 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.02 140.57 90.64 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.591 2.194 . . . . 0.0 110.985 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 11.9 t70 68.82 -158.4 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 131.66 97.98 0.73 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.261 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.08 141.75 23.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 122.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 74' ' ' ILE . 6.7 mp -99.52 130.56 45.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.172 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -82.11 175.29 10.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 110.987 -177.642 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -54.4 -77.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.468 0.175 . . . . 0.0 111.144 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.0 p30 -171.39 139.19 1.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.67 0.271 . . . . 0.0 110.633 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 86.0 Cg_endo -103.3 42.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.586 2.857 . . . . 0.0 112.193 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.4 t -84.78 -23.13 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.842 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 58' ' ' ILE . 19.7 ptt? -48.35 -47.81 36.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.883 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 ' N ' ' HG3' ' A' ' 57' ' ' MET . 47.8 mm -60.12 -35.03 59.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 110.964 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -66.98 -46.14 76.17 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.753 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -79.22 -36.81 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 110.916 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.739 HD22 ' HG3' ' A' ' 120' ' ' MET . 21.9 tp -63.12 -57.82 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.092 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.92 -29.79 69.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.516 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 8.2 mmt180 -78.6 -6.43 55.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.0 pt-20 -69.25 -12.94 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.58 174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 69.4 m-85 -110.86 82.85 3.23 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 64' ' ' GLU . 3.1 Cg_exo -81.46 -9.9 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.117 2.545 . . . . 0.0 112.825 -174.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.06 -25.42 47.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.482 . . . . 0.0 111.736 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -119.97 137.1 54.26 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 p -86.81 114.18 23.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.752 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.473 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 70.9 m95 -81.87 133.48 35.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.825 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 37.2 mt-30 -105.28 108.51 20.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.396 0.617 . . . . 0.0 110.1 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.39 116.6 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.704 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.92 140.85 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.022 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 32.7 pt -125.47 158.1 34.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.541 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . . . -135.09 156.03 49.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.69 -167.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.217 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.74 -53.68 55.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.509 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.67 -44.78 76.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.137 0.494 . . . . 0.0 110.777 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 2.5 mp0 -61.97 -50.54 71.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.615 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 p -63.33 -43.45 97.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -65.62 -36.48 83.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.053 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.99 -44.09 70.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.01 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 93.0 mt -65.34 -41.93 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.123 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.2 98.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.17 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.75 -40.87 89.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.083 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.636 HH12 ' HB2' ' A' ' 28' ' ' ASP . 48.8 mtp180 -52.94 -40.85 63.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.485 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -90.85 -65.6 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.07 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.72 -15.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.262 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.23 95.0 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.789 0.328 . . . . 0.0 110.175 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -133.49 160.76 36.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 56.1 ttt-85 67.09 6.78 4.96 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.565 0.54 . . . . 0.0 110.711 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -128.64 101.68 20.64 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.242 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.79 126.58 10.19 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.737 2.291 . . . . 0.0 112.516 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.91 -175.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.891 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 36.9 m -101.82 120.03 39.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.276 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.99 118.55 32.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.805 HG11 ' HB2' ' A' ' 104' ' ' ARG . 3.8 p -97.81 121.6 48.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.354 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.85 162.21 19.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.47 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.88 129.69 1.81 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.006 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.78 29.53 73.82 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.842 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.0 -6.46 41.68 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.517 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -98.38 156.9 16.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.297 0.57 . . . . 0.0 111.762 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -93.85 130.45 39.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.5 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.805 ' HB2' HG11 ' A' ' 97' ' ' VAL . 37.2 mmt180 -96.45 -59.89 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.643 0.258 . . . . 0.0 110.726 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.69 -153.7 16.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.132 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 53.6 t -121.23 133.7 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.6 mt -109.34 123.71 49.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.229 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -156.35 128.95 7.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.753 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.33 127.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.827 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.8 mm -114.26 -26.47 2.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 0.0 110.637 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.687 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.1 m80 -98.06 -58.92 0.15 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 6.2 Cg_exo -78.82 119.83 4.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.086 1.191 . . . . 0.0 111.807 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.53 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.1 t-105 -96.67 -48.42 5.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.239 -173.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.2 73.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.479 . . . . 0.0 110.616 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.79 -40.73 54.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.452 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 37.1 tp -58.73 -44.26 90.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.259 . . . . 0.0 110.776 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.0 mt -61.8 -48.93 86.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.614 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -51.59 -56.72 11.91 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.212 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.0 mt -62.03 -40.93 97.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.441 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.739 ' HG3' HD22 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -62.19 -48.68 78.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.846 0.355 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.62 -37.83 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.68 -30.07 76.56 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.432 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 98.3 mt -83.28 -49.03 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.82 -30.56 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.397 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.536 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 27.4 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.536 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 36.8 Cg_endo -68.08 -40.55 8.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.283 1.322 . . . . 0.0 110.729 169.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -65.52 -39.21 91.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.428 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -51.99 67.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 109.578 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.7 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.908 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -54.36 42.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -34.35 77.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -60.98 -38.17 85.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 0.0 110.829 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -61.74 -53.8 51.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.516 0.674 . . . . 0.0 109.977 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 55.7 mtp -60.8 -34.99 75.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.37 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.34 -32.09 62.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.14 -23.28 65.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.216 0.532 . . . . 0.0 110.505 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -79.52 -10.71 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.45 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.81 26.65 44.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -89.68 140.93 29.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.441 . . . . 0.0 110.147 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -92.63 123.36 62.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.054 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HA ' HG13 ' A' ' 74' ' ' ILE . 43.7 Cg_endo -70.69 127.23 13.59 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.774 2.316 . . . . 0.0 111.319 172.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.12 136.74 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.514 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -67.8 161.71 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.499 0.5 . . . . 0.0 112.012 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.36 -60.28 2.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 112.047 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 m -78.43 -10.17 59.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -92.37 -22.2 19.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -44.09 91.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.761 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.99 -39.38 90.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -64.2 -56.32 15.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.102 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -67.68 -33.19 74.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.748 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.18 -42.09 99.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.572 0.225 . . . . 0.0 111.182 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -73.05 -25.85 61.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.756 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.78 -19.19 55.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.35 157.37 58.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.012 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.12 -64.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.438 2.092 . . . . 0.0 111.292 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -142.48 168.11 20.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.07 -178.18 48.7 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.569 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 97' ' ' VAL . 30.3 m -138.72 150.01 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.263 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.97 128.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.65 130.36 44.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.043 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.65 -67.42 0.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.563 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.664 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 49.1 m . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.176 0.512 . . . . 0.0 110.879 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.78 76.64 0.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.543 -174.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.9 t30 63.08 81.67 0.22 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.523 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.94 12.12 1.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.103 2.536 . . . . 0.0 111.944 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.11 -34.16 49.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.711 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -56.7 -30.98 64.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.361 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 62' ' ' LEU . 49.8 mm -61.12 -42.9 95.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 110.681 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.68 -33.93 60.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.349 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.44 -32.01 65.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.63 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 58.6 tp -64.37 -49.15 72.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.312 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 58' ' ' ILE . 9.5 mp -58.68 -26.43 63.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -56.17 -19.03 11.82 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.8 pt-20 -87.01 22.08 2.13 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.631 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 55.3 p90 -67.44 122.29 82.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 38.4 Cg_endo -97.51 -53.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.974 2.45 . . . . 0.0 114.095 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.7 -26.16 17.14 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.561 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.5 p90 -143.54 142.57 31.17 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.538 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 t -86.08 151.27 23.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.472 ' CZ2' ' HE1' ' A' ' 68' ' ' TYR . 91.0 m95 -98.4 119.73 37.6 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.011 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.69 98.52 9.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.52 108.34 18.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.504 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.8 138.3 48.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 21' ' ' PRO . 28.8 pt -118.65 145.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.94 167.58 12.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.47 172.66 10.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.947 173.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.86 -42.83 66.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.08 -44.72 83.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.501 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -70.64 -41.99 71.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.776 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -63.04 -42.26 99.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.296 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.15 -36.66 83.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.008 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.03 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.46 -46.2 90.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.48 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.502 ' HA2' ' HB ' ' A' ' 89' ' ' VAL . . . -57.31 -49.25 74.14 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.728 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.26 -42.7 70.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 111.027 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -73.33 -31.56 64.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.737 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -101.61 -25.76 13.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.551 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.5 2.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.342 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.502 ' HB ' ' HA2' ' A' ' 84' ' ' GLY . 38.8 t -118.11 150.07 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.94 163.21 26.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.928 0.394 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -72.96 -9.37 58.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.914 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -70.34 127.09 92.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.553 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.664 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 17.1 Cg_exo -65.57 124.38 12.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.855 2.37 . . . . 0.0 112.338 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.27 3.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.3 m -109.84 127.12 54.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.43 116.99 29.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.515 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -98.76 126.28 51.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.496 0.665 . . . . 0.0 111.499 -175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -115.15 138.47 50.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -148.4 144.14 27.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.27 19.21 66.08 Favored Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.897 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.26 89.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.496 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -120.51 157.25 29.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -79.12 123.22 27.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.349 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -88.99 -60.28 2.0 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.36 -161.36 24.74 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.691 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.38 134.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.43 105.71 17.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.22 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -117.97 97.52 5.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.489 0.661 . . . . 0.0 110.947 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.6 138.05 5.86 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.54 -33.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.998 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.711 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 m-70 -135.48 -54.58 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 111' ' ' HIS . 6.8 Cg_endo -50.18 120.25 5.97 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.677 1.585 . . . . 0.0 112.532 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.63 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 4.0 t-105 -99.11 -46.64 5.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.535 -170.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 118' ' ' ASN . . . -60.17 -34.56 73.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 110.005 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 17.3 mm-40 -68.87 -47.95 64.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.528 176.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.28 -49.52 76.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.82 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 113' ' ' TRP . 52.1 mt -60.29 -41.39 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 114' ' ' ALA . 31.7 t-20 -53.52 -57.59 10.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.569 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 81.1 mt -68.66 -41.68 78.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.293 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -50.48 73.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.721 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.53 ' HA ' HG21 ' A' ' 124' ' ' VAL . 14.5 ttt85 -69.97 -32.63 70.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.267 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.46 75.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.216 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.2 mt -81.62 -50.32 9.47 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.84 -0.212 . . . . 0.0 111.135 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 121' ' ' ARG . 31.1 m -67.0 -38.95 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.635 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 5.0 Cg_exo -74.42 -52.91 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.138 1.892 . . . . 0.0 111.923 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -65.95 -41.07 91.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -53.25 -53.68 47.29 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.14 -49.3 77.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.229 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 52' ' ' SER . 3.0 mm? -59.2 -46.5 88.27 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.294 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.08 -47.86 78.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -61.48 -40.23 93.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.323 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 47.2 mmm-85 -59.26 -54.47 46.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.488 ' HB2' ' CE3' ' A' ' 19' ' ' TRP . 24.6 ptt? -70.99 -29.26 65.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.312 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 11' ' ' TRP . 34.4 mt -57.23 -39.42 75.48 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.34 65.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.804 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -74.29 -15.07 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.0 111.215 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.24 13.87 20.0 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.563 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 49.2 m0 -82.7 122.01 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.039 0.447 . . . . 0.0 109.832 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.5 m -91.94 132.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.613 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 23.0 Cg_exo -65.02 120.36 7.58 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 111.658 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.5 139.79 24.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.217 0.532 . . . . 0.0 110.916 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 m -92.66 150.22 20.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.096 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.35 -50.79 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.5 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 m -85.23 13.55 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.067 0.46 . . . . 0.0 111.293 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -121.23 -10.92 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.683 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.8 tm? -55.11 -43.8 74.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.472 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.41 -43.09 95.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' THR . 17.5 t70 -61.26 -55.57 30.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -62.5 -40.51 96.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.044 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -70.94 -29.43 65.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -75.01 -27.79 60.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.547 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 35.1 mt-30 -90.7 -44.05 9.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.147 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.35 94.57 11.7 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.923 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 8.2 Cg_exo -72.59 140.84 33.47 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.199 2.599 . . . . 0.0 113.556 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t70 73.91 167.07 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.407 1.067 . . . . 0.0 111.474 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.98 -165.35 24.32 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.023 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.88 152.61 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 122.524 0.33 . . . . 0.0 110.793 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.53 131.5 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.49 138.15 38.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.93 175.97 5.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 111.29 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.232 0.539 . . . . 0.0 110.845 -178.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.1 t70 59.43 -85.85 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.662 0.785 . . . . 0.0 112.741 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -144.03 99.31 5.08 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 111.304 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -95.51 -167.72 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.174 2.583 . . . . 0.0 112.454 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.8 t 75.09 -37.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -53.43 -24.31 12.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' HD11 ' A' ' 62' ' ' LEU . 3.0 mp -58.96 -38.95 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.718 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.7 -38.18 94.26 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.406 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -72.79 -28.48 62.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.745 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.2 tp -61.35 -43.68 98.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.266 0.555 . . . . 0.0 110.347 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 58' ' ' ILE . 6.8 mp -64.67 -27.44 68.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.072 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.49 -17.24 63.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.912 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -70.1 -36.37 74.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.689 0.28 . . . . 0.0 110.611 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -141.49 77.78 19.16 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.095 0.474 . . . . 0.0 110.537 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.0 16.83 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.142 2.562 . . . . 0.0 112.598 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.97 -25.67 67.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.524 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -116.71 166.85 11.65 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 p -85.29 105.49 16.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.921 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -91.44 103.57 16.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.752 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.18 122.2 31.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.199 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.8 t -97.96 107.39 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 124.71 50.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.504 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 30.6 pt -110.42 144.41 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . . . -115.41 153.17 31.54 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.769 -0.372 . . . . 0.0 112.001 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.825 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.3 m-20 -61.88 168.86 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.518 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.09 -49.1 74.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.614 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -66.56 -34.47 77.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.23 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.825 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 66.5 mm-40 -75.53 -48.17 23.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.277 -172.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 78.4 p -65.49 -41.4 93.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -58.01 -44.74 87.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.279 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.41 -41.53 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 79' ' ' GLN . 73.9 mt -60.9 -45.33 98.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.955 0.407 . . . . 0.0 110.196 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.28 75.72 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.231 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -38.06 89.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 86' ' ' ARG . 21.3 ttt180 -59.85 -27.93 67.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.428 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.89 -45.14 4.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.02 44.77 0.52 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.672 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.731 HG11 HD21 ' A' ' 96' ' ' LEU . 17.2 t -103.86 156.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 172.6 13.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 0.0 110.729 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 60.4 mtm180 -98.4 -161.01 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.676 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 62.2 m-85 73.93 165.93 0.13 Allowed Pre-proline 0 N--CA 1.467 0.387 0 O-C-N 123.953 0.783 . . . . 0.0 110.83 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 92' ' ' PHE . 21.4 Cg_endo -59.56 123.36 13.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.029 1.819 . . . . 0.0 111.679 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 106' ' ' VAL . . . -161.74 143.04 11.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.783 -174.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 23.8 m -110.77 113.3 25.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.0 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.731 HD21 HG11 ' A' ' 89' ' ' VAL . 5.9 mp -93.43 137.31 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.37 130.11 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.36 119.36 36.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.16 125.72 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.157 0.503 . . . . 0.0 112.051 -172.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.22 -63.32 2.91 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.968 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -136.17 64.47 0.58 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 64.89 -153.42 0.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.534 0.334 . . . . 0.0 111.793 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -50.24 108.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.833 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.71 -38.55 15.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.513 0.673 . . . . 0.0 109.832 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 170.5 -168.43 41.48 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.123 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 14.0 p -136.95 140.68 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.027 0.442 . . . . 0.0 111.037 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 93.7 mt -96.56 107.19 19.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.13 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -148.6 171.8 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.294 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.44 149.4 18.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.101 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.0 102.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 0.0 110.267 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 49.5 m80 -134.33 139.72 33.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 176.04 7.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 0.0 112.219 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.745 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 10.4 t-105 -58.39 -45.41 88.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.375 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.95 87.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.404 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 111' ' ' HIS . 4.4 tp10 -72.76 -33.12 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -63.0 -45.47 92.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.037 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.3 mt -62.9 -43.75 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.099 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -54.5 -58.26 8.18 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 91.7 mt -57.4 -47.44 81.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.463 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.419 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.1 tpt -59.46 -41.56 90.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.599 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -63.35 -40.6 97.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.42 77.8 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.839 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 74.0 mt -81.08 -50.95 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -70.86 -36.35 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.58 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.751 0.786 . . . . 0.0 112.428 179.133 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.708 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.648 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.708 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 6.2 Cg_exo -78.24 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.767 1.645 . . . . 0.0 111.443 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.95 -37.91 84.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.593 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.31 -54.42 33.45 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.35 90.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -58.17 -55.05 40.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.044 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -39.46 93.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.236 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.823 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -57.6 -39.86 77.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.571 0.224 . . . . 0.0 111.165 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -65.05 -53.41 46.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.186 0.517 . . . . 0.0 110.533 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.489 ' HE3' HG23 ' A' ' 74' ' ' ILE . 81.7 mtp -57.9 -37.8 74.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.116 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -34.91 76.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.381 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.79 66.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.023 0.439 . . . . 0.0 111.123 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 28.7 mmt180 -83.66 2.75 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.496 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.65 12.16 80.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.59 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.479 ' HH2' ' HB2' ' A' ' 55' ' ' PRO . 51.5 m0 -77.51 124.01 27.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.503 ' HB ' ' CH2' ' A' ' 30' ' ' TRP . 21.5 m -85.46 123.93 72.2 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.971 -171.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.93 118.75 5.86 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.805 2.337 . . . . 0.0 111.463 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.456 HG13 HD21 ' A' ' 27' ' ' LEU . 14.4 p -126.11 147.08 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m -95.23 165.09 12.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.181 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.26 -48.65 54.71 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.751 0.42 . . . . 0.0 112.114 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 m -59.74 -35.48 74.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.002 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 9.1 tpt180 -94.69 -18.29 21.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.79 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 3.4 tm? -64.05 -40.0 95.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.49 -42.66 96.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.168 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 28.5 t70 -63.14 -57.16 11.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.946 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.503 ' CH2' ' HB ' ' A' ' 20' ' ' THR . 5.9 t90 -59.13 -39.65 83.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.196 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -66.95 -28.1 68.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.478 . . . . 0.0 110.419 177.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.5 m -75.19 -33.06 61.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 19.3 mm-40 -80.64 -48.34 12.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.406 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -73.0 135.3 80.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.401 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 2.1 Cg_endo -81.66 -21.93 5.78 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.911 2.408 . . . . 0.0 111.52 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 3.5 p-10 -95.31 -89.29 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.129 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 87.69 106.92 0.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.599 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 72' ' ' VAL . 5.5 m -131.89 134.08 60.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 171.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 49.2 t -130.5 135.19 61.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.951 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD21 ' HE2' ' A' ' 14' ' ' MET . 7.6 mp -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.2 tt -104.46 128.29 52.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.025 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.865 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' HD13 ' A' ' 10' ' ' LEU . 29.0 t . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 120.783 0.325 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.9 t70 49.55 71.4 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.527 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 t30 66.99 85.59 0.15 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.526 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HB2' ' HH2' ' A' ' 19' ' ' TRP . 96.7 Cg_endo -79.85 -5.7 13.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.526 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 21.6 t -61.9 -35.72 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.405 ' HE2' ' HG ' ' A' ' 116' ' ' LEU . 55.6 ttp -58.95 -37.37 76.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 -177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.448 ' O ' HD11 ' A' ' 62' ' ' LEU . 50.1 mm -69.91 -36.11 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.078 0.466 . . . . 0.0 110.346 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.83 -45.31 65.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.011 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 8.7 mm-40 -68.6 -28.22 66.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.84 0.353 . . . . 0.0 110.468 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 116' ' ' LEU . 24.7 tp -61.68 -54.93 36.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.483 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 58' ' ' ILE . 7.3 mp -52.27 -26.6 12.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.439 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.557 HH11 ' HG3' ' A' ' 63' ' ' ARG . 11.5 mmt85 -61.62 -9.4 6.02 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.99 -12.18 59.42 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 122.015 -0.428 . . . . 0.0 111.181 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -116.79 92.88 39.69 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.826 0.346 . . . . 0.0 110.622 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.77 2.9 6.43 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.75 2.3 . . . . 0.0 112.249 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.95 -26.69 62.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.716 0.77 . . . . 0.0 109.766 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -129.17 133.53 47.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.654 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 p -85.03 102.68 13.4 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.455 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.66 118.98 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.947 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -103.08 107.08 17.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.337 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 38' ' ' VAL . 26.8 t -88.21 120.37 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.22 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -107.15 133.04 52.34 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.263 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.489 HG23 ' HE3' ' A' ' 14' ' ' MET . 26.7 pt -125.98 143.84 38.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.53 156.72 30.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.994 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 169.22 4.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.53 -46.48 88.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.109 0.48 . . . . 0.0 110.35 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -61.82 -44.36 97.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.847 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 83.8 mm-40 -68.58 -39.22 81.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.167 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -58.25 -39.81 80.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.37 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -34.95 79.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.181 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.21 47.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.259 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 79' ' ' GLN . 74.6 mt -64.12 -46.94 92.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.53 96.74 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.946 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.38 -42.15 95.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 111.281 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -61.14 -32.31 72.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -100.55 -43.65 6.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.133 0.492 . . . . 0.0 111.001 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.2 42.6 0.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.59 142.96 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.523 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 21.3 m-85 -73.57 159.81 32.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -83.79 84.89 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.349 0.595 . . . . 0.0 112.13 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 90' ' ' PHE . 30.5 p90 -169.25 152.66 5.1 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.652 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.0 Cg_exo -71.72 126.39 11.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.416 2.077 . . . . 0.0 111.337 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.88 168.77 25.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.531 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 26.2 m -100.85 120.23 39.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.12 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.88 120.34 34.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.8 p -104.89 122.53 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.56 0.695 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.74 -177.97 3.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.495 ' OG1' ' HD3' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -151.23 -171.5 3.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.18 91.79 0.04 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.034 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.44 24.44 70.85 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.354 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.01 159.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.422 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.75 111.99 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -168.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.56 -171.2 34.72 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.046 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.55 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.5 mt -95.29 103.53 15.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -108.5 130.58 55.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.46 -165.56 24.95 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.783 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.7 mm -112.97 -69.52 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 79.1 m-70 70.95 143.32 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.74 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.45 159.65 19.13 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.647 2.231 . . . . 0.0 111.858 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.41 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 15.5 t-105 -54.05 -43.19 69.99 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.08 78.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 111.643 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 4.4 mp0 -72.49 -26.44 61.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.748 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.467 ' CD1' HD22 ' A' ' 61' ' ' LEU . 2.0 tm? -62.72 -47.43 83.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.5 mt -60.84 -45.91 97.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.264 0.554 . . . . 0.0 109.719 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -52.65 -58.28 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 89.6 mt -58.14 -42.22 85.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.595 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.464 ' HG2' HD23 ' A' ' 61' ' ' LEU . 16.9 tpt -57.73 -50.6 72.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 110.642 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.605 ' HA ' HG12 ' A' ' 124' ' ' VAL . 65.0 mtt180 -68.84 -32.05 71.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.31 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.73 -29.89 71.21 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.482 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.83 -45.92 6.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.605 HG12 ' HA ' ' A' ' 121' ' ' ARG . 7.2 p -71.49 -26.04 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -172.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.699 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.439 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 85.3 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 19.3 Cg_endo -60.03 -72.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.961 1.774 . . . . 0.0 113.538 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.64 -33.59 76.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.67 -51.9 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.592 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.547 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -65.15 -44.05 89.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 52' ' ' SER . 3.2 mm? -62.33 -39.76 94.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.339 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -65.46 -44.77 86.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.13 -39.25 78.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.188 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 68.8 mmt-85 -61.57 -53.26 58.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.0 0.429 . . . . 0.0 110.616 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.409 ' SD ' HD23 ' A' ' 40' ' ' LEU . 75.4 mtm -61.4 -32.75 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.078 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.43 -40.09 89.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.608 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.24 65.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 6.2 mmp_? -71.24 -33.66 70.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.468 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.12 39.01 2.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.86 174.35 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.9 m -101.84 118.14 60.1 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.0 111.77 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 4.1 Cg_exo -80.27 126.92 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.41 2.74 . . . . 0.0 111.503 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 75' ' ' ALA . 11.8 p -135.52 142.34 39.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -97.6 167.45 10.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 111.435 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' H ' ' CG ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -52.73 -51.35 60.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.381 -175.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.9 m -75.36 -5.66 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.901 0.381 . . . . 0.0 111.782 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -106.85 -20.45 13.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.254 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.12 -42.21 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.353 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.89 -46.18 72.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.319 0.581 . . . . 0.0 110.573 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 32' ' ' THR . 32.6 t70 -60.46 -53.59 55.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.346 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.93 -43.56 86.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.5 -40.12 95.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.692 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -70.12 -25.46 63.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.67 -42.83 13.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.047 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.79 134.79 94.17 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.401 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.12 -44.42 15.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.483 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.79 ' HB2' ' HE2' ' A' ' 68' ' ' TYR . 1.5 t0 -161.36 177.34 10.23 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.04 -178.96 33.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.695 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 97' ' ' VAL . 20.2 m -138.37 156.48 30.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 122.501 0.32 . . . . 0.0 110.205 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.81 143.57 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.619 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD23 ' SD ' ' A' ' 14' ' ' MET . 7.7 mp -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 63.7 tp -114.93 96.55 5.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.417 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 CA--C 1.538 0.481 0 O-C-N 123.7 0.625 . . . . 0.0 112.562 173.071 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.48 ' HA ' HD12 ' A' ' 10' ' ' LEU . 37.4 t . . . . . 0 C--O 1.234 0.263 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 54' ' ' ASN . 8.9 t70 52.6 -144.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.683 0.614 . . . . 0.0 109.834 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.517 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -151.18 92.3 3.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -61.31 -95.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.797 2.331 . . . . 0.0 113.484 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 97.7 t 73.29 -51.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.326 0.584 . . . . 0.0 110.653 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.522 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 22.9 ptt? -59.51 -24.41 63.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.078 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.25 -45.09 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.897 0.38 . . . . 0.0 110.798 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.35 -40.2 80.51 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.588 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -63.08 -39.16 93.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.514 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 37.0 tp -59.99 -57.03 14.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.723 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.24 -28.02 68.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.132 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -75.43 -6.92 52.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.2 pt-20 -76.39 -13.54 60.12 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.243 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -131.26 71.09 82.06 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.45 12.46 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.25 2.634 . . . . 0.0 112.799 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.51 -14.35 60.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.676 0.75 . . . . 0.0 110.012 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.79 ' HE2' ' HB2' ' A' ' 36' ' ' ASP . 8.7 t80 -122.4 -177.12 3.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.208 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -109.44 123.02 48.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.685 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -108.34 106.67 16.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -90.39 110.91 21.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.015 0.436 . . . . 0.0 110.185 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.97 117.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.975 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.9 55.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.1 pt -119.57 139.33 47.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.493 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.65 171.24 7.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.7 m-20 -64.14 171.8 2.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.822 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -57.73 -54.26 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.568 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -74.61 -33.78 62.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.972 0.415 . . . . 0.0 111.32 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 2.6 mp0 -69.64 -39.52 77.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.06 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.4 m -55.23 -52.99 61.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.48 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 17.6 tp10 -59.93 -44.43 94.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.353 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.83 -41.31 95.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.894 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 79' ' ' GLN . 80.1 mt -63.01 -47.57 92.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.624 0.249 . . . . 0.0 110.964 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.19 92.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.519 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.99 -43.96 82.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.81 0.444 . . . . 0.0 111.262 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -67.7 -27.23 66.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -78.19 -39.06 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 109.944 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.52 -25.85 2.29 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.02 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -86.3 99.73 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.012 0.434 . . . . 0.0 110.142 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -93.76 131.79 38.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.709 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.503 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 0.4 OUTLIER 67.08 179.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.732 0.645 . . . . 0.0 112.011 173.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 70.02 105.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.869 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 37.5 Cg_endo -66.43 135.66 40.32 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.613 2.209 . . . . 0.0 112.528 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.8 -173.68 1.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.153 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 20.4 m -114.91 127.94 55.99 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.7 114.79 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' A' ' 38' ' ' VAL . 7.1 p -99.84 130.49 48.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.313 0.577 . . . . 0.0 111.105 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -123.43 164.95 17.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.804 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.414 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m -154.87 136.4 14.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 170.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.29 14.85 42.5 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.149 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.4 -5.6 84.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.242 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -94.71 149.09 21.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 110.912 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -74.44 126.88 31.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.11 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.503 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 3.5 mmp_? -99.23 -45.11 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.95 -165.13 38.68 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.674 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.44 134.04 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.101 0.477 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.0 mt -100.2 109.83 22.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.569 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -132.19 81.36 1.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.382 0.61 . . . . 0.0 109.605 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.18 64.48 0.34 Allowed Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.309 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 26.0 mm -80.35 83.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.487 0.184 . . . . 0.0 111.093 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 9.9 t-80 175.9 -60.12 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.703 172.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 1.6 Cg_endo -82.98 124.76 3.94 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.476 2.118 . . . . 0.0 113.035 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.522 ' CE3' ' HB2' ' A' ' 57' ' ' MET . 12.1 t-105 -77.09 -49.23 15.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.581 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.58 78.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.034 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 36.9 tt0 -74.23 -34.54 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.725 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.03 -43.33 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.11 -47.91 85.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -53.78 -49.52 68.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.434 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.51 -53.8 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.8 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.539 ' O ' HG21 ' A' ' 124' ' ' VAL . 17.6 tpt -56.76 -51.06 70.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.482 . . . . 0.0 110.512 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 125' ' ' GLU . 24.4 ttt85 -64.77 -31.75 73.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.562 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.9 61.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.669 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.12 -51.88 6.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 120' ' ' MET . 32.8 m -81.64 -24.81 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.631 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 31.3 tt0 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.123 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.644 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 42.1 m . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.87 -66.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.921 1.747 . . . . 0.0 112.124 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.8 -35.07 75.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.42 -53.51 55.66 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -66.44 -43.03 86.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.062 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.77 -37.72 82.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.816 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -64.04 -48.61 75.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.541 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.51 -32.47 71.48 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.525 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 26.2 mmm180 -59.16 -53.32 59.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.002 0.429 . . . . 0.0 110.281 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.612 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 71.7 mtm -62.13 -33.37 74.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.845 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 74' ' ' ILE . 2.7 mm? -59.51 -38.91 82.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.624 176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.04 66.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.39 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -75.63 -6.34 49.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.614 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.75 46.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.598 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.612 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 47.5 m0 -89.51 119.95 30.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 109.931 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -83.7 137.23 41.4 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.401 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 74.1 Cg_endo -76.95 149.83 29.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.48 . . . . 0.0 111.424 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG11 HD21 ' A' ' 27' ' ' LEU . 7.9 p -154.1 156.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 111.18 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 p -99.04 164.5 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.307 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.19 -42.73 73.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 111.66 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -30.44 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.65 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -85.23 -23.17 28.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 110.619 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.485 HD21 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -60.64 -39.26 87.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.622 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.33 -32.92 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.924 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 9.0 t70 -68.3 -55.24 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.047 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -60.69 -34.08 73.8 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.918 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.99 -43.03 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.322 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 29' ' ' ASP . 12.0 t -74.55 -26.39 59.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.782 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 29' ' ' ASP . 98.0 mt-30 -64.57 -44.96 89.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.853 0.358 . . . . 0.0 110.651 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . . . -90.79 161.75 35.16 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.04 -45.56 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.326 2.017 . . . . 0.0 110.993 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -149.17 -178.16 6.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.119 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.11 -168.17 40.23 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.052 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 97' ' ' VAL . 12.1 m -139.13 135.73 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.858 0.361 . . . . 0.0 110.477 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -124.11 133.18 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -95.84 131.43 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.948 0.404 . . . . 0.0 111.258 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.75 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 4.5 tt -107.71 117.19 33.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.612 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.871 179.891 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 CA--C 1.532 0.255 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.68 97.17 11.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.937 0.399 . . . . 0.0 110.701 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.48 153.4 75.1 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.617 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.477 ' HB2' HG12 ' A' ' 58' ' ' ILE . 74.4 Cg_endo -80.74 97.59 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.492 2.128 . . . . 0.0 112.911 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.3 t -93.96 -27.71 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.341 0.591 . . . . 0.0 110.313 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -22.81 65.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.001 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 55' ' ' PRO . 40.3 mm -52.6 -35.83 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -61.42 -43.04 99.85 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -69.25 -30.35 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.196 0.522 . . . . 0.0 110.875 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.863 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 47.6 tp -72.56 -52.67 14.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.345 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 65' ' ' PHE . 8.4 mp -59.2 -27.3 65.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.274 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 16.6 mmm180 -56.3 -14.59 2.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.81 -7.25 47.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.881 0.309 . . . . 0.0 111.62 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.602 ' HD2' ' O ' ' A' ' 62' ' ' LEU . 32.1 p90 -64.71 126.97 91.99 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.393 0.616 . . . . 0.0 111.57 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 1.3 Cg_endo -87.28 -62.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.307 2.671 . . . . 0.0 112.654 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.4 -25.53 10.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.726 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.48 104.37 12.72 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.4 p -79.42 107.22 12.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.073 0.463 . . . . 0.0 110.377 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -75.88 121.65 22.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.525 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.561 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 1.9 tp-100 -83.6 100.73 11.0 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.42 108.48 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.903 0.382 . . . . 0.0 110.055 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.49 48.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 19.6 pt -115.9 148.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.435 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . . . -130.89 167.39 19.03 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.6 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.727 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.6 m-20 -61.71 163.71 6.98 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.52 174.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.82 -48.71 77.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.753 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.72 -24.07 64.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.574 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.727 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 78.5 mm-40 -76.46 -51.83 11.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.75 ' HB3' ' HA ' ' A' ' 41' ' ' LEU . 39.6 m -64.27 -37.38 87.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.91 -45.3 74.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.067 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -45.59 81.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.87 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.71 -49.03 82.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.347 0.404 . . . . 0.0 111.07 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.47 50.78 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.89 -49.61 72.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.272 0.558 . . . . 0.0 110.93 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -63.49 -31.53 72.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.883 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.18 -51.76 6.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 110.593 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.03 44.64 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.712 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -104.68 -14.72 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HD2' ' CE2' ' A' ' 92' ' ' PHE . 41.7 t80 68.19 175.97 0.26 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.035 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -84.08 94.26 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.922 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.447 ' CE2' ' HD2' ' A' ' 90' ' ' PHE . 54.2 m-85 -140.17 132.05 14.5 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.889 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 6.6 Cg_exo -71.66 129.24 15.32 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.172 1.915 . . . . 0.0 110.519 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.39 156.85 2.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.159 0.505 . . . . 0.0 111.68 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.0 m -95.6 120.81 36.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.965 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.9 114.17 26.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 38' ' ' VAL . 6.5 p -99.38 124.86 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.153 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.91 140.81 33.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.544 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 p -134.0 122.48 23.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.979 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.76 25.58 69.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.355 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.81 0.42 88.11 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.61 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.436 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -109.09 143.88 37.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.313 -175.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -82.31 112.86 19.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.119 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -136.69 10.81 3.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.56 137.24 6.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.525 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.93 132.69 69.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.63 95.01 2.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.613 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -81.75 -38.68 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 109.984 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.47 -161.11 24.95 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.516 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 23.1 mm 69.89 163.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 43.6 m80 78.77 151.89 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.193 0.597 . . . . 0.0 110.452 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.45 142.68 96.13 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.546 2.164 . . . . 0.0 113.001 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.863 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 29.5 t-105 -53.79 -33.81 57.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.652 175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.64 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.52 -33.28 48.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 109.936 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 2.7 mm? -58.14 -44.5 87.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.962 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 113' ' ' TRP . 59.9 mt -64.38 -41.91 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.35 -54.83 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.502 0.667 . . . . 0.0 110.824 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.9 mt -59.19 -48.52 81.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.423 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.726 ' HG2' HD22 ' A' ' 61' ' ' LEU . 14.8 tpt -62.29 -38.79 90.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.704 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -66.11 -34.46 78.12 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.041 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.8 74.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.754 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 92.3 mt -75.6 -55.55 5.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.689 -0.256 . . . . 0.0 111.609 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 120' ' ' MET . 34.6 m -77.94 -23.24 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.795 -175.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.0 109.343 176.758 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 21.6 m . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 46.4 Cg_exo -56.97 -66.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.292 1.995 . . . . 0.0 112.995 -175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -60.42 -37.96 82.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.32 . . . . 0.0 110.688 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 7.2 t70 -59.04 -53.15 61.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.486 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.6 88.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.347 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.29 -47.77 75.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.85 -35.62 81.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 14.8 mm100 -57.33 -43.84 83.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.026 176.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 5.0 mmp_? -64.21 -53.35 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.41 ' HE1' HD21 ' A' ' 40' ' ' LEU . 84.4 mtp -56.47 -39.56 73.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.291 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.95 -38.47 79.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.186 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.39 70.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HA ' HH11 ' A' ' 17' ' ' ARG . 10.3 mmm180 -73.06 -15.9 61.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.396 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.92 44.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.312 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -114.5 137.47 51.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 p -96.44 138.03 21.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.9 Cg_endo -86.2 163.46 9.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.616 2.878 . . . . 0.0 112.076 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG13 HD22 ' A' ' 27' ' ' LEU . 7.9 p -162.79 143.74 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.895 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.32 155.25 19.1 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.95 78.35 1.66 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.988 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 53.8 m -171.22 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.26 0.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.544 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.405 ' C ' HD12 ' A' ' 27' ' ' LEU . 2.6 tm? -53.02 -43.31 66.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.72 -43.34 59.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.85 -52.45 65.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.699 0.762 . . . . 0.0 110.407 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.639 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 22.9 t90 -58.75 -42.73 89.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.027 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.4 -33.25 75.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.0 m -60.21 -42.69 95.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.856 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.67 -43.75 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' CD ' ' A' ' 71' ' ' GLN . . . -113.05 94.95 32.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.549 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.34 -170.57 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.258 2.638 . . . . 0.0 112.551 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 49.84 88.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.893 0.854 . . . . 0.0 112.271 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.4 -169.35 27.84 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.153 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.93 145.83 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.625 0.25 . . . . 0.0 110.993 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 11.5 p -138.05 140.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.814 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 HD21 ' HE1' ' A' ' 14' ' ' MET . 7.3 mp -98.67 130.8 45.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 0.0 110.248 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -106.27 112.78 25.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.053 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.469 0.484 0 O-C-N 123.83 0.706 . . . . 0.0 111.371 179.43 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.79 -64.82 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.057 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.49 104.18 1.08 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.19 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.103 2.536 . . . . 0.0 113.285 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 -24.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.04 70.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.091 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.07 -38.35 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.42 -44.45 51.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.164 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.07 -30.05 66.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.644 0.259 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 54.8 tp -62.75 -45.59 91.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.025 0.441 . . . . 0.0 110.633 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.33 -29.9 67.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.756 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.6 -12.11 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 111.19 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 13.1 tp10 -74.37 -26.58 60.21 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -140.59 72.63 30.24 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -93.79 6.81 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.05 2.5 . . . . 0.0 112.39 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.21 -22.08 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 0.0 110.992 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.02 129.81 56.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -66.61 109.86 2.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.788 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.01 133.78 34.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.546 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.465 ' CD ' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -90.89 102.17 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.96 173.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.9 t -95.95 113.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.472 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.639 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -122.09 135.6 54.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 16.7 pt -128.03 148.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.11 171.08 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 79' ' ' GLN . 9.9 t70 -66.49 161.88 21.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 173.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 80' ' ' SER . 63.5 tp -66.91 -55.9 12.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.735 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.444 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . 57.8 mt-10 -73.84 -23.56 59.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.489 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 31.7 tt0 -64.55 -33.94 77.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.937 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 73.1 m -63.67 -40.05 95.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.6 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -55.43 -38.31 68.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 174.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.04 -43.42 62.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.241 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.73 -44.48 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 109.97 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -43.88 96.53 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.81 -49.44 76.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -63.99 -26.0 68.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.43 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -103.28 -4.91 23.62 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.088 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.42 38.3 80.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.186 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -122.03 -14.62 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 110.618 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CE1' ' HG3' ' A' ' 81' ' ' GLU . 45.7 t80 -65.37 114.33 4.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.107 0.479 . . . . 0.0 112.246 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -173.25 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.904 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 11.9 p90 -143.78 145.81 32.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.302 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 13.7 Cg_exo -71.18 138.17 32.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.673 2.248 . . . . 0.0 112.077 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.27 162.94 31.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.8 m -96.67 113.56 25.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.506 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.458 HD23 ' HH ' ' A' ' 103' ' ' TYR . 32.2 mt -94.48 129.98 41.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.21 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.82 135.91 57.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -108.72 125.48 51.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.403 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -104.1 123.44 47.27 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.735 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.91 11.76 63.77 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.46 71.62 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' N ' HD21 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -95.43 143.74 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -177.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.458 ' HH ' HD23 ' A' ' 96' ' ' LEU . 81.0 t80 -78.09 111.1 13.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.273 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -139.29 -19.24 0.97 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.604 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.62 149.27 18.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.931 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.96 134.71 18.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.901 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.9 mt -115.25 117.69 31.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.582 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.63 117.92 30.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.527 0.679 . . . . 0.0 111.28 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.3 -161.54 23.29 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.395 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.3 mm -99.01 -53.53 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 44.6 m80 67.5 159.99 0.14 Allowed Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.725 0.641 . . . . 0.0 110.893 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.718 ' HG2' ' HB2' ' A' ' 115' ' ' GLU . 11.8 Cg_endo -60.25 136.8 70.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.503 1.469 . . . . 0.0 109.473 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.526 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.5 t-105 -54.79 -45.41 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.25 -34.36 72.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.771 0.32 . . . . 0.0 111.493 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 1.3 tm-20 -77.2 -37.13 54.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.448 . . . . 0.0 110.102 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.95 -44.97 91.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.335 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.96 -39.04 82.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.226 0.536 . . . . 0.0 109.946 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -58.11 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.147 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.3 mt -56.82 -45.64 82.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.479 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.44 ' O ' HG21 ' A' ' 124' ' ' VAL . 12.9 tpt -57.74 -47.6 81.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.465 ' HA ' HG21 ' A' ' 124' ' ' VAL . 62.9 mtp180 -64.11 -32.73 74.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.224 0.209 . . . . 0.0 110.916 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.96 74.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.176 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -84.38 -39.48 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 121' ' ' ARG . 34.2 m -82.78 -15.5 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.63 0.252 . . . . 0.0 111.636 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 121' ' ' ARG . 10.1 tp10 . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 174.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.617 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 4.4 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.3 -55.39 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.798 1.666 . . . . 0.0 112.04 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.43 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 44.7 t80 -62.46 -37.11 84.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.975 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.34 -54.59 30.62 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.428 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -42.27 88.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.546 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.85 -57.0 14.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.543 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.562 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.6 t90 -67.7 -36.64 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.305 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -56.87 -44.44 82.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.786 0.326 . . . . 0.0 110.976 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 97.3 mtt180 -63.49 -53.55 50.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 110.727 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.487 ' HE2' HD22 ' A' ' 40' ' ' LEU . 85.0 mtp -60.76 -36.84 79.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.439 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -70.1 -30.39 67.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.423 -177.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.19 64.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -10.37 59.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.824 0.345 . . . . 0.0 111.284 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.69 41.88 14.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.411 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -90.64 -178.69 5.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.675 0.274 . . . . 0.0 110.38 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.1 m -117.49 120.35 33.3 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.172 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 11' ' ' TRP . 2.8 Cg_exo -75.83 121.49 6.29 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.965 2.443 . . . . 0.0 111.172 174.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG12 HD23 ' A' ' 27' ' ' LEU . 14.9 p -117.9 143.47 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.618 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -95.24 163.25 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.557 0.694 . . . . 0.0 112.118 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -68.4 144.7 54.64 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.441 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m 75.12 -10.79 1.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.306 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.28 -23.19 14.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.44 HD23 HG12 ' A' ' 22' ' ' VAL . 3.3 tm? -48.94 -47.27 43.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.403 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.16 -49.4 44.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.961 0.41 . . . . 0.0 110.866 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.478 ' O ' HG21 ' A' ' 32' ' ' THR . 10.4 t70 -55.56 -48.52 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.925 0.869 . . . . 0.0 110.232 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -59.9 -42.31 93.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.858 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.13 -28.64 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 29' ' ' ASP . 7.4 t -80.57 -26.1 38.14 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.87 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -89.67 -38.38 13.93 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.86 106.77 36.2 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -67.76 122.35 9.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.755 2.303 . . . . 0.0 114.213 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.553 ' OD2' ' HB ' ' A' ' 99' ' ' THR . 6.1 m-20 65.64 154.76 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 124.594 1.184 . . . . 0.0 113.361 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 71' ' ' GLN . . . 153.91 -172.9 32.61 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.709 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 97' ' ' VAL . 31.3 m -133.54 156.33 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.545 0.212 . . . . 0.0 110.458 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 73' ' ' ALA . 61.0 t -129.74 131.04 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.076 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD22 ' HE2' ' A' ' 14' ' ' MET . 6.8 mp -98.64 122.22 41.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.403 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.605 HD22 ' HA ' ' A' ' 93' ' ' PRO . 6.6 tt -106.79 97.97 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.808 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 42.4 m . . . . . 0 CA--C 1.536 0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.0 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.4 -90.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.971 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 92.55 1.53 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.63 0.252 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -102.17 41.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.057 2.505 . . . . 0.0 111.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -104.5 -59.66 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -23.86 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.611 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' HD11 ' A' ' 62' ' ' LEU . 47.2 mm -52.59 -46.73 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.257 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -36.51 86.74 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.455 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 mt-10 -80.01 -26.95 39.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.887 0.375 . . . . 0.0 111.135 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.76 HD22 ' HB2' ' A' ' 120' ' ' MET . 42.8 tp -62.24 -45.72 92.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.798 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 70' ' ' TRP . 9.0 mp -56.35 -26.83 53.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.399 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 38.4 mmt180 -60.3 -17.73 44.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 5.6 pt-20 -76.5 -8.66 57.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.004 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -125.65 70.77 65.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.569 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.28 11.98 2.8 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.77 2.313 . . . . 0.0 111.583 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.67 -25.7 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.355 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -131.55 -157.9 0.85 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.025 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.444 ' HB ' ' OE1' ' A' ' 71' ' ' GLN . 6.6 p -111.62 140.08 46.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.602 ' HB3' HD22 ' A' ' 62' ' ' LEU . 82.7 m95 -122.05 95.59 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' OE1' ' HB ' ' A' ' 69' ' ' THR . 1.9 mp0 -84.34 109.86 18.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.23 114.22 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.988 0.423 . . . . 0.0 110.251 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' HG21 ' A' ' 39' ' ' VAL . . . -110.64 137.53 48.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.975 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 12.9 pt -122.72 146.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.78 160.77 31.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 0.0 112.074 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.99 164.84 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.775 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 96.2 mt -59.34 -44.53 92.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.773 0.32 . . . . 0.0 110.807 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.03 -36.31 79.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 0.0 110.081 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -72.81 -31.15 64.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.073 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.603 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 68.2 m -60.08 -43.88 95.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.995 0.426 . . . . 0.0 111.202 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.82 -41.01 97.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.697 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . . . -77.2 -35.18 55.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.568 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 24' ' ' GLU . 73.3 mt -63.63 -49.19 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.539 0.209 . . . . 0.0 110.676 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.03 -45.97 94.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.688 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -52.74 -53.35 49.13 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -73.28 -23.99 60.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 89' ' ' VAL . 10.7 t80 -85.4 -54.58 4.49 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.801 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.41 44.02 0.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.365 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' CD1' ' A' ' 87' ' ' PHE . 57.5 t -125.56 83.74 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.736 ' HB3' ' HD1' ' A' ' 92' ' ' PHE . 86.0 m-85 66.51 -62.59 0.28 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER 95.72 -1.6 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.293 1.837 . . . . 0.0 109.859 -169.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.736 ' HD1' ' HB3' ' A' ' 90' ' ' PHE . 83.8 m-85 -84.98 135.32 39.84 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.508 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.808 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.6 Cg_exo -67.41 134.18 32.53 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.871 2.381 . . . . 0.0 112.196 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . 173.85 -169.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.051 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.5 m -97.53 113.97 25.78 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.7 mt -95.75 127.52 41.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.071 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.682 HG12 ' HB2' ' A' ' 104' ' ' ARG . 5.7 p -109.34 124.13 65.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.458 0.647 . . . . 0.0 111.156 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -124.94 -178.87 4.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.465 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 14.2 p -127.89 -168.91 1.97 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.45 49.45 1.29 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.151 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.1 -41.5 0.85 Allowed Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.425 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -94.08 170.91 9.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.874 . . . . 0.0 112.099 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.44 134.96 55.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.35 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.682 ' HB2' HG12 ' A' ' 97' ' ' VAL . 3.5 mmp_? -105.14 -58.84 1.83 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.555 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -161.25 27.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.517 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.59 134.3 58.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 110.337 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.4 mt -101.51 128.84 47.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.611 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.56 11.15 25.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.797 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.25 -148.33 49.97 Favored Glycine 0 C--O 1.239 0.406 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.186 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.836 HG22 ' H ' ' A' ' 111' ' ' HIS . 10.6 mm 61.28 -168.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.836 ' H ' HG22 ' A' ' 110' ' ' ILE . 66.0 m80 73.39 150.45 0.13 Allowed Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.041 0.536 . . . . 0.0 111.522 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 13.4 Cg_exo -70.46 166.9 26.94 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.515 2.143 . . . . 0.0 111.582 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.478 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 33.5 t-105 -53.86 -43.15 69.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.612 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.51 77.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 22.6 mm-40 -81.22 -25.91 36.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 111.153 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.17 -43.53 91.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 61' ' ' LEU . 62.4 mt -58.81 -42.38 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.607 0.717 . . . . 0.0 109.554 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -54.5 -52.79 60.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.758 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.35 -45.42 93.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.615 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.76 ' HB2' HD22 ' A' ' 61' ' ' LEU . 8.2 tpt -57.1 -47.76 80.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.269 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.49 ' HA ' HG21 ' A' ' 124' ' ' VAL . 15.9 ttm180 -66.27 -37.78 86.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.977 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.14 -30.68 74.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.501 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.419 HD13 HG11 ' A' ' 97' ' ' VAL . 94.8 mt -89.47 -42.47 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 121' ' ' ARG . 35.9 m -73.65 -31.01 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.76 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 10.9 Cg_exo -70.23 -43.37 2.3 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.867 1.712 . . . . 0.0 111.807 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.789 ' HE1' ' HB2' ' A' ' 42' ' ' SER . 76.7 t80 -73.54 -43.04 60.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 24.4 t70 -55.15 -53.62 53.62 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.504 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.19 99.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.544 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.13 -41.27 97.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.753 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -64.41 -40.26 95.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.651 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 24.9 mm-40 -57.89 -39.92 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.36 -52.5 46.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.633 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.6 mtp -55.32 -38.24 68.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.979 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.459 HD23 HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -65.13 -36.42 84.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.754 179.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.64 67.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -73.27 -7.77 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.804 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.49 23.64 36.12 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.266 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -85.1 141.97 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.2 m -84.63 116.08 63.56 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.942 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 57.1 Cg_endo -74.39 129.59 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.553 2.169 . . . . 0.0 110.985 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.441 HG13 HD21 ' A' ' 27' ' ' LEU . 13.8 p -138.57 145.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.892 0.377 . . . . 0.0 111.328 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 p -91.23 160.73 15.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.598 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -32.44 72.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.514 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -66.27 -36.5 83.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.876 0.37 . . . . 0.0 111.112 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -90.52 -24.76 20.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.348 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.441 HD21 HG13 ' A' ' 22' ' ' VAL . 3.1 tm? -58.8 -40.46 84.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.651 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 32' ' ' THR . 17.7 t70 -56.11 -53.4 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.877 0.846 . . . . 0.0 111.105 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.551 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t90 -59.39 -41.53 89.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.88 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.53 -29.11 70.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.181 0.515 . . . . 0.0 110.47 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 86.2 m -66.32 -40.0 89.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -98.91 -14.5 19.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . . . -140.58 90.22 10.04 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.843 0.354 . . . . 0.0 110.048 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.725 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 86.0 Cg_endo -88.61 -14.38 3.07 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.06 2.507 . . . . 0.0 114.409 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -100.22 135.94 40.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 110.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.98 -160.98 28.74 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 97' ' ' VAL . 6.9 m -138.4 134.87 44.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.409 HG23 ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -113.59 132.15 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.0 mp -101.34 122.43 43.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 35.2 tp -83.15 81.2 8.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.789 ' HB2' ' HE1' ' A' ' 7' ' ' PHE . 4.3 p . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.063 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 53.78 -168.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.926 0.891 . . . . 0.0 111.955 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -147.57 92.35 4.8 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.12 98.44 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.746 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.97 -32.67 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.311 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -60.14 -23.76 64.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.877 -177.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.409 HD12 HD22 ' A' ' 116' ' ' LEU . 49.8 mm -53.93 -39.96 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.73 -44.69 95.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.399 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -62.2 -34.83 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.342 . . . . 0.0 111.071 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.617 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 45.0 tp -64.76 -55.0 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.21 -27.99 69.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.369 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.96 -19.9 65.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -86.79 -0.45 56.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.772 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -123.08 71.64 44.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.94 -3.03 10.38 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.53 2.154 . . . . 0.0 113.075 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.53 -17.83 60.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.16 139.14 51.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.274 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -86.25 105.21 16.47 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -80.11 110.63 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.187 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 2.9 mp0 -82.47 119.54 24.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.081 174.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.33 103.33 14.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.551 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -108.45 127.15 53.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 40' ' ' LEU . 23.4 pt -122.59 139.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.954 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -111.68 169.78 8.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 112.242 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.66 168.77 14.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.283 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.25 -54.64 19.72 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.251 0.62 . . . . 0.0 112.18 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -30.3 61.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.546 0.689 . . . . 0.0 110.671 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.434 ' O ' HG13 ' A' ' 83' ' ' ILE . 57.6 mt-30 -77.27 -42.7 36.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.468 -175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 48.6 p -73.38 -37.24 66.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.663 0.268 . . . . 0.0 110.305 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -53.08 -49.79 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.101 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.07 71.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.786 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 79' ' ' GLN . 81.1 mt -67.89 -52.09 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.433 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.53 -44.75 97.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.171 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.94 -39.58 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.21 -30.75 65.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.373 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -84.82 -33.38 22.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 110.715 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.82 31.96 1.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.488 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.55 158.68 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.71 -83.81 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 110.821 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 86.9 mtt180 -148.17 -161.18 1.28 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 88.5 m-85 76.7 148.18 0.12 Allowed Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 124.144 0.903 . . . . 0.0 111.733 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 17.2 Cg_exo -65.39 69.15 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.452 3.434 . . . . 0.0 113.39 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.64 129.56 34.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.339 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 7.3 m -92.22 112.96 25.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.439 HD23 HG21 ' A' ' 106' ' ' VAL . 65.8 mt -93.97 113.9 25.99 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.764 HG11 ' HB2' ' A' ' 104' ' ' ARG . 7.4 p -97.85 127.37 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.202 0.525 . . . . 0.0 110.92 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.93 134.26 55.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.14 137.45 23.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.84 17.6 75.38 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.725 ' HA2' ' HB2' ' A' ' 35' ' ' PRO . . . 79.93 -0.36 83.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.663 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.46 149.34 32.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 111.649 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -69.98 129.47 39.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.417 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.764 ' HB2' HG11 ' A' ' 97' ' ' VAL . 16.7 mmt180 -101.93 -47.29 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.367 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.04 -163.76 36.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.388 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 95' ' ' THR . 59.3 t -122.6 134.26 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.611 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 4.4 mp -101.32 123.58 45.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.78 90.29 2.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.186 0.517 . . . . 0.0 110.026 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.5 146.15 5.73 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.0 -53.27 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 117.165 0.483 . . . . 0.0 111.767 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.6 m170 -73.25 -53.65 4.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 12.5 Cg_exo -68.73 121.91 8.82 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.126 1.217 . . . . 0.0 111.885 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.617 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 9.4 t-105 -87.49 -45.14 10.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.549 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.21 75.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 8.0 tp10 -72.18 -40.59 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.316 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 ' HZ3' ' A' ' 113' ' ' TRP . 30.9 tp -61.31 -44.28 97.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.401 HD11 ' CE2' ' A' ' 113' ' ' TRP . 62.1 mt -63.9 -44.94 98.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -50.23 -59.05 4.33 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.122 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 87.0 mt -65.53 -45.46 83.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.926 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.466 ' HG3' HD23 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -61.37 -48.03 83.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.69 0.281 . . . . 0.0 110.538 -178.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 124' ' ' VAL . 14.0 ttt85 -69.39 -33.03 72.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.199 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.51 -29.15 74.53 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.2 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.5 mt -83.06 -49.59 9.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.409 0.147 . . . . 0.0 111.206 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 121' ' ' ARG . 29.5 m -70.65 -37.94 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.428 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.534 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.702 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 88.0 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.3 Cg_exo -68.58 -58.91 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.551 1.501 . . . . 0.0 111.545 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.41 -35.07 79.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.23 -54.22 49.41 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.566 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -62.26 -48.02 81.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.78 -40.68 89.11 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 111.631 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -69.12 -43.47 74.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 12.3 mm100 -62.36 -32.76 73.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.359 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 50.1 mmm-85 -57.38 -53.59 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.251 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.547 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 73.0 mtm -66.65 -33.0 74.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.957 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 1.9 mm? -67.37 -24.37 65.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.459 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.76 72.9 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -81.36 -3.96 54.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.863 0.363 . . . . 0.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.91 29.99 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.116 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 43.4 m0 -74.09 148.19 42.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.174 0.511 . . . . 0.0 110.215 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.561 ' HB ' ' HZ3' ' A' ' 30' ' ' TRP . 9.5 p -96.85 130.43 30.19 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.9 -169.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.7 Cg_exo -79.31 145.1 18.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.302 2.668 . . . . 0.0 111.345 172.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.7 144.24 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.575 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -95.2 166.06 12.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.6 -55.35 35.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.075 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.3 m -73.27 6.37 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -126.34 -1.34 6.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.251 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.29 -47.08 79.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.828 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.15 -29.81 57.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.467 0.651 . . . . 0.0 110.444 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 32' ' ' THR . 17.1 t70 -61.06 -55.16 35.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.18 0.99 . . . . 0.0 109.661 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.561 ' HZ3' ' HB ' ' A' ' 20' ' ' THR . 14.0 m95 -67.93 -29.05 68.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.067 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.93 -28.85 69.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.628 0.252 . . . . 0.0 111.366 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 29' ' ' ASP . 14.5 t -88.78 -30.2 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.582 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.15 -28.94 18.6 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . . . -98.86 158.0 33.15 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.816 ' HG2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -67.84 149.54 78.17 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.969 1.78 . . . . 0.0 111.741 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.77 112.35 10.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.306 0.574 . . . . 0.0 110.204 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.55 -107.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.974 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 97' ' ' VAL . 12.3 m -135.33 142.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 111.975 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 71.7 t -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.4 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.09 143.26 31.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.466 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -86.28 1.12 52.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 93' ' ' PRO . 89.8 p . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 124.709 1.203 . . . . 0.0 111.73 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 60.0 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.855 0.722 . . . . 0.0 111.357 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -144.86 111.06 4.81 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.241 0.543 . . . . 0.0 109.774 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -97.64 -167.98 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.21 2.607 . . . . 0.0 113.326 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.3 t 76.49 -34.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -32.27 54.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.9 mm -59.18 -44.19 91.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.79 73.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.361 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.69 -32.51 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.237 0.541 . . . . 0.0 109.974 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.491 HD21 ' HG2' ' A' ' 120' ' ' MET . 51.1 tp -70.33 -34.59 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.502 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.9 mp -62.85 -28.12 69.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.262 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -68.7 -8.72 45.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.157 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.47 -24.79 66.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.339 . . . . 0.0 111.099 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.31 94.93 46.39 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.696 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.51 -18.28 13.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.99 2.46 . . . . 0.0 112.033 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.84 -25.55 64.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 0.0 110.801 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -137.66 121.15 17.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.578 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 t -86.26 131.12 34.3 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.907 0.861 . . . . 0.0 110.068 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -88.4 135.24 33.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.173 -173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.816 ' HB2' ' HG2' ' A' ' 35' ' ' PRO . 6.5 tp60 -96.22 122.62 39.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.206 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.35 110.99 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -111.82 127.55 55.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.254 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.5 pt -125.59 140.94 46.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 166.73 18.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.694 0.283 . . . . 0.0 111.069 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.5 m-20 -65.57 165.43 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.303 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.64 -49.14 73.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.13 -34.07 75.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.002 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.5 ' O ' HG13 ' A' ' 83' ' ' ILE . 81.8 mt-30 -77.16 -52.71 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.729 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.603 ' HB3' HD21 ' A' ' 41' ' ' LEU . 20.0 m -60.96 -39.57 90.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.388 -177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.89 -41.68 96.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.51 . . . . 0.0 110.201 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.42 77.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 79' ' ' GLN . 83.2 mt -61.36 -43.44 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.7 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.936 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.48 -36.16 66.31 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.067 0.547 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -51.67 -54.51 27.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.103 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.4 ' HB3' HG21 ' A' ' 89' ' ' VAL . 24.5 t80 -93.57 -19.29 21.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.002 -166.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.03 39.04 6.22 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.527 HG13 HD23 ' A' ' 96' ' ' LEU . 18.7 t -82.45 160.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -60.25 138.64 57.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -83.07 8.79 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.33 142.2 28.16 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.417 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' SER . 41.8 Cg_exo -57.08 126.04 20.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.518 2.146 . . . . 0.0 111.558 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.87 -175.81 3.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.567 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 29.3 m -117.21 120.65 38.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.527 HD23 HG13 ' A' ' 89' ' ' VAL . 5.8 mp -93.97 114.64 26.87 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -96.03 138.94 20.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -125.05 145.61 49.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -154.79 151.13 28.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.02 21.6 68.0 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.13 76.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.638 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.41 176.66 8.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.446 0.641 . . . . 0.0 111.828 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.87 118.03 11.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.127 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 5.7 tpm_? -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.726 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' A' ' 123' ' ' LEU . . . 170.1 -168.75 41.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.595 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.8 t -132.13 134.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.02 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.8 mt -108.02 131.53 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.3 33.67 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -172.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 -120.76 21.41 Favored Glycine 0 C--O 1.236 0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.782 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.33 99.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.93 0.871 . . . . 0.0 110.325 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.723 ' HB3' HD21 ' A' ' 116' ' ' LEU . 11.5 t60 -137.09 143.36 41.75 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -38.47 124.0 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.192 2.594 . . . . 0.0 112.128 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -54.92 -43.48 73.34 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.61 0.569 . . . . 0.0 112.016 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.17 87.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.698 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.76 -29.0 64.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.343 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 111' ' ' HIS . 0.5 OUTLIER -65.82 -48.82 70.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.52 -42.06 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.166 0.508 . . . . 0.0 109.873 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -52.63 -59.29 4.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.02 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.12 -43.66 98.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.543 ' O ' HG21 ' A' ' 124' ' ' VAL . 12.3 tpt -55.34 -48.95 73.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -39.04 92.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.435 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.52 75.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.428 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.469 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 98.6 mt -86.51 -60.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 120' ' ' MET . 30.7 m -63.51 -33.42 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.501 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.333 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.667 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 9.7 Cg_exo -71.69 -44.6 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.457 1.438 . . . . 0.0 110.223 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -68.97 -34.81 75.93 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 27.9 t70 -53.79 -53.85 46.53 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.599 0.714 . . . . 0.0 110.41 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.593 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.35 -46.03 89.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.044 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -60.34 -42.3 95.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.494 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CH2' ' HA ' ' A' ' 76' ' ' ASP . 1.6 t90 -66.54 -40.24 88.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 16.5 mm100 -57.78 -36.86 72.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 29.0 mmm180 -63.16 -54.15 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.664 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.505 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 66.5 mtm -62.55 -33.09 74.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.291 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.02 -40.07 95.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 0.0 110.584 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.35 66.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -74.38 -10.96 60.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.276 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.13 6.41 53.75 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.798 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.505 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 21.7 m0 -83.18 121.93 27.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 109.914 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 m -88.26 125.94 62.24 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.348 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 38.1 Cg_endo -68.5 139.38 44.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.847 2.364 . . . . 0.0 111.959 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.587 HG11 ' HG ' ' A' ' 27' ' ' LEU . 10.7 p -130.92 148.55 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.064 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.7 p -86.62 163.6 17.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 111.49 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.01 -59.02 4.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.336 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 t -77.78 -21.94 50.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 19.2 tpt180 -84.28 -16.94 41.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 109.989 -174.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.587 ' HG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.01 -39.2 90.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.462 176.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.47 -29.36 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.616 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 32' ' ' THR . 35.1 t70 -64.24 -51.73 62.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.305 1.05 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -59.1 -40.9 86.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.074 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 60.5 mt -62.5 -33.59 75.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 29' ' ' ASP . 10.2 t -79.88 -26.02 40.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.743 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.75 -34.17 21.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.713 0.292 . . . . 0.0 111.494 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.42 148.36 46.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.69 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.43 -67.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.505 2.137 . . . . 0.0 112.534 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.75 -90.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.578 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.57 163.79 39.67 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.262 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.03 143.28 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.89 137.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 74' ' ' ILE . 8.7 mp -92.24 121.28 33.61 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 80' ' ' SER . 21.5 tp -114.41 148.66 37.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.745 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.532 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 57.08 -146.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.489 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -120.4 93.28 48.17 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 110.966 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.97 13.15 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.067 2.511 . . . . 0.0 112.276 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -84.02 -16.54 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 0.0 110.848 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -21.98 41.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.68 -33.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.788 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -50.26 69.51 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.143 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.95 -27.73 39.74 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.668 -0.313 . . . . 0.0 111.313 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.569 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.3 tp -58.32 -48.09 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.099 0.476 . . . . 0.0 111.617 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.11 -26.58 67.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.85 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -63.92 -7.92 9.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -67.23 -32.44 73.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 110.56 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.67 75.42 62.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.25 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.38 6.22 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.93 2.42 . . . . 0.0 112.896 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -91.26 2.09 56.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.786 0.803 . . . . 0.0 109.722 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -138.38 147.58 43.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.387 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -87.23 138.65 31.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.856 0.836 . . . . 0.0 111.269 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -117.21 115.25 24.94 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.732 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.09 102.89 15.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.89 106.92 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.91 142.31 41.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.55 HG22 ' HB2' ' A' ' 40' ' ' LEU . 21.0 pt -114.9 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.518 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -92.12 157.24 16.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.896 0.379 . . . . 0.0 111.939 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -59.51 159.68 7.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.328 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -57.24 -55.72 31.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.54 -39.24 46.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.505 0.669 . . . . 0.0 111.076 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.712 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 49.8 mt-30 -72.53 -22.35 61.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.132 -173.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 31.9 p -70.31 -41.1 73.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.026 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.65 -38.87 86.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.07 83.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.017 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 79' ' ' GLN . 84.1 mt -58.33 -41.02 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 110.816 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.53 -53.26 47.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.419 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.27 -40.4 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 110.564 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.41 -36.17 83.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.051 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -92.31 -27.67 17.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.16 20.83 7.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.78 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.643 HG12 ' HB2' ' A' ' 92' ' ' PHE . 25.5 t -126.74 78.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.56 122.98 40.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 111.459 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 70.44 27.8 3.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.993 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.643 ' HB2' HG12 ' A' ' 89' ' ' VAL . 93.6 m-85 -115.83 85.77 15.05 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.032 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.13 125.43 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.11 1.873 . . . . 0.0 111.807 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 107' ' ' LEU . . . -177.07 -176.35 0.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.655 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -104.31 123.22 47.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.339 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.14 133.12 37.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.701 0.286 . . . . 0.0 110.528 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.34 125.77 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.381 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -144.22 129.38 18.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.968 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.8 p -93.14 124.0 36.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.358 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.67 27.3 58.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.99 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.91 83.44 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.571 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -105.04 129.36 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -66.09 124.2 21.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.702 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -103.61 -51.47 3.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.219 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.5 -174.96 47.37 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.424 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.47 133.85 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.983 0.42 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 93.0 mt -85.68 97.2 9.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.01 158.58 39.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.79 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.47 84.83 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.909 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 45.8 mm 65.6 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.516 0.727 . . . . 0.0 111.866 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 74.8 m80 74.22 157.07 0.16 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 123.287 0.635 . . . . 0.0 111.083 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.39 155.3 69.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.337 2.024 . . . . 0.0 111.515 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.569 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 t-105 -54.91 -39.13 68.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.25 -42.47 81.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.663 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.19 -28.77 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.12 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.98 -41.4 95.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.174 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 113' ' ' TRP . 78.4 mt -58.1 -46.01 88.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.321 0.581 . . . . 0.0 110.171 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -54.99 -57.84 10.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.819 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.19 -45.28 87.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.516 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.475 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.7 tpt -53.65 -53.29 53.99 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.351 0.407 . . . . 0.0 110.912 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.19 -33.47 76.08 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.29 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.31 66.42 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.346 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.91 -52.35 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 120' ' ' MET . 8.4 p -69.97 -30.64 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 125.511 1.524 . . . . 0.0 115.104 173.62 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 92.6 m . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 30.3 Cg_exo -62.51 -56.81 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.642 1.561 . . . . 0.0 111.675 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -65.43 -41.79 93.14 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.84 -53.12 53.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.506 0.67 . . . . 0.0 111.006 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -64.84 -45.12 87.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.249 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 52' ' ' SER . 1.9 mm? -60.01 -46.65 88.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.106 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -67.58 -36.61 81.22 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -49.09 74.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.941 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 35.0 mtp180 -61.14 -52.4 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.648 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtp -54.48 -39.75 67.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.338 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HG3' ' A' ' 21' ' ' PRO . 1.8 mm? -67.21 -42.52 83.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.917 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.7 61.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -69.9 -18.0 63.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 110.24 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.6 26.12 9.44 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -91.35 -179.21 5.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.9 m -121.89 124.39 27.05 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.76 0.314 . . . . 0.0 111.645 -174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HG3' HD12 ' A' ' 15' ' ' LEU . 6.5 Cg_exo -73.18 132.72 18.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.941 2.427 . . . . 0.0 110.981 175.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 73' ' ' ALA . 17.4 t -120.99 144.83 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.58 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 25.0 p -99.05 165.96 11.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.972 173.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.75 -54.95 30.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 m -78.38 -13.23 59.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 111.683 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.421 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.8 tpp180 -94.65 -15.99 23.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.3 tm? -60.89 -44.41 97.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.4 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.32 -32.05 62.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.638 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 32' ' ' THR . 33.0 t70 -64.82 -54.58 28.86 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.782 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -66.02 -28.93 69.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.559 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -66.1 -28.11 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.441 0.639 . . . . 0.0 109.855 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 91.5 m -74.5 -41.56 60.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.138 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -83.62 -46.2 12.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . . . -94.52 118.95 66.9 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.411 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.18 124.96 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.551 2.168 . . . . 0.0 112.747 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.4 m-20 68.06 172.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.128 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.34 -163.19 24.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.277 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.56 142.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.0 110.8 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 73' ' ' ALA . 59.8 t -119.28 127.67 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.589 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' HB2' HG23 ' A' ' 74' ' ' ILE . 35.2 mt -101.96 135.69 43.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.994 0.426 . . . . 0.0 110.948 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.99 -69.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.727 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.818 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.466 ' HA ' HD21 ' A' ' 10' ' ' LEU . 10.2 t . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.966 0.412 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.66 123.56 28.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 4.6 p-10 -75.63 131.83 76.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 26.8 Cg_exo -62.98 104.61 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.176 2.584 . . . . 0.0 113.292 -174.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.98 -37.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.204 0.526 . . . . 0.0 109.786 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -24.34 67.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.127 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.0 mm -65.26 -36.42 77.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.38 99.69 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.586 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.68 -28.2 40.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.668 0.27 . . . . 0.0 111.21 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.96 -41.77 97.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.98 0.419 . . . . 0.0 110.6 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.8 mp -58.74 -25.75 63.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.147 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.18 -8.12 7.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.2 -30.18 64.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.593 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.21 92.86 37.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.095 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.54 -0.91 9.98 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.993 2.462 . . . . 0.0 111.601 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.26 -24.9 42.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.794 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -110.39 161.02 16.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 p -95.67 113.93 25.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.063 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -86.94 95.51 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.027 0.441 . . . . 0.0 110.918 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HG2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -88.11 117.66 27.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.769 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 t -90.6 107.89 19.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.037 0.446 . . . . 0.0 110.293 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HB2' HG23 ' A' ' 22' ' ' VAL . . . -105.66 127.57 53.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.349 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 40' ' ' LEU . 22.3 pt -127.15 140.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.46 167.43 19.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.346 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.12 168.4 15.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.8 -37.19 86.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.77 -49.17 78.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -67.6 -45.44 75.5 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.082 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 p -67.24 -32.78 74.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.398 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.61 -49.42 77.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.16 97.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.2 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.471 HD11 ' HG ' ' A' ' 27' ' ' LEU . 92.8 mt -65.98 -41.87 90.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.796 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.87 86.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.661 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.56 -39.82 71.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.0 110.63 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.34 -37.41 72.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.437 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -91.27 -35.33 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.51 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.76 -18.95 5.33 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 t -94.22 96.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.497 ' HD2' ' HG3' ' A' ' 91' ' ' ARG . 46.3 p90 -122.74 154.07 38.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.602 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG3' ' HD2' ' A' ' 90' ' ' PHE . 20.2 mtp180 64.93 22.68 12.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.128 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.12 90.33 13.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.676 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.68 133.64 15.82 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.48 -172.68 3.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.26 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 15.3 m -99.81 108.72 21.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.4 117.42 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.211 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.7 p -102.58 128.76 55.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.234 0.54 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -121.39 134.06 55.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.086 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.595 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 34.2 p -119.99 123.7 44.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.001 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.97 22.9 65.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.488 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 1.44 90.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.923 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -100.51 143.13 31.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.52 0.2 . . . . 0.0 110.516 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.74 112.52 3.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.254 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.481 ' HB3' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.55 -49.75 6.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.48 -173.08 46.03 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.163 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.2 136.51 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.846 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.3 mt -122.52 157.67 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.225 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.496 ' HB2' ' HE1' ' A' ' 111' ' ' HIS . 18.5 m120 -132.39 142.63 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.04 165.62 50.86 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.52 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 110' ' ' ILE . 3.6 mp 60.98 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.673 0.749 . . . . 0.0 111.067 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.496 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 9.0 m80 -155.94 150.19 19.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.167 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' HG2' ' HB3' ' A' ' 115' ' ' GLU . 13.0 Cg_endo -57.22 137.08 80.13 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.56 2.173 . . . . 0.0 111.216 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.52 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.8 t-105 -59.4 -43.97 92.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.581 -173.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.34 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.592 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . 44.6 tt0 -72.5 -39.28 67.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.347 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.82 -45.27 93.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.967 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 113' ' ' TRP . 63.2 mt -60.84 -49.82 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -50.61 -56.19 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.208 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 82.7 mt -64.89 -43.3 93.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.995 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -65.52 -47.45 75.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.45 . . . . 0.0 110.076 -177.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ttt85 -65.62 -32.63 74.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.42 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.2 68.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.956 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 65.4 mt -75.64 -53.2 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.954 -0.145 . . . . 0.0 111.055 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 120' ' ' MET . 18.8 m -64.56 -38.48 82.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.084 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 CA--C 1.539 0.536 0 O-C-N 124.037 0.835 . . . . 0.0 111.996 176.555 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 27.8 m . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 2.9 Cg_exo -76.14 -46.42 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.147 1.898 . . . . 0.0 111.59 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.85 -43.92 94.69 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -50.51 -52.68 36.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.59 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.99 -49.49 77.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.478 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -56.46 -46.47 80.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.871 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.488 ' CZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.4 t90 -66.08 -45.22 82.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.213 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -55.51 -40.13 71.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 16.1 mmm180 -60.24 -54.01 50.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -63.19 -33.28 75.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 74' ' ' ILE . 1.8 mm? -63.19 -30.04 71.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.554 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -29.21 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.739 0.304 . . . . 0.0 111.548 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -75.73 -7.38 54.22 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.35 19.74 44.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.785 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -76.71 128.09 34.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 109.786 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.4 m -83.0 129.71 60.32 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 29.6 Cg_endo -65.55 128.83 20.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.747 175.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.66 144.02 22.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -109.53 168.08 9.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.13 -39.49 94.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.705 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.2 t -77.6 -16.33 58.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.396 0.617 . . . . 0.0 110.815 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -98.91 -9.66 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 27' ' ' LEU . 1.5 tm? -59.59 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.162 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.25 -45.15 89.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 32' ' ' THR . 24.9 t70 -60.61 -55.14 36.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.538 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -57.9 -39.3 77.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.133 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.3 tp -66.54 -28.31 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -89.06 -26.26 21.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.713 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.93 -42.69 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 111.275 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 157.1 44.23 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.743 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.1 -69.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.012 1.808 . . . . 0.0 111.117 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.47 -79.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.982 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.67 -166.9 51.17 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.676 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 97' ' ' VAL . 19.3 m -135.93 150.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.523 ' HB ' ' HE2' ' A' ' 98' ' ' PHE . 74.7 t -129.96 127.07 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.34 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.2 mp -101.0 131.21 46.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.81 -39.58 69.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.488 177.182 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 t70 47.82 78.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.442 -168.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.2 106.31 0.92 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -12.95 81.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.821 4.348 . . . . 0.0 115.126 -159.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.22 -73.3 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.11 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -60.39 -35.06 74.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.648 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.74 -38.11 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -63.75 -47.37 87.05 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.413 -175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.71 -36.32 37.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 111.487 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.723 HD22 ' HG3' ' A' ' 120' ' ' MET . 23.9 tp -66.53 -55.14 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.118 -173.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.49 -27.45 67.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 48.8 mmt-85 -71.6 -7.82 50.19 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.84 -40.33 83.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.146 0.498 . . . . 0.0 110.176 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.619 ' HB3' ' HD2' ' A' ' 68' ' ' TYR . 99.2 m-85 -129.54 84.23 62.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.714 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -82.03 -14.02 9.98 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.871 2.381 . . . . 0.0 113.365 -174.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.77 -25.46 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.387 0.613 . . . . 0.0 110.268 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.619 ' HD2' ' HB3' ' A' ' 65' ' ' PHE . 60.4 m-85 -84.14 111.24 19.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.079 175.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 p -67.96 104.76 1.81 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.006 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -86.81 95.06 9.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.364 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -87.0 105.11 16.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.17 125.77 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.815 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.22 140.63 51.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.56 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 40' ' ' LEU . 13.8 pt -125.44 140.66 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.93 0.395 . . . . 0.0 110.558 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . . . -106.92 157.41 17.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB3' ' CH2' ' A' ' 11' ' ' TRP . 2.8 p30 -87.02 -174.07 4.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -59.44 -42.91 93.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.358 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -75.35 -36.93 60.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.29 0.567 . . . . 0.0 110.874 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 82.3 mm-40 -73.59 -44.66 56.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.499 -175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 p -59.38 -43.24 92.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.73 0.3 . . . . 0.0 110.932 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.98 -41.16 82.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -40.45 61.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.234 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 79' ' ' GLN . 77.8 mt -65.54 -48.06 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.372 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.62 -48.15 83.78 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.894 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.52 -52.41 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 122.636 0.374 . . . . 0.0 110.673 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -68.52 -26.39 65.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.92 -26.61 31.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.078 0.466 . . . . 0.0 110.237 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.79 -0.24 48.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.75 -26.47 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 109.938 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 72.5 m-85 65.14 -141.78 0.22 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.118 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 92' ' ' PHE . 50.7 mtt-85 -92.1 -158.1 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.654 -170.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 90.5 t80 75.16 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.185 0 O-C-N 124.219 0.949 . . . . 0.0 109.456 -172.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.77 131.16 20.64 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.674 2.25 . . . . 0.0 112.27 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.05 -174.8 4.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.37 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.2 m -92.11 113.36 25.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.08 118.85 32.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.178 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.53 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.3 p -98.39 131.65 45.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' HE2' ' HB ' ' A' ' 39' ' ' VAL . 95.2 m-85 -118.22 146.7 44.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.278 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 1.9 m -153.4 146.28 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.28 20.55 63.2 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.059 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 16.43 78.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.755 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -131.47 174.0 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -70.06 112.9 6.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.817 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.71 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.5 tpm_? -90.24 -41.49 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.225 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.59 -175.39 44.44 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.855 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.6 137.97 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.2 mt -94.7 161.34 14.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.705 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -169.31 96.28 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.079 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.79 91.8 0.58 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.727 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.17 -31.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.353 0.597 . . . . 0.0 111.46 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.635 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 6.4 t-80 -68.28 -58.87 6.81 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -168.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 11.8 Cg_exo -71.02 121.87 8.25 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.721 1.614 . . . . 0.0 112.308 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.444 ' CE2' HD11 ' A' ' 117' ' ' ILE . 7.1 t-105 -93.51 -45.41 7.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.214 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.43 98.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.49 -43.46 94.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.696 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 30.7 tp -58.59 -49.39 77.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.904 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.444 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.7 mt -58.17 -48.93 83.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -52.16 -55.63 19.78 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.146 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.2 mt -64.62 -45.26 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.691 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.723 ' HG3' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -60.72 -51.77 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttm-85 -64.09 -39.45 94.09 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.189 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.01 -30.35 73.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.542 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.517 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 95.0 mt -81.43 -56.68 3.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.425 0.155 . . . . 0.0 110.822 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 120' ' ' MET . 31.8 m -68.56 -36.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.557 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 21.3 m . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.557 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 33.1 Cg_endo -65.62 -46.32 5.45 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.693 1.595 . . . . 0.0 112.009 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -66.37 -41.69 89.1 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.267 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.29 -53.59 56.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 110.293 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.79 -42.86 98.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.278 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -60.47 -49.7 76.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.903 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -37.28 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.68 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.81 -37.14 78.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.4 mtt180 -69.89 -52.03 28.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.55 177.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.5 mtp -55.11 -40.7 70.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.843 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.47 -31.01 70.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.279 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.62 68.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -85.34 -1.07 56.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.633 0.254 . . . . 0.0 111.486 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.53 22.84 41.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.009 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -81.55 119.08 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -78.8 121.17 83.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.719 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -82.78 127.88 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.817 2.344 . . . . 0.0 111.79 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.88 137.76 13.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 0.0 111.01 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 25' ' ' SER . 4.4 m -94.43 130.95 40.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.605 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' SER . 1.5 tm-20 17.86 -98.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.727 1.211 . . . . 0.0 111.491 162.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 23' ' ' SER . 14.7 t 23.84 -78.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.021 1.328 . . . . 0.0 113.927 149.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.408 ' HG3' ' HD1' ' A' ' 30' ' ' TRP . 9.7 tpp180 -106.92 -15.61 14.66 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.571 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.51 -36.39 73.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.136 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' HH12 ' A' ' 86' ' ' ARG . 25.5 t70 -66.1 -41.88 90.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.568 ' O ' HG23 ' A' ' 32' ' ' THR . 32.3 t70 -57.93 -49.61 76.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.816 0.817 . . . . 0.0 109.885 174.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.408 ' HD1' ' HG3' ' A' ' 26' ' ' ARG . 5.3 m95 -53.5 -43.01 67.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.406 173.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -38.29 90.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 29' ' ' ASP . 11.0 t -74.35 -25.11 59.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.82 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.99 -10.11 53.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.315 177.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 103.69 44.47 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.62 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.17 -36.35 81.29 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.571 2.18 . . . . 0.0 111.085 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 37' ' ' GLY . 3.2 m-20 -80.78 -88.8 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.249 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . 96.86 113.37 3.0 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.926 173.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 72' ' ' VAL . 11.1 m -138.78 134.28 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 0.0 110.406 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.35 129.1 67.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.515 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.7 117.49 34.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.453 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.67 26.1 7.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 -178.625 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 52.65 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.979 0.799 . . . . 0.0 111.653 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -160.12 85.74 2.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.17 44.15 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.847 2.365 . . . . 0.0 112.971 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.72 -26.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.049 0.452 . . . . 0.0 110.488 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -24.6 67.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.692 -173.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' O ' HD13 ' A' ' 62' ' ' LEU . 48.8 mm -61.77 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 110.575 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.21 68.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.567 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.92 -31.64 70.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.045 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -70.84 -46.03 63.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.04 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 58' ' ' ILE . 10.0 mp -59.07 -27.72 65.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.368 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.86 -14.79 36.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.45 -44.69 82.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.636 0.255 . . . . 0.0 110.834 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.99 72.04 34.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.655 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -91.53 15.99 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.148 2.565 . . . . 0.0 112.822 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.89 -25.35 59.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.482 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -157.31 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.7 p -116.87 102.49 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 112.073 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -95.25 84.41 4.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.89 104.35 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.385 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 38' ' ' VAL . 52.7 t -87.64 103.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.021 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.13 132.25 52.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' A' ' 40' ' ' LEU . 18.0 pt -114.37 139.69 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.31 154.68 19.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.794 0.33 . . . . 0.0 111.358 -176.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 2.0 m-20 -56.96 155.95 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.646 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.33 -53.86 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.21 -26.74 59.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.094 0.473 . . . . 0.0 110.894 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.477 ' CG ' ' HB2' ' A' ' 76' ' ' ASP . 20.1 mm-40 -70.36 -29.66 66.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.719 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -62.86 -38.6 91.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.522 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.68 -42.89 95.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.614 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.07 93.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.17 -47.88 90.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.92 -46.98 93.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.688 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.86 -45.55 86.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.636 HH12 ' HB2' ' A' ' 28' ' ' ASP . 47.6 ttt180 -57.76 -37.34 73.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.468 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' A' ' 89' ' ' VAL . 19.8 t80 -82.26 -40.12 22.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 0.0 109.843 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.1 33.56 4.26 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.593 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 87' ' ' PHE . 21.8 t -92.81 -15.57 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.507 0.194 . . . . 0.0 110.941 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.6 t80 72.15 174.01 0.3 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -172.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -71.23 96.81 1.45 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.808 0.337 . . . . 0.0 111.016 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -142.39 100.82 5.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.83 123.97 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.781 2.32 . . . . 0.0 111.914 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -172.05 -170.08 0.71 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.818 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 30.8 m -96.73 109.27 21.96 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.61 120.32 34.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.048 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.92 130.35 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.982 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.73 172.89 6.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.539 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.68 122.83 7.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.632 175.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.61 29.84 54.86 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.716 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.01 90.63 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.892 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.82 157.09 18.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.092 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -71.69 119.08 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -93.7 -46.27 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.38 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.55 -167.67 40.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.108 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.5 134.58 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.941 0.401 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.2 mt -92.71 114.36 26.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.293 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.7 98.86 6.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.335 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.48 140.35 2.87 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.33 -39.16 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -109.41 -44.56 0.1 Allowed Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 16.5 Cg_exo -65.17 120.32 7.52 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 120.718 1.292 . . . . 0.0 110.897 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.511 ' HE3' ' HA ' ' A' ' 113' ' ' TRP . 2.1 t-105 -97.68 -51.0 4.26 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.825 -168.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.14 73.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 110.466 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -77.84 -35.14 51.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.419 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -62.57 -46.6 87.59 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.1 mt -61.26 -43.0 95.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.399 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -49.75 -58.04 6.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.225 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.5 mt -57.09 -49.2 76.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.724 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.491 ' O ' HG21 ' A' ' 124' ' ' VAL . 15.8 tpt -61.5 -42.78 99.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.547 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.03 -35.99 82.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.09 71.06 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.237 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 95.9 mt -78.06 -47.25 18.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 120' ' ' MET . 34.4 m -77.92 -34.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.297 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.617 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 99.3 m . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 58.8 Cg_endo -75.15 -66.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.336 1.357 . . . . 0.0 113.248 -175.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -60.85 -33.34 72.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.77 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.44 -53.89 50.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.674 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.68 89.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.961 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -55.3 27.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.844 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -65.51 -36.94 85.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.81 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -56.09 -39.64 72.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.588 0.232 . . . . 0.0 111.146 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 32.5 mmt180 -63.19 -51.86 64.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.452 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 87.2 mtp -55.1 -38.87 68.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.272 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.62 -38.23 67.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.999 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.21 -28.14 69.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.99 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -64.08 -20.77 66.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.67 32.49 7.61 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.325 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -98.85 134.81 41.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.012 0.434 . . . . 0.0 110.026 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 2.6 p -86.43 137.79 34.3 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.819 -176.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 1.8 Cg_endo -82.56 141.28 11.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.313 2.675 . . . . 0.0 113.257 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.72 148.04 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -114.77 167.73 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -36.77 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.929 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 t -79.78 4.74 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.381 0.61 . . . . 0.0 110.398 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -118.09 -12.49 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.837 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tt -48.72 -47.77 41.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.269 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -68.32 -51.52 43.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.065 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 32' ' ' THR . 13.4 t70 -54.76 -55.46 29.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.219 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -69.03 -31.61 70.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 HD22 ' A' ' 102' ' ' ASN . 27.9 tp -67.7 -28.36 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.697 0.76 . . . . 0.0 109.688 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 85.6 m -71.32 -29.85 65.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.373 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.73 -61.37 2.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.73 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.74 113.85 59.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.824 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.51 -16.46 4.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.486 2.124 . . . . 0.0 112.888 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 24.6 m-20 -122.19 159.76 26.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.356 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.89 -166.32 25.69 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.209 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.82 137.11 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 99.0 t -117.41 119.65 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.164 0.507 . . . . 0.0 110.03 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' A' ' 74' ' ' ILE . 6.9 mp -101.94 122.15 43.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.216 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.741 ' HB2' ' H ' ' A' ' 94' ' ' ALA . 7.7 mp -94.13 17.94 11.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.855 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.465 0.318 0 O-C-N 124.254 0.971 . . . . 0.0 110.088 -174.618 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.432 0.158 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 54' ' ' ASN . 10.5 t70 50.81 -144.73 0.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.796 0.685 . . . . 0.0 109.573 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 18.5 m120 -131.27 96.51 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.63 15.98 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.334 2.689 . . . . 0.0 113.617 -174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.09 -31.31 34.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.339 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -27.41 69.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.381 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.402 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.8 mm -59.99 -44.54 94.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.072 0.463 . . . . 0.0 110.237 176.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -66.69 -38.72 93.38 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.996 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -70.25 -28.75 65.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.301 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.769 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 63.5 tp -64.81 -49.36 70.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.8 mp -60.56 -25.63 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.797 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 36.7 mmt180 -56.81 -15.15 4.16 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.8 -8.69 59.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.047 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 73.7 m-85 -132.61 63.8 69.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.085 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -85.88 2.16 7.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.379 2.052 . . . . 0.0 112.961 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.8 -13.12 19.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.49 0.662 . . . . 0.0 109.901 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -108.98 120.0 41.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -64.65 110.11 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.648 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 87.8 m95 -91.22 117.24 29.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.551 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.69 106.21 18.19 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.34 105.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.889 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -114.78 140.05 49.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.801 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 24.3 pt -121.93 140.3 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.54 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 80' ' ' SER . . . -97.3 161.6 13.72 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.571 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -65.83 171.81 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.79 -55.7 21.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.052 0.453 . . . . 0.0 109.837 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -78.17 -34.82 49.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.642 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 96.6 mt-30 -67.57 -35.06 78.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.81 -175.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.651 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 29.5 p -60.72 -48.61 81.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -57.98 -47.58 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.138 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.19 81.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.782 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 79' ' ' GLN . 67.9 mt -62.11 -51.38 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.131 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.91 94.01 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.565 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -54.46 -44.69 72.77 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 111.221 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 86' ' ' ARG . 23.1 ttt180 -73.0 -31.15 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.729 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -85.17 -31.13 23.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.27 25.07 11.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.43 111.16 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.858 -0.201 . . . . 0.0 110.893 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 69.77 -58.48 0.52 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.691 0.797 . . . . 0.0 112.859 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 70.9 15.21 6.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.832 0.825 . . . . 0.0 108.826 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -129.6 151.19 77.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.98 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.616 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 51.3 Cg_exo -56.16 132.93 54.93 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.818 2.345 . . . . 0.0 112.744 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.741 ' H ' ' HB2' ' A' ' 41' ' ' LEU . . . -165.22 -175.49 3.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.018 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 43.7 m -109.4 115.53 30.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.02 136.36 44.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -114.71 137.03 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.71 128.88 53.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.558 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -169.7 134.61 1.4 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.13 0.491 . . . . 0.0 112.28 -175.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.29 22.63 65.54 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.737 173.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 130.99 59.78 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.046 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.528 HD22 HD23 ' A' ' 31' ' ' LEU . 1.0 OUTLIER 65.59 -153.53 0.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.906 0.483 . . . . 0.0 111.739 172.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -41.38 112.22 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.222 0.951 . . . . 0.0 111.754 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -101.04 -31.58 11.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.583 -176.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.29 -174.17 42.47 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.353 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.83 137.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.551 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.2 mt -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.408 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -133.18 142.15 48.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.432 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.93 167.17 43.15 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.114 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 51.0 mm -83.22 -69.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 60.9 m80 71.61 156.49 0.16 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 123.8 0.687 . . . . 0.0 111.537 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.16 152.13 82.43 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.411 2.074 . . . . 0.0 111.052 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.769 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 20.9 t-105 -56.75 -40.8 76.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.527 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.04 79.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.359 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -80.26 -26.79 38.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -46.61 85.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.33 -41.03 91.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.876 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.77 -53.87 46.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.434 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.72 -49.16 76.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.407 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.632 ' HG2' HD23 ' A' ' 61' ' ' LEU . 15.4 tpt -54.5 -51.98 63.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.909 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.514 ' HA ' HG23 ' A' ' 124' ' ' VAL . 15.7 ttt180 -70.61 -33.57 71.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.725 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.92 -30.86 74.26 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.538 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.6 mt -83.89 -59.81 2.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.026 0.13 . . . . 0.0 111.058 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 121' ' ' ARG . 27.7 m -65.17 -27.23 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.324 -0.534 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.871 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 31.1 m . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 13.9 Cg_endo -58.23 -55.69 2.06 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.121 1.881 . . . . 0.0 112.657 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -64.71 -42.04 95.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.4 -51.49 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.97 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.15 76.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.556 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -46.05 80.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -65.64 -41.93 92.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.354 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.25 -37.02 74.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.388 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.86 -53.63 47.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.0 mtm -60.87 -36.96 80.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 110.6 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.493 HD23 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.5 -40.45 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.567 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.2 67.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.533 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -75.56 -5.95 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.93 23.27 30.61 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.96 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -88.96 118.89 29.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 m -80.02 121.67 82.28 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.349 -169.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 39.6 Cg_endo -70.08 120.9 7.55 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 0.0 110.761 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 27' ' ' LEU . 12.4 p -124.95 143.82 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.2 t -84.91 159.32 20.35 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.778 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.53 -54.16 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.124 0.57 . . . . 0.0 111.98 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 m -67.05 -23.71 65.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.149 0.499 . . . . 0.0 111.362 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -86.72 -26.1 24.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.332 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.495 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -60.42 -41.36 93.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.05 -42.52 72.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.251 0.548 . . . . 0.0 110.324 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 13.4 t70 -63.72 -55.81 20.44 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.366 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.572 ' HZ3' ' HB1' ' A' ' 73' ' ' ALA . 2.6 t90 -62.94 -35.76 81.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.447 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.494 ' O ' HD11 ' A' ' 31' ' ' LEU . 2.4 tm? -63.83 -32.04 73.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.647 0.737 . . . . 0.0 109.044 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 97.5 m -71.95 -37.49 69.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.793 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 14.6 mm-40 -74.41 -33.72 63.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.13 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.03 142.98 30.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.381 -177.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.6 Cg_exo -69.6 -39.67 6.53 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.822 2.348 . . . . 0.0 111.874 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 6.8 t70 -145.67 154.46 42.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.16 147.68 9.45 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.907 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 97' ' ' VAL . 29.4 m -125.2 142.43 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 55.8 t -125.04 131.9 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.512 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.31 124.77 47.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.4 mp -98.2 125.12 43.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.303 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.66 ' HA ' HG13 ' A' ' 110' ' ' ILE . 14.7 t70 -72.07 113.45 9.12 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 49.72 63.48 10.12 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.991 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.56 -41.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.124 1.883 . . . . 0.0 113.664 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.89 -42.18 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -56.58 -24.44 47.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.456 ' O ' HD13 ' A' ' 62' ' ' LEU . 41.8 mm -62.03 -44.35 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.837 0.351 . . . . 0.0 110.958 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.81 -26.75 74.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.062 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.91 -42.76 38.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.992 0.425 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.758 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 48.9 tp -60.75 -48.28 82.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.646 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.3 mp -58.72 -26.86 64.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.888 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 11.4 mmt180 -68.3 -7.63 32.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 10.1 pt-20 -83.09 4.88 24.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.298 175.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . 97.7 m-85 -109.97 90.15 9.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.03 -43.41 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.056 2.504 . . . . 0.0 113.517 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.72 -25.61 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.223 0.535 . . . . 0.0 110.679 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 65' ' ' PHE . 11.1 t80 -88.77 107.78 19.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.615 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 p -89.06 125.76 35.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.993 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -102.82 129.77 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.118 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -87.39 105.98 17.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.36 115.81 33.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.91 0.386 . . . . 0.0 110.592 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB1' ' HZ3' ' A' ' 30' ' ' TRP . . . -121.76 147.56 45.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.553 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.574 HG22 ' HB2' ' A' ' 40' ' ' LEU . 10.4 pt -134.55 147.4 29.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.058 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.81 39.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 3.5 m-20 -60.43 179.66 0.15 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.63 -55.9 28.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.629 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.52 -42.98 81.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.452 ' OE1' ' HB2' ' A' ' 76' ' ' ASP . 14.3 mp0 -54.96 -51.1 67.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.205 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 p -65.62 -39.58 91.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.59 0.233 . . . . 0.0 110.647 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.58 -46.01 91.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.179 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.29 82.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.334 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.26 -44.23 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.331 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.42 87.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.909 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.35 -50.77 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.179 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -65.49 -27.91 68.82 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -87.48 -23.59 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.014 0.435 . . . . 0.0 109.829 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.16 32.03 10.16 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.507 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.13 82.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 85.8 m-85 53.19 -156.99 0.17 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.385 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -158.28 41.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 87.4 m-85 -129.46 160.19 65.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.136 -174.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 52.0 Cg_exo -53.56 130.52 39.17 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.602 2.201 . . . . 0.0 112.231 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -175.65 158.95 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 32.7 m -107.6 115.16 29.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.671 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.01 129.4 42.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 104' ' ' ARG . 3.9 p -108.21 125.71 64.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.289 0.566 . . . . 0.0 111.545 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.25 119.49 37.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.964 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -101.67 -175.68 2.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.095 -174.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.41 ' H ' HG21 ' A' ' 99' ' ' THR . . . -54.41 -28.17 43.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.442 170.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.11 28.73 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.879 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 102' ' ' ASN . 1.3 t-20 65.99 -156.48 0.26 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.524 0.73 . . . . 0.0 111.113 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -49.51 125.38 11.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.201 0.524 . . . . 0.0 111.633 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.476 ' HB3' HG12 ' A' ' 97' ' ' VAL . 1.7 tpt180 -104.75 -59.57 1.72 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.216 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.76 -159.12 21.07 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.807 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.54 134.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 3.0 mm? -92.99 117.1 29.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.552 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.65 154.05 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.41 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.826 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.66 HG13 ' HA ' ' A' ' 53' ' ' ASP . 41.3 mm -84.2 78.36 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 52.1 m-70 -156.72 -61.38 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 172.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 16.8 Cg_endo -94.73 124.77 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.565 2.177 . . . . 0.0 113.058 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.758 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 19.3 t-105 -82.69 -39.63 21.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.307 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.28 97.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.675 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 20.2 mp0 -64.78 -39.0 92.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.995 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.47 -48.01 82.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.0 mt -61.41 -42.49 93.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.125 0.488 . . . . 0.0 110.244 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -58.04 -49.18 77.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.847 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.6 mt -59.68 -44.8 93.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.905 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt -62.5 -37.47 86.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.728 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 121' ' ' ARG . 3.4 tmm_? -62.96 -41.88 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.21 -30.94 79.22 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.588 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.82 -56.54 4.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.097 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 121' ' ' ARG . 28.5 m -64.02 -41.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.225 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' HB3' HH11 ' A' ' 121' ' ' ARG . 43.5 tt0 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.539 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 56.0 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 119.551 -0.262 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 36.9 Cg_endo -65.76 -64.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.584 1.523 . . . . 0.0 112.831 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 38.2 p90 -66.18 -32.31 73.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -54.93 -54.91 36.64 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.326 0.584 . . . . 0.0 110.763 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.607 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -60.83 -41.17 95.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.462 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -57.01 -47.5 80.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.455 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.94 -43.72 91.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.51 -32.77 71.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.393 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 59.5 mmt-85 -62.84 -54.52 37.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.479 175.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.0 mtm -60.96 -33.45 73.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 74' ' ' ILE . 3.1 mm? -65.05 -37.97 89.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.575 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.6 -19.21 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 17.1 mmm180 -84.85 -4.73 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.16 17.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.857 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -100.66 136.89 39.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.048 0.451 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 m -86.63 124.6 69.19 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.47 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -80.25 146.21 17.58 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.929 2.419 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 HG11 HD21 ' A' ' 27' ' ' LEU . 12.0 p -148.74 145.26 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.67 0.271 . . . . 0.0 111.133 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 m -73.53 159.59 32.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.371 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 8.6 tm-20 -55.56 -58.6 7.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.502 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -70.11 -7.29 40.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.113 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -106.23 -16.83 14.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.324 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.487 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -59.19 -43.04 92.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.359 0.599 . . . . 0.0 110.436 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.502 ' O ' HG21 ' A' ' 32' ' ' THR . 17.3 t70 -63.87 -54.0 41.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.527 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.408 ' CH2' ' HB3' ' A' ' 71' ' ' GLN . 91.1 t90 -54.33 -43.59 71.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.103 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.79 -44.19 94.07 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.382 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.502 HG21 ' O ' ' A' ' 29' ' ' ASP . 6.6 t -74.88 -24.32 58.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.02 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -80.36 -16.9 53.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.087 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.97 152.85 38.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.5 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 -23.0 22.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.353 2.036 . . . . 0.0 112.277 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 7.4 t70 -156.37 -171.61 3.77 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 98' ' ' PHE . . . 165.1 128.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.58 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.34 146.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 59.2 t -133.26 136.77 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.665 0.269 . . . . 0.0 111.021 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -97.68 125.96 42.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 80' ' ' SER . 0.9 OUTLIER -94.84 125.43 39.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.659 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 11.1 t . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 10' ' ' LEU . 32.2 t . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -84.4 -168.47 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.453 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.407 ' OD1' HG12 ' A' ' 58' ' ' ILE . 43.0 t30 62.17 72.78 0.6 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.568 . . . . 0.0 111.67 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -92.78 -40.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.403 2.069 . . . . 0.0 113.491 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.29 -33.12 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.5 -31.56 66.14 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 62' ' ' LEU . 13.5 mm -65.35 -38.75 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.133 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.19 99.67 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.896 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.3 mm-40 -72.8 -28.65 62.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HG ' ' HG2' ' A' ' 120' ' ' MET . 34.8 tp -68.18 -35.04 77.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 58' ' ' ILE . 6.7 mp -60.96 -26.86 67.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.376 176.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 72.8 mtt180 -62.59 -7.42 4.69 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.66 -31.39 68.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 110.383 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.52 88.5 49.89 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.978 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.53 -20.06 16.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.761 2.307 . . . . 0.0 111.774 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.8 -11.66 52.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.59 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -120.41 115.31 23.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.13 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 t -80.59 156.95 26.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.669 0.747 . . . . 0.0 110.554 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -124.76 124.57 42.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.571 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -91.35 98.46 11.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.012 0.434 . . . . 0.0 109.947 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.81 111.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.091 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -123.76 149.28 45.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.36 0.6 . . . . 0.0 111.063 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.8 pt -130.53 140.3 49.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.37 164.01 13.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.006 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.4 m-20 -61.96 150.42 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.989 173.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.423 HD12 ' CD2' ' A' ' 7' ' ' PHE . 15.4 mt -53.6 -45.71 70.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.742 -174.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.94 -47.42 18.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.685 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 39.9 mt-30 -69.79 -18.57 63.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.597 ' HB2' HD21 ' A' ' 41' ' ' LEU . 11.6 p -61.5 -34.0 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.272 0.558 . . . . 0.0 110.559 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.69 -46.67 88.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.625 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . . . -63.51 -40.16 96.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.487 HD13 ' HG ' ' A' ' 27' ' ' LEU . 63.4 mt -62.01 -44.79 99.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.29 -43.49 97.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.685 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.83 -41.97 98.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.66 -32.94 67.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -92.37 -45.64 8.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.962 0.411 . . . . 0.0 110.424 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.55 23.9 4.25 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.081 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.77 -83.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.6 t80 59.01 -163.93 0.21 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.628 0.58 . . . . 0.0 109.927 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.433 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 34.1 ttp180 65.04 80.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.785 0.434 . . . . 0.0 111.757 175.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 89.6 m-85 72.0 141.23 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 13.1 Cg_exo -72.53 138.22 29.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 124.072 3.181 . . . . 0.0 112.73 176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 -178.19 6.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.541 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.613 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.6 m -92.18 122.86 35.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 106' ' ' VAL . 43.6 mt -99.48 113.87 26.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 104' ' ' ARG . 13.4 p -103.55 126.68 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.7 0.762 . . . . 0.0 110.93 -178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.578 ' HD1' ' HA ' ' A' ' 103' ' ' TYR . 46.3 m-85 -122.87 150.55 42.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.427 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 40.6 p -128.43 124.49 36.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.91 28.97 71.15 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.931 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 -1.44 88.75 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.768 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.53 143.76 33.24 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.32 0.581 . . . . 0.0 111.717 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.578 ' HA ' ' HD1' ' A' ' 98' ' ' PHE . 73.3 t80 -69.42 136.99 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.292 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.619 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 1.5 mmp_? -113.79 -64.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.627 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . -172.06 -166.58 30.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.22 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 96' ' ' LEU . 6.5 m -122.23 146.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 122.476 0.31 . . . . 0.0 111.111 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 5.9 mp -99.63 134.0 43.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -123.48 12.61 9.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.383 0.611 . . . . 0.0 110.565 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.21 117.59 5.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.289 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.02 -36.42 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.874 0.368 . . . . 0.0 111.381 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.464 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 91.0 m-70 -122.7 -52.52 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 31.6 Cg_exo -56.84 123.19 13.27 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.729 1.619 . . . . 0.0 112.567 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.492 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.6 t-105 -85.18 -40.43 16.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.616 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.65 86.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 37.9 tt0 -72.84 -32.44 65.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.355 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 29.3 tp -64.46 -46.82 81.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 61.0 mt -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -51.07 -57.49 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.76 -46.89 88.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.077 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.576 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.6 tpt -54.17 -44.67 71.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 125' ' ' GLU . 14.6 mmt180 -55.98 -49.12 74.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.2 -30.12 75.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.734 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.409 HD22 ' HA3' ' A' ' 105' ' ' GLY . 94.4 mt -84.34 -55.09 4.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 120' ' ' MET . 23.9 m -87.01 -26.07 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.723 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 121' ' ' ARG . 31.5 tt0 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.501 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 82.9 m . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 19.7 Cg_endo -63.31 -52.57 1.93 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.654 1.569 . . . . 0.0 111.417 172.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -67.15 -35.21 79.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.369 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.69 -53.77 54.59 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.207 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -57.89 -46.21 85.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.084 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 2.0 mm? -57.17 -51.81 67.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.511 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -65.55 -42.06 92.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.111 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 14.5 mm100 -59.82 -31.76 70.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.585 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 35.5 mmt180 -57.33 -54.52 45.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 110.605 174.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.483 ' HG3' ' HZ3' ' A' ' 19' ' ' TRP . 4.9 mpp? -66.86 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 2.4 mm? -64.57 -48.33 75.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.82 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.92 64.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.008 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 34.5 mmt180 -73.81 -21.15 60.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.648 0.261 . . . . 0.0 110.386 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.43 21.85 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.784 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.483 ' HZ3' ' HG3' ' A' ' 14' ' ' MET . 27.4 m0 -93.05 168.1 11.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.7 m -112.96 130.97 23.01 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 40.4 Cg_endo -68.91 121.4 8.27 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.909 2.406 . . . . 0.0 111.678 172.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.3 145.73 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.565 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 m -112.5 168.42 9.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.271 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.9 -47.47 85.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -71.74 -7.94 51.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.914 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 29' ' ' ASP . 28.3 mmt180 -117.7 -7.02 11.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.719 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.43 -49.45 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.12 -34.69 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.134 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 32' ' ' THR . 22.3 t70 -62.16 -56.98 13.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.038 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -74.65 -26.65 60.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.997 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.18 -35.03 78.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 111.081 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 29' ' ' ASP . 5.6 t -80.97 -26.53 36.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.007 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -96.7 -0.91 47.58 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.011 0.434 . . . . 0.0 111.699 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.8 87.48 3.71 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.73 148.2 36.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.548 2.166 . . . . 0.0 113.62 -171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.8 t70 80.62 144.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.595 1.184 . . . . 0.0 111.649 174.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.03 -173.55 27.16 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.332 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 m -138.09 138.91 43.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 73' ' ' ALA . 52.9 t -122.62 129.41 75.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.66 124.71 32.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.47 98.89 10.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 178.047 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -96.96 -0.28 47.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 110.659 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 49.6 t-20 -78.43 -54.55 1.17 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 54' ' ' ASN . 12.5 Cg_exo -70.88 44.58 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.037 2.491 . . . . 0.0 114.505 -169.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.31 -53.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.56 -25.82 64.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.473 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 62' ' ' LEU . 45.2 mm -60.78 -37.99 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.42 -34.25 89.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.619 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.68 -37.72 62.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.306 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 44.6 tp -64.18 -38.76 92.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.253 -176.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 58' ' ' ILE . 8.6 mp -65.41 -26.24 67.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.643 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -66.46 -9.04 30.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -70.1 -34.02 72.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.66 85.76 57.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.696 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -88.15 4.95 5.52 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.431 2.754 . . . . 0.0 112.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.86 -20.97 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 0.0 111.075 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -167.74 1.35 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 p -129.91 104.93 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -85.88 96.7 9.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.225 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.73 108.24 8.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.481 . . . . 0.0 109.768 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.66 108.27 20.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -116.58 145.01 43.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.912 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 6.9 pt -124.56 140.48 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.019 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.45 143.09 41.28 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.382 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.81 160.93 22.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 58.9 tp -54.49 -43.31 71.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.394 0.434 . . . . 0.0 111.501 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.92 -33.44 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.402 0.62 . . . . 0.0 111.06 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -77.94 -32.06 51.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.094 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.1 p -74.45 -29.1 61.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.723 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 51.2 mt-10 -54.19 -53.12 57.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 175.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.18 73.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.49 -45.35 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 0.0 110.309 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -48.45 71.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.651 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -55.88 -42.67 76.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 110.875 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.12 -38.51 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.729 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -95.85 -36.83 10.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.565 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.08 8.03 13.94 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.735 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 96' ' ' LEU . 48.3 t -79.71 -24.41 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.36 105.57 0.3 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 178.86 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.772 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -146.23 143.62 19.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.977 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.16 124.54 6.67 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.629 2.219 . . . . 0.0 111.263 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.23 174.76 14.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.082 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -101.76 119.5 38.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.727 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 89' ' ' VAL . 85.0 mt -94.18 121.83 36.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 104' ' ' ARG . 6.0 p -95.69 132.63 39.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.149 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 94.7 m-85 -121.52 138.31 54.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.66 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -143.79 149.93 37.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 28.15 56.49 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.71 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.12 13.96 79.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.026 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -135.3 178.51 6.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.146 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.55 129.36 34.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -104.74 -51.83 2.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -176.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.79 -170.82 39.76 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.414 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.9 134.64 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.005 0.431 . . . . 0.0 111.499 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.09 110.38 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.018 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -121.55 129.9 53.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.915 0.388 . . . . 0.0 111.795 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.73 154.08 12.18 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.155 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.7 134.94 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -139.02 144.66 42.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.98 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.7 159.7 23.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.657 2.238 . . . . 0.0 111.546 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.486 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 5.4 t-105 -55.86 -48.79 74.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.0 78.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -40.77 87.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.665 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.5 tp -62.19 -48.0 81.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.475 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.4 mt -60.61 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.015 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -55.11 -54.37 44.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.868 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.88 -47.39 85.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.493 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.2 tpt -59.63 -43.15 93.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.634 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -66.92 -33.75 76.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -30.97 71.14 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.23 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -84.7 -52.03 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.524 0.202 . . . . 0.0 111.527 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.32 -31.47 53.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.763 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.523 ' HB3' ' NH1' ' A' ' 104' ' ' ARG . 33.7 tt0 . . . . . 0 N--CA 1.449 -0.521 0 O-C-N 124.031 0.832 . . . . 0.0 112.679 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.662 ' HG3' HD22 ' A' ' 77' ' ' LEU . 69.4 mtm . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -63.39 116.43 5.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.313 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 67.65 72.81 0.32 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.902 0.751 . . . . 0.0 110.665 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.22 122.96 24.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.536 0.684 . . . . 0.0 110.382 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 40.0 m -159.28 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.673 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 15.3 Cg_endo -58.25 -63.58 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.068 1.845 . . . . 0.0 112.311 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.475 ' HE1' ' HG ' ' A' ' 42' ' ' SER . 86.9 t80 -64.53 -35.81 82.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 110.186 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.03 -51.49 67.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.613 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -64.64 -46.91 80.5 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.552 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 52' ' ' SER . 70.3 mt -55.38 -46.14 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.496 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 12.8 t90 -62.25 -50.64 70.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -58.51 -32.94 69.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.892 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 4.6 mmp_? -61.29 -57.34 12.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 111.166 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.576 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.8 ptt? -70.79 -29.34 65.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.8 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.817 HD23 ' HG3' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -57.42 -46.4 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.085 0.469 . . . . 0.0 109.897 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.72 -10.12 57.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.863 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HD2' ' HA ' ' A' ' 14' ' ' MET . 50.7 mtt180 -84.89 -5.19 59.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 0.0 110.995 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.19 21.65 8.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.144 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.41 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 52.8 m0 -97.14 115.26 27.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.32 140.82 85.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.154 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.817 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 Cg_exo -76.72 141.76 22.18 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.052 2.501 . . . . 0.0 111.48 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 73' ' ' ALA . 14.2 p -123.28 142.11 41.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.897 0.379 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -102.45 165.1 11.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HA ' HG12 ' A' ' 83' ' ' ILE . 3.4 tm-20 -57.21 -55.76 30.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -70.68 -13.39 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.031 0.443 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 26' ' ' ARG . 21.2 mmt180 -96.19 -8.13 33.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.674 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.564 HD21 HG23 ' A' ' 39' ' ' VAL . 3.0 tm? -66.77 -41.34 87.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.32 -37.83 80.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.854 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -60.92 -55.97 26.62 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.039 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -43.32 68.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.181 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.29 -44.74 84.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.914 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -83.3 -26.99 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.705 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -81.66 -29.75 33.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.53 141.58 28.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.0 111.452 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 8.2 Cg_exo -72.47 -38.38 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.577 2.184 . . . . 0.0 111.045 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -160.15 169.18 23.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.637 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.46 -179.63 31.29 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.092 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 HG13 ' HB ' ' A' ' 97' ' ' VAL . 16.9 m -137.07 145.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HD21 ' A' ' 27' ' ' LEU . 45.2 t -119.0 125.24 74.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.402 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.8 mp -98.8 116.44 31.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD11 HD12 ' A' ' 96' ' ' LEU . 9.7 mp -98.24 116.06 29.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.475 ' HG ' ' HE1' ' A' ' 7' ' ' PHE . 32.3 t -121.74 102.73 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.982 0.42 . . . . 0.0 110.942 -174.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.527 ' HB3' HH21 ' A' ' 91' ' ' ARG . 19.3 m -95.13 -73.92 0.57 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -151.11 143.2 16.0 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.173 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.48 148.46 90.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.882 2.388 . . . . 0.0 112.165 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -76.86 -32.74 57.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 47' ' ' ARG . 13.5 ttp180 -175.74 -58.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.581 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.5 m 66.45 141.76 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.193 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.76 -50.93 12.33 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.026 1.817 . . . . 0.0 111.403 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -110.18 -97.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.656 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 t -139.32 -69.59 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.005 0.431 . . . . 0.0 110.352 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 54' ' ' ASN . 46.8 t -92.4 -15.33 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' ASN . 17.8 t70 72.42 -22.26 0.22 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.206 1.002 . . . . 0.0 112.599 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 9.6 t30 83.05 99.54 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 123.572 0.749 . . . . 0.0 110.604 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.76 17.67 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 123.983 3.122 . . . . 0.0 114.599 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.23 -41.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -64.26 -24.79 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.247 -176.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.561 HD12 HD22 ' A' ' 116' ' ' LEU . 47.9 mm -67.74 -38.14 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.462 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.05 -49.32 58.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.222 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.66 -28.61 69.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.509 HD21 ' HG ' ' A' ' 116' ' ' LEU . 66.8 tp -60.87 -56.95 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 110.922 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.5 mp -62.23 -29.92 70.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.248 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -75.05 -7.71 54.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -78.04 -6.87 55.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.086 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.81 78.85 9.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.437 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.06 -12.09 21.38 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.592 2.195 . . . . 0.0 113.081 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.44 -25.28 63.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.524 0.678 . . . . 0.0 110.315 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -103.56 120.72 41.43 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.539 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 p -80.66 103.29 10.41 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.418 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.53 ' HB3' HD23 ' A' ' 62' ' ' LEU . 96.8 m95 -83.9 100.39 10.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.094 -173.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.09 107.19 15.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.566 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -87.65 114.07 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.691 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -110.75 124.61 52.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.555 HG23 ' HB2' ' A' ' 40' ' ' LEU . 8.5 pt -110.34 139.76 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.015 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.42 154.85 21.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.169 0.509 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' HB3' ' CG ' ' A' ' 79' ' ' GLN . 7.1 t70 -65.94 162.99 18.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.198 174.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.662 HD22 ' HG3' ' A' ' 1' ' ' MET . 56.3 tp -59.22 -53.04 62.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.15 -24.57 62.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.251 0.548 . . . . 0.0 110.228 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.473 ' CG ' ' HB3' ' A' ' 76' ' ' ASP . 89.3 mm-40 -76.08 -37.76 57.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.596 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.6 m -59.23 -42.72 91.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -62.45 -42.78 99.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.577 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.13 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.503 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 24' ' ' GLU . 80.2 mt -67.99 -43.77 85.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.351 . . . . 0.0 110.118 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.87 -46.11 94.04 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.636 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.4 -47.32 72.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.014 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.35 -31.17 71.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.732 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -87.77 -34.16 18.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.005 0.431 . . . . 0.0 110.675 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.31 45.09 1.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.145 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 90' ' ' PHE . 3.5 p -100.83 167.82 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' H ' HG23 ' A' ' 89' ' ' VAL . 18.6 m-85 -79.84 -67.61 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.683 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.527 HH21 ' HB3' ' A' ' 43' ' ' SER . 1.9 tpt180 -179.61 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.658 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 90.9 m-85 -51.06 117.22 8.44 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.882 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 5.4 Cg_exo -79.44 132.46 10.09 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.377 2.718 . . . . 0.0 111.889 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.24 -175.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.726 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 m -92.86 109.96 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.806 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.497 HD12 HD11 ' A' ' 41' ' ' LEU . 6.2 mp -96.06 125.86 40.89 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.926 HG13 ' HB2' ' A' ' 104' ' ' ARG . 2.5 p -104.01 132.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.183 0.516 . . . . 0.0 111.288 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -127.68 135.28 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.111 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 m -145.4 144.7 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.97 35.59 54.12 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.119 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.66 12.7 62.23 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.052 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -122.36 166.87 14.02 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 111.288 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -93.79 120.22 33.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.592 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.926 ' HB2' HG13 ' A' ' 97' ' ' VAL . 25.6 mmt180 -79.15 -55.16 5.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.483 0.658 . . . . 0.0 109.78 176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 123' ' ' LEU . . . 162.38 -166.75 36.66 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.939 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.47 134.37 65.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.089 0.471 . . . . 0.0 110.479 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.27 100.3 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.99 -7.9 52.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.174 0.511 . . . . 0.0 110.517 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.49 144.56 23.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.724 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.0 mm -136.53 -56.82 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.649 0.262 . . . . 0.0 111.566 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.762 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 36.9 t60 -88.02 -61.35 0.24 Allowed Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -168.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 23.5 Cg_exo -62.62 123.85 13.1 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.439 1.426 . . . . 0.0 111.864 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.432 ' O ' HG13 ' A' ' 117' ' ' ILE . 11.4 t-105 -76.49 -48.39 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.069 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.32 75.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 110.788 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 39.6 tt0 -75.64 -40.31 56.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.244 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.561 HD22 HD12 ' A' ' 58' ' ' ILE . 50.1 tp -57.57 -44.4 85.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 61' ' ' LEU . 68.8 mt -58.86 -45.37 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 40.5 t30 -61.68 -42.09 98.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.576 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 92.5 mt -60.32 -48.88 79.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.338 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.426 ' O ' HG23 ' A' ' 124' ' ' VAL . 13.3 tpt -65.93 -36.48 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 109.865 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 60.9 ttt180 -56.36 -45.08 80.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.958 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.88 -30.59 70.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.483 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.532 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 83.2 mt -77.63 -36.66 51.42 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.883 -0.186 . . . . 0.0 111.374 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 120' ' ' MET . 34.5 m -82.02 -39.76 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.262 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.38 97.29 34.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.934 0.397 . . . . 0.0 110.156 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 128' ' ' GLN . 59.7 Cg_endo -73.7 -174.1 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.894 2.396 . . . . 0.0 113.688 -175.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 126' ' ' PRO . 41.4 tt0 71.29 -41.48 0.51 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.436 1.094 . . . . 0.0 111.867 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 26.6 mt-30 -95.72 80.93 3.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.371 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER 76.42 121.6 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.338 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -149.31 36.27 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.05 117.01 4.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.611 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' HE1' ' HB3' ' A' ' 49' ' ' PRO . 23.3 mmt . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.639 0.257 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -67.15 89.58 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 47.09 54.42 9.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.143 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.41 ' C ' ' HG1' ' A' ' 5' ' ' THR . 42.2 t0 38.45 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.47 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 51.3 m -162.0 -54.11 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.304 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 34.0 Cg_endo -66.74 -36.57 23.93 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 121.83 1.686 . . . . 0.0 111.829 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CE2' ' HB2' ' A' ' 77' ' ' LEU . 85.9 t80 -75.3 -38.12 60.49 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.388 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -50.22 -51.48 43.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.709 0.766 . . . . 0.0 109.377 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.27 -45.95 92.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.747 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -54.69 -52.05 63.62 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 111.459 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.443 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.2 t90 -65.78 -37.88 87.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.218 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.725 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -60.05 -33.56 72.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 28.4 mmt85 -59.38 -55.28 36.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.324 0.583 . . . . 0.0 110.336 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.6 mtm -67.39 -31.63 71.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.325 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -69.38 -34.94 75.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -22.0 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 17' ' ' ARG . 19.3 mmm180 -82.09 -8.88 59.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.594 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.9 10.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.851 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 20.9 m -93.45 122.84 61.96 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 3.7 Cg_exo -81.66 117.74 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.435 2.757 . . . . 0.0 111.179 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.11 151.39 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -81.2 159.77 24.5 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HG3' ' HB2' ' A' ' 79' ' ' GLN . 1.5 mp0 -49.63 -57.01 8.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.543 0.737 . . . . 0.0 112.978 -170.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -63.23 -32.4 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.97 0.414 . . . . 0.0 111.521 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -88.53 -11.81 44.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.405 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.43 -42.26 83.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.52 -38.91 59.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.628 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 32' ' ' THR . 11.2 t70 -57.83 -55.6 32.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.565 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -59.82 -46.55 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.776 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.47 -41.5 94.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.86 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 29' ' ' ASP . 11.9 t -73.16 -25.92 60.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.381 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -89.86 -8.63 51.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.784 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 146.33 32.73 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.409 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.71 -39.17 12.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.404 2.069 . . . . 0.0 112.295 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.6 t70 -166.58 177.34 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.13 30.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.441 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 97' ' ' VAL . 15.8 m -136.51 146.24 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.41 125.11 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.214 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.4 mp -94.47 128.34 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 93' ' ' PRO . 56.0 tp -87.41 136.46 32.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.189 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 66.3 m -102.4 -153.31 0.46 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.09 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.524 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 70.6 m 75.28 135.24 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.869 0.731 . . . . 0.0 111.288 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 1' ' ' MET . 4.9 p-10 -107.68 92.27 8.5 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.628 . . . . 0.0 110.19 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 43' ' ' SER . 71.9 Cg_endo -95.59 -24.16 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.18 2.587 . . . . 0.0 114.291 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -98.65 -69.73 0.75 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.719 -170.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -179.45 -28.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.607 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.5 m -83.45 116.77 66.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.945 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 92.7 Cg_endo -94.86 8.32 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.426 2.751 . . . . 0.0 113.478 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 88.63 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.381 0.61 . . . . 0.0 109.719 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' H ' HD21 ' A' ' 10' ' ' LEU . 23.7 t -83.98 -24.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.75 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 m -78.79 -60.38 2.4 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.833 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.38 -69.21 0.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.883 0.739 . . . . 0.0 110.426 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -148.68 85.21 6.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.559 ' HG3' ' HB3' ' A' ' 13' ' ' ARG . 89.5 Cg_endo -79.44 44.36 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.079 2.52 . . . . 0.0 113.677 -169.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.37 -40.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.747 0.308 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -28.69 70.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.628 -173.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.46 -43.66 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.33 89.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.964 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.28 -28.18 59.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.009 0.433 . . . . 0.0 110.552 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 117' ' ' ILE . 56.8 tp -63.55 -47.26 82.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.738 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.32 -28.29 69.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 23.1 mmt180 -73.3 -7.71 52.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.172 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -64.07 -35.45 80.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.348 0.594 . . . . 0.0 109.626 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -129.14 81.94 69.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.537 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.75 8.49 3.66 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.886 2.391 . . . . 0.0 113.007 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.64 -25.19 62.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 0.0 110.221 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.47 127.02 53.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.967 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.4 p -71.66 108.75 5.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.928 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -80.71 105.58 12.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.264 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 102.43 5.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.82 106.59 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.282 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.46 126.57 53.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 20.3 pt -112.23 140.78 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.869 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.39 145.46 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.602 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.63 ' HB3' ' HG2' ' A' ' 79' ' ' GLN . 21.0 t70 -63.41 160.06 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.657 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 65.8 tp -55.49 -52.95 61.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.205 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.16 -30.87 58.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.905 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.63 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 7.3 pt20 -77.75 -22.92 49.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.068 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 74.0 m -63.03 -29.24 70.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 110.063 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -56.13 -44.78 79.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.257 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.02 -37.13 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.396 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.06 -47.71 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.82 97.68 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.505 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.97 -38.73 79.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -71.19 -31.56 67.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.668 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -91.2 -29.56 17.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.027 0.442 . . . . 0.0 110.899 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.87 29.51 4.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.048 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.39 122.78 64.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -136.38 18.82 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 110.715 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -99.55 -165.41 1.22 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.697 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -53.15 143.19 34.32 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 123.622 0.576 . . . . 0.0 112.319 -175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HA ' HD21 ' A' ' 41' ' ' LEU . 37.9 Cg_endo -65.87 140.4 60.82 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.358 2.705 . . . . 0.0 112.56 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.7 -178.23 7.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.699 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 28.1 m -99.0 120.09 38.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.465 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.55 118.42 31.66 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.447 ' HA ' HG13 ' A' ' 38' ' ' VAL . 7.0 p -100.91 124.47 54.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.244 0.545 . . . . 0.0 110.991 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 46.1 m-85 -123.5 119.34 29.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.421 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 63.6 p -95.61 123.61 39.24 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.15 16.12 47.1 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.974 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.57 63.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.941 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 98' ' ' PHE . 15.5 m-80 -102.28 141.1 35.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.277 0.561 . . . . 0.0 111.293 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -70.74 118.88 14.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.187 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -98.01 -48.17 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.535 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.04 -166.24 36.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.064 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.62 134.59 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 110.597 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 94.7 mt -97.46 119.97 36.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -138.08 129.33 27.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.729 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.54 127.63 1.93 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.67 -44.57 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.144 0.472 . . . . 0.0 112.233 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -97.42 -51.04 0.22 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.78 120.85 8.2 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 120.692 1.283 . . . . 0.0 111.864 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 t-105 -96.68 -37.74 10.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.813 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.203 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -81.5 -27.58 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.613 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 6.0 mt -56.72 -44.77 81.95 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.458 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.461 ' HA ' HD13 ' A' ' 61' ' ' LEU . 63.1 mt -65.3 -42.32 93.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -57.11 -57.45 12.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.628 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.38 -41.27 75.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.576 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 124' ' ' VAL . 14.9 tpt -60.49 -50.42 73.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.445 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -66.89 -35.68 80.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.227 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.17 -29.52 73.14 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.604 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.39 -45.76 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 120' ' ' MET . 21.4 m -78.51 -28.09 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -112.42 103.63 55.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.557 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.61 99.72 0.75 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.873 2.382 . . . . 0.0 111.276 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -101.84 79.47 1.91 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 122.788 1.28 . . . . 0.0 109.82 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.72 69.43 4.74 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.193 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.38 173.3 6.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.943 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 mtp85 -78.29 98.4 5.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.249 0.547 . . . . 0.0 111.13 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -114.59 2.93 14.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.866 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.667 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HE2' HD21 ' A' ' 77' ' ' LEU . 66.2 mtt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t 62.69 -90.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.951 0.5 . . . . 0.0 111.978 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -87.65 135.27 33.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.684 0.278 . . . . 0.0 110.757 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -81.23 121.08 25.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.18 0.514 . . . . 0.0 111.132 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.649 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 20.9 m -157.15 -61.74 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.234 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 3.9 Cg_exo -76.72 -67.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.126 1.884 . . . . 0.0 112.5 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -59.73 -35.06 73.78 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 110.648 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.41 -49.9 75.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.588 . . . . 0.0 110.725 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.538 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . . . -65.46 -34.23 77.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.533 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.551 ' HG ' HG12 ' A' ' 51' ' ' VAL . 3.1 mm? -65.89 -43.67 87.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.184 0.516 . . . . 0.0 110.074 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -38.1 85.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.807 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.5 -33.56 75.13 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 110.331 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -63.21 -53.62 50.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 109.907 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.432 ' HE3' HG21 ' A' ' 74' ' ' ILE . 74.3 mtp -58.73 -40.11 82.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.697 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.0 -35.38 72.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.347 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.82 68.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.625 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -82.76 2.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.27 -0.68 64.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.97 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -67.93 135.04 51.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 109.752 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.4 m -110.47 130.74 22.57 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.314 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 2.7 Cg_exo -76.8 153.72 33.67 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.267 2.645 . . . . 0.0 112.132 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG13 HD23 ' A' ' 27' ' ' LEU . 13.0 p -148.0 152.48 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.214 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -81.74 158.53 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.253 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -43.61 -61.72 1.31 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.004 0.922 . . . . 0.0 112.854 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.1 m -67.53 -29.25 68.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.69 -171.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 26' ' ' ARG . 5.0 ttp-105 -85.86 -17.34 35.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.859 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 22' ' ' VAL . 3.2 tm? -65.18 -39.65 93.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' HH12 ' A' ' 86' ' ' ARG . 18.7 t70 -62.74 -44.27 96.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.886 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.43 -52.84 63.92 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.212 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -50.67 -49.85 56.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.637 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.0 tp -61.44 -34.85 76.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -89.4 -26.3 21.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 0.0 111.851 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -92.59 -35.25 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . . . -96.28 133.02 25.54 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.315 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.02 140.57 90.64 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.591 2.194 . . . . 0.0 110.985 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 11.9 t70 68.82 -158.4 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 131.66 97.98 0.73 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.261 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.08 141.75 23.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 122.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 74' ' ' ILE . 6.7 mp -99.52 130.56 45.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.172 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -82.11 175.29 10.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.5 p -63.49 117.91 7.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 110.987 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 m -69.75 94.55 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.178 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 12.5 t70 -82.11 129.27 64.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.233 -175.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.694 ' HA ' HG23 ' A' ' 51' ' ' VAL . 19.9 Cg_exo -66.56 -23.73 49.54 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.281 2.654 . . . . 0.0 113.224 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -101.29 -51.15 3.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.014 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 82.0 mtm180 -65.86 -27.05 67.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.955 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.575 ' HB ' HG22 ' A' ' 51' ' ' VAL . 3.8 m -94.69 127.02 45.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.66 -18.39 53.61 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.294 2.662 . . . . 0.0 113.115 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -154.12 102.33 2.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.694 HG23 ' HA ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -104.87 -59.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.066 -172.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -83.35 -2.34 55.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -164.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -54.4 -77.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.468 0.175 . . . . 0.0 111.144 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.0 p30 -171.39 139.19 1.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.67 0.271 . . . . 0.0 110.633 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 86.0 Cg_endo -103.3 42.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.586 2.857 . . . . 0.0 112.193 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.4 t -84.78 -23.13 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.842 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 58' ' ' ILE . 19.7 ptt? -48.35 -47.81 36.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.883 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.471 ' N ' ' HG3' ' A' ' 57' ' ' MET . 47.8 mm -60.12 -35.03 59.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 110.964 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -66.98 -46.14 76.17 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.753 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -79.22 -36.81 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 110.916 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.739 HD22 ' HG3' ' A' ' 120' ' ' MET . 21.9 tp -63.12 -57.82 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.092 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.92 -29.79 69.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.516 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 8.2 mmt180 -78.6 -6.43 55.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.0 pt-20 -69.25 -12.94 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.58 174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 69.4 m-85 -110.86 82.85 3.23 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 64' ' ' GLU . 3.1 Cg_exo -81.46 -9.9 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.117 2.545 . . . . 0.0 112.825 -174.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.06 -25.42 47.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.482 . . . . 0.0 111.736 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -119.97 137.1 54.26 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 p -86.81 114.18 23.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.752 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.473 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 70.9 m95 -81.87 133.48 35.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.825 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 37.2 mt-30 -105.28 108.51 20.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.396 0.617 . . . . 0.0 110.1 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.39 116.6 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.704 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.92 140.85 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.022 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 32.7 pt -125.47 158.1 34.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.541 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . . . -135.09 156.03 49.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.69 -167.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.217 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD21 ' HE2' ' A' ' 1' ' ' MET . 6.1 mp -59.74 -53.68 55.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.509 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.67 -44.78 76.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.137 0.494 . . . . 0.0 110.777 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 2.5 mp0 -61.97 -50.54 71.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.615 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 p -63.33 -43.45 97.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -65.62 -36.48 83.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.053 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.99 -44.09 70.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.01 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 93.0 mt -65.34 -41.93 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.123 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.2 98.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.17 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.75 -40.87 89.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.083 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.636 HH12 ' HB2' ' A' ' 28' ' ' ASP . 48.8 mtp180 -52.94 -40.85 63.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.485 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -90.85 -65.6 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.07 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.72 -15.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.262 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.23 95.0 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.789 0.328 . . . . 0.0 110.175 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -133.49 160.76 36.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' HA ' HH11 ' A' ' 47' ' ' ARG . 56.1 ttt-85 67.09 6.78 4.96 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.565 0.54 . . . . 0.0 110.711 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -128.64 101.68 20.64 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.242 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.79 126.58 10.19 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.737 2.291 . . . . 0.0 112.516 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.91 -175.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.891 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 36.9 m -101.82 120.03 39.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.276 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.99 118.55 32.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.805 HG11 ' HB2' ' A' ' 104' ' ' ARG . 3.8 p -97.81 121.6 48.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.354 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.85 162.21 19.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.47 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.88 129.69 1.81 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.006 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.78 29.53 73.82 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.842 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.0 -6.46 41.68 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.517 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -98.38 156.9 16.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.297 0.57 . . . . 0.0 111.762 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -93.85 130.45 39.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.5 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.805 ' HB2' HG11 ' A' ' 97' ' ' VAL . 37.2 mmt180 -96.45 -59.89 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.643 0.258 . . . . 0.0 110.726 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.69 -153.7 16.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.132 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 53.6 t -121.23 133.7 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.6 mt -109.34 123.71 49.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.229 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -156.35 128.95 7.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.753 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.33 127.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.827 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.8 mm -114.26 -26.47 2.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 0.0 110.637 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.687 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.1 m80 -98.06 -58.92 0.15 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 6.2 Cg_exo -78.82 119.83 4.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.086 1.191 . . . . 0.0 111.807 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.53 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.1 t-105 -96.67 -48.42 5.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.239 -173.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.2 73.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.479 . . . . 0.0 110.616 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.79 -40.73 54.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.452 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 37.1 tp -58.73 -44.26 90.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.259 . . . . 0.0 110.776 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.0 mt -61.8 -48.93 86.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.614 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -51.59 -56.72 11.91 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.212 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.0 mt -62.03 -40.93 97.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.441 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.739 ' HG3' HD22 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -62.19 -48.68 78.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.846 0.355 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.62 -37.83 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.68 -30.07 76.56 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.432 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 98.3 mt -83.28 -49.03 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.466 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 34.3 m -73.82 -30.56 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.54 91.78 2.39 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 84.4 Cg_endo -78.77 115.96 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.587 2.191 . . . . 0.0 114.566 -165.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -97.97 -21.14 17.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 57.07 91.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.309 -1.768 . . . . 0.0 112.406 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 130' ' ' ARG . 11.2 mm-40 -97.03 113.7 25.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.491 171.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 39.1 ttm180 76.8 -51.13 0.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.101 0.875 . . . . 0.0 110.781 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.57 94.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.017 0.823 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -178.05 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.446 0.165 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m 68.78 -72.32 0.1 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 112.534 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -100.41 143.19 30.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -101.47 129.52 47.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.446 0.641 . . . . 0.0 110.178 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.536 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 27.4 m -159.29 -57.18 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.536 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 36.8 Cg_endo -68.08 -40.55 8.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.283 1.322 . . . . 0.0 110.729 169.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -65.52 -39.21 91.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.428 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -51.99 67.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 109.578 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.7 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.908 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.819 HD22 ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.72 -54.36 42.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -34.35 77.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -60.98 -38.17 85.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 0.0 110.829 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -61.74 -53.8 51.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.516 0.674 . . . . 0.0 109.977 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 55.7 mtp -60.8 -34.99 75.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.37 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.34 -32.09 62.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.14 -23.28 65.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.216 0.532 . . . . 0.0 110.505 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -79.52 -10.71 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.45 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.81 26.65 44.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -89.68 140.93 29.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.441 . . . . 0.0 110.147 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -92.63 123.36 62.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.054 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HA ' HG13 ' A' ' 74' ' ' ILE . 43.7 Cg_endo -70.69 127.23 13.59 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.774 2.316 . . . . 0.0 111.319 172.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.12 136.74 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.514 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -67.8 161.71 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.499 0.5 . . . . 0.0 112.012 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.36 -60.28 2.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 112.047 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 m -78.43 -10.17 59.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -92.37 -22.2 19.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -44.09 91.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.761 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.99 -39.38 90.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -64.2 -56.32 15.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.102 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -67.68 -33.19 74.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.748 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.18 -42.09 99.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.572 0.225 . . . . 0.0 111.182 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -73.05 -25.85 61.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.756 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.78 -19.19 55.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.35 157.37 58.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.012 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.12 -64.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.438 2.092 . . . . 0.0 111.292 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -142.48 168.11 20.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.07 -178.18 48.7 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.569 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 97' ' ' VAL . 30.3 m -138.72 150.01 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.263 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.97 128.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.65 130.36 44.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.043 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.65 -67.42 0.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.563 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.664 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 49.1 m 58.27 34.16 23.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.176 0.512 . . . . 0.0 110.879 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.403 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 0.6 OUTLIER -80.97 -86.43 0.09 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.07 104.6 5.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 111.019 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.56 148.64 7.45 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.043 2.495 . . . . 0.0 113.431 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -115.86 -64.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -93.11 -5.75 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.404 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 m -78.03 114.25 40.33 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.711 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.17 -34.83 15.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.0 2.466 . . . . 0.0 112.818 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.939 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -157.8 103.15 1.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.819 ' HB ' HD22 ' A' ' 10' ' ' LEU . 10.8 t -74.94 -31.76 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.204 0.526 . . . . 0.0 110.886 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -2.14 41.12 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.939 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 16.7 t0 -71.78 76.64 0.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.543 -174.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.9 t30 63.08 81.67 0.22 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.523 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.94 12.12 1.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.103 2.536 . . . . 0.0 111.944 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.11 -34.16 49.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.711 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -56.7 -30.98 64.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.361 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 62' ' ' LEU . 49.8 mm -61.12 -42.9 95.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 110.681 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.68 -33.93 60.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.349 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.44 -32.01 65.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.63 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 58.6 tp -64.37 -49.15 72.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.312 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 58' ' ' ILE . 9.5 mp -58.68 -26.43 63.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -56.17 -19.03 11.82 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.8 pt-20 -87.01 22.08 2.13 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.631 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 55.3 p90 -67.44 122.29 82.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 38.4 Cg_endo -97.51 -53.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.974 2.45 . . . . 0.0 114.095 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.7 -26.16 17.14 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.561 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.5 p90 -143.54 142.57 31.17 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.538 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 t -86.08 151.27 23.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.472 ' CZ2' ' HE1' ' A' ' 68' ' ' TYR . 91.0 m95 -98.4 119.73 37.6 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.011 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.69 98.52 9.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.52 108.34 18.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.504 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.8 138.3 48.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 21' ' ' PRO . 28.8 pt -118.65 145.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.94 167.58 12.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.47 172.66 10.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.947 173.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.86 -42.83 66.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.08 -44.72 83.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.501 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -70.64 -41.99 71.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.776 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 43' ' ' SER . 4.2 p -63.04 -42.26 99.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.296 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.15 -36.66 83.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.008 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.03 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.46 -46.2 90.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.48 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.502 ' HA2' ' HB ' ' A' ' 89' ' ' VAL . . . -57.31 -49.25 74.14 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.728 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.26 -42.7 70.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 111.027 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -73.33 -31.56 64.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.737 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -101.61 -25.76 13.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.551 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.5 2.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.342 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.502 ' HB ' ' HA2' ' A' ' 84' ' ' GLY . 38.8 t -118.11 150.07 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.94 163.21 26.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.928 0.394 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -72.96 -9.37 58.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.914 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -70.34 127.09 92.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.553 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.664 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 17.1 Cg_exo -65.57 124.38 12.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.855 2.37 . . . . 0.0 112.338 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.27 3.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.3 m -109.84 127.12 54.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.43 116.99 29.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.515 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -98.76 126.28 51.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.496 0.665 . . . . 0.0 111.499 -175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -115.15 138.47 50.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -148.4 144.14 27.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.27 19.21 66.08 Favored Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.897 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.26 89.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.496 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -120.51 157.25 29.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -79.12 123.22 27.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.349 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -88.99 -60.28 2.0 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.36 -161.36 24.74 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.691 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.38 134.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.43 105.71 17.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.22 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -117.97 97.52 5.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.489 0.661 . . . . 0.0 110.947 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.6 138.05 5.86 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.54 -33.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.998 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.711 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 m-70 -135.48 -54.58 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 111' ' ' HIS . 6.8 Cg_endo -50.18 120.25 5.97 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.677 1.585 . . . . 0.0 112.532 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.63 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 4.0 t-105 -99.11 -46.64 5.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.535 -170.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 118' ' ' ASN . . . -60.17 -34.56 73.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 110.005 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 17.3 mm-40 -68.87 -47.95 64.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.528 176.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.28 -49.52 76.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.82 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 113' ' ' TRP . 52.1 mt -60.29 -41.39 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 114' ' ' ALA . 31.7 t-20 -53.52 -57.59 10.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.569 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 81.1 mt -68.66 -41.68 78.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.293 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -50.48 73.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.721 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.53 ' HA ' HG21 ' A' ' 124' ' ' VAL . 14.5 ttt85 -69.97 -32.63 70.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.267 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.46 75.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.216 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.2 mt -81.62 -50.32 9.47 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.84 -0.212 . . . . 0.0 111.135 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 121' ' ' ARG . 31.1 m -67.0 -38.95 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.48 97.91 7.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 83.8 Cg_endo -89.69 150.73 5.12 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.926 2.417 . . . . 0.0 113.769 -170.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -77.91 -8.29 57.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.958 0.885 . . . . 0.0 109.794 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -146.69 108.5 4.35 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.546 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.71 81.75 0.28 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 111.441 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -81.88 89.47 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.46 141.74 14.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.638 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.974 178.499 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -115.15 97.74 6.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -117.82 75.94 1.03 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.406 ' C ' ' HG1' ' A' ' 5' ' ' THR . 5.6 t70 64.46 174.93 0.19 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.884 -174.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m -160.7 -57.25 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 5.0 Cg_exo -74.42 -52.91 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.138 1.892 . . . . 0.0 111.923 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -65.95 -41.07 91.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -53.25 -53.68 47.29 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.14 -49.3 77.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.229 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 52' ' ' SER . 3.0 mm? -59.2 -46.5 88.27 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.294 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.08 -47.86 78.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -61.48 -40.23 93.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.323 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 47.2 mmm-85 -59.26 -54.47 46.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.488 ' HB2' ' CE3' ' A' ' 19' ' ' TRP . 24.6 ptt? -70.99 -29.26 65.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.312 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 11' ' ' TRP . 34.4 mt -57.23 -39.42 75.48 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.34 65.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.804 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -74.29 -15.07 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.0 111.215 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.24 13.87 20.0 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.563 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 49.2 m0 -82.7 122.01 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.039 0.447 . . . . 0.0 109.832 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.5 m -91.94 132.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.613 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 23.0 Cg_exo -65.02 120.36 7.58 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 111.658 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.5 139.79 24.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.217 0.532 . . . . 0.0 110.916 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 m -92.66 150.22 20.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.096 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.35 -50.79 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.5 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 m -85.23 13.55 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.067 0.46 . . . . 0.0 111.293 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -121.23 -10.92 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.683 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.8 tm? -55.11 -43.8 74.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.472 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.41 -43.09 95.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' THR . 17.5 t70 -61.26 -55.57 30.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -62.5 -40.51 96.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.044 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -70.94 -29.43 65.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -75.01 -27.79 60.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.547 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 35.1 mt-30 -90.7 -44.05 9.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.147 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.35 94.57 11.7 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.923 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 8.2 Cg_exo -72.59 140.84 33.47 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.199 2.599 . . . . 0.0 113.556 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t70 73.91 167.07 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.407 1.067 . . . . 0.0 111.474 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.98 -165.35 24.32 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.023 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.88 152.61 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 122.524 0.33 . . . . 0.0 110.793 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.53 131.5 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.49 138.15 38.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.93 175.97 5.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 111.29 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.4 t -85.5 154.22 21.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.232 0.539 . . . . 0.0 110.845 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 13.5 m -86.2 -47.33 9.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.766 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.2 t70 53.75 80.38 0.3 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 123.567 0.542 . . . . 0.0 110.286 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.6 132.53 23.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.313 2.008 . . . . 0.0 111.791 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.77 -55.23 2.39 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -129.69 -3.91 4.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.091 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -79.74 115.13 51.57 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.865 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 2.8 Cg_endo -81.83 -68.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.086 2.524 . . . . 0.0 112.823 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -95.14 79.75 3.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.556 0.693 . . . . 0.0 110.47 -175.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.21 -24.6 28.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.564 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.09 -64.46 0.91 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.1 t70 59.43 -85.85 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.662 0.785 . . . . 0.0 112.741 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -144.03 99.31 5.08 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 111.304 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -95.51 -167.72 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.174 2.583 . . . . 0.0 112.454 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.8 t 75.09 -37.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -53.43 -24.31 12.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' HD11 ' A' ' 62' ' ' LEU . 3.0 mp -58.96 -38.95 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.718 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.7 -38.18 94.26 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.406 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -72.79 -28.48 62.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.745 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.2 tp -61.35 -43.68 98.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.266 0.555 . . . . 0.0 110.347 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 58' ' ' ILE . 6.8 mp -64.67 -27.44 68.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.072 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.49 -17.24 63.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.912 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -70.1 -36.37 74.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.689 0.28 . . . . 0.0 110.611 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -141.49 77.78 19.16 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.095 0.474 . . . . 0.0 110.537 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.0 16.83 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.142 2.562 . . . . 0.0 112.598 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.97 -25.67 67.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.524 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -116.71 166.85 11.65 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 p -85.29 105.49 16.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.921 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -91.44 103.57 16.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.752 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.18 122.2 31.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.199 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.8 t -97.96 107.39 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 124.71 50.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.504 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 30.6 pt -110.42 144.41 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . . . -115.41 153.17 31.54 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.769 -0.372 . . . . 0.0 112.001 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.825 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.3 m-20 -61.88 168.86 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.518 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.09 -49.1 74.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.614 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -66.56 -34.47 77.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.23 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.825 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 66.5 mm-40 -75.53 -48.17 23.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.277 -172.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 78.4 p -65.49 -41.4 93.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -58.01 -44.74 87.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.279 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.41 -41.53 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 79' ' ' GLN . 73.9 mt -60.9 -45.33 98.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.955 0.407 . . . . 0.0 110.196 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.28 75.72 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.231 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -38.06 89.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 86' ' ' ARG . 21.3 ttt180 -59.85 -27.93 67.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.428 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.89 -45.14 4.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.02 44.77 0.52 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.672 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.731 HG11 HD21 ' A' ' 96' ' ' LEU . 17.2 t -103.86 156.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 172.6 13.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 0.0 110.729 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 60.4 mtm180 -98.4 -161.01 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.676 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 62.2 m-85 73.93 165.93 0.13 Allowed Pre-proline 0 N--CA 1.467 0.387 0 O-C-N 123.953 0.783 . . . . 0.0 110.83 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 92' ' ' PHE . 21.4 Cg_endo -59.56 123.36 13.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.029 1.819 . . . . 0.0 111.679 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 106' ' ' VAL . . . -161.74 143.04 11.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.783 -174.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 23.8 m -110.77 113.3 25.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.0 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.731 HD21 HG11 ' A' ' 89' ' ' VAL . 5.9 mp -93.43 137.31 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.37 130.11 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.36 119.36 36.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.16 125.72 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.157 0.503 . . . . 0.0 112.051 -172.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.22 -63.32 2.91 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.968 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -136.17 64.47 0.58 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 64.89 -153.42 0.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.534 0.334 . . . . 0.0 111.793 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -50.24 108.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.833 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.71 -38.55 15.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.513 0.673 . . . . 0.0 109.832 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 170.5 -168.43 41.48 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.123 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 14.0 p -136.95 140.68 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.027 0.442 . . . . 0.0 111.037 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 93.7 mt -96.56 107.19 19.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.13 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -148.6 171.8 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.294 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.44 149.4 18.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.101 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.0 102.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 0.0 110.267 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 49.5 m80 -134.33 139.72 33.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 176.04 7.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 0.0 112.219 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.745 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 10.4 t-105 -58.39 -45.41 88.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.375 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.95 87.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.404 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 111' ' ' HIS . 4.4 tp10 -72.76 -33.12 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -63.0 -45.47 92.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.037 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.3 mt -62.9 -43.75 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.099 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -54.5 -58.26 8.18 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 91.7 mt -57.4 -47.44 81.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.463 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.419 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.1 tpt -59.46 -41.56 90.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.599 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -63.35 -40.6 97.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.42 77.8 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.839 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 74.0 mt -81.08 -50.95 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -70.86 -36.35 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.58 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 47.0 89.49 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 121.751 0.786 . . . . 0.0 112.428 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.81 169.62 11.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.787 2.325 . . . . 0.0 112.759 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.468 ' HB3' ' OE2' ' A' ' 129' ' ' GLU . 6.3 tt0 -96.39 -4.57 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.705 0.764 . . . . 0.0 109.122 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 67.35 72.88 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.795 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' OE2' ' HB3' ' A' ' 127' ' ' GLN . 3.1 mp0 -87.02 88.69 7.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.12 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -102.64 -164.12 1.06 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.04 43.99 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.435 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.85 178.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.578 ' HG2' ' HG3' ' A' ' 6' ' ' PRO . 24.9 ttt . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -144.3 -53.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.339 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -112.15 159.06 18.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.555 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 3.7 p30 50.58 22.56 1.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.421 1.088 . . . . 0.0 113.65 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.708 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -137.83 -65.31 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.648 175.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.708 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 6.2 Cg_exo -78.24 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.767 1.645 . . . . 0.0 111.443 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.95 -37.91 84.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.593 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 24.7 t70 -64.31 -54.42 33.45 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.35 90.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -58.17 -55.05 40.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.044 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -39.46 93.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.236 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.823 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -57.6 -39.86 77.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.571 0.224 . . . . 0.0 111.165 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -65.05 -53.41 46.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.186 0.517 . . . . 0.0 110.533 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.489 ' HE3' HG23 ' A' ' 74' ' ' ILE . 81.7 mtp -57.9 -37.8 74.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.116 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -34.91 76.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.381 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.79 66.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.023 0.439 . . . . 0.0 111.123 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 28.7 mmt180 -83.66 2.75 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.496 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.65 12.16 80.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.59 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.479 ' HH2' ' HB2' ' A' ' 55' ' ' PRO . 51.5 m0 -77.51 124.01 27.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.503 ' HB ' ' CH2' ' A' ' 30' ' ' TRP . 21.5 m -85.46 123.93 72.2 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.971 -171.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.93 118.75 5.86 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.805 2.337 . . . . 0.0 111.463 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.456 HG13 HD21 ' A' ' 27' ' ' LEU . 14.4 p -126.11 147.08 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m -95.23 165.09 12.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.181 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.26 -48.65 54.71 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.751 0.42 . . . . 0.0 112.114 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 m -59.74 -35.48 74.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.002 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 9.1 tpt180 -94.69 -18.29 21.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.79 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 3.4 tm? -64.05 -40.0 95.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.49 -42.66 96.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.168 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 28.5 t70 -63.14 -57.16 11.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.946 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.503 ' CH2' ' HB ' ' A' ' 20' ' ' THR . 5.9 t90 -59.13 -39.65 83.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.196 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -66.95 -28.1 68.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.478 . . . . 0.0 110.419 177.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.5 m -75.19 -33.06 61.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 19.3 mm-40 -80.64 -48.34 12.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.406 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -73.0 135.3 80.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.401 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 2.1 Cg_endo -81.66 -21.93 5.78 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.911 2.408 . . . . 0.0 111.52 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 3.5 p-10 -95.31 -89.29 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.129 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 87.69 106.92 0.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.599 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 72' ' ' VAL . 5.5 m -131.89 134.08 60.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 171.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 49.2 t -130.5 135.19 61.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.951 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD21 ' HE2' ' A' ' 14' ' ' MET . 7.6 mp -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.2 tt -104.46 128.29 52.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.025 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 m -99.06 132.05 44.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.865 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -157.97 -168.44 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 4.5 m-20 -59.91 123.3 71.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.261 0.35 . . . . 0.0 110.309 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.54 132.83 42.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.203 1.935 . . . . 0.0 111.963 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -126.24 -57.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.642 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -105.86 -28.64 10.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 p -65.62 116.64 33.52 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.615 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.77 -43.03 28.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 0.0 111.661 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.42 ' CG ' ' H ' ' A' ' 51' ' ' VAL . 4.8 tt0 -108.64 -115.18 0.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.084 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.42 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 19.3 t -133.95 -55.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' HD13 ' A' ' 10' ' ' LEU . 29.0 t -111.59 -48.17 3.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.208 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.9 t70 49.55 71.4 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.527 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 t30 66.99 85.59 0.15 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.526 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HB2' ' HH2' ' A' ' 19' ' ' TRP . 96.7 Cg_endo -79.85 -5.7 13.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.526 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 21.6 t -61.9 -35.72 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.405 ' HE2' ' HG ' ' A' ' 116' ' ' LEU . 55.6 ttp -58.95 -37.37 76.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 -177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.448 ' O ' HD11 ' A' ' 62' ' ' LEU . 50.1 mm -69.91 -36.11 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.078 0.466 . . . . 0.0 110.346 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.83 -45.31 65.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.011 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 8.7 mm-40 -68.6 -28.22 66.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.84 0.353 . . . . 0.0 110.468 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 116' ' ' LEU . 24.7 tp -61.68 -54.93 36.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.483 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 58' ' ' ILE . 7.3 mp -52.27 -26.6 12.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.439 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.557 HH11 ' HG3' ' A' ' 63' ' ' ARG . 11.5 mmt85 -61.62 -9.4 6.02 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.99 -12.18 59.42 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 122.015 -0.428 . . . . 0.0 111.181 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -116.79 92.88 39.69 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.826 0.346 . . . . 0.0 110.622 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.77 2.9 6.43 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.75 2.3 . . . . 0.0 112.249 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.95 -26.69 62.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.716 0.77 . . . . 0.0 109.766 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -129.17 133.53 47.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.654 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 p -85.03 102.68 13.4 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.455 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.66 118.98 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.947 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -103.08 107.08 17.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.337 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 38' ' ' VAL . 26.8 t -88.21 120.37 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.22 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -107.15 133.04 52.34 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.263 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.489 HG23 ' HE3' ' A' ' 14' ' ' MET . 26.7 pt -125.98 143.84 38.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.53 156.72 30.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.994 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 169.22 4.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.53 -46.48 88.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.109 0.48 . . . . 0.0 110.35 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -61.82 -44.36 97.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.847 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 83.8 mm-40 -68.58 -39.22 81.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.167 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -58.25 -39.81 80.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.37 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -34.95 79.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.181 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.21 47.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.259 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 79' ' ' GLN . 74.6 mt -64.12 -46.94 92.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.53 96.74 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.946 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.38 -42.15 95.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 111.281 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -61.14 -32.31 72.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -100.55 -43.65 6.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.133 0.492 . . . . 0.0 111.001 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.2 42.6 0.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.59 142.96 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.523 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 21.3 m-85 -73.57 159.81 32.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -83.79 84.89 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.349 0.595 . . . . 0.0 112.13 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' ASP . 30.5 p90 -169.25 152.66 5.1 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.652 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.0 Cg_exo -71.72 126.39 11.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.416 2.077 . . . . 0.0 111.337 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.88 168.77 25.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.531 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 26.2 m -100.85 120.23 39.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.12 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.88 120.34 34.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.8 p -104.89 122.53 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.56 0.695 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.74 -177.97 3.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.495 ' OG1' ' HD3' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -151.23 -171.5 3.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.18 91.79 0.04 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.034 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.44 24.44 70.85 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.354 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.01 159.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.422 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.75 111.99 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -168.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.56 -171.2 34.72 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.046 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.55 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.5 mt -95.29 103.53 15.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -108.5 130.58 55.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.46 -165.56 24.95 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.783 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.7 mm -112.97 -69.52 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 79.1 m-70 70.95 143.32 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.74 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.45 159.65 19.13 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.647 2.231 . . . . 0.0 111.858 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.41 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 15.5 t-105 -54.05 -43.19 69.99 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.08 78.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 111.643 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 4.4 mp0 -72.49 -26.44 61.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.748 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.467 ' CD1' HD22 ' A' ' 61' ' ' LEU . 2.0 tm? -62.72 -47.43 83.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.5 mt -60.84 -45.91 97.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.264 0.554 . . . . 0.0 109.719 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -52.65 -58.28 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 89.6 mt -58.14 -42.22 85.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.595 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.464 ' HG2' HD23 ' A' ' 61' ' ' LEU . 16.9 tpt -57.73 -50.6 72.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 110.642 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.605 ' HA ' HG12 ' A' ' 124' ' ' VAL . 65.0 mtt180 -68.84 -32.05 71.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.31 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.73 -29.89 71.21 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.482 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.404 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 96.6 mt -95.83 -45.92 6.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.605 HG12 ' HA ' ' A' ' 121' ' ' ARG . 7.2 p -71.49 -26.04 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -172.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.5 OUTLIER -68.97 -54.36 12.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.439 -178.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 125' ' ' GLU . 7.9 Cg_exo -73.51 153.24 49.59 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.205 1.937 . . . . 0.0 111.433 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.95 -1.29 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 57.13 48.18 15.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.951 0.881 . . . . 0.0 109.853 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -81.36 95.38 7.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.892 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 130' ' ' ARG . 14.0 ttp180 -167.1 -39.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.048 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.04 162.49 29.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.417 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--N 1.323 -0.571 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.395 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' H ' ' A' ' 2' ' ' SER . 11.2 tpt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.403 ' H ' ' HG3' ' A' ' 1' ' ' MET . 12.1 t -139.29 108.36 6.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.889 0.313 . . . . 0.0 111.668 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.48 145.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.579 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.49 112.05 22.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 85.3 m -158.99 -62.98 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.792 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 19.3 Cg_endo -60.03 -72.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.961 1.774 . . . . 0.0 113.538 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.64 -33.59 76.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.67 -51.9 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.592 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -65.15 -44.05 89.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 52' ' ' SER . 3.2 mm? -62.33 -39.76 94.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.339 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -65.46 -44.77 86.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.13 -39.25 78.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.188 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 68.8 mmt-85 -61.57 -53.26 58.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.0 0.429 . . . . 0.0 110.616 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.409 ' SD ' HD23 ' A' ' 40' ' ' LEU . 75.4 mtm -61.4 -32.75 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.078 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.43 -40.09 89.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.608 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.24 65.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 6.2 mmp_? -71.24 -33.66 70.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.468 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.12 39.01 2.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.86 174.35 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.9 m -101.84 118.14 60.1 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.0 111.77 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 4.1 Cg_exo -80.27 126.92 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.41 2.74 . . . . 0.0 111.503 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 75' ' ' ALA . 11.8 p -135.52 142.34 39.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -97.6 167.45 10.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 111.435 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' H ' ' CG ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -52.73 -51.35 60.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.381 -175.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.9 m -75.36 -5.66 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.901 0.381 . . . . 0.0 111.782 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -106.85 -20.45 13.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.254 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.12 -42.21 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.353 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.89 -46.18 72.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.319 0.581 . . . . 0.0 110.573 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 32' ' ' THR . 32.6 t70 -60.46 -53.59 55.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.346 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.93 -43.56 86.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.5 -40.12 95.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.692 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -70.12 -25.46 63.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.67 -42.83 13.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.047 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.79 134.79 94.17 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.401 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.12 -44.42 15.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.483 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.79 ' HB2' ' HE2' ' A' ' 68' ' ' TYR . 1.5 t0 -161.36 177.34 10.23 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.04 -178.96 33.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.695 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 97' ' ' VAL . 20.2 m -138.37 156.48 30.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 122.501 0.32 . . . . 0.0 110.205 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.81 143.57 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.619 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD23 ' SD ' ' A' ' 14' ' ' MET . 7.7 mp -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 63.7 tp -114.93 96.55 5.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.417 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.9 m 60.22 -167.47 0.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.7 0.625 . . . . 0.0 112.562 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.5 p -137.07 174.48 10.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.923 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 33.2 t70 -69.77 141.25 89.77 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.132 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 13.7 Cg_exo -70.55 -171.89 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.553 2.835 . . . . 0.0 113.897 -175.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -79.99 -39.64 29.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.097 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -69.61 -4.13 17.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.437 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.43 ' HB ' ' OD2' ' A' ' 44' ' ' ASP . 10.8 m -122.96 130.49 24.59 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 122.172 -0.33 . . . . 0.0 110.361 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -91.84 43.36 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.752 2.302 . . . . 0.0 113.053 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -134.25 41.34 2.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.813 0.816 . . . . 0.0 109.34 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' HB3' ' A' ' 44' ' ' ASP . 13.0 t -77.77 -39.65 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.331 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.48 ' HA ' HD12 ' A' ' 10' ' ' LEU . 37.4 t -109.76 -39.06 5.22 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.829 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 54' ' ' ASN . 8.9 t70 52.6 -144.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.683 0.614 . . . . 0.0 109.834 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.517 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -151.18 92.3 3.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -61.31 -95.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.797 2.331 . . . . 0.0 113.484 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 97.7 t 73.29 -51.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.326 0.584 . . . . 0.0 110.653 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.522 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 22.9 ptt? -59.51 -24.41 63.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.078 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.25 -45.09 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.897 0.38 . . . . 0.0 110.798 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.35 -40.2 80.51 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.588 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -63.08 -39.16 93.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.514 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 37.0 tp -59.99 -57.03 14.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.723 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.24 -28.02 68.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.132 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -75.43 -6.92 52.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.2 pt-20 -76.39 -13.54 60.12 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.243 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -131.26 71.09 82.06 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.45 12.46 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.25 2.634 . . . . 0.0 112.799 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.51 -14.35 60.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.676 0.75 . . . . 0.0 110.012 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.79 ' HE2' ' HB2' ' A' ' 36' ' ' ASP . 8.7 t80 -122.4 -177.12 3.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.208 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -109.44 123.02 48.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.685 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -108.34 106.67 16.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -90.39 110.91 21.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.015 0.436 . . . . 0.0 110.185 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.97 117.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.975 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.9 55.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.1 pt -119.57 139.33 47.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.493 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.65 171.24 7.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.7 m-20 -64.14 171.8 2.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.822 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -57.73 -54.26 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.568 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -74.61 -33.78 62.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.972 0.415 . . . . 0.0 111.32 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 2.6 mp0 -69.64 -39.52 77.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.06 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.4 m -55.23 -52.99 61.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.48 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 17.6 tp10 -59.93 -44.43 94.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.353 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.83 -41.31 95.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.894 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 79' ' ' GLN . 80.1 mt -63.01 -47.57 92.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.624 0.249 . . . . 0.0 110.964 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.19 92.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.519 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.99 -43.96 82.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.81 0.444 . . . . 0.0 111.262 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -67.7 -27.23 66.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -78.19 -39.06 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 109.944 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.52 -25.85 2.29 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.02 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -86.3 99.73 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.012 0.434 . . . . 0.0 110.142 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -93.76 131.79 38.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.709 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.503 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 0.4 OUTLIER 67.08 179.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.732 0.645 . . . . 0.0 112.011 173.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 70.02 105.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.869 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 37.5 Cg_endo -66.43 135.66 40.32 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.613 2.209 . . . . 0.0 112.528 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.8 -173.68 1.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.153 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 20.4 m -114.91 127.94 55.99 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.7 114.79 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' A' ' 38' ' ' VAL . 7.1 p -99.84 130.49 48.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.313 0.577 . . . . 0.0 111.105 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -123.43 164.95 17.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.804 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.414 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m -154.87 136.4 14.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 170.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.29 14.85 42.5 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.149 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.4 -5.6 84.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.242 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -94.71 149.09 21.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 110.912 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -74.44 126.88 31.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.11 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.503 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 3.5 mmp_? -99.23 -45.11 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.95 -165.13 38.68 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.674 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.44 134.04 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.101 0.477 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.0 mt -100.2 109.83 22.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.569 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -132.19 81.36 1.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.382 0.61 . . . . 0.0 109.605 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.18 64.48 0.34 Allowed Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.309 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 26.0 mm -80.35 83.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.487 0.184 . . . . 0.0 111.093 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 9.9 t-80 175.9 -60.12 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.703 172.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 1.6 Cg_endo -82.98 124.76 3.94 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.476 2.118 . . . . 0.0 113.035 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.522 ' CE3' ' HB2' ' A' ' 57' ' ' MET . 12.1 t-105 -77.09 -49.23 15.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.581 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.58 78.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.034 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 36.9 tt0 -74.23 -34.54 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.725 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.03 -43.33 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.11 -47.91 85.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -53.78 -49.52 68.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.434 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.51 -53.8 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.8 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.539 ' O ' HG21 ' A' ' 124' ' ' VAL . 17.6 tpt -56.76 -51.06 70.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.482 . . . . 0.0 110.512 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 125' ' ' GLU . 24.4 ttt85 -64.77 -31.75 73.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.562 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.9 61.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.669 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.12 -51.88 6.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 120' ' ' MET . 32.8 m -81.64 -24.81 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.631 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 31.3 tt0 46.48 85.55 0.17 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.123 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.04 92.04 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 110.433 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -64.51 -42.3 95.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.032 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.45 57.24 2.24 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.746 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 104.34 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.937 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 130' ' ' ARG . 10.6 ptm180 -158.01 1.15 0.11 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.577 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -157.28 107.52 2.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.123 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.892 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 10.4 t -95.08 66.77 3.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.273 0.559 . . . . 0.0 110.546 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -168.2 149.29 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.495 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t70 70.96 4.6 5.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.554 0.693 . . . . 0.0 111.715 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.644 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 42.1 m -151.99 -60.71 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.892 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 16.0 Cg_exo -67.87 -66.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.921 1.747 . . . . 0.0 112.124 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.477 ' HA ' HG11 ' A' ' 51' ' ' VAL . 91.5 t80 -60.8 -35.07 75.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.42 -53.51 55.66 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -66.44 -43.03 86.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.062 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HG ' HG13 ' A' ' 51' ' ' VAL . 2.2 mm? -60.77 -37.72 82.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.816 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -64.04 -48.61 75.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.541 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.51 -32.47 71.48 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.525 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 26.2 mmm180 -59.16 -53.32 59.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.002 0.429 . . . . 0.0 110.281 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.612 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 71.7 mtm -62.13 -33.37 74.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.845 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 74' ' ' ILE . 2.7 mm? -59.51 -38.91 82.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.624 176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.04 66.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.39 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -75.63 -6.34 49.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.614 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.75 46.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.598 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.612 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 47.5 m0 -89.51 119.95 30.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 109.931 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -83.7 137.23 41.4 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.401 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 74.1 Cg_endo -76.95 149.83 29.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.48 . . . . 0.0 111.424 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG11 HD21 ' A' ' 27' ' ' LEU . 7.9 p -154.1 156.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 111.18 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 p -99.04 164.5 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.307 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.19 -42.73 73.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 111.66 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -30.44 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.65 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -85.23 -23.17 28.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 110.619 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.485 HD21 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -60.64 -39.26 87.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.622 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.33 -32.92 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.924 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 9.0 t70 -68.3 -55.24 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.047 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -60.69 -34.08 73.8 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.918 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.99 -43.03 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.322 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 29' ' ' ASP . 12.0 t -74.55 -26.39 59.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.782 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 29' ' ' ASP . 98.0 mt-30 -64.57 -44.96 89.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.853 0.358 . . . . 0.0 110.651 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . . . -90.79 161.75 35.16 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.04 -45.56 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.326 2.017 . . . . 0.0 110.993 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -149.17 -178.16 6.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.119 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.11 -168.17 40.23 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.052 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 97' ' ' VAL . 12.1 m -139.13 135.73 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.858 0.361 . . . . 0.0 110.477 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -124.11 133.18 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -95.84 131.43 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.948 0.404 . . . . 0.0 111.258 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.75 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 4.5 tt -107.71 117.19 33.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.612 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -112.46 133.36 54.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.871 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -169.18 -166.84 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.23 117.36 59.56 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 121.588 0.709 . . . . 0.0 111.035 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.831 ' HB3' ' HG2' ' A' ' 93' ' ' PRO . 95.0 Cg_endo -101.65 143.84 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.462 2.775 . . . . 0.0 113.131 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 46' ' ' LYS . 2.1 tmtp? -110.41 -24.61 10.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -75.75 -43.7 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.61 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -93.4 139.14 22.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.51 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -41.55 -68.06 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.56 2.84 . . . . 0.0 113.616 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.55 -66.4 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.152 177.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 HG13 ' HG ' ' A' ' 10' ' ' LEU . 45.0 t -151.01 -30.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.582 0.23 . . . . 0.0 111.343 -173.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t -70.47 -19.5 62.95 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -168.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.68 97.17 11.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.937 0.399 . . . . 0.0 110.701 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.48 153.4 75.1 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.617 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.477 ' HB2' HG12 ' A' ' 58' ' ' ILE . 74.4 Cg_endo -80.74 97.59 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.492 2.128 . . . . 0.0 112.911 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.3 t -93.96 -27.71 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.341 0.591 . . . . 0.0 110.313 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -22.81 65.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.001 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 55' ' ' PRO . 40.3 mm -52.6 -35.83 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -61.42 -43.04 99.85 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -69.25 -30.35 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.196 0.522 . . . . 0.0 110.875 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.863 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 47.6 tp -72.56 -52.67 14.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.345 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 65' ' ' PHE . 8.4 mp -59.2 -27.3 65.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.274 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 16.6 mmm180 -56.3 -14.59 2.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.81 -7.25 47.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.881 0.309 . . . . 0.0 111.62 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.602 ' HD2' ' O ' ' A' ' 62' ' ' LEU . 32.1 p90 -64.71 126.97 91.99 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.393 0.616 . . . . 0.0 111.57 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 1.3 Cg_endo -87.28 -62.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.307 2.671 . . . . 0.0 112.654 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.4 -25.53 10.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.726 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.48 104.37 12.72 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.4 p -79.42 107.22 12.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.073 0.463 . . . . 0.0 110.377 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -75.88 121.65 22.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.525 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.561 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 1.9 tp-100 -83.6 100.73 11.0 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.42 108.48 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.903 0.382 . . . . 0.0 110.055 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.49 48.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 19.6 pt -115.9 148.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.435 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . . . -130.89 167.39 19.03 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.6 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.727 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.6 m-20 -61.71 163.71 6.98 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.52 174.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.82 -48.71 77.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.753 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.72 -24.07 64.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.574 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.727 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 78.5 mm-40 -76.46 -51.83 11.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.75 ' HB3' ' HA ' ' A' ' 41' ' ' LEU . 39.6 m -64.27 -37.38 87.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.91 -45.3 74.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.067 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -45.59 81.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.87 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.71 -49.03 82.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.347 0.404 . . . . 0.0 111.07 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.47 50.78 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.89 -49.61 72.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.272 0.558 . . . . 0.0 110.93 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -63.49 -31.53 72.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.883 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.18 -51.76 6.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 110.593 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.03 44.64 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.712 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -104.68 -14.72 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HD2' ' CE2' ' A' ' 92' ' ' PHE . 41.7 t80 68.19 175.97 0.26 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.035 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -84.08 94.26 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.922 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.447 ' CE2' ' HD2' ' A' ' 90' ' ' PHE . 54.2 m-85 -140.17 132.05 14.5 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.889 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.831 ' HG2' ' HB3' ' A' ' 45' ' ' PRO . 6.6 Cg_exo -71.66 129.24 15.32 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.172 1.915 . . . . 0.0 110.519 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.39 156.85 2.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.159 0.505 . . . . 0.0 111.68 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.0 m -95.6 120.81 36.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.965 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.9 114.17 26.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 38' ' ' VAL . 6.5 p -99.38 124.86 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.153 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.91 140.81 33.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.544 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 p -134.0 122.48 23.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.979 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.76 25.58 69.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.355 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.81 0.42 88.11 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.61 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.436 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -109.09 143.88 37.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.313 -175.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -82.31 112.86 19.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.119 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -136.69 10.81 3.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.56 137.24 6.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.525 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.93 132.69 69.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.63 95.01 2.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.613 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -81.75 -38.68 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 109.984 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.47 -161.11 24.95 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.516 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 23.1 mm 69.89 163.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 43.6 m80 78.77 151.89 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.193 0.597 . . . . 0.0 110.452 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.45 142.68 96.13 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.546 2.164 . . . . 0.0 113.001 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.863 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 29.5 t-105 -53.79 -33.81 57.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.652 175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.64 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.52 -33.28 48.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 109.936 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 2.7 mm? -58.14 -44.5 87.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.962 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 113' ' ' TRP . 59.9 mt -64.38 -41.91 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.35 -54.83 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.502 0.667 . . . . 0.0 110.824 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.9 mt -59.19 -48.52 81.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.423 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.726 ' HG2' HD22 ' A' ' 61' ' ' LEU . 14.8 tpt -62.29 -38.79 90.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.704 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -66.11 -34.46 78.12 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.041 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.8 74.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.754 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 92.3 mt -75.6 -55.55 5.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.689 -0.256 . . . . 0.0 111.609 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 120' ' ' MET . 34.6 m -77.94 -23.24 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.795 -175.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.44 76.0 69.07 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.0 109.343 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.84 113.39 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.05 2.5 . . . . 0.0 113.067 -173.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -83.9 -4.3 58.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.531 171.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 55.79 65.28 1.49 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.222 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 174.37 5.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.033 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -69.05 138.09 54.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.422 0.629 . . . . 0.0 112.123 -174.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.19 113.1 15.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.813 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.227 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.0 m 65.17 28.7 12.12 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.694 0.621 . . . . 0.0 110.477 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -86.42 83.43 7.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.445 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.32 -0.07 1.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.628 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 21.6 m 179.12 -54.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.377 0.671 . . . . 0.0 110.529 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 46.4 Cg_exo -56.97 -66.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.292 1.995 . . . . 0.0 112.995 -175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -60.42 -37.96 82.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.32 . . . . 0.0 110.688 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 7.2 t70 -59.04 -53.15 61.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.486 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.6 88.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.347 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.29 -47.77 75.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.85 -35.62 81.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 14.8 mm100 -57.33 -43.84 83.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.026 176.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 5.0 mmp_? -64.21 -53.35 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.41 ' HE1' HD21 ' A' ' 40' ' ' LEU . 84.4 mtp -56.47 -39.56 73.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.291 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.95 -38.47 79.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.186 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.39 70.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HA ' HH11 ' A' ' 17' ' ' ARG . 10.3 mmm180 -73.06 -15.9 61.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.396 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.92 44.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.312 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -114.5 137.47 51.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 p -96.44 138.03 21.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.9 Cg_endo -86.2 163.46 9.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.616 2.878 . . . . 0.0 112.076 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG13 HD22 ' A' ' 27' ' ' LEU . 7.9 p -162.79 143.74 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.895 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.32 155.25 19.1 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.95 78.35 1.66 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.988 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 53.8 m -171.22 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.26 0.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.544 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.405 ' C ' HD12 ' A' ' 27' ' ' LEU . 2.6 tm? -53.02 -43.31 66.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.72 -43.34 59.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.85 -52.45 65.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.699 0.762 . . . . 0.0 110.407 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.639 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 22.9 t90 -58.75 -42.73 89.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.027 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.4 -33.25 75.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.0 m -60.21 -42.69 95.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.856 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.67 -43.75 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' CD ' ' A' ' 71' ' ' GLN . . . -113.05 94.95 32.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.549 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.34 -170.57 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.258 2.638 . . . . 0.0 112.551 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 49.84 88.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.893 0.854 . . . . 0.0 112.271 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.4 -169.35 27.84 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.153 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.93 145.83 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.625 0.25 . . . . 0.0 110.993 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 11.5 p -138.05 140.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.814 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 HD21 ' HE1' ' A' ' 14' ' ' MET . 7.3 mp -98.67 130.8 45.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 0.0 110.248 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -106.27 112.78 25.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.053 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.8 m 66.52 176.65 0.23 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.83 0.706 . . . . 0.0 111.371 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -144.5 15.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -129.52 86.56 55.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.989 0.423 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -89.31 132.56 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.179 2.586 . . . . 0.0 111.677 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -87.01 -25.17 24.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.291 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -90.5 -18.55 25.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.502 HG23 ' HA2' ' A' ' 109' ' ' GLY . 3.0 m -125.7 88.45 54.2 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.95 -34.2 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.825 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.2 40.58 1.01 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.04 0.448 . . . . 0.0 111.71 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.695 ' HA ' HD11 ' A' ' 110' ' ' ILE . 42.8 t -72.7 -27.17 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.505 0.669 . . . . 0.0 109.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -70.99 -2.79 16.53 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.851 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.79 -64.82 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.057 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.49 104.18 1.08 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.19 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.103 2.536 . . . . 0.0 113.285 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 -24.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.04 70.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.091 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.07 -38.35 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.42 -44.45 51.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.164 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.07 -30.05 66.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.644 0.259 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 54.8 tp -62.75 -45.59 91.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.025 0.441 . . . . 0.0 110.633 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.33 -29.9 67.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.756 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.6 -12.11 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 111.19 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 13.1 tp10 -74.37 -26.58 60.21 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -140.59 72.63 30.24 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -93.79 6.81 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.05 2.5 . . . . 0.0 112.39 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.21 -22.08 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 0.0 110.992 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.02 129.81 56.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -66.61 109.86 2.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.788 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.01 133.78 34.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.546 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.465 ' CD ' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -90.89 102.17 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.96 173.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.9 t -95.95 113.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.472 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.639 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -122.09 135.6 54.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 16.7 pt -128.03 148.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.11 171.08 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 79' ' ' GLN . 9.9 t70 -66.49 161.88 21.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 173.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 80' ' ' SER . 63.5 tp -66.91 -55.9 12.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.735 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . 57.8 mt-10 -73.84 -23.56 59.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.489 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 31.7 tt0 -64.55 -33.94 77.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.937 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 73.1 m -63.67 -40.05 95.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.6 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -55.43 -38.31 68.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 174.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.04 -43.42 62.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.241 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.73 -44.48 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 109.97 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -43.88 96.53 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.81 -49.44 76.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -63.99 -26.0 68.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.43 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -103.28 -4.91 23.62 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.088 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.42 38.3 80.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.186 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -122.03 -14.62 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 110.618 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CE1' ' HG3' ' A' ' 81' ' ' GLU . 45.7 t80 -65.37 114.33 4.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.107 0.479 . . . . 0.0 112.246 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -173.25 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.904 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 11.9 p90 -143.78 145.81 32.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.302 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 13.7 Cg_exo -71.18 138.17 32.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.673 2.248 . . . . 0.0 112.077 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.27 162.94 31.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.8 m -96.67 113.56 25.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.506 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.458 HD23 ' HH ' ' A' ' 103' ' ' TYR . 32.2 mt -94.48 129.98 41.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.21 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.82 135.91 57.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -108.72 125.48 51.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.403 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -104.1 123.44 47.27 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.735 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.91 11.76 63.77 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.46 71.62 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' N ' HD21 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -95.43 143.74 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -177.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.458 ' HH ' HD23 ' A' ' 96' ' ' LEU . 81.0 t80 -78.09 111.1 13.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.273 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -139.29 -19.24 0.97 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.604 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.62 149.27 18.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.931 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.96 134.71 18.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.901 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.9 mt -115.25 117.69 31.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.582 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.63 117.92 30.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.527 0.679 . . . . 0.0 111.28 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA2' HG23 ' A' ' 48' ' ' THR . . . 95.3 -161.54 23.29 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.395 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.695 HD11 ' HA ' ' A' ' 51' ' ' VAL . 49.3 mm -99.01 -53.53 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 44.6 m80 67.5 159.99 0.14 Allowed Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.725 0.641 . . . . 0.0 110.893 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.718 ' HG2' ' HB2' ' A' ' 115' ' ' GLU . 11.8 Cg_endo -60.25 136.8 70.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.503 1.469 . . . . 0.0 109.473 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.526 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.5 t-105 -54.79 -45.41 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.25 -34.36 72.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.771 0.32 . . . . 0.0 111.493 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 1.3 tm-20 -77.2 -37.13 54.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.448 . . . . 0.0 110.102 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.95 -44.97 91.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.335 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.96 -39.04 82.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.226 0.536 . . . . 0.0 109.946 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -58.11 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.147 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.3 mt -56.82 -45.64 82.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.479 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.44 ' O ' HG21 ' A' ' 124' ' ' VAL . 12.9 tpt -57.74 -47.6 81.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.465 ' HA ' HG21 ' A' ' 124' ' ' VAL . 62.9 mtp180 -64.11 -32.73 74.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.224 0.209 . . . . 0.0 110.916 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.96 74.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.176 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 99.1 mt -84.38 -39.48 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 121' ' ' ARG . 34.2 m -82.78 -15.5 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.63 0.252 . . . . 0.0 111.636 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.609 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 10.1 tp10 -45.82 -58.22 6.58 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 125' ' ' GLU . 3.6 Cg_exo -74.79 145.51 32.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.944 1.763 . . . . 0.0 112.708 -175.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.411 . . . . 0.0 111.621 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 64.52 121.43 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.752 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -84.72 156.01 21.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.732 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -71.86 119.85 16.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.324 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.32 161.16 38.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.291 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 121.311 0.577 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -84.25 84.15 7.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.49 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 17.4 m120 -133.8 152.12 51.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.207 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.67 82.55 7.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.997 0.427 . . . . 0.0 110.892 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.617 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 4.4 m -177.29 -61.4 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.911 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.3 -55.39 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.798 1.666 . . . . 0.0 112.04 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.43 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 44.7 t80 -62.46 -37.11 84.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.975 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.34 -54.59 30.62 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.428 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -42.27 88.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.546 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.85 -57.0 14.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.543 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.562 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.6 t90 -67.7 -36.64 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.305 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -56.87 -44.44 82.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.786 0.326 . . . . 0.0 110.976 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 97.3 mtt180 -63.49 -53.55 50.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 110.727 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.487 ' HE2' HD22 ' A' ' 40' ' ' LEU . 85.0 mtp -60.76 -36.84 79.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.439 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -70.1 -30.39 67.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.423 -177.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.19 64.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -10.37 59.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.824 0.345 . . . . 0.0 111.284 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.69 41.88 14.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.411 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -90.64 -178.69 5.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.675 0.274 . . . . 0.0 110.38 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.1 m -117.49 120.35 33.3 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.172 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 11' ' ' TRP . 2.8 Cg_exo -75.83 121.49 6.29 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.965 2.443 . . . . 0.0 111.172 174.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG12 HD23 ' A' ' 27' ' ' LEU . 14.9 p -117.9 143.47 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.618 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -95.24 163.25 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.557 0.694 . . . . 0.0 112.118 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -68.4 144.7 54.64 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.441 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m 75.12 -10.79 1.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.306 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.28 -23.19 14.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.44 HD23 HG12 ' A' ' 22' ' ' VAL . 3.3 tm? -48.94 -47.27 43.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.403 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.16 -49.4 44.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.961 0.41 . . . . 0.0 110.866 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.478 ' O ' HG21 ' A' ' 32' ' ' THR . 10.4 t70 -55.56 -48.52 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.925 0.869 . . . . 0.0 110.232 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -59.9 -42.31 93.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.858 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.13 -28.64 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 29' ' ' ASP . 7.4 t -80.57 -26.1 38.14 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.87 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -89.67 -38.38 13.93 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.86 106.77 36.2 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -67.76 122.35 9.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.755 2.303 . . . . 0.0 114.213 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.553 ' OD2' ' HB ' ' A' ' 99' ' ' THR . 6.1 m-20 65.64 154.76 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 124.594 1.184 . . . . 0.0 113.361 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 71' ' ' GLN . . . 153.91 -172.9 32.61 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.709 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 97' ' ' VAL . 31.3 m -133.54 156.33 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.545 0.212 . . . . 0.0 110.458 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 73' ' ' ALA . 61.0 t -129.74 131.04 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.076 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD22 ' HE2' ' A' ' 14' ' ' MET . 6.8 mp -98.64 122.22 41.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.403 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.605 HD22 ' HA ' ' A' ' 93' ' ' PRO . 6.6 tt -106.79 97.97 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.808 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 42.4 m 61.33 -170.59 0.16 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.0 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 p -130.39 77.55 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -176.61 82.41 0.27 Allowed Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.45 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 3.4 Cg_exo -81.2 -30.61 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.114 2.543 . . . . 0.0 113.839 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.663 ' HG2' ' HD2' ' A' ' 47' ' ' ARG . 77.5 tttt -135.97 -78.67 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.711 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.663 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 3.1 mpt_? -131.79 -35.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.7 m 73.93 104.55 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.564 171.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.36 -12.68 20.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.144 2.563 . . . . 0.0 111.961 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -125.5 -123.38 0.25 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 t -140.85 -54.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.7 t -92.57 -18.31 23.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.387 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.4 -90.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.971 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 92.55 1.53 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.63 0.252 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -102.17 41.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.057 2.505 . . . . 0.0 111.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -104.5 -59.66 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -23.86 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.611 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' HD11 ' A' ' 62' ' ' LEU . 47.2 mm -52.59 -46.73 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.257 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -36.51 86.74 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.455 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 mt-10 -80.01 -26.95 39.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.887 0.375 . . . . 0.0 111.135 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.76 HD22 ' HB2' ' A' ' 120' ' ' MET . 42.8 tp -62.24 -45.72 92.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.798 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 70' ' ' TRP . 9.0 mp -56.35 -26.83 53.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.399 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 38.4 mmt180 -60.3 -17.73 44.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 5.6 pt-20 -76.5 -8.66 57.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.004 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -125.65 70.77 65.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.569 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.28 11.98 2.8 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.77 2.313 . . . . 0.0 111.583 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.67 -25.7 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.355 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -131.55 -157.9 0.85 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.025 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.444 ' HB ' ' OE1' ' A' ' 71' ' ' GLN . 6.6 p -111.62 140.08 46.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.602 ' HB3' HD22 ' A' ' 62' ' ' LEU . 82.7 m95 -122.05 95.59 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' OE1' ' HB ' ' A' ' 69' ' ' THR . 1.9 mp0 -84.34 109.86 18.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.23 114.22 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.988 0.423 . . . . 0.0 110.251 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' HG21 ' A' ' 39' ' ' VAL . . . -110.64 137.53 48.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.975 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 12.9 pt -122.72 146.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.78 160.77 31.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 0.0 112.074 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.99 164.84 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.775 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 96.2 mt -59.34 -44.53 92.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.773 0.32 . . . . 0.0 110.807 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.03 -36.31 79.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 0.0 110.081 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -72.81 -31.15 64.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.073 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.603 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 68.2 m -60.08 -43.88 95.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.995 0.426 . . . . 0.0 111.202 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.82 -41.01 97.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.697 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . . . -77.2 -35.18 55.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.568 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 24' ' ' GLU . 73.3 mt -63.63 -49.19 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.539 0.209 . . . . 0.0 110.676 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.03 -45.97 94.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.688 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -52.74 -53.35 49.13 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -73.28 -23.99 60.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 89' ' ' VAL . 10.7 t80 -85.4 -54.58 4.49 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.801 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.41 44.02 0.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.365 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' CD1' ' A' ' 87' ' ' PHE . 57.5 t -125.56 83.74 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.736 ' HB3' ' HD1' ' A' ' 92' ' ' PHE . 86.0 m-85 66.51 -62.59 0.28 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER 95.72 -1.6 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.293 1.837 . . . . 0.0 109.859 -169.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.736 ' HD1' ' HB3' ' A' ' 90' ' ' PHE . 83.8 m-85 -84.98 135.32 39.84 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.508 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.808 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.6 Cg_exo -67.41 134.18 32.53 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.871 2.381 . . . . 0.0 112.196 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . 173.85 -169.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.051 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.5 m -97.53 113.97 25.78 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.7 mt -95.75 127.52 41.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.071 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.682 HG12 ' HB2' ' A' ' 104' ' ' ARG . 5.7 p -109.34 124.13 65.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.458 0.647 . . . . 0.0 111.156 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -124.94 -178.87 4.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.465 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 14.2 p -127.89 -168.91 1.97 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.45 49.45 1.29 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.151 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.1 -41.5 0.85 Allowed Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.425 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -94.08 170.91 9.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.874 . . . . 0.0 112.099 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.44 134.96 55.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.35 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.682 ' HB2' HG12 ' A' ' 97' ' ' VAL . 3.5 mmp_? -105.14 -58.84 1.83 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.555 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -161.25 27.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.517 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.59 134.3 58.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 110.337 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.4 mt -101.51 128.84 47.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.611 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.56 11.15 25.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.797 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.25 -148.33 49.97 Favored Glycine 0 C--O 1.239 0.406 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.186 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.836 HG22 ' H ' ' A' ' 111' ' ' HIS . 10.6 mm 61.28 -168.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.836 ' H ' HG22 ' A' ' 110' ' ' ILE . 66.0 m80 73.39 150.45 0.13 Allowed Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.041 0.536 . . . . 0.0 111.522 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 13.4 Cg_exo -70.46 166.9 26.94 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.515 2.143 . . . . 0.0 111.582 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.478 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 33.5 t-105 -53.86 -43.15 69.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.612 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.51 77.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 22.6 mm-40 -81.22 -25.91 36.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 111.153 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.17 -43.53 91.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 61' ' ' LEU . 62.4 mt -58.81 -42.38 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.607 0.717 . . . . 0.0 109.554 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -54.5 -52.79 60.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.758 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.35 -45.42 93.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.615 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.76 ' HB2' HD22 ' A' ' 61' ' ' LEU . 8.2 tpt -57.1 -47.76 80.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.269 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.49 ' HA ' HG21 ' A' ' 124' ' ' VAL . 15.9 ttm180 -66.27 -37.78 86.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.977 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.538 ' HA2' HE21 ' A' ' 127' ' ' GLN . . . -61.14 -30.68 74.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.501 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.419 HD13 HG11 ' A' ' 97' ' ' VAL . 94.8 mt -89.47 -42.47 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 121' ' ' ARG . 35.9 m -73.65 -31.01 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.76 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.57 109.42 58.06 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.78 108.72 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.836 2.357 . . . . 0.0 113.294 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.538 HE21 ' HA2' ' A' ' 122' ' ' GLY . 45.8 mt-30 -101.81 -14.68 17.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.483 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 8.3 pt20 -153.57 112.49 3.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.296 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.88 100.36 4.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.02 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.96 148.3 22.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.792 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.74 109.0 12.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.57 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 62.43 59.12 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 t30 59.32 71.76 0.56 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.635 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.54 173.66 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.39 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m -162.68 -55.62 0.01 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.828 -175.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 10.9 Cg_exo -70.23 -43.37 2.3 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.867 1.712 . . . . 0.0 111.807 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.789 ' HE1' ' HB2' ' A' ' 42' ' ' SER . 76.7 t80 -73.54 -43.04 60.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 24.4 t70 -55.15 -53.62 53.62 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.504 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.19 99.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.544 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.13 -41.27 97.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.753 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -64.41 -40.26 95.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.651 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 24.9 mm-40 -57.89 -39.92 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.36 -52.5 46.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.633 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.6 mtp -55.32 -38.24 68.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.979 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.459 HD23 HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -65.13 -36.42 84.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.754 179.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.64 67.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -73.27 -7.77 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.804 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.49 23.64 36.12 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.266 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -85.1 141.97 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.2 m -84.63 116.08 63.56 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.942 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 57.1 Cg_endo -74.39 129.59 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.553 2.169 . . . . 0.0 110.985 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG13 HD21 ' A' ' 27' ' ' LEU . 13.8 p -138.57 145.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.892 0.377 . . . . 0.0 111.328 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 p -91.23 160.73 15.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.598 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -32.44 72.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.514 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -66.27 -36.5 83.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.876 0.37 . . . . 0.0 111.112 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -90.52 -24.76 20.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.348 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.441 HD21 HG13 ' A' ' 22' ' ' VAL . 3.1 tm? -58.8 -40.46 84.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.651 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 32' ' ' THR . 17.7 t70 -56.11 -53.4 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.877 0.846 . . . . 0.0 111.105 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.551 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t90 -59.39 -41.53 89.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.88 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.53 -29.11 70.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.181 0.515 . . . . 0.0 110.47 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 86.2 m -66.32 -40.0 89.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -98.91 -14.5 19.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . . . -140.58 90.22 10.04 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.843 0.354 . . . . 0.0 110.048 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.725 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 86.0 Cg_endo -88.61 -14.38 3.07 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.06 2.507 . . . . 0.0 114.409 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -100.22 135.94 40.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 110.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.98 -160.98 28.74 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 97' ' ' VAL . 6.9 m -138.4 134.87 44.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.409 HG23 ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -113.59 132.15 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.0 mp -101.34 122.43 43.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 35.2 tp -83.15 81.2 8.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.789 ' HB2' ' HE1' ' A' ' 7' ' ' PHE . 4.3 p -58.77 -48.1 82.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.063 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.431 ' OG ' ' HG ' ' A' ' 41' ' ' LEU . 14.4 m 57.42 -102.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.682 0.614 . . . . 0.0 110.599 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' OD1' ' HD3' ' A' ' 91' ' ' ARG . 7.0 p-10 -161.77 142.93 8.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 2.0 Cg_endo -83.59 132.55 5.81 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.477 2.118 . . . . 0.0 111.443 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 36.7 tptt -122.53 -50.33 1.99 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -158.82 -60.29 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.5 m 71.07 143.7 0.1 OUTLIER Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.98 170.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.58 -5.87 6.31 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.944 2.43 . . . . 0.0 112.354 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.824 ' HG2' HG13 ' A' ' 110' ' ' ILE . 11.2 tp10 -151.16 100.01 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -69.05 -52.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.876 -174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 t -126.62 -84.8 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.936 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 53.78 -168.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.926 0.891 . . . . 0.0 111.955 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -147.57 92.35 4.8 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.12 98.44 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.746 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.97 -32.67 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.311 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -60.14 -23.76 64.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.877 -177.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.409 HD12 HD22 ' A' ' 116' ' ' LEU . 49.8 mm -53.93 -39.96 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.73 -44.69 95.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.399 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -62.2 -34.83 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.342 . . . . 0.0 111.071 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.617 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 45.0 tp -64.76 -55.0 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.21 -27.99 69.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.369 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.96 -19.9 65.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -86.79 -0.45 56.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.772 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -123.08 71.64 44.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.94 -3.03 10.38 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.53 2.154 . . . . 0.0 113.075 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.53 -17.83 60.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.16 139.14 51.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.274 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -86.25 105.21 16.47 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -80.11 110.63 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.187 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 2.9 mp0 -82.47 119.54 24.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.081 174.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.33 103.33 14.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.551 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -108.45 127.15 53.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 40' ' ' LEU . 23.4 pt -122.59 139.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.954 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -111.68 169.78 8.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 112.242 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.66 168.77 14.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.283 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 44' ' ' ASP . 9.8 tp -50.25 -54.64 19.72 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.251 0.62 . . . . 0.0 112.18 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -30.3 61.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.546 0.689 . . . . 0.0 110.671 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' O ' HG13 ' A' ' 83' ' ' ILE . 57.6 mt-30 -77.27 -42.7 36.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.468 -175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 48.6 p -73.38 -37.24 66.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.663 0.268 . . . . 0.0 110.305 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -53.08 -49.79 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.101 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.07 71.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.786 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 79' ' ' GLN . 81.1 mt -67.89 -52.09 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.433 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.53 -44.75 97.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.171 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.94 -39.58 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.21 -30.75 65.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.373 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -84.82 -33.38 22.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 110.715 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.82 31.96 1.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.488 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.55 158.68 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.71 -83.81 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 110.821 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.54 ' HD3' ' OD1' ' A' ' 44' ' ' ASP . 86.9 mtt180 -148.17 -161.18 1.28 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 88.5 m-85 76.7 148.18 0.12 Allowed Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 124.144 0.903 . . . . 0.0 111.733 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 17.2 Cg_exo -65.39 69.15 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.452 3.434 . . . . 0.0 113.39 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.64 129.56 34.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.339 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 7.3 m -92.22 112.96 25.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.439 HD23 HG21 ' A' ' 106' ' ' VAL . 65.8 mt -93.97 113.9 25.99 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.764 HG11 ' HB2' ' A' ' 104' ' ' ARG . 7.4 p -97.85 127.37 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.202 0.525 . . . . 0.0 110.92 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.93 134.26 55.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.14 137.45 23.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.84 17.6 75.38 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.725 ' HA2' ' HB2' ' A' ' 35' ' ' PRO . . . 79.93 -0.36 83.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.663 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.46 149.34 32.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 111.649 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -69.98 129.47 39.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.417 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.764 ' HB2' HG11 ' A' ' 97' ' ' VAL . 16.7 mmt180 -101.93 -47.29 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.367 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.04 -163.76 36.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.388 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 95' ' ' THR . 59.3 t -122.6 134.26 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.611 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 4.4 mp -101.32 123.58 45.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.78 90.29 2.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.186 0.517 . . . . 0.0 110.026 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.5 146.15 5.73 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.824 HG13 ' HG2' ' A' ' 50' ' ' GLU . 27.4 mm -123.0 -53.27 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 117.165 0.483 . . . . 0.0 111.767 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.6 m170 -73.25 -53.65 4.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 12.5 Cg_exo -68.73 121.91 8.82 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.126 1.217 . . . . 0.0 111.885 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.617 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 9.4 t-105 -87.49 -45.14 10.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.549 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.21 75.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 8.0 tp10 -72.18 -40.59 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.316 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 ' HZ3' ' A' ' 113' ' ' TRP . 30.9 tp -61.31 -44.28 97.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.401 HD11 ' CE2' ' A' ' 113' ' ' TRP . 62.1 mt -63.9 -44.94 98.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -50.23 -59.05 4.33 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.122 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 87.0 mt -65.53 -45.46 83.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.926 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.466 ' HG3' HD23 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -61.37 -48.03 83.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.69 0.281 . . . . 0.0 110.538 -178.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 124' ' ' VAL . 14.0 ttt85 -69.39 -33.03 72.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.199 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.51 -29.15 74.53 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.2 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.5 mt -83.06 -49.59 9.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.409 0.147 . . . . 0.0 111.206 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 121' ' ' ARG . 29.5 m -70.65 -37.94 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.428 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 35.4 tt0 -101.49 99.19 10.77 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 24.2 Cg_exo -64.87 99.08 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.314 2.676 . . . . 0.0 114.599 -166.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -89.42 76.93 7.42 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 163.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -71.88 75.84 0.89 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.52 77.49 1.77 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 161.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.75 98.58 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.385 -166.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.19 83.56 1.0 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.179 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.007 -176.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HB3' ' HG2' ' A' ' 6' ' ' PRO . 44.8 m 54.52 59.66 4.01 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.02 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -120.61 171.74 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 69.06 7.21 6.1 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.266 0.626 . . . . 0.0 112.395 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.702 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 88.0 m -148.8 -59.51 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.892 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.205 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.3 Cg_exo -68.58 -58.91 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.551 1.501 . . . . 0.0 111.545 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.41 -35.07 79.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.23 -54.22 49.41 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.566 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -62.26 -48.02 81.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.78 -40.68 89.11 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 111.631 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -69.12 -43.47 74.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 12.3 mm100 -62.36 -32.76 73.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.359 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 50.1 mmm-85 -57.38 -53.59 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.251 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.547 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 73.0 mtm -66.65 -33.0 74.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.957 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 1.9 mm? -67.37 -24.37 65.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.459 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.76 72.9 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -81.36 -3.96 54.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.863 0.363 . . . . 0.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.91 29.99 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.116 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 43.4 m0 -74.09 148.19 42.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.174 0.511 . . . . 0.0 110.215 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.561 ' HB ' ' HZ3' ' A' ' 30' ' ' TRP . 9.5 p -96.85 130.43 30.19 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.9 -169.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.7 Cg_exo -79.31 145.1 18.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.302 2.668 . . . . 0.0 111.345 172.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.7 144.24 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.575 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -95.2 166.06 12.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.6 -55.35 35.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.075 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.3 m -73.27 6.37 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -126.34 -1.34 6.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.251 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.29 -47.08 79.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.828 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.15 -29.81 57.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.467 0.651 . . . . 0.0 110.444 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 32' ' ' THR . 17.1 t70 -61.06 -55.16 35.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.18 0.99 . . . . 0.0 109.661 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.561 ' HZ3' ' HB ' ' A' ' 20' ' ' THR . 14.0 m95 -67.93 -29.05 68.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.067 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.93 -28.85 69.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.628 0.252 . . . . 0.0 111.366 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 29' ' ' ASP . 14.5 t -88.78 -30.2 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.582 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.15 -28.94 18.6 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . . . -98.86 158.0 33.15 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.816 ' HG2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -67.84 149.54 78.17 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.969 1.78 . . . . 0.0 111.741 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.77 112.35 10.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.306 0.574 . . . . 0.0 110.204 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.55 -107.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.974 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 97' ' ' VAL . 12.3 m -135.33 142.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 111.975 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 71.7 t -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.4 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.09 143.26 31.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.466 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -86.28 1.12 52.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 93' ' ' PRO . 89.8 p 59.72 169.89 0.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.709 1.203 . . . . 0.0 111.73 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t 64.43 -176.36 0.17 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.263 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.567 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 17.9 t70 -148.22 152.49 39.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 44' ' ' ASP . 78.9 Cg_exo -43.19 169.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.98 3.12 . . . . 0.0 115.151 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -79.97 -23.72 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.916 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -63.48 -28.44 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.873 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.1 m -71.45 127.12 91.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.791 0.329 . . . . 0.0 111.226 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.68 -42.68 29.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.989 3.126 . . . . 0.0 113.76 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.99 -94.02 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.7 t -146.37 -68.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.658 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.4 t -74.47 -44.38 51.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.903 -172.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 60.0 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.855 0.722 . . . . 0.0 111.357 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -144.86 111.06 4.81 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.241 0.543 . . . . 0.0 109.774 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -97.64 -167.98 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.21 2.607 . . . . 0.0 113.326 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.3 t 76.49 -34.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -32.27 54.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.9 mm -59.18 -44.19 91.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.79 73.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.361 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.69 -32.51 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.237 0.541 . . . . 0.0 109.974 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.491 HD21 ' HG2' ' A' ' 120' ' ' MET . 51.1 tp -70.33 -34.59 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.502 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.9 mp -62.85 -28.12 69.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.262 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -68.7 -8.72 45.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.157 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.47 -24.79 66.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.339 . . . . 0.0 111.099 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.31 94.93 46.39 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.696 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.51 -18.28 13.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.99 2.46 . . . . 0.0 112.033 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.84 -25.55 64.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 0.0 110.801 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -137.66 121.15 17.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.578 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 t -86.26 131.12 34.3 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.907 0.861 . . . . 0.0 110.068 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -88.4 135.24 33.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.173 -173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.816 ' HB2' ' HG2' ' A' ' 35' ' ' PRO . 6.5 tp60 -96.22 122.62 39.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.206 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.35 110.99 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -111.82 127.55 55.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.254 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.5 pt -125.59 140.94 46.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 166.73 18.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.694 0.283 . . . . 0.0 111.069 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.5 m-20 -65.57 165.43 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.303 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.64 -49.14 73.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.13 -34.07 75.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.002 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' O ' HG13 ' A' ' 83' ' ' ILE . 81.8 mt-30 -77.16 -52.71 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.729 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.603 ' HB3' HD21 ' A' ' 41' ' ' LEU . 20.0 m -60.96 -39.57 90.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.388 -177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.89 -41.68 96.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.51 . . . . 0.0 110.201 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.42 77.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 79' ' ' GLN . 83.2 mt -61.36 -43.44 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.7 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.936 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.48 -36.16 66.31 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.067 0.547 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -51.67 -54.51 27.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.103 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.4 ' HB3' HG21 ' A' ' 89' ' ' VAL . 24.5 t80 -93.57 -19.29 21.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.002 -166.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.03 39.04 6.22 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.527 HG13 HD23 ' A' ' 96' ' ' LEU . 18.7 t -82.45 160.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -60.25 138.64 57.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -83.07 8.79 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.33 142.2 28.16 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.417 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' SER . 41.8 Cg_exo -57.08 126.04 20.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.518 2.146 . . . . 0.0 111.558 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.87 -175.81 3.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.567 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 29.3 m -117.21 120.65 38.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.527 HD23 HG13 ' A' ' 89' ' ' VAL . 5.8 mp -93.97 114.64 26.87 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -96.03 138.94 20.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -125.05 145.61 49.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -154.79 151.13 28.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.02 21.6 68.0 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.13 76.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.638 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.41 176.66 8.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.446 0.641 . . . . 0.0 111.828 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.87 118.03 11.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.127 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 5.7 tpm_? -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.726 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' A' ' 123' ' ' LEU . . . 170.1 -168.75 41.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.595 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.8 t -132.13 134.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.02 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.8 mt -108.02 131.53 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.3 33.67 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -172.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 -120.76 21.41 Favored Glycine 0 C--O 1.236 0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.782 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.33 99.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.93 0.871 . . . . 0.0 110.325 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.723 ' HB3' HD21 ' A' ' 116' ' ' LEU . 11.5 t60 -137.09 143.36 41.75 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -38.47 124.0 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.192 2.594 . . . . 0.0 112.128 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -54.92 -43.48 73.34 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.61 0.569 . . . . 0.0 112.016 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.17 87.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.698 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.76 -29.0 64.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.343 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 111' ' ' HIS . 0.5 OUTLIER -65.82 -48.82 70.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.52 -42.06 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.166 0.508 . . . . 0.0 109.873 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -52.63 -59.29 4.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.02 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.12 -43.66 98.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.543 ' O ' HG21 ' A' ' 124' ' ' VAL . 12.3 tpt -55.34 -48.95 73.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -39.04 92.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.435 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.52 75.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.428 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.469 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 98.6 mt -86.51 -60.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 120' ' ' MET . 30.7 m -63.51 -33.42 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.501 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.33 91.27 9.52 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.63 114.7 2.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.413 2.742 . . . . 0.0 113.893 -168.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -81.12 -8.1 59.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.581 171.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 52.01 61.27 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.478 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 130' ' ' ARG . 28.7 tt0 -168.77 91.32 0.26 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.403 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 40.4 ttt180 172.64 22.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.527 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.75 141.73 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.062 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.134 0.492 . . . . 0.0 110.471 179.396 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.1 m -58.85 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -145.37 156.35 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.939 0.399 . . . . 0.0 110.684 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.36 85.41 7.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.38 1.086 . . . . 0.0 110.924 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.667 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m -156.01 -52.07 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.73 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 9.7 Cg_exo -71.69 -44.6 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.457 1.438 . . . . 0.0 110.223 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.563 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 38.8 t80 -68.97 -34.81 75.93 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 27.9 t70 -53.79 -53.85 46.53 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.599 0.714 . . . . 0.0 110.41 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.593 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.35 -46.03 89.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.044 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -60.34 -42.3 95.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.494 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CH2' ' HA ' ' A' ' 76' ' ' ASP . 1.6 t90 -66.54 -40.24 88.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 16.5 mm100 -57.78 -36.86 72.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 29.0 mmm180 -63.16 -54.15 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.664 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.505 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 66.5 mtm -62.55 -33.09 74.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.291 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.02 -40.07 95.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 0.0 110.584 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.35 66.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -74.38 -10.96 60.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.276 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.13 6.41 53.75 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.798 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.505 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 21.7 m0 -83.18 121.93 27.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 109.914 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 m -88.26 125.94 62.24 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.348 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 38.1 Cg_endo -68.5 139.38 44.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.847 2.364 . . . . 0.0 111.959 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.587 HG11 ' HG ' ' A' ' 27' ' ' LEU . 10.7 p -130.92 148.55 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.064 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.7 p -86.62 163.6 17.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 111.49 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.01 -59.02 4.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.336 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 t -77.78 -21.94 50.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 19.2 tpt180 -84.28 -16.94 41.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 109.989 -174.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.587 ' HG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.01 -39.2 90.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.462 176.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.47 -29.36 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.616 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 32' ' ' THR . 35.1 t70 -64.24 -51.73 62.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.305 1.05 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -59.1 -40.9 86.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.074 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 60.5 mt -62.5 -33.59 75.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 29' ' ' ASP . 10.2 t -79.88 -26.02 40.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.743 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.75 -34.17 21.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.713 0.292 . . . . 0.0 111.494 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.42 148.36 46.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.69 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.43 -67.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.505 2.137 . . . . 0.0 112.534 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.75 -90.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.578 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.57 163.79 39.67 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.262 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.03 143.28 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.89 137.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 74' ' ' ILE . 8.7 mp -92.24 121.28 33.61 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 80' ' ' SER . 21.5 tp -114.41 148.66 37.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.745 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.8 t -149.59 146.71 27.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.81 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 19.1 m -156.05 53.68 0.57 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 35.1 t70 74.77 124.95 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.028 0.83 . . . . 0.0 109.411 -173.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.66 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 27.1 Cg_exo -61.98 131.16 33.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.661 2.241 . . . . 0.0 114.069 -169.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -136.33 -59.52 0.73 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.16 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -68.99 -37.65 78.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.607 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -70.11 120.6 79.1 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.46 -60.4 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.976 2.451 . . . . 0.0 112.748 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -103.95 -94.33 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.036 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.31 -68.48 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.357 . . . . 0.0 110.808 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.532 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -78.27 -53.34 7.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.477 -175.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 57.08 -146.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.489 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -120.4 93.28 48.17 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 110.966 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.97 13.15 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.067 2.511 . . . . 0.0 112.276 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -84.02 -16.54 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 0.0 110.848 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -21.98 41.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.68 -33.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.788 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -50.26 69.51 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.143 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.95 -27.73 39.74 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.668 -0.313 . . . . 0.0 111.313 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.569 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.3 tp -58.32 -48.09 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.099 0.476 . . . . 0.0 111.617 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.11 -26.58 67.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.85 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -63.92 -7.92 9.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -67.23 -32.44 73.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 110.56 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.67 75.42 62.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.25 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.38 6.22 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.93 2.42 . . . . 0.0 112.896 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -91.26 2.09 56.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.786 0.803 . . . . 0.0 109.722 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -138.38 147.58 43.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.387 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -87.23 138.65 31.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.856 0.836 . . . . 0.0 111.269 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -117.21 115.25 24.94 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.732 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.09 102.89 15.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.89 106.92 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.91 142.31 41.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.55 HG22 ' HB2' ' A' ' 40' ' ' LEU . 21.0 pt -114.9 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.518 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -92.12 157.24 16.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.896 0.379 . . . . 0.0 111.939 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -59.51 159.68 7.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.328 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -57.24 -55.72 31.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.54 -39.24 46.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.505 0.669 . . . . 0.0 111.076 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.712 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 49.8 mt-30 -72.53 -22.35 61.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.132 -173.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 31.9 p -70.31 -41.1 73.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.026 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 41.7 mt-10 -60.65 -38.87 86.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.07 83.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.017 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 79' ' ' GLN . 84.1 mt -58.33 -41.02 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 110.816 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.53 -53.26 47.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.419 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.27 -40.4 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 110.564 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.41 -36.17 83.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.051 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -92.31 -27.67 17.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.16 20.83 7.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.78 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.643 HG12 ' HB2' ' A' ' 92' ' ' PHE . 25.5 t -126.74 78.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.56 122.98 40.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 111.459 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.554 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 34.6 ttt180 70.44 27.8 3.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.993 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.643 ' HB2' HG12 ' A' ' 89' ' ' VAL . 93.6 m-85 -115.83 85.77 15.05 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.032 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HG3' ' HA ' ' A' ' 45' ' ' PRO . 57.4 Cg_endo -73.13 125.43 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.11 1.873 . . . . 0.0 111.807 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 107' ' ' LEU . . . -177.07 -176.35 0.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.655 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -104.31 123.22 47.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.339 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.14 133.12 37.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.701 0.286 . . . . 0.0 110.528 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.34 125.77 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.381 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -144.22 129.38 18.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.968 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.8 p -93.14 124.0 36.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.358 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.67 27.3 58.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.99 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.91 83.44 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.571 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -105.04 129.36 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -66.09 124.2 21.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.702 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -103.61 -51.47 3.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.219 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.5 -174.96 47.37 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.424 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.47 133.85 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.983 0.42 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 93.0 mt -85.68 97.2 9.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.01 158.58 39.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.79 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.47 84.83 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.909 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 45.8 mm 65.6 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.516 0.727 . . . . 0.0 111.866 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 74.8 m80 74.22 157.07 0.16 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 123.287 0.635 . . . . 0.0 111.083 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.39 155.3 69.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.337 2.024 . . . . 0.0 111.515 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.569 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 t-105 -54.91 -39.13 68.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.25 -42.47 81.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.663 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.19 -28.77 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.12 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.98 -41.4 95.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.174 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 113' ' ' TRP . 78.4 mt -58.1 -46.01 88.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.321 0.581 . . . . 0.0 110.171 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -54.99 -57.84 10.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.819 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.19 -45.28 87.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.516 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.475 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.7 tpt -53.65 -53.29 53.99 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.351 0.407 . . . . 0.0 110.912 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.19 -33.47 76.08 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.29 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.31 66.42 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.346 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.91 -52.35 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 120' ' ' MET . 8.4 p -69.97 -30.64 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 9.89 101.05 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 125.511 1.524 . . . . 0.0 115.104 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.56 105.18 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.859 1.706 . . . . 0.0 109.843 170.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -80.62 73.71 7.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.333 1.063 . . . . 0.0 113.276 -167.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -107.52 36.26 2.79 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.243 -1.799 . . . . 0.0 107.131 163.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -133.4 156.57 47.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.288 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -94.78 87.5 5.04 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 121.319 -0.152 . . . . 0.0 111.123 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 33.62 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.693 1.246 . . . . 0.0 113.679 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.552 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.901 0.381 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -142.66 121.66 12.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.18 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -73.28 100.17 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' C ' ' HG1' ' A' ' 5' ' ' THR . 43.6 t0 -60.85 125.52 24.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 111.093 -175.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 92.6 m -162.31 -49.17 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.076 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 30.3 Cg_exo -62.51 -56.81 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.642 1.561 . . . . 0.0 111.675 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -65.43 -41.79 93.14 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.84 -53.12 53.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.506 0.67 . . . . 0.0 111.006 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -64.84 -45.12 87.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.249 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 52' ' ' SER . 1.9 mm? -60.01 -46.65 88.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.106 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -67.58 -36.61 81.22 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -49.09 74.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.941 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 35.0 mtp180 -61.14 -52.4 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.648 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtp -54.48 -39.75 67.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.338 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HG3' ' A' ' 21' ' ' PRO . 1.8 mm? -67.21 -42.52 83.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.917 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.7 61.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -69.9 -18.0 63.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 110.24 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.6 26.12 9.44 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -91.35 -179.21 5.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.9 m -121.89 124.39 27.05 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.76 0.314 . . . . 0.0 111.645 -174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HG3' HD12 ' A' ' 15' ' ' LEU . 6.5 Cg_exo -73.18 132.72 18.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.941 2.427 . . . . 0.0 110.981 175.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 73' ' ' ALA . 17.4 t -120.99 144.83 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.58 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 25.0 p -99.05 165.96 11.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.972 173.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.75 -54.95 30.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 m -78.38 -13.23 59.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 111.683 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.421 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.8 tpp180 -94.65 -15.99 23.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.3 tm? -60.89 -44.41 97.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.4 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.32 -32.05 62.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.638 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 32' ' ' THR . 33.0 t70 -64.82 -54.58 28.86 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.782 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -66.02 -28.93 69.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.559 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -66.1 -28.11 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.441 0.639 . . . . 0.0 109.855 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 91.5 m -74.5 -41.56 60.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.138 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -83.62 -46.2 12.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . . . -94.52 118.95 66.9 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.411 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.18 124.96 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.551 2.168 . . . . 0.0 112.747 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.4 m-20 68.06 172.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.128 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.34 -163.19 24.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.277 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.56 142.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.0 110.8 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 73' ' ' ALA . 59.8 t -119.28 127.67 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.589 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' HB2' HG23 ' A' ' 74' ' ' ILE . 35.2 mt -101.96 135.69 43.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.994 0.426 . . . . 0.0 110.948 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.99 -69.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.727 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.1 m -156.55 178.08 10.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.9 m -80.11 -74.89 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.319 0.387 . . . . 0.0 110.35 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.71 159.78 0.12 Allowed Pre-proline 0 N--CA 1.469 0.511 0 O-C-N 123.643 0.589 . . . . 0.0 111.95 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.29 134.19 30.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.15 1.9 . . . . 0.0 112.024 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 8.1 tmtt? -93.45 -63.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 164.43 -30.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.41 1.069 . . . . 0.0 108.935 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.502 ' O ' HG21 ' A' ' 51' ' ' VAL . 36.3 p -106.39 172.88 3.53 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.793 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 48' ' ' THR . 6.2 Cg_exo -75.5 -0.99 10.76 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.765 2.31 . . . . 0.0 112.436 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.9 1.43 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.474 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 48' ' ' THR . 44.9 t -60.46 -25.11 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 110.816 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.466 ' HA ' HD21 ' A' ' 10' ' ' LEU . 10.2 t -87.68 -4.45 58.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.081 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.66 123.56 28.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 4.6 p-10 -75.63 131.83 76.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 26.8 Cg_exo -62.98 104.61 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.176 2.584 . . . . 0.0 113.292 -174.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.98 -37.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.204 0.526 . . . . 0.0 109.786 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -24.34 67.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.127 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.0 mm -65.26 -36.42 77.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.38 99.69 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.586 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.68 -28.2 40.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.668 0.27 . . . . 0.0 111.21 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.96 -41.77 97.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.98 0.419 . . . . 0.0 110.6 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.8 mp -58.74 -25.75 63.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.147 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.18 -8.12 7.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.2 -30.18 64.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.593 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.21 92.86 37.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.095 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.54 -0.91 9.98 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.993 2.462 . . . . 0.0 111.601 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.26 -24.9 42.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.794 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -110.39 161.02 16.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 p -95.67 113.93 25.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.063 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -86.94 95.51 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.027 0.441 . . . . 0.0 110.918 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HG2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -88.11 117.66 27.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.769 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 t -90.6 107.89 19.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.037 0.446 . . . . 0.0 110.293 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HB2' HG23 ' A' ' 22' ' ' VAL . . . -105.66 127.57 53.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.349 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 40' ' ' LEU . 22.3 pt -127.15 140.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.46 167.43 19.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.346 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.12 168.4 15.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.8 -37.19 86.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.77 -49.17 78.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -67.6 -45.44 75.5 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.082 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 p -67.24 -32.78 74.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.398 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.61 -49.42 77.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.16 97.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.2 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.471 HD11 ' HG ' ' A' ' 27' ' ' LEU . 92.8 mt -65.98 -41.87 90.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.796 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.87 86.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.661 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.56 -39.82 71.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.0 110.63 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.34 -37.41 72.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.437 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -91.27 -35.33 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.51 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.76 -18.95 5.33 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 t -94.22 96.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.497 ' HD2' ' HG3' ' A' ' 91' ' ' ARG . 46.3 p90 -122.74 154.07 38.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.602 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG3' ' HD2' ' A' ' 90' ' ' PHE . 20.2 mtp180 64.93 22.68 12.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.128 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.12 90.33 13.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.676 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.68 133.64 15.82 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.48 -172.68 3.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.26 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 15.3 m -99.81 108.72 21.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.4 117.42 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.211 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.7 p -102.58 128.76 55.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.234 0.54 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -121.39 134.06 55.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.086 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.595 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 34.2 p -119.99 123.7 44.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.001 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.97 22.9 65.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.488 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 1.44 90.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.923 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -100.51 143.13 31.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.52 0.2 . . . . 0.0 110.516 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.74 112.52 3.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.254 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.481 ' HB3' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.55 -49.75 6.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.48 -173.08 46.03 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.163 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.2 136.51 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.846 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.3 mt -122.52 157.67 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.225 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.496 ' HB2' ' HE1' ' A' ' 111' ' ' HIS . 18.5 m120 -132.39 142.63 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.04 165.62 50.86 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.52 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 110' ' ' ILE . 3.6 mp 60.98 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.673 0.749 . . . . 0.0 111.067 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.496 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 9.0 m80 -155.94 150.19 19.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.167 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' HG2' ' HB3' ' A' ' 115' ' ' GLU . 13.0 Cg_endo -57.22 137.08 80.13 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.56 2.173 . . . . 0.0 111.216 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.52 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.8 t-105 -59.4 -43.97 92.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.581 -173.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.34 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.592 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . 44.6 tt0 -72.5 -39.28 67.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.347 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.82 -45.27 93.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.967 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 113' ' ' TRP . 63.2 mt -60.84 -49.82 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -50.61 -56.19 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.208 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 82.7 mt -64.89 -43.3 93.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.995 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -65.52 -47.45 75.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.45 . . . . 0.0 110.076 -177.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ttt85 -65.62 -32.63 74.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.42 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.2 68.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.956 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 65.4 mt -75.64 -53.2 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.954 -0.145 . . . . 0.0 111.055 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 120' ' ' MET . 18.8 m -64.56 -38.48 82.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.084 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 46.6 85.72 0.16 Allowed Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 124.037 0.835 . . . . 0.0 111.996 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -79.66 177.25 8.65 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.754 2.303 . . . . 0.0 112.664 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -77.63 -5.62 50.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.36 0.6 . . . . 0.0 110.513 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 59.35 66.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.056 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 10.7 tp10 -109.42 14.32 23.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.116 0.96 . . . . 0.0 109.842 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -121.65 100.04 6.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.178 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 65.14 174.79 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.924 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.477 0.656 . . . . 0.0 110.376 178.271 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -101.71 -60.29 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.98 106.51 17.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -77.38 141.58 39.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 111.199 -173.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 27.8 m -164.76 -51.86 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.882 -175.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 2.9 Cg_exo -76.14 -46.42 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.147 1.898 . . . . 0.0 111.59 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.85 -43.92 94.69 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -50.51 -52.68 36.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.59 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.99 -49.49 77.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.478 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -56.46 -46.47 80.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.871 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.488 ' CZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.4 t90 -66.08 -45.22 82.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.213 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -55.51 -40.13 71.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 16.1 mmm180 -60.24 -54.01 50.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -63.19 -33.28 75.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 74' ' ' ILE . 1.8 mm? -63.19 -30.04 71.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.554 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -29.21 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.739 0.304 . . . . 0.0 111.548 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -75.73 -7.38 54.22 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.35 19.74 44.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.785 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -76.71 128.09 34.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 109.786 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.4 m -83.0 129.71 60.32 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 29.6 Cg_endo -65.55 128.83 20.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.747 175.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.66 144.02 22.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -109.53 168.08 9.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.13 -39.49 94.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.705 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.2 t -77.6 -16.33 58.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.396 0.617 . . . . 0.0 110.815 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -98.91 -9.66 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 27' ' ' LEU . 1.5 tm? -59.59 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.162 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.25 -45.15 89.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 32' ' ' THR . 24.9 t70 -60.61 -55.14 36.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.538 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -57.9 -39.3 77.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.133 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.3 tp -66.54 -28.31 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -89.06 -26.26 21.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.713 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.93 -42.69 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 111.275 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 157.1 44.23 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.743 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.1 -69.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.012 1.808 . . . . 0.0 111.117 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.47 -79.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.982 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.67 -166.9 51.17 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.676 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 97' ' ' VAL . 19.3 m -135.93 150.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.523 ' HB ' ' HE2' ' A' ' 98' ' ' PHE . 74.7 t -129.96 127.07 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.34 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 74' ' ' ILE . 7.2 mp -101.0 131.21 46.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.81 -39.58 69.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -156.98 -66.76 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.488 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 19.4 m -153.89 -170.04 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.63 ' HB3' HD13 ' A' ' 110' ' ' ILE . 8.5 t70 -128.63 80.87 71.82 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.208 0.528 . . . . 0.0 110.182 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 67.1 Cg_endo -90.76 131.62 1.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.482 2.121 . . . . 0.0 113.824 -173.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 8.8 tmtm? -136.26 -58.6 0.75 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -112.88 -29.17 7.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.37 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' OE2' ' A' ' 50' ' ' GLU . 1.5 m -85.79 135.97 37.26 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.687 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.92 -1.23 10.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.363 2.042 . . . . 0.0 111.415 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.547 ' HG2' ' HB3' ' A' ' 45' ' ' PRO . 21.3 mm-40 72.88 112.34 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.389 1.056 . . . . 0.0 111.211 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.25 -73.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.09 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -128.29 -59.07 1.18 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.13 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 t70 47.82 78.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.442 -168.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.2 106.31 0.92 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -12.95 81.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.821 4.348 . . . . 0.0 115.126 -159.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.22 -73.3 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.11 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -60.39 -35.06 74.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.648 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.74 -38.11 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -63.75 -47.37 87.05 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.413 -175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.71 -36.32 37.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 111.487 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.723 HD22 ' HG3' ' A' ' 120' ' ' MET . 23.9 tp -66.53 -55.14 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.118 -173.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.49 -27.45 67.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 48.8 mmt-85 -71.6 -7.82 50.19 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.84 -40.33 83.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.146 0.498 . . . . 0.0 110.176 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.619 ' HB3' ' HD2' ' A' ' 68' ' ' TYR . 99.2 m-85 -129.54 84.23 62.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.714 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -82.03 -14.02 9.98 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.871 2.381 . . . . 0.0 113.365 -174.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.77 -25.46 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.387 0.613 . . . . 0.0 110.268 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.619 ' HD2' ' HB3' ' A' ' 65' ' ' PHE . 60.4 m-85 -84.14 111.24 19.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.079 175.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 p -67.96 104.76 1.81 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.006 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -86.81 95.06 9.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.364 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -87.0 105.11 16.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.17 125.77 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.815 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.22 140.63 51.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.56 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 40' ' ' LEU . 13.8 pt -125.44 140.66 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.93 0.395 . . . . 0.0 110.558 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . . . -106.92 157.41 17.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB3' ' CH2' ' A' ' 11' ' ' TRP . 2.8 p30 -87.02 -174.07 4.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -59.44 -42.91 93.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.358 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -75.35 -36.93 60.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.29 0.567 . . . . 0.0 110.874 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 82.3 mm-40 -73.59 -44.66 56.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.499 -175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 p -59.38 -43.24 92.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.73 0.3 . . . . 0.0 110.932 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.98 -41.16 82.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -40.45 61.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.234 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 79' ' ' GLN . 77.8 mt -65.54 -48.06 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.372 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.62 -48.15 83.78 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.894 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.52 -52.41 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 122.636 0.374 . . . . 0.0 110.673 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -68.52 -26.39 65.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.92 -26.61 31.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.078 0.466 . . . . 0.0 110.237 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.79 -0.24 48.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.75 -26.47 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 109.938 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' HB3' ' H ' ' A' ' 91' ' ' ARG . 72.5 m-85 65.14 -141.78 0.22 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.118 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 92' ' ' PHE . 50.7 mtt-85 -92.1 -158.1 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.654 -170.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 90.5 t80 75.16 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.185 0 O-C-N 124.219 0.949 . . . . 0.0 109.456 -172.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.77 131.16 20.64 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.674 2.25 . . . . 0.0 112.27 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.05 -174.8 4.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.37 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.2 m -92.11 113.36 25.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.08 118.85 32.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.178 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.53 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.3 p -98.39 131.65 45.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' HE2' ' HB ' ' A' ' 39' ' ' VAL . 95.2 m-85 -118.22 146.7 44.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.278 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 1.9 m -153.4 146.28 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.28 20.55 63.2 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.059 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 16.43 78.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.755 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -131.47 174.0 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -70.06 112.9 6.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.817 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.71 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.5 tpm_? -90.24 -41.49 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.225 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.59 -175.39 44.44 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.855 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.6 137.97 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.2 mt -94.7 161.34 14.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.705 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -169.31 96.28 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.079 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 46' ' ' LYS . . . 130.79 91.8 0.58 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.727 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 44' ' ' ASP . 40.2 mm -62.17 -31.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.353 0.597 . . . . 0.0 111.46 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.635 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 6.4 t-80 -68.28 -58.87 6.81 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -168.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 11.8 Cg_exo -71.02 121.87 8.25 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.721 1.614 . . . . 0.0 112.308 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.444 ' CE2' HD11 ' A' ' 117' ' ' ILE . 7.1 t-105 -93.51 -45.41 7.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.214 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.43 98.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.49 -43.46 94.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.696 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 30.7 tp -58.59 -49.39 77.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.904 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.444 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.7 mt -58.17 -48.93 83.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -52.16 -55.63 19.78 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.146 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.2 mt -64.62 -45.26 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.691 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.723 ' HG3' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -60.72 -51.77 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttm-85 -64.09 -39.45 94.09 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.189 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.01 -30.35 73.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.542 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.517 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 95.0 mt -81.43 -56.68 3.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.425 0.155 . . . . 0.0 110.822 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 120' ' ' MET . 31.8 m -68.56 -36.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -114.31 110.27 48.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 95.57 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.503 2.136 . . . . 0.0 111.972 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -81.14 59.75 4.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.375 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.51 77.72 6.07 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.497 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.25 168.43 11.09 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.882 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -75.58 -13.74 60.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.831 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.8 79.25 9.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.948 -179.619 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.494 0.664 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.0 m -85.17 -47.1 10.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.023 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -109.68 137.77 47.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.425 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -73.23 100.91 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.085 0.469 . . . . 0.0 110.04 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.557 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 21.3 m -158.99 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.557 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 33.1 Cg_endo -65.62 -46.32 5.45 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.693 1.595 . . . . 0.0 112.009 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -66.37 -41.69 89.1 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.267 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.29 -53.59 56.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 110.293 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.79 -42.86 98.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.278 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -60.47 -49.7 76.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.903 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -37.28 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.68 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.81 -37.14 78.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.4 mtt180 -69.89 -52.03 28.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.55 177.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.5 mtp -55.11 -40.7 70.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.843 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.47 -31.01 70.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.279 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.62 68.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -85.34 -1.07 56.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.633 0.254 . . . . 0.0 111.486 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.53 22.84 41.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.009 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -81.55 119.08 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -78.8 121.17 83.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.719 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -82.78 127.88 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.817 2.344 . . . . 0.0 111.79 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.88 137.76 13.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 0.0 111.01 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 25' ' ' SER . 4.4 m -94.43 130.95 40.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.605 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' SER . 1.5 tm-20 17.86 -98.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.727 1.211 . . . . 0.0 111.491 162.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 23' ' ' SER . 14.7 t 23.84 -78.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.021 1.328 . . . . 0.0 113.927 149.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.408 ' HG3' ' HD1' ' A' ' 30' ' ' TRP . 9.7 tpp180 -106.92 -15.61 14.66 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.571 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.51 -36.39 73.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.136 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' HH12 ' A' ' 86' ' ' ARG . 25.5 t70 -66.1 -41.88 90.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.568 ' O ' HG23 ' A' ' 32' ' ' THR . 32.3 t70 -57.93 -49.61 76.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.816 0.817 . . . . 0.0 109.885 174.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.408 ' HD1' ' HG3' ' A' ' 26' ' ' ARG . 5.3 m95 -53.5 -43.01 67.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.406 173.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -38.29 90.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 29' ' ' ASP . 11.0 t -74.35 -25.11 59.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.82 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.99 -10.11 53.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.315 177.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 103.69 44.47 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.62 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.17 -36.35 81.29 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.571 2.18 . . . . 0.0 111.085 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 37' ' ' GLY . 3.2 m-20 -80.78 -88.8 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.249 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . 96.86 113.37 3.0 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.926 173.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 72' ' ' VAL . 11.1 m -138.78 134.28 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 0.0 110.406 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.35 129.1 67.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.515 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.7 117.49 34.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.453 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.67 26.1 7.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.2 m 61.42 -154.15 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.722 ' HA ' ' HB2' ' A' ' 93' ' ' PRO . 73.6 m -150.23 162.34 40.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.513 0.196 . . . . 0.0 110.473 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 25.6 t70 -79.94 117.22 66.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.692 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 2.0 Cg_endo -81.26 133.37 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.916 2.411 . . . . 0.0 111.493 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -114.18 -83.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.024 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -113.21 -31.29 6.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 m -62.59 115.93 20.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.631 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.77 11.89 3.17 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.081 2.52 . . . . 0.0 112.491 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.33 86.68 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.695 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -71.82 -24.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.176 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t -68.76 -42.81 76.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.726 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 52.65 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.979 0.799 . . . . 0.0 111.653 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -160.12 85.74 2.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.17 44.15 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.847 2.365 . . . . 0.0 112.971 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.72 -26.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.049 0.452 . . . . 0.0 110.488 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -24.6 67.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.692 -173.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' O ' HD13 ' A' ' 62' ' ' LEU . 48.8 mm -61.77 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 110.575 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.21 68.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.567 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.92 -31.64 70.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.045 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -70.84 -46.03 63.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.04 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 58' ' ' ILE . 10.0 mp -59.07 -27.72 65.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.368 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.86 -14.79 36.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.45 -44.69 82.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.636 0.255 . . . . 0.0 110.834 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.99 72.04 34.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.655 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -91.53 15.99 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.148 2.565 . . . . 0.0 112.822 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.89 -25.35 59.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.482 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -157.31 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.7 p -116.87 102.49 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 112.073 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -95.25 84.41 4.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.89 104.35 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.385 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 ' HA ' HG22 ' A' ' 38' ' ' VAL . 52.7 t -87.64 103.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.021 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.13 132.25 52.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' A' ' 40' ' ' LEU . 18.0 pt -114.37 139.69 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.31 154.68 19.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.794 0.33 . . . . 0.0 111.358 -176.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 2.0 m-20 -56.96 155.95 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.646 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.33 -53.86 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.21 -26.74 59.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.094 0.473 . . . . 0.0 110.894 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.477 ' CG ' ' HB2' ' A' ' 76' ' ' ASP . 20.1 mm-40 -70.36 -29.66 66.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.719 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -62.86 -38.6 91.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.522 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.68 -42.89 95.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.614 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.07 93.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.17 -47.88 90.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.92 -46.98 93.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.688 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.86 -45.55 86.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.636 HH12 ' HB2' ' A' ' 28' ' ' ASP . 47.6 ttt180 -57.76 -37.34 73.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.468 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' A' ' 89' ' ' VAL . 19.8 t80 -82.26 -40.12 22.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 0.0 109.843 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.1 33.56 4.26 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.593 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 87' ' ' PHE . 21.8 t -92.81 -15.57 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.507 0.194 . . . . 0.0 110.941 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.6 t80 72.15 174.01 0.3 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -172.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -71.23 96.81 1.45 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.808 0.337 . . . . 0.0 111.016 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -142.39 100.82 5.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.722 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 2.4 Cg_endo -83.83 123.97 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.781 2.32 . . . . 0.0 111.914 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -172.05 -170.08 0.71 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.818 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 30.8 m -96.73 109.27 21.96 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.61 120.32 34.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.048 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.92 130.35 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.982 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.73 172.89 6.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.539 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.68 122.83 7.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.632 175.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.61 29.84 54.86 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.716 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.01 90.63 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.892 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.82 157.09 18.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.092 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -71.69 119.08 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -93.7 -46.27 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.38 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.55 -167.67 40.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.108 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.5 134.58 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.941 0.401 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.2 mt -92.71 114.36 26.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.293 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.7 98.86 6.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.335 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.48 140.35 2.87 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.33 -39.16 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -109.41 -44.56 0.1 Allowed Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 16.5 Cg_exo -65.17 120.32 7.52 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 120.718 1.292 . . . . 0.0 110.897 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.511 ' HE3' ' HA ' ' A' ' 113' ' ' TRP . 2.1 t-105 -97.68 -51.0 4.26 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.825 -168.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.14 73.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 110.466 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -77.84 -35.14 51.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.419 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -62.57 -46.6 87.59 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.1 mt -61.26 -43.0 95.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.399 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -49.75 -58.04 6.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.225 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.5 mt -57.09 -49.2 76.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.724 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.491 ' O ' HG21 ' A' ' 124' ' ' VAL . 15.8 tpt -61.5 -42.78 99.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.547 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.03 -35.99 82.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.09 71.06 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.237 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 95.9 mt -78.06 -47.25 18.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 120' ' ' MET . 34.4 m -77.92 -34.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -116.74 87.04 20.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.89 149.96 5.87 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.798 2.332 . . . . 0.0 114.22 -168.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -91.85 -0.2 57.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.995 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 72.35 101.42 0.07 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.629 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -134.69 -178.7 5.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.796 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -74.11 113.73 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 110.359 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 152.44 37.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.484 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -108.05 138.46 44.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.767 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 66.66 174.45 0.25 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.589 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -90.42 115.24 27.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.322 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.617 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 99.3 m -156.62 -65.54 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.947 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 58.8 Cg_endo -75.15 -66.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.336 1.357 . . . . 0.0 113.248 -175.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -60.85 -33.34 72.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.77 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.44 -53.89 50.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.674 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.68 89.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.961 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.447 HD13 HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -62.76 -55.3 27.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.844 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -65.51 -36.94 85.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.81 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -56.09 -39.64 72.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.588 0.232 . . . . 0.0 111.146 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 32.5 mmt180 -63.19 -51.86 64.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.452 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 87.2 mtp -55.1 -38.87 68.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.272 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.62 -38.23 67.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.999 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.21 -28.14 69.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.99 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -64.08 -20.77 66.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.67 32.49 7.61 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.325 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -98.85 134.81 41.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.012 0.434 . . . . 0.0 110.026 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 2.6 p -86.43 137.79 34.3 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.819 -176.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 1.8 Cg_endo -82.56 141.28 11.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.313 2.675 . . . . 0.0 113.257 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.72 148.04 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -114.77 167.73 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -36.77 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.929 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 t -79.78 4.74 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.381 0.61 . . . . 0.0 110.398 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -118.09 -12.49 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.837 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tt -48.72 -47.77 41.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.269 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -68.32 -51.52 43.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.065 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 32' ' ' THR . 13.4 t70 -54.76 -55.46 29.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.219 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -69.03 -31.61 70.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 HD22 ' A' ' 102' ' ' ASN . 27.9 tp -67.7 -28.36 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.697 0.76 . . . . 0.0 109.688 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 85.6 m -71.32 -29.85 65.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.373 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.73 -61.37 2.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.73 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.74 113.85 59.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.824 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.51 -16.46 4.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.486 2.124 . . . . 0.0 112.888 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 24.6 m-20 -122.19 159.76 26.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.356 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.89 -166.32 25.69 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.209 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.82 137.11 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 99.0 t -117.41 119.65 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.164 0.507 . . . . 0.0 110.03 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' A' ' 74' ' ' ILE . 6.9 mp -101.94 122.15 43.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.216 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.741 ' HB2' ' H ' ' A' ' 94' ' ' ALA . 7.7 mp -94.13 17.94 11.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.855 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 t 79.49 168.54 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.254 0.971 . . . . 0.0 110.088 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.696 ' HB2' HG13 ' A' ' 51' ' ' VAL . 7.2 m -82.45 -27.33 31.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.618 -174.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.712 ' HB2' ' HB2' ' A' ' 93' ' ' PRO . 22.7 t70 67.45 132.73 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.81 0.694 . . . . 0.0 111.513 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.97 -24.44 74.02 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.039 2.493 . . . . 0.0 113.512 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -96.26 -41.68 8.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 8.8 tpm_? -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.718 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.7 m -126.42 114.48 23.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.582 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.06 -38.52 91.4 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.842 2.361 . . . . 0.0 112.417 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.56 79.0 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 43' ' ' SER . 9.6 t -57.22 -31.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.156 -1.383 . . . . 0.0 112.244 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -82.79 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.789 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 54' ' ' ASN . 10.5 t70 50.81 -144.73 0.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.796 0.685 . . . . 0.0 109.573 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 18.5 m120 -131.27 96.51 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.63 15.98 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.334 2.689 . . . . 0.0 113.617 -174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.09 -31.31 34.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.339 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -27.41 69.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.381 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.402 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.8 mm -59.99 -44.54 94.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.072 0.463 . . . . 0.0 110.237 176.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -66.69 -38.72 93.38 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.996 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -70.25 -28.75 65.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.301 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.769 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 63.5 tp -64.81 -49.36 70.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.8 mp -60.56 -25.63 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.797 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 36.7 mmt180 -56.81 -15.15 4.16 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.8 -8.69 59.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.047 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 73.7 m-85 -132.61 63.8 69.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.085 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -85.88 2.16 7.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.379 2.052 . . . . 0.0 112.961 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.8 -13.12 19.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.49 0.662 . . . . 0.0 109.901 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -108.98 120.0 41.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -64.65 110.11 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.648 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 87.8 m95 -91.22 117.24 29.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.551 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.69 106.21 18.19 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.34 105.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.889 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -114.78 140.05 49.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.801 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 24.3 pt -121.93 140.3 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.54 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 80' ' ' SER . . . -97.3 161.6 13.72 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.571 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -65.83 171.81 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.79 -55.7 21.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.052 0.453 . . . . 0.0 109.837 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -78.17 -34.82 49.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.642 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 96.6 mt-30 -67.57 -35.06 78.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.81 -175.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.651 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 29.5 p -60.72 -48.61 81.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -57.98 -47.58 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.138 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.19 81.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.782 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 79' ' ' GLN . 67.9 mt -62.11 -51.38 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.131 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.91 94.01 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.565 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -54.46 -44.69 72.77 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 111.221 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 86' ' ' ARG . 23.1 ttt180 -73.0 -31.15 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.729 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -85.17 -31.13 23.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.27 25.07 11.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.43 111.16 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.858 -0.201 . . . . 0.0 110.893 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 69.77 -58.48 0.52 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.691 0.797 . . . . 0.0 112.859 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 70.9 15.21 6.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.832 0.825 . . . . 0.0 108.826 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -129.6 151.19 77.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.98 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.712 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 51.3 Cg_exo -56.16 132.93 54.93 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.818 2.345 . . . . 0.0 112.744 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.741 ' H ' ' HB2' ' A' ' 41' ' ' LEU . . . -165.22 -175.49 3.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.018 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 43.7 m -109.4 115.53 30.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.02 136.36 44.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -114.71 137.03 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.71 128.88 53.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.558 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -169.7 134.61 1.4 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.13 0.491 . . . . 0.0 112.28 -175.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.29 22.63 65.54 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.737 173.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 130.99 59.78 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.046 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.528 HD22 HD23 ' A' ' 31' ' ' LEU . 1.0 OUTLIER 65.59 -153.53 0.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.906 0.483 . . . . 0.0 111.739 172.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -41.38 112.22 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.222 0.951 . . . . 0.0 111.754 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -101.04 -31.58 11.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.583 -176.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.29 -174.17 42.47 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.353 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.83 137.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.551 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.2 mt -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.408 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -133.18 142.15 48.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.432 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.93 167.17 43.15 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.114 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 51.0 mm -83.22 -69.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 60.9 m80 71.61 156.49 0.16 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 123.8 0.687 . . . . 0.0 111.537 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.16 152.13 82.43 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.411 2.074 . . . . 0.0 111.052 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.769 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 20.9 t-105 -56.75 -40.8 76.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.527 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.04 79.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.359 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -80.26 -26.79 38.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -46.61 85.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.33 -41.03 91.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.876 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.77 -53.87 46.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.434 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.72 -49.16 76.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.407 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.632 ' HG2' HD23 ' A' ' 61' ' ' LEU . 15.4 tpt -54.5 -51.98 63.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.909 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.514 ' HA ' HG23 ' A' ' 124' ' ' VAL . 15.7 ttt180 -70.61 -33.57 71.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.725 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.92 -30.86 74.26 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.538 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.6 mt -83.89 -59.81 2.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.026 0.13 . . . . 0.0 111.058 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 121' ' ' ARG . 27.7 m -65.17 -27.23 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.81 82.94 21.44 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -91.73 176.56 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.096 2.53 . . . . 0.0 113.397 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -93.57 -0.13 56.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.009 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 62.68 37.41 12.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.864 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.75 139.66 40.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.936 -1.483 . . . . 0.0 109.165 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 61.61 83.02 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.007 0.817 . . . . 0.0 110.88 -173.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.87 93.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 109.823 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.664 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HG3' ' HB ' ' A' ' 48' ' ' THR . 55.3 mtt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 p -78.39 83.29 4.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 108.935 170.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.539 ' HB2' ' CB ' ' A' ' 7' ' ' PHE . 14.2 p30 -88.32 54.32 3.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.104 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -87.41 11.26 15.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.227 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 31.1 m -151.06 -58.4 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.357 -174.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 13.9 Cg_endo -58.23 -55.69 2.06 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.121 1.881 . . . . 0.0 112.657 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CB ' ' HB2' ' A' ' 3' ' ' ASN . 67.9 t80 -64.71 -42.04 95.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.4 -51.49 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.97 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.15 76.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.556 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -46.05 80.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -65.64 -41.93 92.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.354 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.25 -37.02 74.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.388 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.86 -53.63 47.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.0 mtm -60.87 -36.96 80.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 110.6 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.493 HD23 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.5 -40.45 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.567 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.2 67.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.533 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -75.56 -5.95 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.93 23.27 30.61 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.96 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -88.96 118.89 29.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 m -80.02 121.67 82.28 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.349 -169.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 39.6 Cg_endo -70.08 120.9 7.55 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 0.0 110.761 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 27' ' ' LEU . 12.4 p -124.95 143.82 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.2 t -84.91 159.32 20.35 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.778 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.53 -54.16 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.124 0.57 . . . . 0.0 111.98 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 m -67.05 -23.71 65.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.149 0.499 . . . . 0.0 111.362 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -86.72 -26.1 24.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.332 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.495 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -60.42 -41.36 93.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.05 -42.52 72.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.251 0.548 . . . . 0.0 110.324 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 13.4 t70 -63.72 -55.81 20.44 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.366 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.572 ' HZ3' ' HB1' ' A' ' 73' ' ' ALA . 2.6 t90 -62.94 -35.76 81.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.447 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.494 ' O ' HD11 ' A' ' 31' ' ' LEU . 2.4 tm? -63.83 -32.04 73.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.647 0.737 . . . . 0.0 109.044 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 97.5 m -71.95 -37.49 69.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.793 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 14.6 mm-40 -74.41 -33.72 63.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.13 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.03 142.98 30.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.381 -177.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.6 Cg_exo -69.6 -39.67 6.53 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.822 2.348 . . . . 0.0 111.874 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 6.8 t70 -145.67 154.46 42.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.16 147.68 9.45 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.907 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 97' ' ' VAL . 29.4 m -125.2 142.43 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 55.8 t -125.04 131.9 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.512 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.31 124.77 47.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.4 mp -98.2 125.12 43.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.4 m -84.87 -58.9 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.706 ' HA ' ' HG3' ' A' ' 81' ' ' GLU . 38.7 m 53.1 81.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.91 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -170.62 111.33 0.43 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.95 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -95.9 -22.09 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.21 2.607 . . . . 0.0 112.827 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -124.49 -65.38 1.05 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -162.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.7 tpm_? -93.89 -42.22 9.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -162.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 30.9 m 72.95 92.26 0.05 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 110.365 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.0 -46.23 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.381 2.721 . . . . 0.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -161.66 110.41 1.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.132 0.492 . . . . 0.0 109.96 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.4 -28.51 13.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.778 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.34 -2.37 48.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.703 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.66 ' HA ' HG13 ' A' ' 110' ' ' ILE . 14.7 t70 -72.07 113.45 9.12 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 49.72 63.48 10.12 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.991 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.56 -41.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.124 1.883 . . . . 0.0 113.664 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.89 -42.18 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -56.58 -24.44 47.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.456 ' O ' HD13 ' A' ' 62' ' ' LEU . 41.8 mm -62.03 -44.35 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.837 0.351 . . . . 0.0 110.958 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.81 -26.75 74.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.062 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.91 -42.76 38.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.992 0.425 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.758 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 48.9 tp -60.75 -48.28 82.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.646 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.3 mp -58.72 -26.86 64.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.888 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 11.4 mmt180 -68.3 -7.63 32.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 10.1 pt-20 -83.09 4.88 24.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.298 175.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . 97.7 m-85 -109.97 90.15 9.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.03 -43.41 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.056 2.504 . . . . 0.0 113.517 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.72 -25.61 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.223 0.535 . . . . 0.0 110.679 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 65' ' ' PHE . 11.1 t80 -88.77 107.78 19.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.615 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 p -89.06 125.76 35.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.993 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -102.82 129.77 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.118 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -87.39 105.98 17.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.36 115.81 33.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.91 0.386 . . . . 0.0 110.592 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB1' ' HZ3' ' A' ' 30' ' ' TRP . . . -121.76 147.56 45.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.553 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.574 HG22 ' HB2' ' A' ' 40' ' ' LEU . 10.4 pt -134.55 147.4 29.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.058 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.81 39.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 3.5 m-20 -60.43 179.66 0.15 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.63 -55.9 28.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.629 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.52 -42.98 81.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.452 ' OE1' ' HB2' ' A' ' 76' ' ' ASP . 14.3 mp0 -54.96 -51.1 67.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.205 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 p -65.62 -39.58 91.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.59 0.233 . . . . 0.0 110.647 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 42.8 mt-10 -61.58 -46.01 91.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.179 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.29 82.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.334 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.26 -44.23 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.331 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.42 87.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.909 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.35 -50.77 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.179 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -65.49 -27.91 68.82 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -87.48 -23.59 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.014 0.435 . . . . 0.0 109.829 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.16 32.03 10.16 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.507 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.13 82.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 85.8 m-85 53.19 -156.99 0.17 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.385 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -158.28 41.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 87.4 m-85 -129.46 160.19 65.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.136 -174.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 52.0 Cg_exo -53.56 130.52 39.17 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.602 2.201 . . . . 0.0 112.231 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -175.65 158.95 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 32.7 m -107.6 115.16 29.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.671 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.01 129.4 42.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 104' ' ' ARG . 3.9 p -108.21 125.71 64.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.289 0.566 . . . . 0.0 111.545 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.25 119.49 37.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.964 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -101.67 -175.68 2.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.095 -174.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.41 ' H ' HG21 ' A' ' 99' ' ' THR . . . -54.41 -28.17 43.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.442 170.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.11 28.73 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.879 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 102' ' ' ASN . 1.3 t-20 65.99 -156.48 0.26 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.524 0.73 . . . . 0.0 111.113 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -49.51 125.38 11.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.201 0.524 . . . . 0.0 111.633 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.476 ' HB3' HG12 ' A' ' 97' ' ' VAL . 1.7 tpt180 -104.75 -59.57 1.72 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.216 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.76 -159.12 21.07 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.807 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.54 134.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 3.0 mm? -92.99 117.1 29.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.552 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.65 154.05 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.41 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.826 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.66 HG13 ' HA ' ' A' ' 53' ' ' ASP . 41.3 mm -84.2 78.36 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 52.1 m-70 -156.72 -61.38 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 172.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 16.8 Cg_endo -94.73 124.77 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.565 2.177 . . . . 0.0 113.058 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.758 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 19.3 t-105 -82.69 -39.63 21.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.307 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.28 97.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.675 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 20.2 mp0 -64.78 -39.0 92.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.995 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.47 -48.01 82.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.0 mt -61.41 -42.49 93.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.125 0.488 . . . . 0.0 110.244 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -58.04 -49.18 77.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.847 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.6 mt -59.68 -44.8 93.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.905 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt -62.5 -37.47 86.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.728 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 121' ' ' ARG . 3.4 tmm_? -62.96 -41.88 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.21 -30.94 79.22 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.588 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.82 -56.54 4.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.097 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 121' ' ' ARG . 28.5 m -64.02 -41.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.225 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' HB3' HH11 ' A' ' 121' ' ' ARG . 43.5 tt0 -109.94 96.62 25.65 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.65 143.1 99.73 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.775 2.317 . . . . 0.0 112.646 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.613 ' HB2' ' HB2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -80.73 -14.7 57.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.481 0.658 . . . . 0.0 110.867 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 53.28 68.5 0.83 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.746 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 58.95 29.06 18.44 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.13 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.613 ' HB2' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -72.26 149.6 44.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.205 177.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.46 112.55 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.454 . . . . 0.0 110.61 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 -179.556 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m 71.01 -0.56 3.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.718 0.636 . . . . 0.0 111.497 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.52 133.33 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 109.967 175.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -103.7 104.16 14.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.277 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.539 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 56.0 m -156.88 -63.94 0.02 OUTLIER Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 36.9 Cg_endo -65.76 -64.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.584 1.523 . . . . 0.0 112.831 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 38.2 p90 -66.18 -32.31 73.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -54.93 -54.91 36.64 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.326 0.584 . . . . 0.0 110.763 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.607 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -60.83 -41.17 95.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.462 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -57.01 -47.5 80.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.455 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.94 -43.72 91.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.51 -32.77 71.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.393 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 59.5 mmt-85 -62.84 -54.52 37.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.479 175.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.0 mtm -60.96 -33.45 73.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 74' ' ' ILE . 3.1 mm? -65.05 -37.97 89.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.575 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.6 -19.21 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 17.1 mmm180 -84.85 -4.73 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.16 17.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.857 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -100.66 136.89 39.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.048 0.451 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 m -86.63 124.6 69.19 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.47 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -80.25 146.21 17.58 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.929 2.419 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 HG11 HD21 ' A' ' 27' ' ' LEU . 12.0 p -148.74 145.26 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.67 0.271 . . . . 0.0 111.133 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 m -73.53 159.59 32.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.371 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 8.6 tm-20 -55.56 -58.6 7.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.502 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -70.11 -7.29 40.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.113 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -106.23 -16.83 14.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.324 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.487 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -59.19 -43.04 92.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.359 0.599 . . . . 0.0 110.436 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.502 ' O ' HG21 ' A' ' 32' ' ' THR . 17.3 t70 -63.87 -54.0 41.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.527 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.408 ' CH2' ' HB3' ' A' ' 71' ' ' GLN . 91.1 t90 -54.33 -43.59 71.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.103 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.79 -44.19 94.07 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.382 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.502 HG21 ' O ' ' A' ' 29' ' ' ASP . 6.6 t -74.88 -24.32 58.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.02 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -80.36 -16.9 53.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.087 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.97 152.85 38.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.5 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 -23.0 22.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.353 2.036 . . . . 0.0 112.277 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 7.4 t70 -156.37 -171.61 3.77 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 98' ' ' PHE . . . 165.1 128.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.58 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.34 146.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 59.2 t -133.26 136.77 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.665 0.269 . . . . 0.0 111.021 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -97.68 125.96 42.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 80' ' ' SER . 0.9 OUTLIER -94.84 125.43 39.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.659 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 11.1 t -147.33 105.92 3.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.9 m -143.19 92.92 2.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.783 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.72 71.7 1.44 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.712 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.86 ' HG2' HG23 ' A' ' 51' ' ' VAL . 16.8 Cg_exo -69.1 133.47 26.87 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.464 2.109 . . . . 0.0 111.917 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -111.2 -63.81 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -68.6 -24.93 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -55.79 121.21 38.31 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.7 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.2 -41.6 72.05 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.134 2.556 . . . . 0.0 113.201 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.53 118.64 0.36 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.787 0.803 . . . . 0.0 109.427 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG23 ' HG2' ' A' ' 45' ' ' PRO . 3.9 t -84.83 -24.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.296 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 10' ' ' LEU . 32.2 t -68.57 -3.95 13.58 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -84.4 -168.47 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.453 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.407 ' OD1' HG12 ' A' ' 58' ' ' ILE . 43.0 t30 62.17 72.78 0.6 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.568 . . . . 0.0 111.67 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -92.78 -40.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.403 2.069 . . . . 0.0 113.491 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.29 -33.12 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.5 -31.56 66.14 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 62' ' ' LEU . 13.5 mm -65.35 -38.75 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.133 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.19 99.67 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.896 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.3 mm-40 -72.8 -28.65 62.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HG ' ' HG2' ' A' ' 120' ' ' MET . 34.8 tp -68.18 -35.04 77.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 58' ' ' ILE . 6.7 mp -60.96 -26.86 67.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.376 176.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 72.8 mtt180 -62.59 -7.42 4.69 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.66 -31.39 68.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 110.383 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.52 88.5 49.89 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.978 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.53 -20.06 16.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.761 2.307 . . . . 0.0 111.774 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.8 -11.66 52.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.59 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -120.41 115.31 23.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.13 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 t -80.59 156.95 26.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.669 0.747 . . . . 0.0 110.554 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -124.76 124.57 42.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.571 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -91.35 98.46 11.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.012 0.434 . . . . 0.0 109.947 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.81 111.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.091 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -123.76 149.28 45.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.36 0.6 . . . . 0.0 111.063 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.8 pt -130.53 140.3 49.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.37 164.01 13.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.006 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.4 m-20 -61.96 150.42 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.989 173.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.423 HD12 ' CD2' ' A' ' 7' ' ' PHE . 15.4 mt -53.6 -45.71 70.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.742 -174.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.94 -47.42 18.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.685 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 39.9 mt-30 -69.79 -18.57 63.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.597 ' HB2' HD21 ' A' ' 41' ' ' LEU . 11.6 p -61.5 -34.0 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.272 0.558 . . . . 0.0 110.559 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.69 -46.67 88.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.625 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . . . -63.51 -40.16 96.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.487 HD13 ' HG ' ' A' ' 27' ' ' LEU . 63.4 mt -62.01 -44.79 99.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.29 -43.49 97.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.685 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.83 -41.97 98.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.66 -32.94 67.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -92.37 -45.64 8.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.962 0.411 . . . . 0.0 110.424 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.55 23.9 4.25 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.081 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.77 -83.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.6 t80 59.01 -163.93 0.21 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.628 0.58 . . . . 0.0 109.927 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.433 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 34.1 ttp180 65.04 80.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.785 0.434 . . . . 0.0 111.757 175.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 89.6 m-85 72.0 141.23 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 13.1 Cg_exo -72.53 138.22 29.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 124.072 3.181 . . . . 0.0 112.73 176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 -178.19 6.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.541 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.613 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.6 m -92.18 122.86 35.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 106' ' ' VAL . 43.6 mt -99.48 113.87 26.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 104' ' ' ARG . 13.4 p -103.55 126.68 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.7 0.762 . . . . 0.0 110.93 -178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.578 ' HD1' ' HA ' ' A' ' 103' ' ' TYR . 46.3 m-85 -122.87 150.55 42.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.427 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 40.6 p -128.43 124.49 36.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.91 28.97 71.15 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.931 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 -1.44 88.75 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.768 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.53 143.76 33.24 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.32 0.581 . . . . 0.0 111.717 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.578 ' HA ' ' HD1' ' A' ' 98' ' ' PHE . 73.3 t80 -69.42 136.99 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.292 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.619 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 1.5 mmp_? -113.79 -64.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.627 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . -172.06 -166.58 30.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.22 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 96' ' ' LEU . 6.5 m -122.23 146.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 122.476 0.31 . . . . 0.0 111.111 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 5.9 mp -99.63 134.0 43.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -123.48 12.61 9.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.383 0.611 . . . . 0.0 110.565 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.21 117.59 5.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.289 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.02 -36.42 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.874 0.368 . . . . 0.0 111.381 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.464 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 91.0 m-70 -122.7 -52.52 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 31.6 Cg_exo -56.84 123.19 13.27 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.729 1.619 . . . . 0.0 112.567 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.492 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.6 t-105 -85.18 -40.43 16.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.616 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.65 86.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 37.9 tt0 -72.84 -32.44 65.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.355 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 29.3 tp -64.46 -46.82 81.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 61.0 mt -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -51.07 -57.49 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.76 -46.89 88.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.077 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.576 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.6 tpt -54.17 -44.67 71.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 125' ' ' GLU . 14.6 mmt180 -55.98 -49.12 74.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.2 -30.12 75.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.734 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.409 HD22 ' HA3' ' A' ' 105' ' ' GLY . 94.4 mt -84.34 -55.09 4.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 120' ' ' MET . 23.9 m -87.01 -26.07 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.723 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 121' ' ' ARG . 31.5 tt0 -103.52 85.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.38 106.42 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.533 2.155 . . . . 0.0 114.1 -162.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -71.49 -21.88 61.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.899 170.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -166.46 121.01 1.12 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.686 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -91.98 23.35 3.76 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.612 0.72 . . . . 0.0 109.816 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -64.65 -23.85 67.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.793 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.23 86.38 7.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.59 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.382 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t 63.23 -165.27 0.24 Allowed 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.741 0.651 . . . . 0.0 110.136 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.471 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 8.8 m120 -107.81 125.89 51.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.313 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 89.9 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.501 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 82.9 m -153.22 -58.46 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.504 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 19.7 Cg_endo -63.31 -52.57 1.93 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.654 1.569 . . . . 0.0 111.417 172.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -67.15 -35.21 79.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.369 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.69 -53.77 54.59 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.207 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -57.89 -46.21 85.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.084 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 2.0 mm? -57.17 -51.81 67.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.511 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -65.55 -42.06 92.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.111 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 14.5 mm100 -59.82 -31.76 70.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.585 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 35.5 mmt180 -57.33 -54.52 45.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 110.605 174.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.483 ' HG3' ' HZ3' ' A' ' 19' ' ' TRP . 4.9 mpp? -66.86 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 2.4 mm? -64.57 -48.33 75.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.82 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.92 64.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.008 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 34.5 mmt180 -73.81 -21.15 60.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.648 0.261 . . . . 0.0 110.386 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.43 21.85 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.784 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.483 ' HZ3' ' HG3' ' A' ' 14' ' ' MET . 27.4 m0 -93.05 168.1 11.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.7 m -112.96 130.97 23.01 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 40.4 Cg_endo -68.91 121.4 8.27 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.909 2.406 . . . . 0.0 111.678 172.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.3 145.73 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.565 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 m -112.5 168.42 9.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.271 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.9 -47.47 85.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -71.74 -7.94 51.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.914 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 29' ' ' ASP . 28.3 mmt180 -117.7 -7.02 11.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.719 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.43 -49.45 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.12 -34.69 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.134 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 32' ' ' THR . 22.3 t70 -62.16 -56.98 13.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.038 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -74.65 -26.65 60.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.997 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.18 -35.03 78.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 111.081 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 29' ' ' ASP . 5.6 t -80.97 -26.53 36.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.007 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -96.7 -0.91 47.58 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.011 0.434 . . . . 0.0 111.699 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.8 87.48 3.71 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.73 148.2 36.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.548 2.166 . . . . 0.0 113.62 -171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.8 t70 80.62 144.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.595 1.184 . . . . 0.0 111.649 174.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.03 -173.55 27.16 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.332 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 m -138.09 138.91 43.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 73' ' ' ALA . 52.9 t -122.62 129.41 75.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.66 124.71 32.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.47 98.89 10.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.1 m -71.4 107.29 4.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -107.92 -58.86 1.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.889 0.376 . . . . 0.0 111.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 11.1 t70 -152.59 120.01 3.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.609 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.71 -24.03 13.88 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.265 2.644 . . . . 0.0 112.576 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -82.95 -27.91 30.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.584 0.707 . . . . 0.0 109.394 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 2.4 tpt180 -52.77 -40.51 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.144 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 25.9 m -124.68 120.03 25.79 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 16.3 Cg_exo -68.69 -31.89 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.835 2.357 . . . . 0.0 113.304 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -120.18 81.39 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.635 0.731 . . . . 0.0 111.116 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 t -100.46 -25.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -72.32 -6.97 46.98 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.677 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -96.96 -0.28 47.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 110.659 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 49.6 t-20 -78.43 -54.55 1.17 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 54' ' ' ASN . 12.5 Cg_exo -70.88 44.58 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.037 2.491 . . . . 0.0 114.505 -169.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.31 -53.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.56 -25.82 64.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.473 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 62' ' ' LEU . 45.2 mm -60.78 -37.99 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.42 -34.25 89.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.619 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.68 -37.72 62.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.306 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 44.6 tp -64.18 -38.76 92.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.253 -176.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 58' ' ' ILE . 8.6 mp -65.41 -26.24 67.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.643 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -66.46 -9.04 30.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -70.1 -34.02 72.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.66 85.76 57.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.696 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -88.15 4.95 5.52 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.431 2.754 . . . . 0.0 112.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.86 -20.97 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 0.0 111.075 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -167.74 1.35 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 p -129.91 104.93 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -85.88 96.7 9.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.225 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.73 108.24 8.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.481 . . . . 0.0 109.768 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.66 108.27 20.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -116.58 145.01 43.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.912 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 6.9 pt -124.56 140.48 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.019 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.45 143.09 41.28 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.382 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.81 160.93 22.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 58.9 tp -54.49 -43.31 71.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.394 0.434 . . . . 0.0 111.501 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.92 -33.44 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.402 0.62 . . . . 0.0 111.06 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -77.94 -32.06 51.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.094 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.1 p -74.45 -29.1 61.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.723 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 51.2 mt-10 -54.19 -53.12 57.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 175.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.18 73.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.49 -45.35 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 0.0 110.309 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -48.45 71.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.651 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -55.88 -42.67 76.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 110.875 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.12 -38.51 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.729 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -95.85 -36.83 10.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.565 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.08 8.03 13.94 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.735 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 96' ' ' LEU . 48.3 t -79.71 -24.41 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.36 105.57 0.3 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 178.86 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.772 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -146.23 143.62 19.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.977 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.16 124.54 6.67 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.629 2.219 . . . . 0.0 111.263 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.23 174.76 14.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.082 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -101.76 119.5 38.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.727 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 89' ' ' VAL . 85.0 mt -94.18 121.83 36.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 104' ' ' ARG . 6.0 p -95.69 132.63 39.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.149 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 94.7 m-85 -121.52 138.31 54.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.66 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -143.79 149.93 37.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 28.15 56.49 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.71 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.12 13.96 79.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.026 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -135.3 178.51 6.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.146 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.55 129.36 34.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -104.74 -51.83 2.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -176.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.79 -170.82 39.76 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.414 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.9 134.64 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.005 0.431 . . . . 0.0 111.499 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.09 110.38 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.018 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -121.55 129.9 53.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.915 0.388 . . . . 0.0 111.795 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.73 154.08 12.18 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.155 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.7 134.94 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -139.02 144.66 42.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.98 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.7 159.7 23.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.657 2.238 . . . . 0.0 111.546 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.486 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 5.4 t-105 -55.86 -48.79 74.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.0 78.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -40.77 87.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.665 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.5 tp -62.19 -48.0 81.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.475 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.4 mt -60.61 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.015 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -55.11 -54.37 44.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.868 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.88 -47.39 85.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.493 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.2 tpt -59.63 -43.15 93.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.634 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -66.92 -33.75 76.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -30.97 71.14 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.23 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -84.7 -52.03 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.524 0.202 . . . . 0.0 111.527 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.32 -31.47 53.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.763 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.523 ' HB3' ' NH1' ' A' ' 104' ' ' ARG . 33.7 tt0 60.72 100.91 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 124.031 0.832 . . . . 0.0 112.679 178.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.33 172.15 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.942 2.428 . . . . 0.0 111.682 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -77.06 -7.15 55.2 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.803 0.811 . . . . 0.0 110.499 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -126.76 89.32 2.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.059 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -94.85 151.48 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.888 -171.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -132.04 110.15 10.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.221 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.3 89.73 4.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.022 0.439 . . . . 0.0 111.773 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.86 175.226 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.506 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 40.0 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 15.3 Cg_endo -58.25 -63.58 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.068 1.845 . . . . 0.0 112.311 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.53 -35.81 82.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 110.186 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.03 -51.49 67.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.613 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -64.64 -46.91 80.5 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.552 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 52' ' ' SER . 70.3 mt -55.38 -46.14 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 12.8 t90 -62.25 -50.64 70.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -58.51 -32.94 69.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.892 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 4.6 mmp_? -61.29 -57.34 12.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 111.166 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.8 ptt? -70.79 -29.34 65.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.8 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -57.42 -46.4 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.085 0.469 . . . . 0.0 109.897 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.72 -10.12 57.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.863 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 14' ' ' MET . 50.7 mtt180 -84.89 -5.19 59.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 0.0 110.995 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.19 21.65 8.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.144 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.423 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 52.8 m0 -97.14 115.26 27.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -71.32 140.82 85.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.154 -176.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 15' ' ' LEU . 6.3 Cg_exo -76.72 141.76 22.18 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.052 2.501 . . . . 0.0 111.48 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 14.2 p -123.28 142.11 41.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.897 0.379 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -102.45 165.1 11.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 83' ' ' ILE . 3.4 tm-20 -57.21 -55.76 30.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -70.68 -13.39 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.031 0.443 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 21.2 mmt180 -96.19 -8.13 33.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.674 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD21 HG21 ' A' ' 39' ' ' VAL . 3.0 tm? -66.77 -41.34 87.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.32 -37.83 80.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.854 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -60.92 -55.97 26.62 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.039 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -43.32 68.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.181 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.29 -44.74 84.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.914 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -83.3 -26.99 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.705 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -81.66 -29.75 33.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.53 141.58 28.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.0 111.452 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 8.2 Cg_exo -72.47 -38.38 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.577 2.184 . . . . 0.0 111.045 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -160.15 169.18 23.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.637 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.46 -179.63 31.29 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.092 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' HB ' ' A' ' 97' ' ' VAL . 16.9 m -137.07 145.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.577 HG21 HD21 ' A' ' 27' ' ' LEU . 45.2 t -119.0 125.24 74.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.402 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.8 mp -98.8 116.44 31.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 96' ' ' LEU . 9.7 mp -98.24 116.06 29.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.982 0.42 . . . . 0.0 110.942 -174.446 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 10' ' ' LEU . 46.8 t . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.657 0.265 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 54' ' ' ASN . 17.8 t70 72.42 -22.26 0.22 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.206 1.002 . . . . 0.0 112.599 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 9.6 t30 83.05 99.54 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 123.572 0.749 . . . . 0.0 110.604 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.76 17.67 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 123.983 3.122 . . . . 0.0 114.599 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.23 -41.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -64.26 -24.79 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.247 -176.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 116' ' ' LEU . 47.9 mm -67.74 -38.14 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.462 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.05 -49.32 58.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.222 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.66 -28.61 69.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HG ' ' A' ' 116' ' ' LEU . 66.8 tp -60.87 -56.95 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 110.922 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.5 mp -62.23 -29.92 70.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.248 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 63' ' ' ARG . 7.8 mmt180 -75.05 -7.71 54.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -78.04 -6.87 55.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.086 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.81 78.85 9.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.437 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.06 -12.09 21.38 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.592 2.195 . . . . 0.0 113.081 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.44 -25.28 63.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.524 0.678 . . . . 0.0 110.315 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -103.56 120.72 41.43 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.539 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 p -80.66 103.29 10.41 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.418 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.548 ' HB3' HD23 ' A' ' 62' ' ' LEU . 96.8 m95 -83.9 100.39 10.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.094 -173.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.09 107.19 15.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.566 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -87.65 114.07 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.691 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -110.75 124.61 52.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 40' ' ' LEU . 8.5 pt -110.34 139.76 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.015 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.42 154.85 21.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.169 0.509 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' HB3' ' CG ' ' A' ' 79' ' ' GLN . 7.1 t70 -65.94 162.99 18.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.198 174.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.22 -53.04 62.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.15 -24.57 62.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.251 0.548 . . . . 0.0 110.228 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.483 ' CG ' ' HB3' ' A' ' 76' ' ' ASP . 89.3 mm-40 -76.08 -37.76 57.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.596 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.6 m -59.23 -42.72 91.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -62.45 -42.78 99.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.577 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.13 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.503 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 24' ' ' GLU . 80.2 mt -67.99 -43.77 85.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.351 . . . . 0.0 110.118 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.87 -46.11 94.04 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.636 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.4 -47.32 72.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.014 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.35 -31.17 71.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.732 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -87.77 -34.16 18.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.005 0.431 . . . . 0.0 110.675 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.31 45.09 1.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.145 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 90' ' ' PHE . 3.5 p -100.83 167.82 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' H ' HG22 ' A' ' 89' ' ' VAL . 18.6 m-85 -79.84 -67.61 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.683 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 91' ' ' ARG . 1.9 tpt180 -179.61 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.658 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 90.9 m-85 -51.06 117.22 8.44 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.882 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 5.4 Cg_exo -79.44 132.46 10.09 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.377 2.718 . . . . 0.0 111.889 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.24 -175.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.726 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 m -92.86 109.96 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.806 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 41' ' ' LEU . 6.2 mp -96.06 125.86 40.89 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.968 HG13 ' HB2' ' A' ' 104' ' ' ARG . 2.5 p -104.01 132.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.183 0.516 . . . . 0.0 111.288 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -127.68 135.28 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.111 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 m -145.4 144.7 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.97 35.59 54.12 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.119 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.66 12.7 62.23 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.052 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -122.36 166.87 14.02 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 111.288 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -93.79 120.22 33.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.592 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.968 ' HB2' HG13 ' A' ' 97' ' ' VAL . 25.6 mmt180 -79.15 -55.16 5.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.483 0.658 . . . . 0.0 109.78 176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.476 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 162.38 -166.75 36.66 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.939 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.47 134.37 65.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.089 0.471 . . . . 0.0 110.479 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.27 100.3 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.99 -7.9 52.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.174 0.511 . . . . 0.0 110.517 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.49 144.56 23.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.724 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.0 mm -136.53 -56.82 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.649 0.262 . . . . 0.0 111.566 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.769 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 36.9 t60 -88.02 -61.35 0.24 Allowed Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -168.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 23.5 Cg_exo -62.62 123.85 13.1 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.439 1.426 . . . . 0.0 111.864 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.433 ' O ' HG13 ' A' ' 117' ' ' ILE . 11.4 t-105 -76.49 -48.39 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.069 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.32 75.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 110.788 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 39.6 tt0 -75.64 -40.31 56.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.244 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 58' ' ' ILE . 50.1 tp -57.57 -44.4 85.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.473 ' HA ' HD11 ' A' ' 61' ' ' LEU . 68.8 mt -58.86 -45.37 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 40.5 t30 -61.68 -42.09 98.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.576 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 92.5 mt -60.32 -48.88 79.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.338 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.3 tpt -65.93 -36.48 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 109.865 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 60.9 ttt180 -56.36 -45.08 80.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.958 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.88 -30.59 70.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.483 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 83.2 mt -77.63 -36.66 51.42 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.883 -0.186 . . . . 0.0 111.374 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 120' ' ' MET . 34.5 m -82.02 -39.76 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.262 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 120.934 0.397 . . . . 0.0 110.156 173.42 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 51.3 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 34.0 Cg_endo -66.74 -36.57 23.93 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 121.83 1.686 . . . . 0.0 111.829 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 77' ' ' LEU . 85.9 t80 -75.3 -38.12 60.49 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.388 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -50.22 -51.48 43.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.709 0.766 . . . . 0.0 109.377 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.27 -45.95 92.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.747 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -54.69 -52.05 63.62 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 111.459 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.2 t90 -65.78 -37.88 87.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.218 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -60.05 -33.56 72.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 28.4 mmt85 -59.38 -55.28 36.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.324 0.583 . . . . 0.0 110.336 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.6 mtm -67.39 -31.63 71.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.325 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -69.38 -34.94 75.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -22.0 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 17' ' ' ARG . 19.3 mmm180 -82.09 -8.88 59.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.594 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.9 10.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.851 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 20.9 m -93.45 122.84 61.96 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 3.7 Cg_exo -81.66 117.74 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.435 2.757 . . . . 0.0 111.179 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.11 151.39 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -81.2 159.77 24.5 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 79' ' ' GLN . 1.5 mp0 -49.63 -57.01 8.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.543 0.737 . . . . 0.0 112.978 -170.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -63.23 -32.4 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.97 0.414 . . . . 0.0 111.521 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -88.53 -11.81 44.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.405 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.43 -42.26 83.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.52 -38.91 59.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.628 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 32' ' ' THR . 11.2 t70 -57.83 -55.6 32.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.565 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -59.82 -46.55 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.776 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.47 -41.5 94.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.86 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.9 t -73.16 -25.92 60.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.381 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -89.86 -8.63 51.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.784 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 146.33 32.73 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.409 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.71 -39.17 12.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.404 2.069 . . . . 0.0 112.295 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.6 t70 -166.58 177.34 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.13 30.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.441 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 97' ' ' VAL . 15.8 m -136.51 146.24 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.41 125.11 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.214 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.4 mp -94.47 128.34 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 93' ' ' PRO . 56.0 tp -87.41 136.46 32.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.189 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.427 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 66.3 m . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.09 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.38 -69.21 0.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.883 0.739 . . . . 0.0 110.426 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -148.68 85.21 6.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' A' ' 13' ' ' ARG . 89.5 Cg_endo -79.44 44.36 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.079 2.52 . . . . 0.0 113.677 -169.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.37 -40.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.747 0.308 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -28.69 70.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.628 -173.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.46 -43.66 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.33 89.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.964 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.28 -28.18 59.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.009 0.433 . . . . 0.0 110.552 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD11 ' HA ' ' A' ' 117' ' ' ILE . 56.8 tp -63.55 -47.26 82.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.738 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.32 -28.29 69.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 23.1 mmt180 -73.3 -7.71 52.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.172 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -64.07 -35.45 80.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.348 0.594 . . . . 0.0 109.626 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -129.14 81.94 69.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.537 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.75 8.49 3.66 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.886 2.391 . . . . 0.0 113.007 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.64 -25.19 62.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 0.0 110.221 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.47 127.02 53.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.967 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.4 p -71.66 108.75 5.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.928 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -80.71 105.58 12.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.264 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 102.43 5.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.82 106.59 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.282 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.46 126.57 53.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 20.3 pt -112.23 140.78 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.869 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.39 145.46 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.602 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.619 ' HB3' ' HG2' ' A' ' 79' ' ' GLN . 21.0 t70 -63.41 160.06 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.657 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.654 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 65.8 tp -55.49 -52.95 61.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.205 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.16 -30.87 58.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.905 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 7.3 pt20 -77.75 -22.92 49.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.068 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 74.0 m -63.03 -29.24 70.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 110.063 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 20.5 mm-40 -56.13 -44.78 79.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.257 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.02 -37.13 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.396 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.06 -47.71 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.82 97.68 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.505 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 26.3 t70 -58.97 -38.73 79.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -71.19 -31.56 67.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.668 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -91.2 -29.56 17.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.027 0.442 . . . . 0.0 110.899 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.87 29.51 4.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.048 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.39 122.78 64.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -136.38 18.82 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 110.715 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -99.55 -165.41 1.22 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.697 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -53.15 143.19 34.32 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 123.622 0.576 . . . . 0.0 112.319 -175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' HD23 ' A' ' 41' ' ' LEU . 37.9 Cg_endo -65.87 140.4 60.82 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.358 2.705 . . . . 0.0 112.56 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.7 -178.23 7.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.699 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 28.1 m -99.0 120.09 38.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.465 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.55 118.42 31.66 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.0 p -100.91 124.47 54.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.244 0.545 . . . . 0.0 110.991 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.5 119.34 29.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.421 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 63.6 p -95.61 123.61 39.24 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.15 16.12 47.1 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.974 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.57 63.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.941 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -102.28 141.1 35.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.277 0.561 . . . . 0.0 111.293 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -70.74 118.88 14.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.187 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -98.01 -48.17 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.535 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.04 -166.24 36.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.064 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.62 134.59 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 110.597 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 94.7 mt -97.46 119.97 36.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -138.08 129.33 27.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.729 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.54 127.63 1.93 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.67 -44.57 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.144 0.472 . . . . 0.0 112.233 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -97.42 -51.04 0.22 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.78 120.85 8.2 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 120.692 1.283 . . . . 0.0 111.864 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.567 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 t-105 -96.68 -37.74 10.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.813 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.203 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 30.8 mt-10 -81.5 -27.58 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.613 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 6.0 mt -56.72 -44.77 81.95 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.458 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 61' ' ' LEU . 63.1 mt -65.3 -42.32 93.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -57.11 -57.45 12.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.628 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.3 mt -56.38 -41.27 75.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.576 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 124' ' ' VAL . 14.9 tpt -60.49 -50.42 73.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.445 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -66.89 -35.68 80.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.227 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.17 -29.52 73.14 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.604 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.39 -45.76 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 120' ' ' MET . 21.4 m -78.51 -28.09 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.557 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.663 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 20.9 m . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 119.757 -0.163 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 3.9 Cg_exo -76.72 -67.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.126 1.884 . . . . 0.0 112.5 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -59.73 -35.06 73.78 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 110.648 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.41 -49.9 75.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.588 . . . . 0.0 110.725 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . . . -65.46 -34.23 77.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.533 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.89 -43.67 87.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.184 0.516 . . . . 0.0 110.074 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -38.1 85.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.807 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG2' ' HA ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -62.5 -33.56 75.13 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 110.331 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 48.4 mmm-85 -63.21 -53.62 50.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 109.907 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtp -58.73 -40.11 82.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.697 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.0 -35.38 72.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.347 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.82 68.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.625 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -82.76 2.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.27 -0.68 64.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.97 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -67.93 135.04 51.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 109.752 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.4 m -110.47 130.74 22.57 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.314 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 2.7 Cg_exo -76.8 153.72 33.67 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.267 2.645 . . . . 0.0 112.132 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 27' ' ' LEU . 13.0 p -148.0 152.48 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.214 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -81.74 158.53 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.253 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -43.61 -61.72 1.31 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.004 0.922 . . . . 0.0 112.854 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.1 m -67.53 -29.25 68.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.69 -171.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 26' ' ' ARG . 5.0 ttp-105 -85.86 -17.34 35.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.859 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.464 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -65.18 -39.65 93.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.665 ' HB2' HH12 ' A' ' 86' ' ' ARG . 18.7 t70 -62.74 -44.27 96.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.886 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.43 -52.84 63.92 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.212 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -50.67 -49.85 56.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.637 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.0 tp -61.44 -34.85 76.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -89.4 -26.3 21.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 0.0 111.851 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -92.59 -35.25 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB1' ' NE2' ' A' ' 71' ' ' GLN . . . -96.28 133.02 25.54 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.315 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.02 140.57 90.64 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.591 2.194 . . . . 0.0 110.985 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 11.9 t70 68.82 -158.4 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 131.66 97.98 0.73 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.261 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.08 141.75 23.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 122.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -99.52 130.56 45.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.172 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -82.11 175.29 10.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 110.987 -177.642 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -54.4 -77.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.468 0.175 . . . . 0.0 111.144 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.0 p30 -171.39 139.19 1.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.67 0.271 . . . . 0.0 110.633 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 86.0 Cg_endo -103.3 42.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.586 2.857 . . . . 0.0 112.193 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.4 t -84.78 -23.13 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.842 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.475 ' HG3' ' N ' ' A' ' 58' ' ' ILE . 19.7 ptt? -48.35 -47.81 36.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.883 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.475 ' N ' ' HG3' ' A' ' 57' ' ' MET . 47.8 mm -60.12 -35.03 59.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 110.964 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -66.98 -46.14 76.17 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.753 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -79.22 -36.81 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 110.916 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 120' ' ' MET . 21.9 tp -63.12 -57.82 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.092 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.92 -29.79 69.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.516 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.513 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 8.2 mmt180 -78.6 -6.43 55.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.0 pt-20 -69.25 -12.94 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.58 174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 69.4 m-85 -110.86 82.85 3.23 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 64' ' ' GLU . 3.1 Cg_exo -81.46 -9.9 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.117 2.545 . . . . 0.0 112.825 -174.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.06 -25.42 47.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.482 . . . . 0.0 111.736 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -119.97 137.1 54.26 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 p -86.81 114.18 23.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.752 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.522 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 70.9 m95 -81.87 133.48 35.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.825 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.568 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 37.2 mt-30 -105.28 108.51 20.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.396 0.617 . . . . 0.0 110.1 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.39 116.6 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.704 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.92 140.85 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.022 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 32.7 pt -125.47 158.1 34.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.541 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -135.09 156.03 49.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.69 -167.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.217 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 77' ' ' LEU . 6.1 mp -59.74 -53.68 55.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.509 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.67 -44.78 76.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.137 0.494 . . . . 0.0 110.777 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 2.5 mp0 -61.97 -50.54 71.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.615 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 p -63.33 -43.45 97.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -65.62 -36.48 83.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.053 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.99 -44.09 70.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.01 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 93.0 mt -65.34 -41.93 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.123 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.2 98.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.17 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.75 -40.87 89.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.083 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.665 HH12 ' HB2' ' A' ' 28' ' ' ASP . 48.8 mtp180 -52.94 -40.85 63.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.485 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -90.85 -65.6 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.07 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.72 -15.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.262 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.23 95.0 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.789 0.328 . . . . 0.0 110.175 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -133.49 160.76 36.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 56.1 ttt-85 67.09 6.78 4.96 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.565 0.54 . . . . 0.0 110.711 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.407 ' HE2' HG11 ' A' ' 106' ' ' VAL . 80.7 t80 -128.64 101.68 20.64 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.242 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.79 126.58 10.19 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.737 2.291 . . . . 0.0 112.516 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.91 -175.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.891 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 36.9 m -101.82 120.03 39.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.276 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.99 118.55 32.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 104' ' ' ARG . 3.8 p -97.81 121.6 48.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.354 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.85 162.21 19.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.47 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.88 129.69 1.81 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.006 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.78 29.53 73.82 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.842 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.0 -6.46 41.68 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.517 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -98.38 156.9 16.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.297 0.57 . . . . 0.0 111.762 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -93.85 130.45 39.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.5 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.834 ' HB2' HG13 ' A' ' 97' ' ' VAL . 37.2 mmt180 -96.45 -59.89 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.643 0.258 . . . . 0.0 110.726 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.69 -153.7 16.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.132 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.407 HG11 ' HE2' ' A' ' 92' ' ' PHE . 53.6 t -121.23 133.7 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.6 mt -109.34 123.71 49.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.229 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -156.35 128.95 7.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.753 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.33 127.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.827 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.8 mm -114.26 -26.47 2.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 0.0 110.637 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.1 m80 -98.06 -58.92 0.15 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 6.2 Cg_exo -78.82 119.83 4.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.086 1.191 . . . . 0.0 111.807 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.518 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.1 t-105 -96.67 -48.42 5.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.239 -173.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.2 73.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.479 . . . . 0.0 110.616 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.79 -40.73 54.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.462 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 37.1 tp -58.73 -44.26 90.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.259 . . . . 0.0 110.776 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.0 mt -61.8 -48.93 86.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.614 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -51.59 -56.72 11.91 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.212 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.0 mt -62.03 -40.93 97.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.441 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.759 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -62.19 -48.68 78.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.846 0.355 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.62 -37.83 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.68 -30.07 76.56 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.432 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 98.3 mt -83.28 -49.03 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.82 -30.56 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.397 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 27.4 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 36.8 Cg_endo -68.08 -40.55 8.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.283 1.322 . . . . 0.0 110.729 169.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -65.52 -39.21 91.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.428 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -51.99 67.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 109.578 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.7 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.908 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -54.36 42.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -34.35 77.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -60.98 -38.17 85.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 0.0 110.829 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -61.74 -53.8 51.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.516 0.674 . . . . 0.0 109.977 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 55.7 mtp -60.8 -34.99 75.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.37 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.34 -32.09 62.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.14 -23.28 65.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.216 0.532 . . . . 0.0 110.505 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -79.52 -10.71 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.45 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.81 26.65 44.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -89.68 140.93 29.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.441 . . . . 0.0 110.147 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -92.63 123.36 62.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.054 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.69 127.23 13.59 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.774 2.316 . . . . 0.0 111.319 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.12 136.74 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.514 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -67.8 161.71 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.499 0.5 . . . . 0.0 112.012 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.36 -60.28 2.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 112.047 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 m -78.43 -10.17 59.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -92.37 -22.2 19.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -44.09 91.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.761 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.99 -39.38 90.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -64.2 -56.32 15.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.102 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -67.68 -33.19 74.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.748 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.18 -42.09 99.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.572 0.225 . . . . 0.0 111.182 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -73.05 -25.85 61.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.756 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.78 -19.19 55.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.35 157.37 58.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.012 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.12 -64.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.438 2.092 . . . . 0.0 111.292 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -142.48 168.11 20.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.07 -178.18 48.7 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.569 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 97' ' ' VAL . 30.3 m -138.72 150.01 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.263 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.97 128.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.65 130.36 44.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.043 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.65 -67.42 0.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.563 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.679 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 49.1 m . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.176 0.512 . . . . 0.0 110.879 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.78 76.64 0.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.543 -174.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.9 t30 63.08 81.67 0.22 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.523 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.94 12.12 1.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.103 2.536 . . . . 0.0 111.944 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.11 -34.16 49.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.711 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -56.7 -30.98 64.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.361 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 62' ' ' LEU . 49.8 mm -61.12 -42.9 95.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 110.681 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.68 -33.93 60.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.349 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.44 -32.01 65.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.643 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 58.6 tp -64.37 -49.15 72.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.312 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.5 mp -58.68 -26.43 63.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -56.17 -19.03 11.82 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.8 pt-20 -87.01 22.08 2.13 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.631 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 55.3 p90 -67.44 122.29 82.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 38.4 Cg_endo -97.51 -53.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.974 2.45 . . . . 0.0 114.095 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.7 -26.16 17.14 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.562 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.5 p90 -143.54 142.57 31.17 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.538 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 t -86.08 151.27 23.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 65' ' ' PHE . 91.0 m95 -98.4 119.73 37.6 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.011 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.69 98.52 9.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.52 108.34 18.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.504 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.8 138.3 48.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.8 pt -118.65 145.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.94 167.58 12.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.47 172.66 10.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.947 173.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.86 -42.83 66.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.08 -44.72 83.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.501 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 83' ' ' ILE . 53.7 tt0 -70.64 -41.99 71.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.776 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -63.04 -42.26 99.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.296 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.15 -36.66 83.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.008 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.03 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.401 HD11 HE21 ' A' ' 79' ' ' GLN . 55.2 mt -65.46 -46.2 90.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.48 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.53 ' HA2' ' HB ' ' A' ' 89' ' ' VAL . . . -57.31 -49.25 74.14 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.728 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.26 -42.7 70.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 111.027 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -73.33 -31.56 64.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.737 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -101.61 -25.76 13.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.551 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.5 2.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.342 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 84' ' ' GLY . 38.8 t -118.11 150.07 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.94 163.21 26.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.928 0.394 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -72.96 -9.37 58.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.914 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 53.5 m-85 -70.34 127.09 92.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.553 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 17.1 Cg_exo -65.57 124.38 12.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.855 2.37 . . . . 0.0 112.338 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.27 3.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.3 m -109.84 127.12 54.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.43 116.99 29.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.528 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -98.76 126.28 51.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.496 0.665 . . . . 0.0 111.499 -175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -115.15 138.47 50.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -148.4 144.14 27.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.27 19.21 66.08 Favored Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.897 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.26 89.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.496 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -120.51 157.25 29.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -79.12 123.22 27.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.349 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -88.99 -60.28 2.0 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.36 -161.36 24.74 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.691 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.38 134.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.7 mt -100.43 105.71 17.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.22 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -117.97 97.52 5.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.489 0.661 . . . . 0.0 110.947 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.6 138.05 5.86 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.54 -33.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.998 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.801 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 m-70 -135.48 -54.58 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.801 ' HD2' ' H ' ' A' ' 111' ' ' HIS . 6.8 Cg_endo -50.18 120.25 5.97 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.677 1.585 . . . . 0.0 112.532 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.643 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 4.0 t-105 -99.11 -46.64 5.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.535 -170.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 118' ' ' ASN . . . -60.17 -34.56 73.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 110.005 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 17.3 mm-40 -68.87 -47.95 64.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.528 176.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.28 -49.52 76.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.82 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 113' ' ' TRP . 52.1 mt -60.29 -41.39 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 114' ' ' ALA . 31.7 t-20 -53.52 -57.59 10.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.569 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 81.1 mt -68.66 -41.68 78.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.293 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -50.48 73.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.721 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.531 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.5 ttt85 -69.97 -32.63 70.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.267 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.46 75.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.216 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.2 mt -81.62 -50.32 9.47 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.84 -0.212 . . . . 0.0 111.135 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 121' ' ' ARG . 31.1 m -67.0 -38.95 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.635 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 5.0 Cg_exo -74.42 -52.91 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.138 1.892 . . . . 0.0 111.923 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -65.95 -41.07 91.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -53.25 -53.68 47.29 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.14 -49.3 77.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.229 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 52' ' ' SER . 3.0 mm? -59.2 -46.5 88.27 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.294 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.08 -47.86 78.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -61.48 -40.23 93.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.323 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 47.2 mmm-85 -59.26 -54.47 46.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.502 ' HB2' ' CE3' ' A' ' 19' ' ' TRP . 24.6 ptt? -70.99 -29.26 65.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.312 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 11' ' ' TRP . 34.4 mt -57.23 -39.42 75.48 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.34 65.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.804 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -74.29 -15.07 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.0 111.215 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.24 13.87 20.0 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.563 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 49.2 m0 -82.7 122.01 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.039 0.447 . . . . 0.0 109.832 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.5 m -91.94 132.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.613 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 23.0 Cg_exo -65.02 120.36 7.58 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 111.658 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.5 139.79 24.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.217 0.532 . . . . 0.0 110.916 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 m -92.66 150.22 20.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.096 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.35 -50.79 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.5 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 m -85.23 13.55 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.067 0.46 . . . . 0.0 111.293 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -121.23 -10.92 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.683 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.8 tm? -55.11 -43.8 74.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.472 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 32' ' ' THR . 30.5 t70 -64.41 -43.09 95.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 32' ' ' THR . 17.5 t70 -61.26 -55.57 30.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -62.5 -40.51 96.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.044 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -70.94 -29.43 65.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -75.01 -27.79 60.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.547 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 35.1 mt-30 -90.7 -44.05 9.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.147 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.35 94.57 11.7 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.923 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 8.2 Cg_exo -72.59 140.84 33.47 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.199 2.599 . . . . 0.0 113.556 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t70 73.91 167.07 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.407 1.067 . . . . 0.0 111.474 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.98 -165.35 24.32 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.023 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.88 152.61 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 122.524 0.33 . . . . 0.0 110.793 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.53 131.5 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.49 138.15 38.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.93 175.97 5.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 111.29 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.232 0.539 . . . . 0.0 110.845 -178.869 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.1 t70 59.43 -85.85 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.662 0.785 . . . . 0.0 112.741 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.03 99.31 5.08 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 111.304 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -95.51 -167.72 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.174 2.583 . . . . 0.0 112.454 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.8 t 75.09 -37.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -53.43 -24.31 12.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.496 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.0 mp -58.96 -38.95 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.718 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.7 -38.18 94.26 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.406 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -72.79 -28.48 62.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.742 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.2 tp -61.35 -43.68 98.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.266 0.555 . . . . 0.0 110.347 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.8 mp -64.67 -27.44 68.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.072 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.49 -17.24 63.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.912 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -70.1 -36.37 74.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.689 0.28 . . . . 0.0 110.611 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -141.49 77.78 19.16 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.095 0.474 . . . . 0.0 110.537 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.0 16.83 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.142 2.562 . . . . 0.0 112.598 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.97 -25.67 67.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.524 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -116.71 166.85 11.65 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 p -85.29 105.49 16.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.921 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -91.44 103.57 16.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.752 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.18 122.2 31.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.199 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.8 t -97.96 107.39 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 124.71 50.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.504 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 30.6 pt -110.42 144.41 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -115.41 153.17 31.54 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.769 -0.372 . . . . 0.0 112.001 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.3 m-20 -61.88 168.86 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.518 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.09 -49.1 74.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.614 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -66.56 -34.47 77.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.23 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 66.5 mm-40 -75.53 -48.17 23.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.277 -172.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 78.4 p -65.49 -41.4 93.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -58.01 -44.74 87.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.279 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.41 -41.53 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 79' ' ' GLN . 73.9 mt -60.9 -45.33 98.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.955 0.407 . . . . 0.0 110.196 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.28 75.72 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.231 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -38.06 89.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' HH11 ' A' ' 86' ' ' ARG . 21.3 ttt180 -59.85 -27.93 67.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.428 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.89 -45.14 4.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.02 44.77 0.52 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.672 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.77 HG11 HD21 ' A' ' 96' ' ' LEU . 17.2 t -103.86 156.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 172.6 13.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 0.0 110.729 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 60.4 mtm180 -98.4 -161.01 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.667 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 62.2 m-85 73.93 165.93 0.13 Allowed Pre-proline 0 N--CA 1.467 0.387 0 O-C-N 123.953 0.783 . . . . 0.0 110.83 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 92' ' ' PHE . 21.4 Cg_endo -59.56 123.36 13.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.029 1.819 . . . . 0.0 111.679 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 106' ' ' VAL . . . -161.74 143.04 11.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.783 -174.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 23.8 m -110.77 113.3 25.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.0 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 89' ' ' VAL . 5.9 mp -93.43 137.31 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.37 130.11 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.36 119.36 36.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.16 125.72 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.157 0.503 . . . . 0.0 112.051 -172.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.22 -63.32 2.91 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.968 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -136.17 64.47 0.58 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 64.89 -153.42 0.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.534 0.334 . . . . 0.0 111.793 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -50.24 108.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.833 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.71 -38.55 15.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.513 0.673 . . . . 0.0 109.832 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 170.5 -168.43 41.48 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.123 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.541 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 14.0 p -136.95 140.68 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.027 0.442 . . . . 0.0 111.037 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 93.7 mt -96.56 107.19 19.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.13 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -148.6 171.8 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.294 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.44 149.4 18.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.101 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.0 102.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 0.0 110.267 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 97.7 m-70 -134.33 139.72 33.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 176.04 7.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 0.0 112.219 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.742 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 10.4 t-105 -58.39 -45.41 88.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.375 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.95 87.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.404 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 111' ' ' HIS . 4.4 tp10 -72.76 -33.12 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.441 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -63.0 -45.47 92.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.037 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.3 mt -62.9 -43.75 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.099 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -54.5 -58.26 8.18 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 91.7 mt -57.4 -47.44 81.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.463 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.1 tpt -59.46 -41.56 90.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.599 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -63.35 -40.6 97.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.42 77.8 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.839 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 74.0 mt -81.08 -50.95 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -70.86 -36.35 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.58 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.751 0.786 . . . . 0.0 112.428 179.133 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.724 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.648 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.724 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 6.2 Cg_exo -78.24 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.767 1.645 . . . . 0.0 111.443 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.95 -37.91 84.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.593 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.31 -54.42 33.45 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.35 90.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -58.17 -55.05 40.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.044 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -39.46 93.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.236 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.6 -39.86 77.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.571 0.224 . . . . 0.0 111.165 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -65.05 -53.41 46.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.186 0.517 . . . . 0.0 110.533 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.9 -37.8 74.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.116 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -34.91 76.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.381 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.79 66.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.023 0.439 . . . . 0.0 111.123 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 28.7 mmt180 -83.66 2.75 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.496 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.65 12.16 80.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.59 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HH2' ' HB2' ' A' ' 55' ' ' PRO . 51.5 m0 -77.51 124.01 27.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.501 ' HB ' ' CH2' ' A' ' 30' ' ' TRP . 21.5 m -85.46 123.93 72.2 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.971 -171.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.93 118.75 5.86 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.805 2.337 . . . . 0.0 111.463 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 27' ' ' LEU . 14.4 p -126.11 147.08 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m -95.23 165.09 12.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.181 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.26 -48.65 54.71 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.751 0.42 . . . . 0.0 112.114 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 m -59.74 -35.48 74.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.002 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 9.1 tpt180 -94.69 -18.29 21.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.79 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 3.4 tm? -64.05 -40.0 95.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.49 -42.66 96.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.168 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 28.5 t70 -63.14 -57.16 11.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.946 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CH2' ' HB ' ' A' ' 20' ' ' THR . 5.9 t90 -59.13 -39.65 83.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.196 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -66.95 -28.1 68.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.478 . . . . 0.0 110.419 177.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.5 m -75.19 -33.06 61.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 19.3 mm-40 -80.64 -48.34 12.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.406 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -73.0 135.3 80.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.401 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 2.1 Cg_endo -81.66 -21.93 5.78 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.911 2.408 . . . . 0.0 111.52 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 3.5 p-10 -95.31 -89.29 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.129 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 87.69 106.92 0.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.599 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 72' ' ' VAL . 5.5 m -131.89 134.08 60.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 171.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 73' ' ' ALA . 49.2 t -130.5 135.19 61.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.951 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mp -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.2 tt -104.46 128.29 52.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.025 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.865 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 10' ' ' LEU . 29.0 t . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 120.783 0.325 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.9 t70 49.55 71.4 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.527 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 t30 66.99 85.59 0.15 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.526 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HB2' ' HH2' ' A' ' 19' ' ' TRP . 96.7 Cg_endo -79.85 -5.7 13.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.526 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 21.6 t -61.9 -35.72 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.6 ttp -58.95 -37.37 76.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 62' ' ' LEU . 50.1 mm -69.91 -36.11 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.078 0.466 . . . . 0.0 110.346 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.83 -45.31 65.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.011 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 8.7 mm-40 -68.6 -28.22 66.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.84 0.353 . . . . 0.0 110.468 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 116' ' ' LEU . 24.7 tp -61.68 -54.93 36.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.483 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 58' ' ' ILE . 7.3 mp -52.27 -26.6 12.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.439 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.574 HH11 ' HG3' ' A' ' 63' ' ' ARG . 11.5 mmt85 -61.62 -9.4 6.02 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.99 -12.18 59.42 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 122.015 -0.428 . . . . 0.0 111.181 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -116.79 92.88 39.69 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.826 0.346 . . . . 0.0 110.622 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.77 2.9 6.43 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.75 2.3 . . . . 0.0 112.249 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.95 -26.69 62.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.716 0.77 . . . . 0.0 109.766 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -129.17 133.53 47.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.654 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 p -85.03 102.68 13.4 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.455 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.66 118.98 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.947 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -103.08 107.08 17.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.337 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 38' ' ' VAL . 26.8 t -88.21 120.37 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.22 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -107.15 133.04 52.34 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.263 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.7 pt -125.98 143.84 38.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -120.53 156.72 30.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.994 -174.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 169.22 4.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.53 -46.48 88.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.109 0.48 . . . . 0.0 110.35 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -61.82 -44.36 97.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.847 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 83.8 mm-40 -68.58 -39.22 81.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.167 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -58.25 -39.81 80.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.37 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -34.95 79.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.181 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.21 47.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.259 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 79' ' ' GLN . 74.6 mt -64.12 -46.94 92.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.53 96.74 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.946 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.38 -42.15 95.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 111.281 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -61.14 -32.31 72.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -100.55 -43.65 6.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.133 0.492 . . . . 0.0 111.001 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.2 42.6 0.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.59 142.96 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.537 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 21.3 m-85 -73.57 159.81 32.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -83.79 84.89 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.349 0.595 . . . . 0.0 112.13 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' A' ' 90' ' ' PHE . 30.5 p90 -169.25 152.66 5.1 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.652 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.0 Cg_exo -71.72 126.39 11.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.416 2.077 . . . . 0.0 111.337 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.88 168.77 25.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 26.2 m -100.85 120.23 39.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.12 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.402 HD22 ' OH ' ' A' ' 103' ' ' TYR . 35.6 mt -94.88 120.34 34.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.77 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.8 p -104.89 122.53 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.56 0.695 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.74 -177.97 3.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.505 ' OG1' ' HD3' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -151.23 -171.5 3.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.18 91.79 0.04 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.034 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.44 24.44 70.85 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.354 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -132.01 159.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.422 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' OH ' HD22 ' A' ' 96' ' ' LEU . 51.1 t80 -117.75 111.99 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -168.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.56 -171.2 34.72 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.046 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.55 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.5 mt -95.29 103.53 15.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -108.5 130.58 55.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.46 -165.56 24.95 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.783 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.7 mm -112.97 -69.52 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 79.1 m-70 70.95 143.32 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.74 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.45 159.65 19.13 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.647 2.231 . . . . 0.0 111.858 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 15.5 t-105 -54.05 -43.19 69.99 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.08 78.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 111.643 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 4.4 mp0 -72.49 -26.44 61.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.748 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' CD1' HD22 ' A' ' 61' ' ' LEU . 2.0 tm? -62.72 -47.43 83.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.5 mt -60.84 -45.91 97.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.264 0.554 . . . . 0.0 109.719 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -52.65 -58.28 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 89.6 mt -58.14 -42.22 85.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.595 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.442 ' HG2' HD21 ' A' ' 61' ' ' LEU . 16.9 tpt -57.73 -50.6 72.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 110.642 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.635 ' HA ' HG12 ' A' ' 124' ' ' VAL . 65.0 mtt180 -68.84 -32.05 71.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.31 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.73 -29.89 71.21 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.482 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.83 -45.92 6.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 121' ' ' ARG . 7.2 p -71.49 -26.04 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -172.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.699 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.439 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.501 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 85.3 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 19.3 Cg_endo -60.03 -72.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.961 1.774 . . . . 0.0 113.538 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.64 -33.59 76.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.67 -51.9 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.592 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -65.15 -44.05 89.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 52' ' ' SER . 3.2 mm? -62.33 -39.76 94.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.339 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -65.46 -44.77 86.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -58.13 -39.25 78.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.188 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 68.8 mmt-85 -61.57 -53.26 58.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.0 0.429 . . . . 0.0 110.616 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.415 ' SD ' HD22 ' A' ' 40' ' ' LEU . 75.4 mtm -61.4 -32.75 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.078 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.43 -40.09 89.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.608 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.24 65.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 6.2 mmp_? -71.24 -33.66 70.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.468 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.12 39.01 2.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.86 174.35 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.9 m -101.84 118.14 60.1 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.0 111.77 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 4.1 Cg_exo -80.27 126.92 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.41 2.74 . . . . 0.0 111.503 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 75' ' ' ALA . 11.8 p -135.52 142.34 39.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -97.6 167.45 10.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 111.435 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -52.73 -51.35 60.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.381 -175.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.9 m -75.36 -5.66 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.901 0.381 . . . . 0.0 111.782 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -106.85 -20.45 13.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.254 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 83' ' ' ILE . 2.8 tm? -56.12 -42.21 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.353 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.89 -46.18 72.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.319 0.581 . . . . 0.0 110.573 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 32' ' ' THR . 32.6 t70 -60.46 -53.59 55.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.346 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.93 -43.56 86.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.5 -40.12 95.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.692 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -70.12 -25.46 63.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.67 -42.83 13.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.047 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -66.79 134.79 94.17 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 34.9 Cg_exo -63.12 -44.42 15.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.483 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.802 ' HB2' ' HE2' ' A' ' 68' ' ' TYR . 1.5 t0 -161.36 177.34 10.23 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.04 -178.96 33.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.695 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 97' ' ' VAL . 20.2 m -138.37 156.48 30.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 122.501 0.32 . . . . 0.0 110.205 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.81 143.57 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.619 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' SD ' ' A' ' 14' ' ' MET . 7.7 mp -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 63.7 tp -114.93 96.55 5.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.417 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 CA--C 1.538 0.481 0 O-C-N 123.7 0.625 . . . . 0.0 112.562 173.071 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' HD11 ' A' ' 10' ' ' LEU . 37.4 t . . . . . 0 C--O 1.234 0.263 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 52.6 -144.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.683 0.614 . . . . 0.0 109.834 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.18 92.3 3.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -61.31 -95.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.797 2.331 . . . . 0.0 113.484 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 97.7 t 73.29 -51.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.326 0.584 . . . . 0.0 110.653 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.541 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 22.9 ptt? -59.51 -24.41 63.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.078 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.25 -45.09 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.897 0.38 . . . . 0.0 110.798 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.35 -40.2 80.51 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.588 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -63.08 -39.16 93.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.514 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 37.0 tp -59.99 -57.03 14.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.723 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.24 -28.02 68.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.132 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -75.43 -6.92 52.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.2 pt-20 -76.39 -13.54 60.12 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.243 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -131.26 71.09 82.06 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.45 12.46 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.25 2.634 . . . . 0.0 112.799 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.51 -14.35 60.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.676 0.75 . . . . 0.0 110.012 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.802 ' HE2' ' HB2' ' A' ' 36' ' ' ASP . 8.7 t80 -122.4 -177.12 3.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.208 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -109.44 123.02 48.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.685 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -108.34 106.67 16.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -90.39 110.91 21.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.015 0.436 . . . . 0.0 110.185 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.97 117.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.975 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -116.03 127.9 55.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.1 pt -119.57 139.33 47.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.493 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.65 171.24 7.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.7 m-20 -64.14 171.8 2.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.822 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -57.73 -54.26 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.568 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -74.61 -33.78 62.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.972 0.415 . . . . 0.0 111.32 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 1.3 mp0 -69.64 -39.52 77.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.06 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.4 m -55.23 -52.99 61.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.48 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 17.6 tp10 -59.93 -44.43 94.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.353 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.83 -41.31 95.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.894 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 79' ' ' GLN . 80.1 mt -63.01 -47.57 92.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.624 0.249 . . . . 0.0 110.964 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.19 92.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.519 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.99 -43.96 82.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.81 0.444 . . . . 0.0 111.262 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -67.7 -27.23 66.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -78.19 -39.06 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 109.944 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.52 -25.85 2.29 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.02 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -86.3 99.73 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.012 0.434 . . . . 0.0 110.142 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -93.76 131.79 38.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.709 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 0.4 OUTLIER 67.08 179.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.732 0.645 . . . . 0.0 112.011 173.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 70.02 105.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.869 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 37.5 Cg_endo -66.43 135.66 40.32 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.613 2.209 . . . . 0.0 112.528 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.8 -173.68 1.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.153 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 20.4 m -114.91 127.94 55.99 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.7 114.79 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -99.84 130.49 48.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.313 0.577 . . . . 0.0 111.105 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -123.43 164.95 17.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.804 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m -154.87 136.4 14.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 170.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.29 14.85 42.5 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.149 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.4 -5.6 84.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.242 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.71 149.09 21.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 110.912 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -74.44 126.88 31.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.11 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 3.5 mmp_? -99.23 -45.11 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.95 -165.13 38.68 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.674 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.44 134.04 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.101 0.477 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.0 mt -100.2 109.83 22.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.569 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -132.19 81.36 1.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.382 0.61 . . . . 0.0 109.605 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.18 64.48 0.34 Allowed Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.309 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 26.0 mm -80.35 83.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.487 0.184 . . . . 0.0 111.093 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 9.9 t-80 175.9 -60.12 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.703 172.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 1.6 Cg_endo -82.98 124.76 3.94 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.476 2.118 . . . . 0.0 113.035 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' A' ' 57' ' ' MET . 12.1 t-105 -77.09 -49.23 15.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.581 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.58 78.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.034 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 36.9 tt0 -74.23 -34.54 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.725 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.03 -43.33 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.11 -47.91 85.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -53.78 -49.52 68.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.434 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.51 -53.8 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.8 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 124' ' ' VAL . 17.6 tpt -56.76 -51.06 70.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.482 . . . . 0.0 110.512 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 125' ' ' GLU . 24.4 ttt85 -64.77 -31.75 73.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.562 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.9 61.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.669 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.12 -51.88 6.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' MET . 32.8 m -81.64 -24.81 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.631 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 31.3 tt0 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.123 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 42.1 m . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.87 -66.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.921 1.747 . . . . 0.0 112.124 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.8 -35.07 75.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.42 -53.51 55.66 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -66.44 -43.03 86.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.062 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.77 -37.72 82.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.816 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 15' ' ' LEU . 6.3 t90 -64.04 -48.61 75.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.541 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 45.3 mt-30 -60.51 -32.47 71.48 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.525 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 26.2 mmm180 -59.16 -53.32 59.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.002 0.429 . . . . 0.0 110.281 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.609 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 71.7 mtm -62.13 -33.37 74.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.845 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.548 HD22 HD11 ' A' ' 74' ' ' ILE . 2.7 mm? -59.51 -38.91 82.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.624 176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.04 66.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.39 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -75.63 -6.34 49.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.614 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.75 46.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.598 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 47.5 m0 -89.51 119.95 30.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 109.931 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -83.7 137.23 41.4 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.401 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 74.1 Cg_endo -76.95 149.83 29.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.48 . . . . 0.0 111.424 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -154.1 156.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 111.18 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 p -99.04 164.5 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.307 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.19 -42.73 73.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 111.66 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -30.44 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.65 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -85.23 -23.17 28.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 110.619 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -60.64 -39.26 87.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.622 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.33 -32.92 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.924 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 9.0 t70 -68.3 -55.24 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.047 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -60.69 -34.08 73.8 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.918 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.99 -43.03 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.322 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.0 t -74.55 -26.39 59.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.782 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 29' ' ' ASP . 98.0 mt-30 -64.57 -44.96 89.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.853 0.358 . . . . 0.0 110.651 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 161.75 35.16 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.04 -45.56 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.326 2.017 . . . . 0.0 110.993 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -149.17 -178.16 6.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.119 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.11 -168.17 40.23 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.052 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.1 m -139.13 135.73 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.858 0.361 . . . . 0.0 110.477 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -124.11 133.18 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -95.84 131.43 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.948 0.404 . . . . 0.0 111.258 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 4.5 tt -107.71 117.19 33.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.612 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.871 179.891 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 CA--C 1.532 0.255 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.68 97.17 11.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.937 0.399 . . . . 0.0 110.701 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.48 153.4 75.1 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.617 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB2' HG12 ' A' ' 58' ' ' ILE . 74.4 Cg_endo -80.74 97.59 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.492 2.128 . . . . 0.0 112.911 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HA ' ' HH2' ' A' ' 19' ' ' TRP . 45.3 t -93.96 -27.71 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.341 0.591 . . . . 0.0 110.313 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -22.81 65.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.001 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 55' ' ' PRO . 40.3 mm -52.6 -35.83 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -61.42 -43.04 99.85 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -69.25 -30.35 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.196 0.522 . . . . 0.0 110.875 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.879 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 47.6 tp -72.56 -52.67 14.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.345 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.6 ' O ' ' HD2' ' A' ' 65' ' ' PHE . 8.4 mp -59.2 -27.3 65.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.274 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 16.6 mmm180 -56.3 -14.59 2.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.81 -7.25 47.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.881 0.309 . . . . 0.0 111.62 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' HD2' ' O ' ' A' ' 62' ' ' LEU . 32.1 p90 -64.71 126.97 91.99 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.393 0.616 . . . . 0.0 111.57 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 1.3 Cg_endo -87.28 -62.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.307 2.671 . . . . 0.0 112.654 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.4 -25.53 10.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.726 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.48 104.37 12.72 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.4 p -79.42 107.22 12.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.073 0.463 . . . . 0.0 110.377 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -75.88 121.65 22.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.525 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -83.6 100.73 11.0 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.42 108.48 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.903 0.382 . . . . 0.0 110.055 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.49 48.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 19.6 pt -115.9 148.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.435 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -130.89 167.39 19.03 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.6 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.755 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.6 m-20 -61.71 163.71 6.98 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.52 174.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.82 -48.71 77.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.753 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.72 -24.07 64.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.574 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.755 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 78.5 mm-40 -76.46 -51.83 11.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 41' ' ' LEU . 39.6 m -64.27 -37.38 87.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.91 -45.3 74.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.067 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -45.59 81.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.87 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.71 -49.03 82.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.347 0.404 . . . . 0.0 111.07 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.47 50.78 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.89 -49.61 72.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.272 0.558 . . . . 0.0 110.93 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -63.49 -31.53 72.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.883 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.18 -51.76 6.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 110.593 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.03 44.64 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.712 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -104.68 -14.72 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' HD2' ' CE2' ' A' ' 92' ' ' PHE . 41.7 t80 68.19 175.97 0.26 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.035 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -84.08 94.26 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.922 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CE2' ' HD2' ' A' ' 90' ' ' PHE . 54.2 m-85 -140.17 132.05 14.5 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.889 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 6.6 Cg_exo -71.66 129.24 15.32 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.172 1.915 . . . . 0.0 110.519 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.39 156.85 2.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.159 0.505 . . . . 0.0 111.68 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.0 m -95.6 120.81 36.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.965 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.9 114.17 26.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 38' ' ' VAL . 6.5 p -99.38 124.86 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.153 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.91 140.81 33.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.544 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 p -134.0 122.48 23.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.979 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.76 25.58 69.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.355 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.81 0.42 88.11 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.61 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.09 143.88 37.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.313 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -82.31 112.86 19.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.119 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -136.69 10.81 3.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.56 137.24 6.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.525 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.93 132.69 69.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.63 95.01 2.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.613 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -81.75 -38.68 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 109.984 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.47 -161.11 24.95 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 23.1 mm 69.89 163.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 43.6 m80 78.77 151.89 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.193 0.597 . . . . 0.0 110.452 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.45 142.68 96.13 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.546 2.164 . . . . 0.0 113.001 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.879 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 29.5 t-105 -53.79 -33.81 57.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.652 175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.64 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.52 -33.28 48.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 109.936 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 2.7 mm? -58.14 -44.5 87.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.962 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 113' ' ' TRP . 59.9 mt -64.38 -41.91 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.35 -54.83 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.502 0.667 . . . . 0.0 110.824 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.9 mt -59.19 -48.52 81.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.423 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.7 ' HG2' HD21 ' A' ' 61' ' ' LEU . 14.8 tpt -62.29 -38.79 90.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.704 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 121' ' ' ARG . 16.8 tpt180 -66.11 -34.46 78.12 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.8 74.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.754 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 92.3 mt -75.6 -55.55 5.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.689 -0.256 . . . . 0.0 111.609 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -77.94 -23.24 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.795 -175.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.0 109.343 176.758 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.594 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 21.6 m . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 46.4 Cg_exo -56.97 -66.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.292 1.995 . . . . 0.0 112.995 -175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 64.0 t80 -60.42 -37.96 82.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.32 . . . . 0.0 110.688 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 7.2 t70 -59.04 -53.15 61.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.486 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.6 88.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.347 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.29 -47.77 75.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.85 -35.62 81.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 83.1 mm-40 -57.33 -43.84 83.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.026 176.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 5.0 mmp_? -64.21 -53.35 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 84.4 mtp -56.47 -39.56 73.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.291 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.95 -38.47 79.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.186 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.39 70.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HA ' HH11 ' A' ' 17' ' ' ARG . 10.3 mmm180 -73.06 -15.9 61.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.396 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.92 44.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.312 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -114.5 137.47 51.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 p -96.44 138.03 21.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.9 Cg_endo -86.2 163.46 9.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.616 2.878 . . . . 0.0 112.076 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -162.79 143.74 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.895 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.32 155.25 19.1 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.95 78.35 1.66 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.988 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 53.8 m -171.22 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.529 ' HD3' ' HB2' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.26 0.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.544 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -53.02 -43.31 66.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.72 -43.34 59.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.85 -52.45 65.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.699 0.762 . . . . 0.0 110.407 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.654 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 22.9 t90 -58.75 -42.73 89.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.027 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.4 -33.25 75.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.0 m -60.21 -42.69 95.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.856 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.67 -43.75 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB1' ' CD ' ' A' ' 71' ' ' GLN . . . -113.05 94.95 32.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.549 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.34 -170.57 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.258 2.638 . . . . 0.0 112.551 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 49.84 88.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.893 0.854 . . . . 0.0 112.271 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.4 -169.35 27.84 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.153 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.93 145.83 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.625 0.25 . . . . 0.0 110.993 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 11.5 p -138.05 140.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.814 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.67 130.8 45.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -106.27 112.78 25.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.053 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.438 ' H ' ' CB ' ' A' ' 80' ' ' SER . 39.8 m . . . . . 0 N--CA 1.469 0.484 0 O-C-N 123.83 0.706 . . . . 0.0 111.371 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.79 -64.82 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.057 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.49 104.18 1.08 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.19 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.103 2.536 . . . . 0.0 113.285 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 -24.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.04 70.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.091 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.07 -38.35 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.42 -44.45 51.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.164 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.07 -30.05 66.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.644 0.259 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 54.8 tp -62.75 -45.59 91.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.025 0.441 . . . . 0.0 110.633 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.33 -29.9 67.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.756 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.6 -12.11 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 111.19 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 13.1 tp10 -74.37 -26.58 60.21 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -140.59 72.63 30.24 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -93.79 6.81 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.05 2.5 . . . . 0.0 112.39 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.21 -22.08 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 0.0 110.992 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.02 129.81 56.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -66.61 109.86 2.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.788 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.01 133.78 34.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.546 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' CD ' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -90.89 102.17 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.96 173.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.9 t -95.95 113.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.472 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -122.09 135.6 54.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 16.7 pt -128.03 148.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.11 171.08 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 79' ' ' GLN . 9.9 t70 -66.49 161.88 21.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 173.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' SER . 63.5 tp -66.91 -55.9 12.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.735 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . 57.8 mt-10 -73.84 -23.56 59.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 31.7 tt0 -64.55 -33.94 77.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.937 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.438 ' CB ' ' H ' ' A' ' 42' ' ' SER . 73.1 m -63.67 -40.05 95.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -55.43 -38.31 68.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 174.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.04 -43.42 62.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.241 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.73 -44.48 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 109.97 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -43.88 96.53 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.81 -49.44 76.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -63.99 -26.0 68.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.43 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -103.28 -4.91 23.62 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.088 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.42 38.3 80.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.186 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -122.03 -14.62 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 110.618 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.604 ' CE1' ' HG3' ' A' ' 81' ' ' GLU . 45.7 t80 -65.37 114.33 4.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.107 0.479 . . . . 0.0 112.246 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 23.0 tpt180 -173.25 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.904 172.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 11.9 p90 -143.78 145.81 32.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.302 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 13.7 Cg_exo -71.18 138.17 32.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.673 2.248 . . . . 0.0 112.077 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.27 162.94 31.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.8 m -96.67 113.56 25.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.506 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.2 mt -94.48 129.98 41.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.21 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.82 135.91 57.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -108.72 125.48 51.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.403 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -104.1 123.44 47.27 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.735 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.91 11.76 63.77 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.46 71.62 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' N ' HD22 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -95.43 143.74 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -177.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -78.09 111.1 13.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.273 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -139.29 -19.24 0.97 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.604 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.62 149.27 18.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.931 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.96 134.71 18.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.901 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.9 mt -115.25 117.69 31.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.582 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.63 117.92 30.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.527 0.679 . . . . 0.0 111.28 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.3 -161.54 23.29 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.395 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.3 mm -99.01 -53.53 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 44.6 m80 67.5 159.99 0.14 Allowed Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.725 0.641 . . . . 0.0 110.893 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 115' ' ' GLU . 11.8 Cg_endo -60.25 136.8 70.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.503 1.469 . . . . 0.0 109.473 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.521 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.5 t-105 -54.79 -45.41 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.25 -34.36 72.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.771 0.32 . . . . 0.0 111.493 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.735 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 1.3 tm-20 -77.2 -37.13 54.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.448 . . . . 0.0 110.102 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.95 -44.97 91.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.335 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.96 -39.04 82.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.226 0.536 . . . . 0.0 109.946 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -58.11 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.147 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 97.3 mt -56.82 -45.64 82.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.479 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.451 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.9 tpt -57.74 -47.6 81.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HA ' HG22 ' A' ' 124' ' ' VAL . 62.9 mtp180 -64.11 -32.73 74.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.224 0.209 . . . . 0.0 110.916 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.96 74.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.176 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -84.38 -39.48 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 121' ' ' ARG . 34.2 m -82.78 -15.5 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.63 0.252 . . . . 0.0 111.636 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 121' ' ' ARG . 10.1 tp10 . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 174.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.664 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 4.4 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.3 -55.39 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.798 1.666 . . . . 0.0 112.04 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 44.7 t80 -62.46 -37.11 84.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.975 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.34 -54.59 30.62 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.428 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -42.27 88.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.546 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.85 -57.0 14.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.543 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.6 t90 -67.7 -36.64 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.305 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -56.87 -44.44 82.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.786 0.326 . . . . 0.0 110.976 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 97.3 mtt180 -63.49 -53.55 50.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 110.727 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.76 -36.84 79.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.439 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -70.1 -30.39 67.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.423 -177.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.19 64.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -10.37 59.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.824 0.345 . . . . 0.0 111.284 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.69 41.88 14.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.411 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -90.64 -178.69 5.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.675 0.274 . . . . 0.0 110.38 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.1 m -117.49 120.35 33.3 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.172 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HB3' ' HZ2' ' A' ' 11' ' ' TRP . 2.8 Cg_exo -75.83 121.49 6.29 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.965 2.443 . . . . 0.0 111.172 174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG11 HD23 ' A' ' 27' ' ' LEU . 14.9 p -117.9 143.47 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.618 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -95.24 163.25 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.557 0.694 . . . . 0.0 112.118 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -68.4 144.7 54.64 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.441 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m 75.12 -10.79 1.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.306 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.28 -23.19 14.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.51 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -48.94 -47.27 43.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.403 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.16 -49.4 44.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.961 0.41 . . . . 0.0 110.866 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -55.56 -48.52 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.925 0.869 . . . . 0.0 110.232 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -59.9 -42.31 93.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.858 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.13 -28.64 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 29' ' ' ASP . 7.4 t -80.57 -26.1 38.14 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.87 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -89.67 -38.38 13.93 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -97.86 106.77 36.2 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.9 Cg_exo -67.76 122.35 9.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.755 2.303 . . . . 0.0 114.213 -169.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.571 ' OD2' ' HB ' ' A' ' 99' ' ' THR . 6.1 m-20 65.64 154.76 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 124.594 1.184 . . . . 0.0 113.361 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 71' ' ' GLN . . . 153.91 -172.9 32.61 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.709 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 97' ' ' VAL . 31.3 m -133.54 156.33 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.545 0.212 . . . . 0.0 110.458 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.0 t -129.74 131.04 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.076 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -98.64 122.22 41.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.403 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 80' ' ' SER . 6.6 tt -106.79 97.97 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 42.4 m . . . . . 0 CA--C 1.536 0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.0 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.4 -90.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.971 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 92.55 1.53 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.63 0.252 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -102.17 41.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.057 2.505 . . . . 0.0 111.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -104.5 -59.66 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -23.86 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.611 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.2 mm -52.59 -46.73 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.257 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -36.51 86.74 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.455 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 mt-10 -80.01 -26.95 39.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.887 0.375 . . . . 0.0 111.135 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 120' ' ' MET . 42.8 tp -62.24 -45.72 92.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.798 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.0 mp -56.35 -26.83 53.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.399 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 38.4 mmt180 -60.3 -17.73 44.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 5.6 pt-20 -76.5 -8.66 57.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.004 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -125.65 70.77 65.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.569 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.28 11.98 2.8 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.77 2.313 . . . . 0.0 111.583 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.67 -25.7 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.355 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -131.55 -157.9 0.85 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.025 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' OE1' ' A' ' 71' ' ' GLN . 6.6 p -111.62 140.08 46.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 62' ' ' LEU . 82.7 m95 -122.05 95.59 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' OE1' ' HB ' ' A' ' 69' ' ' THR . 1.9 mp0 -84.34 109.86 18.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.23 114.22 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.988 0.423 . . . . 0.0 110.251 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -110.64 137.53 48.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.975 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 12.9 pt -122.72 146.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.78 160.77 31.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 0.0 112.074 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.99 164.84 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.775 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 96.2 mt -59.34 -44.53 92.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.773 0.32 . . . . 0.0 110.807 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.03 -36.31 79.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 0.0 110.081 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -72.81 -31.15 64.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.073 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.581 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 68.2 m -60.08 -43.88 95.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.995 0.426 . . . . 0.0 111.202 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.82 -41.01 97.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.697 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.551 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . . . -77.2 -35.18 55.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.568 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 24' ' ' GLU . 73.3 mt -63.63 -49.19 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.539 0.209 . . . . 0.0 110.676 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.03 -45.97 94.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.688 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -52.74 -53.35 49.13 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -73.28 -23.99 60.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' A' ' 89' ' ' VAL . 10.7 t80 -85.4 -54.58 4.49 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.801 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.41 44.02 0.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.365 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 87' ' ' PHE . 57.5 t -125.56 83.74 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HB3' ' HD1' ' A' ' 92' ' ' PHE . 86.0 m-85 66.51 -62.59 0.28 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER 95.72 -1.6 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.293 1.837 . . . . 0.0 109.859 -169.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.743 ' HD1' ' HB3' ' A' ' 90' ' ' PHE . 83.8 m-85 -84.98 135.32 39.84 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.508 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.835 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.6 Cg_exo -67.41 134.18 32.53 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.871 2.381 . . . . 0.0 112.196 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . 173.85 -169.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.051 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.5 m -97.53 113.97 25.78 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.7 mt -95.75 127.52 41.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.071 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 104' ' ' ARG . 5.7 p -109.34 124.13 65.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.458 0.647 . . . . 0.0 111.156 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -124.94 -178.87 4.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.465 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 14.2 p -127.89 -168.91 1.97 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.45 49.45 1.29 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.151 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.1 -41.5 0.85 Allowed Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.425 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -94.08 170.91 9.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.874 . . . . 0.0 112.099 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.44 134.96 55.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.35 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.707 ' HB2' HG13 ' A' ' 97' ' ' VAL . 3.5 mmp_? -105.14 -58.84 1.83 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.555 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -161.25 27.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.517 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.59 134.3 58.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 110.337 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.4 mt -101.51 128.84 47.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.611 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.56 11.15 25.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.797 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.25 -148.33 49.97 Favored Glycine 0 C--O 1.239 0.406 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.186 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 111' ' ' HIS . 10.6 mm 61.28 -168.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.883 ' H ' HG22 ' A' ' 110' ' ' ILE . 66.0 m80 73.39 150.45 0.13 Allowed Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.041 0.536 . . . . 0.0 111.522 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 111' ' ' HIS . 13.4 Cg_exo -70.46 166.9 26.94 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.515 2.143 . . . . 0.0 111.582 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.472 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 33.5 t-105 -53.86 -43.15 69.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.612 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.51 77.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 22.6 mm-40 -81.22 -25.91 36.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 111.153 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.17 -43.53 91.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 61' ' ' LEU . 62.4 mt -58.81 -42.38 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.607 0.717 . . . . 0.0 109.554 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -54.5 -52.79 60.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.758 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 91.8 mt -62.35 -45.42 93.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.615 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.775 ' HB2' HD21 ' A' ' 61' ' ' LEU . 8.2 tpt -57.1 -47.76 80.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.269 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.514 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.9 ttm180 -66.27 -37.78 86.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.977 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.14 -30.68 74.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.501 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 97' ' ' VAL . 94.8 mt -89.47 -42.47 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 121' ' ' ARG . 35.9 m -73.65 -31.01 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.76 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.614 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 10.9 Cg_exo -70.23 -43.37 2.3 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.867 1.712 . . . . 0.0 111.807 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.787 ' HE1' ' HB2' ' A' ' 42' ' ' SER . 76.7 t80 -73.54 -43.04 60.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.657 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 24.4 t70 -55.15 -53.62 53.62 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.504 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.19 99.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.544 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.13 -41.27 97.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.753 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -64.41 -40.26 95.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 24.9 mm-40 -57.89 -39.92 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.36 -52.5 46.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.633 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.6 mtp -55.32 -38.24 68.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.979 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -65.13 -36.42 84.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.754 179.154 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.64 67.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -73.27 -7.77 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.804 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.49 23.64 36.12 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.266 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -85.1 141.97 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.2 m -84.63 116.08 63.56 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.942 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 57.1 Cg_endo -74.39 129.59 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.553 2.169 . . . . 0.0 110.985 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG11 HD23 ' A' ' 27' ' ' LEU . 13.8 p -138.57 145.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.892 0.377 . . . . 0.0 111.328 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 p -91.23 160.73 15.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.598 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -32.44 72.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.514 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -66.27 -36.5 83.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.876 0.37 . . . . 0.0 111.112 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -90.52 -24.76 20.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.348 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.469 HD23 HG11 ' A' ' 22' ' ' VAL . 3.1 tm? -58.8 -40.46 84.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.651 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 32' ' ' THR . 17.7 t70 -56.11 -53.4 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.877 0.846 . . . . 0.0 111.105 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t90 -59.39 -41.53 89.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.88 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.53 -29.11 70.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.181 0.515 . . . . 0.0 110.47 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 86.2 m -66.32 -40.0 89.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -98.91 -14.5 19.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 90.22 10.04 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.843 0.354 . . . . 0.0 110.048 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.747 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 86.0 Cg_endo -88.61 -14.38 3.07 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.06 2.507 . . . . 0.0 114.409 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -100.22 135.94 40.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 110.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.98 -160.98 28.74 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 97' ' ' VAL . 6.9 m -138.4 134.87 44.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.5 t -113.59 132.15 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.34 122.43 43.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 35.2 tp -83.15 81.2 8.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.787 ' HB2' ' HE1' ' A' ' 7' ' ' PHE . 4.3 p . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.063 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 53.78 -168.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.926 0.891 . . . . 0.0 111.955 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -147.57 92.35 4.8 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.12 98.44 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.746 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.97 -32.67 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.311 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -60.14 -23.76 64.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.877 -177.069 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 116' ' ' LEU . 49.8 mm -53.93 -39.96 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.73 -44.69 95.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.399 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -62.2 -34.83 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.342 . . . . 0.0 111.071 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.602 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 45.0 tp -64.76 -55.0 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.21 -27.99 69.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.369 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.96 -19.9 65.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -86.79 -0.45 56.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.772 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -123.08 71.64 44.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.94 -3.03 10.38 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.53 2.154 . . . . 0.0 113.075 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.53 -17.83 60.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.16 139.14 51.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.274 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -86.25 105.21 16.47 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -80.11 110.63 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.187 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.47 119.54 24.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.081 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.33 103.33 14.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -108.45 127.15 53.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 15' ' ' LEU . 23.4 pt -122.59 139.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.954 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -111.68 169.78 8.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 112.242 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.66 168.77 14.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.283 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.25 -54.64 19.72 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.251 0.62 . . . . 0.0 112.18 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -30.3 61.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.546 0.689 . . . . 0.0 110.671 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 57.6 mt-30 -77.27 -42.7 36.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.468 -175.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 48.6 p -73.38 -37.24 66.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.663 0.268 . . . . 0.0 110.305 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -53.08 -49.79 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.101 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.07 71.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.786 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 79' ' ' GLN . 81.1 mt -67.89 -52.09 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.433 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.53 -44.75 97.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.171 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.94 -39.58 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.21 -30.75 65.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.373 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -84.82 -33.38 22.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 110.715 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.82 31.96 1.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.488 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.55 158.68 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.71 -83.81 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 110.821 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 86.9 mtt180 -148.17 -161.18 1.28 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 88.5 m-85 76.7 148.18 0.12 Allowed Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 124.144 0.903 . . . . 0.0 111.733 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 17.2 Cg_exo -65.39 69.15 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.452 3.434 . . . . 0.0 113.39 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.64 129.56 34.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.339 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 7.3 m -92.22 112.96 25.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 106' ' ' VAL . 65.8 mt -93.97 113.9 25.99 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 104' ' ' ARG . 7.4 p -97.85 127.37 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.202 0.525 . . . . 0.0 110.92 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.93 134.26 55.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.14 137.45 23.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.84 17.6 75.38 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.747 ' HA2' ' HB2' ' A' ' 35' ' ' PRO . . . 79.93 -0.36 83.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.663 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -112.46 149.34 32.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 111.649 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -69.98 129.47 39.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.417 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.767 ' HB2' HG13 ' A' ' 97' ' ' VAL . 16.7 mmt180 -101.93 -47.29 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.367 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.04 -163.76 36.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.388 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 96' ' ' LEU . 59.3 t -122.6 134.26 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 4.4 mp -101.32 123.58 45.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.78 90.29 2.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.186 0.517 . . . . 0.0 110.026 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.5 146.15 5.73 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.0 -53.27 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 117.165 0.483 . . . . 0.0 111.767 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.6 m170 -73.25 -53.65 4.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 12.5 Cg_exo -68.73 121.91 8.82 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.126 1.217 . . . . 0.0 111.885 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.602 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 9.4 t-105 -87.49 -45.14 10.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.549 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.21 75.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 8.0 tp10 -72.18 -40.59 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.316 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.501 HD23 ' HZ3' ' A' ' 113' ' ' TRP . 30.9 tp -61.31 -44.28 97.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 113' ' ' TRP . 62.1 mt -63.9 -44.94 98.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -50.23 -59.05 4.33 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.122 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 87.0 mt -65.53 -45.46 83.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.926 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.475 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -61.37 -48.03 83.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.69 0.281 . . . . 0.0 110.538 -178.134 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.0 ttt85 -69.39 -33.03 72.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.199 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.51 -29.15 74.53 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.2 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.5 mt -83.06 -49.59 9.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.409 0.147 . . . . 0.0 111.206 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 121' ' ' ARG . 29.5 m -70.65 -37.94 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.428 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.534 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.737 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 88.0 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.3 Cg_exo -68.58 -58.91 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.551 1.501 . . . . 0.0 111.545 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.41 -35.07 79.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.23 -54.22 49.41 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.566 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -62.26 -48.02 81.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.78 -40.68 89.11 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 111.631 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -69.12 -43.47 74.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 76.9 mm-40 -62.36 -32.76 73.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.359 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 50.1 mmm-85 -57.38 -53.59 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.251 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.544 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 73.0 mtm -66.65 -33.0 74.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.957 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 1.9 mm? -67.37 -24.37 65.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.459 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.76 72.9 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -81.36 -3.96 54.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.863 0.363 . . . . 0.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.91 29.99 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.116 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.544 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 43.4 m0 -74.09 148.19 42.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.174 0.511 . . . . 0.0 110.215 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.563 ' HB ' ' HZ3' ' A' ' 30' ' ' TRP . 9.5 p -96.85 130.43 30.19 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.9 -169.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.7 Cg_exo -79.31 145.1 18.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.302 2.668 . . . . 0.0 111.345 172.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.7 144.24 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.575 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -95.2 166.06 12.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.6 -55.35 35.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.075 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.3 m -73.27 6.37 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -126.34 -1.34 6.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.251 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.29 -47.08 79.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.828 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.15 -29.81 57.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.467 0.651 . . . . 0.0 110.444 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 32' ' ' THR . 17.1 t70 -61.06 -55.16 35.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.18 0.99 . . . . 0.0 109.661 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.563 ' HZ3' ' HB ' ' A' ' 20' ' ' THR . 14.0 m95 -67.93 -29.05 68.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.067 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.93 -28.85 69.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.628 0.252 . . . . 0.0 111.366 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' ASP . 14.5 t -88.78 -30.2 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.582 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.15 -28.94 18.6 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -98.86 158.0 33.15 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -67.84 149.54 78.17 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.969 1.78 . . . . 0.0 111.741 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.77 112.35 10.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.306 0.574 . . . . 0.0 110.204 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.55 -107.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.974 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.3 m -135.33 142.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 111.975 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 71.7 t -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.4 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.09 143.26 31.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.466 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -86.28 1.12 52.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 93' ' ' PRO . 89.8 p . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 124.709 1.203 . . . . 0.0 111.73 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 60.0 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.855 0.722 . . . . 0.0 111.357 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -144.86 111.06 4.81 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.241 0.543 . . . . 0.0 109.774 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -97.64 -167.98 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.21 2.607 . . . . 0.0 113.326 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.3 t 76.49 -34.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -32.27 54.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.57 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.9 mm -59.18 -44.19 91.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.79 73.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.361 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.69 -32.51 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.237 0.541 . . . . 0.0 109.974 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 120' ' ' MET . 51.1 tp -70.33 -34.59 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.502 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.9 mp -62.85 -28.12 69.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.262 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -68.7 -8.72 45.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.157 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.47 -24.79 66.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.339 . . . . 0.0 111.099 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.31 94.93 46.39 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.696 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.51 -18.28 13.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.99 2.46 . . . . 0.0 112.033 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.84 -25.55 64.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 0.0 110.801 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -137.66 121.15 17.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.578 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 t -86.26 131.12 34.3 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.907 0.861 . . . . 0.0 110.068 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -88.4 135.24 33.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.173 -173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.839 ' HB2' ' HG2' ' A' ' 35' ' ' PRO . 6.5 tp60 -96.22 122.62 39.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.206 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.35 110.99 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -111.82 127.55 55.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.254 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.5 pt -125.59 140.94 46.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -128.52 166.73 18.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.694 0.283 . . . . 0.0 111.069 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.5 m-20 -65.57 165.43 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.303 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.64 -49.14 73.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.13 -34.07 75.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.002 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 81.8 mt-30 -77.16 -52.71 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.729 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB3' HD22 ' A' ' 41' ' ' LEU . 20.0 m -60.96 -39.57 90.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.388 -177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.89 -41.68 96.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.51 . . . . 0.0 110.201 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.42 77.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 79' ' ' GLN . 83.2 mt -61.36 -43.44 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.7 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.936 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.48 -36.16 66.31 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.067 0.547 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -51.67 -54.51 27.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.103 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' HB3' HG23 ' A' ' 89' ' ' VAL . 24.5 t80 -93.57 -19.29 21.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.002 -166.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.03 39.04 6.22 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 96' ' ' LEU . 18.7 t -82.45 160.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 74.8 m-85 -60.25 138.64 57.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -83.07 8.79 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 88.9 m-85 -90.33 142.2 28.16 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.417 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' SER . 41.8 Cg_exo -57.08 126.04 20.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.518 2.146 . . . . 0.0 111.558 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.87 -175.81 3.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.567 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 29.3 m -117.21 120.65 38.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 89' ' ' VAL . 5.8 mp -93.97 114.64 26.87 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -96.03 138.94 20.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -125.05 145.61 49.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 2.6 m -154.79 151.13 28.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.02 21.6 68.0 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.13 76.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.638 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.41 176.66 8.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.446 0.641 . . . . 0.0 111.828 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.87 118.03 11.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.127 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 5.7 tpm_? -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.726 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.444 ' HA3' HD13 ' A' ' 123' ' ' LEU . . . 170.1 -168.75 41.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.595 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.8 t -132.13 134.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.02 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.8 mt -108.02 131.53 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.3 33.67 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -172.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 -120.76 21.41 Favored Glycine 0 C--O 1.236 0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.782 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.33 99.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.93 0.871 . . . . 0.0 110.325 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.747 ' HB3' HD23 ' A' ' 116' ' ' LEU . 11.5 t60 -137.09 143.36 41.75 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -38.47 124.0 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.192 2.594 . . . . 0.0 112.128 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -54.92 -43.48 73.34 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.61 0.569 . . . . 0.0 112.016 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.17 87.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.698 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.76 -29.0 64.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.343 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 111' ' ' HIS . 0.5 OUTLIER -65.82 -48.82 70.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.52 -42.06 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.166 0.508 . . . . 0.0 109.873 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -52.63 -59.29 4.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.02 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.12 -43.66 98.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.3 tpt -55.34 -48.95 73.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -39.04 92.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.435 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.52 75.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.428 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.463 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 98.6 mt -86.51 -60.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 120' ' ' MET . 30.7 m -63.51 -33.42 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.501 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.333 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.699 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 9.7 Cg_exo -71.69 -44.6 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.457 1.438 . . . . 0.0 110.223 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -68.97 -34.81 75.93 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 27.9 t70 -53.79 -53.85 46.53 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.599 0.714 . . . . 0.0 110.41 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.35 -46.03 89.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.044 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -60.34 -42.3 95.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.494 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.58 ' CH2' ' HA ' ' A' ' 76' ' ' ASP . 1.6 t90 -66.54 -40.24 88.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 87.8 mm-40 -57.78 -36.86 72.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 29.0 mmm180 -63.16 -54.15 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.664 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.499 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 66.5 mtm -62.55 -33.09 74.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.291 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.02 -40.07 95.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 0.0 110.584 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.35 66.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -74.38 -10.96 60.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.276 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.13 6.41 53.75 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.798 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.499 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 21.7 m0 -83.18 121.93 27.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 109.914 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 m -88.26 125.94 62.24 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.348 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 38.1 Cg_endo -68.5 139.38 44.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.847 2.364 . . . . 0.0 111.959 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 27' ' ' LEU . 10.7 p -130.92 148.55 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.064 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.7 p -86.62 163.6 17.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 111.49 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.01 -59.02 4.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.336 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 t -77.78 -21.94 50.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 19.2 tpt180 -84.28 -16.94 41.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 109.989 -174.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.01 -39.2 90.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.462 176.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.47 -29.36 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.616 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 32' ' ' THR . 35.1 t70 -64.24 -51.73 62.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.305 1.05 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -59.1 -40.9 86.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.074 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 60.5 mt -62.5 -33.59 75.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' ASP . 10.2 t -79.88 -26.02 40.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.743 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.75 -34.17 21.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.713 0.292 . . . . 0.0 111.494 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -86.42 148.36 46.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 16.0 Cg_exo -68.43 -67.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.505 2.137 . . . . 0.0 112.534 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.75 -90.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.578 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.57 163.79 39.67 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.262 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.03 143.28 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.89 137.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 74' ' ' ILE . 8.7 mp -92.24 121.28 33.61 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 80' ' ' SER . 21.5 tp -114.41 148.66 37.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.745 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 57.08 -146.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.489 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -120.4 93.28 48.17 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 110.966 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.97 13.15 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.067 2.511 . . . . 0.0 112.276 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -84.02 -16.54 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 0.0 110.848 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -21.98 41.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.68 -33.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.788 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -50.26 69.51 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.143 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.95 -27.73 39.74 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.668 -0.313 . . . . 0.0 111.313 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.3 tp -58.32 -48.09 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.099 0.476 . . . . 0.0 111.617 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.11 -26.58 67.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.85 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -63.92 -7.92 9.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -67.23 -32.44 73.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 110.56 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.67 75.42 62.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.25 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.38 6.22 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.93 2.42 . . . . 0.0 112.896 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -91.26 2.09 56.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.786 0.803 . . . . 0.0 109.722 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -138.38 147.58 43.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.387 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -87.23 138.65 31.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.856 0.836 . . . . 0.0 111.269 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -117.21 115.25 24.94 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.732 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.09 102.89 15.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.89 106.92 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.91 142.31 41.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 40' ' ' LEU . 21.0 pt -114.9 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.518 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -92.12 157.24 16.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.896 0.379 . . . . 0.0 111.939 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -59.51 159.68 7.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.328 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -57.24 -55.72 31.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.54 -39.24 46.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.505 0.669 . . . . 0.0 111.076 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 49.8 mt-30 -72.53 -22.35 61.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.132 -173.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 31.9 p -70.31 -41.1 73.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.026 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.65 -38.87 86.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.07 83.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.017 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 79' ' ' GLN . 84.1 mt -58.33 -41.02 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 110.816 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.53 -53.26 47.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.419 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.27 -40.4 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 110.564 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.41 -36.17 83.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.051 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -92.31 -27.67 17.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.16 20.83 7.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.78 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 92' ' ' PHE . 25.5 t -126.74 78.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.56 122.98 40.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 111.459 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 70.44 27.8 3.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.993 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.647 ' HB2' HG12 ' A' ' 89' ' ' VAL . 93.6 m-85 -115.83 85.77 15.05 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.032 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.13 125.43 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.11 1.873 . . . . 0.0 111.807 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . -177.07 -176.35 0.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.655 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -104.31 123.22 47.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.339 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 96' ' ' LEU . 5.8 mp -94.14 133.12 37.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.701 0.286 . . . . 0.0 110.528 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.34 125.77 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.381 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -144.22 129.38 18.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.968 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.8 p -93.14 124.0 36.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.358 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.67 27.3 58.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.99 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.91 83.44 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.571 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -105.04 129.36 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -66.09 124.2 21.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.702 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 104' ' ' ARG . 12.9 mmt180 -103.61 -51.47 3.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.219 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.5 -174.96 47.37 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.424 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.47 133.85 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.983 0.42 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 93.0 mt -85.68 97.2 9.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -131.01 158.58 39.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.79 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.47 84.83 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.909 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 45.8 mm 65.6 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.516 0.727 . . . . 0.0 111.866 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 74.8 m80 74.22 157.07 0.16 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 123.287 0.635 . . . . 0.0 111.083 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.39 155.3 69.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.337 2.024 . . . . 0.0 111.515 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.573 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 t-105 -54.91 -39.13 68.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.25 -42.47 81.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.663 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.19 -28.77 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.12 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 61' ' ' LEU . 32.4 tp -64.98 -41.4 95.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.174 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' TRP . 78.4 mt -58.1 -46.01 88.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.321 0.581 . . . . 0.0 110.171 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -54.99 -57.84 10.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.819 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.19 -45.28 87.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.516 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.483 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.7 tpt -53.65 -53.29 53.99 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.351 0.407 . . . . 0.0 110.912 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.19 -33.47 76.08 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.29 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.31 66.42 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.346 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.91 -52.35 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 120' ' ' MET . 8.4 p -69.97 -30.64 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 125.511 1.524 . . . . 0.0 115.104 173.62 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 92.6 m . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 30.3 Cg_exo -62.51 -56.81 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.642 1.561 . . . . 0.0 111.675 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -65.43 -41.79 93.14 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.84 -53.12 53.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.506 0.67 . . . . 0.0 111.006 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -64.84 -45.12 87.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.249 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 52' ' ' SER . 1.9 mm? -60.01 -46.65 88.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.106 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -67.58 -36.61 81.22 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -49.09 74.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.941 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 35.0 mtp180 -61.14 -52.4 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.648 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtp -54.48 -39.75 67.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.338 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD11 ' HG3' ' A' ' 21' ' ' PRO . 1.8 mm? -67.21 -42.52 83.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.917 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.7 61.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -69.9 -18.0 63.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 110.24 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.6 26.12 9.44 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -91.35 -179.21 5.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 24.9 m -121.89 124.39 27.05 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.76 0.314 . . . . 0.0 111.645 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG3' HD11 ' A' ' 15' ' ' LEU . 6.5 Cg_exo -73.18 132.72 18.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.941 2.427 . . . . 0.0 110.981 175.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 27' ' ' LEU . 17.4 t -120.99 144.83 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.58 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 25.0 p -99.05 165.96 11.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.972 173.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.75 -54.95 30.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 m -78.38 -13.23 59.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 111.683 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.8 tpp180 -94.65 -15.99 23.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -60.89 -44.41 97.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.4 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.32 -32.05 62.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.638 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 32' ' ' THR . 33.0 t70 -64.82 -54.58 28.86 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.782 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -66.02 -28.93 69.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.559 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -66.1 -28.11 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.441 0.639 . . . . 0.0 109.855 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 91.5 m -74.5 -41.56 60.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.138 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -83.62 -46.2 12.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -94.52 118.95 66.9 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.411 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.18 124.96 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.551 2.168 . . . . 0.0 112.747 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.4 m-20 68.06 172.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.128 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.34 -163.19 24.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.277 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.56 142.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.0 110.8 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 73' ' ' ALA . 59.8 t -119.28 127.67 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.589 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.572 ' HB2' HG22 ' A' ' 74' ' ' ILE . 35.2 mt -101.96 135.69 43.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.994 0.426 . . . . 0.0 110.948 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.99 -69.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.727 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.818 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' HD21 ' A' ' 10' ' ' LEU . 10.2 t . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.966 0.412 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.66 123.56 28.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 4.6 p-10 -75.63 131.83 76.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 26.8 Cg_exo -62.98 104.61 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.176 2.584 . . . . 0.0 113.292 -174.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.98 -37.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.204 0.526 . . . . 0.0 109.786 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -24.34 67.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.127 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.492 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.0 mm -65.26 -36.42 77.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.38 99.69 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.586 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.68 -28.2 40.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.668 0.27 . . . . 0.0 111.21 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.96 -41.77 97.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.98 0.419 . . . . 0.0 110.6 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.8 mp -58.74 -25.75 63.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.147 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.18 -8.12 7.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.2 -30.18 64.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.593 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.21 92.86 37.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.095 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.54 -0.91 9.98 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.993 2.462 . . . . 0.0 111.601 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.26 -24.9 42.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.794 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -110.39 161.02 16.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 p -95.67 113.93 25.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.063 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -86.94 95.51 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.027 0.441 . . . . 0.0 110.918 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HG2' ' HB1' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -88.11 117.66 27.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.769 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 t -90.6 107.89 19.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.037 0.446 . . . . 0.0 110.293 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 22' ' ' VAL . . . -105.66 127.57 53.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.349 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.572 HG22 ' HB2' ' A' ' 40' ' ' LEU . 22.3 pt -127.15 140.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.46 167.43 19.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.346 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.12 168.4 15.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.8 -37.19 86.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.77 -49.17 78.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -67.6 -45.44 75.5 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.082 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 p -67.24 -32.78 74.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.398 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.61 -49.42 77.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.16 97.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.2 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.506 HD13 ' HG ' ' A' ' 27' ' ' LEU . 92.8 mt -65.98 -41.87 90.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.796 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.87 86.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.661 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.56 -39.82 71.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.0 110.63 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.34 -37.41 72.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.437 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -91.27 -35.33 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.51 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.76 -18.95 5.33 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 t -94.22 96.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.512 ' HD2' ' HG3' ' A' ' 91' ' ' ARG . 46.3 p90 -122.74 154.07 38.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.602 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 90' ' ' PHE . 20.2 mtp180 64.93 22.68 12.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.128 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.12 90.33 13.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.676 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.68 133.64 15.82 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.48 -172.68 3.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.26 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 15.3 m -99.81 108.72 21.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.4 117.42 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.211 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.7 p -102.58 128.76 55.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.234 0.54 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -121.39 134.06 55.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.086 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.599 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 34.2 p -119.99 123.7 44.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.001 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.97 22.9 65.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.488 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 1.44 90.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.923 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -100.51 143.13 31.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.52 0.2 . . . . 0.0 110.516 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.74 112.52 3.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.254 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.506 ' HB3' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.55 -49.75 6.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.48 -173.08 46.03 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.163 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.2 136.51 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.846 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.3 mt -122.52 157.67 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.225 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' HB2' ' HE1' ' A' ' 111' ' ' HIS . 18.5 m120 -132.39 142.63 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.04 165.62 50.86 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.52 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.6 mp 60.98 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.673 0.749 . . . . 0.0 111.067 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.517 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 9.0 m80 -155.94 150.19 19.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.167 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 115' ' ' GLU . 13.0 Cg_endo -57.22 137.08 80.13 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.56 2.173 . . . . 0.0 111.216 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.52 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.8 t-105 -59.4 -43.97 92.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.581 -173.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.34 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.598 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . 44.6 tt0 -72.5 -39.28 67.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.347 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.82 -45.27 93.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.967 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 113' ' ' TRP . 63.2 mt -60.84 -49.82 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -50.61 -56.19 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.208 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 82.7 mt -64.89 -43.3 93.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.995 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -65.52 -47.45 75.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.45 . . . . 0.0 110.076 -177.245 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ttt85 -65.62 -32.63 74.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.42 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.2 68.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.956 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 65.4 mt -75.64 -53.2 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.954 -0.145 . . . . 0.0 111.055 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 120' ' ' MET . 18.8 m -64.56 -38.48 82.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.084 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 CA--C 1.539 0.536 0 O-C-N 124.037 0.835 . . . . 0.0 111.996 176.555 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 27.8 m . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 2.9 Cg_exo -76.14 -46.42 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.147 1.898 . . . . 0.0 111.59 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.85 -43.92 94.69 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -50.51 -52.68 36.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.59 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.99 -49.49 77.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.478 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -56.46 -46.47 80.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.871 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.503 ' CZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.4 t90 -66.08 -45.22 82.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.213 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -55.51 -40.13 71.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 16.1 mmm180 -60.24 -54.01 50.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -63.19 -33.28 75.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 74' ' ' ILE . 1.8 mm? -63.19 -30.04 71.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.554 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -29.21 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.739 0.304 . . . . 0.0 111.548 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -75.73 -7.38 54.22 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.35 19.74 44.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.785 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -76.71 128.09 34.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 109.786 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.4 m -83.0 129.71 60.32 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 29.6 Cg_endo -65.55 128.83 20.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.747 175.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.66 144.02 22.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -109.53 168.08 9.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.13 -39.49 94.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.705 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.2 t -77.6 -16.33 58.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.396 0.617 . . . . 0.0 110.815 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -98.91 -9.66 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 27' ' ' LEU . 1.5 tm? -59.59 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.162 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.25 -45.15 89.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' THR . 24.9 t70 -60.61 -55.14 36.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.538 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -57.9 -39.3 77.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.133 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.3 tp -66.54 -28.31 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -89.06 -26.26 21.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.713 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -80.93 -42.69 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 111.275 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 157.1 44.23 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.743 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.1 -69.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.012 1.808 . . . . 0.0 111.117 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.47 -79.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.982 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.67 -166.9 51.17 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.676 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 97' ' ' VAL . 19.3 m -135.93 150.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 98' ' ' PHE . 74.7 t -129.96 127.07 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.34 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.559 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.0 131.21 46.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.81 -39.58 69.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.488 177.182 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 t70 47.82 78.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.442 -168.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.2 106.31 0.92 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -12.95 81.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.821 4.348 . . . . 0.0 115.126 -159.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.22 -73.3 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.11 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -60.39 -35.06 74.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.648 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.74 -38.11 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -63.75 -47.37 87.05 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.413 -175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.71 -36.32 37.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 111.487 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD21 ' HG3' ' A' ' 120' ' ' MET . 23.9 tp -66.53 -55.14 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.118 -173.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.49 -27.45 67.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 48.8 mmt-85 -71.6 -7.82 50.19 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.84 -40.33 83.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.146 0.498 . . . . 0.0 110.176 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.634 ' HB3' ' HD2' ' A' ' 68' ' ' TYR . 99.2 m-85 -129.54 84.23 62.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.714 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -82.03 -14.02 9.98 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.871 2.381 . . . . 0.0 113.365 -174.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.77 -25.46 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.387 0.613 . . . . 0.0 110.268 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.634 ' HD2' ' HB3' ' A' ' 65' ' ' PHE . 60.4 m-85 -84.14 111.24 19.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.079 175.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 p -67.96 104.76 1.81 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.006 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -86.81 95.06 9.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.364 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -87.0 105.11 16.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.17 125.77 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.815 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.22 140.63 51.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.56 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 40' ' ' LEU . 13.8 pt -125.44 140.66 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.93 0.395 . . . . 0.0 110.558 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -106.92 157.41 17.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' CH2' ' A' ' 11' ' ' TRP . 2.8 p30 -87.02 -174.07 4.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -59.44 -42.91 93.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.358 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -75.35 -36.93 60.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.29 0.567 . . . . 0.0 110.874 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.538 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 82.3 mm-40 -73.59 -44.66 56.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.499 -175.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 p -59.38 -43.24 92.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.73 0.3 . . . . 0.0 110.932 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.98 -41.16 82.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -40.45 61.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.234 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 79' ' ' GLN . 77.8 mt -65.54 -48.06 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.372 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.62 -48.15 83.78 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.894 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.52 -52.41 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 122.636 0.374 . . . . 0.0 110.673 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -68.52 -26.39 65.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.92 -26.61 31.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.078 0.466 . . . . 0.0 110.237 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.79 -0.24 48.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.75 -26.47 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 109.938 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 65.14 -141.78 0.22 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 92' ' ' PHE . 50.7 mtt-85 -92.1 -158.1 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.654 -170.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 90.5 t80 75.16 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.185 0 O-C-N 124.219 0.949 . . . . 0.0 109.456 -172.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.77 131.16 20.64 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.674 2.25 . . . . 0.0 112.27 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.05 -174.8 4.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.37 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.2 m -92.11 113.36 25.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.08 118.85 32.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.178 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.3 p -98.39 131.65 45.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.53 ' HE2' ' HB ' ' A' ' 39' ' ' VAL . 95.2 m-85 -118.22 146.7 44.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.278 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 1.9 m -153.4 146.28 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.28 20.55 63.2 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.059 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 16.43 78.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.755 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -131.47 174.0 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -70.06 112.9 6.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.817 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.5 tpm_? -90.24 -41.49 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.225 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.59 -175.39 44.44 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.855 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.6 137.97 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.2 mt -94.7 161.34 14.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.705 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -169.31 96.28 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.079 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.79 91.8 0.58 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.727 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.17 -31.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.353 0.597 . . . . 0.0 111.46 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.636 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 6.4 t-80 -68.28 -58.87 6.81 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -168.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 11.8 Cg_exo -71.02 121.87 8.25 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.721 1.614 . . . . 0.0 112.308 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.441 ' CZ3' HD23 ' A' ' 116' ' ' LEU . 7.1 t-105 -93.51 -45.41 7.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.214 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.43 98.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.49 -43.46 94.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.696 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.441 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 30.7 tp -58.59 -49.39 77.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.904 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.44 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.7 mt -58.17 -48.93 83.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -52.16 -55.63 19.78 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.146 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.2 mt -64.62 -45.26 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.691 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -60.72 -51.77 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttm-85 -64.09 -39.45 94.09 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.189 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.01 -30.35 73.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.542 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 95.0 mt -81.43 -56.68 3.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.425 0.155 . . . . 0.0 110.822 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 120' ' ' MET . 31.8 m -68.56 -36.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.578 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 21.3 m . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 33.1 Cg_endo -65.62 -46.32 5.45 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.693 1.595 . . . . 0.0 112.009 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -66.37 -41.69 89.1 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.267 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.29 -53.59 56.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 110.293 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.79 -42.86 98.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.278 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -60.47 -49.7 76.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.903 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -37.28 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.68 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -59.81 -37.14 78.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.4 mtt180 -69.89 -52.03 28.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.55 177.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.5 mtp -55.11 -40.7 70.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.843 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.402 HD11 ' HD3' ' A' ' 21' ' ' PRO . 2.8 mm? -68.47 -31.01 70.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.62 68.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -85.34 -1.07 56.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.633 0.254 . . . . 0.0 111.486 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.53 22.84 41.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.009 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -81.55 119.08 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -78.8 121.17 83.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.719 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -82.78 127.88 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.817 2.344 . . . . 0.0 111.79 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.88 137.76 13.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 0.0 111.01 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 25' ' ' SER . 4.4 m -94.43 130.95 40.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.605 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' SER . 1.5 tm-20 17.86 -98.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.727 1.211 . . . . 0.0 111.491 162.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' SER . 14.7 t 23.84 -78.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.021 1.328 . . . . 0.0 113.927 149.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 30' ' ' TRP . 9.7 tpp180 -106.92 -15.61 14.66 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.571 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.51 -36.39 73.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.136 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' HH12 ' A' ' 86' ' ' ARG . 25.5 t70 -66.1 -41.88 90.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 32' ' ' THR . 32.3 t70 -57.93 -49.61 76.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.816 0.817 . . . . 0.0 109.885 174.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.428 ' HD1' ' HG3' ' A' ' 26' ' ' ARG . 5.3 m95 -53.5 -43.01 67.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.406 173.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -38.29 90.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.0 t -74.35 -25.11 59.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -86.99 -10.11 53.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.315 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 103.69 44.47 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.62 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.17 -36.35 81.29 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.571 2.18 . . . . 0.0 111.085 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.78 -88.8 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.249 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.86 113.37 3.0 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.926 173.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 72' ' ' VAL . 11.1 m -138.78 134.28 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 0.0 110.406 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.35 129.1 67.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.515 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.7 117.49 34.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.453 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.67 26.1 7.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 -178.625 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 52.65 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.979 0.799 . . . . 0.0 111.653 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -160.12 85.74 2.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.17 44.15 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.847 2.365 . . . . 0.0 112.971 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.72 -26.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.049 0.452 . . . . 0.0 110.488 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -24.6 67.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.692 -173.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 62' ' ' LEU . 48.8 mm -61.77 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 110.575 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.21 68.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.567 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.92 -31.64 70.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.045 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -70.84 -46.03 63.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.04 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ILE . 10.0 mp -59.07 -27.72 65.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.368 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.86 -14.79 36.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.45 -44.69 82.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.636 0.255 . . . . 0.0 110.834 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.99 72.04 34.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.655 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -91.53 15.99 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.148 2.565 . . . . 0.0 112.822 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.89 -25.35 59.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.482 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -157.31 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.7 p -116.87 102.49 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 112.073 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -95.25 84.41 4.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.89 104.35 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.385 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.428 ' HA ' HG23 ' A' ' 38' ' ' VAL . 52.7 t -87.64 103.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.021 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.13 132.25 52.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' HB2' ' A' ' 40' ' ' LEU . 18.0 pt -114.37 139.69 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.31 154.68 19.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.794 0.33 . . . . 0.0 111.358 -176.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 2.0 m-20 -56.96 155.95 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.646 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.33 -53.86 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.21 -26.74 59.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.094 0.473 . . . . 0.0 110.894 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CG ' ' HB2' ' A' ' 76' ' ' ASP . 20.1 mm-40 -70.36 -29.66 66.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.719 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -62.86 -38.6 91.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.522 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.68 -42.89 95.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.614 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.07 93.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.17 -47.88 90.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.92 -46.98 93.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.688 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.86 -45.55 86.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.66 HH12 ' HB2' ' A' ' 28' ' ' ASP . 47.6 ttt180 -57.76 -37.34 73.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.468 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HB3' HG23 ' A' ' 89' ' ' VAL . 19.8 t80 -82.26 -40.12 22.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 0.0 109.843 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.1 33.56 4.26 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.593 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 87' ' ' PHE . 21.8 t -92.81 -15.57 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.507 0.194 . . . . 0.0 110.941 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.6 t80 72.15 174.01 0.3 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -172.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -71.23 96.81 1.45 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.808 0.337 . . . . 0.0 111.016 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -142.39 100.82 5.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.83 123.97 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.781 2.32 . . . . 0.0 111.914 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -172.05 -170.08 0.71 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.818 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 30.8 m -96.73 109.27 21.96 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.61 120.32 34.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.048 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.92 130.35 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.982 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.73 172.89 6.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.539 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.68 122.83 7.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.632 175.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.61 29.84 54.86 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.716 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.01 90.63 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.892 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.82 157.09 18.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.092 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -71.69 119.08 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -93.7 -46.27 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.38 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.55 -167.67 40.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.108 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.5 134.58 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.941 0.401 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.2 mt -92.71 114.36 26.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.293 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.7 98.86 6.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.335 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.48 140.35 2.87 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.33 -39.16 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -109.41 -44.56 0.1 Allowed Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 16.5 Cg_exo -65.17 120.32 7.52 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 120.718 1.292 . . . . 0.0 110.897 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.536 ' HE3' ' HA ' ' A' ' 113' ' ' TRP . 2.1 t-105 -97.68 -51.0 4.26 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.825 -168.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.14 73.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 110.466 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -77.84 -35.14 51.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.419 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -62.57 -46.6 87.59 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.1 mt -61.26 -43.0 95.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.399 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -49.75 -58.04 6.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.225 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.5 mt -57.09 -49.2 76.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.724 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.503 ' O ' HG22 ' A' ' 124' ' ' VAL . 15.8 tpt -61.5 -42.78 99.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.547 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.03 -35.99 82.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.09 71.06 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.237 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 95.9 mt -78.06 -47.25 18.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' MET . 34.4 m -77.92 -34.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.297 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.671 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 99.3 m . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.671 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 58.8 Cg_endo -75.15 -66.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.336 1.357 . . . . 0.0 113.248 -175.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -60.85 -33.34 72.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.77 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.44 -53.89 50.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.674 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.68 89.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.961 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -55.3 27.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.844 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -65.51 -36.94 85.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.81 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -56.09 -39.64 72.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.588 0.232 . . . . 0.0 111.146 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 32.5 mmt180 -63.19 -51.86 64.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.452 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 87.2 mtp -55.1 -38.87 68.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.272 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.62 -38.23 67.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.999 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.21 -28.14 69.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.99 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -64.08 -20.77 66.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.67 32.49 7.61 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.325 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -98.85 134.81 41.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.012 0.434 . . . . 0.0 110.026 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.521 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 2.6 p -86.43 137.79 34.3 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.819 -176.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 1.8 Cg_endo -82.56 141.28 11.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.313 2.675 . . . . 0.0 113.257 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.72 148.04 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -114.77 167.73 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -36.77 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.929 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 t -79.78 4.74 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.381 0.61 . . . . 0.0 110.398 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -118.09 -12.49 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.837 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tt -48.72 -47.77 41.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.269 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -68.32 -51.52 43.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.065 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 32' ' ' THR . 13.4 t70 -54.76 -55.46 29.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.219 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -69.03 -31.61 70.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.7 -28.36 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.697 0.76 . . . . 0.0 109.688 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 85.6 m -71.32 -29.85 65.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.373 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.73 -61.37 2.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.73 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.74 113.85 59.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.824 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.51 -16.46 4.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.486 2.124 . . . . 0.0 112.888 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 24.6 m-20 -122.19 159.76 26.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.356 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.89 -166.32 25.69 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.209 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.82 137.11 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 99.0 t -117.41 119.65 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.164 0.507 . . . . 0.0 110.03 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.94 122.15 43.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.216 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.765 ' HB2' ' H ' ' A' ' 94' ' ' ALA . 7.7 mp -94.13 17.94 11.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.855 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.465 0.318 0 O-C-N 124.254 0.971 . . . . 0.0 110.088 -174.618 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.432 0.158 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 t70 50.81 -144.73 0.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.796 0.685 . . . . 0.0 109.573 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -131.27 96.51 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.63 15.98 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.334 2.689 . . . . 0.0 113.617 -174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.09 -31.31 34.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.339 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -27.41 69.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.381 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.8 mm -59.99 -44.54 94.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.072 0.463 . . . . 0.0 110.237 176.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -66.69 -38.72 93.38 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.996 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 16.9 mm-40 -70.25 -28.75 65.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.301 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 63.5 tp -64.81 -49.36 70.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.8 mp -60.56 -25.63 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.797 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 36.7 mmt180 -56.81 -15.15 4.16 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.8 -8.69 59.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.047 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.708 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 73.7 m-85 -132.61 63.8 69.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.085 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -85.88 2.16 7.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.379 2.052 . . . . 0.0 112.961 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.8 -13.12 19.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.49 0.662 . . . . 0.0 109.901 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -108.98 120.0 41.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -64.65 110.11 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.708 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 87.8 m95 -91.22 117.24 29.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.551 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.69 106.21 18.19 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.34 105.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.889 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -114.78 140.05 49.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.801 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.687 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 24.3 pt -121.93 140.3 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.54 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -97.3 161.6 13.72 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.571 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -65.83 171.81 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.79 -55.7 21.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.052 0.453 . . . . 0.0 109.837 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -78.17 -34.82 49.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.642 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 96.6 mt-30 -67.57 -35.06 78.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.81 -175.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 29.5 p -60.72 -48.61 81.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -57.98 -47.58 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.138 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.19 81.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.782 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 79' ' ' GLN . 67.9 mt -62.11 -51.38 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.131 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.91 94.01 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.565 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -54.46 -44.69 72.77 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 111.221 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 86' ' ' ARG . 23.1 ttt180 -73.0 -31.15 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.729 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -85.17 -31.13 23.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.27 25.07 11.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.43 111.16 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.858 -0.201 . . . . 0.0 110.893 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 69.77 -58.48 0.52 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.691 0.797 . . . . 0.0 112.859 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 70.9 15.21 6.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.832 0.825 . . . . 0.0 108.826 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -129.6 151.19 77.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.98 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.616 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 51.3 Cg_exo -56.16 132.93 54.93 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.818 2.345 . . . . 0.0 112.744 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.765 ' H ' ' HB2' ' A' ' 41' ' ' LEU . . . -165.22 -175.49 3.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.018 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 43.7 m -109.4 115.53 30.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.02 136.36 44.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -114.71 137.03 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.71 128.88 53.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -169.7 134.61 1.4 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.13 0.491 . . . . 0.0 112.28 -175.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.29 22.63 65.54 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.737 173.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 130.99 59.78 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.046 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 103' ' ' TYR . 2.2 t30 65.59 -153.53 0.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.906 0.483 . . . . 0.0 111.739 172.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.5 ' H ' HD21 ' A' ' 102' ' ' ASN . 87.1 t80 -41.38 112.22 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.222 0.951 . . . . 0.0 111.754 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -101.04 -31.58 11.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.583 -176.358 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.29 -174.17 42.47 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.353 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.83 137.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.551 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.2 mt -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.408 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -133.18 142.15 48.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.432 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.93 167.17 43.15 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.114 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 51.0 mm -83.22 -69.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 60.9 m80 71.61 156.49 0.16 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 123.8 0.687 . . . . 0.0 111.537 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.16 152.13 82.43 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.411 2.074 . . . . 0.0 111.052 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 20.9 t-105 -56.75 -40.8 76.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.527 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.04 79.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.359 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -80.26 -26.79 38.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -46.61 85.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.33 -41.03 91.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.876 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.77 -53.87 46.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.434 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.72 -49.16 76.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.407 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.641 ' HG2' HD21 ' A' ' 61' ' ' LEU . 15.4 tpt -54.5 -51.98 63.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.909 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.7 ttt180 -70.61 -33.57 71.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.725 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.92 -30.86 74.26 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.538 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 97.6 mt -83.89 -59.81 2.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.026 0.13 . . . . 0.0 111.058 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 121' ' ' ARG . 27.7 m -65.17 -27.23 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.324 -0.534 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.871 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.504 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 31.1 m . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.504 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 13.9 Cg_endo -58.23 -55.69 2.06 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.121 1.881 . . . . 0.0 112.657 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -64.71 -42.04 95.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.4 -51.49 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.97 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.15 76.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.556 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -46.05 80.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -65.64 -41.93 92.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.354 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -58.25 -37.02 74.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.388 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.86 -53.63 47.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.0 mtm -60.87 -36.96 80.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 110.6 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.5 -40.45 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.567 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.2 67.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.533 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -75.56 -5.95 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.93 23.27 30.61 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.96 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -88.96 118.89 29.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 m -80.02 121.67 82.28 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.349 -169.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 39.6 Cg_endo -70.08 120.9 7.55 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 0.0 110.761 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG11 HD23 ' A' ' 27' ' ' LEU . 12.4 p -124.95 143.82 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.2 t -84.91 159.32 20.35 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.778 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.53 -54.16 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.124 0.57 . . . . 0.0 111.98 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 m -67.05 -23.71 65.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.149 0.499 . . . . 0.0 111.362 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -86.72 -26.1 24.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.332 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.569 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -60.42 -41.36 93.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.05 -42.52 72.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.251 0.548 . . . . 0.0 110.324 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.67 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 13.4 t70 -63.72 -55.81 20.44 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.366 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.6 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t90 -62.94 -35.76 81.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.447 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.4 tm? -63.83 -32.04 73.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.647 0.737 . . . . 0.0 109.044 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 97.5 m -71.95 -37.49 69.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.793 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 14.6 mm-40 -74.41 -33.72 63.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.13 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.03 142.98 30.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.381 -177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.6 Cg_exo -69.6 -39.67 6.53 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.822 2.348 . . . . 0.0 111.874 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 6.8 t70 -145.67 154.46 42.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.16 147.68 9.45 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.907 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 97' ' ' VAL . 29.4 m -125.2 142.43 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 55.8 t -125.04 131.9 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.512 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.31 124.77 47.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.4 mp -98.2 125.12 43.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.303 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.657 ' HA ' HG13 ' A' ' 110' ' ' ILE . 14.7 t70 -72.07 113.45 9.12 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 49.72 63.48 10.12 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.991 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.56 -41.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.124 1.883 . . . . 0.0 113.664 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.89 -42.18 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -56.58 -24.44 47.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.462 ' O ' HD13 ' A' ' 62' ' ' LEU . 41.8 mm -62.03 -44.35 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.837 0.351 . . . . 0.0 110.958 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.81 -26.75 74.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.062 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.91 -42.76 38.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.992 0.425 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 48.9 tp -60.75 -48.28 82.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.646 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.3 mp -58.72 -26.86 64.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.888 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 11.4 mmt180 -68.3 -7.63 32.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 10.1 pt-20 -83.09 4.88 24.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.298 175.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . 97.7 m-85 -109.97 90.15 9.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.03 -43.41 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.056 2.504 . . . . 0.0 113.517 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.72 -25.61 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.223 0.535 . . . . 0.0 110.679 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 65' ' ' PHE . 11.1 t80 -88.77 107.78 19.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.615 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 p -89.06 125.76 35.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.993 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -102.82 129.77 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.118 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -87.39 105.98 17.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.36 115.81 33.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.91 0.386 . . . . 0.0 110.592 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -121.76 147.56 45.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.553 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.627 HG22 ' HB2' ' A' ' 40' ' ' LEU . 10.4 pt -134.55 147.4 29.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.058 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -122.77 153.81 39.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 3.5 m-20 -60.43 179.66 0.15 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.63 -55.9 28.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.629 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.52 -42.98 81.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ASP . 14.3 mp0 -54.96 -51.1 67.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.205 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 p -65.62 -39.58 91.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.59 0.233 . . . . 0.0 110.647 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.58 -46.01 91.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.179 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.29 82.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.334 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.26 -44.23 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.331 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.42 87.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.909 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.35 -50.77 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.179 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -65.49 -27.91 68.82 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -87.48 -23.59 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.014 0.435 . . . . 0.0 109.829 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.16 32.03 10.16 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.507 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.13 82.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 85.8 m-85 53.19 -156.99 0.17 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.385 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -158.28 41.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.412 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 87.4 m-85 -129.46 160.19 65.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.136 -174.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 52.0 Cg_exo -53.56 130.52 39.17 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.602 2.201 . . . . 0.0 112.231 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -175.65 158.95 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 32.7 m -107.6 115.16 29.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.671 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.01 129.4 42.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 104' ' ' ARG . 3.9 p -108.21 125.71 64.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.289 0.566 . . . . 0.0 111.545 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.25 119.49 37.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.964 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.538 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -101.67 -175.68 2.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.095 -174.199 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 99' ' ' THR . . . -54.41 -28.17 43.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.442 170.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.11 28.73 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.879 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.99 -156.48 0.26 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.524 0.73 . . . . 0.0 111.113 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -49.51 125.38 11.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.201 0.524 . . . . 0.0 111.633 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.496 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.7 tpt180 -104.75 -59.57 1.72 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.216 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.76 -159.12 21.07 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.807 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.54 134.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 3.0 mm? -92.99 117.1 29.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.552 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.65 154.05 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.41 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.826 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.657 HG13 ' HA ' ' A' ' 53' ' ' ASP . 41.3 mm -84.2 78.36 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 52.1 m-70 -156.72 -61.38 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 172.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 16.8 Cg_endo -94.73 124.77 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.565 2.177 . . . . 0.0 113.058 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 19.3 t-105 -82.69 -39.63 21.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.307 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.28 97.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.675 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 20.2 mp0 -64.78 -39.0 92.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.995 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.47 -48.01 82.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.0 mt -61.41 -42.49 93.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.125 0.488 . . . . 0.0 110.244 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -58.04 -49.18 77.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.847 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.6 mt -59.68 -44.8 93.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.905 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt -62.5 -37.47 86.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.728 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 121' ' ' ARG . 3.4 tmm_? -62.96 -41.88 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.21 -30.94 79.22 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.588 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.82 -56.54 4.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.097 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' ARG . 28.5 m -64.02 -41.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.225 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.459 ' HB3' HH11 ' A' ' 121' ' ' ARG . 43.5 tt0 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 56.0 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 119.551 -0.262 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 36.9 Cg_endo -65.76 -64.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.584 1.523 . . . . 0.0 112.831 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 77' ' ' LEU . 38.2 p90 -66.18 -32.31 73.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -54.93 -54.91 36.64 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.326 0.584 . . . . 0.0 110.763 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -60.83 -41.17 95.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.462 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -57.01 -47.5 80.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.455 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.94 -43.72 91.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.51 -32.77 71.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.393 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 59.5 mmt-85 -62.84 -54.52 37.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.479 175.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.0 mtm -60.96 -33.45 73.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 74' ' ' ILE . 3.1 mm? -65.05 -37.97 89.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.575 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.6 -19.21 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 17.1 mmm180 -84.85 -4.73 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.16 17.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.857 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -100.66 136.89 39.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.048 0.451 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 m -86.63 124.6 69.19 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.47 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.674 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -80.25 146.21 17.58 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.929 2.419 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG11 HD23 ' A' ' 27' ' ' LEU . 12.0 p -148.74 145.26 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.67 0.271 . . . . 0.0 111.133 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 m -73.53 159.59 32.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.371 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 8.6 tm-20 -55.56 -58.6 7.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.502 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -70.11 -7.29 40.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.113 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.419 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.5 tpp180 -106.23 -16.83 14.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.324 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -59.19 -43.04 92.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.359 0.599 . . . . 0.0 110.436 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 32' ' ' THR . 17.3 t70 -63.87 -54.0 41.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.527 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 73' ' ' ALA . 91.1 t90 -54.33 -43.59 71.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.103 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.79 -44.19 94.07 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.382 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.6 t -74.88 -24.32 58.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.02 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -80.36 -16.9 53.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.087 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.97 152.85 38.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.5 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 -23.0 22.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.353 2.036 . . . . 0.0 112.277 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 7.4 t70 -156.37 -171.61 3.77 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 98' ' ' PHE . . . 165.1 128.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.58 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.34 146.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 59.2 t -133.26 136.77 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.665 0.269 . . . . 0.0 111.021 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -97.68 125.96 42.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 80' ' ' SER . 0.9 OUTLIER -94.84 125.43 39.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.685 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 11.1 t . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' HD11 ' A' ' 10' ' ' LEU . 32.2 t . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -84.4 -168.47 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.453 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.434 ' OD1' HG12 ' A' ' 58' ' ' ILE . 43.0 t30 62.17 72.78 0.6 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.568 . . . . 0.0 111.67 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -92.78 -40.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.403 2.069 . . . . 0.0 113.491 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.29 -33.12 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.5 -31.56 66.14 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' HD13 ' A' ' 62' ' ' LEU . 13.5 mm -65.35 -38.75 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.133 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.19 99.67 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.896 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.3 mm-40 -72.8 -28.65 62.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HG ' ' HG2' ' A' ' 120' ' ' MET . 34.8 tp -68.18 -35.04 77.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.7 mp -60.96 -26.86 67.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.376 176.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 72.8 mtt180 -62.59 -7.42 4.69 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.66 -31.39 68.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 110.383 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.52 88.5 49.89 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.978 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.53 -20.06 16.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.761 2.307 . . . . 0.0 111.774 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.8 -11.66 52.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.59 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -120.41 115.31 23.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.13 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 t -80.59 156.95 26.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.669 0.747 . . . . 0.0 110.554 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -124.76 124.57 42.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.571 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -91.35 98.46 11.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.012 0.434 . . . . 0.0 109.947 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.81 111.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.091 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -123.76 149.28 45.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.36 0.6 . . . . 0.0 111.063 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.8 pt -130.53 140.3 49.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.37 164.01 13.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.006 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.4 m-20 -61.96 150.42 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.989 173.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 7' ' ' PHE . 15.4 mt -53.6 -45.71 70.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.742 -174.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.94 -47.42 18.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.685 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 39.9 mt-30 -69.79 -18.57 63.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' HD22 ' A' ' 41' ' ' LEU . 11.6 p -61.5 -34.0 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.272 0.558 . . . . 0.0 110.559 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.69 -46.67 88.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.625 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.16 96.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.078 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.526 HD13 ' HG ' ' A' ' 27' ' ' LEU . 63.4 mt -62.01 -44.79 99.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.29 -43.49 97.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.685 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.83 -41.97 98.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.66 -32.94 67.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -92.37 -45.64 8.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.962 0.411 . . . . 0.0 110.424 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.55 23.9 4.25 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.081 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.77 -83.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.6 t80 59.01 -163.93 0.21 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.628 0.58 . . . . 0.0 109.927 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 34.1 ttp180 65.04 80.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.785 0.434 . . . . 0.0 111.757 175.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 89.6 m-85 72.0 141.23 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 13.1 Cg_exo -72.53 138.22 29.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 124.072 3.181 . . . . 0.0 112.73 176.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . -160.6 -178.19 6.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.541 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.6 m -92.18 122.86 35.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 106' ' ' VAL . 43.6 mt -99.48 113.87 26.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 123' ' ' LEU . 13.4 p -103.55 126.68 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.7 0.762 . . . . 0.0 110.93 -178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.567 ' HD1' ' HA ' ' A' ' 103' ' ' TYR . 46.3 m-85 -122.87 150.55 42.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 40.6 p -128.43 124.49 36.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.91 28.97 71.15 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.931 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 -1.44 88.75 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.768 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.53 143.76 33.24 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.32 0.581 . . . . 0.0 111.717 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD1' ' A' ' 98' ' ' PHE . 73.3 t80 -69.42 136.99 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.292 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 1.5 mmp_? -113.79 -64.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.627 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . -172.06 -166.58 30.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.22 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 96' ' ' LEU . 6.5 m -122.23 146.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 122.476 0.31 . . . . 0.0 111.111 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 5.9 mp -99.63 134.0 43.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -123.48 12.61 9.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.383 0.611 . . . . 0.0 110.565 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.21 117.59 5.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.289 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.02 -36.42 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.874 0.368 . . . . 0.0 111.381 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 91.0 m-70 -122.7 -52.52 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 31.6 Cg_exo -56.84 123.19 13.27 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.729 1.619 . . . . 0.0 112.567 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.492 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.6 t-105 -85.18 -40.43 16.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.616 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.65 86.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 37.9 tt0 -72.84 -32.44 65.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.355 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 29.3 tp -64.46 -46.82 81.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 61.0 mt -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -51.07 -57.49 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 93.3 mt -60.76 -46.89 88.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.584 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.6 tpt -54.17 -44.67 71.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 125' ' ' GLU . 14.6 mmt180 -55.98 -49.12 74.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.2 -30.12 75.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.734 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 97' ' ' VAL . 94.4 mt -84.34 -55.09 4.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 120' ' ' MET . 23.9 m -87.01 -26.07 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.723 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 121' ' ' ARG . 31.5 tt0 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.518 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 82.9 m . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.518 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 19.7 Cg_endo -63.31 -52.57 1.93 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.654 1.569 . . . . 0.0 111.417 172.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -67.15 -35.21 79.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.369 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.69 -53.77 54.59 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.207 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -57.89 -46.21 85.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.084 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 2.0 mm? -57.17 -51.81 67.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.511 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -65.55 -42.06 92.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.111 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 81.1 mm-40 -59.82 -31.76 70.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 35.5 mmt180 -57.33 -54.52 45.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 110.605 174.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.512 ' HB3' HD13 ' A' ' 74' ' ' ILE . 4.9 mpp? -66.86 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 2.4 mm? -64.57 -48.33 75.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.82 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.92 64.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.008 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 34.5 mmt180 -73.81 -21.15 60.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.648 0.261 . . . . 0.0 110.386 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.43 21.85 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.784 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.502 ' HZ3' ' HG3' ' A' ' 14' ' ' MET . 27.4 m0 -93.05 168.1 11.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.7 m -112.96 130.97 23.01 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 40.4 Cg_endo -68.91 121.4 8.27 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.909 2.406 . . . . 0.0 111.678 172.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.3 145.73 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.565 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 m -112.5 168.42 9.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.271 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.9 -47.47 85.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -71.74 -7.94 51.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.914 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 29' ' ' ASP . 28.3 mmt180 -117.7 -7.02 11.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.719 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.43 -49.45 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.12 -34.69 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.134 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 32' ' ' THR . 22.3 t70 -62.16 -56.98 13.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.038 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -74.65 -26.65 60.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.997 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.18 -35.03 78.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 111.081 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.6 t -80.97 -26.53 36.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.007 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -96.7 -0.91 47.58 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.011 0.434 . . . . 0.0 111.699 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.8 87.48 3.71 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.73 148.2 36.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.548 2.166 . . . . 0.0 113.62 -171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.8 t70 80.62 144.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.595 1.184 . . . . 0.0 111.649 174.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.03 -173.55 27.16 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.332 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 97' ' ' VAL . 5.3 m -138.09 138.91 43.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 73' ' ' ALA . 52.9 t -122.62 129.41 75.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.66 124.71 32.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -97.47 98.89 10.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 178.047 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -96.96 -0.28 47.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 110.659 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 49.6 t-20 -78.43 -54.55 1.17 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 54' ' ' ASN . 12.5 Cg_exo -70.88 44.58 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.037 2.491 . . . . 0.0 114.505 -169.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.31 -53.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.56 -25.82 64.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.473 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' HD13 ' A' ' 62' ' ' LEU . 45.2 mm -60.78 -37.99 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.42 -34.25 89.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.619 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.68 -37.72 62.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.306 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 44.6 tp -64.18 -38.76 92.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.253 -176.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.6 mp -65.41 -26.24 67.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.643 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -66.46 -9.04 30.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -70.1 -34.02 72.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.66 85.76 57.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.696 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -88.15 4.95 5.52 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.431 2.754 . . . . 0.0 112.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.86 -20.97 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 0.0 111.075 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -167.74 1.35 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 p -129.91 104.93 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -85.88 96.7 9.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.225 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.73 108.24 8.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.481 . . . . 0.0 109.768 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.66 108.27 20.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -116.58 145.01 43.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.912 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 6.9 pt -124.56 140.48 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.019 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.45 143.09 41.28 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.382 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.81 160.93 22.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 58.9 tp -54.49 -43.31 71.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.394 0.434 . . . . 0.0 111.501 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.92 -33.44 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.402 0.62 . . . . 0.0 111.06 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -77.94 -32.06 51.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.094 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.1 p -74.45 -29.1 61.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.723 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 51.2 mt-10 -54.19 -53.12 57.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 175.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 86' ' ' ARG . . . -70.58 -37.18 73.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.162 -173.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.49 -45.35 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 0.0 110.309 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -48.45 71.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.651 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -55.88 -42.67 76.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 110.875 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 49.8 ttt180 -57.12 -38.51 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.729 -176.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -95.85 -36.83 10.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.565 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.08 8.03 13.94 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.735 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.666 HG11 HD21 ' A' ' 96' ' ' LEU . 48.3 t -79.71 -24.41 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.36 105.57 0.3 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 178.86 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.772 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 37.1 p90 -146.23 143.62 19.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 3.6 Cg_exo -78.16 124.54 6.67 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.629 2.219 . . . . 0.0 111.263 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.23 174.76 14.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.082 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -101.76 119.5 38.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.727 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 89' ' ' VAL . 85.0 mt -94.18 121.83 36.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.0 p -95.69 132.63 39.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.149 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 94.7 m-85 -121.52 138.31 54.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.66 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -143.79 149.93 37.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 28.15 56.49 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.71 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.12 13.96 79.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.026 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -135.3 178.51 6.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.146 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.55 129.36 34.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -104.74 -51.83 2.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -176.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.79 -170.82 39.76 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.414 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.9 134.64 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.005 0.431 . . . . 0.0 111.499 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.09 110.38 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.018 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -121.55 129.9 53.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.915 0.388 . . . . 0.0 111.795 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.73 154.08 12.18 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.155 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.7 134.94 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -139.02 144.66 42.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.98 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.7 159.7 23.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.657 2.238 . . . . 0.0 111.546 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.482 ' CE2' HD11 ' A' ' 117' ' ' ILE . 5.4 t-105 -55.86 -48.79 74.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.0 78.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -40.77 87.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.665 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.5 tp -62.19 -48.0 81.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.4 mt -60.61 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.015 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -55.11 -54.37 44.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.868 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.88 -47.39 85.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.493 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.2 tpt -59.63 -43.15 93.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.634 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 124' ' ' VAL . 40.2 ttt180 -66.92 -33.75 76.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -30.97 71.14 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.23 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -84.7 -52.03 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.524 0.202 . . . . 0.0 111.527 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 121' ' ' ARG . 8.1 p -66.32 -31.47 53.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.763 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.546 ' HB3' ' NH1' ' A' ' 104' ' ' ARG . 33.7 tt0 . . . . . 0 N--CA 1.449 -0.521 0 O-C-N 124.031 0.832 . . . . 0.0 112.679 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.681 ' HG3' HD21 ' A' ' 77' ' ' LEU . 69.4 mtm . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -63.39 116.43 5.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.313 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 67.65 72.81 0.32 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.902 0.751 . . . . 0.0 110.665 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.22 122.96 24.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.536 0.684 . . . . 0.0 110.382 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.506 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 40.0 m -159.28 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.673 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 15.3 Cg_endo -58.25 -63.58 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.068 1.845 . . . . 0.0 112.311 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.53 -35.81 82.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 110.186 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.03 -51.49 67.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.613 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -64.64 -46.91 80.5 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.552 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 52' ' ' SER . 70.3 mt -55.38 -46.14 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 12.8 t90 -62.25 -50.64 70.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -58.51 -32.94 69.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.892 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 4.6 mmp_? -61.29 -57.34 12.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 111.166 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.8 ptt? -70.79 -29.34 65.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.8 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -57.42 -46.4 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.085 0.469 . . . . 0.0 109.897 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.72 -10.12 57.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.863 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 14' ' ' MET . 50.7 mtt180 -84.89 -5.19 59.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 0.0 110.995 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.19 21.65 8.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.144 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.423 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 52.8 m0 -97.14 115.26 27.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -71.32 140.82 85.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.154 -176.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 15' ' ' LEU . 6.3 Cg_exo -76.72 141.76 22.18 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.052 2.501 . . . . 0.0 111.48 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 14.2 p -123.28 142.11 41.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.897 0.379 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -102.45 165.1 11.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 83' ' ' ILE . 3.4 tm-20 -57.21 -55.76 30.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -70.68 -13.39 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.031 0.443 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 21.2 mmt180 -96.19 -8.13 33.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.674 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD21 HG21 ' A' ' 39' ' ' VAL . 3.0 tm? -66.77 -41.34 87.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.32 -37.83 80.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.854 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -60.92 -55.97 26.62 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.039 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -43.32 68.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.181 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.29 -44.74 84.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.914 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -83.3 -26.99 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.705 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -81.66 -29.75 33.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.53 141.58 28.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.0 111.452 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 8.2 Cg_exo -72.47 -38.38 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.577 2.184 . . . . 0.0 111.045 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -160.15 169.18 23.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.637 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.46 -179.63 31.29 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.092 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' HB ' ' A' ' 97' ' ' VAL . 16.9 m -137.07 145.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.577 HG21 HD21 ' A' ' 27' ' ' LEU . 45.2 t -119.0 125.24 74.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.402 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.8 mp -98.8 116.44 31.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 96' ' ' LEU . 9.7 mp -98.24 116.06 29.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -121.74 102.73 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.982 0.42 . . . . 0.0 110.942 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.555 ' HB3' HH21 ' A' ' 91' ' ' ARG . 19.3 m -95.13 -73.92 0.57 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -151.11 143.2 16.0 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.173 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.48 148.46 90.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.882 2.388 . . . . 0.0 112.165 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -76.86 -32.74 57.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 13.5 ttp180 -175.74 -58.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.581 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.404 HG21 ' O ' ' A' ' 51' ' ' VAL . 15.5 m 66.45 141.76 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.193 -177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.76 -50.93 12.33 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.026 1.817 . . . . 0.0 111.403 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -110.18 -97.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.656 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 48' ' ' THR . 31.0 t -139.32 -69.59 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.005 0.431 . . . . 0.0 110.352 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 10' ' ' LEU . 46.8 t -92.4 -15.33 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 54' ' ' ASN . 17.8 t70 72.42 -22.26 0.22 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.206 1.002 . . . . 0.0 112.599 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 9.6 t30 83.05 99.54 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 123.572 0.749 . . . . 0.0 110.604 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.76 17.67 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 123.983 3.122 . . . . 0.0 114.599 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.23 -41.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -64.26 -24.79 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.247 -176.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 116' ' ' LEU . 47.9 mm -67.74 -38.14 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.462 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.05 -49.32 58.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.222 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.66 -28.61 69.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HG ' ' A' ' 116' ' ' LEU . 66.8 tp -60.87 -56.95 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 110.922 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.5 mp -62.23 -29.92 70.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.248 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 63' ' ' ARG . 7.8 mmt180 -75.05 -7.71 54.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -78.04 -6.87 55.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.086 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.81 78.85 9.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.437 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.06 -12.09 21.38 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.592 2.195 . . . . 0.0 113.081 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.44 -25.28 63.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.524 0.678 . . . . 0.0 110.315 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -103.56 120.72 41.43 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.539 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 p -80.66 103.29 10.41 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.418 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.548 ' HB3' HD23 ' A' ' 62' ' ' LEU . 96.8 m95 -83.9 100.39 10.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.094 -173.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.09 107.19 15.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.566 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -87.65 114.07 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.691 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -110.75 124.61 52.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 40' ' ' LEU . 8.5 pt -110.34 139.76 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.015 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.42 154.85 21.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.169 0.509 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' HB3' ' CG ' ' A' ' 79' ' ' GLN . 7.1 t70 -65.94 162.99 18.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.198 174.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.681 HD21 ' HG3' ' A' ' 1' ' ' MET . 56.3 tp -59.22 -53.04 62.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.15 -24.57 62.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.251 0.548 . . . . 0.0 110.228 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.483 ' CG ' ' HB3' ' A' ' 76' ' ' ASP . 89.3 mm-40 -76.08 -37.76 57.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.596 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.6 m -59.23 -42.72 91.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -62.45 -42.78 99.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.577 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.13 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.503 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 24' ' ' GLU . 80.2 mt -67.99 -43.77 85.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.351 . . . . 0.0 110.118 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.87 -46.11 94.04 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.636 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.4 -47.32 72.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.014 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.35 -31.17 71.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.732 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -87.77 -34.16 18.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.005 0.431 . . . . 0.0 110.675 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.31 45.09 1.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.145 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 90' ' ' PHE . 3.5 p -100.83 167.82 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' H ' HG22 ' A' ' 89' ' ' VAL . 18.6 m-85 -79.84 -67.61 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.683 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.555 HH21 ' HB3' ' A' ' 43' ' ' SER . 1.9 tpt180 -179.61 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.658 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 90.9 m-85 -51.06 117.22 8.44 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.882 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 5.4 Cg_exo -79.44 132.46 10.09 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.377 2.718 . . . . 0.0 111.889 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.24 -175.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.726 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 m -92.86 109.96 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.806 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 41' ' ' LEU . 6.2 mp -96.06 125.86 40.89 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.968 HG13 ' HB2' ' A' ' 104' ' ' ARG . 2.5 p -104.01 132.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.183 0.516 . . . . 0.0 111.288 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -127.68 135.28 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.111 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 m -145.4 144.7 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.97 35.59 54.12 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.119 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.66 12.7 62.23 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.052 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -122.36 166.87 14.02 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 111.288 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -93.79 120.22 33.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.592 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.968 ' HB2' HG13 ' A' ' 97' ' ' VAL . 25.6 mmt180 -79.15 -55.16 5.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.483 0.658 . . . . 0.0 109.78 176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.476 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 162.38 -166.75 36.66 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.939 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.47 134.37 65.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.089 0.471 . . . . 0.0 110.479 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.27 100.3 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.99 -7.9 52.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.174 0.511 . . . . 0.0 110.517 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.49 144.56 23.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.724 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.0 mm -136.53 -56.82 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.649 0.262 . . . . 0.0 111.566 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.769 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 36.9 t60 -88.02 -61.35 0.24 Allowed Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -168.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 23.5 Cg_exo -62.62 123.85 13.1 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.439 1.426 . . . . 0.0 111.864 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.433 ' O ' HG13 ' A' ' 117' ' ' ILE . 11.4 t-105 -76.49 -48.39 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.069 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.32 75.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 110.788 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 39.6 tt0 -75.64 -40.31 56.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.244 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 58' ' ' ILE . 50.1 tp -57.57 -44.4 85.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.473 ' HA ' HD11 ' A' ' 61' ' ' LEU . 68.8 mt -58.86 -45.37 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 40.5 t30 -61.68 -42.09 98.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.576 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 92.5 mt -60.32 -48.88 79.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.338 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.3 tpt -65.93 -36.48 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 109.865 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 60.9 ttt180 -56.36 -45.08 80.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.958 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.88 -30.59 70.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.483 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 83.2 mt -77.63 -36.66 51.42 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.883 -0.186 . . . . 0.0 111.374 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 120' ' ' MET . 34.5 m -82.02 -39.76 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.262 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.38 97.29 34.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.934 0.397 . . . . 0.0 110.156 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 128' ' ' GLN . 59.7 Cg_endo -73.7 -174.1 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.894 2.396 . . . . 0.0 113.688 -175.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 126' ' ' PRO . 41.4 tt0 71.29 -41.48 0.51 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.436 1.094 . . . . 0.0 111.867 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 77.3 mt-30 -95.72 80.93 3.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.371 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER 76.42 121.6 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.338 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -149.31 36.27 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.05 117.01 4.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.611 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG2' ' OD2' ' A' ' 44' ' ' ASP . 23.3 mmt . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.639 0.257 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -67.15 89.58 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 47.09 54.42 9.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.143 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.2 t0 38.45 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 51.3 m -162.0 -54.11 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.304 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 34.0 Cg_endo -66.74 -36.57 23.93 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 121.83 1.686 . . . . 0.0 111.829 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 77' ' ' LEU . 85.9 t80 -75.3 -38.12 60.49 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.388 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -50.22 -51.48 43.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.709 0.766 . . . . 0.0 109.377 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.27 -45.95 92.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.747 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -54.69 -52.05 63.62 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 111.459 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.2 t90 -65.78 -37.88 87.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.218 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -60.05 -33.56 72.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 28.4 mmt85 -59.38 -55.28 36.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.324 0.583 . . . . 0.0 110.336 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.6 mtm -67.39 -31.63 71.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.325 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -69.38 -34.94 75.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -22.0 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 17' ' ' ARG . 19.3 mmm180 -82.09 -8.88 59.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.594 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.9 10.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.851 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 20.9 m -93.45 122.84 61.96 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 3.7 Cg_exo -81.66 117.74 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.435 2.757 . . . . 0.0 111.179 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.11 151.39 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -81.2 159.77 24.5 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 79' ' ' GLN . 1.5 mp0 -49.63 -57.01 8.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.543 0.737 . . . . 0.0 112.978 -170.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -63.23 -32.4 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.97 0.414 . . . . 0.0 111.521 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -88.53 -11.81 44.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.405 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.43 -42.26 83.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.52 -38.91 59.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.628 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 32' ' ' THR . 11.2 t70 -57.83 -55.6 32.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.565 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -59.82 -46.55 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.776 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.47 -41.5 94.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.86 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.9 t -73.16 -25.92 60.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.381 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -89.86 -8.63 51.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.784 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 146.33 32.73 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.409 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.71 -39.17 12.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.404 2.069 . . . . 0.0 112.295 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.6 t70 -166.58 177.34 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.13 30.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.441 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 97' ' ' VAL . 15.8 m -136.51 146.24 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.41 125.11 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.214 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.4 mp -94.47 128.34 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 93' ' ' PRO . 56.0 tp -87.41 136.46 32.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.189 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.427 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 66.3 m -102.4 -153.31 0.46 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.09 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 70.6 m 75.28 135.24 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.869 0.731 . . . . 0.0 111.288 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD2' ' HG2' ' A' ' 1' ' ' MET . 4.9 p-10 -107.68 92.27 8.5 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.628 . . . . 0.0 110.19 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 43' ' ' SER . 71.9 Cg_endo -95.59 -24.16 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.18 2.587 . . . . 0.0 114.291 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -98.65 -69.73 0.75 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.719 -170.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -179.45 -28.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.607 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.5 m -83.45 116.77 66.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.945 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.86 8.32 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.426 2.751 . . . . 0.0 113.478 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 88.63 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.381 0.61 . . . . 0.0 109.719 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.511 ' H ' HD21 ' A' ' 10' ' ' LEU . 23.7 t -83.98 -24.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.75 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 m -78.79 -60.38 2.4 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.833 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.38 -69.21 0.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.883 0.739 . . . . 0.0 110.426 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -148.68 85.21 6.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' A' ' 13' ' ' ARG . 89.5 Cg_endo -79.44 44.36 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.079 2.52 . . . . 0.0 113.677 -169.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.37 -40.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.747 0.308 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -28.69 70.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.628 -173.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.46 -43.66 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.33 89.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.964 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.28 -28.18 59.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.009 0.433 . . . . 0.0 110.552 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD11 ' HA ' ' A' ' 117' ' ' ILE . 56.8 tp -63.55 -47.26 82.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.738 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.32 -28.29 69.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 23.1 mmt180 -73.3 -7.71 52.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.172 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -64.07 -35.45 80.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.348 0.594 . . . . 0.0 109.626 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -129.14 81.94 69.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.537 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.75 8.49 3.66 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.886 2.391 . . . . 0.0 113.007 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.64 -25.19 62.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 0.0 110.221 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.47 127.02 53.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.967 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.4 p -71.66 108.75 5.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.928 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -80.71 105.58 12.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.264 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 102.43 5.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.82 106.59 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.282 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.46 126.57 53.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 20.3 pt -112.23 140.78 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.869 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.39 145.46 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.602 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.619 ' HB3' ' HG2' ' A' ' 79' ' ' GLN . 21.0 t70 -63.41 160.06 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.657 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.654 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 65.8 tp -55.49 -52.95 61.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.205 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.16 -30.87 58.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.905 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 7.3 pt20 -77.75 -22.92 49.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.068 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 74.0 m -63.03 -29.24 70.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 110.063 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 20.5 mm-40 -56.13 -44.78 79.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.257 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.02 -37.13 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.396 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.06 -47.71 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.82 97.68 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.505 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 26.3 t70 -58.97 -38.73 79.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -71.19 -31.56 67.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.668 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -91.2 -29.56 17.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.027 0.442 . . . . 0.0 110.899 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.87 29.51 4.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.048 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.39 122.78 64.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -136.38 18.82 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 110.715 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -99.55 -165.41 1.22 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.697 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -53.15 143.19 34.32 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 123.622 0.576 . . . . 0.0 112.319 -175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' HD23 ' A' ' 41' ' ' LEU . 37.9 Cg_endo -65.87 140.4 60.82 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.358 2.705 . . . . 0.0 112.56 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.7 -178.23 7.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.699 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 28.1 m -99.0 120.09 38.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.465 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.55 118.42 31.66 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.0 p -100.91 124.47 54.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.244 0.545 . . . . 0.0 110.991 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.5 119.34 29.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.421 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 63.6 p -95.61 123.61 39.24 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.15 16.12 47.1 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.974 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.57 63.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.941 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -102.28 141.1 35.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.277 0.561 . . . . 0.0 111.293 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -70.74 118.88 14.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.187 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -98.01 -48.17 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.535 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.04 -166.24 36.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.064 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.62 134.59 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 110.597 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 94.7 mt -97.46 119.97 36.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -138.08 129.33 27.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.729 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.54 127.63 1.93 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.67 -44.57 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.144 0.472 . . . . 0.0 112.233 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -97.42 -51.04 0.22 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.78 120.85 8.2 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 120.692 1.283 . . . . 0.0 111.864 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.567 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 t-105 -96.68 -37.74 10.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.813 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.203 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 30.8 mt-10 -81.5 -27.58 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.613 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 6.0 mt -56.72 -44.77 81.95 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.458 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 61' ' ' LEU . 63.1 mt -65.3 -42.32 93.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -57.11 -57.45 12.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.628 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.3 mt -56.38 -41.27 75.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.576 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 124' ' ' VAL . 14.9 tpt -60.49 -50.42 73.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.445 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -66.89 -35.68 80.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.227 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.17 -29.52 73.14 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.604 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.39 -45.76 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 120' ' ' MET . 21.4 m -78.51 -28.09 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -112.42 103.63 55.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.557 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.61 99.72 0.75 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.873 2.382 . . . . 0.0 111.276 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -101.84 79.47 1.91 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 122.788 1.28 . . . . 0.0 109.82 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.72 69.43 4.74 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.193 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.38 173.3 6.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.943 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 mtp85 -78.29 98.4 5.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.249 0.547 . . . . 0.0 111.13 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -114.59 2.93 14.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.866 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.667 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t 62.69 -90.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.951 0.5 . . . . 0.0 111.978 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -87.65 135.27 33.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.684 0.278 . . . . 0.0 110.757 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -81.23 121.08 25.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.18 0.514 . . . . 0.0 111.132 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.663 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 20.9 m -157.15 -61.74 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.234 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 3.9 Cg_exo -76.72 -67.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.126 1.884 . . . . 0.0 112.5 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -59.73 -35.06 73.78 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 110.648 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.41 -49.9 75.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.588 . . . . 0.0 110.725 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . . . -65.46 -34.23 77.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.533 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.556 ' HG ' HG12 ' A' ' 51' ' ' VAL . 3.1 mm? -65.89 -43.67 87.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.184 0.516 . . . . 0.0 110.074 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -38.1 85.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.807 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG2' ' HA ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -62.5 -33.56 75.13 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 110.331 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 48.4 mmm-85 -63.21 -53.62 50.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 109.907 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtp -58.73 -40.11 82.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.697 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.0 -35.38 72.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.347 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.82 68.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.625 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -82.76 2.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.27 -0.68 64.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.97 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -67.93 135.04 51.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 109.752 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.4 m -110.47 130.74 22.57 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.314 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 2.7 Cg_exo -76.8 153.72 33.67 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.267 2.645 . . . . 0.0 112.132 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 27' ' ' LEU . 13.0 p -148.0 152.48 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.214 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -81.74 158.53 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.253 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -43.61 -61.72 1.31 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.004 0.922 . . . . 0.0 112.854 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.1 m -67.53 -29.25 68.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.69 -171.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 26' ' ' ARG . 5.0 ttp-105 -85.86 -17.34 35.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.859 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.464 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -65.18 -39.65 93.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.665 ' HB2' HH12 ' A' ' 86' ' ' ARG . 18.7 t70 -62.74 -44.27 96.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.886 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.43 -52.84 63.92 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.212 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -50.67 -49.85 56.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.637 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.0 tp -61.44 -34.85 76.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -89.4 -26.3 21.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 0.0 111.851 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -92.59 -35.25 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB1' ' NE2' ' A' ' 71' ' ' GLN . . . -96.28 133.02 25.54 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.315 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.02 140.57 90.64 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.591 2.194 . . . . 0.0 110.985 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 11.9 t70 68.82 -158.4 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 131.66 97.98 0.73 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.261 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.08 141.75 23.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 122.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -99.52 130.56 45.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.172 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -82.11 175.29 10.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.5 p -63.49 117.91 7.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 110.987 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 m -69.75 94.55 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.178 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 12.5 t70 -82.11 129.27 64.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.233 -175.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.784 ' HA ' HG21 ' A' ' 51' ' ' VAL . 19.9 Cg_exo -66.56 -23.73 49.54 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.281 2.654 . . . . 0.0 113.224 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -101.29 -51.15 3.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.014 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.447 HH11 ' HA ' ' A' ' 91' ' ' ARG . 82.0 mtm180 -65.86 -27.05 67.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.955 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 51' ' ' VAL . 3.8 m -94.69 127.02 45.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 22.5 Cg_exo -66.66 -18.39 53.61 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.294 2.662 . . . . 0.0 113.115 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -154.12 102.33 2.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.784 HG21 ' HA ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -104.87 -59.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.066 -172.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -83.35 -2.34 55.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -164.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -54.4 -77.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.468 0.175 . . . . 0.0 111.144 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.0 p30 -171.39 139.19 1.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.67 0.271 . . . . 0.0 110.633 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 86.0 Cg_endo -103.3 42.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.586 2.857 . . . . 0.0 112.193 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.4 t -84.78 -23.13 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.842 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.475 ' HG3' ' N ' ' A' ' 58' ' ' ILE . 19.7 ptt? -48.35 -47.81 36.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.883 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.475 ' N ' ' HG3' ' A' ' 57' ' ' MET . 47.8 mm -60.12 -35.03 59.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 110.964 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -66.98 -46.14 76.17 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.753 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -79.22 -36.81 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 110.916 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 120' ' ' MET . 21.9 tp -63.12 -57.82 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.092 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.92 -29.79 69.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.516 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.513 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 8.2 mmt180 -78.6 -6.43 55.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.0 pt-20 -69.25 -12.94 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.58 174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 69.4 m-85 -110.86 82.85 3.23 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 64' ' ' GLU . 3.1 Cg_exo -81.46 -9.9 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.117 2.545 . . . . 0.0 112.825 -174.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.06 -25.42 47.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.482 . . . . 0.0 111.736 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -119.97 137.1 54.26 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 p -86.81 114.18 23.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.752 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.522 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 70.9 m95 -81.87 133.48 35.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.825 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.568 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 37.2 mt-30 -105.28 108.51 20.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.396 0.617 . . . . 0.0 110.1 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.39 116.6 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.704 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.92 140.85 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.022 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 32.7 pt -125.47 158.1 34.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.541 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -135.09 156.03 49.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.69 -167.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.217 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 77' ' ' LEU . 6.1 mp -59.74 -53.68 55.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.509 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.67 -44.78 76.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.137 0.494 . . . . 0.0 110.777 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 2.5 mp0 -61.97 -50.54 71.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.615 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 p -63.33 -43.45 97.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -65.62 -36.48 83.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.053 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.99 -44.09 70.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.01 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 93.0 mt -65.34 -41.93 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.123 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.2 98.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.17 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.75 -40.87 89.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.083 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.665 HH12 ' HB2' ' A' ' 28' ' ' ASP . 48.8 mtp180 -52.94 -40.85 63.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.485 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -90.85 -65.6 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.07 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.72 -15.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.262 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.23 95.0 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.789 0.328 . . . . 0.0 110.175 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -133.49 160.76 36.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.447 ' HA ' HH11 ' A' ' 47' ' ' ARG . 56.1 ttt-85 67.09 6.78 4.96 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.565 0.54 . . . . 0.0 110.711 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.407 ' HE2' HG11 ' A' ' 106' ' ' VAL . 80.7 t80 -128.64 101.68 20.64 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.242 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.79 126.58 10.19 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.737 2.291 . . . . 0.0 112.516 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.91 -175.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.891 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 36.9 m -101.82 120.03 39.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.276 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.99 118.55 32.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 104' ' ' ARG . 3.8 p -97.81 121.6 48.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.354 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.85 162.21 19.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.47 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.88 129.69 1.81 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.006 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.78 29.53 73.82 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.842 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.0 -6.46 41.68 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.517 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -98.38 156.9 16.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.297 0.57 . . . . 0.0 111.762 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -93.85 130.45 39.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.5 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.834 ' HB2' HG13 ' A' ' 97' ' ' VAL . 37.2 mmt180 -96.45 -59.89 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.643 0.258 . . . . 0.0 110.726 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.69 -153.7 16.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.132 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.407 HG11 ' HE2' ' A' ' 92' ' ' PHE . 53.6 t -121.23 133.7 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.6 mt -109.34 123.71 49.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.229 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -156.35 128.95 7.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.753 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.33 127.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.827 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.8 mm -114.26 -26.47 2.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 0.0 110.637 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.1 m80 -98.06 -58.92 0.15 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 6.2 Cg_exo -78.82 119.83 4.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.086 1.191 . . . . 0.0 111.807 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.518 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.1 t-105 -96.67 -48.42 5.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.239 -173.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.2 73.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.479 . . . . 0.0 110.616 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.79 -40.73 54.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.462 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 37.1 tp -58.73 -44.26 90.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.259 . . . . 0.0 110.776 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.0 mt -61.8 -48.93 86.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.614 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -51.59 -56.72 11.91 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.212 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.0 mt -62.03 -40.93 97.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.441 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.759 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -62.19 -48.68 78.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.846 0.355 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.62 -37.83 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.68 -30.07 76.56 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.432 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 98.3 mt -83.28 -49.03 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 34.3 m -73.82 -30.56 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.54 91.78 2.39 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 84.4 Cg_endo -78.77 115.96 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.587 2.191 . . . . 0.0 114.566 -165.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -97.97 -21.14 17.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 57.07 91.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.309 -1.768 . . . . 0.0 112.406 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 130' ' ' ARG . 11.2 mm-40 -97.03 113.7 25.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.491 171.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 39.1 ttm180 76.8 -51.13 0.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.101 0.875 . . . . 0.0 110.781 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.57 94.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.017 0.823 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -178.05 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.446 0.165 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m 68.78 -72.32 0.1 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 112.534 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -100.41 143.19 30.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -101.47 129.52 47.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.446 0.641 . . . . 0.0 110.178 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 27.4 m -159.29 -57.18 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 36.8 Cg_endo -68.08 -40.55 8.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.283 1.322 . . . . 0.0 110.729 169.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -65.52 -39.21 91.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.428 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -51.99 67.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 109.578 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.7 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.908 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.839 HD21 ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.72 -54.36 42.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -34.35 77.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -60.98 -38.17 85.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 0.0 110.829 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -61.74 -53.8 51.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.516 0.674 . . . . 0.0 109.977 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 55.7 mtp -60.8 -34.99 75.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.37 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.34 -32.09 62.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.14 -23.28 65.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.216 0.532 . . . . 0.0 110.505 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -79.52 -10.71 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.45 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.81 26.65 44.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -89.68 140.93 29.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.441 . . . . 0.0 110.147 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -92.63 123.36 62.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.054 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.69 127.23 13.59 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.774 2.316 . . . . 0.0 111.319 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.12 136.74 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.514 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -67.8 161.71 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.499 0.5 . . . . 0.0 112.012 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.36 -60.28 2.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 112.047 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 m -78.43 -10.17 59.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -92.37 -22.2 19.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -44.09 91.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.761 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.99 -39.38 90.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -64.2 -56.32 15.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.102 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -67.68 -33.19 74.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.748 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.18 -42.09 99.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.572 0.225 . . . . 0.0 111.182 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -73.05 -25.85 61.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.756 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.78 -19.19 55.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.35 157.37 58.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.012 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.12 -64.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.438 2.092 . . . . 0.0 111.292 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -142.48 168.11 20.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.07 -178.18 48.7 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.569 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 97' ' ' VAL . 30.3 m -138.72 150.01 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.263 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.97 128.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.65 130.36 44.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.043 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.65 -67.42 0.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.563 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.679 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 49.1 m 58.27 34.16 23.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.176 0.512 . . . . 0.0 110.879 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.409 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 0.6 OUTLIER -80.97 -86.43 0.09 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.07 104.6 5.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 111.019 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.56 148.64 7.45 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.043 2.495 . . . . 0.0 113.431 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -115.86 -64.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -93.11 -5.75 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.404 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 9.4 m -78.03 114.25 40.33 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.711 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 14.7 Cg_exo -69.17 -34.83 15.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.0 2.466 . . . . 0.0 112.818 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.966 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -157.8 103.15 1.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.839 ' HB ' HD21 ' A' ' 10' ' ' LEU . 10.8 t -74.94 -31.76 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.204 0.526 . . . . 0.0 110.886 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -2.14 41.12 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.966 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 16.7 t0 -71.78 76.64 0.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.543 -174.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.9 t30 63.08 81.67 0.22 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.523 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.94 12.12 1.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.103 2.536 . . . . 0.0 111.944 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.11 -34.16 49.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.711 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -56.7 -30.98 64.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.361 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 62' ' ' LEU . 49.8 mm -61.12 -42.9 95.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 110.681 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.68 -33.93 60.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.349 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.44 -32.01 65.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.643 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 58.6 tp -64.37 -49.15 72.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.312 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.5 mp -58.68 -26.43 63.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -56.17 -19.03 11.82 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.8 pt-20 -87.01 22.08 2.13 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.631 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 55.3 p90 -67.44 122.29 82.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 38.4 Cg_endo -97.51 -53.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.974 2.45 . . . . 0.0 114.095 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.7 -26.16 17.14 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.562 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.5 p90 -143.54 142.57 31.17 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.538 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 t -86.08 151.27 23.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 65' ' ' PHE . 91.0 m95 -98.4 119.73 37.6 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.011 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.69 98.52 9.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.52 108.34 18.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.504 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.8 138.3 48.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.8 pt -118.65 145.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.94 167.58 12.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.47 172.66 10.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.947 173.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.86 -42.83 66.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.08 -44.72 83.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.501 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 83' ' ' ILE . 53.7 tt0 -70.64 -41.99 71.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.776 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 43' ' ' SER . 4.2 p -63.04 -42.26 99.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.296 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.15 -36.66 83.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.008 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.03 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.401 HD11 HE21 ' A' ' 79' ' ' GLN . 55.2 mt -65.46 -46.2 90.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.48 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.53 ' HA2' ' HB ' ' A' ' 89' ' ' VAL . . . -57.31 -49.25 74.14 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.728 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.26 -42.7 70.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 111.027 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -73.33 -31.56 64.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.737 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -101.61 -25.76 13.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.551 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.5 2.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.342 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 84' ' ' GLY . 38.8 t -118.11 150.07 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.94 163.21 26.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.928 0.394 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -72.96 -9.37 58.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.914 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 53.5 m-85 -70.34 127.09 92.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.553 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 17.1 Cg_exo -65.57 124.38 12.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.855 2.37 . . . . 0.0 112.338 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.27 3.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.3 m -109.84 127.12 54.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.43 116.99 29.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.528 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -98.76 126.28 51.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.496 0.665 . . . . 0.0 111.499 -175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -115.15 138.47 50.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -148.4 144.14 27.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.27 19.21 66.08 Favored Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.897 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.26 89.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.496 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -120.51 157.25 29.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -79.12 123.22 27.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.349 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -88.99 -60.28 2.0 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.36 -161.36 24.74 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.691 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.38 134.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.7 mt -100.43 105.71 17.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.22 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -117.97 97.52 5.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.489 0.661 . . . . 0.0 110.947 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.6 138.05 5.86 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.54 -33.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.998 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.801 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 m-70 -135.48 -54.58 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.801 ' HD2' ' H ' ' A' ' 111' ' ' HIS . 6.8 Cg_endo -50.18 120.25 5.97 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.677 1.585 . . . . 0.0 112.532 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.643 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 4.0 t-105 -99.11 -46.64 5.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.535 -170.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 118' ' ' ASN . . . -60.17 -34.56 73.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 110.005 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 17.3 mm-40 -68.87 -47.95 64.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.528 176.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.28 -49.52 76.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.82 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 113' ' ' TRP . 52.1 mt -60.29 -41.39 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 114' ' ' ALA . 31.7 t-20 -53.52 -57.59 10.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.569 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 81.1 mt -68.66 -41.68 78.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.293 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -50.48 73.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.721 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.531 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.5 ttt85 -69.97 -32.63 70.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.267 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.46 75.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.216 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.2 mt -81.62 -50.32 9.47 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.84 -0.212 . . . . 0.0 111.135 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 121' ' ' ARG . 31.1 m -67.0 -38.95 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.48 97.91 7.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 83.8 Cg_endo -89.69 150.73 5.12 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.926 2.417 . . . . 0.0 113.769 -170.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -77.91 -8.29 57.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.958 0.885 . . . . 0.0 109.794 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -146.69 108.5 4.35 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.546 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.71 81.75 0.28 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 111.441 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -81.88 89.47 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.46 141.74 14.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.638 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.974 178.499 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -115.15 97.74 6.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -117.82 75.94 1.03 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 t70 64.46 174.93 0.19 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.884 -174.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m -160.7 -57.25 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 5.0 Cg_exo -74.42 -52.91 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.138 1.892 . . . . 0.0 111.923 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -65.95 -41.07 91.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -53.25 -53.68 47.29 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.14 -49.3 77.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.229 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 52' ' ' SER . 3.0 mm? -59.2 -46.5 88.27 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.294 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.08 -47.86 78.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -61.48 -40.23 93.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.323 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 47.2 mmm-85 -59.26 -54.47 46.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.502 ' HB2' ' CE3' ' A' ' 19' ' ' TRP . 24.6 ptt? -70.99 -29.26 65.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.312 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 11' ' ' TRP . 34.4 mt -57.23 -39.42 75.48 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.34 65.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.804 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -74.29 -15.07 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.0 111.215 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.24 13.87 20.0 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.563 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 49.2 m0 -82.7 122.01 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.039 0.447 . . . . 0.0 109.832 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.5 m -91.94 132.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.613 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 23.0 Cg_exo -65.02 120.36 7.58 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 111.658 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.5 139.79 24.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.217 0.532 . . . . 0.0 110.916 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 m -92.66 150.22 20.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.096 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.35 -50.79 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.5 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 m -85.23 13.55 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.067 0.46 . . . . 0.0 111.293 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -121.23 -10.92 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.683 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.8 tm? -55.11 -43.8 74.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.472 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 32' ' ' THR . 30.5 t70 -64.41 -43.09 95.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 32' ' ' THR . 17.5 t70 -61.26 -55.57 30.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -62.5 -40.51 96.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.044 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -70.94 -29.43 65.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -75.01 -27.79 60.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.547 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 35.1 mt-30 -90.7 -44.05 9.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.147 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.35 94.57 11.7 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.923 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 8.2 Cg_exo -72.59 140.84 33.47 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.199 2.599 . . . . 0.0 113.556 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t70 73.91 167.07 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.407 1.067 . . . . 0.0 111.474 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.98 -165.35 24.32 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.023 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.88 152.61 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 122.524 0.33 . . . . 0.0 110.793 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.53 131.5 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.49 138.15 38.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.93 175.97 5.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 111.29 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.4 t -85.5 154.22 21.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.232 0.539 . . . . 0.0 110.845 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 13.5 m -86.2 -47.33 9.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.766 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.2 t70 53.75 80.38 0.3 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 123.567 0.542 . . . . 0.0 110.286 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.6 132.53 23.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.313 2.008 . . . . 0.0 111.791 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.77 -55.23 2.39 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -129.69 -3.91 4.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.091 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -79.74 115.13 51.57 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.865 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 2.8 Cg_endo -81.83 -68.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.086 2.524 . . . . 0.0 112.823 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -95.14 79.75 3.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.556 0.693 . . . . 0.0 110.47 -175.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.21 -24.6 28.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.564 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.09 -64.46 0.91 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.1 t70 59.43 -85.85 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.662 0.785 . . . . 0.0 112.741 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.03 99.31 5.08 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 111.304 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -95.51 -167.72 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.174 2.583 . . . . 0.0 112.454 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.8 t 75.09 -37.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -53.43 -24.31 12.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.0 mp -58.96 -38.95 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.718 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.7 -38.18 94.26 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.406 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -72.79 -28.48 62.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.742 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.2 tp -61.35 -43.68 98.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.266 0.555 . . . . 0.0 110.347 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.8 mp -64.67 -27.44 68.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.072 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.49 -17.24 63.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.912 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -70.1 -36.37 74.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.689 0.28 . . . . 0.0 110.611 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -141.49 77.78 19.16 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.095 0.474 . . . . 0.0 110.537 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.0 16.83 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.142 2.562 . . . . 0.0 112.598 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.97 -25.67 67.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.524 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -116.71 166.85 11.65 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 p -85.29 105.49 16.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.921 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -91.44 103.57 16.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.752 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.18 122.2 31.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.199 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.8 t -97.96 107.39 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 124.71 50.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.504 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 30.6 pt -110.42 144.41 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -115.41 153.17 31.54 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.769 -0.372 . . . . 0.0 112.001 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.3 m-20 -61.88 168.86 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.518 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.09 -49.1 74.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.614 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -66.56 -34.47 77.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.23 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 66.5 mm-40 -75.53 -48.17 23.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.277 -172.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 78.4 p -65.49 -41.4 93.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -58.01 -44.74 87.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.279 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.41 -41.53 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 79' ' ' GLN . 73.9 mt -60.9 -45.33 98.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.955 0.407 . . . . 0.0 110.196 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.28 75.72 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.231 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -38.06 89.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' HH11 ' A' ' 86' ' ' ARG . 21.3 ttt180 -59.85 -27.93 67.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.428 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.89 -45.14 4.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.02 44.77 0.52 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.672 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.77 HG11 HD21 ' A' ' 96' ' ' LEU . 17.2 t -103.86 156.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 172.6 13.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 0.0 110.729 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 60.4 mtm180 -98.4 -161.01 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.667 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 62.2 m-85 73.93 165.93 0.13 Allowed Pre-proline 0 N--CA 1.467 0.387 0 O-C-N 123.953 0.783 . . . . 0.0 110.83 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 92' ' ' PHE . 21.4 Cg_endo -59.56 123.36 13.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.029 1.819 . . . . 0.0 111.679 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 106' ' ' VAL . . . -161.74 143.04 11.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.783 -174.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 23.8 m -110.77 113.3 25.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.0 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 89' ' ' VAL . 5.9 mp -93.43 137.31 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.37 130.11 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.36 119.36 36.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.16 125.72 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.157 0.503 . . . . 0.0 112.051 -172.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.22 -63.32 2.91 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.968 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -136.17 64.47 0.58 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 64.89 -153.42 0.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.534 0.334 . . . . 0.0 111.793 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -50.24 108.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.833 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.71 -38.55 15.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.513 0.673 . . . . 0.0 109.832 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 170.5 -168.43 41.48 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.123 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.541 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 14.0 p -136.95 140.68 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.027 0.442 . . . . 0.0 111.037 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 93.7 mt -96.56 107.19 19.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.13 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -148.6 171.8 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.294 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.44 149.4 18.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.101 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.0 102.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 0.0 110.267 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 97.7 m-70 -134.33 139.72 33.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 176.04 7.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 0.0 112.219 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.742 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 10.4 t-105 -58.39 -45.41 88.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.375 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.95 87.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.404 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 111' ' ' HIS . 4.4 tp10 -72.76 -33.12 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.441 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -63.0 -45.47 92.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.037 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.3 mt -62.9 -43.75 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.099 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -54.5 -58.26 8.18 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 91.7 mt -57.4 -47.44 81.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.463 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.1 tpt -59.46 -41.56 90.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.599 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -63.35 -40.6 97.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.42 77.8 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.839 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 74.0 mt -81.08 -50.95 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -70.86 -36.35 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.58 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 47.0 89.49 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 121.751 0.786 . . . . 0.0 112.428 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.81 169.62 11.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.787 2.325 . . . . 0.0 112.759 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.47 ' HB3' ' OE2' ' A' ' 129' ' ' GLU . 42.3 tt0 -96.39 -4.57 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.705 0.764 . . . . 0.0 109.122 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 67.35 72.88 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.795 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 127' ' ' GLN . 3.1 mp0 -87.02 88.69 7.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.12 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.408 ' HB3' ' H ' ' A' ' 131' ' ' ALA . 79.8 mtm180 -102.64 -164.12 1.06 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' A' ' 130' ' ' ARG . . . -81.04 43.99 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.435 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.85 178.394 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.623 ' HG2' ' HG3' ' A' ' 6' ' ' PRO . 24.9 ttt . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -144.3 -53.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.339 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -112.15 159.06 18.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.555 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 3.7 p30 50.58 22.56 1.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.421 1.088 . . . . 0.0 113.65 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.724 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -137.83 -65.31 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.648 175.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.724 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 6.2 Cg_exo -78.24 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.767 1.645 . . . . 0.0 111.443 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.95 -37.91 84.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.593 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 24.7 t70 -64.31 -54.42 33.45 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.35 90.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -58.17 -55.05 40.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.044 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -39.46 93.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.236 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.6 -39.86 77.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.571 0.224 . . . . 0.0 111.165 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -65.05 -53.41 46.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.186 0.517 . . . . 0.0 110.533 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.9 -37.8 74.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.116 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -34.91 76.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.381 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.79 66.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.023 0.439 . . . . 0.0 111.123 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 28.7 mmt180 -83.66 2.75 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.496 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.65 12.16 80.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.59 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HH2' ' HB2' ' A' ' 55' ' ' PRO . 51.5 m0 -77.51 124.01 27.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.501 ' HB ' ' CH2' ' A' ' 30' ' ' TRP . 21.5 m -85.46 123.93 72.2 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.971 -171.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.93 118.75 5.86 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.805 2.337 . . . . 0.0 111.463 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 27' ' ' LEU . 14.4 p -126.11 147.08 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m -95.23 165.09 12.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.181 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.26 -48.65 54.71 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.751 0.42 . . . . 0.0 112.114 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 m -59.74 -35.48 74.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.002 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 9.1 tpt180 -94.69 -18.29 21.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.79 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 3.4 tm? -64.05 -40.0 95.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.49 -42.66 96.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.168 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 28.5 t70 -63.14 -57.16 11.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.946 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CH2' ' HB ' ' A' ' 20' ' ' THR . 5.9 t90 -59.13 -39.65 83.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.196 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -66.95 -28.1 68.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.478 . . . . 0.0 110.419 177.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.5 m -75.19 -33.06 61.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 19.3 mm-40 -80.64 -48.34 12.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.406 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -73.0 135.3 80.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.401 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 2.1 Cg_endo -81.66 -21.93 5.78 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.911 2.408 . . . . 0.0 111.52 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 3.5 p-10 -95.31 -89.29 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.129 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 87.69 106.92 0.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.599 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 72' ' ' VAL . 5.5 m -131.89 134.08 60.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 171.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 73' ' ' ALA . 49.2 t -130.5 135.19 61.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.951 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mp -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.2 tt -104.46 128.29 52.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.025 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 m -99.06 132.05 44.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.865 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -157.97 -168.44 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 4.5 m-20 -59.91 123.3 71.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.261 0.35 . . . . 0.0 110.309 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.54 132.83 42.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.203 1.935 . . . . 0.0 111.963 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -126.24 -57.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.642 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.1 tpm_? -105.86 -28.64 10.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 10.5 p -65.62 116.64 33.52 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.615 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 38.8 Cg_exo -61.77 -43.03 28.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 0.0 111.661 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -108.64 -115.18 0.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.084 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.95 -55.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 10' ' ' LEU . 29.0 t -111.59 -48.17 3.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.208 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.9 t70 49.55 71.4 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.527 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 t30 66.99 85.59 0.15 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.526 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HB2' ' HH2' ' A' ' 19' ' ' TRP . 96.7 Cg_endo -79.85 -5.7 13.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.526 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 21.6 t -61.9 -35.72 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.6 ttp -58.95 -37.37 76.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 62' ' ' LEU . 50.1 mm -69.91 -36.11 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.078 0.466 . . . . 0.0 110.346 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.83 -45.31 65.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.011 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 8.7 mm-40 -68.6 -28.22 66.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.84 0.353 . . . . 0.0 110.468 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 116' ' ' LEU . 24.7 tp -61.68 -54.93 36.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.483 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 58' ' ' ILE . 7.3 mp -52.27 -26.6 12.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.439 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.574 HH11 ' HG3' ' A' ' 63' ' ' ARG . 11.5 mmt85 -61.62 -9.4 6.02 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.99 -12.18 59.42 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 122.015 -0.428 . . . . 0.0 111.181 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -116.79 92.88 39.69 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.826 0.346 . . . . 0.0 110.622 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.77 2.9 6.43 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.75 2.3 . . . . 0.0 112.249 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.95 -26.69 62.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.716 0.77 . . . . 0.0 109.766 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -129.17 133.53 47.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.654 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 p -85.03 102.68 13.4 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.455 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.66 118.98 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.947 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -103.08 107.08 17.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.337 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 38' ' ' VAL . 26.8 t -88.21 120.37 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.22 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -107.15 133.04 52.34 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.263 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.7 pt -125.98 143.84 38.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -120.53 156.72 30.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.994 -174.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 169.22 4.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.53 -46.48 88.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.109 0.48 . . . . 0.0 110.35 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -61.82 -44.36 97.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.847 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 83.8 mm-40 -68.58 -39.22 81.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.167 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -58.25 -39.81 80.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.37 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -34.95 79.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.181 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.21 47.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.259 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 79' ' ' GLN . 74.6 mt -64.12 -46.94 92.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.53 96.74 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.946 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.38 -42.15 95.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 111.281 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -61.14 -32.31 72.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -100.55 -43.65 6.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.133 0.492 . . . . 0.0 111.001 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.2 42.6 0.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.59 142.96 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.537 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 21.3 m-85 -73.57 159.81 32.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -83.79 84.89 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.349 0.595 . . . . 0.0 112.13 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 44' ' ' ASP . 30.5 p90 -169.25 152.66 5.1 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.652 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.0 Cg_exo -71.72 126.39 11.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.416 2.077 . . . . 0.0 111.337 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.88 168.77 25.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 26.2 m -100.85 120.23 39.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.12 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.402 HD22 ' OH ' ' A' ' 103' ' ' TYR . 35.6 mt -94.88 120.34 34.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.77 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.8 p -104.89 122.53 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.56 0.695 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.74 -177.97 3.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.505 ' OG1' ' HD3' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -151.23 -171.5 3.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.18 91.79 0.04 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.034 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.44 24.44 70.85 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.354 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -132.01 159.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.422 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' OH ' HD22 ' A' ' 96' ' ' LEU . 51.1 t80 -117.75 111.99 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -168.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.56 -171.2 34.72 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.046 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.55 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.5 mt -95.29 103.53 15.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -108.5 130.58 55.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.46 -165.56 24.95 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.783 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.7 mm -112.97 -69.52 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 79.1 m-70 70.95 143.32 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.74 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.45 159.65 19.13 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.647 2.231 . . . . 0.0 111.858 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 15.5 t-105 -54.05 -43.19 69.99 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.08 78.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 111.643 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 4.4 mp0 -72.49 -26.44 61.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.748 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' CD1' HD22 ' A' ' 61' ' ' LEU . 2.0 tm? -62.72 -47.43 83.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.5 mt -60.84 -45.91 97.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.264 0.554 . . . . 0.0 109.719 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -52.65 -58.28 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 89.6 mt -58.14 -42.22 85.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.595 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.442 ' HG2' HD21 ' A' ' 61' ' ' LEU . 16.9 tpt -57.73 -50.6 72.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 110.642 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.635 ' HA ' HG12 ' A' ' 124' ' ' VAL . 65.0 mtt180 -68.84 -32.05 71.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.31 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.73 -29.89 71.21 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.482 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 96.6 mt -95.83 -45.92 6.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 121' ' ' ARG . 7.2 p -71.49 -26.04 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -172.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.65 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.5 OUTLIER -68.97 -54.36 12.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.439 -178.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 125' ' ' GLU . 7.9 Cg_exo -73.51 153.24 49.59 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.205 1.937 . . . . 0.0 111.433 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.95 -1.29 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 57.13 48.18 15.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.951 0.881 . . . . 0.0 109.853 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -81.36 95.38 7.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.892 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 130' ' ' ARG . 14.0 ttp180 -167.1 -39.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.048 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.04 162.49 29.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.417 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--N 1.323 -0.571 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.395 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t -139.29 108.36 6.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.889 0.313 . . . . 0.0 111.668 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.48 145.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.579 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.49 112.05 22.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.501 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 85.3 m -158.99 -62.98 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.792 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 19.3 Cg_endo -60.03 -72.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.961 1.774 . . . . 0.0 113.538 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.64 -33.59 76.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.67 -51.9 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.592 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -65.15 -44.05 89.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 52' ' ' SER . 3.2 mm? -62.33 -39.76 94.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.339 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -65.46 -44.77 86.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -58.13 -39.25 78.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.188 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 68.8 mmt-85 -61.57 -53.26 58.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.0 0.429 . . . . 0.0 110.616 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.415 ' SD ' HD22 ' A' ' 40' ' ' LEU . 75.4 mtm -61.4 -32.75 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.078 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.43 -40.09 89.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.608 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.24 65.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 6.2 mmp_? -71.24 -33.66 70.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.468 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.12 39.01 2.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.86 174.35 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.9 m -101.84 118.14 60.1 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.0 111.77 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 4.1 Cg_exo -80.27 126.92 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.41 2.74 . . . . 0.0 111.503 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 75' ' ' ALA . 11.8 p -135.52 142.34 39.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -97.6 167.45 10.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 111.435 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -52.73 -51.35 60.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.381 -175.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.9 m -75.36 -5.66 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.901 0.381 . . . . 0.0 111.782 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -106.85 -20.45 13.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.254 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 83' ' ' ILE . 2.8 tm? -56.12 -42.21 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.353 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.89 -46.18 72.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.319 0.581 . . . . 0.0 110.573 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 32' ' ' THR . 32.6 t70 -60.46 -53.59 55.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.346 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.93 -43.56 86.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.5 -40.12 95.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.692 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -70.12 -25.46 63.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.67 -42.83 13.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.047 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -66.79 134.79 94.17 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 34.9 Cg_exo -63.12 -44.42 15.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.483 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.802 ' HB2' ' HE2' ' A' ' 68' ' ' TYR . 1.5 t0 -161.36 177.34 10.23 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.04 -178.96 33.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.695 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 97' ' ' VAL . 20.2 m -138.37 156.48 30.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 122.501 0.32 . . . . 0.0 110.205 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.81 143.57 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.619 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' SD ' ' A' ' 14' ' ' MET . 7.7 mp -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 63.7 tp -114.93 96.55 5.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.417 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.9 m 60.22 -167.47 0.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.7 0.625 . . . . 0.0 112.562 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.5 p -137.07 174.48 10.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.955 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 33.2 t70 -69.77 141.25 89.77 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.132 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 13.7 Cg_exo -70.55 -171.89 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.553 2.835 . . . . 0.0 113.897 -175.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -79.99 -39.64 29.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.097 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 47' ' ' ARG . 67.1 mtt180 -69.61 -4.13 17.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.437 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.449 ' HB ' ' OD2' ' A' ' 44' ' ' ASP . 10.8 m -122.96 130.49 24.59 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 122.172 -0.33 . . . . 0.0 110.361 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -91.84 43.36 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.752 2.302 . . . . 0.0 113.053 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -134.25 41.34 2.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.813 0.816 . . . . 0.0 109.34 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.955 ' HA ' ' HB3' ' A' ' 44' ' ' ASP . 13.0 t -77.77 -39.65 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.331 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' HD11 ' A' ' 10' ' ' LEU . 37.4 t -109.76 -39.06 5.22 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.829 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 52.6 -144.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.683 0.614 . . . . 0.0 109.834 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.18 92.3 3.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -61.31 -95.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.797 2.331 . . . . 0.0 113.484 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 97.7 t 73.29 -51.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.326 0.584 . . . . 0.0 110.653 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.541 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 22.9 ptt? -59.51 -24.41 63.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.078 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.25 -45.09 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.897 0.38 . . . . 0.0 110.798 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.35 -40.2 80.51 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.588 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -63.08 -39.16 93.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.514 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 37.0 tp -59.99 -57.03 14.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.723 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.24 -28.02 68.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.132 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -75.43 -6.92 52.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.2 pt-20 -76.39 -13.54 60.12 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.243 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -131.26 71.09 82.06 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.45 12.46 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.25 2.634 . . . . 0.0 112.799 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.51 -14.35 60.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.676 0.75 . . . . 0.0 110.012 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.802 ' HE2' ' HB2' ' A' ' 36' ' ' ASP . 8.7 t80 -122.4 -177.12 3.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.208 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -109.44 123.02 48.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.685 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -108.34 106.67 16.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -90.39 110.91 21.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.015 0.436 . . . . 0.0 110.185 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.97 117.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.975 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -116.03 127.9 55.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.1 pt -119.57 139.33 47.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.493 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.65 171.24 7.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.7 m-20 -64.14 171.8 2.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.822 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -57.73 -54.26 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.568 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -74.61 -33.78 62.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.972 0.415 . . . . 0.0 111.32 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 1.3 mp0 -69.64 -39.52 77.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.06 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.4 m -55.23 -52.99 61.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.48 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 17.6 tp10 -59.93 -44.43 94.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.353 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.83 -41.31 95.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.894 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 79' ' ' GLN . 80.1 mt -63.01 -47.57 92.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.624 0.249 . . . . 0.0 110.964 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.19 92.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.519 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.99 -43.96 82.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.81 0.444 . . . . 0.0 111.262 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -67.7 -27.23 66.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -78.19 -39.06 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 109.944 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.52 -25.85 2.29 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.02 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -86.3 99.73 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.012 0.434 . . . . 0.0 110.142 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -93.76 131.79 38.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.709 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 0.4 OUTLIER 67.08 179.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.732 0.645 . . . . 0.0 112.011 173.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 70.02 105.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.869 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 37.5 Cg_endo -66.43 135.66 40.32 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.613 2.209 . . . . 0.0 112.528 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.8 -173.68 1.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.153 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 20.4 m -114.91 127.94 55.99 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.7 114.79 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -99.84 130.49 48.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.313 0.577 . . . . 0.0 111.105 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -123.43 164.95 17.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.804 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m -154.87 136.4 14.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 170.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.29 14.85 42.5 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.149 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.4 -5.6 84.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.242 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.71 149.09 21.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 110.912 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -74.44 126.88 31.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.11 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 3.5 mmp_? -99.23 -45.11 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.95 -165.13 38.68 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.674 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.44 134.04 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.101 0.477 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.0 mt -100.2 109.83 22.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.569 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -132.19 81.36 1.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.382 0.61 . . . . 0.0 109.605 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.18 64.48 0.34 Allowed Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.309 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 26.0 mm -80.35 83.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.487 0.184 . . . . 0.0 111.093 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 9.9 t-80 175.9 -60.12 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.703 172.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 1.6 Cg_endo -82.98 124.76 3.94 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.476 2.118 . . . . 0.0 113.035 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' A' ' 57' ' ' MET . 12.1 t-105 -77.09 -49.23 15.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.581 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.58 78.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.034 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 36.9 tt0 -74.23 -34.54 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.725 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.03 -43.33 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.11 -47.91 85.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -53.78 -49.52 68.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.434 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.51 -53.8 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.8 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 124' ' ' VAL . 17.6 tpt -56.76 -51.06 70.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.482 . . . . 0.0 110.512 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 125' ' ' GLU . 24.4 ttt85 -64.77 -31.75 73.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.562 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.9 61.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.669 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.12 -51.88 6.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' MET . 32.8 m -81.64 -24.81 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.631 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 31.3 tt0 46.48 85.55 0.17 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.123 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.412 ' HD2' ' HG3' ' A' ' 121' ' ' ARG . 19.9 Cg_exo -69.04 92.04 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 110.433 170.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -64.51 -42.3 95.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.032 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.45 57.24 2.24 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.746 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 104.34 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.937 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 130' ' ' ARG . 10.6 ptm180 -158.01 1.15 0.11 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.577 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -157.28 107.52 2.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.123 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.917 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 10.4 t -95.08 66.77 3.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.273 0.559 . . . . 0.0 110.546 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -168.2 149.29 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.495 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t70 70.96 4.6 5.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.554 0.693 . . . . 0.0 111.715 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 42.1 m -151.99 -60.71 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.917 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 16.0 Cg_exo -67.87 -66.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.921 1.747 . . . . 0.0 112.124 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.484 ' HA ' HG11 ' A' ' 51' ' ' VAL . 91.5 t80 -60.8 -35.07 75.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.42 -53.51 55.66 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -66.44 -43.03 86.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.062 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 51' ' ' VAL . 2.2 mm? -60.77 -37.72 82.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.816 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 15' ' ' LEU . 6.3 t90 -64.04 -48.61 75.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.541 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 45.3 mt-30 -60.51 -32.47 71.48 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.525 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 26.2 mmm180 -59.16 -53.32 59.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.002 0.429 . . . . 0.0 110.281 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.609 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 71.7 mtm -62.13 -33.37 74.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.845 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.548 HD22 HD11 ' A' ' 74' ' ' ILE . 2.7 mm? -59.51 -38.91 82.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.624 176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.04 66.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.39 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -75.63 -6.34 49.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.614 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.75 46.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.598 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 47.5 m0 -89.51 119.95 30.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 109.931 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -83.7 137.23 41.4 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.401 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 74.1 Cg_endo -76.95 149.83 29.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.48 . . . . 0.0 111.424 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -154.1 156.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 111.18 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 p -99.04 164.5 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.307 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.19 -42.73 73.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 111.66 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -30.44 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.65 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -85.23 -23.17 28.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 110.619 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -60.64 -39.26 87.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.622 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.33 -32.92 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.924 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 9.0 t70 -68.3 -55.24 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.047 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -60.69 -34.08 73.8 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.918 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.99 -43.03 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.322 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.0 t -74.55 -26.39 59.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.782 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 29' ' ' ASP . 98.0 mt-30 -64.57 -44.96 89.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.853 0.358 . . . . 0.0 110.651 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 161.75 35.16 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.04 -45.56 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.326 2.017 . . . . 0.0 110.993 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -149.17 -178.16 6.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.119 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.11 -168.17 40.23 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.052 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.1 m -139.13 135.73 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.858 0.361 . . . . 0.0 110.477 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -124.11 133.18 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -95.84 131.43 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.948 0.404 . . . . 0.0 111.258 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 4.5 tt -107.71 117.19 33.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.612 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -112.46 133.36 54.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.871 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -169.18 -166.84 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.23 117.36 59.56 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 121.588 0.709 . . . . 0.0 111.035 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.869 ' HB3' ' HG2' ' A' ' 93' ' ' PRO . 95.0 Cg_endo -101.65 143.84 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.462 2.775 . . . . 0.0 113.131 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HD3' ' O ' ' A' ' 46' ' ' LYS . 2.1 tmtp? -110.41 -24.61 10.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -75.75 -43.7 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.61 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -93.4 139.14 22.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.51 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -41.55 -68.06 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.56 2.84 . . . . 0.0 113.616 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.55 -66.4 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.152 177.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG12 ' HG ' ' A' ' 10' ' ' LEU . 45.0 t -151.01 -30.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.582 0.23 . . . . 0.0 111.343 -173.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t -70.47 -19.5 62.95 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -168.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.68 97.17 11.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.937 0.399 . . . . 0.0 110.701 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.48 153.4 75.1 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.617 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB2' HG12 ' A' ' 58' ' ' ILE . 74.4 Cg_endo -80.74 97.59 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.492 2.128 . . . . 0.0 112.911 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HA ' ' HH2' ' A' ' 19' ' ' TRP . 45.3 t -93.96 -27.71 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.341 0.591 . . . . 0.0 110.313 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -22.81 65.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.001 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 55' ' ' PRO . 40.3 mm -52.6 -35.83 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -61.42 -43.04 99.85 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -69.25 -30.35 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.196 0.522 . . . . 0.0 110.875 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.879 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 47.6 tp -72.56 -52.67 14.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.345 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.6 ' O ' ' HD2' ' A' ' 65' ' ' PHE . 8.4 mp -59.2 -27.3 65.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.274 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 16.6 mmm180 -56.3 -14.59 2.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.81 -7.25 47.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.881 0.309 . . . . 0.0 111.62 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' HD2' ' O ' ' A' ' 62' ' ' LEU . 32.1 p90 -64.71 126.97 91.99 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.393 0.616 . . . . 0.0 111.57 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 1.3 Cg_endo -87.28 -62.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.307 2.671 . . . . 0.0 112.654 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.4 -25.53 10.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.726 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.48 104.37 12.72 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.4 p -79.42 107.22 12.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.073 0.463 . . . . 0.0 110.377 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -75.88 121.65 22.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.525 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -83.6 100.73 11.0 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.42 108.48 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.903 0.382 . . . . 0.0 110.055 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.49 48.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 19.6 pt -115.9 148.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.435 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -130.89 167.39 19.03 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.6 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.755 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.6 m-20 -61.71 163.71 6.98 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.52 174.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.82 -48.71 77.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.753 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.72 -24.07 64.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.574 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.755 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 78.5 mm-40 -76.46 -51.83 11.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 41' ' ' LEU . 39.6 m -64.27 -37.38 87.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.91 -45.3 74.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.067 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -45.59 81.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.87 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.71 -49.03 82.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.347 0.404 . . . . 0.0 111.07 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.47 50.78 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.89 -49.61 72.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.272 0.558 . . . . 0.0 110.93 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -63.49 -31.53 72.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.883 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.18 -51.76 6.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 110.593 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.03 44.64 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.712 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -104.68 -14.72 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' HD2' ' CE2' ' A' ' 92' ' ' PHE . 41.7 t80 68.19 175.97 0.26 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.035 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -84.08 94.26 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.922 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CE2' ' HD2' ' A' ' 90' ' ' PHE . 54.2 m-85 -140.17 132.05 14.5 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.889 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.869 ' HG2' ' HB3' ' A' ' 45' ' ' PRO . 6.6 Cg_exo -71.66 129.24 15.32 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.172 1.915 . . . . 0.0 110.519 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.39 156.85 2.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.159 0.505 . . . . 0.0 111.68 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.0 m -95.6 120.81 36.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.965 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.9 114.17 26.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 38' ' ' VAL . 6.5 p -99.38 124.86 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.153 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.91 140.81 33.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.544 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 p -134.0 122.48 23.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.979 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.76 25.58 69.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.355 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.81 0.42 88.11 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.61 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.09 143.88 37.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.313 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -82.31 112.86 19.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.119 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -136.69 10.81 3.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.56 137.24 6.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.525 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.93 132.69 69.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.63 95.01 2.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.613 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -81.75 -38.68 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 109.984 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.47 -161.11 24.95 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 23.1 mm 69.89 163.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 43.6 m80 78.77 151.89 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.193 0.597 . . . . 0.0 110.452 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.45 142.68 96.13 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.546 2.164 . . . . 0.0 113.001 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.879 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 29.5 t-105 -53.79 -33.81 57.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.652 175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.64 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.52 -33.28 48.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 109.936 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 2.7 mm? -58.14 -44.5 87.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.962 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 113' ' ' TRP . 59.9 mt -64.38 -41.91 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.35 -54.83 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.502 0.667 . . . . 0.0 110.824 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.9 mt -59.19 -48.52 81.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.423 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.7 ' HG2' HD21 ' A' ' 61' ' ' LEU . 14.8 tpt -62.29 -38.79 90.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.704 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 121' ' ' ARG . 16.8 tpt180 -66.11 -34.46 78.12 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.8 74.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.754 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 92.3 mt -75.6 -55.55 5.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.689 -0.256 . . . . 0.0 111.609 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -77.94 -23.24 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.795 -175.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.44 76.0 69.07 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.0 109.343 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.84 113.39 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.05 2.5 . . . . 0.0 113.067 -173.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -83.9 -4.3 58.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.531 171.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 55.79 65.28 1.49 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.222 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 174.37 5.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.033 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -69.05 138.09 54.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.422 0.629 . . . . 0.0 112.123 -174.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.19 113.1 15.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.813 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.227 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.0 m 65.17 28.7 12.12 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.694 0.621 . . . . 0.0 110.477 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -86.42 83.43 7.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.445 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.32 -0.07 1.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.628 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.594 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 21.6 m 179.12 -54.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.377 0.671 . . . . 0.0 110.529 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 46.4 Cg_exo -56.97 -66.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.292 1.995 . . . . 0.0 112.995 -175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 64.0 t80 -60.42 -37.96 82.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.32 . . . . 0.0 110.688 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 7.2 t70 -59.04 -53.15 61.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.486 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.6 88.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.347 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.29 -47.77 75.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.85 -35.62 81.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 83.1 mm-40 -57.33 -43.84 83.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.026 176.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 5.0 mmp_? -64.21 -53.35 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 84.4 mtp -56.47 -39.56 73.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.291 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.95 -38.47 79.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.186 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.39 70.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HA ' HH11 ' A' ' 17' ' ' ARG . 10.3 mmm180 -73.06 -15.9 61.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.396 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.92 44.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.312 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -114.5 137.47 51.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 p -96.44 138.03 21.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.9 Cg_endo -86.2 163.46 9.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.616 2.878 . . . . 0.0 112.076 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -162.79 143.74 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.895 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.32 155.25 19.1 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.95 78.35 1.66 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.988 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 53.8 m -171.22 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.529 ' HD3' ' HB2' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.26 0.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.544 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -53.02 -43.31 66.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.72 -43.34 59.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.85 -52.45 65.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.699 0.762 . . . . 0.0 110.407 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.654 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 22.9 t90 -58.75 -42.73 89.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.027 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.4 -33.25 75.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.0 m -60.21 -42.69 95.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.856 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.67 -43.75 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB1' ' CD ' ' A' ' 71' ' ' GLN . . . -113.05 94.95 32.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.549 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.34 -170.57 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.258 2.638 . . . . 0.0 112.551 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 49.84 88.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.893 0.854 . . . . 0.0 112.271 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.4 -169.35 27.84 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.153 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.93 145.83 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.625 0.25 . . . . 0.0 110.993 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 11.5 p -138.05 140.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.814 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.67 130.8 45.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -106.27 112.78 25.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.053 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.438 ' H ' ' CB ' ' A' ' 80' ' ' SER . 39.8 m 66.52 176.65 0.23 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.83 0.706 . . . . 0.0 111.371 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -144.5 15.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -129.52 86.56 55.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.989 0.423 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -89.31 132.56 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.179 2.586 . . . . 0.0 111.677 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -87.01 -25.17 24.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.291 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -90.5 -18.55 25.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 HG21 ' HA2' ' A' ' 109' ' ' GLY . 3.0 m -125.7 88.45 54.2 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.95 -34.2 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.825 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.2 40.58 1.01 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.04 0.448 . . . . 0.0 111.71 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.707 ' HA ' HD11 ' A' ' 110' ' ' ILE . 42.8 t -72.7 -27.17 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.505 0.669 . . . . 0.0 109.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -70.99 -2.79 16.53 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.851 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.79 -64.82 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.057 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.49 104.18 1.08 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.19 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.103 2.536 . . . . 0.0 113.285 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 -24.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.04 70.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.091 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.07 -38.35 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.42 -44.45 51.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.164 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.07 -30.05 66.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.644 0.259 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 54.8 tp -62.75 -45.59 91.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.025 0.441 . . . . 0.0 110.633 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.33 -29.9 67.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.756 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.6 -12.11 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 111.19 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 13.1 tp10 -74.37 -26.58 60.21 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -140.59 72.63 30.24 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -93.79 6.81 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.05 2.5 . . . . 0.0 112.39 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.21 -22.08 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 0.0 110.992 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.02 129.81 56.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -66.61 109.86 2.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.788 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.01 133.78 34.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.546 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' CD ' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -90.89 102.17 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.96 173.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.9 t -95.95 113.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.472 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -122.09 135.6 54.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 16.7 pt -128.03 148.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.11 171.08 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 79' ' ' GLN . 9.9 t70 -66.49 161.88 21.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 173.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' SER . 63.5 tp -66.91 -55.9 12.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.735 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . 57.8 mt-10 -73.84 -23.56 59.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 31.7 tt0 -64.55 -33.94 77.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.937 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.438 ' CB ' ' H ' ' A' ' 42' ' ' SER . 73.1 m -63.67 -40.05 95.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -55.43 -38.31 68.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 174.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.04 -43.42 62.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.241 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.73 -44.48 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 109.97 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -43.88 96.53 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.81 -49.44 76.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -63.99 -26.0 68.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.43 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -103.28 -4.91 23.62 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.088 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.42 38.3 80.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.186 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -122.03 -14.62 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 110.618 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.604 ' CE1' ' HG3' ' A' ' 81' ' ' GLU . 45.7 t80 -65.37 114.33 4.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.107 0.479 . . . . 0.0 112.246 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 23.0 tpt180 -173.25 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.904 172.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 11.9 p90 -143.78 145.81 32.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.302 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 13.7 Cg_exo -71.18 138.17 32.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.673 2.248 . . . . 0.0 112.077 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.27 162.94 31.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.8 m -96.67 113.56 25.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.506 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.2 mt -94.48 129.98 41.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.21 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.82 135.91 57.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -108.72 125.48 51.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.403 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -104.1 123.44 47.27 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.735 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.91 11.76 63.77 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.46 71.62 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' N ' HD22 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -95.43 143.74 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -177.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -78.09 111.1 13.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.273 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -139.29 -19.24 0.97 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.604 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.62 149.27 18.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.931 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.96 134.71 18.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.901 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.9 mt -115.25 117.69 31.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.582 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.63 117.92 30.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.527 0.679 . . . . 0.0 111.28 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.511 ' HA2' HG21 ' A' ' 48' ' ' THR . . . 95.3 -161.54 23.29 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.395 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.707 HD11 ' HA ' ' A' ' 51' ' ' VAL . 49.3 mm -99.01 -53.53 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 44.6 m80 67.5 159.99 0.14 Allowed Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.725 0.641 . . . . 0.0 110.893 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 115' ' ' GLU . 11.8 Cg_endo -60.25 136.8 70.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.503 1.469 . . . . 0.0 109.473 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.521 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.5 t-105 -54.79 -45.41 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.25 -34.36 72.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.771 0.32 . . . . 0.0 111.493 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.735 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 1.3 tm-20 -77.2 -37.13 54.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.448 . . . . 0.0 110.102 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.95 -44.97 91.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.335 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.96 -39.04 82.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.226 0.536 . . . . 0.0 109.946 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -58.11 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.147 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 97.3 mt -56.82 -45.64 82.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.479 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.451 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.9 tpt -57.74 -47.6 81.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HA ' HG22 ' A' ' 124' ' ' VAL . 62.9 mtp180 -64.11 -32.73 74.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.224 0.209 . . . . 0.0 110.916 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.96 74.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.176 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.479 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 99.1 mt -84.38 -39.48 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 121' ' ' ARG . 34.2 m -82.78 -15.5 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.63 0.252 . . . . 0.0 111.636 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 10.1 tp10 -45.82 -58.22 6.58 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 125' ' ' GLU . 3.6 Cg_exo -74.79 145.51 32.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.944 1.763 . . . . 0.0 112.708 -175.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.411 . . . . 0.0 111.621 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 64.52 121.43 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.752 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -84.72 156.01 21.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.732 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -71.86 119.85 16.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.324 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.32 161.16 38.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.291 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 121.311 0.577 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -84.25 84.15 7.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.49 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 17.4 m120 -133.8 152.12 51.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.207 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.67 82.55 7.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.997 0.427 . . . . 0.0 110.892 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.664 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 4.4 m -177.29 -61.4 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.911 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.3 -55.39 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.798 1.666 . . . . 0.0 112.04 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 44.7 t80 -62.46 -37.11 84.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.975 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.34 -54.59 30.62 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.428 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -42.27 88.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.546 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.85 -57.0 14.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.543 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.6 t90 -67.7 -36.64 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.305 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -56.87 -44.44 82.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.786 0.326 . . . . 0.0 110.976 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 97.3 mtt180 -63.49 -53.55 50.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 110.727 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.76 -36.84 79.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.439 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -70.1 -30.39 67.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.423 -177.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.19 64.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -10.37 59.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.824 0.345 . . . . 0.0 111.284 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.69 41.88 14.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.411 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -90.64 -178.69 5.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.675 0.274 . . . . 0.0 110.38 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.1 m -117.49 120.35 33.3 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.172 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HB3' ' HZ2' ' A' ' 11' ' ' TRP . 2.8 Cg_exo -75.83 121.49 6.29 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.965 2.443 . . . . 0.0 111.172 174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG11 HD23 ' A' ' 27' ' ' LEU . 14.9 p -117.9 143.47 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.618 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -95.24 163.25 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.557 0.694 . . . . 0.0 112.118 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -68.4 144.7 54.64 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.441 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m 75.12 -10.79 1.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.306 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.28 -23.19 14.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.51 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -48.94 -47.27 43.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.403 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.16 -49.4 44.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.961 0.41 . . . . 0.0 110.866 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -55.56 -48.52 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.925 0.869 . . . . 0.0 110.232 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -59.9 -42.31 93.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.858 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.13 -28.64 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 29' ' ' ASP . 7.4 t -80.57 -26.1 38.14 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.87 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -89.67 -38.38 13.93 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -97.86 106.77 36.2 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.9 Cg_exo -67.76 122.35 9.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.755 2.303 . . . . 0.0 114.213 -169.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.571 ' OD2' ' HB ' ' A' ' 99' ' ' THR . 6.1 m-20 65.64 154.76 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 124.594 1.184 . . . . 0.0 113.361 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 71' ' ' GLN . . . 153.91 -172.9 32.61 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.709 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 97' ' ' VAL . 31.3 m -133.54 156.33 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.545 0.212 . . . . 0.0 110.458 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.0 t -129.74 131.04 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.076 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -98.64 122.22 41.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.403 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 80' ' ' SER . 6.6 tt -106.79 97.97 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 42.4 m 61.33 -170.59 0.16 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.0 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 p -130.39 77.55 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -176.61 82.41 0.27 Allowed Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.45 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 3.4 Cg_exo -81.2 -30.61 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.114 2.543 . . . . 0.0 113.839 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.687 ' HG2' ' HD2' ' A' ' 47' ' ' ARG . 77.5 tttt -135.97 -78.67 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.711 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 3.1 mpt_? -131.79 -35.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.7 m 73.93 104.55 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.564 171.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.36 -12.68 20.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.144 2.563 . . . . 0.0 111.961 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -125.5 -123.38 0.25 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 t -140.85 -54.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.7 t -92.57 -18.31 23.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.387 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.4 -90.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.971 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 92.55 1.53 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.63 0.252 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -102.17 41.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.057 2.505 . . . . 0.0 111.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -104.5 -59.66 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -23.86 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.611 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.2 mm -52.59 -46.73 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.257 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -36.51 86.74 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.455 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 mt-10 -80.01 -26.95 39.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.887 0.375 . . . . 0.0 111.135 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 120' ' ' MET . 42.8 tp -62.24 -45.72 92.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.798 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.0 mp -56.35 -26.83 53.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.399 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 38.4 mmt180 -60.3 -17.73 44.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 5.6 pt-20 -76.5 -8.66 57.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.004 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -125.65 70.77 65.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.569 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.28 11.98 2.8 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.77 2.313 . . . . 0.0 111.583 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.67 -25.7 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.355 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -131.55 -157.9 0.85 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.025 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' OE1' ' A' ' 71' ' ' GLN . 6.6 p -111.62 140.08 46.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 62' ' ' LEU . 82.7 m95 -122.05 95.59 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' OE1' ' HB ' ' A' ' 69' ' ' THR . 1.9 mp0 -84.34 109.86 18.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.23 114.22 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.988 0.423 . . . . 0.0 110.251 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -110.64 137.53 48.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.975 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 12.9 pt -122.72 146.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.78 160.77 31.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 0.0 112.074 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.99 164.84 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.775 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 96.2 mt -59.34 -44.53 92.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.773 0.32 . . . . 0.0 110.807 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.03 -36.31 79.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 0.0 110.081 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -72.81 -31.15 64.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.073 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.581 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 68.2 m -60.08 -43.88 95.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.995 0.426 . . . . 0.0 111.202 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.82 -41.01 97.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.697 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.551 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . . . -77.2 -35.18 55.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.568 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 24' ' ' GLU . 73.3 mt -63.63 -49.19 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.539 0.209 . . . . 0.0 110.676 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.03 -45.97 94.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.688 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -52.74 -53.35 49.13 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -73.28 -23.99 60.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' A' ' 89' ' ' VAL . 10.7 t80 -85.4 -54.58 4.49 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.801 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.41 44.02 0.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.365 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 87' ' ' PHE . 57.5 t -125.56 83.74 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HB3' ' HD1' ' A' ' 92' ' ' PHE . 86.0 m-85 66.51 -62.59 0.28 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER 95.72 -1.6 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.293 1.837 . . . . 0.0 109.859 -169.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.743 ' HD1' ' HB3' ' A' ' 90' ' ' PHE . 83.8 m-85 -84.98 135.32 39.84 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.508 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.835 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.6 Cg_exo -67.41 134.18 32.53 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.871 2.381 . . . . 0.0 112.196 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . 173.85 -169.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.051 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.5 m -97.53 113.97 25.78 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.7 mt -95.75 127.52 41.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.071 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 104' ' ' ARG . 5.7 p -109.34 124.13 65.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.458 0.647 . . . . 0.0 111.156 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -124.94 -178.87 4.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.465 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 14.2 p -127.89 -168.91 1.97 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.45 49.45 1.29 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.151 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.1 -41.5 0.85 Allowed Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.425 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -94.08 170.91 9.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.874 . . . . 0.0 112.099 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.44 134.96 55.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.35 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.707 ' HB2' HG13 ' A' ' 97' ' ' VAL . 3.5 mmp_? -105.14 -58.84 1.83 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.555 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -161.25 27.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.517 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.59 134.3 58.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 110.337 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.4 mt -101.51 128.84 47.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.611 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.56 11.15 25.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.797 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.25 -148.33 49.97 Favored Glycine 0 C--O 1.239 0.406 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.186 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 111' ' ' HIS . 10.6 mm 61.28 -168.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.883 ' H ' HG22 ' A' ' 110' ' ' ILE . 66.0 m80 73.39 150.45 0.13 Allowed Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.041 0.536 . . . . 0.0 111.522 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 111' ' ' HIS . 13.4 Cg_exo -70.46 166.9 26.94 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.515 2.143 . . . . 0.0 111.582 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.472 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 33.5 t-105 -53.86 -43.15 69.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.612 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.51 77.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 22.6 mm-40 -81.22 -25.91 36.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 111.153 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.17 -43.53 91.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 61' ' ' LEU . 62.4 mt -58.81 -42.38 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.607 0.717 . . . . 0.0 109.554 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -54.5 -52.79 60.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.758 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 91.8 mt -62.35 -45.42 93.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.615 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.775 ' HB2' HD21 ' A' ' 61' ' ' LEU . 8.2 tpt -57.1 -47.76 80.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.269 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.514 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.9 ttm180 -66.27 -37.78 86.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.977 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.14 -30.68 74.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.501 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 97' ' ' VAL . 94.8 mt -89.47 -42.47 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 121' ' ' ARG . 35.9 m -73.65 -31.01 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.76 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.57 109.42 58.06 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.78 108.72 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.836 2.357 . . . . 0.0 113.294 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -101.81 -14.68 17.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.483 174.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 8.3 pt20 -153.57 112.49 3.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.296 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 4.2 pt-20 -74.88 100.36 4.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.02 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.96 148.3 22.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.792 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.74 109.0 12.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.57 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 62.43 59.12 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 t30 59.32 71.76 0.56 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.635 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.54 173.66 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.39 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.614 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m -162.68 -55.62 0.01 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.828 -175.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 10.9 Cg_exo -70.23 -43.37 2.3 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.867 1.712 . . . . 0.0 111.807 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.787 ' HE1' ' HB2' ' A' ' 42' ' ' SER . 76.7 t80 -73.54 -43.04 60.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.657 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 24.4 t70 -55.15 -53.62 53.62 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.504 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.19 99.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.544 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.13 -41.27 97.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.753 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -64.41 -40.26 95.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 24.9 mm-40 -57.89 -39.92 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.36 -52.5 46.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.633 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.6 mtp -55.32 -38.24 68.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.979 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -65.13 -36.42 84.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.754 179.154 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.64 67.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -73.27 -7.77 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.804 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.49 23.64 36.12 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.266 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -85.1 141.97 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.2 m -84.63 116.08 63.56 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.942 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 57.1 Cg_endo -74.39 129.59 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.553 2.169 . . . . 0.0 110.985 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG11 HD23 ' A' ' 27' ' ' LEU . 13.8 p -138.57 145.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.892 0.377 . . . . 0.0 111.328 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 p -91.23 160.73 15.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.598 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -32.44 72.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.514 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -66.27 -36.5 83.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.876 0.37 . . . . 0.0 111.112 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -90.52 -24.76 20.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.348 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.469 HD23 HG11 ' A' ' 22' ' ' VAL . 3.1 tm? -58.8 -40.46 84.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.651 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 32' ' ' THR . 17.7 t70 -56.11 -53.4 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.877 0.846 . . . . 0.0 111.105 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t90 -59.39 -41.53 89.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.88 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.53 -29.11 70.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.181 0.515 . . . . 0.0 110.47 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 86.2 m -66.32 -40.0 89.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -98.91 -14.5 19.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 90.22 10.04 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.843 0.354 . . . . 0.0 110.048 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.747 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 86.0 Cg_endo -88.61 -14.38 3.07 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.06 2.507 . . . . 0.0 114.409 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -100.22 135.94 40.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 110.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.98 -160.98 28.74 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 97' ' ' VAL . 6.9 m -138.4 134.87 44.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.5 t -113.59 132.15 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.34 122.43 43.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 35.2 tp -83.15 81.2 8.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.787 ' HB2' ' HE1' ' A' ' 7' ' ' PHE . 4.3 p -58.77 -48.1 82.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.063 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HG ' ' A' ' 41' ' ' LEU . 14.4 m 57.42 -102.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.682 0.614 . . . . 0.0 110.599 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD1' ' HD3' ' A' ' 91' ' ' ARG . 7.0 p-10 -161.77 142.93 8.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 2.0 Cg_endo -83.59 132.55 5.81 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.477 2.118 . . . . 0.0 111.443 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 36.7 tptt -122.53 -50.33 1.99 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -158.82 -60.29 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 50' ' ' GLU . 4.5 m 71.07 143.7 0.1 OUTLIER Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.98 170.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.58 -5.87 6.31 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.944 2.43 . . . . 0.0 112.354 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.847 ' HG2' HG13 ' A' ' 110' ' ' ILE . 11.2 tp10 -151.16 100.01 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -69.05 -52.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.876 -174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 t -126.62 -84.8 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.936 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 53.78 -168.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.926 0.891 . . . . 0.0 111.955 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -147.57 92.35 4.8 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.12 98.44 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.746 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.97 -32.67 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.311 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -60.14 -23.76 64.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.877 -177.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 116' ' ' LEU . 49.8 mm -53.93 -39.96 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.73 -44.69 95.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.399 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -62.2 -34.83 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.342 . . . . 0.0 111.071 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.602 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 45.0 tp -64.76 -55.0 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.21 -27.99 69.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.369 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.96 -19.9 65.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -86.79 -0.45 56.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.772 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -123.08 71.64 44.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.94 -3.03 10.38 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.53 2.154 . . . . 0.0 113.075 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.53 -17.83 60.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.16 139.14 51.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.274 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -86.25 105.21 16.47 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -80.11 110.63 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.187 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.47 119.54 24.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.081 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.33 103.33 14.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -108.45 127.15 53.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 15' ' ' LEU . 23.4 pt -122.59 139.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.954 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -111.68 169.78 8.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 112.242 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.66 168.77 14.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.283 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' A' ' 44' ' ' ASP . 9.8 tp -50.25 -54.64 19.72 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.251 0.62 . . . . 0.0 112.18 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -30.3 61.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.546 0.689 . . . . 0.0 110.671 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 57.6 mt-30 -77.27 -42.7 36.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.468 -175.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 48.6 p -73.38 -37.24 66.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.663 0.268 . . . . 0.0 110.305 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -53.08 -49.79 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.101 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.07 71.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.786 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 79' ' ' GLN . 81.1 mt -67.89 -52.09 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.433 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.53 -44.75 97.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.171 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.94 -39.58 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.21 -30.75 65.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.373 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -84.82 -33.38 22.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 110.715 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.82 31.96 1.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.488 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.55 158.68 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.71 -83.81 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 110.821 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.548 ' HD3' ' OD1' ' A' ' 44' ' ' ASP . 86.9 mtt180 -148.17 -161.18 1.28 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 88.5 m-85 76.7 148.18 0.12 Allowed Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 124.144 0.903 . . . . 0.0 111.733 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 17.2 Cg_exo -65.39 69.15 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.452 3.434 . . . . 0.0 113.39 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.64 129.56 34.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.339 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 7.3 m -92.22 112.96 25.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 106' ' ' VAL . 65.8 mt -93.97 113.9 25.99 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 104' ' ' ARG . 7.4 p -97.85 127.37 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.202 0.525 . . . . 0.0 110.92 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.93 134.26 55.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.14 137.45 23.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.84 17.6 75.38 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.747 ' HA2' ' HB2' ' A' ' 35' ' ' PRO . . . 79.93 -0.36 83.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.663 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -112.46 149.34 32.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 111.649 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -69.98 129.47 39.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.417 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.767 ' HB2' HG13 ' A' ' 97' ' ' VAL . 16.7 mmt180 -101.93 -47.29 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.367 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.04 -163.76 36.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.388 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 96' ' ' LEU . 59.3 t -122.6 134.26 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 4.4 mp -101.32 123.58 45.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.78 90.29 2.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.186 0.517 . . . . 0.0 110.026 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.5 146.15 5.73 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.847 HG13 ' HG2' ' A' ' 50' ' ' GLU . 27.4 mm -123.0 -53.27 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 117.165 0.483 . . . . 0.0 111.767 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.6 m170 -73.25 -53.65 4.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 12.5 Cg_exo -68.73 121.91 8.82 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.126 1.217 . . . . 0.0 111.885 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.602 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 9.4 t-105 -87.49 -45.14 10.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.549 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.21 75.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 8.0 tp10 -72.18 -40.59 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.316 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.501 HD23 ' HZ3' ' A' ' 113' ' ' TRP . 30.9 tp -61.31 -44.28 97.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 113' ' ' TRP . 62.1 mt -63.9 -44.94 98.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -50.23 -59.05 4.33 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.122 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 87.0 mt -65.53 -45.46 83.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.926 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.475 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -61.37 -48.03 83.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.69 0.281 . . . . 0.0 110.538 -178.134 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.0 ttt85 -69.39 -33.03 72.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.199 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.51 -29.15 74.53 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.2 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.5 mt -83.06 -49.59 9.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.409 0.147 . . . . 0.0 111.206 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 121' ' ' ARG . 29.5 m -70.65 -37.94 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.428 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 35.4 tt0 -101.49 99.19 10.77 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 24.2 Cg_exo -64.87 99.08 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.314 2.676 . . . . 0.0 114.599 -166.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -89.42 76.93 7.42 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 163.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -71.88 75.84 0.89 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.52 77.49 1.77 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 161.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.75 98.58 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.385 -166.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.19 83.56 1.0 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.179 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.007 -176.619 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 6' ' ' PRO . 44.8 m 54.52 59.66 4.01 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.02 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -120.61 171.74 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 69.06 7.21 6.1 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.266 0.626 . . . . 0.0 112.395 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.737 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 88.0 m -148.8 -59.51 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.892 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.205 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.3 Cg_exo -68.58 -58.91 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.551 1.501 . . . . 0.0 111.545 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.41 -35.07 79.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.23 -54.22 49.41 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.566 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -62.26 -48.02 81.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.78 -40.68 89.11 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 111.631 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -69.12 -43.47 74.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 76.9 mm-40 -62.36 -32.76 73.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.359 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 50.1 mmm-85 -57.38 -53.59 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.251 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.544 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 73.0 mtm -66.65 -33.0 74.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.957 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 1.9 mm? -67.37 -24.37 65.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.459 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.76 72.9 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -81.36 -3.96 54.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.863 0.363 . . . . 0.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.91 29.99 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.116 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.544 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 43.4 m0 -74.09 148.19 42.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.174 0.511 . . . . 0.0 110.215 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.563 ' HB ' ' HZ3' ' A' ' 30' ' ' TRP . 9.5 p -96.85 130.43 30.19 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.9 -169.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.7 Cg_exo -79.31 145.1 18.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.302 2.668 . . . . 0.0 111.345 172.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.7 144.24 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.575 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -95.2 166.06 12.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.6 -55.35 35.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.075 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.3 m -73.27 6.37 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -126.34 -1.34 6.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.251 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.29 -47.08 79.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.828 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.15 -29.81 57.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.467 0.651 . . . . 0.0 110.444 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 32' ' ' THR . 17.1 t70 -61.06 -55.16 35.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.18 0.99 . . . . 0.0 109.661 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.563 ' HZ3' ' HB ' ' A' ' 20' ' ' THR . 14.0 m95 -67.93 -29.05 68.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.067 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.93 -28.85 69.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.628 0.252 . . . . 0.0 111.366 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' ASP . 14.5 t -88.78 -30.2 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.582 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.15 -28.94 18.6 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -98.86 158.0 33.15 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -67.84 149.54 78.17 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.969 1.78 . . . . 0.0 111.741 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.77 112.35 10.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.306 0.574 . . . . 0.0 110.204 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.55 -107.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.974 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.3 m -135.33 142.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 111.975 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 71.7 t -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.4 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.09 143.26 31.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.466 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -86.28 1.12 52.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 93' ' ' PRO . 89.8 p 59.72 169.89 0.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.709 1.203 . . . . 0.0 111.73 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t 64.43 -176.36 0.17 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.263 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.577 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 17.9 t70 -148.22 152.49 39.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 44' ' ' ASP . 78.9 Cg_exo -43.19 169.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.98 3.12 . . . . 0.0 115.151 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -79.97 -23.72 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.916 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -63.48 -28.44 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.873 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.1 m -71.45 127.12 91.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.791 0.329 . . . . 0.0 111.226 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.68 -42.68 29.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.989 3.126 . . . . 0.0 113.76 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.99 -94.02 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.7 t -146.37 -68.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.658 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.4 t -74.47 -44.38 51.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.903 -172.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 60.0 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.855 0.722 . . . . 0.0 111.357 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -144.86 111.06 4.81 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.241 0.543 . . . . 0.0 109.774 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -97.64 -167.98 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.21 2.607 . . . . 0.0 113.326 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.3 t 76.49 -34.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -32.27 54.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.57 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.9 mm -59.18 -44.19 91.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.79 73.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.361 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.69 -32.51 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.237 0.541 . . . . 0.0 109.974 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 120' ' ' MET . 51.1 tp -70.33 -34.59 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.502 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.9 mp -62.85 -28.12 69.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.262 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -68.7 -8.72 45.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.157 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.47 -24.79 66.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.339 . . . . 0.0 111.099 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.31 94.93 46.39 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.696 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.51 -18.28 13.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.99 2.46 . . . . 0.0 112.033 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.84 -25.55 64.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 0.0 110.801 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -137.66 121.15 17.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.578 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 t -86.26 131.12 34.3 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.907 0.861 . . . . 0.0 110.068 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -88.4 135.24 33.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.173 -173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.839 ' HB2' ' HG2' ' A' ' 35' ' ' PRO . 6.5 tp60 -96.22 122.62 39.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.206 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.35 110.99 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -111.82 127.55 55.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.254 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.5 pt -125.59 140.94 46.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -128.52 166.73 18.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.694 0.283 . . . . 0.0 111.069 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.5 m-20 -65.57 165.43 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.303 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.64 -49.14 73.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.13 -34.07 75.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.002 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 81.8 mt-30 -77.16 -52.71 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.729 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB3' HD22 ' A' ' 41' ' ' LEU . 20.0 m -60.96 -39.57 90.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.388 -177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.89 -41.68 96.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.51 . . . . 0.0 110.201 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.42 77.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 79' ' ' GLN . 83.2 mt -61.36 -43.44 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.7 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.936 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.48 -36.16 66.31 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.067 0.547 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -51.67 -54.51 27.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.103 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' HB3' HG23 ' A' ' 89' ' ' VAL . 24.5 t80 -93.57 -19.29 21.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.002 -166.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.03 39.04 6.22 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 96' ' ' LEU . 18.7 t -82.45 160.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 74.8 m-85 -60.25 138.64 57.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -83.07 8.79 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 88.9 m-85 -90.33 142.2 28.16 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.417 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' SER . 41.8 Cg_exo -57.08 126.04 20.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.518 2.146 . . . . 0.0 111.558 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.87 -175.81 3.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.567 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 29.3 m -117.21 120.65 38.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 89' ' ' VAL . 5.8 mp -93.97 114.64 26.87 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -96.03 138.94 20.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -125.05 145.61 49.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 2.6 m -154.79 151.13 28.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.02 21.6 68.0 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.13 76.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.638 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.41 176.66 8.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.446 0.641 . . . . 0.0 111.828 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.87 118.03 11.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.127 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 5.7 tpm_? -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.726 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.444 ' HA3' HD13 ' A' ' 123' ' ' LEU . . . 170.1 -168.75 41.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.595 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.8 t -132.13 134.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.02 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.8 mt -108.02 131.53 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.3 33.67 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -172.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 -120.76 21.41 Favored Glycine 0 C--O 1.236 0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.782 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.33 99.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.93 0.871 . . . . 0.0 110.325 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.747 ' HB3' HD23 ' A' ' 116' ' ' LEU . 11.5 t60 -137.09 143.36 41.75 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -38.47 124.0 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.192 2.594 . . . . 0.0 112.128 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -54.92 -43.48 73.34 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.61 0.569 . . . . 0.0 112.016 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.17 87.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.698 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.76 -29.0 64.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.343 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 111' ' ' HIS . 0.5 OUTLIER -65.82 -48.82 70.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.52 -42.06 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.166 0.508 . . . . 0.0 109.873 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -52.63 -59.29 4.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.02 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.12 -43.66 98.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.3 tpt -55.34 -48.95 73.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -39.04 92.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.435 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.52 75.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.428 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.463 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 98.6 mt -86.51 -60.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 120' ' ' MET . 30.7 m -63.51 -33.42 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.501 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.33 91.27 9.52 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 47.3 Cg_exo -57.63 114.7 2.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.413 2.742 . . . . 0.0 113.893 -168.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -81.12 -8.1 59.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.581 171.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 52.01 61.27 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.478 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 130' ' ' ARG . 28.7 tt0 -168.77 91.32 0.26 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.403 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 40.4 ttt180 172.64 22.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.527 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.75 141.73 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.062 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.134 0.492 . . . . 0.0 110.471 179.396 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.1 m -58.85 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -145.37 156.35 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.939 0.399 . . . . 0.0 110.684 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.36 85.41 7.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.38 1.086 . . . . 0.0 110.924 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.699 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m -156.01 -52.07 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.73 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 9.7 Cg_exo -71.69 -44.6 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.457 1.438 . . . . 0.0 110.223 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -68.97 -34.81 75.93 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 27.9 t70 -53.79 -53.85 46.53 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.599 0.714 . . . . 0.0 110.41 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.35 -46.03 89.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.044 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -60.34 -42.3 95.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.494 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.58 ' CH2' ' HA ' ' A' ' 76' ' ' ASP . 1.6 t90 -66.54 -40.24 88.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 87.8 mm-40 -57.78 -36.86 72.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 29.0 mmm180 -63.16 -54.15 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.664 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.499 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 66.5 mtm -62.55 -33.09 74.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.291 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.02 -40.07 95.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 0.0 110.584 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.35 66.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -74.38 -10.96 60.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.276 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.13 6.41 53.75 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.798 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.499 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 21.7 m0 -83.18 121.93 27.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 109.914 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 m -88.26 125.94 62.24 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.348 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 38.1 Cg_endo -68.5 139.38 44.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.847 2.364 . . . . 0.0 111.959 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 27' ' ' LEU . 10.7 p -130.92 148.55 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.064 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.7 p -86.62 163.6 17.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 111.49 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.01 -59.02 4.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.336 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 t -77.78 -21.94 50.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 19.2 tpt180 -84.28 -16.94 41.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 109.989 -174.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.01 -39.2 90.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.462 176.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.47 -29.36 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.616 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 32' ' ' THR . 35.1 t70 -64.24 -51.73 62.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.305 1.05 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -59.1 -40.9 86.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.074 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 60.5 mt -62.5 -33.59 75.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' ASP . 10.2 t -79.88 -26.02 40.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.743 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.75 -34.17 21.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.713 0.292 . . . . 0.0 111.494 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -86.42 148.36 46.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 16.0 Cg_exo -68.43 -67.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.505 2.137 . . . . 0.0 112.534 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.75 -90.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.578 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.57 163.79 39.67 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.262 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.03 143.28 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.89 137.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 74' ' ' ILE . 8.7 mp -92.24 121.28 33.61 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 80' ' ' SER . 21.5 tp -114.41 148.66 37.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.745 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.8 t -149.59 146.71 27.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.837 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 19.1 m -156.05 53.68 0.57 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 35.1 t70 74.77 124.95 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.028 0.83 . . . . 0.0 109.411 -173.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.702 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 27.1 Cg_exo -61.98 131.16 33.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.661 2.241 . . . . 0.0 114.069 -169.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -136.33 -59.52 0.73 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.16 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -68.99 -37.65 78.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.607 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -70.11 120.6 79.1 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.46 -60.4 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.976 2.451 . . . . 0.0 112.748 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -103.95 -94.33 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.036 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.31 -68.48 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.357 . . . . 0.0 110.808 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -78.27 -53.34 7.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.477 -175.6 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 57.08 -146.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.489 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -120.4 93.28 48.17 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 110.966 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.97 13.15 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.067 2.511 . . . . 0.0 112.276 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -84.02 -16.54 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 0.0 110.848 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -21.98 41.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.68 -33.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.788 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -50.26 69.51 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.143 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.95 -27.73 39.74 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.668 -0.313 . . . . 0.0 111.313 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.3 tp -58.32 -48.09 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.099 0.476 . . . . 0.0 111.617 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.11 -26.58 67.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.85 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -63.92 -7.92 9.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -67.23 -32.44 73.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 110.56 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.67 75.42 62.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.25 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.38 6.22 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.93 2.42 . . . . 0.0 112.896 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -91.26 2.09 56.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.786 0.803 . . . . 0.0 109.722 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -138.38 147.58 43.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.387 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -87.23 138.65 31.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.856 0.836 . . . . 0.0 111.269 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -117.21 115.25 24.94 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.732 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.09 102.89 15.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.89 106.92 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.91 142.31 41.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 40' ' ' LEU . 21.0 pt -114.9 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.518 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -92.12 157.24 16.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.896 0.379 . . . . 0.0 111.939 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -59.51 159.68 7.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.328 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -57.24 -55.72 31.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.54 -39.24 46.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.505 0.669 . . . . 0.0 111.076 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 49.8 mt-30 -72.53 -22.35 61.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.132 -173.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 31.9 p -70.31 -41.1 73.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.026 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.837 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 41.7 mt-10 -60.65 -38.87 86.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.07 83.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.017 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 79' ' ' GLN . 84.1 mt -58.33 -41.02 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 110.816 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.53 -53.26 47.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.419 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.27 -40.4 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 110.564 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.41 -36.17 83.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.051 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -92.31 -27.67 17.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.16 20.83 7.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.78 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 92' ' ' PHE . 25.5 t -126.74 78.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.56 122.98 40.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 111.459 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 34.6 ttt180 70.44 27.8 3.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.993 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.647 ' HB2' HG12 ' A' ' 89' ' ' VAL . 93.6 m-85 -115.83 85.77 15.05 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.032 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.702 ' HG3' ' HA ' ' A' ' 45' ' ' PRO . 57.4 Cg_endo -73.13 125.43 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.11 1.873 . . . . 0.0 111.807 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . -177.07 -176.35 0.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.655 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -104.31 123.22 47.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.339 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 96' ' ' LEU . 5.8 mp -94.14 133.12 37.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.701 0.286 . . . . 0.0 110.528 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.34 125.77 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.381 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -144.22 129.38 18.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.968 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.8 p -93.14 124.0 36.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.358 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.67 27.3 58.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.99 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.91 83.44 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.571 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -105.04 129.36 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -66.09 124.2 21.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.702 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 104' ' ' ARG . 12.9 mmt180 -103.61 -51.47 3.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.219 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.5 -174.96 47.37 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.424 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 108' ' ' ASN . 9.2 p -132.47 133.85 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.983 0.42 . . . . 0.0 110.284 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 93.0 mt -85.68 97.2 9.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.42 HD22 HG13 ' A' ' 106' ' ' VAL . 7.7 p30 -131.01 158.58 39.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.79 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.47 84.83 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.909 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 45.8 mm 65.6 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.516 0.727 . . . . 0.0 111.866 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 74.8 m80 74.22 157.07 0.16 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 123.287 0.635 . . . . 0.0 111.083 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.39 155.3 69.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.337 2.024 . . . . 0.0 111.515 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.573 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 t-105 -54.91 -39.13 68.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.25 -42.47 81.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.663 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.19 -28.77 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.12 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 61' ' ' LEU . 32.4 tp -64.98 -41.4 95.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.174 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' TRP . 78.4 mt -58.1 -46.01 88.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.321 0.581 . . . . 0.0 110.171 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -54.99 -57.84 10.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.819 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.19 -45.28 87.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.516 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.483 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.7 tpt -53.65 -53.29 53.99 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.351 0.407 . . . . 0.0 110.912 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.19 -33.47 76.08 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.29 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.31 66.42 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.346 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.91 -52.35 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 120' ' ' MET . 8.4 p -69.97 -30.64 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 32.7 tt0 9.89 101.05 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 125.511 1.524 . . . . 0.0 115.104 173.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 125' ' ' GLU . 29.2 Cg_endo -63.56 105.18 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.859 1.706 . . . . 0.0 109.843 170.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -80.62 73.71 7.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.333 1.063 . . . . 0.0 113.276 -167.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -107.52 36.26 2.79 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.243 -1.799 . . . . 0.0 107.131 163.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -133.4 156.57 47.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.288 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -94.78 87.5 5.04 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 121.319 -0.152 . . . . 0.0 111.123 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 33.62 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.693 1.246 . . . . 0.0 113.679 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.552 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.901 0.381 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -142.66 121.66 12.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.18 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -73.28 100.17 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.85 125.52 24.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 111.093 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 92.6 m -162.31 -49.17 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.076 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 30.3 Cg_exo -62.51 -56.81 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.642 1.561 . . . . 0.0 111.675 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -65.43 -41.79 93.14 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.84 -53.12 53.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.506 0.67 . . . . 0.0 111.006 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -64.84 -45.12 87.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.249 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 52' ' ' SER . 1.9 mm? -60.01 -46.65 88.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.106 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -67.58 -36.61 81.22 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -49.09 74.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.941 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 35.0 mtp180 -61.14 -52.4 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.648 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtp -54.48 -39.75 67.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.338 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD11 ' HG3' ' A' ' 21' ' ' PRO . 1.8 mm? -67.21 -42.52 83.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.917 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.7 61.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -69.9 -18.0 63.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 110.24 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.6 26.12 9.44 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -91.35 -179.21 5.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 24.9 m -121.89 124.39 27.05 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.76 0.314 . . . . 0.0 111.645 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG3' HD11 ' A' ' 15' ' ' LEU . 6.5 Cg_exo -73.18 132.72 18.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.941 2.427 . . . . 0.0 110.981 175.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 27' ' ' LEU . 17.4 t -120.99 144.83 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.58 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 25.0 p -99.05 165.96 11.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.972 173.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.75 -54.95 30.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 m -78.38 -13.23 59.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 111.683 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.8 tpp180 -94.65 -15.99 23.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -60.89 -44.41 97.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.4 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.32 -32.05 62.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.638 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 32' ' ' THR . 33.0 t70 -64.82 -54.58 28.86 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.782 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -66.02 -28.93 69.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.559 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -66.1 -28.11 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.441 0.639 . . . . 0.0 109.855 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 91.5 m -74.5 -41.56 60.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.138 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -83.62 -46.2 12.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -94.52 118.95 66.9 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.411 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.18 124.96 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.551 2.168 . . . . 0.0 112.747 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.4 m-20 68.06 172.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.128 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.34 -163.19 24.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.277 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.56 142.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.0 110.8 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 73' ' ' ALA . 59.8 t -119.28 127.67 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.589 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.572 ' HB2' HG22 ' A' ' 74' ' ' ILE . 35.2 mt -101.96 135.69 43.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.994 0.426 . . . . 0.0 110.948 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.99 -69.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.727 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.1 m -156.55 178.08 10.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.9 m -80.11 -74.89 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.319 0.387 . . . . 0.0 110.35 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.71 159.78 0.12 Allowed Pre-proline 0 N--CA 1.469 0.511 0 O-C-N 123.643 0.589 . . . . 0.0 111.95 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.29 134.19 30.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.15 1.9 . . . . 0.0 112.024 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB2' HG22 ' A' ' 51' ' ' VAL . 8.1 tmtt? -93.45 -63.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 164.43 -30.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.41 1.069 . . . . 0.0 108.935 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 51' ' ' VAL . 36.3 p -106.39 172.88 3.53 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.793 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 48' ' ' THR . 6.2 Cg_exo -75.5 -0.99 10.76 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.765 2.31 . . . . 0.0 112.436 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.9 1.43 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.474 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 48' ' ' THR . 44.9 t -60.46 -25.11 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 110.816 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' HD21 ' A' ' 10' ' ' LEU . 10.2 t -87.68 -4.45 58.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.081 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.66 123.56 28.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 4.6 p-10 -75.63 131.83 76.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 26.8 Cg_exo -62.98 104.61 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.176 2.584 . . . . 0.0 113.292 -174.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.98 -37.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.204 0.526 . . . . 0.0 109.786 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -24.34 67.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.127 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.492 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.0 mm -65.26 -36.42 77.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.38 99.69 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.586 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.68 -28.2 40.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.668 0.27 . . . . 0.0 111.21 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.96 -41.77 97.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.98 0.419 . . . . 0.0 110.6 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.8 mp -58.74 -25.75 63.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.147 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.18 -8.12 7.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.2 -30.18 64.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.593 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.21 92.86 37.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.095 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.54 -0.91 9.98 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.993 2.462 . . . . 0.0 111.601 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.26 -24.9 42.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.794 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -110.39 161.02 16.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 p -95.67 113.93 25.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.063 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -86.94 95.51 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.027 0.441 . . . . 0.0 110.918 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HG2' ' HB1' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -88.11 117.66 27.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.769 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 t -90.6 107.89 19.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.037 0.446 . . . . 0.0 110.293 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 22' ' ' VAL . . . -105.66 127.57 53.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.349 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.572 HG22 ' HB2' ' A' ' 40' ' ' LEU . 22.3 pt -127.15 140.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.46 167.43 19.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.346 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.12 168.4 15.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.8 -37.19 86.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.77 -49.17 78.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -67.6 -45.44 75.5 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.082 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 p -67.24 -32.78 74.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.398 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.61 -49.42 77.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.16 97.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.2 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.506 HD13 ' HG ' ' A' ' 27' ' ' LEU . 92.8 mt -65.98 -41.87 90.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.796 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.87 86.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.661 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.56 -39.82 71.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.0 110.63 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.34 -37.41 72.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.437 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -91.27 -35.33 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.51 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.76 -18.95 5.33 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 t -94.22 96.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.512 ' HD2' ' HG3' ' A' ' 91' ' ' ARG . 46.3 p90 -122.74 154.07 38.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.602 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 90' ' ' PHE . 20.2 mtp180 64.93 22.68 12.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.128 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.12 90.33 13.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.676 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.68 133.64 15.82 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.48 -172.68 3.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.26 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 15.3 m -99.81 108.72 21.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.4 117.42 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.211 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.7 p -102.58 128.76 55.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.234 0.54 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -121.39 134.06 55.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.086 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.599 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 34.2 p -119.99 123.7 44.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.001 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.97 22.9 65.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.488 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 1.44 90.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.923 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -100.51 143.13 31.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.52 0.2 . . . . 0.0 110.516 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.74 112.52 3.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.254 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.506 ' HB3' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.55 -49.75 6.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.48 -173.08 46.03 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.163 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.2 136.51 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.846 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.3 mt -122.52 157.67 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.225 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' HB2' ' HE1' ' A' ' 111' ' ' HIS . 18.5 m120 -132.39 142.63 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.04 165.62 50.86 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.52 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.6 mp 60.98 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.673 0.749 . . . . 0.0 111.067 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.517 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 9.0 m80 -155.94 150.19 19.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.167 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 115' ' ' GLU . 13.0 Cg_endo -57.22 137.08 80.13 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.56 2.173 . . . . 0.0 111.216 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.52 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.8 t-105 -59.4 -43.97 92.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.581 -173.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.34 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.598 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . 44.6 tt0 -72.5 -39.28 67.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.347 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.82 -45.27 93.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.967 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 113' ' ' TRP . 63.2 mt -60.84 -49.82 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -50.61 -56.19 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.208 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 82.7 mt -64.89 -43.3 93.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.995 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -65.52 -47.45 75.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.45 . . . . 0.0 110.076 -177.245 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ttt85 -65.62 -32.63 74.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.42 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.2 68.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.956 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 65.4 mt -75.64 -53.2 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.954 -0.145 . . . . 0.0 111.055 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 120' ' ' MET . 18.8 m -64.56 -38.48 82.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.084 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 46.6 85.72 0.16 Allowed Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 124.037 0.835 . . . . 0.0 111.996 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -79.66 177.25 8.65 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.754 2.303 . . . . 0.0 112.664 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -77.63 -5.62 50.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.36 0.6 . . . . 0.0 110.513 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 59.35 66.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.056 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -109.42 14.32 23.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.116 0.96 . . . . 0.0 109.842 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -121.65 100.04 6.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.178 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 65.14 174.79 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.924 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.477 0.656 . . . . 0.0 110.376 178.271 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -101.71 -60.29 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.98 106.51 17.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -77.38 141.58 39.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 111.199 -173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 27.8 m -164.76 -51.86 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.882 -175.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 2.9 Cg_exo -76.14 -46.42 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.147 1.898 . . . . 0.0 111.59 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.85 -43.92 94.69 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -50.51 -52.68 36.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.59 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.99 -49.49 77.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.478 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -56.46 -46.47 80.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.871 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.503 ' CZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.4 t90 -66.08 -45.22 82.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.213 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -55.51 -40.13 71.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 16.1 mmm180 -60.24 -54.01 50.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -63.19 -33.28 75.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 74' ' ' ILE . 1.8 mm? -63.19 -30.04 71.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.554 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -29.21 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.739 0.304 . . . . 0.0 111.548 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -75.73 -7.38 54.22 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.35 19.74 44.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.785 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -76.71 128.09 34.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 109.786 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.4 m -83.0 129.71 60.32 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 29.6 Cg_endo -65.55 128.83 20.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.747 175.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.66 144.02 22.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -109.53 168.08 9.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.13 -39.49 94.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.705 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.2 t -77.6 -16.33 58.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.396 0.617 . . . . 0.0 110.815 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -98.91 -9.66 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 27' ' ' LEU . 1.5 tm? -59.59 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.162 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.25 -45.15 89.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' THR . 24.9 t70 -60.61 -55.14 36.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.538 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -57.9 -39.3 77.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.133 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.3 tp -66.54 -28.31 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -89.06 -26.26 21.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.713 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -80.93 -42.69 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 111.275 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 157.1 44.23 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.743 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.1 -69.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.012 1.808 . . . . 0.0 111.117 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.47 -79.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.982 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.67 -166.9 51.17 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.676 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 97' ' ' VAL . 19.3 m -135.93 150.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 98' ' ' PHE . 74.7 t -129.96 127.07 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.34 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.559 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.0 131.21 46.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.81 -39.58 69.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -156.98 -66.76 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.488 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.454 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 19.4 m -153.89 -170.04 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.65 ' HB3' HD11 ' A' ' 110' ' ' ILE . 8.5 t70 -128.63 80.87 71.82 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.208 0.528 . . . . 0.0 110.182 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 67.1 Cg_endo -90.76 131.62 1.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.482 2.121 . . . . 0.0 113.824 -173.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 8.8 tmtm? -136.26 -58.6 0.75 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -112.88 -29.17 7.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.37 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HB ' ' OE2' ' A' ' 50' ' ' GLU . 1.5 m -85.79 135.97 37.26 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.687 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.92 -1.23 10.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.363 2.042 . . . . 0.0 111.415 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.563 ' HG2' ' HB3' ' A' ' 45' ' ' PRO . 21.3 mm-40 72.88 112.34 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.389 1.056 . . . . 0.0 111.211 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.25 -73.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.09 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -128.29 -59.07 1.18 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.13 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 t70 47.82 78.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.442 -168.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.2 106.31 0.92 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -12.95 81.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.821 4.348 . . . . 0.0 115.126 -159.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.22 -73.3 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.11 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -60.39 -35.06 74.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.648 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.74 -38.11 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -63.75 -47.37 87.05 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.413 -175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.71 -36.32 37.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 111.487 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD21 ' HG3' ' A' ' 120' ' ' MET . 23.9 tp -66.53 -55.14 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.118 -173.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.49 -27.45 67.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 48.8 mmt-85 -71.6 -7.82 50.19 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.84 -40.33 83.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.146 0.498 . . . . 0.0 110.176 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.634 ' HB3' ' HD2' ' A' ' 68' ' ' TYR . 99.2 m-85 -129.54 84.23 62.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.714 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -82.03 -14.02 9.98 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.871 2.381 . . . . 0.0 113.365 -174.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.77 -25.46 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.387 0.613 . . . . 0.0 110.268 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.634 ' HD2' ' HB3' ' A' ' 65' ' ' PHE . 60.4 m-85 -84.14 111.24 19.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.079 175.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 p -67.96 104.76 1.81 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.006 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -86.81 95.06 9.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.364 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -87.0 105.11 16.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.17 125.77 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.815 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.22 140.63 51.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.56 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 40' ' ' LEU . 13.8 pt -125.44 140.66 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.93 0.395 . . . . 0.0 110.558 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -106.92 157.41 17.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' CH2' ' A' ' 11' ' ' TRP . 2.8 p30 -87.02 -174.07 4.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -59.44 -42.91 93.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.358 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -75.35 -36.93 60.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.29 0.567 . . . . 0.0 110.874 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.538 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 82.3 mm-40 -73.59 -44.66 56.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.499 -175.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 p -59.38 -43.24 92.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.73 0.3 . . . . 0.0 110.932 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.98 -41.16 82.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -40.45 61.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.234 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 79' ' ' GLN . 77.8 mt -65.54 -48.06 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.372 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.62 -48.15 83.78 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.894 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.52 -52.41 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 122.636 0.374 . . . . 0.0 110.673 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -68.52 -26.39 65.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.92 -26.61 31.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.078 0.466 . . . . 0.0 110.237 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.79 -0.24 48.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.75 -26.47 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 109.938 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 65.14 -141.78 0.22 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 92' ' ' PHE . 50.7 mtt-85 -92.1 -158.1 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.654 -170.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 90.5 t80 75.16 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.185 0 O-C-N 124.219 0.949 . . . . 0.0 109.456 -172.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.77 131.16 20.64 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.674 2.25 . . . . 0.0 112.27 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.05 -174.8 4.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.37 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.2 m -92.11 113.36 25.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.08 118.85 32.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.178 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.3 p -98.39 131.65 45.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.53 ' HE2' ' HB ' ' A' ' 39' ' ' VAL . 95.2 m-85 -118.22 146.7 44.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.278 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 1.9 m -153.4 146.28 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.28 20.55 63.2 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.059 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 16.43 78.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.755 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -131.47 174.0 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -70.06 112.9 6.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.817 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.5 tpm_? -90.24 -41.49 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.225 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.59 -175.39 44.44 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.855 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.6 137.97 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.2 mt -94.7 161.34 14.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.705 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -169.31 96.28 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.079 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 46' ' ' LYS . . . 130.79 91.8 0.58 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.727 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 44' ' ' ASP . 40.2 mm -62.17 -31.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.353 0.597 . . . . 0.0 111.46 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.636 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 6.4 t-80 -68.28 -58.87 6.81 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -168.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 11.8 Cg_exo -71.02 121.87 8.25 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.721 1.614 . . . . 0.0 112.308 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.441 ' CZ3' HD23 ' A' ' 116' ' ' LEU . 7.1 t-105 -93.51 -45.41 7.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.214 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.43 98.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.49 -43.46 94.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.696 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.441 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 30.7 tp -58.59 -49.39 77.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.904 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.44 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.7 mt -58.17 -48.93 83.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -52.16 -55.63 19.78 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.146 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.2 mt -64.62 -45.26 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.691 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -60.72 -51.77 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttm-85 -64.09 -39.45 94.09 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.189 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.01 -30.35 73.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.542 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 95.0 mt -81.43 -56.68 3.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.425 0.155 . . . . 0.0 110.822 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 120' ' ' MET . 31.8 m -68.56 -36.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -114.31 110.27 48.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 95.57 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.503 2.136 . . . . 0.0 111.972 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -81.14 59.75 4.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.375 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.51 77.72 6.07 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.497 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.25 168.43 11.09 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.882 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -75.58 -13.74 60.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.831 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.8 79.25 9.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.948 -179.619 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.494 0.664 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.0 m -85.17 -47.1 10.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.023 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -109.68 137.77 47.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.425 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -73.23 100.91 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.085 0.469 . . . . 0.0 110.04 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.578 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 21.3 m -158.99 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 33.1 Cg_endo -65.62 -46.32 5.45 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.693 1.595 . . . . 0.0 112.009 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -66.37 -41.69 89.1 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.267 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.29 -53.59 56.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 110.293 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.79 -42.86 98.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.278 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -60.47 -49.7 76.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.903 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -37.28 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.68 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -59.81 -37.14 78.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.4 mtt180 -69.89 -52.03 28.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.55 177.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.5 mtp -55.11 -40.7 70.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.843 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.402 HD11 ' HD3' ' A' ' 21' ' ' PRO . 2.8 mm? -68.47 -31.01 70.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.62 68.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -85.34 -1.07 56.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.633 0.254 . . . . 0.0 111.486 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.53 22.84 41.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.009 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -81.55 119.08 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -78.8 121.17 83.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.719 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -82.78 127.88 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.817 2.344 . . . . 0.0 111.79 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.88 137.76 13.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 0.0 111.01 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 25' ' ' SER . 4.4 m -94.43 130.95 40.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.605 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' SER . 1.5 tm-20 17.86 -98.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.727 1.211 . . . . 0.0 111.491 162.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' SER . 14.7 t 23.84 -78.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.021 1.328 . . . . 0.0 113.927 149.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 30' ' ' TRP . 9.7 tpp180 -106.92 -15.61 14.66 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.571 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.51 -36.39 73.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.136 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' HH12 ' A' ' 86' ' ' ARG . 25.5 t70 -66.1 -41.88 90.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 32' ' ' THR . 32.3 t70 -57.93 -49.61 76.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.816 0.817 . . . . 0.0 109.885 174.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.428 ' HD1' ' HG3' ' A' ' 26' ' ' ARG . 5.3 m95 -53.5 -43.01 67.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.406 173.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -38.29 90.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.0 t -74.35 -25.11 59.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -86.99 -10.11 53.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.315 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 103.69 44.47 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.62 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.17 -36.35 81.29 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.571 2.18 . . . . 0.0 111.085 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.78 -88.8 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.249 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.86 113.37 3.0 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.926 173.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 72' ' ' VAL . 11.1 m -138.78 134.28 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 0.0 110.406 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.35 129.1 67.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.515 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.7 117.49 34.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.453 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.67 26.1 7.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.2 m 61.42 -154.15 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.738 ' HA ' ' HB2' ' A' ' 93' ' ' PRO . 73.6 m -150.23 162.34 40.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.513 0.196 . . . . 0.0 110.473 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 25.6 t70 -79.94 117.22 66.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.692 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 2.0 Cg_endo -81.26 133.37 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.916 2.411 . . . . 0.0 111.493 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -114.18 -83.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.024 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -113.21 -31.29 6.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 50' ' ' GLU . 7.2 m -62.59 115.93 20.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.631 176.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.77 11.89 3.17 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.081 2.52 . . . . 0.0 112.491 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.44 ' H ' HG22 ' A' ' 48' ' ' THR . 43.6 mt-10 -126.33 86.68 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.695 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -71.82 -24.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.176 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t -68.76 -42.81 76.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.726 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 52.65 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.979 0.799 . . . . 0.0 111.653 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -160.12 85.74 2.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.17 44.15 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.847 2.365 . . . . 0.0 112.971 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.72 -26.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.049 0.452 . . . . 0.0 110.488 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -24.6 67.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.692 -173.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 62' ' ' LEU . 48.8 mm -61.77 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 110.575 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.21 68.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.567 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.92 -31.64 70.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.045 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -70.84 -46.03 63.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.04 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ILE . 10.0 mp -59.07 -27.72 65.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.368 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.86 -14.79 36.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.45 -44.69 82.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.636 0.255 . . . . 0.0 110.834 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.99 72.04 34.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.655 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -91.53 15.99 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.148 2.565 . . . . 0.0 112.822 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.89 -25.35 59.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.482 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -157.31 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.7 p -116.87 102.49 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 112.073 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -95.25 84.41 4.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.89 104.35 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.385 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.428 ' HA ' HG23 ' A' ' 38' ' ' VAL . 52.7 t -87.64 103.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.021 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.13 132.25 52.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' HB2' ' A' ' 40' ' ' LEU . 18.0 pt -114.37 139.69 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.31 154.68 19.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.794 0.33 . . . . 0.0 111.358 -176.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 2.0 m-20 -56.96 155.95 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.646 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.33 -53.86 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.21 -26.74 59.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.094 0.473 . . . . 0.0 110.894 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CG ' ' HB2' ' A' ' 76' ' ' ASP . 20.1 mm-40 -70.36 -29.66 66.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.719 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -62.86 -38.6 91.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.522 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.68 -42.89 95.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.614 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.07 93.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.17 -47.88 90.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.92 -46.98 93.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.688 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.86 -45.55 86.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.66 HH12 ' HB2' ' A' ' 28' ' ' ASP . 47.6 ttt180 -57.76 -37.34 73.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.468 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HB3' HG23 ' A' ' 89' ' ' VAL . 19.8 t80 -82.26 -40.12 22.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 0.0 109.843 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.1 33.56 4.26 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.593 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 87' ' ' PHE . 21.8 t -92.81 -15.57 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.507 0.194 . . . . 0.0 110.941 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.6 t80 72.15 174.01 0.3 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -172.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -71.23 96.81 1.45 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.808 0.337 . . . . 0.0 111.016 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -142.39 100.82 5.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.738 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 2.4 Cg_endo -83.83 123.97 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.781 2.32 . . . . 0.0 111.914 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -172.05 -170.08 0.71 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.818 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 30.8 m -96.73 109.27 21.96 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.61 120.32 34.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.048 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.92 130.35 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.982 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.73 172.89 6.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.539 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.68 122.83 7.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.632 175.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.61 29.84 54.86 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.716 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.01 90.63 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.892 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.82 157.09 18.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.092 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -71.69 119.08 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -93.7 -46.27 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.38 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.55 -167.67 40.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.108 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.5 134.58 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.941 0.401 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.2 mt -92.71 114.36 26.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.293 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.7 98.86 6.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.335 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.48 140.35 2.87 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.33 -39.16 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -109.41 -44.56 0.1 Allowed Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 16.5 Cg_exo -65.17 120.32 7.52 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 120.718 1.292 . . . . 0.0 110.897 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.536 ' HE3' ' HA ' ' A' ' 113' ' ' TRP . 2.1 t-105 -97.68 -51.0 4.26 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.825 -168.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.14 73.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 110.466 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -77.84 -35.14 51.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.419 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -62.57 -46.6 87.59 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.1 mt -61.26 -43.0 95.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.399 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -49.75 -58.04 6.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.225 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.5 mt -57.09 -49.2 76.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.724 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.503 ' O ' HG22 ' A' ' 124' ' ' VAL . 15.8 tpt -61.5 -42.78 99.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.547 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.03 -35.99 82.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.09 71.06 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.237 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 95.9 mt -78.06 -47.25 18.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' MET . 34.4 m -77.92 -34.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -116.74 87.04 20.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.89 149.96 5.87 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.798 2.332 . . . . 0.0 114.22 -168.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -91.85 -0.2 57.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.995 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 72.35 101.42 0.07 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.629 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -134.69 -178.7 5.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.796 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -74.11 113.73 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 110.359 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 152.44 37.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.484 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -108.05 138.46 44.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.767 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 66.66 174.45 0.25 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.589 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -90.42 115.24 27.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.322 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.671 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 99.3 m -156.62 -65.54 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.947 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.671 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 58.8 Cg_endo -75.15 -66.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.336 1.357 . . . . 0.0 113.248 -175.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -60.85 -33.34 72.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.77 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.44 -53.89 50.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.674 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.68 89.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.961 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -62.76 -55.3 27.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.844 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -65.51 -36.94 85.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.81 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -56.09 -39.64 72.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.588 0.232 . . . . 0.0 111.146 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 32.5 mmt180 -63.19 -51.86 64.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.452 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 87.2 mtp -55.1 -38.87 68.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.272 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.62 -38.23 67.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.999 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.21 -28.14 69.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.99 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -64.08 -20.77 66.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.67 32.49 7.61 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.325 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -98.85 134.81 41.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.012 0.434 . . . . 0.0 110.026 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.521 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 2.6 p -86.43 137.79 34.3 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.819 -176.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 1.8 Cg_endo -82.56 141.28 11.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.313 2.675 . . . . 0.0 113.257 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.72 148.04 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -114.77 167.73 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -36.77 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.929 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 t -79.78 4.74 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.381 0.61 . . . . 0.0 110.398 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -118.09 -12.49 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.837 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tt -48.72 -47.77 41.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.269 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -68.32 -51.52 43.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.065 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 32' ' ' THR . 13.4 t70 -54.76 -55.46 29.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.219 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -69.03 -31.61 70.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.7 -28.36 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.697 0.76 . . . . 0.0 109.688 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 85.6 m -71.32 -29.85 65.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.373 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.73 -61.37 2.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.73 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.74 113.85 59.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.824 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.51 -16.46 4.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.486 2.124 . . . . 0.0 112.888 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 24.6 m-20 -122.19 159.76 26.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.356 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.89 -166.32 25.69 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.209 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.82 137.11 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 99.0 t -117.41 119.65 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.164 0.507 . . . . 0.0 110.03 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.94 122.15 43.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.216 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.765 ' HB2' ' H ' ' A' ' 94' ' ' ALA . 7.7 mp -94.13 17.94 11.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.855 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 t 79.49 168.54 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.254 0.971 . . . . 0.0 110.088 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.711 ' HB2' HG13 ' A' ' 51' ' ' VAL . 7.2 m -82.45 -27.33 31.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.618 -174.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 93' ' ' PRO . 22.7 t70 67.45 132.73 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.81 0.694 . . . . 0.0 111.513 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.97 -24.44 74.02 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.039 2.493 . . . . 0.0 113.512 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -96.26 -41.68 8.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 8.8 tpm_? -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.718 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 17.7 m -126.42 114.48 23.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.582 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 48' ' ' THR . 17.5 Cg_endo -58.06 -38.52 91.4 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.842 2.361 . . . . 0.0 112.417 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.56 79.0 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 43' ' ' SER . 9.6 t -57.22 -31.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.156 -1.383 . . . . 0.0 112.244 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -82.79 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.789 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 t70 50.81 -144.73 0.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.796 0.685 . . . . 0.0 109.573 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -131.27 96.51 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.63 15.98 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.334 2.689 . . . . 0.0 113.617 -174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.09 -31.31 34.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.339 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -27.41 69.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.381 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.8 mm -59.99 -44.54 94.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.072 0.463 . . . . 0.0 110.237 176.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -66.69 -38.72 93.38 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.996 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 16.9 mm-40 -70.25 -28.75 65.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.301 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 63.5 tp -64.81 -49.36 70.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.8 mp -60.56 -25.63 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.797 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 36.7 mmt180 -56.81 -15.15 4.16 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.8 -8.69 59.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.047 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.708 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 73.7 m-85 -132.61 63.8 69.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.085 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -85.88 2.16 7.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.379 2.052 . . . . 0.0 112.961 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.8 -13.12 19.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.49 0.662 . . . . 0.0 109.901 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -108.98 120.0 41.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -64.65 110.11 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.708 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 87.8 m95 -91.22 117.24 29.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.551 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.69 106.21 18.19 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.34 105.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.889 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -114.78 140.05 49.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.801 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.687 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 24.3 pt -121.93 140.3 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.54 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -97.3 161.6 13.72 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.571 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -65.83 171.81 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.79 -55.7 21.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.052 0.453 . . . . 0.0 109.837 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -78.17 -34.82 49.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.642 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 96.6 mt-30 -67.57 -35.06 78.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.81 -175.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 29.5 p -60.72 -48.61 81.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -57.98 -47.58 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.138 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.19 81.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.782 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 79' ' ' GLN . 67.9 mt -62.11 -51.38 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.131 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.91 94.01 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.565 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -54.46 -44.69 72.77 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 111.221 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 86' ' ' ARG . 23.1 ttt180 -73.0 -31.15 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.729 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -85.17 -31.13 23.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.27 25.07 11.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.43 111.16 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.858 -0.201 . . . . 0.0 110.893 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 69.77 -58.48 0.52 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.691 0.797 . . . . 0.0 112.859 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 70.9 15.21 6.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.832 0.825 . . . . 0.0 108.826 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -129.6 151.19 77.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.98 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.75 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 51.3 Cg_exo -56.16 132.93 54.93 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.818 2.345 . . . . 0.0 112.744 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.765 ' H ' ' HB2' ' A' ' 41' ' ' LEU . . . -165.22 -175.49 3.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.018 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 43.7 m -109.4 115.53 30.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.02 136.36 44.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -114.71 137.03 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.71 128.88 53.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -169.7 134.61 1.4 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.13 0.491 . . . . 0.0 112.28 -175.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.29 22.63 65.54 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.737 173.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 130.99 59.78 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.046 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 103' ' ' TYR . 2.2 t30 65.59 -153.53 0.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.906 0.483 . . . . 0.0 111.739 172.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.5 ' H ' HD21 ' A' ' 102' ' ' ASN . 87.1 t80 -41.38 112.22 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.222 0.951 . . . . 0.0 111.754 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -101.04 -31.58 11.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.583 -176.358 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.29 -174.17 42.47 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.353 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.83 137.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.551 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.2 mt -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.408 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -133.18 142.15 48.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.432 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.93 167.17 43.15 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.114 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 51.0 mm -83.22 -69.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 60.9 m80 71.61 156.49 0.16 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 123.8 0.687 . . . . 0.0 111.537 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.16 152.13 82.43 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.411 2.074 . . . . 0.0 111.052 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 20.9 t-105 -56.75 -40.8 76.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.527 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.04 79.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.359 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -80.26 -26.79 38.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -46.61 85.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.33 -41.03 91.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.876 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.77 -53.87 46.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.434 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.72 -49.16 76.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.407 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.641 ' HG2' HD21 ' A' ' 61' ' ' LEU . 15.4 tpt -54.5 -51.98 63.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.909 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.7 ttt180 -70.61 -33.57 71.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.725 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.92 -30.86 74.26 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.538 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 97.6 mt -83.89 -59.81 2.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.026 0.13 . . . . 0.0 111.058 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 121' ' ' ARG . 27.7 m -65.17 -27.23 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.81 82.94 21.44 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -91.73 176.56 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.096 2.53 . . . . 0.0 113.397 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -93.57 -0.13 56.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.009 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 62.68 37.41 12.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.864 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.75 139.66 40.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.936 -1.483 . . . . 0.0 109.165 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 61.61 83.02 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.007 0.817 . . . . 0.0 110.88 -173.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.87 93.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 109.823 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.664 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG3' ' HB ' ' A' ' 48' ' ' THR . 55.3 mtt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 p -78.39 83.29 4.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 108.935 170.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 7' ' ' PHE . 14.2 p30 -88.32 54.32 3.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.104 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -87.41 11.26 15.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.227 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.511 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 31.1 m -151.06 -58.4 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.357 -174.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 5' ' ' THR . 13.9 Cg_endo -58.23 -55.69 2.06 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.121 1.881 . . . . 0.0 112.657 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.543 ' CB ' ' HB2' ' A' ' 3' ' ' ASN . 67.9 t80 -64.71 -42.04 95.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.4 -51.49 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.97 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.15 76.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.556 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -46.05 80.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -65.64 -41.93 92.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.354 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -58.25 -37.02 74.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.388 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.86 -53.63 47.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.0 mtm -60.87 -36.96 80.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 110.6 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.5 -40.45 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.567 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.2 67.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.533 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -75.56 -5.95 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.93 23.27 30.61 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.96 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -88.96 118.89 29.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 m -80.02 121.67 82.28 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.349 -169.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 39.6 Cg_endo -70.08 120.9 7.55 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 0.0 110.761 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG11 HD23 ' A' ' 27' ' ' LEU . 12.4 p -124.95 143.82 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.2 t -84.91 159.32 20.35 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.778 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.53 -54.16 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.124 0.57 . . . . 0.0 111.98 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 m -67.05 -23.71 65.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.149 0.499 . . . . 0.0 111.362 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -86.72 -26.1 24.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.332 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -60.42 -41.36 93.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.05 -42.52 72.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.251 0.548 . . . . 0.0 110.324 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.67 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 13.4 t70 -63.72 -55.81 20.44 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.366 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.6 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t90 -62.94 -35.76 81.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.447 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.4 tm? -63.83 -32.04 73.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.647 0.737 . . . . 0.0 109.044 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 97.5 m -71.95 -37.49 69.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.793 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 14.6 mm-40 -74.41 -33.72 63.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.13 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.03 142.98 30.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.381 -177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.6 Cg_exo -69.6 -39.67 6.53 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.822 2.348 . . . . 0.0 111.874 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 6.8 t70 -145.67 154.46 42.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.16 147.68 9.45 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.907 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 97' ' ' VAL . 29.4 m -125.2 142.43 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 55.8 t -125.04 131.9 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.512 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.31 124.77 47.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.4 mp -98.2 125.12 43.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.4 m -84.87 -58.9 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.728 ' HA ' ' HG3' ' A' ' 81' ' ' GLU . 38.7 m 53.1 81.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.91 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -170.62 111.33 0.43 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.95 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -95.9 -22.09 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.21 2.607 . . . . 0.0 112.827 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -124.49 -65.38 1.05 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -162.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.7 tpm_? -93.89 -42.22 9.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -162.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 30.9 m 72.95 92.26 0.05 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 110.365 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.0 -46.23 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.381 2.721 . . . . 0.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -161.66 110.41 1.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.132 0.492 . . . . 0.0 109.96 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.4 -28.51 13.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.778 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.34 -2.37 48.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.703 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.657 ' HA ' HG13 ' A' ' 110' ' ' ILE . 14.7 t70 -72.07 113.45 9.12 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 49.72 63.48 10.12 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.991 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.56 -41.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.124 1.883 . . . . 0.0 113.664 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.89 -42.18 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -56.58 -24.44 47.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.462 ' O ' HD13 ' A' ' 62' ' ' LEU . 41.8 mm -62.03 -44.35 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.837 0.351 . . . . 0.0 110.958 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.81 -26.75 74.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.062 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.91 -42.76 38.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.992 0.425 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 48.9 tp -60.75 -48.28 82.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.646 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.3 mp -58.72 -26.86 64.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.888 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 11.4 mmt180 -68.3 -7.63 32.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 10.1 pt-20 -83.09 4.88 24.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.298 175.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . 97.7 m-85 -109.97 90.15 9.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.03 -43.41 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.056 2.504 . . . . 0.0 113.517 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.72 -25.61 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.223 0.535 . . . . 0.0 110.679 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 65' ' ' PHE . 11.1 t80 -88.77 107.78 19.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.615 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 p -89.06 125.76 35.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.993 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -102.82 129.77 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.118 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -87.39 105.98 17.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.36 115.81 33.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.91 0.386 . . . . 0.0 110.592 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -121.76 147.56 45.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.553 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.627 HG22 ' HB2' ' A' ' 40' ' ' LEU . 10.4 pt -134.55 147.4 29.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.058 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -122.77 153.81 39.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 3.5 m-20 -60.43 179.66 0.15 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.63 -55.9 28.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.629 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.52 -42.98 81.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ASP . 14.3 mp0 -54.96 -51.1 67.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.205 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 p -65.62 -39.58 91.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.59 0.233 . . . . 0.0 110.647 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.728 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 42.8 mt-10 -61.58 -46.01 91.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.179 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.29 82.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.334 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.26 -44.23 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.331 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.42 87.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.909 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.35 -50.77 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.179 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -65.49 -27.91 68.82 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -87.48 -23.59 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.014 0.435 . . . . 0.0 109.829 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.16 32.03 10.16 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.507 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.13 82.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 85.8 m-85 53.19 -156.99 0.17 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.385 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -158.28 41.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 87.4 m-85 -129.46 160.19 65.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.136 -174.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 52.0 Cg_exo -53.56 130.52 39.17 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.602 2.201 . . . . 0.0 112.231 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -175.65 158.95 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 32.7 m -107.6 115.16 29.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.671 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.01 129.4 42.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 104' ' ' ARG . 3.9 p -108.21 125.71 64.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.289 0.566 . . . . 0.0 111.545 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.25 119.49 37.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.964 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.538 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -101.67 -175.68 2.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.095 -174.199 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 99' ' ' THR . . . -54.41 -28.17 43.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.442 170.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.11 28.73 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.879 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.99 -156.48 0.26 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.524 0.73 . . . . 0.0 111.113 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -49.51 125.38 11.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.201 0.524 . . . . 0.0 111.633 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.496 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.7 tpt180 -104.75 -59.57 1.72 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.216 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.76 -159.12 21.07 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.807 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.54 134.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 3.0 mm? -92.99 117.1 29.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.552 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.65 154.05 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.41 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.826 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.657 HG13 ' HA ' ' A' ' 53' ' ' ASP . 41.3 mm -84.2 78.36 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 52.1 m-70 -156.72 -61.38 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 172.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 16.8 Cg_endo -94.73 124.77 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.565 2.177 . . . . 0.0 113.058 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 19.3 t-105 -82.69 -39.63 21.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.307 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.28 97.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.675 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 20.2 mp0 -64.78 -39.0 92.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.995 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.47 -48.01 82.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.0 mt -61.41 -42.49 93.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.125 0.488 . . . . 0.0 110.244 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -58.04 -49.18 77.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.847 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.6 mt -59.68 -44.8 93.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.905 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt -62.5 -37.47 86.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.728 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 121' ' ' ARG . 3.4 tmm_? -62.96 -41.88 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.21 -30.94 79.22 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.588 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.82 -56.54 4.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.097 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' ARG . 28.5 m -64.02 -41.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.225 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.459 ' HB3' HH11 ' A' ' 121' ' ' ARG . 43.5 tt0 -109.94 96.62 25.65 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.65 143.1 99.73 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.775 2.317 . . . . 0.0 112.646 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.653 ' HB2' ' HB2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -80.73 -14.7 57.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.481 0.658 . . . . 0.0 110.867 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 53.28 68.5 0.83 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.746 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 58.95 29.06 18.44 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.13 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -72.26 149.6 44.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.205 177.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.46 112.55 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.454 . . . . 0.0 110.61 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 -179.556 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m 71.01 -0.56 3.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.718 0.636 . . . . 0.0 111.497 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.52 133.33 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 109.967 175.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -103.7 104.16 14.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.277 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 56.0 m -156.88 -63.94 0.02 OUTLIER Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 36.9 Cg_endo -65.76 -64.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.584 1.523 . . . . 0.0 112.831 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 77' ' ' LEU . 38.2 p90 -66.18 -32.31 73.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -54.93 -54.91 36.64 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.326 0.584 . . . . 0.0 110.763 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -60.83 -41.17 95.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.462 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -57.01 -47.5 80.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.455 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.94 -43.72 91.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.51 -32.77 71.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.393 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 59.5 mmt-85 -62.84 -54.52 37.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.479 175.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.0 mtm -60.96 -33.45 73.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 74' ' ' ILE . 3.1 mm? -65.05 -37.97 89.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.575 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.6 -19.21 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 17.1 mmm180 -84.85 -4.73 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.16 17.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.857 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -100.66 136.89 39.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.048 0.451 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 m -86.63 124.6 69.19 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.47 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.674 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -80.25 146.21 17.58 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.929 2.419 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG11 HD23 ' A' ' 27' ' ' LEU . 12.0 p -148.74 145.26 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.67 0.271 . . . . 0.0 111.133 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 m -73.53 159.59 32.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.371 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 8.6 tm-20 -55.56 -58.6 7.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.502 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -70.11 -7.29 40.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.113 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.419 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.5 tpp180 -106.23 -16.83 14.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.324 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -59.19 -43.04 92.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.359 0.599 . . . . 0.0 110.436 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 32' ' ' THR . 17.3 t70 -63.87 -54.0 41.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.527 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 73' ' ' ALA . 91.1 t90 -54.33 -43.59 71.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.103 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.79 -44.19 94.07 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.382 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.6 t -74.88 -24.32 58.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.02 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -80.36 -16.9 53.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.087 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.97 152.85 38.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.5 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 -23.0 22.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.353 2.036 . . . . 0.0 112.277 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 7.4 t70 -156.37 -171.61 3.77 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 98' ' ' PHE . . . 165.1 128.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.58 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.34 146.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 59.2 t -133.26 136.77 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.665 0.269 . . . . 0.0 111.021 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -97.68 125.96 42.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 80' ' ' SER . 0.9 OUTLIER -94.84 125.43 39.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.685 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 11.1 t -147.33 105.92 3.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.9 m -143.19 92.92 2.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.783 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.72 71.7 1.44 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.712 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.866 ' HG2' HG21 ' A' ' 51' ' ' VAL . 16.8 Cg_exo -69.1 133.47 26.87 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.464 2.109 . . . . 0.0 111.917 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -111.2 -63.81 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -68.6 -24.93 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -55.79 121.21 38.31 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.7 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.2 -41.6 72.05 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.134 2.556 . . . . 0.0 113.201 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.53 118.64 0.36 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.787 0.803 . . . . 0.0 109.427 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG21 ' HG2' ' A' ' 45' ' ' PRO . 3.9 t -84.83 -24.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.296 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' HD11 ' A' ' 10' ' ' LEU . 32.2 t -68.57 -3.95 13.58 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -84.4 -168.47 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.453 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.434 ' OD1' HG12 ' A' ' 58' ' ' ILE . 43.0 t30 62.17 72.78 0.6 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.568 . . . . 0.0 111.67 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -92.78 -40.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.403 2.069 . . . . 0.0 113.491 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.29 -33.12 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.5 -31.56 66.14 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' HD13 ' A' ' 62' ' ' LEU . 13.5 mm -65.35 -38.75 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.133 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.19 99.67 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.896 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.3 mm-40 -72.8 -28.65 62.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HG ' ' HG2' ' A' ' 120' ' ' MET . 34.8 tp -68.18 -35.04 77.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.7 mp -60.96 -26.86 67.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.376 176.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 72.8 mtt180 -62.59 -7.42 4.69 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.66 -31.39 68.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 110.383 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.52 88.5 49.89 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.978 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.53 -20.06 16.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.761 2.307 . . . . 0.0 111.774 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.8 -11.66 52.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.59 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -120.41 115.31 23.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.13 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 t -80.59 156.95 26.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.669 0.747 . . . . 0.0 110.554 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -124.76 124.57 42.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.571 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -91.35 98.46 11.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.012 0.434 . . . . 0.0 109.947 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.81 111.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.091 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -123.76 149.28 45.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.36 0.6 . . . . 0.0 111.063 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.8 pt -130.53 140.3 49.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.37 164.01 13.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.006 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.4 m-20 -61.96 150.42 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.989 173.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 7' ' ' PHE . 15.4 mt -53.6 -45.71 70.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.742 -174.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.94 -47.42 18.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.685 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 39.9 mt-30 -69.79 -18.57 63.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' HD22 ' A' ' 41' ' ' LEU . 11.6 p -61.5 -34.0 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.272 0.558 . . . . 0.0 110.559 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.69 -46.67 88.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.625 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.16 96.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.078 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.526 HD13 ' HG ' ' A' ' 27' ' ' LEU . 63.4 mt -62.01 -44.79 99.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.29 -43.49 97.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.685 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.83 -41.97 98.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.66 -32.94 67.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -92.37 -45.64 8.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.962 0.411 . . . . 0.0 110.424 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.55 23.9 4.25 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.081 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.77 -83.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.6 t80 59.01 -163.93 0.21 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.628 0.58 . . . . 0.0 109.927 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 34.1 ttp180 65.04 80.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.785 0.434 . . . . 0.0 111.757 175.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 89.6 m-85 72.0 141.23 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 13.1 Cg_exo -72.53 138.22 29.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 124.072 3.181 . . . . 0.0 112.73 176.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . -160.6 -178.19 6.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.541 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.6 m -92.18 122.86 35.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 106' ' ' VAL . 43.6 mt -99.48 113.87 26.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 123' ' ' LEU . 13.4 p -103.55 126.68 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.7 0.762 . . . . 0.0 110.93 -178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.567 ' HD1' ' HA ' ' A' ' 103' ' ' TYR . 46.3 m-85 -122.87 150.55 42.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 40.6 p -128.43 124.49 36.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.91 28.97 71.15 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.931 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 -1.44 88.75 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.768 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.53 143.76 33.24 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.32 0.581 . . . . 0.0 111.717 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD1' ' A' ' 98' ' ' PHE . 73.3 t80 -69.42 136.99 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.292 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 1.5 mmp_? -113.79 -64.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.627 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . -172.06 -166.58 30.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.22 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 96' ' ' LEU . 6.5 m -122.23 146.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 122.476 0.31 . . . . 0.0 111.111 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 5.9 mp -99.63 134.0 43.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -123.48 12.61 9.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.383 0.611 . . . . 0.0 110.565 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.21 117.59 5.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.289 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.02 -36.42 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.874 0.368 . . . . 0.0 111.381 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 91.0 m-70 -122.7 -52.52 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 31.6 Cg_exo -56.84 123.19 13.27 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.729 1.619 . . . . 0.0 112.567 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.492 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.6 t-105 -85.18 -40.43 16.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.616 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.65 86.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 37.9 tt0 -72.84 -32.44 65.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.355 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 29.3 tp -64.46 -46.82 81.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 61.0 mt -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -51.07 -57.49 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 93.3 mt -60.76 -46.89 88.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.584 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.6 tpt -54.17 -44.67 71.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 125' ' ' GLU . 14.6 mmt180 -55.98 -49.12 74.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.2 -30.12 75.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.734 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 97' ' ' VAL . 94.4 mt -84.34 -55.09 4.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 120' ' ' MET . 23.9 m -87.01 -26.07 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.723 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 121' ' ' ARG . 31.5 tt0 -103.52 85.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.38 106.42 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.533 2.155 . . . . 0.0 114.1 -162.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -71.49 -21.88 61.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.899 170.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -166.46 121.01 1.12 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.686 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -91.98 23.35 3.76 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.612 0.72 . . . . 0.0 109.816 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -64.65 -23.85 67.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.793 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.23 86.38 7.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.59 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.382 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t 63.23 -165.27 0.24 Allowed 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.741 0.651 . . . . 0.0 110.136 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 8.8 m120 -107.81 125.89 51.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.313 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 89.9 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.518 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 82.9 m -153.22 -58.46 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.504 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 19.7 Cg_endo -63.31 -52.57 1.93 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.654 1.569 . . . . 0.0 111.417 172.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -67.15 -35.21 79.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.369 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.69 -53.77 54.59 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.207 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -57.89 -46.21 85.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.084 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 2.0 mm? -57.17 -51.81 67.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.511 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -65.55 -42.06 92.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.111 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 81.1 mm-40 -59.82 -31.76 70.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 35.5 mmt180 -57.33 -54.52 45.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 110.605 174.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.512 ' HB3' HD13 ' A' ' 74' ' ' ILE . 4.9 mpp? -66.86 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 2.4 mm? -64.57 -48.33 75.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.82 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.92 64.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.008 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 34.5 mmt180 -73.81 -21.15 60.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.648 0.261 . . . . 0.0 110.386 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.43 21.85 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.784 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.502 ' HZ3' ' HG3' ' A' ' 14' ' ' MET . 27.4 m0 -93.05 168.1 11.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.7 m -112.96 130.97 23.01 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 40.4 Cg_endo -68.91 121.4 8.27 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.909 2.406 . . . . 0.0 111.678 172.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.3 145.73 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.565 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 m -112.5 168.42 9.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.271 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.9 -47.47 85.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -71.74 -7.94 51.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.914 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 29' ' ' ASP . 28.3 mmt180 -117.7 -7.02 11.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.719 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.43 -49.45 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.12 -34.69 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.134 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 32' ' ' THR . 22.3 t70 -62.16 -56.98 13.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.038 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -74.65 -26.65 60.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.997 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.18 -35.03 78.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 111.081 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.6 t -80.97 -26.53 36.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.007 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -96.7 -0.91 47.58 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.011 0.434 . . . . 0.0 111.699 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.8 87.48 3.71 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.73 148.2 36.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.548 2.166 . . . . 0.0 113.62 -171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.8 t70 80.62 144.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.595 1.184 . . . . 0.0 111.649 174.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.03 -173.55 27.16 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.332 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 97' ' ' VAL . 5.3 m -138.09 138.91 43.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 73' ' ' ALA . 52.9 t -122.62 129.41 75.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.66 124.71 32.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -97.47 98.89 10.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.1 m -71.4 107.29 4.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -107.92 -58.86 1.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.889 0.376 . . . . 0.0 111.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.689 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 11.1 t70 -152.59 120.01 3.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.609 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.71 -24.03 13.88 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.265 2.644 . . . . 0.0 112.576 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -82.95 -27.91 30.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.584 0.707 . . . . 0.0 109.394 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 2.4 tpt180 -52.77 -40.51 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.144 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 25.9 m -124.68 120.03 25.79 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 16.3 Cg_exo -68.69 -31.89 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.835 2.357 . . . . 0.0 113.304 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -120.18 81.39 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.635 0.731 . . . . 0.0 111.116 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 t -100.46 -25.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -72.32 -6.97 46.98 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.677 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -96.96 -0.28 47.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 110.659 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 49.6 t-20 -78.43 -54.55 1.17 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 54' ' ' ASN . 12.5 Cg_exo -70.88 44.58 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.037 2.491 . . . . 0.0 114.505 -169.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.31 -53.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.56 -25.82 64.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.473 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' HD13 ' A' ' 62' ' ' LEU . 45.2 mm -60.78 -37.99 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.42 -34.25 89.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.619 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.68 -37.72 62.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.306 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 44.6 tp -64.18 -38.76 92.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.253 -176.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.6 mp -65.41 -26.24 67.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.643 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -66.46 -9.04 30.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -70.1 -34.02 72.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.66 85.76 57.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.696 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -88.15 4.95 5.52 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.431 2.754 . . . . 0.0 112.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.86 -20.97 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 0.0 111.075 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -167.74 1.35 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 p -129.91 104.93 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -85.88 96.7 9.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.225 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.73 108.24 8.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.481 . . . . 0.0 109.768 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.66 108.27 20.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -116.58 145.01 43.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.912 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 6.9 pt -124.56 140.48 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.019 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.45 143.09 41.28 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.382 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.81 160.93 22.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 58.9 tp -54.49 -43.31 71.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.394 0.434 . . . . 0.0 111.501 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.92 -33.44 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.402 0.62 . . . . 0.0 111.06 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -77.94 -32.06 51.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.094 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.1 p -74.45 -29.1 61.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.723 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 51.2 mt-10 -54.19 -53.12 57.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 175.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 86' ' ' ARG . . . -70.58 -37.18 73.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.162 -173.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.49 -45.35 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 0.0 110.309 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -48.45 71.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.651 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -55.88 -42.67 76.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 110.875 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 49.8 ttt180 -57.12 -38.51 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.729 -176.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -95.85 -36.83 10.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.565 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.08 8.03 13.94 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.735 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.666 HG11 HD21 ' A' ' 96' ' ' LEU . 48.3 t -79.71 -24.41 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.36 105.57 0.3 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 178.86 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.772 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 37.1 p90 -146.23 143.62 19.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 3.6 Cg_exo -78.16 124.54 6.67 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.629 2.219 . . . . 0.0 111.263 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.23 174.76 14.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.082 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -101.76 119.5 38.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.727 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 89' ' ' VAL . 85.0 mt -94.18 121.83 36.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.0 p -95.69 132.63 39.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.149 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 94.7 m-85 -121.52 138.31 54.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.66 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -143.79 149.93 37.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 28.15 56.49 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.71 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.12 13.96 79.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.026 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -135.3 178.51 6.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.146 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.55 129.36 34.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -104.74 -51.83 2.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -176.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.79 -170.82 39.76 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.414 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.9 134.64 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.005 0.431 . . . . 0.0 111.499 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.09 110.38 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.018 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -121.55 129.9 53.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.915 0.388 . . . . 0.0 111.795 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.73 154.08 12.18 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.155 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.7 134.94 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -139.02 144.66 42.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.98 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.7 159.7 23.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.657 2.238 . . . . 0.0 111.546 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.482 ' CE2' HD11 ' A' ' 117' ' ' ILE . 5.4 t-105 -55.86 -48.79 74.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.0 78.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -40.77 87.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.665 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.5 tp -62.19 -48.0 81.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.4 mt -60.61 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.015 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -55.11 -54.37 44.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.868 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.88 -47.39 85.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.493 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.2 tpt -59.63 -43.15 93.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.634 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 124' ' ' VAL . 40.2 ttt180 -66.92 -33.75 76.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -30.97 71.14 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.23 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -84.7 -52.03 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.524 0.202 . . . . 0.0 111.527 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 121' ' ' ARG . 8.1 p -66.32 -31.47 53.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.763 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.546 ' HB3' ' NH1' ' A' ' 104' ' ' ARG . 33.7 tt0 60.72 100.91 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 124.031 0.832 . . . . 0.0 112.679 178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.33 172.15 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.942 2.428 . . . . 0.0 111.682 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -77.06 -7.15 55.2 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.803 0.811 . . . . 0.0 110.499 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -126.76 89.32 2.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.059 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -94.85 151.48 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.888 -171.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 130' ' ' ARG . 2.2 mmp_? -132.04 110.15 10.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.221 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.3 89.73 4.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.022 0.439 . . . . 0.0 111.773 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.86 175.226 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.506 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 40.0 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 15.3 Cg_endo -58.25 -63.58 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.068 1.845 . . . . 0.0 112.311 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.53 -35.81 82.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 110.186 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.03 -51.49 67.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.613 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -64.64 -46.91 80.5 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.552 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 52' ' ' SER . 70.3 mt -55.38 -46.14 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 12.8 t90 -62.25 -50.64 70.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -58.51 -32.94 69.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.892 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 4.6 mmp_? -61.29 -57.34 12.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 111.166 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.8 ptt? -70.79 -29.34 65.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.8 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -57.42 -46.4 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.085 0.469 . . . . 0.0 109.897 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.72 -10.12 57.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.863 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 14' ' ' MET . 50.7 mtt180 -84.89 -5.19 59.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 0.0 110.995 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.19 21.65 8.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.144 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.423 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 52.8 m0 -97.14 115.26 27.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -71.32 140.82 85.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.154 -176.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 15' ' ' LEU . 6.3 Cg_exo -76.72 141.76 22.18 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.052 2.501 . . . . 0.0 111.48 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 14.2 p -123.28 142.11 41.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.897 0.379 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -102.45 165.1 11.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 83' ' ' ILE . 3.4 tm-20 -57.21 -55.76 30.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -70.68 -13.39 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.031 0.443 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 21.2 mmt180 -96.19 -8.13 33.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.674 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD21 HG21 ' A' ' 39' ' ' VAL . 3.0 tm? -66.77 -41.34 87.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.32 -37.83 80.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.854 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -60.92 -55.97 26.62 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.039 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -43.32 68.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.181 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.29 -44.74 84.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.914 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -83.3 -26.99 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.705 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -81.66 -29.75 33.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.53 141.58 28.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.0 111.452 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 8.2 Cg_exo -72.47 -38.38 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.577 2.184 . . . . 0.0 111.045 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -160.15 169.18 23.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.637 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.46 -179.63 31.29 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.092 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' HB ' ' A' ' 97' ' ' VAL . 16.9 m -137.07 145.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.577 HG21 HD21 ' A' ' 27' ' ' LEU . 45.2 t -119.0 125.24 74.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.402 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.8 mp -98.8 116.44 31.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 96' ' ' LEU . 9.7 mp -98.24 116.06 29.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.982 0.42 . . . . 0.0 110.942 -174.446 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 10' ' ' LEU . 46.8 t . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.657 0.265 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 54' ' ' ASN . 17.8 t70 72.42 -22.26 0.22 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.206 1.002 . . . . 0.0 112.599 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 9.6 t30 83.05 99.54 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 123.572 0.749 . . . . 0.0 110.604 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.76 17.67 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 123.983 3.122 . . . . 0.0 114.599 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.23 -41.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -64.26 -24.79 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.247 -176.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 116' ' ' LEU . 47.9 mm -67.74 -38.14 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.462 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.05 -49.32 58.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.222 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.66 -28.61 69.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HG ' ' A' ' 116' ' ' LEU . 66.8 tp -60.87 -56.95 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 110.922 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.5 mp -62.23 -29.92 70.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.248 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 63' ' ' ARG . 7.8 mmt180 -75.05 -7.71 54.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -78.04 -6.87 55.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.086 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.81 78.85 9.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.437 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.06 -12.09 21.38 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.592 2.195 . . . . 0.0 113.081 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.44 -25.28 63.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.524 0.678 . . . . 0.0 110.315 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -103.56 120.72 41.43 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.539 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 p -80.66 103.29 10.41 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.418 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.548 ' HB3' HD23 ' A' ' 62' ' ' LEU . 96.8 m95 -83.9 100.39 10.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.094 -173.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.09 107.19 15.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.566 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -87.65 114.07 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.691 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -110.75 124.61 52.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 40' ' ' LEU . 8.5 pt -110.34 139.76 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.015 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.42 154.85 21.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.169 0.509 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' HB3' ' CG ' ' A' ' 79' ' ' GLN . 7.1 t70 -65.94 162.99 18.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.198 174.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.22 -53.04 62.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.15 -24.57 62.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.251 0.548 . . . . 0.0 110.228 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.483 ' CG ' ' HB3' ' A' ' 76' ' ' ASP . 89.3 mm-40 -76.08 -37.76 57.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.596 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.6 m -59.23 -42.72 91.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -62.45 -42.78 99.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.577 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.13 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.503 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 24' ' ' GLU . 80.2 mt -67.99 -43.77 85.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.351 . . . . 0.0 110.118 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.87 -46.11 94.04 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.636 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.4 -47.32 72.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.014 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.35 -31.17 71.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.732 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -87.77 -34.16 18.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.005 0.431 . . . . 0.0 110.675 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.31 45.09 1.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.145 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 90' ' ' PHE . 3.5 p -100.83 167.82 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' H ' HG22 ' A' ' 89' ' ' VAL . 18.6 m-85 -79.84 -67.61 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.683 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 91' ' ' ARG . 1.9 tpt180 -179.61 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.658 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 90.9 m-85 -51.06 117.22 8.44 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.882 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 5.4 Cg_exo -79.44 132.46 10.09 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.377 2.718 . . . . 0.0 111.889 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.24 -175.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.726 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 m -92.86 109.96 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.806 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 41' ' ' LEU . 6.2 mp -96.06 125.86 40.89 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.968 HG13 ' HB2' ' A' ' 104' ' ' ARG . 2.5 p -104.01 132.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.183 0.516 . . . . 0.0 111.288 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -127.68 135.28 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.111 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 m -145.4 144.7 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.97 35.59 54.12 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.119 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.66 12.7 62.23 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.052 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -122.36 166.87 14.02 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 111.288 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -93.79 120.22 33.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.592 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.968 ' HB2' HG13 ' A' ' 97' ' ' VAL . 25.6 mmt180 -79.15 -55.16 5.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.483 0.658 . . . . 0.0 109.78 176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.476 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 162.38 -166.75 36.66 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.939 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.47 134.37 65.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.089 0.471 . . . . 0.0 110.479 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.27 100.3 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.99 -7.9 52.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.174 0.511 . . . . 0.0 110.517 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.49 144.56 23.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.724 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.0 mm -136.53 -56.82 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.649 0.262 . . . . 0.0 111.566 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.769 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 36.9 t60 -88.02 -61.35 0.24 Allowed Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -168.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 23.5 Cg_exo -62.62 123.85 13.1 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.439 1.426 . . . . 0.0 111.864 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.433 ' O ' HG13 ' A' ' 117' ' ' ILE . 11.4 t-105 -76.49 -48.39 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.069 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.32 75.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 110.788 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 39.6 tt0 -75.64 -40.31 56.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.244 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 58' ' ' ILE . 50.1 tp -57.57 -44.4 85.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.473 ' HA ' HD11 ' A' ' 61' ' ' LEU . 68.8 mt -58.86 -45.37 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 40.5 t30 -61.68 -42.09 98.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.576 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 92.5 mt -60.32 -48.88 79.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.338 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.3 tpt -65.93 -36.48 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 109.865 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 60.9 ttt180 -56.36 -45.08 80.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.958 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.88 -30.59 70.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.483 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 83.2 mt -77.63 -36.66 51.42 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.883 -0.186 . . . . 0.0 111.374 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 120' ' ' MET . 34.5 m -82.02 -39.76 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.262 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 120.934 0.397 . . . . 0.0 110.156 173.42 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 51.3 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 34.0 Cg_endo -66.74 -36.57 23.93 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 121.83 1.686 . . . . 0.0 111.829 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 77' ' ' LEU . 85.9 t80 -75.3 -38.12 60.49 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.388 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -50.22 -51.48 43.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.709 0.766 . . . . 0.0 109.377 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.27 -45.95 92.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.747 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -54.69 -52.05 63.62 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 111.459 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.2 t90 -65.78 -37.88 87.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.218 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.739 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -60.05 -33.56 72.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 28.4 mmt85 -59.38 -55.28 36.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.324 0.583 . . . . 0.0 110.336 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.6 mtm -67.39 -31.63 71.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.325 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -69.38 -34.94 75.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -22.0 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 17' ' ' ARG . 19.3 mmm180 -82.09 -8.88 59.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.594 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.9 10.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.851 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 20.9 m -93.45 122.84 61.96 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 3.7 Cg_exo -81.66 117.74 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.435 2.757 . . . . 0.0 111.179 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.11 151.39 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -81.2 159.77 24.5 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 79' ' ' GLN . 1.5 mp0 -49.63 -57.01 8.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.543 0.737 . . . . 0.0 112.978 -170.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -63.23 -32.4 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.97 0.414 . . . . 0.0 111.521 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -88.53 -11.81 44.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.405 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.43 -42.26 83.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.52 -38.91 59.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.628 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 32' ' ' THR . 11.2 t70 -57.83 -55.6 32.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.565 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -59.82 -46.55 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.776 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.47 -41.5 94.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.86 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.9 t -73.16 -25.92 60.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.381 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -89.86 -8.63 51.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.784 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 146.33 32.73 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.409 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.71 -39.17 12.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.404 2.069 . . . . 0.0 112.295 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.6 t70 -166.58 177.34 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.13 30.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.441 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 97' ' ' VAL . 15.8 m -136.51 146.24 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.41 125.11 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.214 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.4 mp -94.47 128.34 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 93' ' ' PRO . 56.0 tp -87.41 136.46 32.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.189 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.427 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 66.3 m . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.09 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.38 -69.21 0.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.883 0.739 . . . . 0.0 110.426 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -148.68 85.21 6.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' A' ' 13' ' ' ARG . 89.5 Cg_endo -79.44 44.36 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.079 2.52 . . . . 0.0 113.677 -169.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.37 -40.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.747 0.308 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -28.69 70.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.628 -173.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.46 -43.66 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.33 89.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.964 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.28 -28.18 59.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.009 0.433 . . . . 0.0 110.552 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD11 ' HA ' ' A' ' 117' ' ' ILE . 56.8 tp -63.55 -47.26 82.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.738 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.32 -28.29 69.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 23.1 mmt180 -73.3 -7.71 52.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.172 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -64.07 -35.45 80.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.348 0.594 . . . . 0.0 109.626 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -129.14 81.94 69.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.537 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.75 8.49 3.66 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.886 2.391 . . . . 0.0 113.007 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.64 -25.19 62.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 0.0 110.221 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.47 127.02 53.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.967 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.4 p -71.66 108.75 5.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.928 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -80.71 105.58 12.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.264 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 102.43 5.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.82 106.59 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.282 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.46 126.57 53.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 20.3 pt -112.23 140.78 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.869 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.39 145.46 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.602 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.619 ' HB3' ' HG2' ' A' ' 79' ' ' GLN . 21.0 t70 -63.41 160.06 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.657 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.654 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 65.8 tp -55.49 -52.95 61.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.205 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.16 -30.87 58.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.905 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 7.3 pt20 -77.75 -22.92 49.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.068 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 74.0 m -63.03 -29.24 70.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 110.063 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 20.5 mm-40 -56.13 -44.78 79.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.257 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.02 -37.13 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.396 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.06 -47.71 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.82 97.68 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.505 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 26.3 t70 -58.97 -38.73 79.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -71.19 -31.56 67.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.668 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -91.2 -29.56 17.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.027 0.442 . . . . 0.0 110.899 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.87 29.51 4.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.048 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.39 122.78 64.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -136.38 18.82 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 110.715 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -99.55 -165.41 1.22 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.697 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -53.15 143.19 34.32 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 123.622 0.576 . . . . 0.0 112.319 -175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' HD23 ' A' ' 41' ' ' LEU . 37.9 Cg_endo -65.87 140.4 60.82 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.358 2.705 . . . . 0.0 112.56 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.7 -178.23 7.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.699 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 28.1 m -99.0 120.09 38.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.465 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.55 118.42 31.66 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.0 p -100.91 124.47 54.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.244 0.545 . . . . 0.0 110.991 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.5 119.34 29.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.421 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 63.6 p -95.61 123.61 39.24 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.15 16.12 47.1 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.974 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.57 63.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.941 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -102.28 141.1 35.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.277 0.561 . . . . 0.0 111.293 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -70.74 118.88 14.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.187 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -98.01 -48.17 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.535 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.04 -166.24 36.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.064 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.62 134.59 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 110.597 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 94.7 mt -97.46 119.97 36.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -138.08 129.33 27.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.729 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.54 127.63 1.93 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.67 -44.57 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.144 0.472 . . . . 0.0 112.233 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -97.42 -51.04 0.22 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.78 120.85 8.2 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 120.692 1.283 . . . . 0.0 111.864 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.567 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 t-105 -96.68 -37.74 10.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.813 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.203 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 30.8 mt-10 -81.5 -27.58 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.613 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 6.0 mt -56.72 -44.77 81.95 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.458 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 61' ' ' LEU . 63.1 mt -65.3 -42.32 93.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -57.11 -57.45 12.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.628 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.3 mt -56.38 -41.27 75.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.576 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 124' ' ' VAL . 14.9 tpt -60.49 -50.42 73.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.445 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -66.89 -35.68 80.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.227 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.17 -29.52 73.14 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.604 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.39 -45.76 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 120' ' ' MET . 21.4 m -78.51 -28.09 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.557 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.663 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 20.9 m . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 119.757 -0.163 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 3.9 Cg_exo -76.72 -67.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.126 1.884 . . . . 0.0 112.5 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -59.73 -35.06 73.78 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 110.648 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.41 -49.9 75.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.588 . . . . 0.0 110.725 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . . . -65.46 -34.23 77.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.533 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.89 -43.67 87.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.184 0.516 . . . . 0.0 110.074 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -38.1 85.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.807 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG2' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.5 -33.56 75.13 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 110.331 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 48.4 mmm-85 -63.21 -53.62 50.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 109.907 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtp -58.73 -40.11 82.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.697 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.0 -35.38 72.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.347 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.82 68.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.625 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -82.76 2.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.27 -0.68 64.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.97 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -67.93 135.04 51.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 109.752 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.4 m -110.47 130.74 22.57 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.314 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 2.7 Cg_exo -76.8 153.72 33.67 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.267 2.645 . . . . 0.0 112.132 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 27' ' ' LEU . 13.0 p -148.0 152.48 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.214 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -81.74 158.53 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.253 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -43.61 -61.72 1.31 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.004 0.922 . . . . 0.0 112.854 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.1 m -67.53 -29.25 68.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.69 -171.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 26' ' ' ARG . 5.0 ttp-105 -85.86 -17.34 35.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.859 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.464 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -65.18 -39.65 93.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.665 ' HB2' HH12 ' A' ' 86' ' ' ARG . 18.7 t70 -62.74 -44.27 96.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.886 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.43 -52.84 63.92 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.212 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -50.67 -49.85 56.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.637 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.0 tp -61.44 -34.85 76.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -89.4 -26.3 21.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 0.0 111.851 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -92.59 -35.25 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB1' ' NE2' ' A' ' 71' ' ' GLN . . . -96.28 133.02 25.54 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.315 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.02 140.57 90.64 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.591 2.194 . . . . 0.0 110.985 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 11.9 t70 68.82 -158.4 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 131.66 97.98 0.73 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.261 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.08 141.75 23.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 122.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -99.52 130.56 45.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.172 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -82.11 175.29 10.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 110.987 -177.642 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -54.4 -77.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.468 0.175 . . . . 0.0 111.144 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.0 p30 -171.39 139.19 1.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.67 0.271 . . . . 0.0 110.633 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 86.0 Cg_endo -103.3 42.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.586 2.857 . . . . 0.0 112.193 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.4 t -84.78 -23.13 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.842 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.475 ' HG3' ' N ' ' A' ' 58' ' ' ILE . 19.7 ptt? -48.35 -47.81 36.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.883 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.475 ' N ' ' HG3' ' A' ' 57' ' ' MET . 47.8 mm -60.12 -35.03 59.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 110.964 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -66.98 -46.14 76.17 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.753 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -79.22 -36.81 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 110.916 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 120' ' ' MET . 21.9 tp -63.12 -57.82 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.092 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.92 -29.79 69.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.516 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.513 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 8.2 mmt180 -78.6 -6.43 55.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.0 pt-20 -69.25 -12.94 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.58 174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 69.4 m-85 -110.86 82.85 3.23 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 64' ' ' GLU . 3.1 Cg_exo -81.46 -9.9 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.117 2.545 . . . . 0.0 112.825 -174.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.06 -25.42 47.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.482 . . . . 0.0 111.736 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -119.97 137.1 54.26 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 p -86.81 114.18 23.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.752 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.522 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 70.9 m95 -81.87 133.48 35.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.825 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.568 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 37.2 mt-30 -105.28 108.51 20.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.396 0.617 . . . . 0.0 110.1 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.39 116.6 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.704 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.92 140.85 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.022 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 32.7 pt -125.47 158.1 34.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.541 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -135.09 156.03 49.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.69 -167.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.217 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 77' ' ' LEU . 6.1 mp -59.74 -53.68 55.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.509 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.67 -44.78 76.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.137 0.494 . . . . 0.0 110.777 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 2.5 mp0 -61.97 -50.54 71.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.615 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 p -63.33 -43.45 97.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -65.62 -36.48 83.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.053 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.99 -44.09 70.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.01 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 93.0 mt -65.34 -41.93 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.123 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.2 98.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.17 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.75 -40.87 89.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.083 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.665 HH12 ' HB2' ' A' ' 28' ' ' ASP . 48.8 mtp180 -52.94 -40.85 63.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.485 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -90.85 -65.6 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.07 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.72 -15.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.262 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.23 95.0 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.789 0.328 . . . . 0.0 110.175 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -133.49 160.76 36.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 56.1 ttt-85 67.09 6.78 4.96 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.565 0.54 . . . . 0.0 110.711 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.407 ' HE2' HG11 ' A' ' 106' ' ' VAL . 80.7 t80 -128.64 101.68 20.64 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.242 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.79 126.58 10.19 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.737 2.291 . . . . 0.0 112.516 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.91 -175.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.891 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 36.9 m -101.82 120.03 39.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.276 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.99 118.55 32.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 104' ' ' ARG . 3.8 p -97.81 121.6 48.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.354 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.85 162.21 19.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.47 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.88 129.69 1.81 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.006 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.78 29.53 73.82 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.842 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.0 -6.46 41.68 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.517 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -98.38 156.9 16.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.297 0.57 . . . . 0.0 111.762 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -93.85 130.45 39.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.5 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.834 ' HB2' HG13 ' A' ' 97' ' ' VAL . 37.2 mmt180 -96.45 -59.89 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.643 0.258 . . . . 0.0 110.726 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.69 -153.7 16.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.132 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.407 HG11 ' HE2' ' A' ' 92' ' ' PHE . 53.6 t -121.23 133.7 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.6 mt -109.34 123.71 49.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.229 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -156.35 128.95 7.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.753 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.33 127.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.827 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.8 mm -114.26 -26.47 2.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 0.0 110.637 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.1 m80 -98.06 -58.92 0.15 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 6.2 Cg_exo -78.82 119.83 4.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.086 1.191 . . . . 0.0 111.807 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.518 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.1 t-105 -96.67 -48.42 5.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.239 -173.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.2 73.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.479 . . . . 0.0 110.616 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.79 -40.73 54.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.462 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 37.1 tp -58.73 -44.26 90.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.259 . . . . 0.0 110.776 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.0 mt -61.8 -48.93 86.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.614 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -51.59 -56.72 11.91 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.212 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.0 mt -62.03 -40.93 97.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.441 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.759 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -62.19 -48.68 78.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.846 0.355 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.62 -37.83 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.68 -30.07 76.56 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.432 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 98.3 mt -83.28 -49.03 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.82 -30.56 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.397 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 27.4 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 36.8 Cg_endo -68.08 -40.55 8.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.283 1.322 . . . . 0.0 110.729 169.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -65.52 -39.21 91.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.428 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -51.99 67.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 109.578 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.7 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.908 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -54.36 42.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -34.35 77.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -60.98 -38.17 85.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 0.0 110.829 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -61.74 -53.8 51.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.516 0.674 . . . . 0.0 109.977 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 55.7 mtp -60.8 -34.99 75.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.37 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.34 -32.09 62.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.14 -23.28 65.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.216 0.532 . . . . 0.0 110.505 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -79.52 -10.71 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.45 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.81 26.65 44.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -89.68 140.93 29.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.441 . . . . 0.0 110.147 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -92.63 123.36 62.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.054 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.69 127.23 13.59 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.774 2.316 . . . . 0.0 111.319 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.12 136.74 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.514 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -67.8 161.71 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.499 0.5 . . . . 0.0 112.012 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.36 -60.28 2.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 112.047 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 m -78.43 -10.17 59.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -92.37 -22.2 19.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -44.09 91.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.761 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.99 -39.38 90.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -64.2 -56.32 15.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.102 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -67.68 -33.19 74.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.748 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.18 -42.09 99.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.572 0.225 . . . . 0.0 111.182 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -73.05 -25.85 61.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.756 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.78 -19.19 55.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.35 157.37 58.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.012 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.12 -64.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.438 2.092 . . . . 0.0 111.292 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -142.48 168.11 20.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.07 -178.18 48.7 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.569 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 97' ' ' VAL . 30.3 m -138.72 150.01 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.263 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.97 128.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.65 130.36 44.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.043 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.65 -67.42 0.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.563 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.679 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 49.1 m . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.176 0.512 . . . . 0.0 110.879 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.78 76.64 0.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.543 -174.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.9 t30 63.08 81.67 0.22 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.523 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.94 12.12 1.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.103 2.536 . . . . 0.0 111.944 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.11 -34.16 49.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.711 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -56.7 -30.98 64.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.361 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 62' ' ' LEU . 49.8 mm -61.12 -42.9 95.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 110.681 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.68 -33.93 60.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.349 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.44 -32.01 65.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.643 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 58.6 tp -64.37 -49.15 72.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.312 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.5 mp -58.68 -26.43 63.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -56.17 -19.03 11.82 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.8 pt-20 -87.01 22.08 2.13 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.631 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 55.3 p90 -67.44 122.29 82.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 38.4 Cg_endo -97.51 -53.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.974 2.45 . . . . 0.0 114.095 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.7 -26.16 17.14 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.562 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.5 p90 -143.54 142.57 31.17 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.538 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 t -86.08 151.27 23.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 65' ' ' PHE . 91.0 m95 -98.4 119.73 37.6 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.011 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.69 98.52 9.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.52 108.34 18.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.504 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.8 138.3 48.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.8 pt -118.65 145.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.94 167.58 12.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.47 172.66 10.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.947 173.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.86 -42.83 66.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.08 -44.72 83.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.501 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 83' ' ' ILE . 53.7 tt0 -70.64 -41.99 71.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.776 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -63.04 -42.26 99.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.296 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.15 -36.66 83.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.008 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.03 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.401 HD11 HE21 ' A' ' 79' ' ' GLN . 55.2 mt -65.46 -46.2 90.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.48 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.53 ' HA2' ' HB ' ' A' ' 89' ' ' VAL . . . -57.31 -49.25 74.14 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.728 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.26 -42.7 70.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 111.027 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -73.33 -31.56 64.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.737 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -101.61 -25.76 13.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.551 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.5 2.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.342 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 84' ' ' GLY . 38.8 t -118.11 150.07 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.94 163.21 26.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.928 0.394 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -72.96 -9.37 58.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.914 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 53.5 m-85 -70.34 127.09 92.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.553 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 17.1 Cg_exo -65.57 124.38 12.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.855 2.37 . . . . 0.0 112.338 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.27 3.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.3 m -109.84 127.12 54.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.43 116.99 29.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.528 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -98.76 126.28 51.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.496 0.665 . . . . 0.0 111.499 -175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -115.15 138.47 50.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -148.4 144.14 27.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.27 19.21 66.08 Favored Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.897 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.26 89.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.496 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -120.51 157.25 29.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -79.12 123.22 27.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.349 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -88.99 -60.28 2.0 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.36 -161.36 24.74 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.691 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.38 134.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.7 mt -100.43 105.71 17.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.22 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -117.97 97.52 5.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.489 0.661 . . . . 0.0 110.947 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.6 138.05 5.86 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.54 -33.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.998 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.801 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 m-70 -135.48 -54.58 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.801 ' HD2' ' H ' ' A' ' 111' ' ' HIS . 6.8 Cg_endo -50.18 120.25 5.97 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.677 1.585 . . . . 0.0 112.532 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.643 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 4.0 t-105 -99.11 -46.64 5.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.535 -170.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 118' ' ' ASN . . . -60.17 -34.56 73.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 110.005 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 17.3 mm-40 -68.87 -47.95 64.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.528 176.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.28 -49.52 76.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.82 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 113' ' ' TRP . 52.1 mt -60.29 -41.39 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 114' ' ' ALA . 31.7 t-20 -53.52 -57.59 10.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.569 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 81.1 mt -68.66 -41.68 78.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.293 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -50.48 73.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.721 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.531 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.5 ttt85 -69.97 -32.63 70.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.267 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.46 75.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.216 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.2 mt -81.62 -50.32 9.47 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.84 -0.212 . . . . 0.0 111.135 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 121' ' ' ARG . 31.1 m -67.0 -38.95 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.635 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 5.0 Cg_exo -74.42 -52.91 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.138 1.892 . . . . 0.0 111.923 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -65.95 -41.07 91.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -53.25 -53.68 47.29 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.14 -49.3 77.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.229 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 52' ' ' SER . 3.0 mm? -59.2 -46.5 88.27 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.294 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.08 -47.86 78.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -61.48 -40.23 93.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.323 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 47.2 mmm-85 -59.26 -54.47 46.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.502 ' HB2' ' CE3' ' A' ' 19' ' ' TRP . 24.6 ptt? -70.99 -29.26 65.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.312 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 11' ' ' TRP . 34.4 mt -57.23 -39.42 75.48 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.34 65.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.804 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -74.29 -15.07 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.0 111.215 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.24 13.87 20.0 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.563 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 49.2 m0 -82.7 122.01 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.039 0.447 . . . . 0.0 109.832 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.5 m -91.94 132.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.613 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 23.0 Cg_exo -65.02 120.36 7.58 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 111.658 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.5 139.79 24.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.217 0.532 . . . . 0.0 110.916 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 m -92.66 150.22 20.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.096 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.35 -50.79 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.5 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 m -85.23 13.55 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.067 0.46 . . . . 0.0 111.293 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -121.23 -10.92 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.683 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.8 tm? -55.11 -43.8 74.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.472 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 32' ' ' THR . 30.5 t70 -64.41 -43.09 95.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 32' ' ' THR . 17.5 t70 -61.26 -55.57 30.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -62.5 -40.51 96.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.044 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -70.94 -29.43 65.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -75.01 -27.79 60.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.547 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 35.1 mt-30 -90.7 -44.05 9.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.147 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.35 94.57 11.7 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.923 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 8.2 Cg_exo -72.59 140.84 33.47 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.199 2.599 . . . . 0.0 113.556 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t70 73.91 167.07 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.407 1.067 . . . . 0.0 111.474 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.98 -165.35 24.32 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.023 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.88 152.61 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 122.524 0.33 . . . . 0.0 110.793 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.53 131.5 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.49 138.15 38.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.93 175.97 5.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 111.29 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.232 0.539 . . . . 0.0 110.845 -178.869 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.1 t70 59.43 -85.85 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.662 0.785 . . . . 0.0 112.741 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -144.03 99.31 5.08 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 111.304 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -95.51 -167.72 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.174 2.583 . . . . 0.0 112.454 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.8 t 75.09 -37.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -53.43 -24.31 12.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.496 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.0 mp -58.96 -38.95 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.718 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.7 -38.18 94.26 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.406 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -72.79 -28.48 62.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.742 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.2 tp -61.35 -43.68 98.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.266 0.555 . . . . 0.0 110.347 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.8 mp -64.67 -27.44 68.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.072 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.49 -17.24 63.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.912 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -70.1 -36.37 74.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.689 0.28 . . . . 0.0 110.611 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -141.49 77.78 19.16 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.095 0.474 . . . . 0.0 110.537 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.0 16.83 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.142 2.562 . . . . 0.0 112.598 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.97 -25.67 67.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.524 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -116.71 166.85 11.65 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 p -85.29 105.49 16.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.921 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -91.44 103.57 16.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.752 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.18 122.2 31.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.199 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.8 t -97.96 107.39 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 124.71 50.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.504 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 30.6 pt -110.42 144.41 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -115.41 153.17 31.54 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.769 -0.372 . . . . 0.0 112.001 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.3 m-20 -61.88 168.86 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.518 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.09 -49.1 74.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.614 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -66.56 -34.47 77.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.23 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 66.5 mm-40 -75.53 -48.17 23.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.277 -172.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 78.4 p -65.49 -41.4 93.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -58.01 -44.74 87.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.279 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.41 -41.53 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 79' ' ' GLN . 73.9 mt -60.9 -45.33 98.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.955 0.407 . . . . 0.0 110.196 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.28 75.72 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.231 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -38.06 89.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' HH11 ' A' ' 86' ' ' ARG . 21.3 ttt180 -59.85 -27.93 67.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.428 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.89 -45.14 4.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.02 44.77 0.52 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.672 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.77 HG11 HD21 ' A' ' 96' ' ' LEU . 17.2 t -103.86 156.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 172.6 13.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 0.0 110.729 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 60.4 mtm180 -98.4 -161.01 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.667 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 62.2 m-85 73.93 165.93 0.13 Allowed Pre-proline 0 N--CA 1.467 0.387 0 O-C-N 123.953 0.783 . . . . 0.0 110.83 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 92' ' ' PHE . 21.4 Cg_endo -59.56 123.36 13.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.029 1.819 . . . . 0.0 111.679 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 106' ' ' VAL . . . -161.74 143.04 11.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.783 -174.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 23.8 m -110.77 113.3 25.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.0 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 89' ' ' VAL . 5.9 mp -93.43 137.31 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.37 130.11 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.36 119.36 36.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.16 125.72 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.157 0.503 . . . . 0.0 112.051 -172.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.22 -63.32 2.91 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.968 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -136.17 64.47 0.58 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 64.89 -153.42 0.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.534 0.334 . . . . 0.0 111.793 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -50.24 108.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.833 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.71 -38.55 15.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.513 0.673 . . . . 0.0 109.832 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 170.5 -168.43 41.48 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.123 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.541 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 14.0 p -136.95 140.68 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.027 0.442 . . . . 0.0 111.037 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 93.7 mt -96.56 107.19 19.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.13 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -148.6 171.8 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.294 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.44 149.4 18.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.101 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.0 102.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 0.0 110.267 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 49.5 m80 -134.33 139.72 33.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 176.04 7.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 0.0 112.219 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.742 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 10.4 t-105 -58.39 -45.41 88.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.375 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.95 87.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.404 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 111' ' ' HIS . 4.4 tp10 -72.76 -33.12 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.441 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -63.0 -45.47 92.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.037 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.3 mt -62.9 -43.75 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.099 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -54.5 -58.26 8.18 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 91.7 mt -57.4 -47.44 81.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.463 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.1 tpt -59.46 -41.56 90.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.599 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -63.35 -40.6 97.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.42 77.8 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.839 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 74.0 mt -81.08 -50.95 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -70.86 -36.35 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.58 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.751 0.786 . . . . 0.0 112.428 179.133 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.724 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.648 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.724 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 6.2 Cg_exo -78.24 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.767 1.645 . . . . 0.0 111.443 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.95 -37.91 84.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.593 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.31 -54.42 33.45 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.35 90.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -58.17 -55.05 40.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.044 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -39.46 93.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.236 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.834 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -57.6 -39.86 77.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.571 0.224 . . . . 0.0 111.165 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -65.05 -53.41 46.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.186 0.517 . . . . 0.0 110.533 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.9 -37.8 74.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.116 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -34.91 76.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.381 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.79 66.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.023 0.439 . . . . 0.0 111.123 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 28.7 mmt180 -83.66 2.75 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.496 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.65 12.16 80.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.59 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HH2' ' HB2' ' A' ' 55' ' ' PRO . 51.5 m0 -77.51 124.01 27.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.501 ' HB ' ' CH2' ' A' ' 30' ' ' TRP . 21.5 m -85.46 123.93 72.2 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.971 -171.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.93 118.75 5.86 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.805 2.337 . . . . 0.0 111.463 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 27' ' ' LEU . 14.4 p -126.11 147.08 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m -95.23 165.09 12.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.181 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.26 -48.65 54.71 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.751 0.42 . . . . 0.0 112.114 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 m -59.74 -35.48 74.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.002 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 9.1 tpt180 -94.69 -18.29 21.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.79 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 3.4 tm? -64.05 -40.0 95.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.49 -42.66 96.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.168 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 28.5 t70 -63.14 -57.16 11.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.946 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CH2' ' HB ' ' A' ' 20' ' ' THR . 5.9 t90 -59.13 -39.65 83.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.196 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -66.95 -28.1 68.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.478 . . . . 0.0 110.419 177.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.5 m -75.19 -33.06 61.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 19.3 mm-40 -80.64 -48.34 12.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.406 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -73.0 135.3 80.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.401 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 2.1 Cg_endo -81.66 -21.93 5.78 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.911 2.408 . . . . 0.0 111.52 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 3.5 p-10 -95.31 -89.29 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.129 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 87.69 106.92 0.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.599 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 72' ' ' VAL . 5.5 m -131.89 134.08 60.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 171.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 73' ' ' ALA . 49.2 t -130.5 135.19 61.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.951 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mp -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.2 tt -104.46 128.29 52.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.025 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.865 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 10' ' ' LEU . 29.0 t . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 120.783 0.325 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.9 t70 49.55 71.4 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.527 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 t30 66.99 85.59 0.15 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.526 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HB2' ' HH2' ' A' ' 19' ' ' TRP . 96.7 Cg_endo -79.85 -5.7 13.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.526 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 21.6 t -61.9 -35.72 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.6 ttp -58.95 -37.37 76.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 62' ' ' LEU . 50.1 mm -69.91 -36.11 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.078 0.466 . . . . 0.0 110.346 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.83 -45.31 65.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.011 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 8.7 mm-40 -68.6 -28.22 66.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.84 0.353 . . . . 0.0 110.468 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 116' ' ' LEU . 24.7 tp -61.68 -54.93 36.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.483 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 58' ' ' ILE . 7.3 mp -52.27 -26.6 12.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.439 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.574 HH11 ' HG3' ' A' ' 63' ' ' ARG . 11.5 mmt85 -61.62 -9.4 6.02 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.99 -12.18 59.42 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 122.015 -0.428 . . . . 0.0 111.181 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -116.79 92.88 39.69 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.826 0.346 . . . . 0.0 110.622 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.77 2.9 6.43 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.75 2.3 . . . . 0.0 112.249 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.95 -26.69 62.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.716 0.77 . . . . 0.0 109.766 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -129.17 133.53 47.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.654 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 p -85.03 102.68 13.4 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.455 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.66 118.98 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.947 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -103.08 107.08 17.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.337 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 38' ' ' VAL . 26.8 t -88.21 120.37 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.22 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -107.15 133.04 52.34 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.263 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.7 pt -125.98 143.84 38.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -120.53 156.72 30.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.994 -174.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 169.22 4.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.53 -46.48 88.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.109 0.48 . . . . 0.0 110.35 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -61.82 -44.36 97.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.847 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 83.8 mm-40 -68.58 -39.22 81.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.167 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -58.25 -39.81 80.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.37 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -34.95 79.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.181 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.21 47.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.259 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 79' ' ' GLN . 74.6 mt -64.12 -46.94 92.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.53 96.74 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.946 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.38 -42.15 95.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 111.281 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -61.14 -32.31 72.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -100.55 -43.65 6.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.133 0.492 . . . . 0.0 111.001 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.2 42.6 0.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.59 142.96 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.537 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 21.3 m-85 -73.57 159.81 32.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -83.79 84.89 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.349 0.595 . . . . 0.0 112.13 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' A' ' 90' ' ' PHE . 30.5 p90 -169.25 152.66 5.1 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.652 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.0 Cg_exo -71.72 126.39 11.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.416 2.077 . . . . 0.0 111.337 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.88 168.77 25.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 26.2 m -100.85 120.23 39.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.12 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.402 HD22 ' OH ' ' A' ' 103' ' ' TYR . 35.6 mt -94.88 120.34 34.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.77 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.8 p -104.89 122.53 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.56 0.695 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.74 -177.97 3.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.505 ' OG1' ' HD3' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -151.23 -171.5 3.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.18 91.79 0.04 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.034 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.44 24.44 70.85 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.354 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.01 159.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.422 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' OH ' HD22 ' A' ' 96' ' ' LEU . 51.1 t80 -117.75 111.99 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -168.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.56 -171.2 34.72 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.046 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.55 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.5 mt -95.29 103.53 15.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -108.5 130.58 55.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.46 -165.56 24.95 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.783 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.7 mm -112.97 -69.52 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 79.1 m-70 70.95 143.32 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.74 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.45 159.65 19.13 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.647 2.231 . . . . 0.0 111.858 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 15.5 t-105 -54.05 -43.19 69.99 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.08 78.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 111.643 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 4.4 mp0 -72.49 -26.44 61.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.748 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' CD1' HD22 ' A' ' 61' ' ' LEU . 2.0 tm? -62.72 -47.43 83.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.5 mt -60.84 -45.91 97.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.264 0.554 . . . . 0.0 109.719 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -52.65 -58.28 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 89.6 mt -58.14 -42.22 85.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.595 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.442 ' HG2' HD21 ' A' ' 61' ' ' LEU . 16.9 tpt -57.73 -50.6 72.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 110.642 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.635 ' HA ' HG12 ' A' ' 124' ' ' VAL . 65.0 mtt180 -68.84 -32.05 71.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.31 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.73 -29.89 71.21 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.482 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.83 -45.92 6.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 121' ' ' ARG . 7.2 p -71.49 -26.04 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -172.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.699 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.439 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.501 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 85.3 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 19.3 Cg_endo -60.03 -72.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.961 1.774 . . . . 0.0 113.538 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.64 -33.59 76.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.67 -51.9 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.592 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -65.15 -44.05 89.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 52' ' ' SER . 3.2 mm? -62.33 -39.76 94.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.339 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -65.46 -44.77 86.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.13 -39.25 78.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.188 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 68.8 mmt-85 -61.57 -53.26 58.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.0 0.429 . . . . 0.0 110.616 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.415 ' SD ' HD22 ' A' ' 40' ' ' LEU . 75.4 mtm -61.4 -32.75 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.078 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.43 -40.09 89.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.608 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.24 65.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 6.2 mmp_? -71.24 -33.66 70.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.468 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.12 39.01 2.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.86 174.35 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.9 m -101.84 118.14 60.1 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.0 111.77 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 4.1 Cg_exo -80.27 126.92 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.41 2.74 . . . . 0.0 111.503 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 75' ' ' ALA . 11.8 p -135.52 142.34 39.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -97.6 167.45 10.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 111.435 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -52.73 -51.35 60.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.381 -175.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.9 m -75.36 -5.66 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.901 0.381 . . . . 0.0 111.782 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -106.85 -20.45 13.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.254 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 83' ' ' ILE . 2.8 tm? -56.12 -42.21 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.353 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.89 -46.18 72.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.319 0.581 . . . . 0.0 110.573 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 32' ' ' THR . 32.6 t70 -60.46 -53.59 55.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.346 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.93 -43.56 86.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.5 -40.12 95.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.692 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -70.12 -25.46 63.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.67 -42.83 13.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.047 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -66.79 134.79 94.17 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 34.9 Cg_exo -63.12 -44.42 15.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.483 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.802 ' HB2' ' HE2' ' A' ' 68' ' ' TYR . 1.5 t0 -161.36 177.34 10.23 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.04 -178.96 33.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.695 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 97' ' ' VAL . 20.2 m -138.37 156.48 30.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 122.501 0.32 . . . . 0.0 110.205 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.81 143.57 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.619 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' SD ' ' A' ' 14' ' ' MET . 7.7 mp -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 63.7 tp -114.93 96.55 5.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.417 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 CA--C 1.538 0.481 0 O-C-N 123.7 0.625 . . . . 0.0 112.562 173.071 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' HD11 ' A' ' 10' ' ' LEU . 37.4 t . . . . . 0 C--O 1.234 0.263 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 52.6 -144.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.683 0.614 . . . . 0.0 109.834 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.527 ' N ' HD22 ' A' ' 54' ' ' ASN . 0.0 OUTLIER -151.18 92.3 3.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -61.31 -95.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.797 2.331 . . . . 0.0 113.484 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 97.7 t 73.29 -51.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.326 0.584 . . . . 0.0 110.653 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.541 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 22.9 ptt? -59.51 -24.41 63.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.078 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.25 -45.09 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.897 0.38 . . . . 0.0 110.798 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.35 -40.2 80.51 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.588 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -63.08 -39.16 93.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.514 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 37.0 tp -59.99 -57.03 14.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.723 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.24 -28.02 68.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.132 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -75.43 -6.92 52.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.2 pt-20 -76.39 -13.54 60.12 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.243 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -131.26 71.09 82.06 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.45 12.46 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.25 2.634 . . . . 0.0 112.799 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.51 -14.35 60.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.676 0.75 . . . . 0.0 110.012 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.802 ' HE2' ' HB2' ' A' ' 36' ' ' ASP . 8.7 t80 -122.4 -177.12 3.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.208 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -109.44 123.02 48.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.685 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -108.34 106.67 16.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -90.39 110.91 21.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.015 0.436 . . . . 0.0 110.185 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.97 117.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.975 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -116.03 127.9 55.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -176.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.1 pt -119.57 139.33 47.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.493 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.65 171.24 7.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.7 m-20 -64.14 171.8 2.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.822 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -57.73 -54.26 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.568 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -74.61 -33.78 62.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.972 0.415 . . . . 0.0 111.32 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 2.6 mp0 -69.64 -39.52 77.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.06 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.4 m -55.23 -52.99 61.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.48 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 17.6 tp10 -59.93 -44.43 94.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.353 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.83 -41.31 95.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.894 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 79' ' ' GLN . 80.1 mt -63.01 -47.57 92.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.624 0.249 . . . . 0.0 110.964 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.19 92.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.519 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.99 -43.96 82.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.81 0.444 . . . . 0.0 111.262 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -67.7 -27.23 66.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -78.19 -39.06 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 109.944 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.52 -25.85 2.29 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.02 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -86.3 99.73 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.012 0.434 . . . . 0.0 110.142 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -93.76 131.79 38.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.709 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 0.4 OUTLIER 67.08 179.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.732 0.645 . . . . 0.0 112.011 173.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 70.02 105.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.869 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 37.5 Cg_endo -66.43 135.66 40.32 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.613 2.209 . . . . 0.0 112.528 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.8 -173.68 1.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.153 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 20.4 m -114.91 127.94 55.99 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.7 114.79 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -99.84 130.49 48.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.313 0.577 . . . . 0.0 111.105 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -123.43 164.95 17.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.804 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m -154.87 136.4 14.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 170.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.29 14.85 42.5 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.149 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.4 -5.6 84.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.242 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -94.71 149.09 21.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 110.912 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -74.44 126.88 31.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.11 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 3.5 mmp_? -99.23 -45.11 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.95 -165.13 38.68 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.674 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.44 134.04 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.101 0.477 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.0 mt -100.2 109.83 22.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.569 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -132.19 81.36 1.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.382 0.61 . . . . 0.0 109.605 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.18 64.48 0.34 Allowed Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.309 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 26.0 mm -80.35 83.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.487 0.184 . . . . 0.0 111.093 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 9.9 t-80 175.9 -60.12 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.703 172.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 1.6 Cg_endo -82.98 124.76 3.94 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.476 2.118 . . . . 0.0 113.035 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' A' ' 57' ' ' MET . 12.1 t-105 -77.09 -49.23 15.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.581 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.58 78.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.034 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 36.9 tt0 -74.23 -34.54 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.725 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.03 -43.33 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.11 -47.91 85.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -53.78 -49.52 68.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.434 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.51 -53.8 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.8 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 124' ' ' VAL . 17.6 tpt -56.76 -51.06 70.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.482 . . . . 0.0 110.512 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 125' ' ' GLU . 24.4 ttt85 -64.77 -31.75 73.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.562 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.9 61.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.669 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.12 -51.88 6.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' MET . 32.8 m -81.64 -24.81 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.631 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 31.3 tt0 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.123 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 42.1 m . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.87 -66.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.921 1.747 . . . . 0.0 112.124 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.8 -35.07 75.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.42 -53.51 55.66 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -66.44 -43.03 86.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.062 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.77 -37.72 82.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.816 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 15' ' ' LEU . 6.3 t90 -64.04 -48.61 75.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.541 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 45.3 mt-30 -60.51 -32.47 71.48 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.525 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 26.2 mmm180 -59.16 -53.32 59.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.002 0.429 . . . . 0.0 110.281 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.609 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 71.7 mtm -62.13 -33.37 74.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.845 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.548 HD22 HD11 ' A' ' 74' ' ' ILE . 2.7 mm? -59.51 -38.91 82.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.624 176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.04 66.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.39 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -75.63 -6.34 49.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.614 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.75 46.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.598 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 47.5 m0 -89.51 119.95 30.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 109.931 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -83.7 137.23 41.4 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.401 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 74.1 Cg_endo -76.95 149.83 29.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.48 . . . . 0.0 111.424 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -154.1 156.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 111.18 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 p -99.04 164.5 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.307 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.19 -42.73 73.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 111.66 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -30.44 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.65 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -85.23 -23.17 28.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 110.619 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -60.64 -39.26 87.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.622 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.33 -32.92 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.924 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 9.0 t70 -68.3 -55.24 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.047 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -60.69 -34.08 73.8 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.918 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.99 -43.03 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.322 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.0 t -74.55 -26.39 59.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.782 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 29' ' ' ASP . 98.0 mt-30 -64.57 -44.96 89.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.853 0.358 . . . . 0.0 110.651 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . . . -90.79 161.75 35.16 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.04 -45.56 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.326 2.017 . . . . 0.0 110.993 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -149.17 -178.16 6.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.119 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.11 -168.17 40.23 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.052 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.1 m -139.13 135.73 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.858 0.361 . . . . 0.0 110.477 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -124.11 133.18 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -95.84 131.43 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.948 0.404 . . . . 0.0 111.258 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 4.5 tt -107.71 117.19 33.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.612 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.871 179.891 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 CA--C 1.532 0.255 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.68 97.17 11.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.937 0.399 . . . . 0.0 110.701 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.48 153.4 75.1 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.617 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB2' HG12 ' A' ' 58' ' ' ILE . 74.4 Cg_endo -80.74 97.59 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.492 2.128 . . . . 0.0 112.911 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HA ' ' HH2' ' A' ' 19' ' ' TRP . 45.3 t -93.96 -27.71 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.341 0.591 . . . . 0.0 110.313 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -22.81 65.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.001 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 55' ' ' PRO . 40.3 mm -52.6 -35.83 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -61.42 -43.04 99.85 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -69.25 -30.35 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.196 0.522 . . . . 0.0 110.875 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.879 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 47.6 tp -72.56 -52.67 14.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.345 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.6 ' O ' ' HD2' ' A' ' 65' ' ' PHE . 8.4 mp -59.2 -27.3 65.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.274 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 16.6 mmm180 -56.3 -14.59 2.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.81 -7.25 47.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.881 0.309 . . . . 0.0 111.62 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' HD2' ' O ' ' A' ' 62' ' ' LEU . 32.1 p90 -64.71 126.97 91.99 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.393 0.616 . . . . 0.0 111.57 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 1.3 Cg_endo -87.28 -62.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.307 2.671 . . . . 0.0 112.654 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.4 -25.53 10.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.726 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.48 104.37 12.72 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.4 p -79.42 107.22 12.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.073 0.463 . . . . 0.0 110.377 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -75.88 121.65 22.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.525 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' A' ' 34' ' ' ALA . 1.9 tp-100 -83.6 100.73 11.0 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.42 108.48 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.903 0.382 . . . . 0.0 110.055 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.49 48.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 19.6 pt -115.9 148.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.435 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -130.89 167.39 19.03 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.6 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.755 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.6 m-20 -61.71 163.71 6.98 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.52 174.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.82 -48.71 77.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.753 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.72 -24.07 64.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.574 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.755 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 78.5 mm-40 -76.46 -51.83 11.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 41' ' ' LEU . 39.6 m -64.27 -37.38 87.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.91 -45.3 74.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.067 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -45.59 81.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.87 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.71 -49.03 82.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.347 0.404 . . . . 0.0 111.07 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.47 50.78 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.89 -49.61 72.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.272 0.558 . . . . 0.0 110.93 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -63.49 -31.53 72.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.883 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.18 -51.76 6.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 110.593 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.03 44.64 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.712 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -104.68 -14.72 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' HD2' ' CE2' ' A' ' 92' ' ' PHE . 41.7 t80 68.19 175.97 0.26 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.035 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -84.08 94.26 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.922 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CE2' ' HD2' ' A' ' 90' ' ' PHE . 54.2 m-85 -140.17 132.05 14.5 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.889 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 6.6 Cg_exo -71.66 129.24 15.32 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.172 1.915 . . . . 0.0 110.519 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.39 156.85 2.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.159 0.505 . . . . 0.0 111.68 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.0 m -95.6 120.81 36.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.965 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.9 114.17 26.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 38' ' ' VAL . 6.5 p -99.38 124.86 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.153 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.91 140.81 33.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.544 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 p -134.0 122.48 23.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.979 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.76 25.58 69.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.355 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.81 0.42 88.11 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.61 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -109.09 143.88 37.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.313 -175.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -82.31 112.86 19.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.119 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -136.69 10.81 3.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.56 137.24 6.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.525 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.93 132.69 69.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.63 95.01 2.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.613 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -81.75 -38.68 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 109.984 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.47 -161.11 24.95 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 23.1 mm 69.89 163.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 43.6 m80 78.77 151.89 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.193 0.597 . . . . 0.0 110.452 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.45 142.68 96.13 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.546 2.164 . . . . 0.0 113.001 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.879 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 29.5 t-105 -53.79 -33.81 57.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.652 175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.64 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.52 -33.28 48.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 109.936 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 2.7 mm? -58.14 -44.5 87.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.962 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 113' ' ' TRP . 59.9 mt -64.38 -41.91 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.35 -54.83 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.502 0.667 . . . . 0.0 110.824 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.9 mt -59.19 -48.52 81.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.423 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.7 ' HG2' HD21 ' A' ' 61' ' ' LEU . 14.8 tpt -62.29 -38.79 90.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.704 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 121' ' ' ARG . 16.8 tpt180 -66.11 -34.46 78.12 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.8 74.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.754 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 92.3 mt -75.6 -55.55 5.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.689 -0.256 . . . . 0.0 111.609 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -77.94 -23.24 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.795 -175.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.0 109.343 176.758 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.594 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 21.6 m . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 46.4 Cg_exo -56.97 -66.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.292 1.995 . . . . 0.0 112.995 -175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 64.0 t80 -60.42 -37.96 82.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.32 . . . . 0.0 110.688 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 7.2 t70 -59.04 -53.15 61.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.486 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.6 88.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.347 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.29 -47.77 75.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.85 -35.62 81.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 14.8 mm100 -57.33 -43.84 83.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.026 176.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 5.0 mmp_? -64.21 -53.35 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 84.4 mtp -56.47 -39.56 73.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.291 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.95 -38.47 79.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.186 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.39 70.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HA ' HH11 ' A' ' 17' ' ' ARG . 10.3 mmm180 -73.06 -15.9 61.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.396 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.92 44.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.312 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -114.5 137.47 51.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 p -96.44 138.03 21.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.9 Cg_endo -86.2 163.46 9.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.616 2.878 . . . . 0.0 112.076 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -162.79 143.74 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.895 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.32 155.25 19.1 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.95 78.35 1.66 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.988 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 53.8 m -171.22 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.529 ' HD3' ' HB2' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.26 0.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.544 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -53.02 -43.31 66.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.72 -43.34 59.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.85 -52.45 65.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.699 0.762 . . . . 0.0 110.407 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.654 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 22.9 t90 -58.75 -42.73 89.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.027 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.4 -33.25 75.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.0 m -60.21 -42.69 95.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.856 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.67 -43.75 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB1' ' CD ' ' A' ' 71' ' ' GLN . . . -113.05 94.95 32.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.549 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.34 -170.57 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.258 2.638 . . . . 0.0 112.551 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 49.84 88.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.893 0.854 . . . . 0.0 112.271 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.4 -169.35 27.84 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.153 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.93 145.83 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.625 0.25 . . . . 0.0 110.993 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 11.5 p -138.05 140.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.814 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.67 130.8 45.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -106.27 112.78 25.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.053 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.438 ' H ' ' CB ' ' A' ' 80' ' ' SER . 39.8 m . . . . . 0 N--CA 1.469 0.484 0 O-C-N 123.83 0.706 . . . . 0.0 111.371 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.79 -64.82 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.057 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.49 104.18 1.08 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.19 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.103 2.536 . . . . 0.0 113.285 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 -24.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.04 70.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.091 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.07 -38.35 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.42 -44.45 51.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.164 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.07 -30.05 66.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.644 0.259 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 54.8 tp -62.75 -45.59 91.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.025 0.441 . . . . 0.0 110.633 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.33 -29.9 67.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.756 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.6 -12.11 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 111.19 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 13.1 tp10 -74.37 -26.58 60.21 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -140.59 72.63 30.24 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -93.79 6.81 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.05 2.5 . . . . 0.0 112.39 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.21 -22.08 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 0.0 110.992 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.02 129.81 56.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -66.61 109.86 2.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.788 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.01 133.78 34.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.546 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' CD ' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -90.89 102.17 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.96 173.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.9 t -95.95 113.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.472 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -122.09 135.6 54.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 16.7 pt -128.03 148.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.11 171.08 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 79' ' ' GLN . 9.9 t70 -66.49 161.88 21.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 173.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' SER . 63.5 tp -66.91 -55.9 12.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.735 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . 57.8 mt-10 -73.84 -23.56 59.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 31.7 tt0 -64.55 -33.94 77.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.937 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.438 ' CB ' ' H ' ' A' ' 42' ' ' SER . 73.1 m -63.67 -40.05 95.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -55.43 -38.31 68.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 174.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.04 -43.42 62.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.241 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.73 -44.48 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 109.97 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -43.88 96.53 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.81 -49.44 76.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -63.99 -26.0 68.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.43 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -103.28 -4.91 23.62 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.088 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.42 38.3 80.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.186 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -122.03 -14.62 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 110.618 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.604 ' CE1' ' HG3' ' A' ' 81' ' ' GLU . 45.7 t80 -65.37 114.33 4.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.107 0.479 . . . . 0.0 112.246 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 23.0 tpt180 -173.25 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.904 172.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 11.9 p90 -143.78 145.81 32.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.302 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 13.7 Cg_exo -71.18 138.17 32.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.673 2.248 . . . . 0.0 112.077 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.27 162.94 31.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.8 m -96.67 113.56 25.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.506 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.2 mt -94.48 129.98 41.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.21 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.82 135.91 57.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -108.72 125.48 51.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.403 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -104.1 123.44 47.27 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.735 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.91 11.76 63.77 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.46 71.62 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' N ' HD22 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -95.43 143.74 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -177.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -78.09 111.1 13.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.273 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -139.29 -19.24 0.97 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.604 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.62 149.27 18.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.931 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.96 134.71 18.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.901 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.9 mt -115.25 117.69 31.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.582 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.63 117.92 30.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.527 0.679 . . . . 0.0 111.28 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.3 -161.54 23.29 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.395 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.3 mm -99.01 -53.53 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 44.6 m80 67.5 159.99 0.14 Allowed Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.725 0.641 . . . . 0.0 110.893 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 115' ' ' GLU . 11.8 Cg_endo -60.25 136.8 70.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.503 1.469 . . . . 0.0 109.473 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.521 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.5 t-105 -54.79 -45.41 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.25 -34.36 72.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.771 0.32 . . . . 0.0 111.493 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.735 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 1.3 tm-20 -77.2 -37.13 54.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.448 . . . . 0.0 110.102 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.95 -44.97 91.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.335 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.96 -39.04 82.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.226 0.536 . . . . 0.0 109.946 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -58.11 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.147 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 97.3 mt -56.82 -45.64 82.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.479 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.451 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.9 tpt -57.74 -47.6 81.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HA ' HG22 ' A' ' 124' ' ' VAL . 62.9 mtp180 -64.11 -32.73 74.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.224 0.209 . . . . 0.0 110.916 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.96 74.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.176 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -84.38 -39.48 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 121' ' ' ARG . 34.2 m -82.78 -15.5 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.63 0.252 . . . . 0.0 111.636 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 121' ' ' ARG . 10.1 tp10 . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 174.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.664 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 4.4 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.3 -55.39 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.798 1.666 . . . . 0.0 112.04 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 44.7 t80 -62.46 -37.11 84.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.975 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.34 -54.59 30.62 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.428 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -42.27 88.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.546 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.85 -57.0 14.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.543 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.6 t90 -67.7 -36.64 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.305 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -56.87 -44.44 82.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.786 0.326 . . . . 0.0 110.976 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 97.3 mtt180 -63.49 -53.55 50.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 110.727 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.76 -36.84 79.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.439 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -70.1 -30.39 67.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.423 -177.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.19 64.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -10.37 59.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.824 0.345 . . . . 0.0 111.284 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.69 41.88 14.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.411 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -90.64 -178.69 5.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.675 0.274 . . . . 0.0 110.38 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.1 m -117.49 120.35 33.3 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.172 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HB3' ' HZ2' ' A' ' 11' ' ' TRP . 2.8 Cg_exo -75.83 121.49 6.29 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.965 2.443 . . . . 0.0 111.172 174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG11 HD23 ' A' ' 27' ' ' LEU . 14.9 p -117.9 143.47 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.618 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -95.24 163.25 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.557 0.694 . . . . 0.0 112.118 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -68.4 144.7 54.64 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.441 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m 75.12 -10.79 1.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.306 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.28 -23.19 14.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.51 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -48.94 -47.27 43.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.403 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.16 -49.4 44.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.961 0.41 . . . . 0.0 110.866 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -55.56 -48.52 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.925 0.869 . . . . 0.0 110.232 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -59.9 -42.31 93.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.858 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.13 -28.64 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 29' ' ' ASP . 7.4 t -80.57 -26.1 38.14 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.87 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -89.67 -38.38 13.93 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -97.86 106.77 36.2 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.9 Cg_exo -67.76 122.35 9.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.755 2.303 . . . . 0.0 114.213 -169.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.571 ' OD2' ' HB ' ' A' ' 99' ' ' THR . 6.1 m-20 65.64 154.76 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 124.594 1.184 . . . . 0.0 113.361 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 71' ' ' GLN . . . 153.91 -172.9 32.61 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.709 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 97' ' ' VAL . 31.3 m -133.54 156.33 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.545 0.212 . . . . 0.0 110.458 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.0 t -129.74 131.04 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.076 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -98.64 122.22 41.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.403 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 80' ' ' SER . 6.6 tt -106.79 97.97 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 42.4 m . . . . . 0 CA--C 1.536 0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.0 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.4 -90.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.971 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 92.55 1.53 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.63 0.252 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -102.17 41.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.057 2.505 . . . . 0.0 111.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -104.5 -59.66 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -23.86 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.611 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.2 mm -52.59 -46.73 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.257 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -36.51 86.74 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.455 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 mt-10 -80.01 -26.95 39.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.887 0.375 . . . . 0.0 111.135 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 120' ' ' MET . 42.8 tp -62.24 -45.72 92.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.798 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.0 mp -56.35 -26.83 53.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.399 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 38.4 mmt180 -60.3 -17.73 44.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 5.6 pt-20 -76.5 -8.66 57.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.004 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -125.65 70.77 65.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.569 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.28 11.98 2.8 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.77 2.313 . . . . 0.0 111.583 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.67 -25.7 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.355 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -131.55 -157.9 0.85 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.025 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' OE1' ' A' ' 71' ' ' GLN . 6.6 p -111.62 140.08 46.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 62' ' ' LEU . 82.7 m95 -122.05 95.59 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' OE1' ' HB ' ' A' ' 69' ' ' THR . 1.9 mp0 -84.34 109.86 18.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.23 114.22 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.988 0.423 . . . . 0.0 110.251 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -110.64 137.53 48.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.975 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 12.9 pt -122.72 146.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.78 160.77 31.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 0.0 112.074 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.99 164.84 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.775 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 96.2 mt -59.34 -44.53 92.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.773 0.32 . . . . 0.0 110.807 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.03 -36.31 79.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 0.0 110.081 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -72.81 -31.15 64.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.073 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.581 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 68.2 m -60.08 -43.88 95.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.995 0.426 . . . . 0.0 111.202 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.82 -41.01 97.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.697 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.551 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . . . -77.2 -35.18 55.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.568 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 24' ' ' GLU . 73.3 mt -63.63 -49.19 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.539 0.209 . . . . 0.0 110.676 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.03 -45.97 94.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.688 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -52.74 -53.35 49.13 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -73.28 -23.99 60.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' A' ' 89' ' ' VAL . 10.7 t80 -85.4 -54.58 4.49 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.801 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.41 44.02 0.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.365 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 87' ' ' PHE . 57.5 t -125.56 83.74 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HB3' ' HD1' ' A' ' 92' ' ' PHE . 86.0 m-85 66.51 -62.59 0.28 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER 95.72 -1.6 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.293 1.837 . . . . 0.0 109.859 -169.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.743 ' HD1' ' HB3' ' A' ' 90' ' ' PHE . 83.8 m-85 -84.98 135.32 39.84 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.508 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.835 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.6 Cg_exo -67.41 134.18 32.53 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.871 2.381 . . . . 0.0 112.196 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . 173.85 -169.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.051 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.5 m -97.53 113.97 25.78 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.7 mt -95.75 127.52 41.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.071 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 104' ' ' ARG . 5.7 p -109.34 124.13 65.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.458 0.647 . . . . 0.0 111.156 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -124.94 -178.87 4.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.465 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 14.2 p -127.89 -168.91 1.97 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.45 49.45 1.29 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.151 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.1 -41.5 0.85 Allowed Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.425 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -94.08 170.91 9.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.874 . . . . 0.0 112.099 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.44 134.96 55.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.35 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.707 ' HB2' HG13 ' A' ' 97' ' ' VAL . 3.5 mmp_? -105.14 -58.84 1.83 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.555 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -161.25 27.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.517 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.59 134.3 58.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 110.337 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.4 mt -101.51 128.84 47.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.611 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.56 11.15 25.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.797 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.25 -148.33 49.97 Favored Glycine 0 C--O 1.239 0.406 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.186 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 111' ' ' HIS . 10.6 mm 61.28 -168.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.883 ' H ' HG22 ' A' ' 110' ' ' ILE . 66.0 m80 73.39 150.45 0.13 Allowed Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.041 0.536 . . . . 0.0 111.522 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 111' ' ' HIS . 13.4 Cg_exo -70.46 166.9 26.94 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.515 2.143 . . . . 0.0 111.582 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.472 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 33.5 t-105 -53.86 -43.15 69.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.612 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.51 77.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 22.6 mm-40 -81.22 -25.91 36.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 111.153 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.17 -43.53 91.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 61' ' ' LEU . 62.4 mt -58.81 -42.38 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.607 0.717 . . . . 0.0 109.554 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -54.5 -52.79 60.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.758 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 91.8 mt -62.35 -45.42 93.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.615 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.775 ' HB2' HD21 ' A' ' 61' ' ' LEU . 8.2 tpt -57.1 -47.76 80.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.269 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.514 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.9 ttm180 -66.27 -37.78 86.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.977 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.14 -30.68 74.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.501 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 97' ' ' VAL . 94.8 mt -89.47 -42.47 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 121' ' ' ARG . 35.9 m -73.65 -31.01 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.76 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.614 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 10.9 Cg_exo -70.23 -43.37 2.3 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.867 1.712 . . . . 0.0 111.807 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.787 ' HE1' ' HB2' ' A' ' 42' ' ' SER . 76.7 t80 -73.54 -43.04 60.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.657 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 24.4 t70 -55.15 -53.62 53.62 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.504 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.19 99.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.544 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.13 -41.27 97.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.753 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -64.41 -40.26 95.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 24.9 mm-40 -57.89 -39.92 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.36 -52.5 46.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.633 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.6 mtp -55.32 -38.24 68.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.979 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -65.13 -36.42 84.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.754 179.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.64 67.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -73.27 -7.77 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.804 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.49 23.64 36.12 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.266 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -85.1 141.97 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.2 m -84.63 116.08 63.56 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.942 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 57.1 Cg_endo -74.39 129.59 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.553 2.169 . . . . 0.0 110.985 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG11 HD23 ' A' ' 27' ' ' LEU . 13.8 p -138.57 145.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.892 0.377 . . . . 0.0 111.328 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 p -91.23 160.73 15.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.598 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -32.44 72.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.514 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -66.27 -36.5 83.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.876 0.37 . . . . 0.0 111.112 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -90.52 -24.76 20.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.348 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.469 HD23 HG11 ' A' ' 22' ' ' VAL . 3.1 tm? -58.8 -40.46 84.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.651 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 32' ' ' THR . 17.7 t70 -56.11 -53.4 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.877 0.846 . . . . 0.0 111.105 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t90 -59.39 -41.53 89.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.88 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.53 -29.11 70.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.181 0.515 . . . . 0.0 110.47 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 86.2 m -66.32 -40.0 89.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -98.91 -14.5 19.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB1' HE21 ' A' ' 71' ' ' GLN . . . -140.58 90.22 10.04 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.843 0.354 . . . . 0.0 110.048 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.747 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 86.0 Cg_endo -88.61 -14.38 3.07 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.06 2.507 . . . . 0.0 114.409 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -100.22 135.94 40.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 110.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.98 -160.98 28.74 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 97' ' ' VAL . 6.9 m -138.4 134.87 44.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.5 t -113.59 132.15 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.34 122.43 43.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 35.2 tp -83.15 81.2 8.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.787 ' HB2' ' HE1' ' A' ' 7' ' ' PHE . 4.3 p . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.063 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 53.78 -168.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.926 0.891 . . . . 0.0 111.955 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -147.57 92.35 4.8 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.12 98.44 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.746 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.97 -32.67 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.311 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -60.14 -23.76 64.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.877 -177.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 116' ' ' LEU . 49.8 mm -53.93 -39.96 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.73 -44.69 95.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.399 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -62.2 -34.83 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.342 . . . . 0.0 111.071 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.602 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 45.0 tp -64.76 -55.0 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.21 -27.99 69.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.369 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.96 -19.9 65.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -86.79 -0.45 56.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.772 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -123.08 71.64 44.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.94 -3.03 10.38 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.53 2.154 . . . . 0.0 113.075 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.53 -17.83 60.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.16 139.14 51.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.274 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -86.25 105.21 16.47 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -80.11 110.63 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.187 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.525 HE21 ' HB1' ' A' ' 34' ' ' ALA . 2.9 mp0 -82.47 119.54 24.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.081 174.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.33 103.33 14.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -108.45 127.15 53.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 15' ' ' LEU . 23.4 pt -122.59 139.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.954 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -111.68 169.78 8.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 112.242 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.66 168.77 14.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.283 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.25 -54.64 19.72 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.251 0.62 . . . . 0.0 112.18 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -30.3 61.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.546 0.689 . . . . 0.0 110.671 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 57.6 mt-30 -77.27 -42.7 36.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.468 -175.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 48.6 p -73.38 -37.24 66.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.663 0.268 . . . . 0.0 110.305 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -53.08 -49.79 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.101 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.07 71.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.786 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 79' ' ' GLN . 81.1 mt -67.89 -52.09 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.433 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.53 -44.75 97.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.171 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.94 -39.58 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.21 -30.75 65.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.373 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -84.82 -33.38 22.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 110.715 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.82 31.96 1.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.488 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.55 158.68 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.71 -83.81 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 110.821 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 86.9 mtt180 -148.17 -161.18 1.28 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 88.5 m-85 76.7 148.18 0.12 Allowed Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 124.144 0.903 . . . . 0.0 111.733 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 17.2 Cg_exo -65.39 69.15 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.452 3.434 . . . . 0.0 113.39 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.64 129.56 34.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.339 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 7.3 m -92.22 112.96 25.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 106' ' ' VAL . 65.8 mt -93.97 113.9 25.99 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 104' ' ' ARG . 7.4 p -97.85 127.37 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.202 0.525 . . . . 0.0 110.92 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.93 134.26 55.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.14 137.45 23.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.84 17.6 75.38 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.747 ' HA2' ' HB2' ' A' ' 35' ' ' PRO . . . 79.93 -0.36 83.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.663 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.46 149.34 32.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 111.649 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -69.98 129.47 39.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.417 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.767 ' HB2' HG13 ' A' ' 97' ' ' VAL . 16.7 mmt180 -101.93 -47.29 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.367 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.04 -163.76 36.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.388 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 96' ' ' LEU . 59.3 t -122.6 134.26 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 4.4 mp -101.32 123.58 45.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.78 90.29 2.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.186 0.517 . . . . 0.0 110.026 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.5 146.15 5.73 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.0 -53.27 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 117.165 0.483 . . . . 0.0 111.767 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.6 m170 -73.25 -53.65 4.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 12.5 Cg_exo -68.73 121.91 8.82 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.126 1.217 . . . . 0.0 111.885 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.602 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 9.4 t-105 -87.49 -45.14 10.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.549 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.21 75.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 8.0 tp10 -72.18 -40.59 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.316 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.501 HD23 ' HZ3' ' A' ' 113' ' ' TRP . 30.9 tp -61.31 -44.28 97.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 113' ' ' TRP . 62.1 mt -63.9 -44.94 98.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -50.23 -59.05 4.33 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.122 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 87.0 mt -65.53 -45.46 83.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.926 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.475 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -61.37 -48.03 83.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.69 0.281 . . . . 0.0 110.538 -178.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.0 ttt85 -69.39 -33.03 72.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.199 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.51 -29.15 74.53 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.2 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.5 mt -83.06 -49.59 9.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.409 0.147 . . . . 0.0 111.206 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 121' ' ' ARG . 29.5 m -70.65 -37.94 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.428 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.534 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.737 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 88.0 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.3 Cg_exo -68.58 -58.91 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.551 1.501 . . . . 0.0 111.545 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.41 -35.07 79.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.23 -54.22 49.41 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.566 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -62.26 -48.02 81.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.78 -40.68 89.11 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 111.631 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -69.12 -43.47 74.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 12.3 mm100 -62.36 -32.76 73.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.359 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 50.1 mmm-85 -57.38 -53.59 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.251 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.544 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 73.0 mtm -66.65 -33.0 74.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.957 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 1.9 mm? -67.37 -24.37 65.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.459 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.76 72.9 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -81.36 -3.96 54.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.863 0.363 . . . . 0.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.91 29.99 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.116 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.544 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 43.4 m0 -74.09 148.19 42.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.174 0.511 . . . . 0.0 110.215 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.563 ' HB ' ' HZ3' ' A' ' 30' ' ' TRP . 9.5 p -96.85 130.43 30.19 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.9 -169.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.7 Cg_exo -79.31 145.1 18.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.302 2.668 . . . . 0.0 111.345 172.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.7 144.24 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.575 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -95.2 166.06 12.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.6 -55.35 35.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.075 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.3 m -73.27 6.37 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -126.34 -1.34 6.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.251 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.29 -47.08 79.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.828 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.15 -29.81 57.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.467 0.651 . . . . 0.0 110.444 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 32' ' ' THR . 17.1 t70 -61.06 -55.16 35.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.18 0.99 . . . . 0.0 109.661 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.563 ' HZ3' ' HB ' ' A' ' 20' ' ' THR . 14.0 m95 -67.93 -29.05 68.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.067 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.93 -28.85 69.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.628 0.252 . . . . 0.0 111.366 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' ASP . 14.5 t -88.78 -30.2 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.582 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.15 -28.94 18.6 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -98.86 158.0 33.15 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -67.84 149.54 78.17 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.969 1.78 . . . . 0.0 111.741 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.77 112.35 10.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.306 0.574 . . . . 0.0 110.204 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.55 -107.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.974 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.3 m -135.33 142.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 111.975 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 71.7 t -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.4 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.09 143.26 31.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.466 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -86.28 1.12 52.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 93' ' ' PRO . 89.8 p . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 124.709 1.203 . . . . 0.0 111.73 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 60.0 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.855 0.722 . . . . 0.0 111.357 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -144.86 111.06 4.81 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.241 0.543 . . . . 0.0 109.774 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -97.64 -167.98 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.21 2.607 . . . . 0.0 113.326 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.3 t 76.49 -34.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -32.27 54.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.57 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.9 mm -59.18 -44.19 91.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.79 73.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.361 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.69 -32.51 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.237 0.541 . . . . 0.0 109.974 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 120' ' ' MET . 51.1 tp -70.33 -34.59 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.502 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.9 mp -62.85 -28.12 69.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.262 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -68.7 -8.72 45.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.157 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.47 -24.79 66.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.339 . . . . 0.0 111.099 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.31 94.93 46.39 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.696 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.51 -18.28 13.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.99 2.46 . . . . 0.0 112.033 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.84 -25.55 64.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 0.0 110.801 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -137.66 121.15 17.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.578 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 t -86.26 131.12 34.3 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.907 0.861 . . . . 0.0 110.068 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -88.4 135.24 33.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.173 -173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.839 ' HB2' ' HG2' ' A' ' 35' ' ' PRO . 6.5 tp60 -96.22 122.62 39.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.206 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.35 110.99 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -111.82 127.55 55.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.254 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.5 pt -125.59 140.94 46.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -128.52 166.73 18.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.694 0.283 . . . . 0.0 111.069 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.5 m-20 -65.57 165.43 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.303 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.64 -49.14 73.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.13 -34.07 75.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.002 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 81.8 mt-30 -77.16 -52.71 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.729 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB3' HD22 ' A' ' 41' ' ' LEU . 20.0 m -60.96 -39.57 90.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.388 -177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.89 -41.68 96.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.51 . . . . 0.0 110.201 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.42 77.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 79' ' ' GLN . 83.2 mt -61.36 -43.44 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.7 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.936 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.48 -36.16 66.31 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.067 0.547 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -51.67 -54.51 27.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.103 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' HB3' HG23 ' A' ' 89' ' ' VAL . 24.5 t80 -93.57 -19.29 21.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.002 -166.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.03 39.04 6.22 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 96' ' ' LEU . 18.7 t -82.45 160.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 74.8 m-85 -60.25 138.64 57.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -83.07 8.79 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 88.9 m-85 -90.33 142.2 28.16 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.417 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' SER . 41.8 Cg_exo -57.08 126.04 20.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.518 2.146 . . . . 0.0 111.558 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.87 -175.81 3.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.567 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 29.3 m -117.21 120.65 38.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 89' ' ' VAL . 5.8 mp -93.97 114.64 26.87 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -96.03 138.94 20.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -125.05 145.61 49.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 2.6 m -154.79 151.13 28.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.02 21.6 68.0 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.13 76.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.638 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.41 176.66 8.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.446 0.641 . . . . 0.0 111.828 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.87 118.03 11.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.127 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 5.7 tpm_? -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.726 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.444 ' HA3' HD13 ' A' ' 123' ' ' LEU . . . 170.1 -168.75 41.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.595 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.8 t -132.13 134.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.02 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.8 mt -108.02 131.53 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.3 33.67 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -172.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 -120.76 21.41 Favored Glycine 0 C--O 1.236 0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.782 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.33 99.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.93 0.871 . . . . 0.0 110.325 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.747 ' HB3' HD23 ' A' ' 116' ' ' LEU . 11.5 t60 -137.09 143.36 41.75 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -38.47 124.0 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.192 2.594 . . . . 0.0 112.128 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -54.92 -43.48 73.34 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.61 0.569 . . . . 0.0 112.016 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.17 87.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.698 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.76 -29.0 64.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.343 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 111' ' ' HIS . 0.5 OUTLIER -65.82 -48.82 70.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.52 -42.06 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.166 0.508 . . . . 0.0 109.873 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -52.63 -59.29 4.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.02 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.12 -43.66 98.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.3 tpt -55.34 -48.95 73.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -39.04 92.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.435 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.52 75.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.428 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.463 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 98.6 mt -86.51 -60.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 120' ' ' MET . 30.7 m -63.51 -33.42 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.501 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.333 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.699 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 9.7 Cg_exo -71.69 -44.6 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.457 1.438 . . . . 0.0 110.223 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -68.97 -34.81 75.93 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 27.9 t70 -53.79 -53.85 46.53 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.599 0.714 . . . . 0.0 110.41 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.35 -46.03 89.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.044 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -60.34 -42.3 95.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.494 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.58 ' CH2' ' HA ' ' A' ' 76' ' ' ASP . 1.6 t90 -66.54 -40.24 88.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 16.5 mm100 -57.78 -36.86 72.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 29.0 mmm180 -63.16 -54.15 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.664 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.499 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 66.5 mtm -62.55 -33.09 74.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.291 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.02 -40.07 95.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 0.0 110.584 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.35 66.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -74.38 -10.96 60.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.276 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.13 6.41 53.75 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.798 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.499 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 21.7 m0 -83.18 121.93 27.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 109.914 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 m -88.26 125.94 62.24 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.348 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 38.1 Cg_endo -68.5 139.38 44.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.847 2.364 . . . . 0.0 111.959 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 27' ' ' LEU . 10.7 p -130.92 148.55 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.064 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.7 p -86.62 163.6 17.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 111.49 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.01 -59.02 4.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.336 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 t -77.78 -21.94 50.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 19.2 tpt180 -84.28 -16.94 41.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 109.989 -174.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.01 -39.2 90.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.462 176.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.47 -29.36 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.616 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 32' ' ' THR . 35.1 t70 -64.24 -51.73 62.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.305 1.05 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -59.1 -40.9 86.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.074 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 60.5 mt -62.5 -33.59 75.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' ASP . 10.2 t -79.88 -26.02 40.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.743 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.75 -34.17 21.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.713 0.292 . . . . 0.0 111.494 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -86.42 148.36 46.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 16.0 Cg_exo -68.43 -67.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.505 2.137 . . . . 0.0 112.534 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.75 -90.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.578 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.57 163.79 39.67 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.262 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.03 143.28 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.89 137.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 74' ' ' ILE . 8.7 mp -92.24 121.28 33.61 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 80' ' ' SER . 21.5 tp -114.41 148.66 37.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.745 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 57.08 -146.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.489 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -120.4 93.28 48.17 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 110.966 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.97 13.15 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.067 2.511 . . . . 0.0 112.276 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -84.02 -16.54 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 0.0 110.848 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -21.98 41.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.68 -33.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.788 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -50.26 69.51 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.143 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.95 -27.73 39.74 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.668 -0.313 . . . . 0.0 111.313 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.3 tp -58.32 -48.09 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.099 0.476 . . . . 0.0 111.617 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.11 -26.58 67.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.85 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -63.92 -7.92 9.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -67.23 -32.44 73.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 110.56 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.67 75.42 62.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.25 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.38 6.22 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.93 2.42 . . . . 0.0 112.896 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -91.26 2.09 56.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.786 0.803 . . . . 0.0 109.722 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -138.38 147.58 43.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.387 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -87.23 138.65 31.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.856 0.836 . . . . 0.0 111.269 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -117.21 115.25 24.94 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.732 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.09 102.89 15.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.89 106.92 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.91 142.31 41.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 40' ' ' LEU . 21.0 pt -114.9 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.518 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -92.12 157.24 16.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.896 0.379 . . . . 0.0 111.939 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -59.51 159.68 7.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.328 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -57.24 -55.72 31.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.54 -39.24 46.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.505 0.669 . . . . 0.0 111.076 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 49.8 mt-30 -72.53 -22.35 61.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.132 -173.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 31.9 p -70.31 -41.1 73.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.026 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.65 -38.87 86.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.07 83.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.017 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 79' ' ' GLN . 84.1 mt -58.33 -41.02 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 110.816 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.53 -53.26 47.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.419 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.27 -40.4 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 110.564 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.41 -36.17 83.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.051 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -92.31 -27.67 17.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.16 20.83 7.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.78 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 92' ' ' PHE . 25.5 t -126.74 78.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.56 122.98 40.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 111.459 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 70.44 27.8 3.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.993 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.647 ' HB2' HG12 ' A' ' 89' ' ' VAL . 93.6 m-85 -115.83 85.77 15.05 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.032 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.13 125.43 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.11 1.873 . . . . 0.0 111.807 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . -177.07 -176.35 0.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.655 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -104.31 123.22 47.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.339 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 96' ' ' LEU . 5.8 mp -94.14 133.12 37.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.701 0.286 . . . . 0.0 110.528 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.34 125.77 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.381 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -144.22 129.38 18.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.968 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.8 p -93.14 124.0 36.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.358 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.67 27.3 58.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.99 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.91 83.44 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.571 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -105.04 129.36 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -66.09 124.2 21.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.702 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 104' ' ' ARG . 12.9 mmt180 -103.61 -51.47 3.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.219 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.5 -174.96 47.37 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.424 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 108' ' ' ASN . 9.2 p -132.47 133.85 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.983 0.42 . . . . 0.0 110.284 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 93.0 mt -85.68 97.2 9.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.42 HD22 HG13 ' A' ' 106' ' ' VAL . 7.7 p30 -131.01 158.58 39.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.79 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.47 84.83 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.909 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 45.8 mm 65.6 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.516 0.727 . . . . 0.0 111.866 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 74.8 m80 74.22 157.07 0.16 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 123.287 0.635 . . . . 0.0 111.083 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.39 155.3 69.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.337 2.024 . . . . 0.0 111.515 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.573 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 t-105 -54.91 -39.13 68.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.25 -42.47 81.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.663 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.19 -28.77 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.12 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 61' ' ' LEU . 32.4 tp -64.98 -41.4 95.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.174 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' TRP . 78.4 mt -58.1 -46.01 88.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.321 0.581 . . . . 0.0 110.171 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -54.99 -57.84 10.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.819 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.19 -45.28 87.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.516 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.483 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.7 tpt -53.65 -53.29 53.99 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.351 0.407 . . . . 0.0 110.912 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.19 -33.47 76.08 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.29 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.31 66.42 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.346 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.91 -52.35 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 120' ' ' MET . 8.4 p -69.97 -30.64 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 125.511 1.524 . . . . 0.0 115.104 173.62 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 92.6 m . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 30.3 Cg_exo -62.51 -56.81 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.642 1.561 . . . . 0.0 111.675 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -65.43 -41.79 93.14 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.84 -53.12 53.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.506 0.67 . . . . 0.0 111.006 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -64.84 -45.12 87.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.249 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 52' ' ' SER . 1.9 mm? -60.01 -46.65 88.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.106 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -67.58 -36.61 81.22 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -49.09 74.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.941 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 35.0 mtp180 -61.14 -52.4 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.648 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtp -54.48 -39.75 67.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.338 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD11 ' HG3' ' A' ' 21' ' ' PRO . 1.8 mm? -67.21 -42.52 83.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.917 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.7 61.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -69.9 -18.0 63.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 110.24 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.6 26.12 9.44 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -91.35 -179.21 5.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 24.9 m -121.89 124.39 27.05 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.76 0.314 . . . . 0.0 111.645 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG3' HD11 ' A' ' 15' ' ' LEU . 6.5 Cg_exo -73.18 132.72 18.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.941 2.427 . . . . 0.0 110.981 175.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 27' ' ' LEU . 17.4 t -120.99 144.83 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.58 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 25.0 p -99.05 165.96 11.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.972 173.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.75 -54.95 30.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 m -78.38 -13.23 59.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 111.683 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.8 tpp180 -94.65 -15.99 23.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -60.89 -44.41 97.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.4 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.32 -32.05 62.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.638 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 32' ' ' THR . 33.0 t70 -64.82 -54.58 28.86 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.782 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -66.02 -28.93 69.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.559 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -66.1 -28.11 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.441 0.639 . . . . 0.0 109.855 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 91.5 m -74.5 -41.56 60.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.138 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -83.62 -46.2 12.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -94.52 118.95 66.9 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.411 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.18 124.96 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.551 2.168 . . . . 0.0 112.747 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.4 m-20 68.06 172.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.128 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.34 -163.19 24.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.277 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.56 142.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.0 110.8 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 73' ' ' ALA . 59.8 t -119.28 127.67 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.589 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.572 ' HB2' HG22 ' A' ' 74' ' ' ILE . 35.2 mt -101.96 135.69 43.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.994 0.426 . . . . 0.0 110.948 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.99 -69.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.727 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.818 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' HD21 ' A' ' 10' ' ' LEU . 10.2 t . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.966 0.412 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.66 123.56 28.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 4.6 p-10 -75.63 131.83 76.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 26.8 Cg_exo -62.98 104.61 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.176 2.584 . . . . 0.0 113.292 -174.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.98 -37.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.204 0.526 . . . . 0.0 109.786 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -24.34 67.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.127 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.492 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.0 mm -65.26 -36.42 77.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.38 99.69 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.586 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.68 -28.2 40.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.668 0.27 . . . . 0.0 111.21 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.96 -41.77 97.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.98 0.419 . . . . 0.0 110.6 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.8 mp -58.74 -25.75 63.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.147 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.18 -8.12 7.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.2 -30.18 64.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.593 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.21 92.86 37.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.095 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.54 -0.91 9.98 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.993 2.462 . . . . 0.0 111.601 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.26 -24.9 42.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.794 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -110.39 161.02 16.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 p -95.67 113.93 25.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.063 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -86.94 95.51 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.027 0.441 . . . . 0.0 110.918 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HG2' ' HB1' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -88.11 117.66 27.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.769 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 t -90.6 107.89 19.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.037 0.446 . . . . 0.0 110.293 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 22' ' ' VAL . . . -105.66 127.57 53.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.349 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.572 HG22 ' HB2' ' A' ' 40' ' ' LEU . 22.3 pt -127.15 140.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.46 167.43 19.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.346 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.12 168.4 15.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.8 -37.19 86.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.77 -49.17 78.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -67.6 -45.44 75.5 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.082 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 p -67.24 -32.78 74.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.398 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.61 -49.42 77.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.16 97.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.2 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.506 HD13 ' HG ' ' A' ' 27' ' ' LEU . 92.8 mt -65.98 -41.87 90.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.796 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.87 86.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.661 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.56 -39.82 71.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.0 110.63 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.34 -37.41 72.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.437 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -91.27 -35.33 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.51 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.76 -18.95 5.33 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 t -94.22 96.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.512 ' HD2' ' HG3' ' A' ' 91' ' ' ARG . 46.3 p90 -122.74 154.07 38.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.602 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 90' ' ' PHE . 20.2 mtp180 64.93 22.68 12.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.128 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.12 90.33 13.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.676 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.68 133.64 15.82 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.48 -172.68 3.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.26 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 15.3 m -99.81 108.72 21.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.4 117.42 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.211 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.7 p -102.58 128.76 55.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.234 0.54 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -121.39 134.06 55.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.086 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.599 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 34.2 p -119.99 123.7 44.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.001 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.97 22.9 65.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.488 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 1.44 90.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.923 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -100.51 143.13 31.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.52 0.2 . . . . 0.0 110.516 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.74 112.52 3.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.254 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.506 ' HB3' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.55 -49.75 6.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.48 -173.08 46.03 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.163 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.2 136.51 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.846 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.3 mt -122.52 157.67 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.225 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' HB2' ' HE1' ' A' ' 111' ' ' HIS . 18.5 m120 -132.39 142.63 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.04 165.62 50.86 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.52 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.6 mp 60.98 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.673 0.749 . . . . 0.0 111.067 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.517 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 9.0 m80 -155.94 150.19 19.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.167 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 115' ' ' GLU . 13.0 Cg_endo -57.22 137.08 80.13 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.56 2.173 . . . . 0.0 111.216 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.52 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.8 t-105 -59.4 -43.97 92.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.581 -173.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.34 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.598 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . 44.6 tt0 -72.5 -39.28 67.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.347 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.82 -45.27 93.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.967 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 113' ' ' TRP . 63.2 mt -60.84 -49.82 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -50.61 -56.19 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.208 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 82.7 mt -64.89 -43.3 93.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.995 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -65.52 -47.45 75.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.45 . . . . 0.0 110.076 -177.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ttt85 -65.62 -32.63 74.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.42 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.2 68.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.956 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 65.4 mt -75.64 -53.2 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.954 -0.145 . . . . 0.0 111.055 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 120' ' ' MET . 18.8 m -64.56 -38.48 82.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.084 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 CA--C 1.539 0.536 0 O-C-N 124.037 0.835 . . . . 0.0 111.996 176.555 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 27.8 m . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 2.9 Cg_exo -76.14 -46.42 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.147 1.898 . . . . 0.0 111.59 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.85 -43.92 94.69 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -50.51 -52.68 36.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.59 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.99 -49.49 77.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.478 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -56.46 -46.47 80.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.871 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.503 ' CZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.4 t90 -66.08 -45.22 82.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.213 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -55.51 -40.13 71.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 16.1 mmm180 -60.24 -54.01 50.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -63.19 -33.28 75.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 74' ' ' ILE . 1.8 mm? -63.19 -30.04 71.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.554 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -29.21 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.739 0.304 . . . . 0.0 111.548 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -75.73 -7.38 54.22 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.35 19.74 44.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.785 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -76.71 128.09 34.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 109.786 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.4 m -83.0 129.71 60.32 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 29.6 Cg_endo -65.55 128.83 20.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.747 175.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.66 144.02 22.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -109.53 168.08 9.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.13 -39.49 94.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.705 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.2 t -77.6 -16.33 58.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.396 0.617 . . . . 0.0 110.815 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -98.91 -9.66 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 27' ' ' LEU . 1.5 tm? -59.59 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.162 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.25 -45.15 89.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' THR . 24.9 t70 -60.61 -55.14 36.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.538 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -57.9 -39.3 77.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.133 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.3 tp -66.54 -28.31 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -89.06 -26.26 21.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.713 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.93 -42.69 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 111.275 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 157.1 44.23 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.743 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.1 -69.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.012 1.808 . . . . 0.0 111.117 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.47 -79.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.982 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.67 -166.9 51.17 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.676 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 97' ' ' VAL . 19.3 m -135.93 150.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 98' ' ' PHE . 74.7 t -129.96 127.07 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.34 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.559 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.0 131.21 46.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.81 -39.58 69.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.488 177.182 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 t70 47.82 78.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.442 -168.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.2 106.31 0.92 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -12.95 81.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.821 4.348 . . . . 0.0 115.126 -159.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.22 -73.3 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.11 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -60.39 -35.06 74.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.648 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.74 -38.11 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -63.75 -47.37 87.05 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.413 -175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.71 -36.32 37.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 111.487 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD21 ' HG3' ' A' ' 120' ' ' MET . 23.9 tp -66.53 -55.14 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.118 -173.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.49 -27.45 67.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 48.8 mmt-85 -71.6 -7.82 50.19 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.84 -40.33 83.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.146 0.498 . . . . 0.0 110.176 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.634 ' HB3' ' HD2' ' A' ' 68' ' ' TYR . 99.2 m-85 -129.54 84.23 62.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.714 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -82.03 -14.02 9.98 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.871 2.381 . . . . 0.0 113.365 -174.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.77 -25.46 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.387 0.613 . . . . 0.0 110.268 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.634 ' HD2' ' HB3' ' A' ' 65' ' ' PHE . 60.4 m-85 -84.14 111.24 19.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.079 175.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 p -67.96 104.76 1.81 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.006 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -86.81 95.06 9.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.364 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -87.0 105.11 16.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.17 125.77 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.815 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.22 140.63 51.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.56 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 40' ' ' LEU . 13.8 pt -125.44 140.66 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.93 0.395 . . . . 0.0 110.558 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -106.92 157.41 17.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' CH2' ' A' ' 11' ' ' TRP . 2.8 p30 -87.02 -174.07 4.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -59.44 -42.91 93.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.358 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -75.35 -36.93 60.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.29 0.567 . . . . 0.0 110.874 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.538 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 82.3 mm-40 -73.59 -44.66 56.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.499 -175.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 p -59.38 -43.24 92.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.73 0.3 . . . . 0.0 110.932 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.98 -41.16 82.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -40.45 61.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.234 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 79' ' ' GLN . 77.8 mt -65.54 -48.06 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.372 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.62 -48.15 83.78 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.894 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.52 -52.41 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 122.636 0.374 . . . . 0.0 110.673 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -68.52 -26.39 65.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.92 -26.61 31.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.078 0.466 . . . . 0.0 110.237 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.79 -0.24 48.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.75 -26.47 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 109.938 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 65.14 -141.78 0.22 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 92' ' ' PHE . 50.7 mtt-85 -92.1 -158.1 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.654 -170.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 90.5 t80 75.16 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.185 0 O-C-N 124.219 0.949 . . . . 0.0 109.456 -172.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.77 131.16 20.64 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.674 2.25 . . . . 0.0 112.27 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.05 -174.8 4.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.37 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.2 m -92.11 113.36 25.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.08 118.85 32.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.178 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.3 p -98.39 131.65 45.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.53 ' HE2' ' HB ' ' A' ' 39' ' ' VAL . 95.2 m-85 -118.22 146.7 44.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.278 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 1.9 m -153.4 146.28 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.28 20.55 63.2 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.059 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 16.43 78.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.755 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -131.47 174.0 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -70.06 112.9 6.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.817 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.5 tpm_? -90.24 -41.49 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.225 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.59 -175.39 44.44 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.855 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.6 137.97 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.2 mt -94.7 161.34 14.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.705 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -169.31 96.28 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.079 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.79 91.8 0.58 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.727 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.17 -31.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.353 0.597 . . . . 0.0 111.46 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.636 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 6.4 t-80 -68.28 -58.87 6.81 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -168.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 11.8 Cg_exo -71.02 121.87 8.25 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.721 1.614 . . . . 0.0 112.308 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.441 ' CZ3' HD23 ' A' ' 116' ' ' LEU . 7.1 t-105 -93.51 -45.41 7.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.214 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.43 98.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.49 -43.46 94.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.696 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.441 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 30.7 tp -58.59 -49.39 77.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.904 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.44 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.7 mt -58.17 -48.93 83.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -52.16 -55.63 19.78 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.146 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.2 mt -64.62 -45.26 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.691 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -60.72 -51.77 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttm-85 -64.09 -39.45 94.09 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.189 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.01 -30.35 73.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.542 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 95.0 mt -81.43 -56.68 3.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.425 0.155 . . . . 0.0 110.822 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 120' ' ' MET . 31.8 m -68.56 -36.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.578 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 21.3 m . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 33.1 Cg_endo -65.62 -46.32 5.45 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.693 1.595 . . . . 0.0 112.009 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -66.37 -41.69 89.1 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.267 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.29 -53.59 56.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 110.293 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.79 -42.86 98.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.278 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -60.47 -49.7 76.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.903 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -37.28 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.68 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.81 -37.14 78.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.4 mtt180 -69.89 -52.03 28.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.55 177.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.5 mtp -55.11 -40.7 70.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.843 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.402 HD11 ' HD3' ' A' ' 21' ' ' PRO . 2.8 mm? -68.47 -31.01 70.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.62 68.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -85.34 -1.07 56.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.633 0.254 . . . . 0.0 111.486 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.53 22.84 41.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.009 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -81.55 119.08 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -78.8 121.17 83.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.719 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -82.78 127.88 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.817 2.344 . . . . 0.0 111.79 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.88 137.76 13.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 0.0 111.01 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 25' ' ' SER . 4.4 m -94.43 130.95 40.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.605 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' SER . 1.5 tm-20 17.86 -98.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.727 1.211 . . . . 0.0 111.491 162.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' SER . 14.7 t 23.84 -78.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.021 1.328 . . . . 0.0 113.927 149.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 30' ' ' TRP . 9.7 tpp180 -106.92 -15.61 14.66 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.571 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.51 -36.39 73.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.136 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' HH12 ' A' ' 86' ' ' ARG . 25.5 t70 -66.1 -41.88 90.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 32' ' ' THR . 32.3 t70 -57.93 -49.61 76.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.816 0.817 . . . . 0.0 109.885 174.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.428 ' HD1' ' HG3' ' A' ' 26' ' ' ARG . 5.3 m95 -53.5 -43.01 67.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.406 173.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -38.29 90.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.0 t -74.35 -25.11 59.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.857 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.99 -10.11 53.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.315 177.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 103.69 44.47 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.62 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.17 -36.35 81.29 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.571 2.18 . . . . 0.0 111.085 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.78 -88.8 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.249 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.86 113.37 3.0 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.926 173.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 72' ' ' VAL . 11.1 m -138.78 134.28 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 0.0 110.406 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.35 129.1 67.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.515 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.7 117.49 34.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.453 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.67 26.1 7.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 -178.625 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 52.65 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.979 0.799 . . . . 0.0 111.653 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -160.12 85.74 2.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.17 44.15 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.847 2.365 . . . . 0.0 112.971 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.72 -26.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.049 0.452 . . . . 0.0 110.488 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -24.6 67.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.692 -173.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 62' ' ' LEU . 48.8 mm -61.77 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 110.575 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.21 68.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.567 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.92 -31.64 70.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.045 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -70.84 -46.03 63.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.04 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ILE . 10.0 mp -59.07 -27.72 65.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.368 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.86 -14.79 36.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.45 -44.69 82.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.636 0.255 . . . . 0.0 110.834 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.99 72.04 34.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.655 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -91.53 15.99 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.148 2.565 . . . . 0.0 112.822 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.89 -25.35 59.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.482 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -157.31 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.7 p -116.87 102.49 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 112.073 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -95.25 84.41 4.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.89 104.35 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.385 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.428 ' HA ' HG23 ' A' ' 38' ' ' VAL . 52.7 t -87.64 103.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.021 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.13 132.25 52.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' HB2' ' A' ' 40' ' ' LEU . 18.0 pt -114.37 139.69 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.31 154.68 19.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.794 0.33 . . . . 0.0 111.358 -176.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 2.0 m-20 -56.96 155.95 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.646 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.33 -53.86 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.21 -26.74 59.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.094 0.473 . . . . 0.0 110.894 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CG ' ' HB2' ' A' ' 76' ' ' ASP . 20.1 mm-40 -70.36 -29.66 66.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.719 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -62.86 -38.6 91.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.522 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.68 -42.89 95.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.614 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.07 93.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.17 -47.88 90.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.92 -46.98 93.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.688 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.86 -45.55 86.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.66 HH12 ' HB2' ' A' ' 28' ' ' ASP . 47.6 ttt180 -57.76 -37.34 73.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.468 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HB3' HG23 ' A' ' 89' ' ' VAL . 19.8 t80 -82.26 -40.12 22.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 0.0 109.843 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.1 33.56 4.26 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.593 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 87' ' ' PHE . 21.8 t -92.81 -15.57 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.507 0.194 . . . . 0.0 110.941 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.6 t80 72.15 174.01 0.3 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -172.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -71.23 96.81 1.45 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.808 0.337 . . . . 0.0 111.016 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -142.39 100.82 5.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.83 123.97 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.781 2.32 . . . . 0.0 111.914 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -172.05 -170.08 0.71 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.818 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 30.8 m -96.73 109.27 21.96 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.61 120.32 34.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.048 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.92 130.35 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.982 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.73 172.89 6.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.539 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.68 122.83 7.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.632 175.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.61 29.84 54.86 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.716 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.01 90.63 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.892 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.82 157.09 18.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.092 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -71.69 119.08 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -93.7 -46.27 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.38 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.55 -167.67 40.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.108 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.5 134.58 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.941 0.401 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.2 mt -92.71 114.36 26.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.293 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.7 98.86 6.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.335 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.48 140.35 2.87 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.33 -39.16 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -109.41 -44.56 0.1 Allowed Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 16.5 Cg_exo -65.17 120.32 7.52 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 120.718 1.292 . . . . 0.0 110.897 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.536 ' HE3' ' HA ' ' A' ' 113' ' ' TRP . 2.1 t-105 -97.68 -51.0 4.26 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.825 -168.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.14 73.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 110.466 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -77.84 -35.14 51.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.419 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -62.57 -46.6 87.59 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.1 mt -61.26 -43.0 95.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.399 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -49.75 -58.04 6.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.225 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.5 mt -57.09 -49.2 76.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.724 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.503 ' O ' HG22 ' A' ' 124' ' ' VAL . 15.8 tpt -61.5 -42.78 99.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.547 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.03 -35.99 82.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.09 71.06 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.237 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 95.9 mt -78.06 -47.25 18.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' MET . 34.4 m -77.92 -34.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.297 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.671 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 99.3 m . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.671 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 58.8 Cg_endo -75.15 -66.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.336 1.357 . . . . 0.0 113.248 -175.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -60.85 -33.34 72.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.77 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.44 -53.89 50.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.674 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.68 89.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.961 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -55.3 27.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.844 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -65.51 -36.94 85.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.81 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -56.09 -39.64 72.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.588 0.232 . . . . 0.0 111.146 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 32.5 mmt180 -63.19 -51.86 64.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.452 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 87.2 mtp -55.1 -38.87 68.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.272 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.62 -38.23 67.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.999 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.21 -28.14 69.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.99 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -64.08 -20.77 66.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.67 32.49 7.61 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.325 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -98.85 134.81 41.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.012 0.434 . . . . 0.0 110.026 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.521 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 2.6 p -86.43 137.79 34.3 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.819 -176.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 1.8 Cg_endo -82.56 141.28 11.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.313 2.675 . . . . 0.0 113.257 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.72 148.04 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -114.77 167.73 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -36.77 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.929 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 t -79.78 4.74 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.381 0.61 . . . . 0.0 110.398 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -118.09 -12.49 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.837 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tt -48.72 -47.77 41.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.269 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -68.32 -51.52 43.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.065 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 32' ' ' THR . 13.4 t70 -54.76 -55.46 29.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.219 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -69.03 -31.61 70.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 102' ' ' ASN . 27.9 tp -67.7 -28.36 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.697 0.76 . . . . 0.0 109.688 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 85.6 m -71.32 -29.85 65.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.373 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.73 -61.37 2.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.73 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.74 113.85 59.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.824 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.51 -16.46 4.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.486 2.124 . . . . 0.0 112.888 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 24.6 m-20 -122.19 159.76 26.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.356 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.89 -166.32 25.69 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.209 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.82 137.11 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 99.0 t -117.41 119.65 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.164 0.507 . . . . 0.0 110.03 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.94 122.15 43.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.216 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.765 ' HB2' ' H ' ' A' ' 94' ' ' ALA . 7.7 mp -94.13 17.94 11.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.855 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.465 0.318 0 O-C-N 124.254 0.971 . . . . 0.0 110.088 -174.618 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.432 0.158 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 t70 50.81 -144.73 0.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.796 0.685 . . . . 0.0 109.573 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -131.27 96.51 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.63 15.98 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.334 2.689 . . . . 0.0 113.617 -174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.09 -31.31 34.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.339 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -27.41 69.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.381 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.8 mm -59.99 -44.54 94.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.072 0.463 . . . . 0.0 110.237 176.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -66.69 -38.72 93.38 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.996 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 16.9 mm-40 -70.25 -28.75 65.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.301 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 63.5 tp -64.81 -49.36 70.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.8 mp -60.56 -25.63 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.797 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 36.7 mmt180 -56.81 -15.15 4.16 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.8 -8.69 59.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.047 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.708 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 73.7 m-85 -132.61 63.8 69.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.085 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -85.88 2.16 7.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.379 2.052 . . . . 0.0 112.961 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.8 -13.12 19.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.49 0.662 . . . . 0.0 109.901 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -108.98 120.0 41.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -64.65 110.11 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.708 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 87.8 m95 -91.22 117.24 29.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.551 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.69 106.21 18.19 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.34 105.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.889 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -114.78 140.05 49.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.801 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.687 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 24.3 pt -121.93 140.3 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.54 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -97.3 161.6 13.72 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.571 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -65.83 171.81 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.79 -55.7 21.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.052 0.453 . . . . 0.0 109.837 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -78.17 -34.82 49.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.642 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 96.6 mt-30 -67.57 -35.06 78.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.81 -175.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 29.5 p -60.72 -48.61 81.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -57.98 -47.58 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.138 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.19 81.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.782 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 79' ' ' GLN . 67.9 mt -62.11 -51.38 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.131 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.91 94.01 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.565 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -54.46 -44.69 72.77 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 111.221 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 86' ' ' ARG . 23.1 ttt180 -73.0 -31.15 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.729 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -85.17 -31.13 23.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.27 25.07 11.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.43 111.16 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.858 -0.201 . . . . 0.0 110.893 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 69.77 -58.48 0.52 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.691 0.797 . . . . 0.0 112.859 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 70.9 15.21 6.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.832 0.825 . . . . 0.0 108.826 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -129.6 151.19 77.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.98 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.616 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 51.3 Cg_exo -56.16 132.93 54.93 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.818 2.345 . . . . 0.0 112.744 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.765 ' H ' ' HB2' ' A' ' 41' ' ' LEU . . . -165.22 -175.49 3.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.018 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 43.7 m -109.4 115.53 30.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.02 136.36 44.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -114.71 137.03 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.71 128.88 53.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -169.7 134.61 1.4 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.13 0.491 . . . . 0.0 112.28 -175.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.29 22.63 65.54 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.737 173.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 130.99 59.78 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.046 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.566 HD21 HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER 65.59 -153.53 0.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.906 0.483 . . . . 0.0 111.739 172.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -41.38 112.22 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.222 0.951 . . . . 0.0 111.754 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -101.04 -31.58 11.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.583 -176.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.29 -174.17 42.47 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.353 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.83 137.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.551 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.2 mt -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.408 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -133.18 142.15 48.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.432 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.93 167.17 43.15 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.114 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 51.0 mm -83.22 -69.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 60.9 m80 71.61 156.49 0.16 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 123.8 0.687 . . . . 0.0 111.537 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.16 152.13 82.43 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.411 2.074 . . . . 0.0 111.052 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 20.9 t-105 -56.75 -40.8 76.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.527 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.04 79.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.359 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -80.26 -26.79 38.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -46.61 85.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.33 -41.03 91.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.876 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.77 -53.87 46.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.434 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.72 -49.16 76.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.407 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.641 ' HG2' HD21 ' A' ' 61' ' ' LEU . 15.4 tpt -54.5 -51.98 63.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.909 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.7 ttt180 -70.61 -33.57 71.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.725 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.92 -30.86 74.26 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.538 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 97.6 mt -83.89 -59.81 2.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.026 0.13 . . . . 0.0 111.058 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 121' ' ' ARG . 27.7 m -65.17 -27.23 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.324 -0.534 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.871 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.504 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 31.1 m . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.504 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 13.9 Cg_endo -58.23 -55.69 2.06 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.121 1.881 . . . . 0.0 112.657 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -64.71 -42.04 95.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.4 -51.49 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.97 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.15 76.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.556 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -46.05 80.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -65.64 -41.93 92.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.354 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.25 -37.02 74.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.388 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.86 -53.63 47.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.0 mtm -60.87 -36.96 80.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 110.6 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.5 -40.45 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.567 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.2 67.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.533 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -75.56 -5.95 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.93 23.27 30.61 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.96 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -88.96 118.89 29.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 m -80.02 121.67 82.28 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.349 -169.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 39.6 Cg_endo -70.08 120.9 7.55 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 0.0 110.761 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG11 HD23 ' A' ' 27' ' ' LEU . 12.4 p -124.95 143.82 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.2 t -84.91 159.32 20.35 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.778 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.53 -54.16 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.124 0.57 . . . . 0.0 111.98 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 m -67.05 -23.71 65.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.149 0.499 . . . . 0.0 111.362 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -86.72 -26.1 24.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.332 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.569 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -60.42 -41.36 93.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.05 -42.52 72.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.251 0.548 . . . . 0.0 110.324 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.67 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 13.4 t70 -63.72 -55.81 20.44 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.366 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.6 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t90 -62.94 -35.76 81.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.447 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.4 tm? -63.83 -32.04 73.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.647 0.737 . . . . 0.0 109.044 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 97.5 m -71.95 -37.49 69.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.793 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 14.6 mm-40 -74.41 -33.72 63.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.13 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.03 142.98 30.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.381 -177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.6 Cg_exo -69.6 -39.67 6.53 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.822 2.348 . . . . 0.0 111.874 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 6.8 t70 -145.67 154.46 42.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.16 147.68 9.45 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.907 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 97' ' ' VAL . 29.4 m -125.2 142.43 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 55.8 t -125.04 131.9 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.512 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.31 124.77 47.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.4 mp -98.2 125.12 43.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.303 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.657 ' HA ' HG13 ' A' ' 110' ' ' ILE . 14.7 t70 -72.07 113.45 9.12 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 49.72 63.48 10.12 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.991 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.56 -41.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.124 1.883 . . . . 0.0 113.664 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.89 -42.18 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -56.58 -24.44 47.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.462 ' O ' HD13 ' A' ' 62' ' ' LEU . 41.8 mm -62.03 -44.35 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.837 0.351 . . . . 0.0 110.958 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.81 -26.75 74.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.062 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.91 -42.76 38.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.992 0.425 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 48.9 tp -60.75 -48.28 82.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.646 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.3 mp -58.72 -26.86 64.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.888 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 11.4 mmt180 -68.3 -7.63 32.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 10.1 pt-20 -83.09 4.88 24.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.298 175.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . 97.7 m-85 -109.97 90.15 9.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.03 -43.41 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.056 2.504 . . . . 0.0 113.517 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.72 -25.61 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.223 0.535 . . . . 0.0 110.679 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 65' ' ' PHE . 11.1 t80 -88.77 107.78 19.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.615 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 p -89.06 125.76 35.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.993 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -102.82 129.77 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.118 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -87.39 105.98 17.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.36 115.81 33.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.91 0.386 . . . . 0.0 110.592 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -121.76 147.56 45.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.553 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.627 HG22 ' HB2' ' A' ' 40' ' ' LEU . 10.4 pt -134.55 147.4 29.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.058 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -122.77 153.81 39.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 3.5 m-20 -60.43 179.66 0.15 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.63 -55.9 28.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.629 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.52 -42.98 81.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ASP . 14.3 mp0 -54.96 -51.1 67.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.205 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 p -65.62 -39.58 91.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.59 0.233 . . . . 0.0 110.647 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.58 -46.01 91.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.179 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.29 82.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.334 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.26 -44.23 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.331 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.42 87.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.909 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.35 -50.77 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.179 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -65.49 -27.91 68.82 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -87.48 -23.59 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.014 0.435 . . . . 0.0 109.829 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.16 32.03 10.16 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.507 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.13 82.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 85.8 m-85 53.19 -156.99 0.17 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.385 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -158.28 41.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.412 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 87.4 m-85 -129.46 160.19 65.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.136 -174.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 52.0 Cg_exo -53.56 130.52 39.17 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.602 2.201 . . . . 0.0 112.231 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -175.65 158.95 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 32.7 m -107.6 115.16 29.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.671 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.01 129.4 42.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 104' ' ' ARG . 3.9 p -108.21 125.71 64.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.289 0.566 . . . . 0.0 111.545 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.25 119.49 37.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.964 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.538 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -101.67 -175.68 2.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.095 -174.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 99' ' ' THR . . . -54.41 -28.17 43.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.442 170.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.11 28.73 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.879 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 102' ' ' ASN . 1.3 t-20 65.99 -156.48 0.26 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.524 0.73 . . . . 0.0 111.113 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -49.51 125.38 11.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.201 0.524 . . . . 0.0 111.633 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.496 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.7 tpt180 -104.75 -59.57 1.72 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.216 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.76 -159.12 21.07 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.807 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.54 134.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 3.0 mm? -92.99 117.1 29.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.552 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.65 154.05 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.41 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.826 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.657 HG13 ' HA ' ' A' ' 53' ' ' ASP . 41.3 mm -84.2 78.36 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 52.1 m-70 -156.72 -61.38 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 172.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 16.8 Cg_endo -94.73 124.77 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.565 2.177 . . . . 0.0 113.058 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 19.3 t-105 -82.69 -39.63 21.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.307 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.28 97.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.675 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 20.2 mp0 -64.78 -39.0 92.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.995 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.47 -48.01 82.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.0 mt -61.41 -42.49 93.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.125 0.488 . . . . 0.0 110.244 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -58.04 -49.18 77.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.847 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.6 mt -59.68 -44.8 93.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.905 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt -62.5 -37.47 86.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.728 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 121' ' ' ARG . 3.4 tmm_? -62.96 -41.88 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.21 -30.94 79.22 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.588 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.82 -56.54 4.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.097 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' ARG . 28.5 m -64.02 -41.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.225 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.459 ' HB3' HH11 ' A' ' 121' ' ' ARG . 43.5 tt0 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 56.0 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 119.551 -0.262 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 36.9 Cg_endo -65.76 -64.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.584 1.523 . . . . 0.0 112.831 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 77' ' ' LEU . 38.2 p90 -66.18 -32.31 73.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -54.93 -54.91 36.64 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.326 0.584 . . . . 0.0 110.763 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -60.83 -41.17 95.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.462 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -57.01 -47.5 80.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.455 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.94 -43.72 91.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.51 -32.77 71.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.393 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 59.5 mmt-85 -62.84 -54.52 37.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.479 175.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.0 mtm -60.96 -33.45 73.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 74' ' ' ILE . 3.1 mm? -65.05 -37.97 89.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.575 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.6 -19.21 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 17.1 mmm180 -84.85 -4.73 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.16 17.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.857 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -100.66 136.89 39.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.048 0.451 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 m -86.63 124.6 69.19 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.47 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.674 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -80.25 146.21 17.58 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.929 2.419 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG11 HD23 ' A' ' 27' ' ' LEU . 12.0 p -148.74 145.26 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.67 0.271 . . . . 0.0 111.133 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 m -73.53 159.59 32.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.371 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 8.6 tm-20 -55.56 -58.6 7.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.502 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -70.11 -7.29 40.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.113 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.419 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.5 tpp180 -106.23 -16.83 14.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.324 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -59.19 -43.04 92.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.359 0.599 . . . . 0.0 110.436 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 32' ' ' THR . 17.3 t70 -63.87 -54.0 41.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.527 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 73' ' ' ALA . 91.1 t90 -54.33 -43.59 71.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.103 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.79 -44.19 94.07 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.382 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.6 t -74.88 -24.32 58.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.02 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -80.36 -16.9 53.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.087 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.97 152.85 38.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.5 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 -23.0 22.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.353 2.036 . . . . 0.0 112.277 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 7.4 t70 -156.37 -171.61 3.77 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 98' ' ' PHE . . . 165.1 128.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.58 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.34 146.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 59.2 t -133.26 136.77 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.665 0.269 . . . . 0.0 111.021 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -97.68 125.96 42.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 80' ' ' SER . 0.9 OUTLIER -94.84 125.43 39.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.685 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 11.1 t . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' HD11 ' A' ' 10' ' ' LEU . 32.2 t . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -84.4 -168.47 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.453 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.434 ' OD1' HG12 ' A' ' 58' ' ' ILE . 43.0 t30 62.17 72.78 0.6 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.568 . . . . 0.0 111.67 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -92.78 -40.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.403 2.069 . . . . 0.0 113.491 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.29 -33.12 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.5 -31.56 66.14 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' HD13 ' A' ' 62' ' ' LEU . 13.5 mm -65.35 -38.75 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.133 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.19 99.67 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.896 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.3 mm-40 -72.8 -28.65 62.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HG ' ' HG2' ' A' ' 120' ' ' MET . 34.8 tp -68.18 -35.04 77.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.7 mp -60.96 -26.86 67.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.376 176.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 72.8 mtt180 -62.59 -7.42 4.69 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.66 -31.39 68.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 110.383 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.52 88.5 49.89 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.978 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.53 -20.06 16.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.761 2.307 . . . . 0.0 111.774 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.8 -11.66 52.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.59 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -120.41 115.31 23.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.13 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 t -80.59 156.95 26.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.669 0.747 . . . . 0.0 110.554 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -124.76 124.57 42.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.571 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -91.35 98.46 11.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.012 0.434 . . . . 0.0 109.947 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.81 111.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.091 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -123.76 149.28 45.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.36 0.6 . . . . 0.0 111.063 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.8 pt -130.53 140.3 49.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.37 164.01 13.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.006 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.4 m-20 -61.96 150.42 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.989 173.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 7' ' ' PHE . 15.4 mt -53.6 -45.71 70.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.742 -174.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.94 -47.42 18.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.685 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 39.9 mt-30 -69.79 -18.57 63.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' HD22 ' A' ' 41' ' ' LEU . 11.6 p -61.5 -34.0 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.272 0.558 . . . . 0.0 110.559 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.69 -46.67 88.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.625 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.16 96.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.078 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.526 HD13 ' HG ' ' A' ' 27' ' ' LEU . 63.4 mt -62.01 -44.79 99.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.29 -43.49 97.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.685 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.83 -41.97 98.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.66 -32.94 67.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -92.37 -45.64 8.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.962 0.411 . . . . 0.0 110.424 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.55 23.9 4.25 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.081 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.77 -83.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.6 t80 59.01 -163.93 0.21 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.628 0.58 . . . . 0.0 109.927 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 34.1 ttp180 65.04 80.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.785 0.434 . . . . 0.0 111.757 175.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 89.6 m-85 72.0 141.23 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 13.1 Cg_exo -72.53 138.22 29.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 124.072 3.181 . . . . 0.0 112.73 176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . -160.6 -178.19 6.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.541 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.6 m -92.18 122.86 35.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 106' ' ' VAL . 43.6 mt -99.48 113.87 26.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 123' ' ' LEU . 13.4 p -103.55 126.68 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.7 0.762 . . . . 0.0 110.93 -178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.567 ' HD1' ' HA ' ' A' ' 103' ' ' TYR . 46.3 m-85 -122.87 150.55 42.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 40.6 p -128.43 124.49 36.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.91 28.97 71.15 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.931 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 -1.44 88.75 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.768 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.53 143.76 33.24 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.32 0.581 . . . . 0.0 111.717 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD1' ' A' ' 98' ' ' PHE . 73.3 t80 -69.42 136.99 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.292 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 1.5 mmp_? -113.79 -64.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.627 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . -172.06 -166.58 30.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.22 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 96' ' ' LEU . 6.5 m -122.23 146.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 122.476 0.31 . . . . 0.0 111.111 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 5.9 mp -99.63 134.0 43.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -123.48 12.61 9.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.383 0.611 . . . . 0.0 110.565 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.21 117.59 5.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.289 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.02 -36.42 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.874 0.368 . . . . 0.0 111.381 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 91.0 m-70 -122.7 -52.52 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 31.6 Cg_exo -56.84 123.19 13.27 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.729 1.619 . . . . 0.0 112.567 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.492 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.6 t-105 -85.18 -40.43 16.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.616 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.65 86.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 37.9 tt0 -72.84 -32.44 65.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.355 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 29.3 tp -64.46 -46.82 81.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 61.0 mt -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -51.07 -57.49 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 93.3 mt -60.76 -46.89 88.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.584 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.6 tpt -54.17 -44.67 71.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 125' ' ' GLU . 14.6 mmt180 -55.98 -49.12 74.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.2 -30.12 75.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.734 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 97' ' ' VAL . 94.4 mt -84.34 -55.09 4.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 120' ' ' MET . 23.9 m -87.01 -26.07 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.723 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 121' ' ' ARG . 31.5 tt0 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.518 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 82.9 m . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.518 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 19.7 Cg_endo -63.31 -52.57 1.93 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.654 1.569 . . . . 0.0 111.417 172.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -67.15 -35.21 79.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.369 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.69 -53.77 54.59 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.207 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -57.89 -46.21 85.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.084 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 2.0 mm? -57.17 -51.81 67.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.511 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -65.55 -42.06 92.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.111 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 14.5 mm100 -59.82 -31.76 70.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 35.5 mmt180 -57.33 -54.52 45.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 110.605 174.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.512 ' HB3' HD13 ' A' ' 74' ' ' ILE . 4.9 mpp? -66.86 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 2.4 mm? -64.57 -48.33 75.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.82 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.92 64.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.008 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 34.5 mmt180 -73.81 -21.15 60.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.648 0.261 . . . . 0.0 110.386 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.43 21.85 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.784 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.502 ' HZ3' ' HG3' ' A' ' 14' ' ' MET . 27.4 m0 -93.05 168.1 11.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.7 m -112.96 130.97 23.01 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 40.4 Cg_endo -68.91 121.4 8.27 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.909 2.406 . . . . 0.0 111.678 172.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.3 145.73 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.565 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 m -112.5 168.42 9.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.271 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.9 -47.47 85.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -71.74 -7.94 51.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.914 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 29' ' ' ASP . 28.3 mmt180 -117.7 -7.02 11.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.719 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.43 -49.45 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.12 -34.69 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.134 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 32' ' ' THR . 22.3 t70 -62.16 -56.98 13.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.038 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -74.65 -26.65 60.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.997 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.18 -35.03 78.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 111.081 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.6 t -80.97 -26.53 36.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.007 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -96.7 -0.91 47.58 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.011 0.434 . . . . 0.0 111.699 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.8 87.48 3.71 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.73 148.2 36.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.548 2.166 . . . . 0.0 113.62 -171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.8 t70 80.62 144.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.595 1.184 . . . . 0.0 111.649 174.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.03 -173.55 27.16 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.332 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 97' ' ' VAL . 5.3 m -138.09 138.91 43.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 73' ' ' ALA . 52.9 t -122.62 129.41 75.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.66 124.71 32.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -97.47 98.89 10.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 178.047 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -96.96 -0.28 47.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 110.659 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 49.6 t-20 -78.43 -54.55 1.17 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 54' ' ' ASN . 12.5 Cg_exo -70.88 44.58 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.037 2.491 . . . . 0.0 114.505 -169.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.31 -53.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.56 -25.82 64.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.473 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' HD13 ' A' ' 62' ' ' LEU . 45.2 mm -60.78 -37.99 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.42 -34.25 89.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.619 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.68 -37.72 62.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.306 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 44.6 tp -64.18 -38.76 92.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.253 -176.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.6 mp -65.41 -26.24 67.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.643 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -66.46 -9.04 30.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -70.1 -34.02 72.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.66 85.76 57.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.696 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -88.15 4.95 5.52 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.431 2.754 . . . . 0.0 112.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.86 -20.97 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 0.0 111.075 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -167.74 1.35 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 p -129.91 104.93 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -85.88 96.7 9.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.225 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.73 108.24 8.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.481 . . . . 0.0 109.768 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.66 108.27 20.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -116.58 145.01 43.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.912 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 6.9 pt -124.56 140.48 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.019 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.45 143.09 41.28 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.382 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.81 160.93 22.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 58.9 tp -54.49 -43.31 71.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.394 0.434 . . . . 0.0 111.501 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.92 -33.44 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.402 0.62 . . . . 0.0 111.06 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -77.94 -32.06 51.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.094 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.1 p -74.45 -29.1 61.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.723 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 51.2 mt-10 -54.19 -53.12 57.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 175.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 86' ' ' ARG . . . -70.58 -37.18 73.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.162 -173.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.49 -45.35 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 0.0 110.309 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -48.45 71.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.651 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -55.88 -42.67 76.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 110.875 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 49.8 ttt180 -57.12 -38.51 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.729 -176.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -95.85 -36.83 10.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.565 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.08 8.03 13.94 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.735 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.666 HG11 HD21 ' A' ' 96' ' ' LEU . 48.3 t -79.71 -24.41 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.36 105.57 0.3 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 178.86 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.772 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 37.1 p90 -146.23 143.62 19.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 3.6 Cg_exo -78.16 124.54 6.67 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.629 2.219 . . . . 0.0 111.263 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.23 174.76 14.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.082 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -101.76 119.5 38.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.727 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 89' ' ' VAL . 85.0 mt -94.18 121.83 36.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.0 p -95.69 132.63 39.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.149 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 94.7 m-85 -121.52 138.31 54.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.66 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -143.79 149.93 37.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 28.15 56.49 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.71 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.12 13.96 79.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.026 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -135.3 178.51 6.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.146 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.55 129.36 34.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -104.74 -51.83 2.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -176.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.79 -170.82 39.76 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.414 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.9 134.64 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.005 0.431 . . . . 0.0 111.499 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.09 110.38 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.018 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -121.55 129.9 53.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.915 0.388 . . . . 0.0 111.795 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.73 154.08 12.18 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.155 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.7 134.94 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -139.02 144.66 42.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.98 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.7 159.7 23.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.657 2.238 . . . . 0.0 111.546 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.482 ' CE2' HD11 ' A' ' 117' ' ' ILE . 5.4 t-105 -55.86 -48.79 74.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.0 78.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -40.77 87.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.665 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.5 tp -62.19 -48.0 81.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.4 mt -60.61 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.015 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -55.11 -54.37 44.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.868 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.88 -47.39 85.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.493 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.2 tpt -59.63 -43.15 93.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.634 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 124' ' ' VAL . 40.2 ttt180 -66.92 -33.75 76.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -30.97 71.14 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.23 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -84.7 -52.03 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.524 0.202 . . . . 0.0 111.527 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 121' ' ' ARG . 8.1 p -66.32 -31.47 53.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.763 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.546 ' HB3' ' NH1' ' A' ' 104' ' ' ARG . 33.7 tt0 . . . . . 0 N--CA 1.449 -0.521 0 O-C-N 124.031 0.832 . . . . 0.0 112.679 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.681 ' HG3' HD21 ' A' ' 77' ' ' LEU . 69.4 mtm . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -63.39 116.43 5.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.313 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 67.65 72.81 0.32 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.902 0.751 . . . . 0.0 110.665 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.22 122.96 24.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.536 0.684 . . . . 0.0 110.382 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.506 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 40.0 m -159.28 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.673 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 15.3 Cg_endo -58.25 -63.58 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.068 1.845 . . . . 0.0 112.311 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.53 -35.81 82.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 110.186 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.03 -51.49 67.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.613 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -64.64 -46.91 80.5 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.552 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 52' ' ' SER . 70.3 mt -55.38 -46.14 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 12.8 t90 -62.25 -50.64 70.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -58.51 -32.94 69.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.892 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 4.6 mmp_? -61.29 -57.34 12.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 111.166 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.8 ptt? -70.79 -29.34 65.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.8 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -57.42 -46.4 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.085 0.469 . . . . 0.0 109.897 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.72 -10.12 57.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.863 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 14' ' ' MET . 50.7 mtt180 -84.89 -5.19 59.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 0.0 110.995 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.19 21.65 8.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.144 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.423 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 52.8 m0 -97.14 115.26 27.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -71.32 140.82 85.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.154 -176.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 15' ' ' LEU . 6.3 Cg_exo -76.72 141.76 22.18 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.052 2.501 . . . . 0.0 111.48 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 14.2 p -123.28 142.11 41.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.897 0.379 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -102.45 165.1 11.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 83' ' ' ILE . 3.4 tm-20 -57.21 -55.76 30.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -70.68 -13.39 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.031 0.443 . . . . 0.0 110.796 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 21.2 mmt180 -96.19 -8.13 33.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.674 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD21 HG21 ' A' ' 39' ' ' VAL . 3.0 tm? -66.77 -41.34 87.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.32 -37.83 80.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.854 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -60.92 -55.97 26.62 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.039 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -43.32 68.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.181 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.29 -44.74 84.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.914 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -83.3 -26.99 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.705 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -81.66 -29.75 33.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.53 141.58 28.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.0 111.452 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 8.2 Cg_exo -72.47 -38.38 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.577 2.184 . . . . 0.0 111.045 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -160.15 169.18 23.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.637 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.46 -179.63 31.29 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.092 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' HB ' ' A' ' 97' ' ' VAL . 16.9 m -137.07 145.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.577 HG21 HD21 ' A' ' 27' ' ' LEU . 45.2 t -119.0 125.24 74.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.402 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.8 mp -98.8 116.44 31.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 96' ' ' LEU . 9.7 mp -98.24 116.06 29.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 173.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -121.74 102.73 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.982 0.42 . . . . 0.0 110.942 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.555 ' HB3' HH21 ' A' ' 91' ' ' ARG . 19.3 m -95.13 -73.92 0.57 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.962 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -151.11 143.2 16.0 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.173 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.48 148.46 90.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.882 2.388 . . . . 0.0 112.165 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -76.86 -32.74 57.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 13.5 ttp180 -175.74 -58.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.581 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.404 HG21 ' O ' ' A' ' 51' ' ' VAL . 15.5 m 66.45 141.76 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.193 -177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.76 -50.93 12.33 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.026 1.817 . . . . 0.0 111.403 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -110.18 -97.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.656 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 48' ' ' THR . 31.0 t -139.32 -69.59 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.005 0.431 . . . . 0.0 110.352 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 10' ' ' LEU . 46.8 t -92.4 -15.33 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 54' ' ' ASN . 17.8 t70 72.42 -22.26 0.22 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.206 1.002 . . . . 0.0 112.599 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 9.6 t30 83.05 99.54 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 123.572 0.749 . . . . 0.0 110.604 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.76 17.67 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 123.983 3.122 . . . . 0.0 114.599 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.23 -41.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -64.26 -24.79 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.247 -176.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 116' ' ' LEU . 47.9 mm -67.74 -38.14 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.462 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.05 -49.32 58.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.222 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.66 -28.61 69.22 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HG ' ' A' ' 116' ' ' LEU . 66.8 tp -60.87 -56.95 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 110.922 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.5 mp -62.23 -29.92 70.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.248 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 63' ' ' ARG . 7.8 mmt180 -75.05 -7.71 54.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -78.04 -6.87 55.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.086 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.81 78.85 9.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.437 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.06 -12.09 21.38 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.592 2.195 . . . . 0.0 113.081 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.44 -25.28 63.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.524 0.678 . . . . 0.0 110.315 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -103.56 120.72 41.43 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.539 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 p -80.66 103.29 10.41 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.418 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.548 ' HB3' HD23 ' A' ' 62' ' ' LEU . 96.8 m95 -83.9 100.39 10.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.094 -173.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -83.09 107.19 15.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.566 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -87.65 114.07 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.691 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -110.75 124.61 52.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.621 HG22 ' HB2' ' A' ' 40' ' ' LEU . 8.5 pt -110.34 139.76 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.015 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.42 154.85 21.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.169 0.509 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' HB3' ' CG ' ' A' ' 79' ' ' GLN . 7.1 t70 -65.94 162.99 18.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.198 174.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.681 HD21 ' HG3' ' A' ' 1' ' ' MET . 56.3 tp -59.22 -53.04 62.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.15 -24.57 62.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.251 0.548 . . . . 0.0 110.228 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.483 ' CG ' ' HB3' ' A' ' 76' ' ' ASP . 89.3 mm-40 -76.08 -37.76 57.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.596 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.6 m -59.23 -42.72 91.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 110.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -62.45 -42.78 99.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.577 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.13 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.503 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 24' ' ' GLU . 80.2 mt -67.99 -43.77 85.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.838 0.351 . . . . 0.0 110.118 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.87 -46.11 94.04 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.636 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.4 -47.32 72.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.142 0.496 . . . . 0.0 111.014 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.35 -31.17 71.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.732 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -87.77 -34.16 18.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.005 0.431 . . . . 0.0 110.675 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.31 45.09 1.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.145 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 90' ' ' PHE . 3.5 p -100.83 167.82 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' H ' HG22 ' A' ' 89' ' ' VAL . 18.6 m-85 -79.84 -67.61 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.683 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.555 HH21 ' HB3' ' A' ' 43' ' ' SER . 1.9 tpt180 -179.61 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.658 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 90.9 m-85 -51.06 117.22 8.44 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.882 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 5.4 Cg_exo -79.44 132.46 10.09 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.377 2.718 . . . . 0.0 111.889 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.24 -175.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.726 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.7 m -92.86 109.96 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.806 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 41' ' ' LEU . 6.2 mp -96.06 125.86 40.89 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.968 HG13 ' HB2' ' A' ' 104' ' ' ARG . 2.5 p -104.01 132.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.183 0.516 . . . . 0.0 111.288 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -127.68 135.28 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.111 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 m -145.4 144.7 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.97 35.59 54.12 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.119 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.66 12.7 62.23 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.052 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -122.36 166.87 14.02 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 111.288 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -93.79 120.22 33.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.592 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.968 ' HB2' HG13 ' A' ' 97' ' ' VAL . 25.6 mmt180 -79.15 -55.16 5.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.483 0.658 . . . . 0.0 109.78 176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.476 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 162.38 -166.75 36.66 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.939 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.47 134.37 65.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.089 0.471 . . . . 0.0 110.479 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.27 100.3 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.99 -7.9 52.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.174 0.511 . . . . 0.0 110.517 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.49 144.56 23.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.724 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.0 mm -136.53 -56.82 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.649 0.262 . . . . 0.0 111.566 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.769 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 36.9 t60 -88.02 -61.35 0.24 Allowed Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -168.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 23.5 Cg_exo -62.62 123.85 13.1 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.439 1.426 . . . . 0.0 111.864 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.433 ' O ' HG13 ' A' ' 117' ' ' ILE . 11.4 t-105 -76.49 -48.39 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.069 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.32 75.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 110.788 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 39.6 tt0 -75.64 -40.31 56.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.244 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 58' ' ' ILE . 50.1 tp -57.57 -44.4 85.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.473 ' HA ' HD11 ' A' ' 61' ' ' LEU . 68.8 mt -58.86 -45.37 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.287 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 40.5 t30 -61.68 -42.09 98.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.576 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 92.5 mt -60.32 -48.88 79.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.338 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.3 tpt -65.93 -36.48 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 0.0 109.865 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 60.9 ttt180 -56.36 -45.08 80.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.958 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.88 -30.59 70.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.483 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 83.2 mt -77.63 -36.66 51.42 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.883 -0.186 . . . . 0.0 111.374 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 120' ' ' MET . 34.5 m -82.02 -39.76 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.262 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.38 97.29 34.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.934 0.397 . . . . 0.0 110.156 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 128' ' ' GLN . 59.7 Cg_endo -73.7 -174.1 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.894 2.396 . . . . 0.0 113.688 -175.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 126' ' ' PRO . 41.4 tt0 71.29 -41.48 0.51 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.436 1.094 . . . . 0.0 111.867 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 26.6 mt-30 -95.72 80.93 3.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.371 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER 76.42 121.6 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.338 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -149.31 36.27 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.05 117.01 4.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.611 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG2' ' OD2' ' A' ' 44' ' ' ASP . 23.3 mmt . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.639 0.257 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -67.15 89.58 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 47.09 54.42 9.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.143 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.2 t0 38.45 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.488 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 51.3 m -162.0 -54.11 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.304 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 34.0 Cg_endo -66.74 -36.57 23.93 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 121.83 1.686 . . . . 0.0 111.829 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 77' ' ' LEU . 85.9 t80 -75.3 -38.12 60.49 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.388 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -50.22 -51.48 43.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.709 0.766 . . . . 0.0 109.377 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.27 -45.95 92.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.747 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -54.69 -52.05 63.62 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 111.459 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.2 t90 -65.78 -37.88 87.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.218 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.739 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -60.05 -33.56 72.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.156 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 28.4 mmt85 -59.38 -55.28 36.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.324 0.583 . . . . 0.0 110.336 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.6 mtm -67.39 -31.63 71.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.325 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -69.38 -34.94 75.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -22.0 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 17' ' ' ARG . 19.3 mmm180 -82.09 -8.88 59.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.594 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.9 10.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.851 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 20.9 m -93.45 122.84 61.96 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 3.7 Cg_exo -81.66 117.74 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.435 2.757 . . . . 0.0 111.179 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.11 151.39 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -81.2 159.77 24.5 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 79' ' ' GLN . 1.5 mp0 -49.63 -57.01 8.0 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.543 0.737 . . . . 0.0 112.978 -170.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -63.23 -32.4 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.97 0.414 . . . . 0.0 111.521 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -88.53 -11.81 44.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.405 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.43 -42.26 83.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.52 -38.91 59.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.628 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 32' ' ' THR . 11.2 t70 -57.83 -55.6 32.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.565 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -59.82 -46.55 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.776 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.47 -41.5 94.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.86 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.9 t -73.16 -25.92 60.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.381 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -89.86 -8.63 51.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.924 0.392 . . . . 0.0 110.784 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 146.33 32.73 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.409 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.71 -39.17 12.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.404 2.069 . . . . 0.0 112.295 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.6 t70 -166.58 177.34 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.13 30.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.441 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 97' ' ' VAL . 15.8 m -136.51 146.24 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.6 t -116.41 125.11 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.214 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.4 mp -94.47 128.34 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 93' ' ' PRO . 56.0 tp -87.41 136.46 32.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.189 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.427 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 66.3 m -102.4 -153.31 0.46 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.09 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 45' ' ' PRO . 70.6 m 75.28 135.24 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.869 0.731 . . . . 0.0 111.288 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD2' ' HG2' ' A' ' 1' ' ' MET . 4.9 p-10 -107.68 92.27 8.5 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.628 . . . . 0.0 110.19 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 43' ' ' SER . 71.9 Cg_endo -95.59 -24.16 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.18 2.587 . . . . 0.0 114.291 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -98.65 -69.73 0.75 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.719 -170.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -179.45 -28.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.607 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.5 m -83.45 116.77 66.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.945 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.86 8.32 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.426 2.751 . . . . 0.0 113.478 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 88.63 2.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.381 0.61 . . . . 0.0 109.719 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.511 ' H ' HD21 ' A' ' 10' ' ' LEU . 23.7 t -83.98 -24.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.75 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.5 m -78.79 -60.38 2.4 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.833 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.38 -69.21 0.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.883 0.739 . . . . 0.0 110.426 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -148.68 85.21 6.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' A' ' 13' ' ' ARG . 89.5 Cg_endo -79.44 44.36 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.079 2.52 . . . . 0.0 113.677 -169.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.37 -40.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.747 0.308 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -28.69 70.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.628 -173.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.46 -43.66 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.33 89.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.964 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.28 -28.18 59.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.009 0.433 . . . . 0.0 110.552 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD11 ' HA ' ' A' ' 117' ' ' ILE . 56.8 tp -63.55 -47.26 82.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.738 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.32 -28.29 69.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 23.1 mmt180 -73.3 -7.71 52.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.172 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -64.07 -35.45 80.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.348 0.594 . . . . 0.0 109.626 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -129.14 81.94 69.51 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.537 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.75 8.49 3.66 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.886 2.391 . . . . 0.0 113.007 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.64 -25.19 62.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 0.0 110.221 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.47 127.02 53.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.967 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.4 p -71.66 108.75 5.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.928 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -80.71 105.58 12.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.264 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 102.43 5.73 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.82 106.59 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.282 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.46 126.57 53.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 20.3 pt -112.23 140.78 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.869 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -103.39 145.46 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.602 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.619 ' HB3' ' HG2' ' A' ' 79' ' ' GLN . 21.0 t70 -63.41 160.06 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.657 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.654 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 65.8 tp -55.49 -52.95 61.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.205 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.16 -30.87 58.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.905 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 7.3 pt20 -77.75 -22.92 49.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.068 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 42' ' ' SER . 74.0 m -63.03 -29.24 70.67 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 110.063 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 20.5 mm-40 -56.13 -44.78 79.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.257 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.02 -37.13 55.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.396 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.06 -47.71 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.57 -41.82 97.68 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.505 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 26.3 t70 -58.97 -38.73 79.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -71.19 -31.56 67.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.668 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -91.2 -29.56 17.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.027 0.442 . . . . 0.0 110.899 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.87 29.51 4.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.048 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.39 122.78 64.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -136.38 18.82 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 110.715 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -99.55 -165.41 1.22 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.697 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -53.15 143.19 34.32 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 123.622 0.576 . . . . 0.0 112.319 -175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' HD23 ' A' ' 41' ' ' LEU . 37.9 Cg_endo -65.87 140.4 60.82 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.358 2.705 . . . . 0.0 112.56 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.7 -178.23 7.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.699 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 28.1 m -99.0 120.09 38.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.465 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.55 118.42 31.66 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.0 p -100.91 124.47 54.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.244 0.545 . . . . 0.0 110.991 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.5 119.34 29.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.421 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 63.6 p -95.61 123.61 39.24 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.15 16.12 47.1 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.974 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.57 63.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.941 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -102.28 141.1 35.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.277 0.561 . . . . 0.0 111.293 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -70.74 118.88 14.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.187 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -98.01 -48.17 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.535 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.04 -166.24 36.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.064 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.62 134.59 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 110.597 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 94.7 mt -97.46 119.97 36.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -138.08 129.33 27.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.729 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.54 127.63 1.93 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.67 -44.57 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 117.144 0.472 . . . . 0.0 112.233 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -97.42 -51.04 0.22 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.78 120.85 8.2 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 120.692 1.283 . . . . 0.0 111.864 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.567 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 t-105 -96.68 -37.74 10.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.813 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.203 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 30.8 mt-10 -81.5 -27.58 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.613 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 6.0 mt -56.72 -44.77 81.95 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.458 173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 61' ' ' LEU . 63.1 mt -65.3 -42.32 93.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 110.379 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -57.11 -57.45 12.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.628 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.3 mt -56.38 -41.27 75.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.576 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 124' ' ' VAL . 14.9 tpt -60.49 -50.42 73.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.445 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -66.89 -35.68 80.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.227 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.17 -29.52 73.14 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.604 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.39 -45.76 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 120' ' ' MET . 21.4 m -78.51 -28.09 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -112.42 103.63 55.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.557 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.61 99.72 0.75 Allowed 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.873 2.382 . . . . 0.0 111.276 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -101.84 79.47 1.91 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 122.788 1.28 . . . . 0.0 109.82 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.72 69.43 4.74 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.193 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.38 173.3 6.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.943 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 mtp85 -78.29 98.4 5.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.249 0.547 . . . . 0.0 111.13 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -114.59 2.93 14.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.866 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.667 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t 62.69 -90.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.951 0.5 . . . . 0.0 111.978 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -87.65 135.27 33.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.684 0.278 . . . . 0.0 110.757 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -81.23 121.08 25.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.18 0.514 . . . . 0.0 111.132 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.663 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 20.9 m -157.15 -61.74 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.234 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 3.9 Cg_exo -76.72 -67.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.126 1.884 . . . . 0.0 112.5 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -59.73 -35.06 73.78 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 120.91 0.386 . . . . 0.0 110.648 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.41 -49.9 75.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.588 . . . . 0.0 110.725 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' HG2' ' A' ' 12' ' ' GLN . . . -65.46 -34.23 77.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.533 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.556 ' HG ' HG12 ' A' ' 51' ' ' VAL . 3.1 mm? -65.89 -43.67 87.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.184 0.516 . . . . 0.0 110.074 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -38.1 85.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.807 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG2' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.5 -33.56 75.13 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 110.331 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 48.4 mmm-85 -63.21 -53.62 50.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 109.907 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtp -58.73 -40.11 82.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.697 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.0 -35.38 72.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.347 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.02 -27.82 68.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.625 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -82.76 2.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.27 -0.68 64.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.97 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -67.93 135.04 51.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 109.752 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.4 m -110.47 130.74 22.57 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.314 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 2.7 Cg_exo -76.8 153.72 33.67 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.267 2.645 . . . . 0.0 112.132 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 27' ' ' LEU . 13.0 p -148.0 152.48 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.214 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -81.74 158.53 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.253 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -43.61 -61.72 1.31 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.004 0.922 . . . . 0.0 112.854 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.1 m -67.53 -29.25 68.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.69 -171.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 26' ' ' ARG . 5.0 ttp-105 -85.86 -17.34 35.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.859 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.464 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -65.18 -39.65 93.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.665 ' HB2' HH12 ' A' ' 86' ' ' ARG . 18.7 t70 -62.74 -44.27 96.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.886 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.43 -52.84 63.92 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.212 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -50.67 -49.85 56.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.637 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.0 tp -61.44 -34.85 76.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -89.4 -26.3 21.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 0.0 111.851 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -92.59 -35.25 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB1' ' NE2' ' A' ' 71' ' ' GLN . . . -96.28 133.02 25.54 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.315 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.02 140.57 90.64 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.591 2.194 . . . . 0.0 110.985 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 11.9 t70 68.82 -158.4 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 131.66 97.98 0.73 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.261 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.08 141.75 23.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 122.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -99.52 130.56 45.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.172 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -82.11 175.29 10.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.5 p -63.49 117.91 7.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 110.987 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 m -69.75 94.55 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.178 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 12.5 t70 -82.11 129.27 64.77 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.233 -175.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.784 ' HA ' HG21 ' A' ' 51' ' ' VAL . 19.9 Cg_exo -66.56 -23.73 49.54 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.281 2.654 . . . . 0.0 113.224 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -101.29 -51.15 3.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.014 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.447 HH11 ' HA ' ' A' ' 91' ' ' ARG . 82.0 mtm180 -65.86 -27.05 67.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.955 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 51' ' ' VAL . 3.8 m -94.69 127.02 45.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 22.5 Cg_exo -66.66 -18.39 53.61 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.294 2.662 . . . . 0.0 113.115 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -154.12 102.33 2.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.784 HG21 ' HA ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -104.87 -59.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.066 -172.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -83.35 -2.34 55.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -164.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -54.4 -77.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.468 0.175 . . . . 0.0 111.144 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.0 p30 -171.39 139.19 1.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.67 0.271 . . . . 0.0 110.633 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 86.0 Cg_endo -103.3 42.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.586 2.857 . . . . 0.0 112.193 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.4 t -84.78 -23.13 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.842 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.475 ' HG3' ' N ' ' A' ' 58' ' ' ILE . 19.7 ptt? -48.35 -47.81 36.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.883 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.475 ' N ' ' HG3' ' A' ' 57' ' ' MET . 47.8 mm -60.12 -35.03 59.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 110.964 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -66.98 -46.14 76.17 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.753 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -79.22 -36.81 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 110.916 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 120' ' ' MET . 21.9 tp -63.12 -57.82 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.092 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.92 -29.79 69.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.516 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.513 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 8.2 mmt180 -78.6 -6.43 55.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.0 pt-20 -69.25 -12.94 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.58 174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 69.4 m-85 -110.86 82.85 3.23 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 64' ' ' GLU . 3.1 Cg_exo -81.46 -9.9 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.117 2.545 . . . . 0.0 112.825 -174.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.06 -25.42 47.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.113 0.482 . . . . 0.0 111.736 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -119.97 137.1 54.26 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 p -86.81 114.18 23.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.752 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.522 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 70.9 m95 -81.87 133.48 35.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.825 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.568 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 37.2 mt-30 -105.28 108.51 20.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.396 0.617 . . . . 0.0 110.1 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.39 116.6 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.704 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.92 140.85 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.022 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 32.7 pt -125.47 158.1 34.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.541 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -135.09 156.03 49.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.69 -167.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.217 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 77' ' ' LEU . 6.1 mp -59.74 -53.68 55.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.509 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.67 -44.78 76.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.137 0.494 . . . . 0.0 110.777 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 2.5 mp0 -61.97 -50.54 71.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.615 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 p -63.33 -43.45 97.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -65.62 -36.48 83.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.053 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.99 -44.09 70.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.01 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 93.0 mt -65.34 -41.93 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.123 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.2 98.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.17 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.75 -40.87 89.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.083 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.665 HH12 ' HB2' ' A' ' 28' ' ' ASP . 48.8 mtp180 -52.94 -40.85 63.97 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.485 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -90.85 -65.6 1.0 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.07 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.72 -15.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.262 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.23 95.0 4.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.789 0.328 . . . . 0.0 110.175 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -133.49 160.76 36.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.447 ' HA ' HH11 ' A' ' 47' ' ' ARG . 56.1 ttt-85 67.09 6.78 4.96 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.565 0.54 . . . . 0.0 110.711 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.407 ' HE2' HG11 ' A' ' 106' ' ' VAL . 80.7 t80 -128.64 101.68 20.64 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.242 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.79 126.58 10.19 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.737 2.291 . . . . 0.0 112.516 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.91 -175.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.891 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 36.9 m -101.82 120.03 39.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.276 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.99 118.55 32.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 104' ' ' ARG . 3.8 p -97.81 121.6 48.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.354 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.85 162.21 19.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.47 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.88 129.69 1.81 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.006 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.78 29.53 73.82 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.842 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.0 -6.46 41.68 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.517 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -98.38 156.9 16.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.297 0.57 . . . . 0.0 111.762 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -93.85 130.45 39.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.5 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.834 ' HB2' HG13 ' A' ' 97' ' ' VAL . 37.2 mmt180 -96.45 -59.89 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.643 0.258 . . . . 0.0 110.726 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.69 -153.7 16.75 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.132 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.407 HG11 ' HE2' ' A' ' 92' ' ' PHE . 53.6 t -121.23 133.7 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.6 mt -109.34 123.71 49.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.229 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -156.35 128.95 7.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.753 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.33 127.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.827 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.8 mm -114.26 -26.47 2.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 0.0 110.637 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.1 m80 -98.06 -58.92 0.15 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 6.2 Cg_exo -78.82 119.83 4.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.086 1.191 . . . . 0.0 111.807 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.518 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.1 t-105 -96.67 -48.42 5.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.239 -173.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.2 73.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.479 . . . . 0.0 110.616 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.79 -40.73 54.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.462 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 37.1 tp -58.73 -44.26 90.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.643 0.259 . . . . 0.0 110.776 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.0 mt -61.8 -48.93 86.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.614 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -51.59 -56.72 11.91 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.212 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.0 mt -62.03 -40.93 97.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.441 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.759 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -62.19 -48.68 78.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.846 0.355 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.62 -37.83 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.68 -30.07 76.56 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.432 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 98.3 mt -83.28 -49.03 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 34.3 m -73.82 -30.56 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.54 91.78 2.39 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 84.4 Cg_endo -78.77 115.96 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.587 2.191 . . . . 0.0 114.566 -165.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -97.97 -21.14 17.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 57.07 91.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.309 -1.768 . . . . 0.0 112.406 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 130' ' ' ARG . 11.2 mm-40 -97.03 113.7 25.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.491 171.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 39.1 ttm180 76.8 -51.13 0.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.101 0.875 . . . . 0.0 110.781 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.57 94.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.017 0.823 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -178.05 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.446 0.165 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m 68.78 -72.32 0.1 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 112.534 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -100.41 143.19 30.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.766 0.317 . . . . 0.0 110.64 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -101.47 129.52 47.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.446 0.641 . . . . 0.0 110.178 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 27.4 m -159.29 -57.18 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 36.8 Cg_endo -68.08 -40.55 8.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.283 1.322 . . . . 0.0 110.729 169.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -65.52 -39.21 91.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.428 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -51.99 67.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 109.578 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.7 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.908 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.839 HD21 ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.72 -54.36 42.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -34.35 77.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -60.98 -38.17 85.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 0.0 110.829 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -61.74 -53.8 51.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.516 0.674 . . . . 0.0 109.977 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 55.7 mtp -60.8 -34.99 75.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.37 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.34 -32.09 62.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.14 -23.28 65.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.216 0.532 . . . . 0.0 110.505 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -79.52 -10.71 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.45 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.81 26.65 44.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -89.68 140.93 29.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.441 . . . . 0.0 110.147 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -92.63 123.36 62.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.054 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.69 127.23 13.59 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.774 2.316 . . . . 0.0 111.319 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.12 136.74 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.514 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.0 m -67.8 161.71 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.499 0.5 . . . . 0.0 112.012 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.36 -60.28 2.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 112.047 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 m -78.43 -10.17 59.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -92.37 -22.2 19.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -44.09 91.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.761 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.99 -39.38 90.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -64.2 -56.32 15.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.102 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -67.68 -33.19 74.43 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.748 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.18 -42.09 99.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.572 0.225 . . . . 0.0 111.182 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -73.05 -25.85 61.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.756 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.78 -19.19 55.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 111.238 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.35 157.37 58.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.012 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.12 -64.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.438 2.092 . . . . 0.0 111.292 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -142.48 168.11 20.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.07 -178.18 48.7 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.485 -1.341 . . . . 0.0 113.569 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 97' ' ' VAL . 30.3 m -138.72 150.01 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.263 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.97 128.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.65 130.36 44.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.043 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.65 -67.42 0.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.563 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.679 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 49.1 m 58.27 34.16 23.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.176 0.512 . . . . 0.0 110.879 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.409 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 0.6 OUTLIER -80.97 -86.43 0.09 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.07 104.6 5.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.933 0.397 . . . . 0.0 111.019 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.56 148.64 7.45 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.043 2.495 . . . . 0.0 113.431 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -115.86 -64.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -93.11 -5.75 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.404 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 9.4 m -78.03 114.25 40.33 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.711 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 14.7 Cg_exo -69.17 -34.83 15.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.0 2.466 . . . . 0.0 112.818 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.966 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -157.8 103.15 1.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.839 ' HB ' HD21 ' A' ' 10' ' ' LEU . 10.8 t -74.94 -31.76 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.204 0.526 . . . . 0.0 110.886 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.59 -2.14 41.12 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.06 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.966 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 16.7 t0 -71.78 76.64 0.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.543 -174.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.9 t30 63.08 81.67 0.22 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.523 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.94 12.12 1.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.103 2.536 . . . . 0.0 111.944 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.11 -34.16 49.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.711 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -56.7 -30.98 64.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.361 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 62' ' ' LEU . 49.8 mm -61.12 -42.9 95.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.022 0.439 . . . . 0.0 110.681 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.68 -33.93 60.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.349 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.44 -32.01 65.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.935 0.398 . . . . 0.0 110.955 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.643 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 58.6 tp -64.37 -49.15 72.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.312 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.5 mp -58.68 -26.43 63.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -56.17 -19.03 11.82 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 9.8 pt-20 -87.01 22.08 2.13 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.631 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 55.3 p90 -67.44 122.29 82.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 38.4 Cg_endo -97.51 -53.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.974 2.45 . . . . 0.0 114.095 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.7 -26.16 17.14 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.562 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 17.5 p90 -143.54 142.57 31.17 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.538 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 t -86.08 151.27 23.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 65' ' ' PHE . 91.0 m95 -98.4 119.73 37.6 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.011 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.69 98.52 9.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.52 108.34 18.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.504 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.8 138.3 48.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.8 pt -118.65 145.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.94 167.58 12.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.47 172.66 10.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.947 173.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.86 -42.83 66.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.08 -44.72 83.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.501 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 83' ' ' ILE . 53.7 tt0 -70.64 -41.99 71.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.776 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 43' ' ' SER . 4.2 p -63.04 -42.26 99.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.296 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.15 -36.66 83.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.008 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.03 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.401 HD11 HE21 ' A' ' 79' ' ' GLN . 55.2 mt -65.46 -46.2 90.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.48 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.53 ' HA2' ' HB ' ' A' ' 89' ' ' VAL . . . -57.31 -49.25 74.14 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.728 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.26 -42.7 70.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 111.027 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -73.33 -31.56 64.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.737 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -101.61 -25.76 13.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.551 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.5 2.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.342 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' HB ' ' HA2' ' A' ' 84' ' ' GLY . 38.8 t -118.11 150.07 20.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.94 163.21 26.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.928 0.394 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -72.96 -9.37 58.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.914 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 53.5 m-85 -70.34 127.09 92.43 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.553 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 17.1 Cg_exo -65.57 124.38 12.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.855 2.37 . . . . 0.0 112.338 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.37 -173.27 3.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.3 m -109.84 127.12 54.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.43 116.99 29.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.528 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -98.76 126.28 51.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.496 0.665 . . . . 0.0 111.499 -175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -115.15 138.47 50.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -148.4 144.14 27.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.27 19.21 66.08 Favored Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.897 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.26 89.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.496 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -120.51 157.25 29.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -79.12 123.22 27.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.349 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -88.99 -60.28 2.0 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.36 -161.36 24.74 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.691 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.38 134.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.7 mt -100.43 105.71 17.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.22 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -117.97 97.52 5.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.489 0.661 . . . . 0.0 110.947 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.6 138.05 5.86 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.54 -33.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.998 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.801 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 m-70 -135.48 -54.58 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.801 ' HD2' ' H ' ' A' ' 111' ' ' HIS . 6.8 Cg_endo -50.18 120.25 5.97 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.677 1.585 . . . . 0.0 112.532 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.643 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 4.0 t-105 -99.11 -46.64 5.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.535 -170.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 118' ' ' ASN . . . -60.17 -34.56 73.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 110.005 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 17.3 mm-40 -68.87 -47.95 64.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.528 176.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.28 -49.52 76.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.82 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 113' ' ' TRP . 52.1 mt -60.29 -41.39 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 114' ' ' ALA . 31.7 t-20 -53.52 -57.59 10.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.569 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 81.1 mt -68.66 -41.68 78.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.293 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -50.48 73.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.721 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.531 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.5 ttt85 -69.97 -32.63 70.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.267 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.46 75.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.216 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.2 mt -81.62 -50.32 9.47 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.84 -0.212 . . . . 0.0 111.135 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 121' ' ' ARG . 31.1 m -67.0 -38.95 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.48 97.91 7.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 83.8 Cg_endo -89.69 150.73 5.12 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.926 2.417 . . . . 0.0 113.769 -170.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -77.91 -8.29 57.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.958 0.885 . . . . 0.0 109.794 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -146.69 108.5 4.35 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.546 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.71 81.75 0.28 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 111.441 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -81.88 89.47 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.46 141.74 14.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.638 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.974 178.499 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -115.15 97.74 6.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -117.82 75.94 1.03 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 t70 64.46 174.93 0.19 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.884 -174.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m -160.7 -57.25 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 5.0 Cg_exo -74.42 -52.91 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.138 1.892 . . . . 0.0 111.923 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -65.95 -41.07 91.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -53.25 -53.68 47.29 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.554 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -61.14 -49.3 77.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.229 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 52' ' ' SER . 3.0 mm? -59.2 -46.5 88.27 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.294 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.08 -47.86 78.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -61.48 -40.23 93.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.323 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 47.2 mmm-85 -59.26 -54.47 46.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.502 ' HB2' ' CE3' ' A' ' 19' ' ' TRP . 24.6 ptt? -70.99 -29.26 65.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.312 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 11' ' ' TRP . 34.4 mt -57.23 -39.42 75.48 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.34 65.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.804 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -74.29 -15.07 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.0 111.215 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.24 13.87 20.0 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.563 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 14' ' ' MET . 49.2 m0 -82.7 122.01 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.039 0.447 . . . . 0.0 109.832 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.5 m -91.94 132.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.613 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 23.0 Cg_exo -65.02 120.36 7.58 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 111.658 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.5 139.79 24.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.217 0.532 . . . . 0.0 110.916 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 m -92.66 150.22 20.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.096 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.35 -50.79 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.5 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.6 m -85.23 13.55 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.067 0.46 . . . . 0.0 111.293 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -121.23 -10.92 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.683 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.8 tm? -55.11 -43.8 74.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.472 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 32' ' ' THR . 30.5 t70 -64.41 -43.09 95.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 32' ' ' THR . 17.5 t70 -61.26 -55.57 30.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -62.5 -40.51 96.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.044 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -70.94 -29.43 65.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -75.01 -27.79 60.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.547 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 35.1 mt-30 -90.7 -44.05 9.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.147 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.35 94.57 11.7 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.923 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 8.2 Cg_exo -72.59 140.84 33.47 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.199 2.599 . . . . 0.0 113.556 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t70 73.91 167.07 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.407 1.067 . . . . 0.0 111.474 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.98 -165.35 24.32 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.023 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.88 152.61 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 122.524 0.33 . . . . 0.0 110.793 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.53 131.5 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.49 138.15 38.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.93 175.97 5.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 111.29 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.4 t -85.5 154.22 21.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.232 0.539 . . . . 0.0 110.845 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 92' ' ' PHE . 13.5 m -86.2 -47.33 9.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.766 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.2 t70 53.75 80.38 0.3 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 123.567 0.542 . . . . 0.0 110.286 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.6 132.53 23.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.313 2.008 . . . . 0.0 111.791 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.77 -55.23 2.39 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -129.69 -3.91 4.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.091 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -79.74 115.13 51.57 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.865 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 2.8 Cg_endo -81.83 -68.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.086 2.524 . . . . 0.0 112.823 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -95.14 79.75 3.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.556 0.693 . . . . 0.0 110.47 -175.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.21 -24.6 28.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.564 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -58.09 -64.46 0.91 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.1 t70 59.43 -85.85 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.662 0.785 . . . . 0.0 112.741 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -144.03 99.31 5.08 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 111.304 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -95.51 -167.72 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.174 2.583 . . . . 0.0 112.454 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.8 t 75.09 -37.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -53.43 -24.31 12.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.0 mp -58.96 -38.95 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.718 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.7 -38.18 94.26 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.406 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -72.79 -28.48 62.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.535 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.742 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.2 tp -61.35 -43.68 98.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.266 0.555 . . . . 0.0 110.347 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.8 mp -64.67 -27.44 68.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.072 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.49 -17.24 63.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.912 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -70.1 -36.37 74.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.689 0.28 . . . . 0.0 110.611 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -141.49 77.78 19.16 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.095 0.474 . . . . 0.0 110.537 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.0 16.83 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.142 2.562 . . . . 0.0 112.598 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.97 -25.67 67.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.524 -176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -116.71 166.85 11.65 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 p -85.29 105.49 16.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.921 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -91.44 103.57 16.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.752 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.18 122.2 31.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.199 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.8 t -97.96 107.39 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 124.71 50.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.504 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 30.6 pt -110.42 144.41 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -115.41 153.17 31.54 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.769 -0.372 . . . . 0.0 112.001 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.3 m-20 -61.88 168.86 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.518 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.09 -49.1 74.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.614 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -66.56 -34.47 77.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.23 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 66.5 mm-40 -75.53 -48.17 23.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.277 -172.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 78.4 p -65.49 -41.4 93.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -58.01 -44.74 87.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.279 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.41 -41.53 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 79' ' ' GLN . 73.9 mt -60.9 -45.33 98.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.955 0.407 . . . . 0.0 110.196 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.28 75.72 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.231 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -38.06 89.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' HH11 ' A' ' 86' ' ' ARG . 21.3 ttt180 -59.85 -27.93 67.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.428 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.89 -45.14 4.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.02 44.77 0.52 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.672 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.77 HG11 HD21 ' A' ' 96' ' ' LEU . 17.2 t -103.86 156.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 172.6 13.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 0.0 110.729 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 60.4 mtm180 -98.4 -161.01 0.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.667 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 62.2 m-85 73.93 165.93 0.13 Allowed Pre-proline 0 N--CA 1.467 0.387 0 O-C-N 123.953 0.783 . . . . 0.0 110.83 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 92' ' ' PHE . 21.4 Cg_endo -59.56 123.36 13.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.029 1.819 . . . . 0.0 111.679 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 106' ' ' VAL . . . -161.74 143.04 11.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.783 -174.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 23.8 m -110.77 113.3 25.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.0 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 89' ' ' VAL . 5.9 mp -93.43 137.31 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.37 130.11 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.36 119.36 36.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.16 125.72 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.157 0.503 . . . . 0.0 112.051 -172.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.22 -63.32 2.91 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.968 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -136.17 64.47 0.58 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 64.89 -153.42 0.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.534 0.334 . . . . 0.0 111.793 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -50.24 108.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.833 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.71 -38.55 15.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.513 0.673 . . . . 0.0 109.832 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . 170.5 -168.43 41.48 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.123 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.541 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 14.0 p -136.95 140.68 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.027 0.442 . . . . 0.0 111.037 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 93.7 mt -96.56 107.19 19.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.13 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -148.6 171.8 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.294 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.44 149.4 18.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.101 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.0 102.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 0.0 110.267 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 49.5 m80 -134.33 139.72 33.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 176.04 7.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 0.0 112.219 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.742 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 10.4 t-105 -58.39 -45.41 88.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.375 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.95 87.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.404 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 111' ' ' HIS . 4.4 tp10 -72.76 -33.12 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.441 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -63.0 -45.47 92.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.037 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.3 mt -62.9 -43.75 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.099 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -54.5 -58.26 8.18 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 91.7 mt -57.4 -47.44 81.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.463 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' VAL . 13.1 tpt -59.46 -41.56 90.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.599 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -63.35 -40.6 97.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.17 -30.42 77.8 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.839 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 74.0 mt -81.08 -50.95 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -70.86 -36.35 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.58 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 47.0 89.49 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 121.751 0.786 . . . . 0.0 112.428 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.81 169.62 11.78 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.787 2.325 . . . . 0.0 112.759 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.47 ' HB3' ' OE2' ' A' ' 129' ' ' GLU . 6.3 tt0 -96.39 -4.57 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.705 0.764 . . . . 0.0 109.122 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 67.35 72.88 0.34 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.795 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 127' ' ' GLN . 3.1 mp0 -87.02 88.69 7.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.12 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.408 ' HB3' ' H ' ' A' ' 131' ' ' ALA . 79.8 mtm180 -102.64 -164.12 1.06 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' A' ' 130' ' ' ARG . . . -81.04 43.99 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.435 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.85 178.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.623 ' HG2' ' HG3' ' A' ' 6' ' ' PRO . 24.9 ttt . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -144.3 -53.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.339 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -112.15 159.06 18.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.555 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 3.7 p30 50.58 22.56 1.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.421 1.088 . . . . 0.0 113.65 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.724 ' OG1' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -137.83 -65.31 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.648 175.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.724 ' HD3' ' OG1' ' A' ' 5' ' ' THR . 6.2 Cg_exo -78.24 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.767 1.645 . . . . 0.0 111.443 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.95 -37.91 84.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.593 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 24.7 t70 -64.31 -54.42 33.45 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.35 90.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 52' ' ' SER . 0.2 OUTLIER -58.17 -55.05 40.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.044 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -39.46 93.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.236 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.834 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -57.6 -39.86 77.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.571 0.224 . . . . 0.0 111.165 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -65.05 -53.41 46.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.186 0.517 . . . . 0.0 110.533 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.9 -37.8 74.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.116 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -34.91 76.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.381 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.79 66.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.023 0.439 . . . . 0.0 111.123 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 28.7 mmt180 -83.66 2.75 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.496 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.65 12.16 80.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.59 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.475 ' HH2' ' HB2' ' A' ' 55' ' ' PRO . 51.5 m0 -77.51 124.01 27.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.501 ' HB ' ' CH2' ' A' ' 30' ' ' TRP . 21.5 m -85.46 123.93 72.2 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.971 -171.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.93 118.75 5.86 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.805 2.337 . . . . 0.0 111.463 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 27' ' ' LEU . 14.4 p -126.11 147.08 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m -95.23 165.09 12.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.181 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.26 -48.65 54.71 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.751 0.42 . . . . 0.0 112.114 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 m -59.74 -35.48 74.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.002 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 9.1 tpt180 -94.69 -18.29 21.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.79 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 3.4 tm? -64.05 -40.0 95.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.49 -42.66 96.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.168 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 28.5 t70 -63.14 -57.16 11.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.946 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CH2' ' HB ' ' A' ' 20' ' ' THR . 5.9 t90 -59.13 -39.65 83.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.196 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -66.95 -28.1 68.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.478 . . . . 0.0 110.419 177.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.5 m -75.19 -33.06 61.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 19.3 mm-40 -80.64 -48.34 12.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.406 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -73.0 135.3 80.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.401 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 2.1 Cg_endo -81.66 -21.93 5.78 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.911 2.408 . . . . 0.0 111.52 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 3.5 p-10 -95.31 -89.29 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.129 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 87.69 106.92 0.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.599 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 72' ' ' VAL . 5.5 m -131.89 134.08 60.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 171.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 73' ' ' ALA . 49.2 t -130.5 135.19 61.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.951 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mp -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.2 tt -104.46 128.29 52.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.025 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 m -99.06 132.05 44.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.865 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -157.97 -168.44 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 4.5 m-20 -59.91 123.3 71.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.261 0.35 . . . . 0.0 110.309 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.54 132.83 42.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.203 1.935 . . . . 0.0 111.963 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -126.24 -57.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.642 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.1 tpm_? -105.86 -28.64 10.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 10.5 p -65.62 116.64 33.52 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.615 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 38.8 Cg_exo -61.77 -43.03 28.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 0.0 111.661 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -108.64 -115.18 0.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.084 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.95 -55.25 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 10' ' ' LEU . 29.0 t -111.59 -48.17 3.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.208 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.9 t70 49.55 71.4 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.527 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 t30 66.99 85.59 0.15 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.526 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HB2' ' HH2' ' A' ' 19' ' ' TRP . 96.7 Cg_endo -79.85 -5.7 13.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.526 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 21.6 t -61.9 -35.72 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.6 ttp -58.95 -37.37 76.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 62' ' ' LEU . 50.1 mm -69.91 -36.11 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.078 0.466 . . . . 0.0 110.346 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.83 -45.31 65.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.011 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 8.7 mm-40 -68.6 -28.22 66.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.84 0.353 . . . . 0.0 110.468 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 116' ' ' LEU . 24.7 tp -61.68 -54.93 36.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.483 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 58' ' ' ILE . 7.3 mp -52.27 -26.6 12.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.439 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.574 HH11 ' HG3' ' A' ' 63' ' ' ARG . 11.5 mmt85 -61.62 -9.4 6.02 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.99 -12.18 59.42 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 122.015 -0.428 . . . . 0.0 111.181 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -116.79 92.88 39.69 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.826 0.346 . . . . 0.0 110.622 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.77 2.9 6.43 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.75 2.3 . . . . 0.0 112.249 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.95 -26.69 62.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.716 0.77 . . . . 0.0 109.766 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -129.17 133.53 47.63 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.654 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 p -85.03 102.68 13.4 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.455 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.66 118.98 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.947 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -103.08 107.08 17.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.337 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 38' ' ' VAL . 26.8 t -88.21 120.37 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.22 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -107.15 133.04 52.34 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.263 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.7 pt -125.98 143.84 38.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -120.53 156.72 30.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.994 -174.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 169.22 4.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.53 -46.48 88.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.109 0.48 . . . . 0.0 110.35 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -61.82 -44.36 97.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.847 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 83' ' ' ILE . 83.8 mm-40 -68.58 -39.22 81.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.167 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.0 m -58.25 -39.81 80.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.37 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -34.95 79.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.181 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.21 47.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.259 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 79' ' ' GLN . 74.6 mt -64.12 -46.94 92.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.53 96.74 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.946 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.38 -42.15 95.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 111.281 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -61.14 -32.31 72.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -100.55 -43.65 6.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.133 0.492 . . . . 0.0 111.001 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.2 42.6 0.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.59 142.96 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.537 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 21.3 m-85 -73.57 159.81 32.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -83.79 84.89 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.349 0.595 . . . . 0.0 112.13 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 44' ' ' ASP . 30.5 p90 -169.25 152.66 5.1 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.652 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.0 Cg_exo -71.72 126.39 11.99 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.416 2.077 . . . . 0.0 111.337 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.88 168.77 25.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 26.2 m -100.85 120.23 39.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.12 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.402 HD22 ' OH ' ' A' ' 103' ' ' TYR . 35.6 mt -94.88 120.34 34.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.77 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.8 p -104.89 122.53 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.56 0.695 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.74 -177.97 3.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.505 ' OG1' ' HD3' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -151.23 -171.5 3.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.18 91.79 0.04 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.034 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.44 24.44 70.85 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.354 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.01 159.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.422 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' OH ' HD22 ' A' ' 96' ' ' LEU . 51.1 t80 -117.75 111.99 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -168.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.56 -171.2 34.72 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.046 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.55 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.5 mt -95.29 103.53 15.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -108.5 130.58 55.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.46 -165.56 24.95 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.783 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 49.7 mm -112.97 -69.52 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 79.1 m-70 70.95 143.32 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.74 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.45 159.65 19.13 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.647 2.231 . . . . 0.0 111.858 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 15.5 t-105 -54.05 -43.19 69.99 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.08 78.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 111.643 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 4.4 mp0 -72.49 -26.44 61.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.748 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' CD1' HD22 ' A' ' 61' ' ' LEU . 2.0 tm? -62.72 -47.43 83.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.5 mt -60.84 -45.91 97.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.264 0.554 . . . . 0.0 109.719 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -52.65 -58.28 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 89.6 mt -58.14 -42.22 85.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.595 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.442 ' HG2' HD21 ' A' ' 61' ' ' LEU . 16.9 tpt -57.73 -50.6 72.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 110.642 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.635 ' HA ' HG12 ' A' ' 124' ' ' VAL . 65.0 mtt180 -68.84 -32.05 71.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.31 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.73 -29.89 71.21 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.482 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 96.6 mt -95.83 -45.92 6.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 121' ' ' ARG . 7.2 p -71.49 -26.04 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -172.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.65 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 0.5 OUTLIER -68.97 -54.36 12.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.439 -178.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 125' ' ' GLU . 7.9 Cg_exo -73.51 153.24 49.59 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.205 1.937 . . . . 0.0 111.433 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.95 -1.29 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 57.13 48.18 15.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.951 0.881 . . . . 0.0 109.853 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -81.36 95.38 7.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.892 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 130' ' ' ARG . 14.0 ttp180 -167.1 -39.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.048 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.04 162.49 29.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.417 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--N 1.323 -0.571 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.395 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t -139.29 108.36 6.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.889 0.313 . . . . 0.0 111.668 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.48 145.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.579 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.49 112.05 22.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.501 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 85.3 m -158.99 -62.98 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.792 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 19.3 Cg_endo -60.03 -72.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.961 1.774 . . . . 0.0 113.538 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.64 -33.59 76.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.67 -51.9 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.592 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -65.15 -44.05 89.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 52' ' ' SER . 3.2 mm? -62.33 -39.76 94.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.339 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -65.46 -44.77 86.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.13 -39.25 78.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.188 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 68.8 mmt-85 -61.57 -53.26 58.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.0 0.429 . . . . 0.0 110.616 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.415 ' SD ' HD22 ' A' ' 40' ' ' LEU . 75.4 mtm -61.4 -32.75 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.078 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.43 -40.09 89.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.608 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.24 65.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.055 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 6.2 mmp_? -71.24 -33.66 70.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.468 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.12 39.01 2.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.86 174.35 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.467 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.9 m -101.84 118.14 60.1 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.0 111.77 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 4.1 Cg_exo -80.27 126.92 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.41 2.74 . . . . 0.0 111.503 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 75' ' ' ALA . 11.8 p -135.52 142.34 39.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -97.6 167.45 10.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 111.435 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -52.73 -51.35 60.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.381 -175.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.9 m -75.36 -5.66 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.901 0.381 . . . . 0.0 111.782 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -106.85 -20.45 13.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.254 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 83' ' ' ILE . 2.8 tm? -56.12 -42.21 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.353 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.89 -46.18 72.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.319 0.581 . . . . 0.0 110.573 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 32' ' ' THR . 32.6 t70 -60.46 -53.59 55.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.346 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.93 -43.56 86.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.5 -40.12 95.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.692 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -70.12 -25.46 63.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.67 -42.83 13.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.047 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -66.79 134.79 94.17 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 34.9 Cg_exo -63.12 -44.42 15.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.483 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.802 ' HB2' ' HE2' ' A' ' 68' ' ' TYR . 1.5 t0 -161.36 177.34 10.23 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.04 -178.96 33.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.695 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 97' ' ' VAL . 20.2 m -138.37 156.48 30.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 122.501 0.32 . . . . 0.0 110.205 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.81 143.57 40.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.619 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' SD ' ' A' ' 14' ' ' MET . 7.7 mp -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 63.7 tp -114.93 96.55 5.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.417 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.9 m 60.22 -167.47 0.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.7 0.625 . . . . 0.0 112.562 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.5 p -137.07 174.48 10.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.955 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 33.2 t70 -69.77 141.25 89.77 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.132 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 13.7 Cg_exo -70.55 -171.89 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.553 2.835 . . . . 0.0 113.897 -175.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -79.99 -39.64 29.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.097 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 47' ' ' ARG . 67.1 mtt180 -69.61 -4.13 17.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.437 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.449 ' HB ' ' OD2' ' A' ' 44' ' ' ASP . 10.8 m -122.96 130.49 24.59 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 122.172 -0.33 . . . . 0.0 110.361 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -91.84 43.36 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.752 2.302 . . . . 0.0 113.053 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -134.25 41.34 2.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.813 0.816 . . . . 0.0 109.34 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.955 ' HA ' ' HB3' ' A' ' 44' ' ' ASP . 13.0 t -77.77 -39.65 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.331 -171.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' HD11 ' A' ' 10' ' ' LEU . 37.4 t -109.76 -39.06 5.22 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.829 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 52.6 -144.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.683 0.614 . . . . 0.0 109.834 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.527 ' N ' HD22 ' A' ' 54' ' ' ASN . 0.0 OUTLIER -151.18 92.3 3.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -61.31 -95.85 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.797 2.331 . . . . 0.0 113.484 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 97.7 t 73.29 -51.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.326 0.584 . . . . 0.0 110.653 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.541 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 22.9 ptt? -59.51 -24.41 63.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.078 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.25 -45.09 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.897 0.38 . . . . 0.0 110.798 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.35 -40.2 80.51 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.588 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -63.08 -39.16 93.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.514 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 37.0 tp -59.99 -57.03 14.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.723 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.24 -28.02 68.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.132 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -75.43 -6.92 52.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.2 pt-20 -76.39 -13.54 60.12 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.243 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -131.26 71.09 82.06 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.45 12.46 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.25 2.634 . . . . 0.0 112.799 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.51 -14.35 60.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.676 0.75 . . . . 0.0 110.012 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.802 ' HE2' ' HB2' ' A' ' 36' ' ' ASP . 8.7 t80 -122.4 -177.12 3.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.208 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -109.44 123.02 48.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.685 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -108.34 106.67 16.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -90.39 110.91 21.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.015 0.436 . . . . 0.0 110.185 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.97 117.91 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.975 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -116.03 127.9 55.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -176.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.1 pt -119.57 139.33 47.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.493 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.65 171.24 7.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 4.7 m-20 -64.14 171.8 2.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.822 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -57.73 -54.26 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.568 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -74.61 -33.78 62.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.972 0.415 . . . . 0.0 111.32 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 2.6 mp0 -69.64 -39.52 77.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.06 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.4 m -55.23 -52.99 61.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.48 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 17.6 tp10 -59.93 -44.43 94.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.353 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.83 -41.31 95.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.894 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 79' ' ' GLN . 80.1 mt -63.01 -47.57 92.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.624 0.249 . . . . 0.0 110.964 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.19 92.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.519 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.99 -43.96 82.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.81 0.444 . . . . 0.0 111.262 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -67.7 -27.23 66.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -78.19 -39.06 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 109.944 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.52 -25.85 2.29 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.02 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.6 t -86.3 99.73 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.012 0.434 . . . . 0.0 110.142 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -93.76 131.79 38.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.709 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 0.4 OUTLIER 67.08 179.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.732 0.645 . . . . 0.0 112.011 173.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 70.02 105.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.869 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 37.5 Cg_endo -66.43 135.66 40.32 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.613 2.209 . . . . 0.0 112.528 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -171.8 -173.68 1.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.153 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 20.4 m -114.91 127.94 55.99 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.7 114.79 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -99.84 130.49 48.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.313 0.577 . . . . 0.0 111.105 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -123.43 164.95 17.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.804 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m -154.87 136.4 14.25 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 170.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.29 14.85 42.5 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.149 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.4 -5.6 84.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.242 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -94.71 149.09 21.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 110.912 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -74.44 126.88 31.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.11 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 3.5 mmp_? -99.23 -45.11 6.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.95 -165.13 38.68 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.674 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.44 134.04 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.101 0.477 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.0 mt -100.2 109.83 22.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.569 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -132.19 81.36 1.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.382 0.61 . . . . 0.0 109.605 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.18 64.48 0.34 Allowed Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.309 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 26.0 mm -80.35 83.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.487 0.184 . . . . 0.0 111.093 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 9.9 t-80 175.9 -60.12 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.703 172.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 1.6 Cg_endo -82.98 124.76 3.94 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.476 2.118 . . . . 0.0 113.035 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' A' ' 57' ' ' MET . 12.1 t-105 -77.09 -49.23 15.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.581 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.58 78.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.034 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 36.9 tt0 -74.23 -34.54 63.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.725 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.03 -43.33 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.11 -47.91 85.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -53.78 -49.52 68.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.434 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.51 -53.8 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.8 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 124' ' ' VAL . 17.6 tpt -56.76 -51.06 70.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.482 . . . . 0.0 110.512 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 125' ' ' GLU . 24.4 ttt85 -64.77 -31.75 73.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.562 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.47 -30.9 61.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.669 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.12 -51.88 6.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' MET . 32.8 m -81.64 -24.81 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.631 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 31.3 tt0 46.48 85.55 0.17 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.123 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.412 ' HD2' ' HG3' ' A' ' 121' ' ' ARG . 19.9 Cg_exo -69.04 92.04 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 110.433 170.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -64.51 -42.3 95.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.032 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.45 57.24 2.24 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.746 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 104.34 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.937 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 130' ' ' ARG . 10.6 ptm180 -158.01 1.15 0.11 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.577 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -157.28 107.52 2.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.123 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.917 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 10.4 t -95.08 66.77 3.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.273 0.559 . . . . 0.0 110.546 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -168.2 149.29 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.495 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t70 70.96 4.6 5.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.554 0.693 . . . . 0.0 111.715 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 42.1 m -151.99 -60.71 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.917 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 16.0 Cg_exo -67.87 -66.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.921 1.747 . . . . 0.0 112.124 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.484 ' HA ' HG11 ' A' ' 51' ' ' VAL . 91.5 t80 -60.8 -35.07 75.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.42 -53.51 55.66 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -66.44 -43.03 86.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.062 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 51' ' ' VAL . 2.2 mm? -60.77 -37.72 82.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.816 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 15' ' ' LEU . 6.3 t90 -64.04 -48.61 75.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.541 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 45.3 mt-30 -60.51 -32.47 71.48 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.525 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 26.2 mmm180 -59.16 -53.32 59.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.002 0.429 . . . . 0.0 110.281 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.609 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 71.7 mtm -62.13 -33.37 74.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.845 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.548 HD22 HD11 ' A' ' 74' ' ' ILE . 2.7 mm? -59.51 -38.91 82.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.624 176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.04 66.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.39 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -75.63 -6.34 49.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.614 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.75 46.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.598 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 47.5 m0 -89.51 119.95 30.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.055 0.455 . . . . 0.0 109.931 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -83.7 137.23 41.4 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.401 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 74.1 Cg_endo -76.95 149.83 29.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.48 . . . . 0.0 111.424 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -154.1 156.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 111.18 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 p -99.04 164.5 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.307 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.19 -42.73 73.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 111.66 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -30.44 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.65 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -85.23 -23.17 28.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 0.0 110.619 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 22' ' ' VAL . 3.2 tm? -60.64 -39.26 87.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.622 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.33 -32.92 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.924 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 9.0 t70 -68.3 -55.24 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.047 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -60.69 -34.08 73.8 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.918 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.99 -43.03 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.322 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.0 t -74.55 -26.39 59.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.782 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 29' ' ' ASP . 98.0 mt-30 -64.57 -44.96 89.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.853 0.358 . . . . 0.0 110.651 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HB2' ' NE2' ' A' ' 71' ' ' GLN . . . -90.79 161.75 35.16 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.04 -45.56 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.326 2.017 . . . . 0.0 110.993 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -149.17 -178.16 6.23 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.119 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.11 -168.17 40.23 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.052 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.1 m -139.13 135.73 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.858 0.361 . . . . 0.0 110.477 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -124.11 133.18 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -95.84 131.43 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.948 0.404 . . . . 0.0 111.258 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.775 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 4.5 tt -107.71 117.19 33.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.612 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -112.46 133.36 54.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.871 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -169.18 -166.84 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.23 117.36 59.56 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 121.588 0.709 . . . . 0.0 111.035 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.869 ' HB3' ' HG2' ' A' ' 93' ' ' PRO . 95.0 Cg_endo -101.65 143.84 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.462 2.775 . . . . 0.0 113.131 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HD3' ' O ' ' A' ' 46' ' ' LYS . 2.1 tmtp? -110.41 -24.61 10.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -75.75 -43.7 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.61 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -93.4 139.14 22.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.51 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -41.55 -68.06 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.56 2.84 . . . . 0.0 113.616 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.55 -66.4 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.152 177.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG12 ' HG ' ' A' ' 10' ' ' LEU . 45.0 t -151.01 -30.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.582 0.23 . . . . 0.0 111.343 -173.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t -70.47 -19.5 62.95 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -168.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.68 97.17 11.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.937 0.399 . . . . 0.0 110.701 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.48 153.4 75.1 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.617 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB2' HG12 ' A' ' 58' ' ' ILE . 74.4 Cg_endo -80.74 97.59 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.492 2.128 . . . . 0.0 112.911 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HA ' ' HH2' ' A' ' 19' ' ' TRP . 45.3 t -93.96 -27.71 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.341 0.591 . . . . 0.0 110.313 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -22.81 65.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.001 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 55' ' ' PRO . 40.3 mm -52.6 -35.83 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -61.42 -43.04 99.85 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -69.25 -30.35 68.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.196 0.522 . . . . 0.0 110.875 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.879 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 47.6 tp -72.56 -52.67 14.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.345 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.6 ' O ' ' HD2' ' A' ' 65' ' ' PHE . 8.4 mp -59.2 -27.3 65.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.274 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 16.6 mmm180 -56.3 -14.59 2.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.81 -7.25 47.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.881 0.309 . . . . 0.0 111.62 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' HD2' ' O ' ' A' ' 62' ' ' LEU . 32.1 p90 -64.71 126.97 91.99 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.393 0.616 . . . . 0.0 111.57 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 65' ' ' PHE . 1.3 Cg_endo -87.28 -62.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.307 2.671 . . . . 0.0 112.654 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.4 -25.53 10.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.726 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -82.48 104.37 12.72 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.4 p -79.42 107.22 12.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.073 0.463 . . . . 0.0 110.377 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -75.88 121.65 22.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.525 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' A' ' 34' ' ' ALA . 1.9 tp-100 -83.6 100.73 11.0 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.42 108.48 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.903 0.382 . . . . 0.0 110.055 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.49 48.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 19.6 pt -115.9 148.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.435 175.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -130.89 167.39 19.03 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.6 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.755 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 3.6 m-20 -61.71 163.71 6.98 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.52 174.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.82 -48.71 77.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.753 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.72 -24.07 64.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.574 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.755 ' HG2' ' HB2' ' A' ' 76' ' ' ASP . 78.5 mm-40 -76.46 -51.83 11.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 41' ' ' LEU . 39.6 m -64.27 -37.38 87.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.91 -45.3 74.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.067 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -45.59 81.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.87 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.71 -49.03 82.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.347 0.404 . . . . 0.0 111.07 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.47 50.78 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -55.89 -49.61 72.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.272 0.558 . . . . 0.0 110.93 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -63.49 -31.53 72.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.883 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.18 -51.76 6.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 110.593 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.03 44.64 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.712 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -104.68 -14.72 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' HD2' ' CE2' ' A' ' 92' ' ' PHE . 41.7 t80 68.19 175.97 0.26 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.035 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -84.08 94.26 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.922 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CE2' ' HD2' ' A' ' 90' ' ' PHE . 54.2 m-85 -140.17 132.05 14.5 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.889 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.869 ' HG2' ' HB3' ' A' ' 45' ' ' PRO . 6.6 Cg_exo -71.66 129.24 15.32 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.172 1.915 . . . . 0.0 110.519 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.39 156.85 2.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.159 0.505 . . . . 0.0 111.68 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.0 m -95.6 120.81 36.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.965 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.9 114.17 26.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 38' ' ' VAL . 6.5 p -99.38 124.86 52.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.153 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.91 140.81 33.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.544 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 p -134.0 122.48 23.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.979 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.76 25.58 69.19 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.355 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.81 0.42 88.11 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.61 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -109.09 143.88 37.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.313 -175.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -82.31 112.86 19.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.119 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -136.69 10.81 3.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.56 137.24 6.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.525 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.93 132.69 69.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.63 95.01 2.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.613 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -81.75 -38.68 25.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 109.984 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.47 -161.11 24.95 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 23.1 mm 69.89 163.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 43.6 m80 78.77 151.89 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.193 0.597 . . . . 0.0 110.452 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.45 142.68 96.13 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.546 2.164 . . . . 0.0 113.001 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.879 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 29.5 t-105 -53.79 -33.81 57.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.652 175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.64 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.52 -33.28 48.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 109.936 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 113' ' ' TRP . 2.7 mm? -58.14 -44.5 87.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.962 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 113' ' ' TRP . 59.9 mt -64.38 -41.91 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.35 -54.83 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.502 0.667 . . . . 0.0 110.824 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.9 mt -59.19 -48.52 81.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.423 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.7 ' HG2' HD21 ' A' ' 61' ' ' LEU . 14.8 tpt -62.29 -38.79 90.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.704 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 121' ' ' ARG . 16.8 tpt180 -66.11 -34.46 78.12 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.8 74.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.754 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 92.3 mt -75.6 -55.55 5.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.689 -0.256 . . . . 0.0 111.609 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 120' ' ' MET . 34.6 m -77.94 -23.24 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.795 -175.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.44 76.0 69.07 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.0 109.343 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.84 113.39 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.05 2.5 . . . . 0.0 113.067 -173.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -83.9 -4.3 58.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.531 171.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 55.79 65.28 1.49 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.222 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 174.37 5.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.033 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -69.05 138.09 54.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.422 0.629 . . . . 0.0 112.123 -174.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.19 113.1 15.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.813 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.227 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.0 m 65.17 28.7 12.12 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.694 0.621 . . . . 0.0 110.477 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -86.42 83.43 7.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.445 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.32 -0.07 1.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.628 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.594 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 21.6 m 179.12 -54.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.377 0.671 . . . . 0.0 110.529 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 46.4 Cg_exo -56.97 -66.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.292 1.995 . . . . 0.0 112.995 -175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 77' ' ' LEU . 64.0 t80 -60.42 -37.96 82.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.32 . . . . 0.0 110.688 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 7.2 t70 -59.04 -53.15 61.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.486 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.6 88.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.347 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.29 -47.77 75.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.85 -35.62 81.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 14.8 mm100 -57.33 -43.84 83.71 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.026 176.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 5.0 mmp_? -64.21 -53.35 50.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 84.4 mtp -56.47 -39.56 73.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.291 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.95 -38.47 79.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.186 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.39 70.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HA ' HH11 ' A' ' 17' ' ' ARG . 10.3 mmm180 -73.06 -15.9 61.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.396 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.92 44.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.312 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -114.5 137.47 51.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 p -96.44 138.03 21.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.9 Cg_endo -86.2 163.46 9.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.616 2.878 . . . . 0.0 112.076 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 27' ' ' LEU . 7.9 p -162.79 143.74 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.895 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.32 155.25 19.1 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.95 78.35 1.66 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.988 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 53.8 m -171.22 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.529 ' HD3' ' HB2' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.26 0.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.544 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -53.02 -43.31 66.44 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 170.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.72 -43.34 59.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.739 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.85 -52.45 65.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.699 0.762 . . . . 0.0 110.407 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.654 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 22.9 t90 -58.75 -42.73 89.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.027 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.4 -33.25 75.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.0 m -60.21 -42.69 95.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.856 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.67 -43.75 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB1' ' CD ' ' A' ' 71' ' ' GLN . . . -113.05 94.95 32.56 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.549 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.34 -170.57 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.258 2.638 . . . . 0.0 112.551 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 49.84 88.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.893 0.854 . . . . 0.0 112.271 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.4 -169.35 27.84 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.153 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -136.93 145.83 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.625 0.25 . . . . 0.0 110.993 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 11.5 p -138.05 140.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.814 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.67 130.8 45.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -106.27 112.78 25.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.053 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.438 ' H ' ' CB ' ' A' ' 80' ' ' SER . 39.8 m 66.52 176.65 0.23 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.83 0.706 . . . . 0.0 111.371 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -144.5 15.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -129.52 86.56 55.56 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.989 0.423 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -89.31 132.56 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.179 2.586 . . . . 0.0 111.677 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -87.01 -25.17 24.38 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.291 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -90.5 -18.55 25.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 HG21 ' HA2' ' A' ' 109' ' ' GLY . 3.0 m -125.7 88.45 54.2 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.95 -34.2 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.825 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.2 40.58 1.01 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.04 0.448 . . . . 0.0 111.71 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.707 ' HA ' HD11 ' A' ' 110' ' ' ILE . 42.8 t -72.7 -27.17 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.505 0.669 . . . . 0.0 109.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -70.99 -2.79 16.53 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.851 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.79 -64.82 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.057 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -162.49 104.18 1.08 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.19 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.103 2.536 . . . . 0.0 113.285 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 -24.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.04 70.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.091 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.07 -38.35 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.42 -44.45 51.18 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.164 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.07 -30.05 66.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.644 0.259 . . . . 0.0 110.775 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 54.8 tp -62.75 -45.59 91.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.025 0.441 . . . . 0.0 110.633 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.33 -29.9 67.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.756 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.6 -12.11 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 111.19 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 13.1 tp10 -74.37 -26.58 60.21 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -140.59 72.63 30.24 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 109.836 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -93.79 6.81 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.05 2.5 . . . . 0.0 112.39 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.21 -22.08 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 0.0 110.992 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.02 129.81 56.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -66.61 109.86 2.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.788 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.01 133.78 34.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.546 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' CD ' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -90.89 102.17 14.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.96 173.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.9 t -95.95 113.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.472 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -122.09 135.6 54.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 16.7 pt -128.03 148.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.11 171.08 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 79' ' ' GLN . 9.9 t70 -66.49 161.88 21.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 173.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' SER . 63.5 tp -66.91 -55.9 12.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.735 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . 57.8 mt-10 -73.84 -23.56 59.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 31.7 tt0 -64.55 -33.94 77.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.937 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.438 ' CB ' ' H ' ' A' ' 42' ' ' SER . 73.1 m -63.67 -40.05 95.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -55.43 -38.31 68.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 174.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.04 -43.42 62.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.241 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.73 -44.48 98.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 109.97 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -43.88 96.53 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.81 -49.44 76.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -63.99 -26.0 68.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.43 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -103.28 -4.91 23.62 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.088 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.42 38.3 80.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.186 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.8 t -122.03 -14.62 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.069 0.461 . . . . 0.0 110.618 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.604 ' CE1' ' HG3' ' A' ' 81' ' ' GLU . 45.7 t80 -65.37 114.33 4.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.107 0.479 . . . . 0.0 112.246 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 23.0 tpt180 -173.25 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.904 172.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 11.9 p90 -143.78 145.81 32.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.302 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 13.7 Cg_exo -71.18 138.17 32.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.673 2.248 . . . . 0.0 112.077 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.27 162.94 31.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.8 m -96.67 113.56 25.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.506 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.2 mt -94.48 129.98 41.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.21 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.82 135.91 57.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -108.72 125.48 51.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.403 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -104.1 123.44 47.27 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.735 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.91 11.76 63.77 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -174.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.46 71.62 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' N ' HD22 ' A' ' 102' ' ' ASN . 0.9 OUTLIER -95.43 143.74 26.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -177.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -78.09 111.1 13.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.273 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -139.29 -19.24 0.97 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.604 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.62 149.27 18.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.931 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.96 134.71 18.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.901 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.9 mt -115.25 117.69 31.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.582 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.63 117.92 30.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.527 0.679 . . . . 0.0 111.28 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.511 ' HA2' HG21 ' A' ' 48' ' ' THR . . . 95.3 -161.54 23.29 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.395 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.707 HD11 ' HA ' ' A' ' 51' ' ' VAL . 49.3 mm -99.01 -53.53 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 44.6 m80 67.5 159.99 0.14 Allowed Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.725 0.641 . . . . 0.0 110.893 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 115' ' ' GLU . 11.8 Cg_endo -60.25 136.8 70.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.503 1.469 . . . . 0.0 109.473 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.521 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 5.5 t-105 -54.79 -45.41 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.25 -34.36 72.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.771 0.32 . . . . 0.0 111.493 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.735 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . 1.3 tm-20 -77.2 -37.13 54.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.042 0.448 . . . . 0.0 110.102 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.95 -44.97 91.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.335 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.96 -39.04 82.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.226 0.536 . . . . 0.0 109.946 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -58.11 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.147 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 97.3 mt -56.82 -45.64 82.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.479 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.451 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.9 tpt -57.74 -47.6 81.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HA ' HG22 ' A' ' 124' ' ' VAL . 62.9 mtp180 -64.11 -32.73 74.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 122.224 0.209 . . . . 0.0 110.916 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.96 74.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.176 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.479 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 99.1 mt -84.38 -39.48 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 121' ' ' ARG . 34.2 m -82.78 -15.5 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.63 0.252 . . . . 0.0 111.636 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 126' ' ' PRO . 10.1 tp10 -45.82 -58.22 6.58 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 125' ' ' GLU . 3.6 Cg_exo -74.79 145.51 32.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.944 1.763 . . . . 0.0 112.708 -175.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.411 . . . . 0.0 111.621 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 64.52 121.43 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.752 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -84.72 156.01 21.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.732 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -71.86 119.85 16.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.324 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.32 161.16 38.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.291 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 121.311 0.577 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -84.25 84.15 7.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.49 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 17.4 m120 -133.8 152.12 51.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.207 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.67 82.55 7.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.997 0.427 . . . . 0.0 110.892 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.664 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 4.4 m -177.29 -61.4 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.911 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.0 Cg_exo -67.3 -55.39 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.798 1.666 . . . . 0.0 112.04 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 44.7 t80 -62.46 -37.11 84.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.975 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.34 -54.59 30.62 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.428 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -58.79 -42.27 88.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.546 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.85 -57.0 14.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.543 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.6 t90 -67.7 -36.64 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.305 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -56.87 -44.44 82.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.786 0.326 . . . . 0.0 110.976 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 97.3 mtt180 -63.49 -53.55 50.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 110.727 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.76 -36.84 79.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.439 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 11' ' ' TRP . 0.3 OUTLIER -70.1 -30.39 67.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.423 -177.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.19 64.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -10.37 59.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.824 0.345 . . . . 0.0 111.284 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.69 41.88 14.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.411 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -90.64 -178.69 5.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.675 0.274 . . . . 0.0 110.38 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 26.1 m -117.49 120.35 33.3 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.172 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.586 ' HB3' ' HZ2' ' A' ' 11' ' ' TRP . 2.8 Cg_exo -75.83 121.49 6.29 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.965 2.443 . . . . 0.0 111.172 174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG11 HD23 ' A' ' 27' ' ' LEU . 14.9 p -117.9 143.47 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.618 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -95.24 163.25 13.35 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.557 0.694 . . . . 0.0 112.118 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -68.4 144.7 54.64 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.441 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m 75.12 -10.79 1.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.306 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.28 -23.19 14.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.51 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -48.94 -47.27 43.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.403 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.16 -49.4 44.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.961 0.41 . . . . 0.0 110.866 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' THR . 10.4 t70 -55.56 -48.52 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.925 0.869 . . . . 0.0 110.232 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -59.9 -42.31 93.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.858 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.13 -28.64 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 29' ' ' ASP . 7.4 t -80.57 -26.1 38.14 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.87 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -89.67 -38.38 13.93 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -97.86 106.77 36.2 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.9 Cg_exo -67.76 122.35 9.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.755 2.303 . . . . 0.0 114.213 -169.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.571 ' OD2' ' HB ' ' A' ' 99' ' ' THR . 6.1 m-20 65.64 154.76 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 124.594 1.184 . . . . 0.0 113.361 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 71' ' ' GLN . . . 153.91 -172.9 32.61 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.709 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 97' ' ' VAL . 31.3 m -133.54 156.33 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.545 0.212 . . . . 0.0 110.458 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.0 t -129.74 131.04 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.076 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -98.64 122.22 41.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.403 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 80' ' ' SER . 6.6 tt -106.79 97.97 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 42.4 m 61.33 -170.59 0.16 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.0 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 p -130.39 77.55 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -176.61 82.41 0.27 Allowed Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.45 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 3.4 Cg_exo -81.2 -30.61 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.114 2.543 . . . . 0.0 113.839 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.687 ' HG2' ' HD2' ' A' ' 47' ' ' ARG . 77.5 tttt -135.97 -78.67 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.711 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 3.1 mpt_? -131.79 -35.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.7 m 73.93 104.55 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.564 171.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.36 -12.68 20.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.144 2.563 . . . . 0.0 111.961 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -125.5 -123.38 0.25 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 t -140.85 -54.57 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.7 t -92.57 -18.31 23.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.387 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.4 -90.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.971 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 92.55 1.53 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.63 0.252 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -102.17 41.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.057 2.505 . . . . 0.0 111.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -104.5 -59.66 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -23.86 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.611 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.2 mm -52.59 -46.73 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.257 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -36.51 86.74 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.455 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 mt-10 -80.01 -26.95 39.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.887 0.375 . . . . 0.0 111.135 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 120' ' ' MET . 42.8 tp -62.24 -45.72 92.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.798 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 70' ' ' TRP . 9.0 mp -56.35 -26.83 53.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.399 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 38.4 mmt180 -60.3 -17.73 44.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 5.6 pt-20 -76.5 -8.66 57.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.004 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -125.65 70.77 65.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.569 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.28 11.98 2.8 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.77 2.313 . . . . 0.0 111.583 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.67 -25.7 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.355 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -131.55 -157.9 0.85 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.025 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' OE1' ' A' ' 71' ' ' GLN . 6.6 p -111.62 140.08 46.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 62' ' ' LEU . 82.7 m95 -122.05 95.59 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' OE1' ' HB ' ' A' ' 69' ' ' THR . 1.9 mp0 -84.34 109.86 18.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.23 114.22 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.988 0.423 . . . . 0.0 110.251 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -110.64 137.53 48.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.975 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 12.9 pt -122.72 146.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.78 160.77 31.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 0.0 112.074 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.99 164.84 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.775 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 96.2 mt -59.34 -44.53 92.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.773 0.32 . . . . 0.0 110.807 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.03 -36.31 79.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 0.0 110.081 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -72.81 -31.15 64.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.073 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.581 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 68.2 m -60.08 -43.88 95.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.995 0.426 . . . . 0.0 111.202 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.82 -41.01 97.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.697 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.551 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . . . -77.2 -35.18 55.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.568 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 24' ' ' GLU . 73.3 mt -63.63 -49.19 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.539 0.209 . . . . 0.0 110.676 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.03 -45.97 94.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.688 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -52.74 -53.35 49.13 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -73.28 -23.99 60.37 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' A' ' 89' ' ' VAL . 10.7 t80 -85.4 -54.58 4.49 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.801 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.41 44.02 0.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.365 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 87' ' ' PHE . 57.5 t -125.56 83.74 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HB3' ' HD1' ' A' ' 92' ' ' PHE . 86.0 m-85 66.51 -62.59 0.28 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER 95.72 -1.6 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.293 1.837 . . . . 0.0 109.859 -169.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.743 ' HD1' ' HB3' ' A' ' 90' ' ' PHE . 83.8 m-85 -84.98 135.32 39.84 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.508 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.835 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.6 Cg_exo -67.41 134.18 32.53 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.871 2.381 . . . . 0.0 112.196 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . 173.85 -169.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.051 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 24.5 m -97.53 113.97 25.78 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.7 mt -95.75 127.52 41.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.071 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 104' ' ' ARG . 5.7 p -109.34 124.13 65.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.458 0.647 . . . . 0.0 111.156 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -124.94 -178.87 4.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.465 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 14.2 p -127.89 -168.91 1.97 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.45 49.45 1.29 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.151 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.1 -41.5 0.85 Allowed Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.425 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -94.08 170.91 9.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.874 . . . . 0.0 112.099 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.44 134.96 55.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.35 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.707 ' HB2' HG13 ' A' ' 97' ' ' VAL . 3.5 mmp_? -105.14 -58.84 1.83 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.555 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -161.25 27.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.517 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.59 134.3 58.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 110.337 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.4 mt -101.51 128.84 47.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.611 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.56 11.15 25.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.797 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.25 -148.33 49.97 Favored Glycine 0 C--O 1.239 0.406 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.186 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 111' ' ' HIS . 10.6 mm 61.28 -168.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.883 ' H ' HG22 ' A' ' 110' ' ' ILE . 66.0 m80 73.39 150.45 0.13 Allowed Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.041 0.536 . . . . 0.0 111.522 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 111' ' ' HIS . 13.4 Cg_exo -70.46 166.9 26.94 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.515 2.143 . . . . 0.0 111.582 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.472 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 33.5 t-105 -53.86 -43.15 69.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.612 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.51 77.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 112' ' ' PRO . 22.6 mm-40 -81.22 -25.91 36.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 111.153 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.17 -43.53 91.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 61' ' ' LEU . 62.4 mt -58.81 -42.38 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.607 0.717 . . . . 0.0 109.554 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -54.5 -52.79 60.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.758 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 91.8 mt -62.35 -45.42 93.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.615 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.775 ' HB2' HD21 ' A' ' 61' ' ' LEU . 8.2 tpt -57.1 -47.76 80.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.269 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.514 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.9 ttm180 -66.27 -37.78 86.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.977 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.598 ' HA2' HE21 ' A' ' 127' ' ' GLN . . . -61.14 -30.68 74.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.501 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 97' ' ' VAL . 94.8 mt -89.47 -42.47 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 121' ' ' ARG . 35.9 m -73.65 -31.01 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.76 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.57 109.42 58.06 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.78 108.72 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.836 2.357 . . . . 0.0 113.294 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.598 HE21 ' HA2' ' A' ' 122' ' ' GLY . 45.8 mt-30 -101.81 -14.68 17.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.483 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 8.3 pt20 -153.57 112.49 3.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.296 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 4.2 pt-20 -74.88 100.36 4.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.02 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.96 148.3 22.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.792 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.74 109.0 12.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.57 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 62.43 59.12 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 t30 59.32 71.76 0.56 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.635 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.54 173.66 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.39 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.614 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 7.4 m -162.68 -55.62 0.01 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.828 -175.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 10.9 Cg_exo -70.23 -43.37 2.3 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.867 1.712 . . . . 0.0 111.807 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.787 ' HE1' ' HB2' ' A' ' 42' ' ' SER . 76.7 t80 -73.54 -43.04 60.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.657 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 24.4 t70 -55.15 -53.62 53.62 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.504 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.19 99.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.544 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.13 -41.27 97.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.753 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -64.41 -40.26 95.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 24.9 mm-40 -57.89 -39.92 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.36 -52.5 46.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.633 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.6 mtp -55.32 -38.24 68.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.979 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -65.13 -36.42 84.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.754 179.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.64 67.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -73.27 -7.77 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.804 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.49 23.64 36.12 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.266 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -85.1 141.97 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.2 m -84.63 116.08 63.56 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.942 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 57.1 Cg_endo -74.39 129.59 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.553 2.169 . . . . 0.0 110.985 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG11 HD23 ' A' ' 27' ' ' LEU . 13.8 p -138.57 145.18 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.892 0.377 . . . . 0.0 111.328 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 p -91.23 160.73 15.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.598 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -32.44 72.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.514 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -66.27 -36.5 83.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.876 0.37 . . . . 0.0 111.112 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -90.52 -24.76 20.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.348 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.469 HD23 HG11 ' A' ' 22' ' ' VAL . 3.1 tm? -58.8 -40.46 84.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.651 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 32' ' ' THR . 17.7 t70 -56.11 -53.4 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.877 0.846 . . . . 0.0 111.105 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t90 -59.39 -41.53 89.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.88 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.53 -29.11 70.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.181 0.515 . . . . 0.0 110.47 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 86.2 m -66.32 -40.0 89.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -98.91 -14.5 19.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB1' HE21 ' A' ' 71' ' ' GLN . . . -140.58 90.22 10.04 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.843 0.354 . . . . 0.0 110.048 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.747 ' HB2' ' HA2' ' A' ' 101' ' ' GLY . 86.0 Cg_endo -88.61 -14.38 3.07 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.06 2.507 . . . . 0.0 114.409 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -100.22 135.94 40.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 110.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.98 -160.98 28.74 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 97' ' ' VAL . 6.9 m -138.4 134.87 44.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 73' ' ' ALA . 61.5 t -113.59 132.15 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.34 122.43 43.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 35.2 tp -83.15 81.2 8.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.787 ' HB2' ' HE1' ' A' ' 7' ' ' PHE . 4.3 p -58.77 -48.1 82.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.063 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HG ' ' A' ' 41' ' ' LEU . 14.4 m 57.42 -102.23 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.682 0.614 . . . . 0.0 110.599 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD1' ' HD3' ' A' ' 91' ' ' ARG . 7.0 p-10 -161.77 142.93 8.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 2.0 Cg_endo -83.59 132.55 5.81 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.477 2.118 . . . . 0.0 111.443 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 36.7 tptt -122.53 -50.33 1.99 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -158.82 -60.29 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 50' ' ' GLU . 4.5 m 71.07 143.7 0.1 OUTLIER Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.98 170.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.58 -5.87 6.31 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.944 2.43 . . . . 0.0 112.354 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.847 ' HG2' HG13 ' A' ' 110' ' ' ILE . 11.2 tp10 -151.16 100.01 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -69.05 -52.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.876 -174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 t -126.62 -84.8 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.936 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 53.78 -168.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.926 0.891 . . . . 0.0 111.955 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -147.57 92.35 4.8 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.12 98.44 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.746 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.97 -32.67 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.311 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -60.14 -23.76 64.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.877 -177.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 116' ' ' LEU . 49.8 mm -53.93 -39.96 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.73 -44.69 95.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.399 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -62.2 -34.83 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.342 . . . . 0.0 111.071 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.602 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 45.0 tp -64.76 -55.0 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.21 -27.99 69.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.369 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.96 -19.9 65.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -86.79 -0.45 56.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.772 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -123.08 71.64 44.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.94 -3.03 10.38 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.53 2.154 . . . . 0.0 113.075 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.53 -17.83 60.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.16 139.14 51.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.274 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -86.25 105.21 16.47 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -80.11 110.63 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.187 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.525 HE21 ' HB1' ' A' ' 34' ' ' ALA . 2.9 mp0 -82.47 119.54 24.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.081 174.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.33 103.33 14.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -108.45 127.15 53.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 15' ' ' LEU . 23.4 pt -122.59 139.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.954 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -111.68 169.78 8.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 112.242 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.66 168.77 14.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.283 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' A' ' 44' ' ' ASP . 9.8 tp -50.25 -54.64 19.72 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.251 0.62 . . . . 0.0 112.18 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -30.3 61.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.546 0.689 . . . . 0.0 110.671 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 57.6 mt-30 -77.27 -42.7 36.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.468 -175.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 48.6 p -73.38 -37.24 66.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.663 0.268 . . . . 0.0 110.305 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -53.08 -49.79 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.101 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.07 71.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.786 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 79' ' ' GLN . 81.1 mt -67.89 -52.09 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.433 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.53 -44.75 97.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.171 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.94 -39.58 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.21 -30.75 65.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.373 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -84.82 -33.38 22.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 110.715 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.82 31.96 1.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.488 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.55 158.68 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.71 -83.81 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 110.821 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.548 ' HD3' ' OD1' ' A' ' 44' ' ' ASP . 86.9 mtt180 -148.17 -161.18 1.28 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 88.5 m-85 76.7 148.18 0.12 Allowed Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 124.144 0.903 . . . . 0.0 111.733 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 17.2 Cg_exo -65.39 69.15 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.452 3.434 . . . . 0.0 113.39 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.64 129.56 34.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.339 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 7.3 m -92.22 112.96 25.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 106' ' ' VAL . 65.8 mt -93.97 113.9 25.99 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 104' ' ' ARG . 7.4 p -97.85 127.37 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.202 0.525 . . . . 0.0 110.92 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.93 134.26 55.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.14 137.45 23.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.84 17.6 75.38 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.747 ' HA2' ' HB2' ' A' ' 35' ' ' PRO . . . 79.93 -0.36 83.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.663 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.46 149.34 32.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 111.649 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -69.98 129.47 39.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.417 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.767 ' HB2' HG13 ' A' ' 97' ' ' VAL . 16.7 mmt180 -101.93 -47.29 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.367 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.04 -163.76 36.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.388 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 96' ' ' LEU . 59.3 t -122.6 134.26 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 4.4 mp -101.32 123.58 45.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.78 90.29 2.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.186 0.517 . . . . 0.0 110.026 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.5 146.15 5.73 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.847 HG13 ' HG2' ' A' ' 50' ' ' GLU . 27.4 mm -123.0 -53.27 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 117.165 0.483 . . . . 0.0 111.767 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 41.6 m170 -73.25 -53.65 4.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 12.5 Cg_exo -68.73 121.91 8.82 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.126 1.217 . . . . 0.0 111.885 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.602 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 9.4 t-105 -87.49 -45.14 10.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.549 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.21 75.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 8.0 tp10 -72.18 -40.59 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.316 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.501 HD23 ' HZ3' ' A' ' 113' ' ' TRP . 30.9 tp -61.31 -44.28 97.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 113' ' ' TRP . 62.1 mt -63.9 -44.94 98.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -50.23 -59.05 4.33 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.122 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 87.0 mt -65.53 -45.46 83.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.926 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.475 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -61.37 -48.03 83.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.69 0.281 . . . . 0.0 110.538 -178.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 124' ' ' VAL . 14.0 ttt85 -69.39 -33.03 72.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.199 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.51 -29.15 74.53 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.2 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 96.5 mt -83.06 -49.59 9.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.409 0.147 . . . . 0.0 111.206 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 121' ' ' ARG . 29.5 m -70.65 -37.94 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.428 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 35.4 tt0 -101.49 99.19 10.77 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 24.2 Cg_exo -64.87 99.08 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.314 2.676 . . . . 0.0 114.599 -166.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -89.42 76.93 7.42 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 163.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -71.88 75.84 0.89 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.835 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.52 77.49 1.77 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 161.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.75 98.58 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.385 -166.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.19 83.56 1.0 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.179 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.007 -176.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 6' ' ' PRO . 44.8 m 54.52 59.66 4.01 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.02 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -120.61 171.74 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.688 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 69.06 7.21 6.1 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.266 0.626 . . . . 0.0 112.395 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.737 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 88.0 m -148.8 -59.51 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.892 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.205 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 16.3 Cg_exo -68.58 -58.91 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.551 1.501 . . . . 0.0 111.545 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.41 -35.07 79.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.23 -54.22 49.41 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.566 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -62.26 -48.02 81.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.88 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.78 -40.68 89.11 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 111.631 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -69.12 -43.47 74.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 12.3 mm100 -62.36 -32.76 73.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.359 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 50.1 mmm-85 -57.38 -53.59 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.43 . . . . 0.0 110.251 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.544 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 73.0 mtm -66.65 -33.0 74.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.957 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 1.9 mm? -67.37 -24.37 65.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.459 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.76 72.9 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -81.36 -3.96 54.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.863 0.363 . . . . 0.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.91 29.99 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.116 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.544 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 43.4 m0 -74.09 148.19 42.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.174 0.511 . . . . 0.0 110.215 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.563 ' HB ' ' HZ3' ' A' ' 30' ' ' TRP . 9.5 p -96.85 130.43 30.19 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.9 -169.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 5.7 Cg_exo -79.31 145.1 18.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.302 2.668 . . . . 0.0 111.345 172.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.7 144.24 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.575 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -95.2 166.06 12.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.6 -55.35 35.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.075 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.3 m -73.27 6.37 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -126.34 -1.34 6.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.251 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.29 -47.08 79.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.828 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.15 -29.81 57.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.467 0.651 . . . . 0.0 110.444 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 32' ' ' THR . 17.1 t70 -61.06 -55.16 35.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.18 0.99 . . . . 0.0 109.661 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.563 ' HZ3' ' HB ' ' A' ' 20' ' ' THR . 14.0 m95 -67.93 -29.05 68.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.067 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.93 -28.85 69.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.628 0.252 . . . . 0.0 111.366 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' ASP . 14.5 t -88.78 -30.2 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.582 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.15 -28.94 18.6 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -98.86 158.0 33.15 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -67.84 149.54 78.17 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.969 1.78 . . . . 0.0 111.741 174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.77 112.35 10.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.306 0.574 . . . . 0.0 110.204 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.55 -107.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.974 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 97' ' ' VAL . 12.3 m -135.33 142.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 111.975 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 71.7 t -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.4 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.0 mp -101.09 143.26 31.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.466 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -86.28 1.12 52.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 93' ' ' PRO . 89.8 p 59.72 169.89 0.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.709 1.203 . . . . 0.0 111.73 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t 64.43 -176.36 0.17 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.263 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.577 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 17.9 t70 -148.22 152.49 39.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 44' ' ' ASP . 78.9 Cg_exo -43.19 169.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.98 3.12 . . . . 0.0 115.151 175.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -79.97 -23.72 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.916 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -63.48 -28.44 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.873 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.1 m -71.45 127.12 91.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.791 0.329 . . . . 0.0 111.226 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.68 -42.68 29.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.989 3.126 . . . . 0.0 113.76 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.99 -94.02 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.7 t -146.37 -68.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.658 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.4 t -74.47 -44.38 51.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.903 -172.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 60.0 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.855 0.722 . . . . 0.0 111.357 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -144.86 111.06 4.81 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.241 0.543 . . . . 0.0 109.774 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -97.64 -167.98 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.21 2.607 . . . . 0.0 113.326 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.3 t 76.49 -34.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 172.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -32.27 54.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.57 ' O ' HD13 ' A' ' 62' ' ' LEU . 47.9 mm -59.18 -44.19 91.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.79 73.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.361 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.69 -32.51 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.237 0.541 . . . . 0.0 109.974 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 120' ' ' MET . 51.1 tp -70.33 -34.59 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.502 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.9 mp -62.85 -28.12 69.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.262 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -68.7 -8.72 45.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.157 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.47 -24.79 66.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.339 . . . . 0.0 111.099 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.31 94.93 46.39 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.696 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.51 -18.28 13.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.99 2.46 . . . . 0.0 112.033 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.84 -25.55 64.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 0.0 110.801 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -137.66 121.15 17.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.578 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 t -86.26 131.12 34.3 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.907 0.861 . . . . 0.0 110.068 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -88.4 135.24 33.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.173 -173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.839 ' HB2' ' HG2' ' A' ' 35' ' ' PRO . 6.5 tp60 -96.22 122.62 39.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.206 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.35 110.99 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -111.82 127.55 55.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.254 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.5 pt -125.59 140.94 46.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -128.52 166.73 18.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.694 0.283 . . . . 0.0 111.069 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 6.5 m-20 -65.57 165.43 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.303 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.64 -49.14 73.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.13 -34.07 75.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.002 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 81.8 mt-30 -77.16 -52.71 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.729 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB3' HD22 ' A' ' 41' ' ' LEU . 20.0 m -60.96 -39.57 90.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.388 -177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.89 -41.68 96.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.17 0.51 . . . . 0.0 110.201 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.42 77.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 79' ' ' GLN . 83.2 mt -61.36 -43.44 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.7 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.936 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.48 -36.16 66.31 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.067 0.547 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -51.67 -54.51 27.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.103 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' HB3' HG23 ' A' ' 89' ' ' VAL . 24.5 t80 -93.57 -19.29 21.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.002 -166.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.03 39.04 6.22 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 96' ' ' LEU . 18.7 t -82.45 160.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 74.8 m-85 -60.25 138.64 57.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -83.07 8.79 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 88.9 m-85 -90.33 142.2 28.16 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.417 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' SER . 41.8 Cg_exo -57.08 126.04 20.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.518 2.146 . . . . 0.0 111.558 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.87 -175.81 3.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.567 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 29.3 m -117.21 120.65 38.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 89' ' ' VAL . 5.8 mp -93.97 114.64 26.87 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.1 p -96.03 138.94 20.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -125.05 145.61 49.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 2.6 m -154.79 151.13 28.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.02 21.6 68.0 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.13 76.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.638 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.41 176.66 8.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.446 0.641 . . . . 0.0 111.828 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -68.87 118.03 11.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.127 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 104' ' ' ARG . 5.7 tpm_? -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.726 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.444 ' HA3' HD13 ' A' ' 123' ' ' LEU . . . 170.1 -168.75 41.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.595 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.8 t -132.13 134.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.02 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 89.8 mt -108.02 131.53 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.3 33.67 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -172.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.82 -120.76 21.41 Favored Glycine 0 C--O 1.236 0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.782 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.33 99.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.93 0.871 . . . . 0.0 110.325 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.747 ' HB3' HD23 ' A' ' 116' ' ' LEU . 11.5 t60 -137.09 143.36 41.75 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -38.47 124.0 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.192 2.594 . . . . 0.0 112.128 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -54.92 -43.48 73.34 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.61 0.569 . . . . 0.0 112.016 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.17 87.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.698 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.76 -29.0 64.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.343 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 111' ' ' HIS . 0.5 OUTLIER -65.82 -48.82 70.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.52 -42.06 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.166 0.508 . . . . 0.0 109.873 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -52.63 -59.29 4.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.02 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.12 -43.66 98.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 124' ' ' VAL . 12.3 tpt -55.34 -48.95 73.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -39.04 92.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.435 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.52 75.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.428 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.463 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 98.6 mt -86.51 -60.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 120' ' ' MET . 30.7 m -63.51 -33.42 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.501 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.33 91.27 9.52 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 124' ' ' VAL . 47.3 Cg_exo -57.63 114.7 2.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.413 2.742 . . . . 0.0 113.893 -168.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -81.12 -8.1 59.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.581 171.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 52.01 61.27 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.478 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 130' ' ' ARG . 28.7 tt0 -168.77 91.32 0.26 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.403 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 40.4 ttt180 172.64 22.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.527 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.75 141.73 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.062 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.134 0.492 . . . . 0.0 110.471 179.396 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.1 m -58.85 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -145.37 156.35 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.939 0.399 . . . . 0.0 110.684 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.36 85.41 7.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.38 1.086 . . . . 0.0 110.924 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.699 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m -156.01 -52.07 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.73 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 9.7 Cg_exo -71.69 -44.6 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.457 1.438 . . . . 0.0 110.223 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -68.97 -34.81 75.93 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 27.9 t70 -53.79 -53.85 46.53 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.599 0.714 . . . . 0.0 110.41 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.35 -46.03 89.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.044 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -60.34 -42.3 95.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.494 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.58 ' CH2' ' HA ' ' A' ' 76' ' ' ASP . 1.6 t90 -66.54 -40.24 88.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ASP . 16.5 mm100 -57.78 -36.86 72.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 29.0 mmm180 -63.16 -54.15 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.664 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.499 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 66.5 mtm -62.55 -33.09 74.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.291 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.02 -40.07 95.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 0.0 110.584 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.35 66.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -74.38 -10.96 60.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.276 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.13 6.41 53.75 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.798 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.499 ' HE3' ' HB3' ' A' ' 14' ' ' MET . 21.7 m0 -83.18 121.93 27.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 109.914 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 m -88.26 125.94 62.24 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.348 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 38.1 Cg_endo -68.5 139.38 44.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.847 2.364 . . . . 0.0 111.959 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 27' ' ' LEU . 10.7 p -130.92 148.55 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.064 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.7 p -86.62 163.6 17.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 111.49 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.01 -59.02 4.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.336 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 t -77.78 -21.94 50.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 19.2 tpt180 -84.28 -16.94 41.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 109.989 -174.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.01 -39.2 90.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.462 176.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.47 -29.36 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.616 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 32' ' ' THR . 35.1 t70 -64.24 -51.73 62.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.305 1.05 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -59.1 -40.9 86.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.074 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 60.5 mt -62.5 -33.59 75.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' ASP . 10.2 t -79.88 -26.02 40.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.743 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.75 -34.17 21.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.713 0.292 . . . . 0.0 111.494 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -86.42 148.36 46.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 16.0 Cg_exo -68.43 -67.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.505 2.137 . . . . 0.0 112.534 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.75 -90.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.578 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.57 163.79 39.67 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.262 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.03 143.28 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.012 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.89 137.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 74' ' ' ILE . 8.7 mp -92.24 121.28 33.61 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 80' ' ' SER . 21.5 tp -114.41 148.66 37.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.745 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.8 t -149.59 146.71 27.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.837 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 19.1 m -156.05 53.68 0.57 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 35.1 t70 74.77 124.95 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.028 0.83 . . . . 0.0 109.411 -173.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.702 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 27.1 Cg_exo -61.98 131.16 33.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.661 2.241 . . . . 0.0 114.069 -169.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -136.33 -59.52 0.73 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.16 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -68.99 -37.65 78.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.607 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -70.11 120.6 79.1 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.46 -60.4 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.976 2.451 . . . . 0.0 112.748 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -103.95 -94.33 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.036 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.31 -68.48 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.357 . . . . 0.0 110.808 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.541 ' HA ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -78.27 -53.34 7.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.477 -175.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 57.08 -146.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.489 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -120.4 93.28 48.17 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.887 0.375 . . . . 0.0 110.966 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.97 13.15 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.067 2.511 . . . . 0.0 112.276 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -84.02 -16.54 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 0.0 110.848 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -21.98 41.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.68 -33.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.788 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -50.26 69.51 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.143 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.95 -27.73 39.74 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.668 -0.313 . . . . 0.0 111.313 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 52.3 tp -58.32 -48.09 81.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.099 0.476 . . . . 0.0 111.617 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.11 -26.58 67.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.85 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -63.92 -7.92 9.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -67.23 -32.44 73.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 110.56 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.67 75.42 62.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.25 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -87.38 6.22 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.93 2.42 . . . . 0.0 112.896 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -91.26 2.09 56.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.786 0.803 . . . . 0.0 109.722 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -138.38 147.58 43.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.387 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 t -87.23 138.65 31.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.856 0.836 . . . . 0.0 111.269 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -117.21 115.25 24.94 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.732 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.09 102.89 15.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.89 106.92 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.91 142.31 41.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 40' ' ' LEU . 21.0 pt -114.9 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.518 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -92.12 157.24 16.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.896 0.379 . . . . 0.0 111.939 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -59.51 159.68 7.96 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.328 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -57.24 -55.72 31.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.54 -39.24 46.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.505 0.669 . . . . 0.0 111.076 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 49.8 mt-30 -72.53 -22.35 61.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.132 -173.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 31.9 p -70.31 -41.1 73.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.026 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.837 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 41.7 mt-10 -60.65 -38.87 86.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.07 83.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.017 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 79' ' ' GLN . 84.1 mt -58.33 -41.02 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.577 0.227 . . . . 0.0 110.816 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.53 -53.26 47.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.419 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.27 -40.4 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 110.564 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.41 -36.17 83.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.051 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -92.31 -27.67 17.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.16 20.83 7.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.78 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 92' ' ' PHE . 25.5 t -126.74 78.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -96.56 122.98 40.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 111.459 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 34.6 ttt180 70.44 27.8 3.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.993 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.647 ' HB2' HG12 ' A' ' 89' ' ' VAL . 93.6 m-85 -115.83 85.77 15.05 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.032 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.702 ' HG3' ' HA ' ' A' ' 45' ' ' PRO . 57.4 Cg_endo -73.13 125.43 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.11 1.873 . . . . 0.0 111.807 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 107' ' ' LEU . . . -177.07 -176.35 0.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.655 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -104.31 123.22 47.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.339 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 96' ' ' LEU . 5.8 mp -94.14 133.12 37.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.701 0.286 . . . . 0.0 110.528 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.34 125.77 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.381 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -144.22 129.38 18.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.968 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.8 p -93.14 124.0 36.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.358 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.67 27.3 58.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.99 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.91 83.44 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.571 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -105.04 129.36 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -66.09 124.2 21.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.702 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 104' ' ' ARG . 12.9 mmt180 -103.61 -51.47 3.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.219 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.5 -174.96 47.37 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.424 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 108' ' ' ASN . 9.2 p -132.47 133.85 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.983 0.42 . . . . 0.0 110.284 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 93.0 mt -85.68 97.2 9.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.42 HD22 HG13 ' A' ' 106' ' ' VAL . 7.7 p30 -131.01 158.58 39.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.79 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.47 84.83 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.909 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 45.8 mm 65.6 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.516 0.727 . . . . 0.0 111.866 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 74.8 m80 74.22 157.07 0.16 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 123.287 0.635 . . . . 0.0 111.083 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.39 155.3 69.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.337 2.024 . . . . 0.0 111.515 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.573 ' HH2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 t-105 -54.91 -39.13 68.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.25 -42.47 81.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.663 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.19 -28.77 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.12 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 61' ' ' LEU . 32.4 tp -64.98 -41.4 95.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.174 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' TRP . 78.4 mt -58.1 -46.01 88.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.321 0.581 . . . . 0.0 110.171 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -54.99 -57.84 10.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.819 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.19 -45.28 87.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.516 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.483 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.7 tpt -53.65 -53.29 53.99 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.351 0.407 . . . . 0.0 110.912 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.19 -33.47 76.08 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.29 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.31 66.42 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.346 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.91 -52.35 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 120' ' ' MET . 8.4 p -69.97 -30.64 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 32.7 tt0 9.89 101.05 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 125.511 1.524 . . . . 0.0 115.104 173.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 125' ' ' GLU . 29.2 Cg_endo -63.56 105.18 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.859 1.706 . . . . 0.0 109.843 170.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -80.62 73.71 7.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.333 1.063 . . . . 0.0 113.276 -167.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -107.52 36.26 2.79 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.243 -1.799 . . . . 0.0 107.131 163.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -133.4 156.57 47.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.288 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -94.78 87.5 5.04 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 121.319 -0.152 . . . . 0.0 111.123 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 33.62 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.693 1.246 . . . . 0.0 113.679 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.552 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.901 0.381 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -142.66 121.66 12.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.18 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -73.28 100.17 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.85 125.52 24.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.366 0.603 . . . . 0.0 111.093 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 92.6 m -162.31 -49.17 0.01 OUTLIER Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.076 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 30.3 Cg_exo -62.51 -56.81 0.56 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.642 1.561 . . . . 0.0 111.675 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -65.43 -41.79 93.14 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.84 -53.12 53.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.506 0.67 . . . . 0.0 111.006 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -64.84 -45.12 87.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.249 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 52' ' ' SER . 1.9 mm? -60.01 -46.65 88.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.106 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -67.58 -36.61 81.22 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -49.09 74.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.941 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 35.0 mtp180 -61.14 -52.4 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.648 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtp -54.48 -39.75 67.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.338 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD11 ' HG3' ' A' ' 21' ' ' PRO . 1.8 mm? -67.21 -42.52 83.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.917 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.58 -15.7 61.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -69.9 -18.0 63.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 110.24 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.6 26.12 9.44 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -91.35 -179.21 5.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 24.9 m -121.89 124.39 27.05 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.76 0.314 . . . . 0.0 111.645 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG3' HD11 ' A' ' 15' ' ' LEU . 6.5 Cg_exo -73.18 132.72 18.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.941 2.427 . . . . 0.0 110.981 175.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 27' ' ' LEU . 17.4 t -120.99 144.83 28.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.58 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 25.0 p -99.05 165.96 11.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.972 173.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.75 -54.95 30.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 m -78.38 -13.23 59.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 111.683 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.8 tpp180 -94.65 -15.99 23.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -60.89 -44.41 97.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.4 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.32 -32.05 62.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.638 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 32' ' ' THR . 33.0 t70 -64.82 -54.58 28.86 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.782 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -66.02 -28.93 69.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.559 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -66.1 -28.11 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.441 0.639 . . . . 0.0 109.855 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 91.5 m -74.5 -41.56 60.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.138 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -83.62 -46.2 12.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -94.52 118.95 66.9 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.411 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.18 124.96 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.551 2.168 . . . . 0.0 112.747 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 1.4 m-20 68.06 172.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.128 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.34 -163.19 24.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.277 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.56 142.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.0 110.8 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 73' ' ' ALA . 59.8 t -119.28 127.67 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.589 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.572 ' HB2' HG22 ' A' ' 74' ' ' ILE . 35.2 mt -101.96 135.69 43.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.994 0.426 . . . . 0.0 110.948 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.99 -69.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.727 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.1 m -156.55 178.08 10.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.9 m -80.11 -74.89 0.28 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.319 0.387 . . . . 0.0 110.35 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.71 159.78 0.12 Allowed Pre-proline 0 N--CA 1.469 0.511 0 O-C-N 123.643 0.589 . . . . 0.0 111.95 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.29 134.19 30.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.15 1.9 . . . . 0.0 112.024 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB2' HG22 ' A' ' 51' ' ' VAL . 8.1 tmtt? -93.45 -63.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 164.43 -30.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.41 1.069 . . . . 0.0 108.935 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 51' ' ' VAL . 36.3 p -106.39 172.88 3.53 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.793 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 48' ' ' THR . 6.2 Cg_exo -75.5 -0.99 10.76 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.765 2.31 . . . . 0.0 112.436 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.9 1.43 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.474 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 48' ' ' THR . 44.9 t -60.46 -25.11 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 110.816 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' HD21 ' A' ' 10' ' ' LEU . 10.2 t -87.68 -4.45 58.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.081 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.66 123.56 28.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 4.6 p-10 -75.63 131.83 76.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 54' ' ' ASN . 26.8 Cg_exo -62.98 104.61 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.176 2.584 . . . . 0.0 113.292 -174.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.98 -37.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.204 0.526 . . . . 0.0 109.786 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -24.34 67.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.127 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.492 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.0 mm -65.26 -36.42 77.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.38 99.69 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.586 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.68 -28.2 40.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.668 0.27 . . . . 0.0 111.21 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.96 -41.77 97.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.98 0.419 . . . . 0.0 110.6 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 58' ' ' ILE . 5.8 mp -58.74 -25.75 63.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.147 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.18 -8.12 7.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.2 -30.18 64.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.838 0.351 . . . . 0.0 110.593 174.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.21 92.86 37.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.095 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.54 -0.91 9.98 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.993 2.462 . . . . 0.0 111.601 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.26 -24.9 42.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.794 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -110.39 161.02 16.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 p -95.67 113.93 25.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.063 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -86.94 95.51 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.027 0.441 . . . . 0.0 110.918 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HG2' ' HB1' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -88.11 117.66 27.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.769 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 t -90.6 107.89 19.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.037 0.446 . . . . 0.0 110.293 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 22' ' ' VAL . . . -105.66 127.57 53.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.349 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.572 HG22 ' HB2' ' A' ' 40' ' ' LEU . 22.3 pt -127.15 140.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -131.46 167.43 19.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.346 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.12 168.4 15.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.8 -37.19 86.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.77 -49.17 78.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -67.6 -45.44 75.5 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.082 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 p -67.24 -32.78 74.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.398 -174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.61 -49.42 77.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.16 97.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.2 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.506 HD13 ' HG ' ' A' ' 27' ' ' LEU . 92.8 mt -65.98 -41.87 90.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.796 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.87 86.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.661 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.56 -39.82 71.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.0 110.63 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.34 -37.41 72.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.437 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -91.27 -35.33 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.51 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.76 -18.95 5.33 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 t -94.22 96.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.512 ' HD2' ' HG3' ' A' ' 91' ' ' ARG . 46.3 p90 -122.74 154.07 38.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.602 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 90' ' ' PHE . 20.2 mtp180 64.93 22.68 12.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.128 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.12 90.33 13.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.676 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.68 133.64 15.82 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -161.48 -172.68 3.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.26 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 15.3 m -99.81 108.72 21.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.4 117.42 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.211 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.7 p -102.58 128.76 55.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.234 0.54 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -121.39 134.06 55.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.086 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.599 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 34.2 p -119.99 123.7 44.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.001 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.97 22.9 65.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.488 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 1.44 90.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.923 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -100.51 143.13 31.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.52 0.2 . . . . 0.0 110.516 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.74 112.52 3.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.254 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.506 ' HB3' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.55 -49.75 6.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.48 -173.08 46.03 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.163 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.2 136.51 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.846 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 96.3 mt -122.52 157.67 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.225 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' HB2' ' HE1' ' A' ' 111' ' ' HIS . 18.5 m120 -132.39 142.63 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.04 165.62 50.86 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.52 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.6 mp 60.98 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.673 0.749 . . . . 0.0 111.067 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.517 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 9.0 m80 -155.94 150.19 19.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.167 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 115' ' ' GLU . 13.0 Cg_endo -57.22 137.08 80.13 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.56 2.173 . . . . 0.0 111.216 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.52 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.8 t-105 -59.4 -43.97 92.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.581 -173.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.34 93.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.598 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . 44.6 tt0 -72.5 -39.28 67.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.347 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.82 -45.27 93.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.967 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 113' ' ' TRP . 63.2 mt -60.84 -49.82 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -50.61 -56.19 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.208 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 82.7 mt -64.89 -43.3 93.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.995 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -65.52 -47.45 75.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.45 . . . . 0.0 110.076 -177.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.6 ttt85 -65.62 -32.63 74.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.42 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.2 68.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.956 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 104' ' ' ARG . 65.4 mt -75.64 -53.2 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.954 -0.145 . . . . 0.0 111.055 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 120' ' ' MET . 18.8 m -64.56 -38.48 82.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.084 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 46.6 85.72 0.16 Allowed Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 124.037 0.835 . . . . 0.0 111.996 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -79.66 177.25 8.65 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.754 2.303 . . . . 0.0 112.664 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -77.63 -5.62 50.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.36 0.6 . . . . 0.0 110.513 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 59.35 66.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.056 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -109.42 14.32 23.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.116 0.96 . . . . 0.0 109.842 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -121.65 100.04 6.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.178 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 65.14 174.79 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.924 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.477 0.656 . . . . 0.0 110.376 178.271 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -101.71 -60.29 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.98 106.51 17.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -77.38 141.58 39.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 111.199 -173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 27.8 m -164.76 -51.86 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.882 -175.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 2.9 Cg_exo -76.14 -46.42 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.147 1.898 . . . . 0.0 111.59 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.85 -43.92 94.69 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -50.51 -52.68 36.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.59 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -59.99 -49.49 77.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.478 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -56.46 -46.47 80.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.871 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.503 ' CZ2' ' HB3' ' A' ' 21' ' ' PRO . 1.4 t90 -66.08 -45.22 82.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.213 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -55.51 -40.13 71.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 16.1 mmm180 -60.24 -54.01 50.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -63.19 -33.28 75.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 74' ' ' ILE . 1.8 mm? -63.19 -30.04 71.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.554 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -29.21 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.739 0.304 . . . . 0.0 111.548 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -75.73 -7.38 54.22 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.35 19.74 44.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.785 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -76.71 128.09 34.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.121 0.486 . . . . 0.0 109.786 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.4 m -83.0 129.71 60.32 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.258 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 29.6 Cg_endo -65.55 128.83 20.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.747 175.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.66 144.02 22.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -109.53 168.08 9.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.13 -39.49 94.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.705 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.2 t -77.6 -16.33 58.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.396 0.617 . . . . 0.0 110.815 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -98.91 -9.66 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 27' ' ' LEU . 1.5 tm? -59.59 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.162 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.25 -45.15 89.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' THR . 24.9 t70 -60.61 -55.14 36.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.538 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -57.9 -39.3 77.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.133 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.3 tp -66.54 -28.31 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ASP . 12.6 t -89.06 -26.26 21.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.713 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.93 -42.69 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 111.275 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 157.1 44.23 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.743 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.1 -69.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.012 1.808 . . . . 0.0 111.117 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.47 -79.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.982 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.67 -166.9 51.17 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.676 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 97' ' ' VAL . 19.3 m -135.93 150.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HE2' ' A' ' 98' ' ' PHE . 74.7 t -129.96 127.07 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.34 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.559 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.0 131.21 46.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.81 -39.58 69.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.213 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -156.98 -66.76 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.488 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.454 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 19.4 m -153.89 -170.04 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.65 ' HB3' HD11 ' A' ' 110' ' ' ILE . 8.5 t70 -128.63 80.87 71.82 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.208 0.528 . . . . 0.0 110.182 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 67.1 Cg_endo -90.76 131.62 1.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.482 2.121 . . . . 0.0 113.824 -173.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 8.8 tmtm? -136.26 -58.6 0.75 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -112.88 -29.17 7.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.37 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HB ' ' OE2' ' A' ' 50' ' ' GLU . 1.5 m -85.79 135.97 37.26 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.687 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.92 -1.23 10.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.363 2.042 . . . . 0.0 111.415 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.563 ' HG2' ' HB3' ' A' ' 45' ' ' PRO . 21.3 mm-40 72.88 112.34 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 124.389 1.056 . . . . 0.0 111.211 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.25 -73.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.09 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -128.29 -59.07 1.18 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.13 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 t70 47.82 78.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.442 -168.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.2 106.31 0.92 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -12.95 81.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.821 4.348 . . . . 0.0 115.126 -159.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.22 -73.3 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.11 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -60.39 -35.06 74.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.648 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.74 -38.11 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -63.75 -47.37 87.05 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.413 -175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.71 -36.32 37.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 111.487 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD21 ' HG3' ' A' ' 120' ' ' MET . 23.9 tp -66.53 -55.14 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.118 -173.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.49 -27.45 67.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 48.8 mmt-85 -71.6 -7.82 50.19 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.84 -40.33 83.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.146 0.498 . . . . 0.0 110.176 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.634 ' HB3' ' HD2' ' A' ' 68' ' ' TYR . 99.2 m-85 -129.54 84.23 62.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.714 175.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -82.03 -14.02 9.98 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.871 2.381 . . . . 0.0 113.365 -174.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.77 -25.46 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.387 0.613 . . . . 0.0 110.268 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.634 ' HD2' ' HB3' ' A' ' 65' ' ' PHE . 60.4 m-85 -84.14 111.24 19.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.079 175.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 p -67.96 104.76 1.81 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.006 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -86.81 95.06 9.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.364 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -87.0 105.11 16.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.17 125.77 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.815 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.22 140.63 51.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.56 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 40' ' ' LEU . 13.8 pt -125.44 140.66 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.93 0.395 . . . . 0.0 110.558 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 79' ' ' GLN . . . -106.92 157.41 17.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' CH2' ' A' ' 11' ' ' TRP . 2.8 p30 -87.02 -174.07 4.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -59.44 -42.91 93.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.358 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -75.35 -36.93 60.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.29 0.567 . . . . 0.0 110.874 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.538 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 82.3 mm-40 -73.59 -44.66 56.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.499 -175.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 p -59.38 -43.24 92.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.73 0.3 . . . . 0.0 110.932 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.98 -41.16 82.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -40.45 61.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.234 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 79' ' ' GLN . 77.8 mt -65.54 -48.06 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.372 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.62 -48.15 83.78 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.894 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.52 -52.41 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 122.636 0.374 . . . . 0.0 110.673 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -68.52 -26.39 65.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.92 -26.61 31.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.078 0.466 . . . . 0.0 110.237 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.79 -0.24 48.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.75 -26.47 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 109.938 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 65.14 -141.78 0.22 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 92' ' ' PHE . 50.7 mtt-85 -92.1 -158.1 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.654 -170.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 90.5 t80 75.16 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.185 0 O-C-N 124.219 0.949 . . . . 0.0 109.456 -172.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.77 131.16 20.64 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.674 2.25 . . . . 0.0 112.27 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.05 -174.8 4.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.37 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.2 m -92.11 113.36 25.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.08 118.85 32.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.178 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.3 p -98.39 131.65 45.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.53 ' HE2' ' HB ' ' A' ' 39' ' ' VAL . 95.2 m-85 -118.22 146.7 44.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.278 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 104' ' ' ARG . 1.9 m -153.4 146.28 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.28 20.55 63.2 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.059 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 16.43 78.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.755 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -131.47 174.0 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -70.06 112.9 6.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.817 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.5 tpm_? -90.24 -41.49 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.225 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.59 -175.39 44.44 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.855 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.6 137.97 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 88.2 mt -94.7 161.34 14.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.705 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -169.31 96.28 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.079 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 46' ' ' LYS . . . 130.79 91.8 0.58 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.727 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 44' ' ' ASP . 40.2 mm -62.17 -31.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.353 0.597 . . . . 0.0 111.46 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.636 ' HB3' ' HD3' ' A' ' 112' ' ' PRO . 6.4 t-80 -68.28 -58.87 6.81 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -168.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 111' ' ' HIS . 11.8 Cg_exo -71.02 121.87 8.25 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.721 1.614 . . . . 0.0 112.308 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.441 ' CZ3' HD23 ' A' ' 116' ' ' LEU . 7.1 t-105 -93.51 -45.41 7.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.214 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.43 98.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.49 -43.46 94.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.696 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.441 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 30.7 tp -58.59 -49.39 77.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.904 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.44 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.7 mt -58.17 -48.93 83.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.73 0.3 . . . . 0.0 110.528 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -52.16 -55.63 19.78 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.146 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 90.2 mt -64.62 -45.26 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.691 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -60.72 -51.77 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttm-85 -64.09 -39.45 94.09 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.189 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.01 -30.35 73.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.542 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 95.0 mt -81.43 -56.68 3.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.425 0.155 . . . . 0.0 110.822 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 120' ' ' MET . 31.8 m -68.56 -36.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -114.31 110.27 48.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 95.57 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.503 2.136 . . . . 0.0 111.972 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -81.14 59.75 4.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.375 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.51 77.72 6.07 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.497 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.25 168.43 11.09 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.882 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -75.58 -13.74 60.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.831 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.8 79.25 9.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.948 -179.619 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.494 0.664 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.0 m -85.17 -47.1 10.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.023 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -109.68 137.77 47.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.425 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -73.23 100.91 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.085 0.469 . . . . 0.0 110.04 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.578 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 21.3 m -158.99 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 33.1 Cg_endo -65.62 -46.32 5.45 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.693 1.595 . . . . 0.0 112.009 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -66.37 -41.69 89.1 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.267 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.29 -53.59 56.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.467 0.651 . . . . 0.0 110.293 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' ARG . . . -60.79 -42.86 98.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.278 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -60.47 -49.7 76.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.903 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -37.28 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.68 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -59.81 -37.14 78.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 9' ' ' ALA . 53.4 mtt180 -69.89 -52.03 28.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.55 177.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.5 mtp -55.11 -40.7 70.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.843 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.402 HD11 ' HD3' ' A' ' 21' ' ' PRO . 2.8 mm? -68.47 -31.01 70.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.62 68.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -85.34 -1.07 56.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.633 0.254 . . . . 0.0 111.486 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.53 22.84 41.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.009 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -81.55 119.08 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -78.8 121.17 83.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.719 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -82.78 127.88 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.817 2.344 . . . . 0.0 111.79 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.88 137.76 13.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 0.0 111.01 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 25' ' ' SER . 4.4 m -94.43 130.95 40.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.605 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' SER . 1.5 tm-20 17.86 -98.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.727 1.211 . . . . 0.0 111.491 162.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' SER . 14.7 t 23.84 -78.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.021 1.328 . . . . 0.0 113.927 149.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 30' ' ' TRP . 9.7 tpp180 -106.92 -15.61 14.66 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.571 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.51 -36.39 73.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.136 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' HH12 ' A' ' 86' ' ' ARG . 25.5 t70 -66.1 -41.88 90.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 32' ' ' THR . 32.3 t70 -57.93 -49.61 76.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.816 0.817 . . . . 0.0 109.885 174.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.428 ' HD1' ' HG3' ' A' ' 26' ' ' ARG . 5.3 m95 -53.5 -43.01 67.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.406 173.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.13 -38.29 90.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 29' ' ' ASP . 11.0 t -74.35 -25.11 59.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.609 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.857 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.99 -10.11 53.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.315 177.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 103.69 44.47 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.62 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.17 -36.35 81.29 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.571 2.18 . . . . 0.0 111.085 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.78 -88.8 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.249 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.86 113.37 3.0 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.926 173.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 72' ' ' VAL . 11.1 m -138.78 134.28 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 0.0 110.406 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.35 129.1 67.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.515 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' A' ' 74' ' ' ILE . 7.2 mp -101.7 117.49 34.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.453 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.67 26.1 7.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.2 m 61.42 -154.15 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.738 ' HA ' ' HB2' ' A' ' 93' ' ' PRO . 73.6 m -150.23 162.34 40.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.513 0.196 . . . . 0.0 110.473 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 25.6 t70 -79.94 117.22 66.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.692 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 2.0 Cg_endo -81.26 133.37 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.916 2.411 . . . . 0.0 111.493 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -114.18 -83.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.024 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -113.21 -31.29 6.67 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 50' ' ' GLU . 7.2 m -62.59 115.93 20.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.631 176.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.77 11.89 3.17 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.081 2.52 . . . . 0.0 112.491 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.44 ' H ' HG22 ' A' ' 48' ' ' THR . 43.6 mt-10 -126.33 86.68 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.695 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -71.82 -24.49 23.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.176 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t -68.76 -42.81 76.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.726 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.0 t70 52.65 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.979 0.799 . . . . 0.0 111.653 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -160.12 85.74 2.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.17 44.15 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.847 2.365 . . . . 0.0 112.971 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.72 -26.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.049 0.452 . . . . 0.0 110.488 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -24.6 67.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.692 -173.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 62' ' ' LEU . 48.8 mm -61.77 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 110.575 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.21 68.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.567 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.92 -31.64 70.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.045 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -70.84 -46.03 63.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.04 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ILE . 10.0 mp -59.07 -27.72 65.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.368 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -61.86 -14.79 36.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.45 -44.69 82.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.636 0.255 . . . . 0.0 110.834 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.99 72.04 34.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.655 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -91.53 15.99 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.148 2.565 . . . . 0.0 112.822 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.89 -25.35 59.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.482 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -157.31 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.7 p -116.87 102.49 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.329 0.585 . . . . 0.0 112.073 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -95.25 84.41 4.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.89 104.35 7.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.385 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.428 ' HA ' HG23 ' A' ' 38' ' ' VAL . 52.7 t -87.64 103.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.021 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.13 132.25 52.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' HB2' ' A' ' 40' ' ' LEU . 18.0 pt -114.37 139.69 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.31 154.68 19.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.794 0.33 . . . . 0.0 111.358 -176.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . 2.0 m-20 -56.96 155.95 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.646 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.33 -53.86 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.21 -26.74 59.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.094 0.473 . . . . 0.0 110.894 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' CG ' ' HB2' ' A' ' 76' ' ' ASP . 20.1 mm-40 -70.36 -29.66 66.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.719 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -62.86 -38.6 91.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.522 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.68 -42.89 95.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.614 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.07 93.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.17 -47.88 90.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.92 -46.98 93.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.688 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.86 -45.55 86.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.66 HH12 ' HB2' ' A' ' 28' ' ' ASP . 47.6 ttt180 -57.76 -37.34 73.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.468 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HB3' HG23 ' A' ' 89' ' ' VAL . 19.8 t80 -82.26 -40.12 22.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 0.0 109.843 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.1 33.56 4.26 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.593 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 87' ' ' PHE . 21.8 t -92.81 -15.57 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.507 0.194 . . . . 0.0 110.941 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.6 t80 72.15 174.01 0.3 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -172.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -71.23 96.81 1.45 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.808 0.337 . . . . 0.0 111.016 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -142.39 100.82 5.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.738 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 2.4 Cg_endo -83.83 123.97 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.781 2.32 . . . . 0.0 111.914 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -172.05 -170.08 0.71 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.818 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 30.8 m -96.73 109.27 21.96 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.61 120.32 34.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.048 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.92 130.35 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.982 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.73 172.89 6.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.539 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.68 122.83 7.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.632 175.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.61 29.84 54.86 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.716 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.01 90.63 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.892 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.82 157.09 18.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.092 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -71.69 119.08 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -93.7 -46.27 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.38 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.55 -167.67 40.05 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.108 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.5 134.58 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.941 0.401 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 97.2 mt -92.71 114.36 26.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.293 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.7 98.86 6.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.335 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.48 140.35 2.87 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.699 -0.561 . . . . 0.0 111.699 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.33 -39.16 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -109.41 -44.56 0.1 Allowed Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 16.5 Cg_exo -65.17 120.32 7.52 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 120.718 1.292 . . . . 0.0 110.897 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.536 ' HE3' ' HA ' ' A' ' 113' ' ' TRP . 2.1 t-105 -97.68 -51.0 4.26 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.825 -168.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.14 73.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 0.0 110.466 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -77.84 -35.14 51.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.419 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -62.57 -46.6 87.59 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 113' ' ' TRP . 68.1 mt -61.26 -43.0 95.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.399 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -49.75 -58.04 6.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.225 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 89.5 mt -57.09 -49.2 76.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.724 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.503 ' O ' HG22 ' A' ' 124' ' ' VAL . 15.8 tpt -61.5 -42.78 99.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.547 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.03 -35.99 82.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.09 71.06 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.237 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 95.9 mt -78.06 -47.25 18.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 120' ' ' MET . 34.4 m -77.92 -34.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -116.74 87.04 20.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.89 149.96 5.87 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.798 2.332 . . . . 0.0 114.22 -168.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -91.85 -0.2 57.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.995 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 72.35 101.42 0.07 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.614 -1.63 . . . . 0.0 111.629 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -134.69 -178.7 5.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.796 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -74.11 113.73 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 110.359 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 152.44 37.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.484 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -108.05 138.46 44.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.767 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 66.66 174.45 0.25 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.589 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -90.42 115.24 27.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.322 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.671 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 99.3 m -156.62 -65.54 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.947 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.671 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 58.8 Cg_endo -75.15 -66.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.336 1.357 . . . . 0.0 113.248 -175.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -60.85 -33.34 72.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.77 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.44 -53.89 50.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.674 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.68 89.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.961 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -62.76 -55.3 27.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.844 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -65.51 -36.94 85.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.81 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -56.09 -39.64 72.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.588 0.232 . . . . 0.0 111.146 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 32.5 mmt180 -63.19 -51.86 64.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.452 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 87.2 mtp -55.1 -38.87 68.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.272 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.62 -38.23 67.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.999 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.21 -28.14 69.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.99 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -64.08 -20.77 66.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.67 32.49 7.61 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.325 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -98.85 134.81 41.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.012 0.434 . . . . 0.0 110.026 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.521 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 2.6 p -86.43 137.79 34.3 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.819 -176.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 1.8 Cg_endo -82.56 141.28 11.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.313 2.675 . . . . 0.0 113.257 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.72 148.04 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 m -114.77 167.73 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -36.77 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.929 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 t -79.78 4.74 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.381 0.61 . . . . 0.0 110.398 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -118.09 -12.49 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.837 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tt -48.72 -47.77 41.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.269 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -68.32 -51.52 43.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.065 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 32' ' ' THR . 13.4 t70 -54.76 -55.46 29.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.219 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -69.03 -31.61 70.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 102' ' ' ASN . 27.9 tp -67.7 -28.36 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.697 0.76 . . . . 0.0 109.688 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 85.6 m -71.32 -29.85 65.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.373 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.73 -61.37 2.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.73 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.74 113.85 59.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.824 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.51 -16.46 4.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.486 2.124 . . . . 0.0 112.888 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 24.6 m-20 -122.19 159.76 26.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.356 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.89 -166.32 25.69 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.209 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.82 137.11 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 99.0 t -117.41 119.65 62.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.164 0.507 . . . . 0.0 110.03 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.94 122.15 43.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.216 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.765 ' HB2' ' H ' ' A' ' 94' ' ' ALA . 7.7 mp -94.13 17.94 11.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.855 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 t 79.49 168.54 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.254 0.971 . . . . 0.0 110.088 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.711 ' HB2' HG13 ' A' ' 51' ' ' VAL . 7.2 m -82.45 -27.33 31.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.618 -174.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 93' ' ' PRO . 22.7 t70 67.45 132.73 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.81 0.694 . . . . 0.0 111.513 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.97 -24.44 74.02 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.039 2.493 . . . . 0.0 113.512 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -96.26 -41.68 8.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 8.8 tpm_? -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.718 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 17.7 m -126.42 114.48 23.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.582 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 48' ' ' THR . 17.5 Cg_endo -58.06 -38.52 91.4 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.842 2.361 . . . . 0.0 112.417 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.56 79.0 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 43' ' ' SER . 9.6 t -57.22 -31.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.156 -1.383 . . . . 0.0 112.244 -173.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -82.79 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.789 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 t70 50.81 -144.73 0.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.796 0.685 . . . . 0.0 109.573 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -131.27 96.51 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.63 15.98 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.334 2.689 . . . . 0.0 113.617 -174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.09 -31.31 34.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.339 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -27.41 69.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.381 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 62' ' ' LEU . 46.8 mm -59.99 -44.54 94.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.072 0.463 . . . . 0.0 110.237 176.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -66.69 -38.72 93.38 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.996 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 16.9 mm-40 -70.25 -28.75 65.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.301 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 63.5 tp -64.81 -49.36 70.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 58' ' ' ILE . 9.8 mp -60.56 -25.63 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.797 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 59' ' ' GLY . 36.7 mmt180 -56.81 -15.15 4.16 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.8 -8.69 59.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.047 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.708 ' HB2' ' HE1' ' A' ' 70' ' ' TRP . 73.7 m-85 -132.61 63.8 69.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.085 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -85.88 2.16 7.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.379 2.052 . . . . 0.0 112.961 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.8 -13.12 19.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.49 0.662 . . . . 0.0 109.901 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -108.98 120.0 41.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -64.65 110.11 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.708 ' HE1' ' HB2' ' A' ' 65' ' ' PHE . 87.8 m95 -91.22 117.24 29.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.551 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.69 106.21 18.19 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.34 105.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.889 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -114.78 140.05 49.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.801 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.687 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 24.3 pt -121.93 140.3 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.54 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 80' ' ' SER . . . -97.3 161.6 13.72 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.571 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -65.83 171.81 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.854 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.79 -55.7 21.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.052 0.453 . . . . 0.0 109.837 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -78.17 -34.82 49.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.642 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 96.6 mt-30 -67.57 -35.06 78.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.81 -175.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 29.5 p -60.72 -48.61 81.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -57.98 -47.58 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.138 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.19 81.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.782 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 79' ' ' GLN . 67.9 mt -62.11 -51.38 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.131 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.91 94.01 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.565 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -54.46 -44.69 72.77 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 111.221 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 86' ' ' ARG . 23.1 ttt180 -73.0 -31.15 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.729 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -85.17 -31.13 23.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.27 25.07 11.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.43 111.16 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.858 -0.201 . . . . 0.0 110.893 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 69.77 -58.48 0.52 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.691 0.797 . . . . 0.0 112.859 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 70.9 15.21 6.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.832 0.825 . . . . 0.0 108.826 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -129.6 151.19 77.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.98 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.75 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 51.3 Cg_exo -56.16 132.93 54.93 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.818 2.345 . . . . 0.0 112.744 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.765 ' H ' ' HB2' ' A' ' 41' ' ' LEU . . . -165.22 -175.49 3.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.018 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 43.7 m -109.4 115.53 30.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.02 136.36 44.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 104' ' ' ARG . 7.1 p -114.71 137.03 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.71 128.88 53.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -169.7 134.61 1.4 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.13 0.491 . . . . 0.0 112.28 -175.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.29 22.63 65.54 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.737 173.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 130.99 59.78 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.046 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.566 HD21 HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER 65.59 -153.53 0.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.906 0.483 . . . . 0.0 111.739 172.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -41.38 112.22 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.222 0.951 . . . . 0.0 111.754 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -101.04 -31.58 11.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.583 -176.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.29 -174.17 42.47 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.353 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.83 137.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.551 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 95.2 mt -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.408 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -133.18 142.15 48.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.432 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.93 167.17 43.15 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.114 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 51.0 mm -83.22 -69.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 60.9 m80 71.61 156.49 0.16 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 123.8 0.687 . . . . 0.0 111.537 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.16 152.13 82.43 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.411 2.074 . . . . 0.0 111.052 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 20.9 t-105 -56.75 -40.8 76.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.527 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.04 79.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.359 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -80.26 -26.79 38.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -46.61 85.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.33 -41.03 91.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.876 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.77 -53.87 46.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.434 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.72 -49.16 76.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.407 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.641 ' HG2' HD21 ' A' ' 61' ' ' LEU . 15.4 tpt -54.5 -51.98 63.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.909 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 124' ' ' VAL . 15.7 ttt180 -70.61 -33.57 71.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.725 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.92 -30.86 74.26 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.538 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 97.6 mt -83.89 -59.81 2.3 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.026 0.13 . . . . 0.0 111.058 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 121' ' ' ARG . 27.7 m -65.17 -27.23 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.81 82.94 21.44 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -91.73 176.56 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.096 2.53 . . . . 0.0 113.397 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -93.57 -0.13 56.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.009 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 62.68 37.41 12.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.864 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.75 139.66 40.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.936 -1.483 . . . . 0.0 109.165 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 61.61 83.02 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.007 0.817 . . . . 0.0 110.88 -173.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.87 93.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 109.823 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.664 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG3' ' HB ' ' A' ' 48' ' ' THR . 55.3 mtt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 p -78.39 83.29 4.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 108.935 170.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 7' ' ' PHE . 14.2 p30 -88.32 54.32 3.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.104 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -87.41 11.26 15.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.227 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.511 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 31.1 m -151.06 -58.4 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.357 -174.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 5' ' ' THR . 13.9 Cg_endo -58.23 -55.69 2.06 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.121 1.881 . . . . 0.0 112.657 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.543 ' CB ' ' HB2' ' A' ' 3' ' ' ASN . 67.9 t80 -64.71 -42.04 95.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.751 0.31 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.4 -51.49 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.97 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.15 76.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.556 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -46.05 80.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -65.64 -41.93 92.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.354 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -58.25 -37.02 74.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.388 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.86 -53.63 47.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.0 mtm -60.87 -36.96 80.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 110.6 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.5 -40.45 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.567 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.2 67.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.533 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -75.56 -5.95 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.93 23.27 30.61 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.96 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -88.96 118.89 29.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 m -80.02 121.67 82.28 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.349 -169.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 39.6 Cg_endo -70.08 120.9 7.55 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 0.0 110.761 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG11 HD23 ' A' ' 27' ' ' LEU . 12.4 p -124.95 143.82 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.2 t -84.91 159.32 20.35 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.778 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.53 -54.16 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.124 0.57 . . . . 0.0 111.98 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 m -67.05 -23.71 65.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.149 0.499 . . . . 0.0 111.362 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -86.72 -26.1 24.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.332 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD23 HG11 ' A' ' 22' ' ' VAL . 3.3 tm? -60.42 -41.36 93.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.05 -42.52 72.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.251 0.548 . . . . 0.0 110.324 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.67 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 13.4 t70 -63.72 -55.81 20.44 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.366 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.6 ' HZ3' ' HB2' ' A' ' 73' ' ' ALA . 2.6 t90 -62.94 -35.76 81.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.447 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.4 tm? -63.83 -32.04 73.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.647 0.737 . . . . 0.0 109.044 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 29' ' ' ASP . 97.5 m -71.95 -37.49 69.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.793 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 14.6 mm-40 -74.41 -33.72 63.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.13 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -89.03 142.98 30.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.381 -177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 14.6 Cg_exo -69.6 -39.67 6.53 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.822 2.348 . . . . 0.0 111.874 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 99' ' ' THR . 6.8 t70 -145.67 154.46 42.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.16 147.68 9.45 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.907 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 97' ' ' VAL . 29.4 m -125.2 142.43 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 55.8 t -125.04 131.9 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.512 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.9 mp -101.31 124.77 47.53 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' PRO . 8.4 mp -98.2 125.12 43.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.4 m -84.87 -58.9 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.728 ' HA ' ' HG3' ' A' ' 81' ' ' GLU . 38.7 m 53.1 81.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.91 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -170.62 111.33 0.43 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.95 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -95.9 -22.09 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.21 2.607 . . . . 0.0 112.827 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -124.49 -65.38 1.05 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -162.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.7 tpm_? -93.89 -42.22 9.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -162.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 30.9 m 72.95 92.26 0.05 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 110.365 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.0 -46.23 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.381 2.721 . . . . 0.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -161.66 110.41 1.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.132 0.492 . . . . 0.0 109.96 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.4 -28.51 13.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.778 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.34 -2.37 48.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.703 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.657 ' HA ' HG13 ' A' ' 110' ' ' ILE . 14.7 t70 -72.07 113.45 9.12 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 49.72 63.48 10.12 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.991 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.56 -41.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.124 1.883 . . . . 0.0 113.664 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.89 -42.18 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -56.58 -24.44 47.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.462 ' O ' HD13 ' A' ' 62' ' ' LEU . 41.8 mm -62.03 -44.35 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.837 0.351 . . . . 0.0 110.958 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.81 -26.75 74.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.062 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.91 -42.76 38.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.992 0.425 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.766 ' HB2' ' HH2' ' A' ' 113' ' ' TRP . 48.9 tp -60.75 -48.28 82.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.646 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.3 mp -58.72 -26.86 64.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.888 -177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 63' ' ' ARG . 11.4 mmt180 -68.3 -7.63 32.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 10.1 pt-20 -83.09 4.88 24.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.298 175.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . 97.7 m-85 -109.97 90.15 9.04 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.03 -43.41 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.056 2.504 . . . . 0.0 113.517 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.72 -25.61 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.223 0.535 . . . . 0.0 110.679 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 65' ' ' PHE . 11.1 t80 -88.77 107.78 19.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.615 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 p -89.06 125.76 35.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.993 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -102.82 129.77 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.118 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -87.39 105.98 17.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -93.36 115.81 33.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.91 0.386 . . . . 0.0 110.592 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HZ3' ' A' ' 30' ' ' TRP . . . -121.76 147.56 45.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.553 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.627 HG22 ' HB2' ' A' ' 40' ' ' LEU . 10.4 pt -134.55 147.4 29.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.058 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . -122.77 153.81 39.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' HB2' ' OE1' ' A' ' 79' ' ' GLN . 3.5 m-20 -60.43 179.66 0.15 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.63 -55.9 28.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.629 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.52 -42.98 81.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ASP . 14.3 mp0 -54.96 -51.1 67.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.205 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 p -65.62 -39.58 91.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.59 0.233 . . . . 0.0 110.647 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.728 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 42.8 mt-10 -61.58 -46.01 91.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.179 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.29 82.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.334 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.26 -44.23 95.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.331 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.52 -47.42 87.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.909 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.35 -50.77 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.179 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -65.49 -27.91 68.82 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -87.48 -23.59 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.014 0.435 . . . . 0.0 109.829 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.16 32.03 10.16 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.507 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.13 82.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HB3' ' HD2' ' A' ' 92' ' ' PHE . 85.8 m-85 53.19 -156.99 0.17 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.385 174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -158.28 41.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 87.4 m-85 -129.46 160.19 65.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.136 -174.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 52.0 Cg_exo -53.56 130.52 39.17 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.602 2.201 . . . . 0.0 112.231 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -175.65 158.95 2.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.457 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 32.7 m -107.6 115.16 29.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.671 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.01 129.4 42.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 104' ' ' ARG . 3.9 p -108.21 125.71 64.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.289 0.566 . . . . 0.0 111.545 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.25 119.49 37.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.964 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.538 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -101.67 -175.68 2.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.095 -174.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 99' ' ' THR . . . -54.41 -28.17 43.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.442 170.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.11 28.73 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.879 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 102' ' ' ASN . 1.3 t-20 65.99 -156.48 0.26 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.524 0.73 . . . . 0.0 111.113 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -49.51 125.38 11.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.201 0.524 . . . . 0.0 111.633 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.496 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.7 tpt180 -104.75 -59.57 1.72 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.216 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.76 -159.12 21.07 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.807 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.54 134.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 3.0 mm? -92.99 117.1 29.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.552 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.65 154.05 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.41 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.826 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.657 HG13 ' HA ' ' A' ' 53' ' ' ASP . 41.3 mm -84.2 78.36 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 52.1 m-70 -156.72 -61.38 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 172.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 111' ' ' HIS . 16.8 Cg_endo -94.73 124.77 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.565 2.177 . . . . 0.0 113.058 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 61' ' ' LEU . 19.3 t-105 -82.69 -39.63 21.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.307 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.28 97.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.675 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' PRO . 20.2 mp0 -64.78 -39.0 92.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.995 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.47 -48.01 82.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 57.0 mt -61.41 -42.49 93.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.125 0.488 . . . . 0.0 110.244 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -58.04 -49.18 77.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.847 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 115' ' ' GLU . 93.6 mt -59.68 -44.8 93.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.905 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt -62.5 -37.47 86.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.728 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 121' ' ' ARG . 3.4 tmm_? -62.96 -41.88 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.21 -30.94 79.22 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.588 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.82 -56.54 4.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.097 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' ARG . 28.5 m -64.02 -41.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.225 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.459 ' HB3' HH11 ' A' ' 121' ' ' ARG . 43.5 tt0 -109.94 96.62 25.65 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.65 143.1 99.73 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.775 2.317 . . . . 0.0 112.646 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.653 ' HB2' ' HB2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -80.73 -14.7 57.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.481 0.658 . . . . 0.0 110.867 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 53.28 68.5 0.83 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.746 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 58.95 29.06 18.44 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.13 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -72.26 149.6 44.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.205 177.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.46 112.55 3.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.454 . . . . 0.0 110.61 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 -179.556 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m 71.01 -0.56 3.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.718 0.636 . . . . 0.0 111.497 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.52 133.33 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 109.967 175.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -103.7 104.16 14.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.277 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 56.0 m -156.88 -63.94 0.02 OUTLIER Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 36.9 Cg_endo -65.76 -64.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.584 1.523 . . . . 0.0 112.831 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 77' ' ' LEU . 38.2 p90 -66.18 -32.31 73.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -54.93 -54.91 36.64 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.326 0.584 . . . . 0.0 110.763 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -60.83 -41.17 95.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.462 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -57.01 -47.5 80.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.455 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -64.94 -43.72 91.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.51 -32.77 71.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.393 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 59.5 mmt-85 -62.84 -54.52 37.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.831 0.348 . . . . 0.0 110.479 175.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.0 mtm -60.96 -33.45 73.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 74' ' ' ILE . 3.1 mm? -65.05 -37.97 89.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.575 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.6 -19.21 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 17.1 mmm180 -84.85 -4.73 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.16 17.03 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.857 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -100.66 136.89 39.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.048 0.451 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 m -86.63 124.6 69.19 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.47 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.674 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 72.9 Cg_endo -80.25 146.21 17.58 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.929 2.419 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG11 HD23 ' A' ' 27' ' ' LEU . 12.0 p -148.74 145.26 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.67 0.271 . . . . 0.0 111.133 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 m -73.53 159.59 32.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.371 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 8.6 tm-20 -55.56 -58.6 7.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.502 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -70.11 -7.29 40.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.113 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.419 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 24.5 tpp180 -106.23 -16.83 14.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.324 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 83' ' ' ILE . 3.3 tm? -59.19 -43.04 92.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.359 0.599 . . . . 0.0 110.436 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 32' ' ' THR . 17.3 t70 -63.87 -54.0 41.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.527 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 73' ' ' ALA . 91.1 t90 -54.33 -43.59 71.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.103 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.79 -44.19 94.07 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.382 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.6 t -74.88 -24.32 58.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.02 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -80.36 -16.9 53.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.087 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.97 152.85 38.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.5 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 -23.0 22.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.353 2.036 . . . . 0.0 112.277 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 99' ' ' THR . 7.4 t70 -156.37 -171.61 3.77 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 98' ' ' PHE . . . 165.1 128.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.58 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.34 146.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 59.2 t -133.26 136.77 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.665 0.269 . . . . 0.0 111.021 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 74' ' ' ILE . 6.7 mp -97.68 125.96 42.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 80' ' ' SER . 0.9 OUTLIER -94.84 125.43 39.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.685 ' HA ' ' HB3' ' A' ' 93' ' ' PRO . 11.1 t -147.33 105.92 3.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.9 m -143.19 92.92 2.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.783 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.72 71.7 1.44 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.712 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.866 ' HG2' HG21 ' A' ' 51' ' ' VAL . 16.8 Cg_exo -69.1 133.47 26.87 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.464 2.109 . . . . 0.0 111.917 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -111.2 -63.81 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -68.6 -24.93 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -55.79 121.21 38.31 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.7 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.2 -41.6 72.05 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.134 2.556 . . . . 0.0 113.201 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.53 118.64 0.36 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.787 0.803 . . . . 0.0 109.427 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG21 ' HG2' ' A' ' 45' ' ' PRO . 3.9 t -84.83 -24.08 7.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.296 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' HD11 ' A' ' 10' ' ' LEU . 32.2 t -68.57 -3.95 13.58 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -84.4 -168.47 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.453 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.434 ' OD1' HG12 ' A' ' 58' ' ' ILE . 43.0 t30 62.17 72.78 0.6 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.568 . . . . 0.0 111.67 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -92.78 -40.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.403 2.069 . . . . 0.0 113.491 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.29 -33.12 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.5 -31.56 66.14 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' HD13 ' A' ' 62' ' ' LEU . 13.5 mm -65.35 -38.75 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.133 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.06 -41.19 99.67 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.896 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.3 mm-40 -72.8 -28.65 62.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HG ' ' HG2' ' A' ' 120' ' ' MET . 34.8 tp -68.18 -35.04 77.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 58' ' ' ILE . 6.7 mp -60.96 -26.86 67.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.376 176.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 72.8 mtt180 -62.59 -7.42 4.69 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.66 -31.39 68.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 110.383 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.52 88.5 49.89 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.978 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.53 -20.06 16.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.761 2.307 . . . . 0.0 111.774 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.8 -11.66 52.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.59 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -120.41 115.31 23.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.13 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 t -80.59 156.95 26.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.669 0.747 . . . . 0.0 110.554 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -124.76 124.57 42.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.571 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -91.35 98.46 11.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.012 0.434 . . . . 0.0 109.947 175.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.81 111.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.091 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 39' ' ' VAL . . . -123.76 149.28 45.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.36 0.6 . . . . 0.0 111.063 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.8 pt -130.53 140.3 49.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.37 164.01 13.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.006 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.4 m-20 -61.96 150.42 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.989 173.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 7' ' ' PHE . 15.4 mt -53.6 -45.71 70.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.742 -174.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.94 -47.42 18.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.685 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 39.9 mt-30 -69.79 -18.57 63.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' HD22 ' A' ' 41' ' ' LEU . 11.6 p -61.5 -34.0 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.272 0.558 . . . . 0.0 110.559 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.69 -46.67 88.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.625 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.51 -40.16 96.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.078 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.526 HD13 ' HG ' ' A' ' 27' ' ' LEU . 63.4 mt -62.01 -44.79 99.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.29 -43.49 97.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.685 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.83 -41.97 98.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.66 -32.94 67.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -92.37 -45.64 8.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.962 0.411 . . . . 0.0 110.424 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.55 23.9 4.25 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.081 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.77 -83.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.6 t80 59.01 -163.93 0.21 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.628 0.58 . . . . 0.0 109.927 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 34.1 ttp180 65.04 80.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.785 0.434 . . . . 0.0 111.757 175.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 89.6 m-85 72.0 141.23 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 13.1 Cg_exo -72.53 138.22 29.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 124.072 3.181 . . . . 0.0 112.73 176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . -160.6 -178.19 6.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.541 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 10.6 m -92.18 122.86 35.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 106' ' ' VAL . 43.6 mt -99.48 113.87 26.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 123' ' ' LEU . 13.4 p -103.55 126.68 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.7 0.762 . . . . 0.0 110.93 -178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.567 ' HD1' ' HA ' ' A' ' 103' ' ' TYR . 46.3 m-85 -122.87 150.55 42.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.418 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 40.6 p -128.43 124.49 36.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 61.91 28.97 71.15 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.931 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.8 -1.44 88.75 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.768 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.53 143.76 33.24 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.32 0.581 . . . . 0.0 111.717 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD1' ' A' ' 98' ' ' PHE . 73.3 t80 -69.42 136.99 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.292 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 1.5 mmp_? -113.79 -64.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.627 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' HA3' HD22 ' A' ' 123' ' ' LEU . . . -172.06 -166.58 30.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.22 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 96' ' ' LEU . 6.5 m -122.23 146.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 122.476 0.31 . . . . 0.0 111.111 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 5.9 mp -99.63 134.0 43.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -123.48 12.61 9.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.383 0.611 . . . . 0.0 110.565 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.21 117.59 5.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.289 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.02 -36.42 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.874 0.368 . . . . 0.0 111.381 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 91.0 m-70 -122.7 -52.52 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 31.6 Cg_exo -56.84 123.19 13.27 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.729 1.619 . . . . 0.0 112.567 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.492 ' O ' HG13 ' A' ' 117' ' ' ILE . 13.6 t-105 -85.18 -40.43 16.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.616 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.65 86.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.016 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 37.9 tt0 -72.84 -32.44 65.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.355 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 113' ' ' TRP . 29.3 tp -64.46 -46.82 81.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 113' ' ' TRP . 61.0 mt -60.05 -44.91 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -51.07 -57.49 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.263 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 93.3 mt -60.76 -46.89 88.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.077 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.584 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.6 tpt -54.17 -44.67 71.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 125' ' ' GLU . 14.6 mmt180 -55.98 -49.12 74.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.2 -30.12 75.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.734 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 97' ' ' VAL . 94.4 mt -84.34 -55.09 4.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 120' ' ' MET . 23.9 m -87.01 -26.07 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.723 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 121' ' ' ARG . 31.5 tt0 -103.52 85.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.38 106.42 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.533 2.155 . . . . 0.0 114.1 -162.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -71.49 -21.88 61.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.899 170.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -166.46 121.01 1.12 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.686 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -91.98 23.35 3.76 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.612 0.72 . . . . 0.0 109.816 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -64.65 -23.85 67.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.793 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.23 86.38 7.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.59 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.382 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t 63.23 -165.27 0.24 Allowed 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.741 0.651 . . . . 0.0 110.136 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 8.8 m120 -107.81 125.89 51.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.313 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 89.9 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.744 0.783 . . . . 0.0 109.87 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.518 ' HB ' ' CD ' ' A' ' 6' ' ' PRO . 82.9 m -153.22 -58.46 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.504 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' CD ' ' HB ' ' A' ' 5' ' ' THR . 19.7 Cg_endo -63.31 -52.57 1.93 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.654 1.569 . . . . 0.0 111.417 172.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -67.15 -35.21 79.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.369 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.69 -53.77 54.59 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.207 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 13' ' ' ARG . . . -57.89 -46.21 85.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.084 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 2.0 mm? -57.17 -51.81 67.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.511 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -65.55 -42.06 92.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.111 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 15' ' ' LEU . 14.5 mm100 -59.82 -31.76 70.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 35.5 mmt180 -57.33 -54.52 45.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 110.605 174.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.512 ' HB3' HD13 ' A' ' 74' ' ' ILE . 4.9 mpp? -66.86 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 2.4 mm? -64.57 -48.33 75.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.82 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.92 64.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.008 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 34.5 mmt180 -73.81 -21.15 60.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.648 0.261 . . . . 0.0 110.386 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.43 21.85 11.09 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.784 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.502 ' HZ3' ' HG3' ' A' ' 14' ' ' MET . 27.4 m0 -93.05 168.1 11.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.7 m -112.96 130.97 23.01 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 40.4 Cg_endo -68.91 121.4 8.27 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.909 2.406 . . . . 0.0 111.678 172.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.3 145.73 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.565 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.3 m -112.5 168.42 9.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.271 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.9 -47.47 85.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -71.74 -7.94 51.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.914 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 29' ' ' ASP . 28.3 mmt180 -117.7 -7.02 11.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.719 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.43 -49.45 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.12 -34.69 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.134 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 32' ' ' THR . 22.3 t70 -62.16 -56.98 13.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.038 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -74.65 -26.65 60.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.997 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.18 -35.03 78.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 111.081 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.6 t -80.97 -26.53 36.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.007 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -96.7 -0.91 47.58 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.011 0.434 . . . . 0.0 111.699 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.8 87.48 3.71 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.73 148.2 36.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.548 2.166 . . . . 0.0 113.62 -171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 38.8 t70 80.62 144.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.595 1.184 . . . . 0.0 111.649 174.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.03 -173.55 27.16 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.332 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 97' ' ' VAL . 5.3 m -138.09 138.91 43.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 73' ' ' ALA . 52.9 t -122.62 129.41 75.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.66 124.71 32.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -97.47 98.89 10.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.1 m -71.4 107.29 4.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -107.92 -58.86 1.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.889 0.376 . . . . 0.0 111.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.689 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 11.1 t70 -152.59 120.01 3.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.609 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.71 -24.03 13.88 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.265 2.644 . . . . 0.0 112.576 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -82.95 -27.91 30.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.584 0.707 . . . . 0.0 109.394 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 2.4 tpt180 -52.77 -40.51 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.144 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 25.9 m -124.68 120.03 25.79 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.789 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 48' ' ' THR . 16.3 Cg_exo -68.69 -31.89 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.835 2.357 . . . . 0.0 113.304 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -120.18 81.39 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.635 0.731 . . . . 0.0 111.116 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 t -100.46 -25.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -72.32 -6.97 46.98 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.677 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -96.96 -0.28 47.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 110.659 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 49.6 t-20 -78.43 -54.55 1.17 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 54' ' ' ASN . 12.5 Cg_exo -70.88 44.58 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.037 2.491 . . . . 0.0 114.505 -169.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.31 -53.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -59.56 -25.82 64.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.473 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' HD13 ' A' ' 62' ' ' LEU . 45.2 mm -60.78 -37.99 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.067 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.42 -34.25 89.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.619 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.68 -37.72 62.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.306 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HA ' ' HH2' ' A' ' 113' ' ' TRP . 44.6 tp -64.18 -38.76 92.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.253 -176.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 58' ' ' ILE . 8.6 mp -65.41 -26.24 67.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.643 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -66.46 -9.04 30.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -70.1 -34.02 72.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.66 85.76 57.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.696 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -88.15 4.95 5.52 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.431 2.754 . . . . 0.0 112.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.86 -20.97 37.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 0.0 111.075 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.98 -167.74 1.35 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 p -129.91 104.93 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -85.88 96.7 9.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.225 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.73 108.24 8.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.481 . . . . 0.0 109.768 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.66 108.27 20.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 39' ' ' VAL . . . -116.58 145.01 43.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.912 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 6.9 pt -124.56 140.48 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.019 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.45 143.09 41.28 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.382 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.81 160.93 22.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 58.9 tp -54.49 -43.31 71.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.394 0.434 . . . . 0.0 111.501 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.92 -33.44 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.402 0.62 . . . . 0.0 111.06 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -77.94 -32.06 51.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.094 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.1 p -74.45 -29.1 61.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.723 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 51.2 mt-10 -54.19 -53.12 57.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 175.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 86' ' ' ARG . . . -70.58 -37.18 73.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.162 -173.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.49 -45.35 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 0.0 110.309 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -48.45 71.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.651 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -55.88 -42.67 76.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 110.875 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 49.8 ttt180 -57.12 -38.51 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.729 -176.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -95.85 -36.83 10.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.565 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.08 8.03 13.94 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.735 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.666 HG11 HD21 ' A' ' 96' ' ' LEU . 48.3 t -79.71 -24.41 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.36 105.57 0.3 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 178.86 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.772 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 37.1 p90 -146.23 143.62 19.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' PHE . 3.6 Cg_exo -78.16 124.54 6.67 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.629 2.219 . . . . 0.0 111.263 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.23 174.76 14.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.082 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -101.76 119.5 38.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.727 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 89' ' ' VAL . 85.0 mt -94.18 121.83 36.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 104' ' ' ARG . 6.0 p -95.69 132.63 39.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.149 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 94.7 m-85 -121.52 138.31 54.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.66 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -143.79 149.93 37.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.73 28.15 56.49 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.71 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.12 13.96 79.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.026 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -135.3 178.51 6.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.146 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.55 129.36 34.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -104.74 -51.83 2.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -176.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.79 -170.82 39.76 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.414 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.9 134.64 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.005 0.431 . . . . 0.0 111.499 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.09 110.38 19.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.018 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -121.55 129.9 53.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.915 0.388 . . . . 0.0 111.795 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.73 154.08 12.18 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.155 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -66.7 134.94 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -139.02 144.66 42.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.98 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.7 159.7 23.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.657 2.238 . . . . 0.0 111.546 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.482 ' CE2' HD11 ' A' ' 117' ' ' ILE . 5.4 t-105 -55.86 -48.79 74.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.0 78.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -40.77 87.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.665 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.5 tp -62.19 -48.0 81.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 113' ' ' TRP . 71.4 mt -60.61 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.015 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -55.11 -54.37 44.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.868 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.88 -47.39 85.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.493 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 124' ' ' VAL . 15.2 tpt -59.63 -43.15 93.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.634 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 124' ' ' VAL . 40.2 ttt180 -66.92 -33.75 76.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -30.97 71.14 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.23 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -84.7 -52.03 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.524 0.202 . . . . 0.0 111.527 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 121' ' ' ARG . 8.1 p -66.32 -31.47 53.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.763 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.546 ' HB3' ' NH1' ' A' ' 104' ' ' ARG . 33.7 tt0 60.72 100.91 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 124.031 0.832 . . . . 0.0 112.679 178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.33 172.15 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.942 2.428 . . . . 0.0 111.682 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -77.06 -7.15 55.2 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.803 0.811 . . . . 0.0 110.499 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -126.76 89.32 2.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.059 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -94.85 151.48 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.888 -171.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 130' ' ' ARG . 2.2 mmp_? -132.04 110.15 10.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.221 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.3 89.73 4.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.022 0.439 . . . . 0.0 111.773 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.86 175.226 . . . . . . . . 0 0 . 1 stop_ save_